博文
2021年药物和家庭日用化学品领域在欧专利的布局与竞争——罗氏制药有限公司、欧莱雅、诺华公司领先
|
█武汉大学科教管理与评价研究中心 陈立新 张琳 黄颖
第三部分 2021年欧洲专利统计分析报告
28 各领域的欧洲专利布局和竞争
28.5 药物和家庭日用化学品领域的欧洲专利竞争态势
第5个技术领域是药物和家庭日用化学品，主要包括医用配置品和药物制剂，以及盥洗、梳妆和化妆等家庭日用化学品。2021年，欧洲专利局在该领域共授权专利5847项（增长率为-16%），占总授权量的5.4%，是专利数量第4多的领域。
2021年，美国在该领域获得专利权2123项，占该领域专利授权总量的36.3%。中国在该领域做出专利发明347项，获得专利权306项。日本和韩国获得的专利权数量分别为496和196项。
表28.5-1 2021年各国药物和家庭日用化学品领域的在欧专利发明和专利权数量
国家 和地区 | 发明 数量 | 专利权 数量 | 净流失 数量 | 专利 流失率 | 发明 份额 | 专利权 份额 | 份额 流失量 | |
1 | 美国 | 2210 | 2123 | 87 | 3.9% | 37.8% | 36.3% | 1.5% |
2 | 德国 | 464 | 446 | 18 | 3.9% | 7.9% | 7.6% | 0.3% |
3 | 日本 | 485 | 496 | -11 | -2.3% | 8.3% | 8.5% | -0.2% |
4 | 法国 | 378 | 360 | 18 | 4.8% | 6.5% | 6.2% | 0.3% |
5 | 中国 | 347 | 306 | 41 | 11.8% | 5.9% | 5.2% | 0.7% |
6 | 韩国 | 195 | 196 | -1 | -0.5% | 3.3% | 3.4% | 0.0% |
7 | 英国 | 300 | 292 | 8 | 2.7% | 5.1% | 5.0% | 0.1% |
8 | 意大利 | 170 | 155 | 15 | 8.8% | 2.9% | 2.7% | 0.3% |
9 | 荷兰 | 68 | 131 | -63 | -92.6% | 1.2% | 2.2% | -1.1% |
10 | 瑞士 | 191 | 295 | -104 | -54.5% | 3.3% | 5.0% | -1.8% |
11 | 瑞典 | 84 | 95 | -11 | -13.1% | 1.4% | 1.6% | -0.2% |
12 | 加拿大 | 100 | 94 | 6 | 6.0% | 1.7% | 1.6% | 0.1% |
13 | 以色列 | 84 | 86 | -2 | -2.4% | 1.4% | 1.5% | 0.0% |
14 | 印度 | 99 | 71 | 28 | 28.3% | 1.7% | 1.2% | 0.5% |
15 | 其他 | 672 | 701 | -29 | -4.3% | 11.5% | 12.0% | -0.5% |
小计 | 5847 | 5847 | 0 | 0% | 100% | 100% | 0% |
注：本表分别按照专利第一发明人和第一权利人进行统计（中国的数据暂未包含香港、澳门、台湾地区的专利）。
图28.5-1 2021年各国药物和家庭日用化学品领域的在欧专利发明和专利权数量对比
2021年，在药物和家庭日用化学品领域上获得欧洲专利授权最多的机构是罗氏制药有限公司、欧莱雅、诺华公司。
表28.5-2 2021年药物和家庭日用化学品领域在欧专利授权前10机构
机构名称 | 国家 | 机构英文名称 | 2021 | |
1 | 罗氏制药有限公司 | 瑞士 | HOFFMANN LA ROCHE | 71 |
2 | 欧莱雅 | 法国 | OREAL | 64 |
3 | 诺华公司 | 瑞士 | NOVARTIS AG | 59 |
4 | 默沙东公司 | 美国 | MERCK SHARP & DOHME | 55 |
5 | 百时美施贵宝公司 | 美国 | SQUIBB BRISTOL MYERS CO | 51 |
6 | 高露洁棕榄公司 | 美国 | COLGATE PALMOLIVE CO | 48 |
7 | 宝洁公司 | 美国 | PROCTER & GAMBLE | 42 |
8 | 加州大学 | 美国 | UNIV CALIFORNIA | 38 |
9 | 联合利华有限公司 | 荷兰 | UNILEVER NV | 33 |
10 | 勃林格殷格翰公司 | 德国 | BOEHRINGER INGELHEIM INT | 33 |
注：本表数据按照第一权利人进行统计。
图28.5-2 2021年药物和家庭日用化学品领域在欧专利授权前10机构
致谢
感谢大连理工大学刘则渊教授、河南师范大学梁立明教授、科技部中国科学技术发展战略研究院武夷山研究员、大连理工大学丁堃教授、大连理工大学杨中楷教授对本报告的大力支持与帮助。同时，向以不同形式对本报告提出意见和建议的专家学者们表示诚挚的感谢。
如需要中美欧日韩五局及PCT专利数据、专利报告，以及咨询相关专利问题请添加微信号。
附表 2021年该领域欧洲授权专利
| PATENT NO. | TITLE | INVENTOR | ASSIGNEE |
| EP1385476 | METHODS OF DIAGNOSING AND TREATING SMALL INTESTINAL BACTERIAL OVERGROWTH (SIBO) AND SIBO-RELATED CONDITIONS | LIN HENRY C | CEDARS SINAI MEDICAL CENTER |
| EP1422268 | Iridescent pigment having high brilliance and high chroma | TAMIO NOGUCHI DR | MERCK PATENT GMBH |
| EP1454921 | RADICAL POLYMERIZATION CATALYSTS AND ADHESIVE KIT FOR DENTAL USE | OGURI MAKOTO | TOKUYAMA CORP |
| EP1461014 | AMPHIPHILIC COMPOUNDS AND VESICLES/LIPOSOMES FOR ORGAN-SPECIFIC DRUG TARGETING | HELDMAN ELIAHU | UNIV BEN GURION |
| EP1469833 | METHOD FOR MAKING HOMOGENEOUS SPRAY-DRIED SOLID AMORPHOUS DRUG DISPERSIONS UTILIZING MODIFIED SPRAY-DRYING APPARATUS | BEYERINCK RONALD ARTHUR | PFIZER PROD INC |
| EP1496899 | USE OF MATERIALS HAVING ZINC IONOPHORIC BEHAVIOR | SCHWARTZ JAMES ROBERT | PROCTER & GAMBLE |
| EP1546235 | WATER-SOLUBLE POLYMER ALKANALS | KOZLOWSKI ANTONI | NEKTAR THERAPEUTICS AL CORP |
| EP1572339 | BIODEGRADABLE POLYURETHANE/UREA COMPOSITIONS | ADHIKARI RAJU | COMMW SCIENT IND RES ORG |
| EP1587540 | IDENTIFICATION AND ENGINEERING OF ANTIBODIES WITH VARIANT Fc REGIONS AND METHODS OF USING SAME | STAVENHAGEN JEFFREY | MACROGENICS INC |
| EP1635762 | LOW DOSE PHARMACEUTICAL POWDERS FOR INHALATION | HRKACH JEFFREY S | ADVANCED INHALATION RES INC |
| EP1679962 | ZEOLITE MOLECULAR SIEVES FOR THE REMOVAL OF TOXINS | FRYKMAN GREGORY K | FRAMEWORK THERAPEUTICS L L C |
| EP1713450 | RAPIDLY DISSOLVING FILM FOR DELIVERY OF AN ACTIVE AGENT | SINGH PARMINDER | CORIUM INT INC |
| EP1713514 | DRUGS AND GENE CARRIER PARTICLES THAT RAPIDLY MOVE THROUGH MUCOUS BARRIERS | HANES JUSTIN | UNIV JOHNS HOPKINS |
| EP1725262 | POLYMER-BASED COMPOSITIONS AND CONJUGATES OF HIV ENTRY INHIBITORS | BENTLEY MICHAEL D | NEKTAR THERAPEUTICS AL CORP |
| EP1781335 | HYDROGEL CONJUGATES | HERSEL ULRICH | COMPLEX BIOSYSTEMS GMBH |
| EP1827109 | USE OF NATURAL PLANT EXTRACTS IN COSMETICS COMPOSITIONS | HINES MICHELLE D | AVON PROD INC |
| EP1836216 | BINDING PARTNERS OF ANTIBODIES SPECIFIC FOR DENDRITIC CELL ANTIGENS | HART DEREK NIGEL | ORDER SISTERS OF MERCY QUEENSL |
| EP1887008 | THIENOTRIAZOLODIAZEPINE COMPOUND AND A MEDICINAL USE THEREOF | ADACHI KUNITOMO | MITSUBISHI TANABE PHARMA CORP |
| EP1896066 | IMMUNOGENIC COMPOSITION | BIEMANS RALPH LEON | GLAXOSMITHKLINE BIOLOG SA |
| EP1919472 | COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF HYPERURICEMIA RELATED HEALTH CONSEQUENCES | JOHNSON RICHARD J | UNIV FLORIDA |
| EP1945231 | CONFORMABLE SOLVENT-BASED BANDAGE AND COATING MATERIAL | SALAMONE JOSEPH C | SALAMONE ANN BEAL |
| EP1948236 | METHODS AND COMPOSITIONS FOR TREATMENT OF SKIN | DE RIJK JAN | NATURALITE BENELUX B V |
| EP1959922 | COSMETIC COMPOSITIONS WITH ENCAPSULATED PIGMENTS AND A METHOD FOR USING | SIMARD CLAUDE C | AVON PROD INC |
| EP1976504 | COMPOSITION COMPRISING POLYUNSATURATED FATTY ACIDS, PROTEINS AND MANGANESE AND/OR MOLYBDEN FOR IMPROVING MEMBRANE COMPOSITION | HAGEMAN ROBERT JOHAN JOSEPH | NUTRICIA NV |
| EP2008639 | New emulsion-form shower preparation | ARGEMBEAUX HORST | BEIERSDORF AG |
| EP2022463 | ONE-PART DENTAL ADHESIVE COMPOSITION | MATSUSHIGE KOJI | TOKUYAMA DENTAL CORP |
| EP2032115 | COMPOSITIONS BASED ON HYPERBRANCHED CONDENSATION POLYMERS AND NOVEL HYPERBRANCHED CONDENSATION POLYMERS | BAUMER RAPHAEL | DSM IP ASSETS BV |
| EP2034948 | FIBER-REINFORCED COMPOSITES AND METHOD FOR THE MANUFACTURE THEREOF | LASSILA LIPPO V J | STICK TECH OY |
| EP2043955 | METAL OXIDE HYDROGELS AND HYDROSOLS, THEIR PREPARATION AND USE | KESSLER VADIM G | KESSLER VADIM G |
| EP2056883 | MICROSPHERE-BASED COMPOSITION FOR PREVENTING AND/OR REVERSING NEW-ONSET AUTOIMMUNE DIABETES | BROWN LARRY R | BAXTER INT |
| EP2069470 | STRUCTURED SURFACTANT SYSTEM | WARBURTON STEWART A | RHODIA |
| EP2114157 | PHOSPHORAMIDATE ALKYLATOR PRODRUGS FOR THE TREATMENT OF CANCER | AMMONS STEVE | THRESHOLD PHARMACEUTICALS INC |
| EP2114282 | PROBES FOR ULTRASOUND IMAGING SYSTEMS | RANDALL KEVIN S | PENRITH CORP |
| EP2123246 | ADHESIVE COMPOSITION FOR DENTAL USE | MATSUSHIGE KOJI | TOKUYAMA DENTAL CORP |
| EP2129371 | COMPOSITION FOR TREATING DIABETES AND METABOLIC DISORDERS WITH QUERCETIN, MYRCETIN AND CHLOROGENIC ACID | AHRENS MILTON JOSEPH | ATM METABOLICS LLLP |
| EP2136779 | HIGH SHINE, STICK-SHAPED COSMETIC PRODUCTS | CASTRO JOHN R | ELC MAN LLC |
| EP2152078 | FORMULATIONS CONTAINING CLOPIDOGREL AND SULFOALKYL ETHER CYCLODEXTRIN AND METHODS OF USE | MOSHER GEROLD L | CYDEX PHARMACEUTICALS INC |
| EP2162144 | A NOVEL REFERENCE PLANT, A METHOD FOR ITS PRODUCTION, EXTRACTS OBTAINED THEREFROM AND THEIR USE | DE MEIJER ETIENNE | GW PHARMA LTD |
| EP2164447 | POLYMER-BASED PIGMENT-BEARING INK | BAUER BARBARA | SCHWAN STABILO COSMETICS GMBH |
| EP2170334 | NMDA RECEPTOR ANTAGONISTS FOR NEUROPROTECTION | LIOTTA DENNIS C | UNIV EMORY |
| EP2203222 | INJECTABLE DERMATOLOGICAL COMPOSITION FOR TREATMENT OF WRINKLES | CAVALLO GIOVANNI | ITALFARMACIA S R L |
| EP2207533 | DIRECTLY COMPRESSIBLE HIGH FUNCTIONALITY GRANULAR MICROCRYSTALLINE CELLULOSE BASED EXCIPIENT, MANUFACTURING PROCESS AND USE THEREOF | DEORKAR NANDU | MALLINCKRODT BAKER INC |
| EP2213747 | METHOD FOR PRODUCING MEMBRANE PROTEIN | YOKOYAMA SHIGEYUKI | RIKEN |
| EP2214646 | DENDRIMERS FOR SUSTAINED RELEASE OF COMPOUNDS | RANGARAMANUJAM KANNAN | UNIV WAYNE STATE |
| EP2214681 | NOVEL NUTRACEUTICAL COMPOSITIONS CONTAINING STEVIA EXTRACT OR STEVIA EXTRACT CONSTITUENTS AND USES THEREOF | FOWLER ANN | DSM IP ASSETS BV |
| EP2214716 | HYDROXYAPATITE-TARGETING MULTIARM POLYMERS AND CONJUGATES MADE THEREFROM | MCMANUS SAMUEL P | NEKTAR THERAPEUTICS |
| EP2219678 | NANOPARTICLES OF THERAPEUTIC AGENTS HAVING LOW WATER SOLUBILITY | COUVREUR PATRICK | CENTRE NAT RECH SCIENT |
| EP2222290 | ALPHA-AMINOAMIDE DERIVATIVES USEFUL IN THE TREATMENT OF PSYCHIATRIC DISORDERS | IZZO EMANUELA | NEWRON PHARM SPA |
| EP2234617 | DOSING REGIMEN ASSOCIATED WITH LONG ACTING INJECTABLE PALIPERIDONE ESTERS | VERMEULEN AN MARGRIET CORNELIA | JANSSEN PHARMACEUTICA NV |
| EP2242504 | THERAPEUTIC COMPOSITIONS FOR TREATMENT OF OCULAR INFLAMMATORY DISORDERS | DANA REZA | SCHEPENS EYE RES INST |
| EP2244814 | RECOMBINANT VWF FORMULATIONS | MATTHIESSEN PETER | BAXTER INT |
| EP2249783 | ORAL CARE PRODUCT AND METHODS OF USE THEREOF | KOHLI RAJNISH | COLGATE PALMOLIVE CO |
| EP2251418 | Mature dendritic cell compositions and methods for culturing same | HEALEY DON | ARGOS THERAPEUTICS INC |
| EP2265245 | COOLING COSMETIC OR DERMATOLOGICAL PREPARATIONS HAVING A CONTENT OF (1R,2S,5R)-2-ISOPROPYL-5-METHYL-N-(2-(PYRIDYNE-2-YL)ETHYL-CYCLOHEXANE CARBOXAMIDE AND/OR (1R,2S,5R)-N-(4-(CYANOMETHYL)PHENYL)-2-ISPROPYL-5-METHYLCYCLOHEXANE CARBOXAMIDE FOR THE REDUCTION OF ERYTHEMA | KOLBE LUDGER | BEIERSDORF AG |
| EP2275132 | Multivalent PCV2 immunogenic compositions and methods of producing them | EICHMEYER MARC ALLAN | BOEHRINGER INGELHEIM VETMED |
| EP2276470 | ALPHA ADRENERGIC RECEPTOR AGONISTS FOR TREATMENT OF PAIN AND/OR INFLAMMATION | ZANELLA JOHN MYERS | WARSAW ORTHOPEDIC INC |
| EP2276475 | BIODEGRADABLE NANOSHELLS FOR DELIVERY OF THERAPEUTIC AND/OR IMAGING MOLECULES | PANDIT ABHAY | NAT UNIV IRELAND |
| EP2278989 | METHODS OF INHIBITING AND TREATING BIOFILMS USING GLYCOPEPTIDE ANTIBIOTICS | NEESHAM-GRENON EVE | TARGANTA THERAPEUTICS CORP |
| EP2293818 | CONJUGATES OF A CHOLINESTERASE MOIETY AND A POLYMER | BOSSARD MARY J | NEKTAR THERAPEUTICS |
| EP2297217 | HYDROPHILIC INTERPENETRATING POLYMER NETWORKS DERIVED FROM HYDROPHOBIC POLYMERS | MYUNG DAVID | BIOMIMEDICA INC |
| EP2303227 | CONTROLLED RELEASE CORTICOSTEROID COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS | LICHTER JAY | OTONOMY INC |
| EP2307056 | STABILIZED AQUEOUS FORMULATION CONTAINING PARACETAMOL | #VALUE! | PHARMIS BIOFARMACEUTICA LDA |
| EP2307444 | ANALYSIS OF LACTOBACILLUS ACIDOPHILUS LA-5 SIGNAL INTERFERENCE MOLECULES | GRIFFITHS MANSEL | UNIV GUELPH |
| EP2313068 | ORAL COMPOSITIONS AND USES THEREOF | NOWAK ANDREW | COLGATE PALMOLIVE CO |
| EP2314692 | Methods and compositions for enhancing the efficacy and specificity of RNAi | ZAMORE PHILIP D | UNIV MASSACHUSETTS |
| EP2316407 | Dental composition | KLEE JOACHIM E PROF | DENTSPLY DETREY GMBH |
| EP2316942 | Conserved HBV and HCV sequences useful for gene silencing | PACHUK CATHERINE | ALNYLAM PHARMACEUTICALS INC |
| EP2326342 | METHODS FOR USING INTERFERON GAMMA TO ABSORB FLUID FROM THE SUBRETINAL SPACE | LI RONG | US HEALTH |
| EP2331082 | SOLVENT EXTRACTION MICROENCAPSULATION WITH TUNABLE EXTRACTION RATES | ATKINSON JEFFREY L | SURMODICS PHARMACEUTICALS INC |
| EP2334288 | MICROENCAPSULATION PROCESS WITH SOLVENT AND SALT | RAICHE ADRIAN | SURMODICS PHARMACEUTICALS INC |
| EP2334311 | NON-TYPEABLE HAEMOPHILUS INFLUENZAE VACCINES AND THEIR USES | DUNKLEY MARGARET | HUNTER IMMUNOLOGY LTD |
| EP2334380 | ANTI-LIGANDS MOLECULES AND BIOLOGICAL APPLICATIONS | BORGNE-SANCHEZ ANNIE | MITOLOGICS |
| EP2341897 | NANOPARTICLES FOR IMMUNOTHERAPY | HUBBELL JEFFREY A | ECOLE POLYTECH |
| EP2342220 | METHODS AND SYSTEMS FOR PREDICTING MISFOLDED PROTEIN EPITOPES | CASHMAN NEIL R | UNIV BRITISH COLUMBIA |
| EP2345635 | AMINO ACID DERIVATIVE | OOKUBO TOMOHIRO | NIPPON ZOKI PHARMACEUTICAL CO |
| EP2345668 | Sclerostin epitopes | LU HSIENG SEN | UCB PHARMA SA |
| EP2346926 | BIOLOGICALLY ACTIVE SILICIC ACID | KEREK FRANZ | SINATUR GMBH |
| EP2348983 | DETECTION OF CANCER | BAYFORD RICHARD HAROLD | MIDDLESEX UNIVERSITY HIGHER EDUCATION CORP |
| EP2350086 | FUSED DIIMIDAZODIAZEPINE COMPOUNDS AND METHODS OF USE AND MANUFACTURE THEREOF | HOSMANE RAMACHANDRA S | UNIV MARYLAND |
| EP2350664 | TREATMENT OF CANCER USING HYPOXIA ACTIVATED PRODRUGS | CURD JOHN G | THRESHOLD PHARMACEUTICALS INC |
| EP2364099 | TRACE ELEMENTS | SMITH WILLIAM ALFRED | WARBURTON TECHNOLOGY LTD |
| EP2371528 | METHOD FOR ADHERING NANOFIBER SHEET | TOJO TAKEHIKO | KAO CORP |
| EP2373312 | A COMPOSITION FOR USE ON SKIN AND WOUND | BOWLER PHILLIP GODFREY | CONVATEC TECHNOLOGIES INC |
| EP2385080 | POLYPROPYLENE RESIN PRE-FOAMED PARTICLE AND METHOD FOR PRODUCING SAME, AND POLYPROPYLENE RESIN IN-MOLD FOAMING MOLDED ARTICLE | YOSHIDA TORU | KANEKA CORP |
| EP2388003 | Colchicine derivatives | YANG LI-XI | CALIFORNIA PACIFIC MED CENTER |
| EP2389163 | CONTROLLED RELEASE PHARMACEUTICAL OR FOOD FORMULATION AND PROCESS FOR ITS PREPARATION | SELVA STEFANO | ACRAF |
| EP2389205 | BIOACTIVE GRAFTS AND COMPOSITES | GOVIL AMIT PRAKASH | ADVANCED BIOLOG LLC |
| EP2392012 | COMPOSITIONS FOR RADIOLABELING DIETHYLENETRIAMINEPENTAACETIC ACID (DTPA)-DEXTRAN | MAGNESON GERALD ROSS | NEOPROBE CORP |
| EP2393518 | STRUCTURED POLYCYCLIC PEPTIDE | HEINIS CHRISTIAN | MEDICAL RES COUNCIL |
| EP2394628 | DENTAL FILLING REPAIR KIT | KAJIKAWA MIHOKO | TOKUYAMA DENTAL CORP |
| EP2394663 | Compositions for injectable in-situ biodegradable implants | GUIERRO ADURIZ IBON | ROVI LAB FARMACEUT SA |
| EP2398466 | METHODS AND COMPOSITIONS FOR LOCALIZED AGENT DELIVERY | IRVINE DARRELL J | MASSACHUSETTS INST TECHNOLOGY |
| EP2401024 | DEVICES, SYSTEMS AND METHODS FOR MAGNETIC-ASSISTED THERAPEUTIC AGENT DELIVERY | SHAPIRO BENJAMIN | UNIV MARYLAND |
| EP2403536 | ORAL DELIVERY OF HYDROPHILIC DRUGS TO THE BRAIN | UCHEGBU IJEOMA | UNIV LONDON PHARMACY |
| EP2405895 | COMPOSITIONS COMPRISING A FATTY ACID OIL MIXTURE COMPRISING EPA AND DHA IN FREE ACID FORM AND A SURFACTANT, AND METHODS AND USES THEREOF | HUSTVEDT SVEIN OLAF | PRONOVA BIOPHARMA NORGE AS |
| EP2405902 | COMPOSITIONS COMPRISING A FATTY ACID OIL MIXTURE AND A SURFACTANT, AND METHODS AND USES THEREOF | HUSTVEDT SVEIN OLAF | PRONOVA BIOPHARMA NORGE AS |
| EP2405940 | ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS | SHONE CLIFFORD | HEALTH PROT AGENCY |
| EP2412380 | Epitopes related to coeliac disease | ANDERSON ROBERT | BTG INT LTD |
| EP2413899 | DENTAL ANESTHETIC COMPRISING TETRACAINE AND A VASOCONSTRICTOR FOR INTRANASAL ADMINISTRATION | KOLLAR MARK DAVID | ST RENATUS LLC |
| EP2413972 | BONDING PRODUCTS OF AMINATED POLYSACCHARIDES | MEIER BERND HORST | BRAUN MELSUNGEN AG |
| EP2414328 | DIHYDROOROTATE DEHYDROGENASE INHIBITORS | THUNUGUNTLA SIVA SANJEEVA RAO | MERCK SERONO SA |
| EP2416793 | A plant extract comprising statins and preparation techniques and uses thereof | LOH HENG MENG | NANYANG POLYTECHNIC |
| EP2417960 | EASILY-DISPERSIBLE POWDER, THE SURFACE OF WHICH HAS UNDERGONE LIPOPHILIZATION TREATMENT, AND COSMETIC BLENDED THEREWITH | SATO KAZUO | MIYOSHI KASEI INC |
| EP2421578 | ASSEMBLY, DEVICE KIT AND METHOD FOR PREPARING PLATELET-RICH PLASMA (PRP) | ESTERON AARON | ESTERON AARON |
| EP2424621 | METHODS FOR IMPROVING TASTE AND ORAL CARE COMPOSITIONS WITH IMPROVED TASTE | HAUGHT JOHN CHRISTIAN | PROCTER & GAMBLE |
| EP2427775 | PEPTIDE LIGANDS OF SOMATOSTATIN RECEPTORS | PARENTE DUENA ANTONIO | BCN PEPTIDES SA |
| EP2432456 | SOLID PHARMACEUTICAL COMPOSITIONS AND PROCESSES FOR THEIR PRODUCTION | MITTAL BHAVISHYA | MILLENNIUM PHARM INC |
| EP2432478 | THE IMPROVEMENT OF GASTROINTESTINAL HEALTH, IMMUNITY AND PERFORMANCE BY DIETARY INTERVENTION | O'SULLIVAN JOHN T | BIOATLANTIS LTD |
| EP2432480 | COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY ARTHRITIS | KWONG YOKLAM | UNIV HONG KONG |
| EP2440574 | STABLE IMMUNOGENIC PROTEIN HAVING MULTIPLE CYSTEINES MOLECULES PROCESS THEREFOR AND COMPOSITION THEREOF | ELLA KRISHNA MURTHY | BHARAT BIOTECH INT LTD |
| EP2441456 | DHEA compositions for treating menopose | LABRIE FERNAND | ENDORECH INC |
| EP2442829 | STRUCTURED VIRAL PEPTIDE COMPOSITIONS AND METHODS OF USE | WALENSKY LOREN D | DANA FARBER CANCER INST INC |
| EP2448569 | PHARMACOLOGY OF VISUAL CYCLE MODULATORS | KUBOTA RYO | ACUCELA INC |
| EP2448968 | N-TERMINAL TRUNCATED AMYLOID BETA PROTOFIBRILS/ OLIGOMERS FOR USE IN THERAPEUTIC AND DIAGNOSTIC METHODS FOR ALZHEIMER'S DISEASE | GELLERFORS PAER | BIOARCTIC NEUROSCIENCE AB |
| EP2453873 | IMPROVEMENTS IN AND RELATING TO COLON CLEANSING COMPOSITIONS | ATTWELL MARK | NORGINE BV |
| EP2454371 | CHEMICAL MODIFICATION OF SMALL HAIRPIN RNAS FOR INHIBITION OF GENE EXPRESSION | GE QING | SOMAGENICS INC |
| EP2456412 | COMPOSITION AND METHOD FOR COLOURING HAIR | UELLNER MARTIN | KPSS KAO GMBH |
| EP2459151 | CATIONICALLY HARDENABLE DENTAL COMPOSITION, PROCESS OF PRODUCTION AND USE THEREOF | ZECH JOACHIM W | 3M INNOVATIVE PROPERTIES CO |
| EP2459187 | COMPOSITIONS AND METHODS FOR INHIBITING HAIR GROWTH | DELONG MITCHELL A | UNIV DUKE |
| EP2459227 | Prodrugs containing an aromatic amine connected by an amide bond to a carrier | RAU HARALD | ASCENDIS PHARMA AS |
| EP2459555 | PROCESSES FOR CRYSTALLIZATION OF RIVAROXABAN | ZUPANCIC SILVO | KRKA D D NOVO MESTO |
| EP2459607 | HYBRID COPOLYMER COMPOSITIONS FOR PERSONAL CARE APPLICATIONS | THOMAIDES JOHN S | AKZO NOBEL NV |
| EP2460513 | A method for producing adapalene gels | EBEL MAURICE | GALDERMA RES & DEV |
| EP2477639 | PLANT EXTRACT, COMPOSITONS CONTAINING SAME, METHOD OF EXTRACTION AND USES THEREOF | XIE CHEN | BOTAN CENTURY BEIJING CO LTD |
| EP2478907 | Methods and compositions for treating cancer | AUERBACH ALAN H | COUGAR BIOTECHNOLOGY INC |
| EP2480258 | CHEMICAL PRODUCTION MODULE AND DOSE SYNTHESIS CARD FOR PET BIOMARKER PRODUCTION SYSTEM | NUTT RONALD | MCFARLAND AARON |
| EP2482803 | FORMULATIONS FOR C-MET KINASE INHIBITORS | WARD ROBERT | MERCK SHARP & DOHME |
| EP2484336 | PIGMENT FOR COSMETIC PREPARATIONS, METHOD FOR PRODUCING SAME, AND COSMETIC PREPARATION CONTAINING THE PIGMENT FOR COSMETIC PREPARATIONS | KITAGAWA MASARU | TOYO BOSEKI |
| EP2486935 | Epitopes related to Coeliac Disease | ANDERSON ROBERT | BTG INT LTD |
| EP2488164 | RELEASE OF AGENTS FROM CELLS | KARP JEFFREY M | BRIGHAM & WOMENS HOSPITAL |
| EP2489344 | Dental material based on an anti-microbial compound | SALZ ULRICH DR | IVOCLAR VIVADENT AG |
| EP2490678 | COATED CAPSULES AND TABLETS OF A FATTY ACID OIL MIXTURE | KLAVENESS JO ERIK JOHNSRUD | PRONOVA BIOPHARMA NORGE AS |
| EP2491953 | OPTICAL IMAGING CONTRAST AGENT, USE AND DEVICE THEREOF | YOO JEONG-SOO | KYUNGPOOK NAT UNIV IND ACAD |
| EP2493312 | SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING AN INTEGRASE INHIBITOR | MAHJOUR MAJID | MERCK SHARP & DOHME |
| EP2493466 | NOVEL ANTITUMORAL USE OF CABAZITAXEL | GUPTA SUNIL | AVENTIS PHARMA SA |
| EP2496214 | OPHTHALMIC FORMULATIONS CONTAINING SUBSTITUTED GAMMA LACTAMS AND METHODS FOR USE THEREOF | GORE ANURADHA | ALLERGAN INC |
| EP2496263 | LIPID LAYER FORMING COMPOSITION FOR ADMINISTRATION ONTO A SURFACE OF A LIVING ORGANISM | HOLMBAECK JAN | LIPIDOR AB |
| EP2506840 | USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS | LIU YANG | ONCOIMMUNE INC |
| EP2506877 | THERAPIES FOR PREVENTING OR SUPPRESSING CLOSTRIDIUM DIFFICILE INFECTION | SHONE CLIFFORD | HEALTH PROT AGENCY |
| EP2508190 | MACROPHAGE PHAGOCYTOSIS-ACTIVATING COMPOSITION AND/OR COMPOSITION PROMOTING CYTOKINE PRODUCTION IN MACROPHAGES | MORIYA NAOYUKI | AUREO CO LTD |
| EP2509604 | METHOD FOR REMOVING CYTOKINES FROM BLOOD WITH SURFACE IMMOBILIZED POLYSACCHARIDES | WARD ROBERT S | EXTHERA MEDICAL LLC |
| EP2512436 | CONDITIONING COMPOSITION FOR HAIR | MOLENDA MICHAEL | KAO GERMANY GMBH |
| EP2512581 | IMPLANTABLE DEVICE WITH INTRAVESICAL TOLERABILITY AND METHODS OF TREATMENT | CIMA MICHAEL J | TARIS BIOMEDICAL INC |
| EP2515947 | TREATMENT OF UNCOUPLING PROTEIN 2 (UCP2) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO UCP2 | COLLARD JOSEPH | CURNA INC |
| EP2525789 | PHARMACEUTICAL FORMULATIONS OF NAPROXEN FOR SOFT GEL ENCAPSULATION AND COMBINATIONS THEREOF | LOPEZ JOHN | ACCUCAPS IND LTD |
| EP2528578 | DENTAL COMPOSITION COMPRISING A CALCIUM SOURCE | OGLIARI FABRICIO AULO | ANGELUS IND DE PRODUTOS ODONTOLOGICOS S A |
| EP2529756 | Risperidone and/or Paliperidone implant formulation | GUTIERRO ADURIZ IBON | ROVI LAB FARMACEUT SA |
| EP2531597 | ENGINEERED ENZYMES WITH METHIONINE-GAMMA-LYASE ENZYMES AND PHARMACOLOGICAL PREPARATIONS THEROF | GEORGIOU GEORGE | UNIV TEXAS |
| EP2533749 | A PROCESS FOR IMPROVING THE STABILITY OF YTTRIUM STABILISED ZIRCONIA FOR DENTAL RESTORATIONS | THOLEY MICHAEL | RAUTER VITA ZAHNFABRIK |
| EP2533752 | PREPARATIONS FOR STABILISING/FORMING THE TEXTURE OF LIVING TISSUE SUCH AS SKIN, AND USES THEREOF | BEUTLER RALF | BÖRLIND GESELLSCHAFT FüR KOSMETISCHE ERZEUGNISSE MBH |
| EP2533772 | METHODS AND COMPOSITIONS FOR WOUND HEALING | ABBOTT NICHOLAS L | WOUND ENGINEERING LLC |
| EP2537922 | CD49F PROMOTING PROLIFERATION, MULTIPOTENCY AND REPROGRAMMING OF ADULT STEM CELLS THROUGH PI3K/AKT/GSK3 PATHWAY | KANG KYUNG SUN | KANG STEM HOLDINGS CO LTD |
| EP2538992 | SLOW RELEASE LIQUID DRUG DELIVERY DEVICE | SHEKALIM AVRAHAM | MICROSERT LTD |
| EP2539436 | MODULATION OF MACROPHAGE ACTIVATION | TING ANTHONY E | ABT HOLDING CO |
| EP2539715 | METHODS FOR PREPARING PEG-HEMOGLOBIN CONJUGATES USING REDUCED REACTANT RATIOS | MALAVALLI ASHOK | SANGART INC |
| EP2542076 | INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS | WOLKENBERG SCOTT | MERCK SHARP & DOHME |
| EP2547362 | DISRUPTED ADENOVIRUS-BASED VACCINE AGAINST DRUGS OF ABUSE | CRYSTAL RONALD G | UNIV CORNELL |
| EP2549995 | USE OF ANATABINE TO TREAT INFLAMMATION AND METHODS OF SYNTHESIZING ANATABINE | WILLIAMS JONNIE R | ROCK CREEK PHARMACEUTICALS INC |
| EP2552443 | IMPROVED TREATMENT OF RENAL CELL CARCINOMA | HARALDSSON BOERJE | ONCORENA AB |
| EP2556081 | A CYTOSINE ANALOGUE, A METHOD OF PREPARATION OF A CYTOSINE ANALOGUE, A DNA METHYLTRANSFERASE 1 INHIBITOR, A METHOD FOR DNA METHYLATION INHIBITION, THE USE OF THE ANALOGUE IN THE TREATMENT OF DISEASES ASSOCIATED WITH DEVIATIONS FROM NORMAL DNA METHYLATION | BARCISZEWSKI JAN | INST CHEMII BIOORG PAN |
| EP2558063 | VERY LOW-DOSED SOLID ORAL DOSAGE FORMS FOR HRT | MLETZKO STEPHAN | BAYER IP GMBH |
| EP2559441 | Protein complex for intracellular delivery and uses thereof | LEE JAE-IL | SAMSUNG ELECTRONICS CO LTD |
| EP2560604 | IMPLANT WITH ANTIMICROBIAL COATING | THULL ROGER | DERU GMBH ENTWICKLUNG VON MEDIZINISCHEN PRODUKTEN |
| EP2560665 | COSMETIC OR DERMATOLOGICAL PREPARATIONS COMPRISING COMBINATIONS OF MAGNOLIA BARK EXTRACT AND ALKYL SULPHATES | SCHLAEGER TORSTEN | BEIERSDORF AG |
| EP2560966 | MULTISUBSTITUTED AROMATIC COMPOUNDS AS INHIBITORS OF THROMBIN | SHORT KEVIN MICHAEL | VERSEON CORP |
| EP2560986 | GENETICALLY MODIFIED SENDAI VIRUS FOR TREATMENT OF TUMOURS | LAUER ULRICH MANFRED | UNIV EBERHARD KARLS |
| EP2561861 | WATER-SOLUBLE PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE THERAPEUTICALLY ACTIVE SUBSTANCE HAVING HYDROPHOBIC PROPERTIES AND AT LEAST ONE COMPOUND SELECTED FROM AMONG SIALOGLYCOSPHINGOLIPIDS, GLYCOSPHINGOLIPIDS OR A MIXTURE OF SIALOGLYCOSPHINGOLIPIDS AND GLYCOSPHINGOLIPIDS | LEONHARD VICTORIA | CONSEJO NAC INVEST CIENT TEC |
| EP2563817 | FLUORESCENT FUSION POLYPEPTIDES AND METHODS OF USE | MARKIV ANATOLIY | STC UNM |
| EP2563911 | INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF ALANYL TRNA SYNTHETASES | GREENE LESLIE ANN | ATYR PHARMA INC |
| EP2566965 | ANTAGONISTS OF SEMA3E/PLEXIND1 INTERACTION AS ANTI-CANCER AGENTS | ROYET AMELIE | NETRIS PHARMA |
| EP2568989 | LANTHANUM CARBONATE HYDROXIDE, LANTHANUM OXYCARBONATE AND METHODS OF THEIR MANUFACTURE AND USE | DIXIT MILIND | SPECTRUM PHARMACEUTICALS INC |
| EP2569276 | NOVEL CATIONIC LIPIDS AND METHODS OF USE THEREOF | HEYES JAMES | PROTIVA BIOTHERAPEUTICS INC |
| EP2571524 | ANTI-VIRAL AGENTS AND COMPOSITIONS THEREOF | FERRUTI PAOLO | FERRUTI PAOLO |
| EP2571898 | HIGH-AFFINITY FULLY FUNCTIONAL SOLUBLE SINGLE-DOMAIN HUMAN CD4, ANTIBODIES, AND RELATED FUSION PROTEINS | DIMITROV DIMITER S | US HEALTH |
| EP2574331 | Method for colouring hair | KLINGELMEYER ANNETTE | PROCTER & GAMBLE |
| EP2574662 | Apparatus and method for electroporation of biological samples | DZEKUNOV SERGEY M | MAXCYTE INC |
| EP2579849 | NOVEL PROCESS | DE CUPERE VINCIANE | GLAXOSMITHKLINE BIOLOG SA |
| EP2581087 | COMPOSITION CONTAINING IRIDOIDS AND USES THEREOF | LI LIN | XUANWU HOSPITAL OF CAPITAL MEDICAL UNIVERSITY |
| EP2585075 | METHODS OF TREATMENT FOR ESOPHAGEAL INFLAMMATION | PHILLIPS ELAINE | MERITAGE PHARMA INC |
| EP2585096 | BIFUNCTIONAL CONJUGATE COMPOSITIONS AND ASSOCIATED METHODS | BERKLAND CORY | UNIV KANSAS |
| EP2588097 | PHARMACEUTICAL COMPOSITIONS COMPRISING PARACETAMOL AND PROCESS FOR PREPARING THE SAME | PATEL KETAN R | TROIKAA PHARMACEUTICALS LTD |
| EP2589373 | NANOFIBER LAMINATE SHEET | TOJO TAKEHIKO | KAO CORP |
| EP2589375 | Use of magnolia bark extract to counteract skin aging | SCHLAEGER TORSTEN | BEIERSDORF AG |
| EP2591778 | Polyunsaturated fatty acid compositions obtainable by a simulated moving bed chromatographic separation process | KELLIHER ADAM | BASF PHARMA CALLANISH LTD |
| EP2593090 | C-MET MODULATOR PHARMACEUTICAL COMPOSITIONS | WILSON JO ANN | EXELIXIS INC |
| EP2593110 | TREATMENT OF LUNG INFECTIONS BY ADMINISTRATION OF TOBRAMYCIN BY AEROLISATION | NORLING THOMAS | XELLIA PHARMACEUTICALS APS |
| EP2596805 | Prodrug comprising a drug linker conjugate | CLEEMANN FELIX | ASCENDIS PHARMA AS |
| EP2598206 | A METHOD OF MANAGING BRONCHO-CONSTRICTIVE CONDITION | BHASKARAN SUNIL | INDUS BIOTECH PRIVATE LTD |
| EP2598500 | COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY | LI HUI | RIGEL PHARMACEUTICALS INC |
| EP2601944 | TRANSDERMAL PATCH AND METHOD FOR AUGMENTING ADHESIVE STRENGTH THEREOF | SHINODA TOMOHIRO | HISAMITSU PHARMACEUTICAL CO |
| EP2603226 | TREATMENT OF DIABETES WITH PANCREATIC ENDOCRINE PRECURSOR CELLS | XU JEAN | JANSSEN BIOTECH INC |
| EP2603231 | ENVIRONMENTALLY SENSITIVE COMPOSITIONS | RESHETNYAK YANA K | RHODE ISLAND BOARD OF GOVERNORS FOR HIGHER EDUCATION |
| EP2607348 | Plasminogen Activator Inhibitor-1 Inhibitor | MIYATA TOSHIO | RENASCIENCE CO LTD |
| EP2611453 | ANTIFUNGAL COMPOSITION | GANNABATHULA SWAPNA | COMVITA NEW ZEALAND LTD |
| EP2613844 | PERCUTANEOUS APPLICATION SYSTEM | TESLENKO ALEXANDER | MEDDROP TECHNOLOGY AG |
| EP2618827 | ANTIDIABETIC SOLID PHARMACEUTICAL COMPOSITIONS | LEE KATHLEEN M | INTEKRIN THERAPEUTICS INC |
| EP2623101 | Piperidine and piperazine derivatives as autotaxin inhibitors | SCHIEMANN KAI | MERCK PATENT GMBH |
| EP2625190 | DERIVATIVES OF STEROID BENZYLAMINES, HAVING AN ANTIPARASITIC, ANTIBACTERIAL, ANTIMYCOTIC AND/OR ANTIVIRAL ACTION | BECKER KATJA | UNIV GIESSEN JUSTUS LIEBIG |
| EP2626059 | Silicone impression material having high hydrophilicity | SHIMOSOYAMA SHUN | SHOFU INC |
| EP2626370 | Immunogenic compositions containing Escherichia coli H7 flagella and methods of use thereof | GALLY DAVID | UNIV EDINBURGH |
| EP2627639 | N-OPTIONALLY SUBSTITUTED ARYL-2-OLIGOMER-3-ALKOXYPROPIONAMIDES | RIGGS-SAUTHIER JENNIFER | NEKTAR THERAPEUTICS |
| EP2629740 | DENTAL COMPOSITION | STELZIG SIMON | DENTSPLY DETREY GMBH |
| EP2630955 | Immediate release and sustained release ibuprofen dosing regimen | LEE DER-YANG | MCNEIL PPC INC |
| EP2637687 | VACCINES COMPRISING NON-SPECIFIC NUCLEOSIDE HYDROLASE AND STEROL 24-C-METHYLTRANSFERASE (SMT) POLYPEPTIDES FOR THE TREATMENT AND DIAGNOSIS OF LEISHMANIASIS | BHATIA AJAY | INFECTIOUS DISEASE RES INST |
| EP2637694 | CONJUGATES OF AN IL-2 MOIETY AND A POLYMER | BOSSARD MARY J | NEKTAR THERAPEUTICS |
| EP2637696 | SUSTAINED RELEASE COMPOSITIONS | PILGAONKAR PRATIBHA SUDHIR | RUBICON RES PRIVATE LTD |
| EP2637730 | INTRAVAGINAL DEVICES FOR CONTROLLED DELIVERY OF LUBRICANTS | KISER PATRICK F | UNIV UTAH RES FOUND |
| EP2638893 | ALGINATE IMPRESSION MATERIAL FOR DENTAL USE AND CURING AGENT PASTE USED THEREFOR | NAGASAWA YUKO | TOKUYAMA DENTAL CORP |
| EP2640188 | NANOPARTICLE ISOFLAVONE COMPOSITIONS & METHODS OF MAKING AND USING THE SAME | ELDER EDMUND JOSEPH | HUMANETICS CORP |
| EP2642974 | PROCESS FOR TREATING PERSPIRATION USING A CARBONYL COMPOUND CAPABLE OF REACTING VIA THE MAILLARD REACTION | BERNARD DOMINIQUE | OREAL |
| EP2643345 | IMMUNOGENIC PEPTIDES FOR USE IN THE PREVENTION AND/OR TREATMENT OF INFECTIOUS DISEASES, AUTOIMMUNE DISEASES, IMMUNE RESPONSES TO ALLOFACTORS, ALLERGIC DISEASES, TUMORS, GRAFT REJECTION AND IMMUNE RESPONSES AGAINST VIRAL VECTORS USED FOR GENE THERAPY OR GENE VACCINATION | SAINT-REMY JEAN-MARIE | IMNATE SARL |
| EP2649095 | MIMETIC PEPTIDES DERIVED FROM COLLAGEN TYPE IV AND THEIR USE FOR TREATING ANGIOGENESIS- AND LYMPHANGIOGENESIS- DEPENDENT DISEASES | POPEL ALEKSANDER S | POPEL ALEKSANDER S |
| EP2649101 | PROCESS OF PREPARING A CROSS LINKED GEL | MEUNIER STEPHANE | TEOXANE |
| EP2650004 | PRODUCTION OF STANDARDIZED EXTRACTS OF THE PLANT KNOWN AS "CUACHALALATE" (AMPHIPTERYGIUM ADSTRINGENS) AND USES THEREOF IN THE FIELD OF SUN PROTECTION. | MAS OLIVA JAIME | BIOEXTRACTO S A DE C V |
| EP2654803 | RADIOLABLED HER2 BINDING PEPTIDES | SYUD FAISAL | GEN ELECTRIC |
| EP2656860 | Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy | FAHL WILLIAM E | WISCONSIN ALUMNI RES FOUND |
| EP2658508 | TWO-PART HAIR COLOURING COMPOSITION | UELLNER MARTIN | KAO GERMANY GMBH |
| EP2658573 | EXPRESSION SYSTEMS | VITELLI ALESSANDRA | OKAIROS AG |
| EP2661255 | NANOTUBES AS CARRIERS OF NUCLEIC ACIDS INTO CELLS | WEBSTER THOMAS J | UNIV BROWN |
| EP2661263 | USE OF THE PHYTOCANNABINOID CANNABIDIOL (CBD) IN COMBINATION WITH A STANDARD ANTI-EPILEPTIC DRUG (SAED) IN THE TREATMENT OF EPILEPSY | WHALLEY BENJAMIN | GW PHARMA LTD |
| EP2661281 | HYDROPHOBIC MOLECULE-INDUCED BRANCHED POLYMER AGGREGATES AND THEIR USE | QIN DUJIE | ANP TECHNOLOGIES INC |
| EP2666458 | Pre-mix for a non-lathering personal care article, the article having the form of a solid foam | GLENN JR ROBERT | PROCTER & GAMBLE |
| EP2667856 | MEDICAL DEVICE CONTAINING A CAKE COMPOSITION COMPRISING ARIPIPRAZOLE AS AN ACTIVE INGREDIENT, AND A CAKE COMPOSITION COMPRISING ARIPIPRAZOLE AS AN ACTIVE INGREDIENT | HIRAOKA SHOGO | OTSUKA PHARMA CO LTD |
| EP2667891 | COMBINATION VACCINES | MULLBACHER ARNO | GAMMA VACCINES PTY LTD |
| EP2670403 | METHODS FOR TREATING BRAIN INJURY | KOPKE RICHARD D | HOUGH EAR INST |
| EP2670432 | IMMUNOGENIC BORDETELLA BRONCHISEPTICA COMPOSITIONS | ABDELMAGID OMAR YOUSIF | ZOETIS LLC |
| EP2670489 | ORAL CARE COMPOSITIONS | VOGT ROBERT | COLGATE PALMOLIVE CO |
| EP2673262 | PROCESSES FOR PREPARING QUINOLINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS | WILSON JO ANN | EXELIXIS INC |
| EP2679245 | Formulations which stabilize and inhibit precipitation of immunogenic compositions | KHANDKE LAKSHMI | WYETH LLC |
| EP2680879 | PEPTIDE LINKERS FOR POLYPEPTIDE COMPOSITIONS AND METHODS FOR USING SAME | MARTINI PAOLO | SHIRE HUMAN GENETIC THERAPIES |
| EP2682136 | ROOT CANAL FILLING MATERIAL CONTAINING MESENCHYMAL STEM CELLS AND DENTAL TISSUE REGENERATION METHOD USING SAME | NAKASHIMA MISAKO | NAT CT GERIATRICS & GERONTOLOGY |
| EP2683394 | ACTIVE AGENT PRODRUGS WITH HETEROCYCLIC LINKERS | JENKINS THOMAS E | SIGNATURE THERAPEUTICS INC |
| EP2684551 | SYSTEM FOR DELIVERING OXYGEN CARRIER, OXYGENATION DEVICE FOR OXYGEN CARRIER, AND HOUSING FOR OXYGEN CARRIER | ISHIZUKA TAKANOBU | TERUMO CORP |
| EP2684571 | Immunomodulatory properties of multipotent adult progenitor cells and uses thereof | DEANS ROBERT J | ATHERSYS INC |
| EP2685958 | DENTAL CERAMIC ARTICLE, PROCESS OF PRODUCTION AND USE THEREOF | SCHECHNER GALLUS | 3M INNOVATIVE PROPERTIES CO |
| EP2686000 | MULTIPLEXED DETECTION WITH ISOTOPE-CODED REPORTERS | KWONG GABRIEL A | MASSACHUSETTS INST TECHNOLOGY |
| EP2688481 | CONNECTIVE TISSUE MONITORING, COMPOSITIONS FOR CONNECTIVE TISSUE TREATMENT AND METHODS FOR TREATING CONNECTIVE TISSUE | DAFFY JOHN | TRACKSIDE TECHNOLOGIES PTY LTD |
| EP2689785 | Method for generating dry vaccine powder formulation for intranasal delivery | NAGATA RYOICHI | SHIN NIPPON BIOMEDICAL LAB LTD |
| EP2692329 | WATER-IN-OIL EMULSION COSMETIC COMPOSITION | IBE AYAKO | SHISEIDO CO LTD |
| EP2692355 | Apolactoferrin for the treatment of iron accumulation diseases | BIANCARDI BIAGIO | BIANCARDI BIAGIO |
| EP2694532 | AUREOBASIDIUM DERIVATIVES AND METHODS OF SYNTHESIS | WUTS PETER | AUREOGEN BIOSCIENCES INC |
| EP2696855 | COATED MESOPOROUS NANOPARTICLES | DUCHEYNE PAUL | UNIV PENNSYLVANIA |
| EP2696890 | TREATMENT OF MICROBIAL INFECTIONS | O'FLAHERTY VINCENT | NAT UNIV IRELAND |
| EP2697385 | FERMENTATION PROCESS | DEHOTTAY PHILIPPE MARC HELENE | GLAXOSMITHKLINE BIOLOG SA |
| EP2698158 | Immunomodulation by IAP Inhibitors | ZAWEL LEIGH | NOVARTIS AG |
| EP2701670 | CLEAR WET SPRAYS AND GELS | FARES HANI M | ISP INVESTMENTS INC |
| EP2705094 | DISULFIDE DYES | MARQUAIS-BIENEWALD SOPHIE | BASF SE |
| EP2706991 | MULTIPLE ANTIGEN PRESENTING IMMUNOGENIC COMPOSITION, AND METHODS AND USES THEREOF | MALLEY RICHARD | CHILDRENS MEDICAL CENTER |
| EP2709588 | CONTROLLED RELEASE NASAL TESTOSTERONE GELS, METHODS AND PRE-FILLED MULTI-DOSE APPLICATOR SYSTEMS FOR PERNASAL ADMINISTRATION | KREPPNER WAYNE | TRIMEL BIOPHARMA SRL |
| EP2709603 | MODIFIED BIOTIN-BINDING PROTEIN, FUSION PROTEINS THEREOF AND APPLICATIONS | MALLEY RICHARD | CHILDRENS MEDICAL CENTER |
| EP2709666 | BIO-ORTHOGONAL DRUG ACTIVATION | ROBILLARD MARC STEFAN | KONINKLIJKE PHILIPS NV |
| EP2710018 | MACROCYCLIC COMPOUNDS AS PROTEIN KINASE INHIBITORS | PASTOR FERNANDEZ JOAQUIN | CT NAC INVESTIGACIONES ONCOLOGICAS CNIO |
| EP2710033 | HUMAN IMMUNODEFICIENCY VIRUS NEUTRALIZING ANTIBODIES AND METHODS OF USE THEREOF | SCHEID JOHANNES | UNIV ROCKEFELLER |
| EP2710122 | CELL POPULATIONS HAVING IMMUNOREGULATORY ACTIVITY, METHODS FOR THE PREPARATION AND USES THEREOF | DE LA ROSA OLGA | TIGENIX S A U |
| EP2712315 | LYSINE DEMETHYLASE INHIBITORS FOR MYELOPROLIFERATIVE DISORDERS | BAKER JONATHAN ALLEMAN | ORYZON GENOMICS SA |
| EP2713727 | COMBINATION OF MEK INHIBITORS AND SELECTIVE INHIBITORS OF AURORA A KINASE | CHAKRAVARTY ARIJIT | MILLENNIUM PHARM INC |
| EP2713997 | PROCESS FOR TREATING STRAIGHTENED KERATIN FIBRES | CABOURG JULIEN | OREAL |
| EP2714073 | IN SITU ANTIGEN-GENERATING CANCER VACCINE | GADISH OR | HARVARD COLLEGE |
| EP2714703 | TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE | SHEN WANG | NEWGEN THERAPEUTICS INC |
| EP2714735 | ANTIBODIES SPECIFIC FOR TGF-BETA | BEDINGER DANIEL | XOMA TECHNOLOGY LTD |
| EP2716756 | REIC-EXPRESSING ADENOVIRUS VECTOR | KUMON HIROMI | UNIV OKAYAMA NAT UNIV CORP |
| EP2717885 | ANTIINFECTIVE COMPOSITION | REINMUELLER JOHANNES | REINMUELLER JOHANNES |
| EP2717886 | METAL CHELATING COMPOSITIONS AND METHODS FOR CONTROLLING THE GROWTH OR ACTIVITIES OF A LIVING CELL OR ORGANISM | HOLBEIN BRUCE EDWARD | CHELATION PARTNERS INC |
| EP2720742 | MEDICINAL INHALATION DEVICES, VALVES AND COMPONENTS THEREOF | JINKS PHILIP A | 3M INNOVATIVE PROPERTIES CO |
| EP2723302 | DENTAL RESTORATION, METHOD FOR PRODUCTION THEREOF AND GLASS CERAMIC | DURSCHANG BERNHARD | FRAUNHOFER GES FORSCHUNG |
| EP2723388 | CONTROLLED RELEASE SYSTEM | RIJCKEN CRISTIANNE JOHANNA FERDINAND | CRISTAL DELIVERY B V |
| EP2726066 | DOSAGE FORMS FOR ORAL ADMINISTRATION AND METHODS OF TREATMENT USING THE SAME | TENGLER MARK | NEOS THERAPEUTICS LP |
| EP2727583 | Drug carrier and drug carrier kit for inhibiting fibrosis | NIITSU YOSHIRO | NITTO DENKO CORP |
| EP2729151 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF | BROEDL ULI | BOEHRINGER INGELHEIM INT |
| EP2729170 | ANTIBODY VARIANTS AND USES THEREOF | PARREN PAUL | GENMAB BV |
| EP2729175 | PHOSPHORS AND SCINTILLATORS FOR LIGHT STIMULATION WITHIN A MEDIUM | BOURKE FREDERIC A | UNIV DUKE |
| EP2734180 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING A MEROCYANINE DERIVATIVE COMPRISING SPECIFIC POLAR GROUPS CONSISTING OF HYDROXYL- AND ETHER-FUNCTIONALITIES | RICHARD HERVé | OREAL |
| EP2734209 | INTRANASAL ADMINISTRATION OF AGENTS WITH PRO-INFLAMMATORY ACTIVITY FOR THE THERAPY OF NEUROLOGICAL DISORDERS | SALVINELLI FABRIZIO | SALVINELLI FABRIZIO |
| EP2734573 | BIODEGRADABLE, SEMI-CRYSTALLINE, PHASE SEPARATED, THERMOPLASTIC MULTI BLOCK COPOLYMERS FOR CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | STEENDAM ROB | INNOCORE TECHNOLOGIES B V |
| EP2735305 | Stabilised liquid pharmaceutical preparations | VALENTI MAURO | FARMACOLOGICO MILANESE S R L LAB |
| EP2735312 | ANTI-GLYCATION AGENT COMPRISING A GARCINIA KOLA EXTRACT OR FRACTION | DERBRE SéVERINE | UNIV ANGERS |
| EP2736512 | METHODS AND COMPOSITIONS FOR TREATMENT OF EPITHELIAL WOUNDS | ZAGON IAN S | ZAGON IAN S |
| EP2737901 | Therapeutic Use of Compounds | WILLIAMS ROBIN SIMON BROOKE | UCL BUSINESS PLC |
| EP2741729 | CURABLE COMPOSITION WITH SHORTENED SETTING TIME, PROCESS OF PRODUCTION AND USE THEREOF | OSSWALD PETER U | 3M INNOVATIVE PROPERTIES CO |
| EP2742019 | N1-CYCLIC AMINE-N5-SUBSTITUTED PHENYL BIGUANIDE DERIVATIVES, METHODS OF PREPARING THE SAME AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | KIM SUNG WUK | HANALL BIOPHARMA CO LTD |
| EP2742047 | ANTIBACTERIAL PIPERIDINYL SUBSTITUTED 3,4-DIHYDRO-1H-[1,8]NAPHTHYRIDINONES | GUILLEMONT JERÔME EMILE GEORGES | JANSSEN R & D IRELAND |
| EP2742070 | DEGRADATION-RESISTANT CROSS-LINKED, LOW-MOLECULAR-WEIGHT HYALURONATE | ORESTE PASQUA ANNA | GLYCORES 2000 SRL |
| EP2742953 | THERAPEUTIC AGENT FOR AUTOIMMUNE DISEASES COMPRISING PD-1 AGONIST | SHIBAYAMA SHIRO | ONO PHARMACEUTICAL CO |
| EP2744343 | METHOD OF PRODUCING PHYSIOLOGICAL AND THERAPEUTIC LEVELS OF NITRIC OXIDE THROUGH AN ORAL DELIVERY SYSTEM | BRYAN NATHAN S | UNIV TEXAS |
| EP2744832 | MATRICES COMPRISING A MODIFIED POLYSACCHARIDE | SHASTRI V PRASAD | ALBERT LUDWIGS UNIVERSITÄT FREIBURG |
| EP2749273 | Solid oral preparation with modified release | PASOTTI GINO | I P S INTERNAT PRODUCTS & SERVICES S R L |
| EP2749641 | CANCER STEM CELL ISOLATION | YAMAZAKI TATSUMI | PHARMALOGICALS RES PTE LTD |
| EP2750679 | TREATING PANCREATIC CANCER AND NON-SMALL CELL LUNG CANCER WITH ATR INHIBITORS | POLLARD JOHN ROBERT | VERTEX PHARMA |
| EP2751095 | NOVEL BENZODIAZEPINONES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR FUNCTIONS AND NEUROLOGICAL USES THEREOF | HUTCHINSON JOHN HOWARD | SANFORD BURNHAM MED RES INST |
| EP2751128 | CELL-PENETRATING PEPTIDES HAVING A CENTRAL HYDROPHOBIC DOMAIN | GAIT MICHAEL JOHN | MEDICAL RES COUNCIL |
| EP2752190 | METHOD FOR IMPROVING THERAPY FOR AUTOIMMUNE DISEASES SUCH AS RHEUMATOID ARTHRITIS | TANAKA KEIICHI | TOYAMA CHEMICAL CO LTD |
| EP2753308 | COMPOSITIONS OF LOPINAVIR AND RITONAVIR | GIARDIELLO MARCO NORMAN | UNIV LIVERPOOL |
| EP2753310 | FORMULATION FOR THE CONTROLLED RELEASE OF ONE OR SEVERAL SUBSTANCES IN THE DIGESTIVE TRACT OF A MAMMAL | SAUR-BROSCH ROLAND | SAUR-BROSCH ROLAND |
| EP2753321 | EPINEPHRINE NANOPARTICLES, METHODS OF FABRICATION THEREOF, AND METHODS FOR USE THEREOF FOR TREATMENT OF CONDITIONS RESPONSIVE TO EPINEPHRINE | RAWAS-QALAJI MUTASEM | UNIV NOVA SOUTHEASTERN |
| EP2753356 | ANTI-SIGLEC-15 ANTIBODIES AND USES THEREOF | ELVIN JOHN | MEDIMMUNE LTD |
| EP2754439 | Use of aminolevulinic acid derivatives | WULF HANS CHRISTIAN | PHOTOCURE ASA |
| EP2755480 | GALACTO-RHAMNOGALACTURONATE COMPOSITIONS FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS AND NON-ALCOHOLIC FATTY LIVER DISEASE | TRABER PETER G | GALECTIN THERAPEUTICS INC |
| EP2755625 | SHELLAC BASED SPRAYABLE SUNSCREEN | BARRIE WILLIAM E | MANTROSE HAEUSER CO INC |
| EP2755652 | N-SUBSTITUTED HETEROCYCLYL CARBOXAMIDES | BALA KAMLESH JAGDIS | NOVARTIS AG |
| EP2757883 | TRIAZOLOPYRIDYL COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITORS | BENNETT D JONATHAN | MERCK SHARP & DOHME |
| EP2758032 | COMPOSITIONS AND METHODS FOR TREATING CONDITIONS OF COMPROMISED SKIN BARRIER FUNCTION | YU BETTY | LIVING PROOF INC |
| EP2758041 | LOW MOLECULAR WEIGHT MODULATORS OF THE COLD-MENTHOL RECEPTOR TRPM8 AND USE THEREOF | SUBKOWSKI THOMAS | BASF SE |
| EP2758048 | MITOCHONDRIA-TARGETED ANTIOXIDANTS FOR TREATMENT OF AGE-RELATED BRAIN DISORDERS | SKULACHEV MAXIM VLADIMIROVICH | MITOTECH SA |
| EP2758065 | ALPHA1-PROTEINASE INHIBITOR FOR DELAYING THE ONSET OR PROGRESSION OF PULMONARY EXACERBATIONS | FORSHAG MARK | GRIFOLS SA |
| EP2761002 | INHIBITION OF MICRORNA-134 FOR THE TREATMENT OF SEIZURE-RELATED DISORDERS AND NEUROLOGIC INJURIES | HENSHALL DAVID | ROYAL COLLEGE OF SURGEONS IE |
| EP2762493 | ANTIGEN-BINDING MOLECULE PROMOTING DISAPPEARANCE OF ANTIGENS HAVING PLURALITY OF BIOLOGICAL ACTIVITIES | IGAWA TOMOYUKI | CHUGAI PHARMACEUTICAL CO LTD |
| EP2763533 | TRIAZOLYL PDE10 INHIBITORS | COX CHRISTOPHER D | MERCK SHARP & DOHME |
| EP2763658 | TARGETED LIPOSOMES IN CANCER THERAPY | LAMBROS MARIA POLIKANDRITOU | UNIV WESTERN HEALTH SCIENCES |
| EP2764028 | METHOD FOR PREPARING CATIONIC GALACTOMANNANS | LE-THIESSE JEAN-CLAUDE | RHODIA OPERATIONS |
| EP2765927 | DELIVERY DEVICE | KENDALL MARK ANTHONY FERNACE | UNIV QUEENSLAND |
| EP2765973 | DENTURE ADHESIVE COMPOSITIONS | RAJAIAH JAYANTH | PROCTER & GAMBLE |
| EP2766047 | METHODS | GOOD LIAM | ROYAL VETERINARY COLLEGE |
| EP2766339 | THE USE OF (2R, 6R)-HYDROXYNORKETAMINE, (S)-DEHYDRONORKETAMINE AND OTHER STEREOISOMERIC DEHYDRO AND HYDROXYLATED METABOLITES OF (R,S)- KETAMINE IN THE TREATMENT OF DEPRESSION AND NEUROPATHIC PAIN | WAINER IRVING W | US HEALTH |
| EP2768478 | PASTE COMPRISING NON-STEROIDAL ANTI-INFLAMMATORY | REYNOLDS LOUISE | NORBROOK LAB LTD |
| EP2769718 | MEDICINAL COMPOSITION | IWATA YASUHIRO | RAQUALIA PHARMA INC |
| EP2771040 | NONAQUEOUS COMPOSITIONS FOR BONE HEMOSTASIS, AND METHODS FOR THEIR USE AND MANUFACTURE | GORNA KATARZYNA I | BAXTER INT |
| EP2771070 | DEVICE FOR SELF-FOAMING OXIDATION DYEING, READY-FOR-USE SELF-FOAMING COMPOSITION AND METHOD FOR DYEING KERATINOUS FIBRES | SAMAIN HENRI | ORéAL L |
| EP2772251 | Protamine/RNA nanoparticles for immunostimulation | PASCOLO STEVE | UNIVERSITÄT ZüRICH |
| EP2773346 | PHARMACEUTICAL COMPOSITIONS OF HYDROPHOBIC CAMPTOTHECIN DERIVATIVES | KAN PEI | |
| EP2773427 | AN ANDROGEN RECEPTOR OR ESTRADIOL RECEPTOR INHIBITOR FOR USE IN THE TREATMENT OF A CANCEROUS OR NON-CANCEROUS CONDITION | ECCLESTON MARK | VALIRX PLC |
| EP2773671 | STABLE HETERODIMERIC ANTIBODY DESIGN WITH MUTATIONS IN THE FC DOMAIN | SPRETER VON KREUDENSTEIN THOMAS | ZYMEWORKS INC |
| EP2776018 | PKC ACTIVATORS AND COMBINATIONS THEREOF | ALKON DANIEL L | BRNI NEUROSCIENCES INST |
| EP2776567 | COMPOSITIONS AND METHODS FOR TREATMENT OF CYTOMEGALOVIRUS | ANDERSON DAVID E | VARIATION BIOTECHNOLOGIES INC |
| EP2777696 | Preparation of stable pharmaceutical dosage forms | KAWALE SANJAY RANGNATHRAO | NAVINTA LLC |
| EP2780083 | NATURAL SILICONE REPLACEMENTS FOR SILICONE FLUIDS IN PERSONAL CARE FORMULATIONS | BURGO ROCCO | INOLEX INVESTMENT CORP |
| EP2780700 | 2-HYDROXYGLUTARATE AS A BIOMARKER FOR CHRONIC HYPOXIA | WISE DAVID R | SLOAN KETTERING INST CANCER |
| EP2782566 | L-SERINE AS ONLY ACTIVE PRINCIPLE FOR USE IN TREATING NEURODEGENERATIVE DISORDERS | RODGERS KENNETH | INST ETHNOMEDICINE |
| EP2782584 | NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES | BERNICK BRIAN A | THERAPEUTICSMD INC |
| EP2785322 | JOJOBA EXTRACT USEFUL IN IMPROVING SKIN BARRIER FUNCTIONS | SOUDANT ETIENNE | IBR ISRAELI BIOTECHNOLOGY RES LTD |
| EP2785337 | ACAMPROSATE FORMULATIONS, METHODS OF USING THE SAME, AND COMBINATIONS COMPRISING THE SAME | KERNS WILLIAM D | SYNCHRONEURON INC |
| EP2785370 | VACCINE FOR FALCIPARUM MALARIA | KURTIS JONATHAN | RHODE ISLAND HOSPITAL |
| EP2785910 | AMINOFUNCTIONAL ORGANOSILOXANES | BOUZELOC SYLVIE | DOW CORNING |
| EP2787969 | EFFICIENT LIPID DELIVERY TO HUMAN TEAR FILM USING A SALT-SENSITIVE EMULSION SYSTEM | VEHIGE JOSEPH G | ALLERGAN INC |
| EP2789348 | LIPOSOMES AND CORRESPONDING PRODUCTION METHOD | CAVACO PAULO ARTUR MANUEL | UNIV DO MINHO |
| EP2790686 | TREATMENT OF TINNITUS THROUGH MODULATION OF CHLORIDE CO-TRANSPORTER NKCC1 IN THE AUDITORY SYSTEM | KNIPPER MARLIES | AURIS MEDICAL AG |
| EP2793804 | MAKEUP PROCESS | SAMAIN HENRI | ORéAL L |
| EP2793821 | COSMETIC USE OF STEVIOL, OF A STEVIOL GLYCOSIDE DERIVATIVE OR OF ONE OF THEIR ISOMERS TO STIMULATE, RESTORE OR REGULATE THE METABOLISM OF THE CELLS OF THE SKIN AND SEMIMUCUS MEMBRANES | LABOUREAU JULIEN | ORéAL L |
| EP2793840 | PIGMENT DYEING COMPOSITION BASED ON A PARTICULAR ACRYLIC POLYMER AND ON SILICONE COPOLYMER, AND DYEING METHOD | TEBOUL KAREN | OREAL |
| EP2793841 | COMPOSITION COMPRISING A SPECIFIC ACRYLIC POLYMER AND A SILICONE COPOLYMER, AND METHOD FOR TREATING KERATIN FIBRES USING SAME | TEBOUL KAREN | OREAL |
| EP2793867 | GELATIN/ALGINATE DELAYED RELEASE CAPSULES COMPRISING OMEGA-3 FATTY ACIDS, AND METHODS AND USES THEREOF | BAES ERIK | BAES ERIK |
| EP2793872 | COMBINATION OF A COMPOUND HAVING THE ABILITY TO REARRANGE A LYSOSOMAL ENZYME AND AMBROXOL AND/OR A DERIVATIVE OF AMBROXOL | LUKAS JAN | CENTOGENE IP GMBH |
| EP2793914 | A COMBINATION THERAPY FOR A STABLE AND LONG TERM ENGRAFTMENT | REISNER YAIR | YEDA RES & DEV |
| EP2793947 | ENZYMATIC CONJUGATION OF POLYPEPTIDES | BREGEON DELPHINE | INNATE PHARMA |
| EP2794858 | COMPOSITIONS AND METHODS INCLUDING B LYMPHOCYTE CELL LINE EXPRESSING MEMBRANE IMMUNOGLOBULIN DIFFERENT FROM SECRETED IMMUNOGLOBULIN | HYDE RODERICK A | ELWHA LLC |
| EP2796150 | NOVEL OLIGONUCLEOTIDE CONJUGATES AND USE THEREOF | CHAE JEIWOOK | BIONEER CORP |
| EP2797574 | OXIDATIVE DYEING COMPOSITION | EHMIG JüRGEN | KAO GERMANY GMBH |
| EP2797590 | INHIBITOR OF TRPM-4 ION CHANNEL FOR TREATING OR PREVENTING NEURODEGENERATION | FRIESE MANUEL | UNIVERSITÄTSKLINIKUM HAMBURG EPPENDORF |
| EP2797612 | USE OF WHOLE SOFT AVOCADOS FOR PREPARING AVOCADO OIL RICH IN UNSAPONIFIABLES | MSIKA PHILIPPE | EXPANSCIENCE LAB |
| EP2799066 | TOLTERODINE-CONTAINING ADHESIVE PATCH | SHIBATA TAIKI | TEIKOKU SEIYAKU KK |
| EP2799088 | Factor VIII polymer conjugates | TURECEK PETER | BAXTER INT |
| EP2799537 | NORMALIZATION OF CULTURE OF CORNEAL ENDOTHELIAL CELLS | KINOSHITA SHIGERU | KYOTO PREFECTURAL PUBLIC UNIV CORP |
| EP2800469 | COMPOSITIONS AND METHODS FOR LOWERING LEVELS OF HIGH-SENSITIVITY (HS-CRP) IN A SUBJECT | MANKU MEHAR | AMARIN PHARMACEUTICALS IE LTD |
| EP2800573 | OPHTHALMIC COMPOSITION | ZOLOTARIOV EYAL | MEDICURE TECHNOLOGIES LTD |
| EP2802335 | USE OF AVOCADO PIT FOR OBTAINING AN AVOCADO OIL ENRICHED WITH ALKYL POLYOLS AND/OR ACETYLATED DERIVATIVES THEREOF | MSIKA PHILIPPE | EXPANSCIENCE LAB |
| EP2802336 | USE OF AVOCADO SKIN FOR OBTAINING AN AVOCADO UNSAPONIFIABLE MATERIAL ENRICHED WITH SATURATED ALIPHATIC HYDROCARBONS AND WITH STEROLS | MSIKA PHILIPPE | EXPANSCIENCE LAB |
| EP2804619 | SYNTHETIC PEPTIDES FOR TREATMENT OF BACTERIAL INFECTIONS | SHIRVAN ANAT | ATOX BIO LTD |
| EP2804631 | SURROBODY COJUGATES | HOROWITZ LAWRENCE C | SEA LANE BIOTECHNOLOGIES LLC |
| EP2806864 | TREATMENT OF CIRCADIAN RHYTHM DISORDERS | DRESSMAN MARLENE MICHELLE | VANDA PHARMACEUTICALS INC |
| EP2806900 | RNA MODULATING OLIGONUCLEOTIDES WITH IMPROVED CHARACTERISTICS FOR THE TREATMENT OF DUCHENNE AND BECKER MUSCULAR DYSTROPHY | DE VISSER PETER CHRISTIAN | PROSENSA TECHNOLOGIES BV |
| EP2806914 | A SYSTEM AND METHOD FOR OBTAINING A CELLULAR SAMPLE ENRICHED WITH DEFINED CELLS SUCH AS PLATELET RICH PLASMA(PRP) | ESTERON AARON | ESTAR TECHNOLOGIES LTD |
| EP2807112 | LOW DENSITY, HIGHLY POROUS NANO STRUCTURE | FU AIHUA | NVIGEN INC |
| EP2809340 | BIOMATERIAL FOR ARTICULAR CARTILAGE MAINTENANCE AND TREATMENT OF ARTHRITIS | MURRAY MARTHA M | CHILDRENS MEDICAL CENTER |
| EP2809354 | NEGATIVELY CHARGED NUCLEIC ACID COMPRISING COMPLEXES FOR IMMUNOSTIMULATION | BAUMHOF PATRICK | CUREVAC GMBH |
| EP2810662 | Factor VIII polymer conjugates | TURECEK PETER | BAXTER INT |
| EP2811987 | MULTI-LAYER BIOMATERIAL FOR TISSUE REGENERATION AND WOUND HEALING | MAUNEY JOSHUA R | CHILDRENS MEDICAL CENTER |
| EP2811999 | NOVEL CYSTEINE PROTEASE INHIBITORS AND USES THEREOF | FA MAURO | UNIV COLUMBIA |
| EP2812349 | METHODS FOR THE CHARACTERISATION OF INTERACTION SITES ON TARGET PROTEINS | WATT PAUL | PHYLOGICA LTD |
| EP2813228 | Agent for improvement of skin barrier function | TANIMOTO ATSUO | JAPAN TOBACCO INC |
| EP2814451 | STABLE WATER-IN-OIL EMULSIONS WITH SPREADABLE OILS | VON DER FECHT STEPHANIE | BEIERSDORF AG |
| EP2814495 | METHOD FOR TREATING INTESTINAL DISEASES PRESENTING AT LEAST ONE INFLAMMATORY COMPONENT | MORO LUIGI | COSMO TECHNOLOGIES LTD |
| EP2814511 | FORMULATIONS AND KITS FOR FORMING BIOADHESIVE MATRICES | ZILBERMAN MEITAL | TECHNOLOGY INNOVATION MOMENTUM FUND ISRAEL LTD PARTNERSHIP |
| EP2814577 | STABLE WATER-IN-OIL EMULSIONS WITH IMPROVED SENSORY PROPERTIES | KOCH PETRA | BEIERSDORF AG |
| EP2816106 | RECOMBINANT STRAIN OF MYCOBACTERIUM BOVIS BACILLUS CALMETTE-GUERIN (BCG) IMMUNOGENIC COMPOSITION AND USE | DE CERQUEIRA LEITE LUCIANA CEZAR | FUNDAÇ O BUTANTAN |
| EP2817000 | ORAL PHARMACEUTICAL COMPOSITIONS OF DABIGATRAN ETEXILATE | PILGAONKAR PRATIBHA S | ESTEVE LABOR DR |
| EP2818173 | CELL PREPARATION INCLUDING FAT CELL | SAEKI MASANORI | SAEKI MASANORI |
| EP2819666 | GELLING FORMULATION BASED ON CALCIUM GLUCONATE | BOUDY VINCENT | ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS |
| EP2819669 | NOVEL PROPELLANT-GAS-CONTAINING TIOTROPIUM FORMULATION | BERNER BETTINA | BOEHRINGER INGELHEIM INT |
| EP2822386 | FOLATE RECEPTOR ALPHA BINDING LIGANDS | LOW PHILIP STEWART | PURDUE RESEARCH FOUNDATION |
| EP2822533 | BIOMATERIALS FOR DELIVERY OF BLOOD EXTRACTS AND METHODS OF USING SAME | MARINER PETER D | MOSAIC BIOSCIENCES INC |
| EP2822936 | AMINOQUINOLINE DERIVATIVES AND USES THEREOF | RAWAT DIWAN S | MCLEAN HOSPITAL CORP |
| EP2823807 | SUNSCREEN COMPOSITION | TANAKA MASAHIKO | OTSUKA PHARMA CO LTD |
| EP2823819 | PHARMACEUTICAL COMPOSITION CONTAINING OLEANOLIC ACID ACETATE AS AN ACTIVE INGREDIENT FOR PREVENTING OR TREATING TLR- OR IL-6-MEDIATED DISEASES | RHO MUN CHUAL | KOREA RES INST OF BIOSCIENCE |
| EP2824105 | Indolopyridines as Eg5 kinesin modulators | VENNEMANN MATTHIAS | 4SC AG |
| EP2825041 | SOLID FORMS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR | LAI MEI | CELGENE AVILOMICS RES INC |
| EP2825151 | COMPOSITION | HOTZ JUTTA | GIVAUDAN SA |
| EP2825155 | SYSTEM AND METHOD FOR GENERATION OF EMULSIONS WITH LOW INTERFACIAL TENSION | SHUM HO CHEUNG | UNIV HONG KONG |
| EP2825179 | METHODS OF ADMINISTERING HIGH CONCENTRATIONS OF NITRIC OXIDE | GOLDSTEIN BRAHM | INO THERAPEUTICS LLC |
| EP2826474 | USE OF SUBSTITUTED DIPHENYLAMINE COMPOUNDS IN PREPARING ANTI-TUMOUR DRUGS | LIU CHANGLING | SINOCHEM CORP |
| EP2826476 | Calcium-free dialysis fluid | DE JONG GIJSBERTUS MARIA THEODORUS | DE JONG GIJSBERTUS MARIA THEODORUS |
| EP2826822 | Pigment mixture based on spherical particles | KLEIN SYLKE | MERCK PATENT GMBH |
| EP2827874 | PHARMACEUTICAL COMPOSITION COMPRISING EMPAGLIFLOZIN AND ANTIOBESITY DRUG | MAYOUX ERIC WILLIAMS | BOEHRINGER INGELHEIM INT |
| EP2827952 | COMPOSITIONS AND METHODS FOR REGULATING HAIR GROWTH | COTSARELIS GEORGE | UNIV PENNSYLVANIA |
| EP2828250 | QUINAZOLINE COMPOUNDS AND THEIR USE IN THERAPY | BROWN ROBERT | IMP INNOVATIONS LTD |
| EP2830638 | DIASPIRIN CROSSLINKED PEGYLATED HEMOGLOBIN | VANDEGRIFF KIM D | SANGART INC |
| EP2830640 | METHODS AND COMPOSITIONS FOR TREATING ARTERIOSCLEROTIC VASCULAR DISEASES | LIU SHENG-YUNG | GOLDEN BIOTECHNOLOGY CORP |
| EP2830653 | MICROPARTICLE VACCINE AGAINST MALARIA | POWELL THOMAS J | ARTIFICIAL CELL TECHNOLOGIES INC |
| EP2832368 | FIBROSIS SUPPRESSION BY INHIBITING INTEGRIN ALPHA8BETA1 FUNCTION | YOKOSAKI YASUYUKI | UNIV HIROSHIMA |
| EP2833721 | NITRIC OXIDE RELEASING PHARMACEUTICAL COMPOSITIONS | DOXEY RYAN | NOVAN INC |
| EP2834246 | COMBINATION PRODUCTS WITH TYROSINE KINASE INHIBITORS AND THEIR USE | TIEDT RALPH | NOVARTIS AG |
| EP2836187 | SELF-STANDING COSMETIC SHEET | SHIROYA TOSHIFUMI | ORéAL L |
| EP2836195 | SYSTEM AND METHOD FOR MULTIPHASIC RELEASE OF GROWTH FACTORS | CLOKIE CAMERON M L | INDUCE BIOLOG INC |
| EP2836223 | PROBIOTIC BACTERIA | O'NEILL CATHERINE | UNIV MANCHESTER |
| EP2836581 | A HIGHLY EFFICIENT AND CONVENIENT FORM OF MICROFIBROUS CELLULOSE | SWAZEY JOHN | CP KELCO US INC |
| EP2838506 | MAGNESIUM COMPOSITIONS FOR MODULATING THE PHARMACOKINETICS AND PHARMACODYNAMICS OF INSULIN AND INSULIN ANALOGS, AND INJECTION SITE PAIN | POHL RODERIKE | BIODEL INC |
| EP2838549 | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE | LIM SE YOUNG | HANMI SCIENCE CO LTD |
| EP2839005 | MIRNA MODULATORS OF THERMOGENESIS | THIBONNIER MARC | APTAMIR THERAPEUTICS INC |
| EP2841049 | COSMETIC COMPOSITION COMPRISING MATTIFYING FILLERS AND A SILANE | LORANT RALUCA | ORéAL L |
| EP2841066 | ENHANCED ANTI-INFLUENZA AGENTS CONJUGATED WITH ANTI-INFLAMMATORY ACTIVITY | WONG CHI-HUEY | |
| EP2841077 | DIETARY FIBER COMPOSITIONS FOR THE TREATMENT OF METABOLIC DISEASE | GAHLER ROLAND JACQUES | INOVOBIOLOGIC INC |
| EP2841107 | CYTOTOXIC-DRUG DELIVERING MOLECULES TARGETING HIV (CDM-HS), CYTOTOXIC ACTIVITY AGAINST THE HUMAN IMMUNODEFICIENCY VIRUS AND METHODS OF USE | SPIEGEL DAVID | UNIV YALE |
| EP2844288 | BINDING PROTEINS HAVING TETHERED LIGHT CHAINS | HUNTER MICHAEL | JANSSEN BIOTECH INC |
| EP2844303 | LIPIDS THAT INCREASE INSULIN SENSITIVITY AND METHODS OF USING THE SAME | KAHN BARBARA | BETH ISRAEL HOSPITAL |
| EP2844344 | TREATING INFLAMMATORY CONDITIONS AND IMPROVING ORAL HYGIENE USING METAL MODULATORS WITH METHYLSULFONYLMETHANE AS TRANSPORT ENHANCER | BHUSHAN RAJIV | BHUSHAN RAJIV |
| EP2844743 | ENHANCED AFFINITY T CELL RECEPTORS AND METHODS FOR MAKING THE SAME | SCHMITT THOMAS M | HUTCHINSON FRED CANCER RES |
| EP2846825 | TREATMENT OF INFLAMMATORY DISORDERS IN NON-HUMAN MAMMALS | GUEDES ALONSO G P | UNIV CALIFORNIA |
| EP2846829 | VACCINE COMBINATIONS | ELLA KRISHNA MURTHY | BHARAT BIOTECH INT LTD |
| EP2846831 | USE OF SEMAPHORIN-4D BINDING MOLECULES TO PROMOTE NEUROGENESIS FOLLOWING STROKE | SMITH ERNEST S | VACCINEX INC |
| EP2849776 | GLUCOKINASE ACTIVATOR COMPOSITIONS FOR THE TREATMENT OF DIABETES | VALCARCE LOPEZ MARIA CARMEN | TRANSTECH PHARMA LLC |
| EP2849779 | CELLULAR VACCINE AND METHOD OF INDUCING AN IMMUNE RESPONSE IN A SUBJECT | GOWANS ERIC JAMES | ADELAIDE RES & INNOVATION PTY |
| EP2849798 | OLIGONUCLEOTIDE CHELATE COMPLEX-POLYPEPTIDE COMPOSITIONS AND METHODS | BAZINET MICHEL | REPLICOR INC |
| EP2851062 | Antimicrobial, antibacterial and spore germination inhibiting activity from an avocado extract enriched in bioactive compounds | HERNANDEZ-BRENES CARMEN | ITESM |
| EP2851075 | PREPARATION CONTAINING 6,7-UNSATURATED-7-CARBAMOYLMORPHINAN DERIVATIVE | MASHIMO AKIRA | SHIONOGI & CO |
| EP2851095 | SHEET MOLDING AND HEMOSTATIC MATERIAL | KAGEYAMA YUKAKO | TEIJIN LTD |
| EP2851361 | HIGHLY UNSATURATED FATTY ACID OR HIGHLY UNSATURATED FATTY ACID ETHYL ESTER WITH REDUCED ENVIRONMENTAL POLLUTANTS, AND METHOD FOR PRODUCING SAME | DOISAKI NOBUSHIGE | NIPPON SUISAN KAISHA LTD |
| EP2852391 | SYSTEMS FOR TREATING PULMONARY INFECTIONS | PERKINS WALTER | INSMED INC |
| EP2852412 | ACID RESISTANT BANDING SOLUTION FOR TWO PIECE HARD CAPSULES | TAKUBO TAKAHISA | CAPSUGEL BELGIUM NV |
| EP2852589 | TRIAZOLES AS KV3 INHIBITORS | MARASCO AGOSTINO | AUTIFONY THERAPEUTICS LTD |
| EP2852600 | BISPHOSPHONATES VINYLIC MONOMERS AND POLYMERS AND USES THEREOF | MARGEL SHLOMO | BAR ILAN RES & DEV COMPANY LTD |
| EP2853263 | MULTILAYER COATING FORM OF ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION CONTAINING OMEGA-3 FATTY ACID OR ALKYL ESTER THEREOF AND STATIN BASED DRUG | CHO JAE-PYOUNG | KUHNIL PHARM CO LTD |
| EP2854756 | TEMPORARY STAIN REPELIENT FOR PREVENTING STAINING OF TEETH | WAWILUK ALEX ANTHONY | GOLDSPIRE GROUP LTD |
| EP2854793 | LIPID NANOCAPSULES COMPRISING A RETINOID, NANODISPERSION AND COMPOSITION CONTAINING SAME, METHOD OF PRODUCING SAME AND USE THEREOF IN DERMATOLOGY | MALLARD CLAIRE | GALDERMA RES & DEV |
| EP2854830 | NEW RELEASE SYSTEM OF HYDROPHOBIC PROTEINS | CAMPISI MONICA | FIDIA FARMACEUTICI |
| EP2854850 | METHODS FOR TREATING GI SYNDROME AND GRAFT VERSUS HOST DISEASE | KOLESNICK RICHARD | SLOAN KETTERING INST CANCER |
| EP2854947 | USE OF AN H4 AGONIST MOLECULE FOR TREATING CYSTIC FIBROSIS | TERRASSE GAËTAN | TERRASSE GAËTAN |
| EP2856152 | NEW BIOMARKERS TO ESTIMATE THE RISK OF ALLOGRAFT FAILURE AND PATIENT MORTALITY AFTER ORGAN TRANSPLANTATION | VERMEER CORNELIS | VITAK BV |
| EP2857015 | Modulators of the prostacyclin (PG12) receptor useful for the treatment of disorders related thereto | TRAN THUY-ANH | ARENA PHARM INC |
| EP2857830 | FLUORESCENT PROBE FOR HIGH-SENSITIVITY PANCREATIC FLUID DETECTION, AND METHOD FOR DETECTING PANCREATIC FLUID | URANO YASUTERU | UNIV TOKYO |
| EP2858679 | PULMONARY DELIVERY OF MRNA TO NON-LUNG TARGET CELLS | HEARTLEIN MICHAEL | SHIRE HUMAN GENETIC THERAPIES |
| EP2859898 | THERAPEUTIC AGENT, TREATMENT METHOD AND TEST METHOD FOR DISEASES ASSOCIATED WITH ACTIVATION OF NEUTROPHILS | NISHIBORI MASAHIRO | UNIV OKAYAMA NAT UNIV CORP |
| EP2860178 | P2X3 receptor antagonists for treatment of pain | BURGEY CHRISTOPHER S | MERCK SHARP & DOHME |
| EP2860245 | METHOD FOR PRODUCING CILIARY MARGINAL ZONE-LIKE STRUCTURE | NAKANO TOKUSHIGE | SUMITOMO CHEMICAL CO |
| EP2861073 | SOLUBLE ESTRADIOL CAPSULE FOR VAGINAL INSERTION | BERNICK BRIAN A | THERAPEUTICSMD INC |
| EP2861241 | IMPROVED CD31 PEPTIDES | CALIGIURI GIUSEPPINA | INST NAT SANTé ET DE LA RECH MéDICALE INSERM |
| EP2861246 | COMPOSITIONS AND METHODS OF INHIBITING MASP-1 AND/OR MASP-2 AND/OR MASP-3 FOR THE TREATMENT OF VARIOUS DISEASES AND DISORDERS | SCHWAEBLE HANS-WILHELM | OMEROS CORP |
| EP2861257 | POLYMERIC TREATMENT COMPOSITIONS | CRUISE GREGORY M | MICROVENTION INC |
| EP2861719 | COMPOSITIONS AND METHODS FOR DIMINISHING AN IMMUNE RESPONSE | FLAVELL RICHARD A | OSPEDALE SAN RAFFAELE SRL |
| EP2862581 | Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid | KONG XIANQI | BHI LTD PARTNERSHIP |
| EP2863862 | COSMETIC COMPOSITION COMPRISING AN AQUEOUS DISPERSION OF HYDROPHOBIC SILICA AEROGEL PARTICLES AND A PARTICULAR ALCOHOL | BEBOT CéCILE | ORéAL L |
| EP2863895 | TABLET FORMULATION COMPRISING A PEPTIDE AND A DELIVERY AGENT | BJERREGAARD SIMON | NOVO NORDISK AS |
| EP2863996 | LIQUID COSMETIC COMPOSITION COMPRISING AN OIL, HYDROPHOBIC SILICA AEROGEL PARTICLES AND A WAX WITH A MELTING POINT OF GREATER THAN 60掳C | JULIEN NATHALIE | ORéAL L |
| EP2863998 | COSMETIC SOLID COMPOSITION COMPRISING A NON VOLATILE HYDROCARBONATED OIL, WAXES AND A HIGH CONTENT FROM NON VOLATILE PHENYLATED SILICONE OIL | SHIMIZU MOMOKO | OREAL |
| EP2864312 | NOVEL ANTI-CANCER THIOPHENE COMPOUNDS | BALZARINI JAN | UNIV LEUVEN KATH |
| EP2865669 | NOVEL REBAMIPIDE PRODRUG, METHOD FOR PRODUCING SAME, AND USAGE THEREOF | CHO EUI-HWAN | SAMJIN PHARM CO LTD |
| EP2866017 | METHOD FOR RENDERING BIOLOGICAL MATERIAL TRANSPARENT AND PROCESSING KIT FOR RENDERING BIOLOGICAL MATERIAL TRANSPARENT | IMAI TAKESHI | RIKEN |
| EP2867356 | PRODUCTION AND APPLICATION OF PROTOZOA CULTURES OF HISTOMONAS MELEAGRIDIS (H. MELEAGRIDIS) | HESS MICHAEL | VETERINÄRMEDIZINISCHE UNIVERSITÄT WIEN |
| EP2868327 | NASAL VACCINE AGAINST THE DEVELOPMENT OF ATHEROSCLEROSIS DISEASE AND FATTY LIVER | MAS OLIVA JAIME | UNIV NAC AUTóNOMA DE MéXICO |
| EP2868634 | Lithium disilicate apatite glass ceramic with transition metal oxide | RAMPF MARKUS | IVOCLAR VIVADENT AG |
| EP2869841 | NOVEL PRIME-BOOSTING REGIMENS INVOLVING IMMUNOGENIC POLYPEPTIDES ENCODED BY POLYNUCLEOTIDES | NICOSIA ALFREDO | GLAXOSMITHKLINE BIOLOG SA |
| EP2872105 | IMPROVED COMPOSITIONS FOR ENDODONTIC PROCEDURES | BERGER TODD | DENTSPLY INT INC |
| EP2872107 | COSMETIC COMPOSITION CONTAINING SCREENING COMPOSITE PARTICLES | WILLIEN MAUD | ORéAL L |
| EP2872166 | COMPOSITIONS AND METHODS FOR DETECTING, TREATING AND PREVENTING DISEASES AND DISORDERS | DESIR GARY | UNIV YALE |
| EP2872169 | IMMUNOREGULATORY VACCINE | MUDDE GEERT | TARGET THERAPEUTICS GMBH S |
| EP2872171 | TOXICITY MANAGEMENT FOR ANTI-TUMOR ACTIVITY OF CARS | JUNE CARL H | UNIV PENNSYLVANIA |
| EP2872491 | INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR | BIFULCO NEIL JR | BLUEPRINT MEDICINES CORP |
| EP2872608 | A PROCESS FOR OBTAINING POLYHYDROXYLATED FATTY ALCOHOLS FROM AVOCADO SEED AND THEIR USE IN COSMETICS AND MEDICINE | SEGAL JOSEPH | POLYOL BIOTECH LTD |
| EP2873455 | METHOD FOR MANUFACTURING MICROCAPSULE POWDER | MIZUKAMI SEITARO | TAKEDA PHARMACEUTICAL |
| EP2874634 | USE OF PREPARATIONS COMPRISING EXOSOMES DERIVED FROM MESENCHYMAL STEM CELLS (MSCS) IN THE PREVENTION AND THERAPY OF INFLAMMATORY CONDITIONS | BEELEN DIETRICH WILHELM | UNIVERSITÄT DUISBURG ESSEN |
| EP2875029 | 5,5-HETEROAROMATIC ANTI-INFECTIVE COMPOUNDS | MORASKI GARRETT | MORASKI GARRETT |
| EP2875807 | Tablet formulation of colesevelam | TüRKYILMAZ ALI | SANOVEL ILAC SANAYI VE TICARET AS |
| EP2877189 | ENHANCED RECONSTITUTION AND AUTORECONSTITUTION OF THE HEMATOPOIETIC COMPARTMENT | TURNER BRIAN C | TAIGA BIOTECHNOLOGIES INC |
| EP2877208 | VACCINE COMPOSITIONS | BOUCKENOOGHE ALAIN | SANOFI PASTEUR |
| EP2878294 | Uses of compounds and mixtures from antrodia cinnamomea mycelia | HUANG KAI-WEN | |
| EP2879647 | SKIN CARE | SHARMA RICHA | UNIV PRETORIA |
| EP2879648 | FORMULATION FOR GRITTY FOAM DISPENSER | GRIMADELL LOUISE | PIBED LTD |
| EP2879714 | CYCLODEXTRIN FOR THE TREATMENT OF LYSOSOMAL STORAGE DISEASES | MCKEW JOHN | US HEALTH |
| EP2881122 | PHYSICAL ANTIMICROBIAL METHOD | CAI YOULIANG | NMS TECHNOLOGIES CO LTD |
| EP2881143 | Hair colouring methods and kits thereof | BONAUER CHRISTOPH | PROCTER & GAMBLE |
| EP2882422 | NEUROPROTECTIVE LIPOSOME COMPOSITIONS AND METHODS FOR TREATMENT OF STROKE | HUANG SHAO-LING | UNIV TEXAS |
| EP2882435 | PHARMACEUTICAL FORMULATIONS CONTAINING 3-(4-CINNAMYL-L-PIPERAZINYL) AMINO DERIVATIVES OF 3-FORMYLRIFAMYCIN S | KONSTANTINOVA RUMYANA GUEORGUIEVA | ADIPHARM EAD |
| EP2882442 | METHODS OF TREATING CANCER USING 3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE | SCHAFER PETER H | CELGENE CORP |
| EP2882453 | ANTI-DENGUE VIRUS ANTIBODIES AND USES THEREOF | SASISEKHARAN RAM | MASSACHUSETTS INST TECHNOLOGY |
| EP2882727 | IMMUNOMODULATORY COMPOUNDS | HARNETT MARGARET | UNIV STRATHCLYDE |
| EP2883546 | NEW DIFFERENTIAL-RELEASE PHARMACEUTICAL COMPOSITION CONTAINING THREE ACTIVE PRINCIPLES | AGAPITO PERALTA DARIO | LANDSTEINER SCIENT S A DE C V |
| EP2885003 | COMBINATION OF PI3K INHIBITOR AND C-MET INHIBITOR | CAPONIGRO GIORDANO | NOVARTIS AG |
| EP2885288 | 1,4-DISUBSTITUTED PYRIDAZINE ANALOGS AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS | CHEUNG ATWOOD | NOVARTIS AG |
| EP2887804 | CYCLOALKANYL[B]INDOLES USEFUL AS GLP-1 MODULATORS | WU JIMMY | DARTMOUTH COLLEGE |
| EP2887944 | METHODS OF TREATING EPILEPSY OR TATUS EPILEPTICUS | REDDY KIRAN | SAGE THERAPEUTICS INC |
| EP2887946 | MANAGING WEIGHT LOSS AND BODY MASS | PAN YUANLONG | NESTEC SA |
| EP2887958 | LIPOSOME FORMULATIONS | SANTOS ARTURO | OPKO PHARMACEUTICALS LLC |
| EP2887961 | NEP INHIBITORS FOR TREATING DISEASES CHARACTERIZED BY ATRIAL ENLARGEMENT OR REMODELING | SCHUMACHER CHRISTOPH | NOVARTIS AG |
| EP2887962 | CHEMICAL COMPOSITIONS AND METHODS FOR ENHANCING TRANSDERMAL DELIVERY OF THERAPEUTIC AGENTS | VALIA KIRTI H | INTEGURX THERAPEUTICS LLC |
| EP2888010 | METHODS FOR INHIBITING FASCIN | HUANG XIN-YUN | UNIV CORNELL |
| EP2890256 | NICOTINE COMPOSITION | HEARN ALEX | KIND CONSUMER LTD |
| EP2890360 | STERILISED COMPOSITION COMPRISING AT LEAST ONE HYALURONIC ACID AND MAGNESIUM ASCORBYL PHOSPHATE | BON BETEMPS JéRéMIE | VIVACY LAB |
| EP2890375 | SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B | VANDYCK KOEN | JANSSEN SCIENCES IRELAND UC |
| EP2890384 | DRUG DELIVERY SYSTEMS AND METHODS FOR TREATMENT OF BLADDER CANCER COMPRISING OXALIPLATIN | GIESING DENNIS | TARIS BIOMEDICAL LLC |
| EP2892506 | TREATING HEARING LOSS | EDGE ALBERT | MASSACHUSETTS EYE & EAR INFIRM |
| EP2892511 | BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF | LINDER CHARLES | LAUREN SCIENCES LLC |
| EP2892534 | COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR | LIN JACK | PLEXXIKON INC |
| EP2892535 | METHOD OF ADJUVANT CANCER TREATMENT | LAQUERRE SYLVIE | GLAXOSMITHKLINE LLC |
| EP2892541 | USE OF DECELLULARIZED EXTRACELLULAR MATRIX FOR ENCAPSULATING CELLS | MACHLUF MARCELLE | TECHNION RES & DEV FOUNDATION |
| EP2892997 | URINE STEM CELLS FOR SKELETAL MUSCLE GENERATION AND USES THEREOF | ZHANG YUANYUAN | UNIV WAKE FOREST HEALTH SCIENCES |
| EP2893003 | SELECTIVE AND CONTROLLED EXPANSION OF EDUCATED NK CELLS | MALMBERG KARL-JOHAN | INVEN2 AS |
| EP2893921 | Method and apparatus for producing dry particles | BATYCKY RICHARD P | CIVITAS THERAPEUTICS INC |
| EP2893922 | Pharmaceutical formulations for the treatment of pulmonary arterial hypertension | YACOUB MAGDI | HEART BIOTECH PHARMA LTD |
| EP2893923 | RELEASE OF SUBSTANCES INTO SENESCENT CELLS | MARTíNEZ MáÑEZ RAMóN | UNIV POLITéCNICA DE VALENCIA UPV |
| EP2895143 | A COMPOSITION FOR COGNITION AND COSMESTIC PURPOSES | V K GEORGE ANNIE GEORGE | BIOTROPICS MALAYSIA BERHAD |
| EP2895607 | DOUBLE-STRANDED OLIGONUCLEOTIDE MOLECULES TO DDIT4 AND METHODS OF USE THEREOF | FEINSTEIN ELENA | QUARK PHARMACEUTICALS INC |
| EP2897583 | SLURRY POWDER COSMETIC COMPOSITIONS AND METHODS | FINJAN TALAL | ELC MAN LLC |
| EP2897618 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | QIAN XIANGPING | NEUPHARMA INC |
| EP2897622 | METHODS FOR TREATMENT OR PREVENTION OF DAMAGE RESULTING FROM RADIATION | BAKER SHENDA M | SYNEDGEN INC |
| EP2898873 | A method of treatment of the dental pulp and filling root canals using water-based materials | PRIMUS CAROLYN M | DENTSPLY INT INC |
| EP2900231 | TOPICAL KETOPROFEN COMPOSITION | BUYUKTIMKIN SERVET | ACHELIOS THERAPEUTICS INC |
| EP2900331 | COMBINATION METHODS AND COMPOSITIONS INCLUDING SLEEP THERAPEUTICS FOR TREATING MOOD | FEUERSTEIN SETH D | FEUERSTEIN SETH D |
| EP2902006 | CURABLE COMPOSITION FOR DENTISTRY, AND METHOD FOR PRODUCING SAME | ISHIHARA SHUMEI | KURARAY NORITAKE DENTAL INC |
| EP2903590 | PLANT LIPID COMPOSITION FOR MODULATING FUNCTIONS OF KERATINOUS MATERIALS, METHOD FOR MODULATING SAID FUNCTIONS AND USE OF SAID PLANT LIPIDS | FERRARI CINTIA ROSA | NATURA COSMéTICOS S A |
| EP2903610 | CANCER TREATMENTS | MARKOVIC SVETOMIR N | MAYO FOUNDATION |
| EP2903614 | NOVEL COMPOUNDS, THEIR SYNTHESIS AND THEIR USES | DUGAR SUNDEEP | SPHAERA PHARMA PTE LTD |
| EP2903615 | INDOLINE COMPOUNDS AS ALDOSTERONE SYNTHASE INHIBITIORS RELATED APPLICATIONS | ALI AMJAD | MERCK SHARP & DOHME |
| EP2903651 | CARBOXYLATED POLYAMINE DERIVATIVES AS TRANSFECTION REAGENTS | PANZNER STEFFEN | LIPOCALYX GMBH |
| EP2906040 | NOVEL BENZIMIDAZOLE TETRAHYDROPYRAN DERIVATIVES | APGAR JAMES M | MERCK SHARP & DOHME |
| EP2906225 | METHODS OF TREATING KENNEDY'S DISEASE | HUNG GENE | ISIS PHARMACEUTICALS INC |
| EP2906245 | DIAGNOSIS, PREVENTION AND TREATMENT OF DISEASES OF THE JOINT | VETTER DIRK | ASCENDIS PHARMA AS |
| EP2908805 | LEVODOPA FORMULATIONS FOR RAPID RELIEF OF PARKINSON'S DISEASE | FREED MARTIN | CIVITAS THERAPEUTICS INC |
| EP2909184 | NEW COMPOUNDS HAVING A PROTECTIVE ACTIVITY AGAINST TOXINS WITH INTRACELLULAR ACTIVITY | GILLET DANIEL | COMMISSARIAT L éNERGIE ATOMIQUE ET AUX éNERGIES ALTERNATIVES |
| EP2909222 | 2',4'-BRIDGED NUCLEOSIDES FOR HCV INFECTION | MAYES BENJAMIN ALEXANDER | IDENIX PHARMACEUTICALS INC |
| EP2909313 | PRODUCTION OF RED BLOOD CELLS AND PLATELETS FROM STEM CELLS | MURPHY GEORGE J | BOSTON MEDICAL CT CORP |
| EP2910240 | Method for the manufacture of globules | HOFMANN WERNER | BIOLOG HEILMITTEL HEEL GMBH |
| EP2911511 | STABLE PRESERVATIVE-FREE MYDRIATIC AND ANTI-INFLAMMATORY SOLUTIONS FOR INJECTION | DEMOPULOS GREGORY A | OMEROS CORP |
| EP2911686 | PEPTIDES AND METHODS FOR PREVENTING ISCHEMIC TISSUE INJURY | HUSAIN MANSOOR | UNIV HEALTH NETWORK |
| EP2912019 | HETEROARYL INHIBITORS OF PDE4 | GURNEY MARK E | TETRA DISCOVERY PARTNERS LLC |
| EP2912186 | PLATELET TARGETED TREATMENT | WILCOX DAVID A | PLATELET TARGETED THERAPEUTICS LLC |
| EP2914229 | EASY ACCESS BANDAGES, PACKAGING, AND SYSTEMS FOR APPLICATION | HOLSTEIN MICHAEL | GENUINE FIRST AID INTERNAT LTD |
| EP2914233 | DENTAL COMPOSITIONS | TADROS JOSHUA GEORGE | OZDENT PTY LTD |
| EP2914255 | TREATMENT OR PREVENTION OF CARDIOVASCULAR EVENTS VIA THE ADMINISTRATION OF A COLCHICINE DERIVATIVE | NIDORF MARK | MURRAY & POOLE ENTPR LTD |
| EP2914271 | AGENTS FOR THE PREVENTION AND/OR TREATMENT OF CENTRAL NERVOUS SYSTEM DAMAGE | TURNBULL JEREMY EWAN | UNIV LIVERPOOL |
| EP2914278 | XBP1, CD138, AND CS1 PEPTIDES, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THE PEPTIDES, AND METHODS OF USING SUCH PEPTIDES AND COMPOSITIONS | BAE JOOEUN | DANA FARBER CANCER INST INC |
| EP2914286 | NOVEL IMMUNOTHERAPEUTIC MOLECULES AND USES THEREOF | O'HEHIR ROBYN | UNIV MONASH |
| EP2914616 | PEPTIDES THAT BIND TO AMINO-TERMINAL TRUNCATED AMYLOID-BETA-PEPTIDE AND USE OF SAID PEPTIDES | WILLBOLD DIETER | FORSCHUNGSZENTRUM JüLICH GMBH |
| EP2914627 | ANTI-CD40 ANTIBODIES AND METHODS OF USE | ZHANG YONGKE | APEXIGEN INC |
| EP2914630 | NOVEL ANTIGEN BINDING PROTEINS AND THEIR USE AS ADDRESSING PRODUCT FOR THE TREATMENT OF CANCER | BEAU-LARVOR CHARLOTTE | PIERRE FABRE MéDICAMENT |
| EP2914633 | ANTIBODY/DRUG CONJUGATES AND METHODS OF USE | LEUSCHNER CAROLA | ESPERANCE PHARMACEUTICALS INC |
| EP2915525 | Sublingual abuse-resistant tablets comprising buprenorphine and naloxone | FISCHER ANDREAS | OREXO AB |
| EP2915526 | Pharmaceutical compositions comprising anagrelide | ARROYO HIDALGO SERGIO | GALENICUM HEALTH SL |
| EP2916826 | ULTRA LOW DENSITY PULMONARY POWDERS | LIPP MICHAEL M | CIVITAS THERAPEUTICS INC |
| EP2917244 | APROTININ-DERIVED POLYPEPTIDE-ANTIBODY CONJUGATES | TRIPATHY SASMITA | ANGIOCHEM INC |
| EP2918265 | PRESSURE-SENSITIVE HYDROGEL AND METHOD OF USE | LIAO CHUN JEN | |
| EP2918284 | POLYPEPTIDES DERIVED FROM TGF AND USES THEREOF | CORRIA OSORIO áNGEL DE JESúS | CENTRO INMUNOLOGIA MOLECULAR |
| EP2919585 | ECTOPARASITICIDAL METHODS AND FORMULATIONS | WINKLE JOSEPH RAYMOND | LILLY CO ELI |
| EP2919705 | THREE-DIMENSIONAL FABRICATING MATERIAL SYSTEMS FOR PRODUCING DENTAL PRODUCTS | SUN BENJAMIN JIEMIN | DENTSPLY INT INC |
| EP2919766 | SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB | NI YONG | INCYTE CORP |
| EP2919794 | MINCED CARTILAGE SYSTEMS AND METHODS | SHI YALING | ALLOSOURCE |
| EP2919795 | SOLUBILIZATION OF ANTIGEN COMPONENTS FOR REMOVAL FROM TISSUES | GRIFFITHS LEIGH G | UNIV CALIFORNIA |
| EP2919796 | USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS | CANI PATRICE | UNIVERSITé CATHOLIQUE DE LOUVAIN |
| EP2919799 | SOLUBLE MEDIATOR | HARRISON LEONARD CHARLES | INST MEDICAL W & E HALL |
| EP2920168 | HETEROCYCLIC GLUTAMINASE INHIBITORS | LI JIM | CALITHERA BIOSCIENCES INC |
| EP2920298 | METHOD OF EXTRACTING NEURAL STEM CELLS USING NANOPARTICLES | YUNG KIN-LAM | UNIV HONG KONG BAPTIST |
| EP2922526 | MANUFACTURING OF SEMI-PLASTIC PHARMACEUTICAL DOSAGE UNITS | KLUGER DOMINIQUE | INTERVET INT BV |
| EP2922535 | THROMBIN INHIBITORS | CHOBANIAN HARRY | MERCK SHARP & DOHME |
| EP2922591 | TREATMENT OF THALAMOCORTICAL DYSRHYTHMIA | BEST STEVEN RICHARD DEVORE | BEST STEVEN RICHARD DEVORE |
| EP2922816 | DTPA DI-ETHYL ESTERS, COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME | JAY MICHAEL | UNIV NORTH CAROLINA |
| EP2922829 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | ROBERTS TUCKER CURRAN | RQX PHARMACEUTICALS INC |
| EP2922859 | PHOSPHONUCLEOSIDES USEFUL IN THE TREATMENT OF VIRAL DISORDERS | DEHAEN WIM | UNIV CORK |
| EP2922867 | METHOD OF INCREASING THE HYDRODYNAMIC VOLUME OF POLYPEPTIDES BY ATTACHING TO GONADOTROPHIN CARBOXY TERMINAL PEPTIDES | HERSHKOVITZ OREN | OPKO BIOLOG LTD |
| EP2923698 | USE OF STATIN COMPOUND IN PREPARATION OF TOPICAL DRUG FOR TREATING OBESITY, DIABETES, HYPERTENSION AND HYPERLIPAEMIA | SONG CHUNLI | UNIV PEKING 3RD HOSPITAL |
| EP2925296 | COMPOSITIONS FOR THE TREATMENT OF ROSACEA | SERTCHOOK HANAN | SOL GEL TECHNOLOGIES LTD |
| EP2925320 | NOVEL METHOD FOR IMPROVING THE BIOAVAILABILITY OF LOW AQUEOUS SOLUBILITY DRUGS | KARAVAS EVANGELOS | PHARMATHEN SA |
| EP2925329 | USE OF POST-TRANSPLANT CYCLOPHOSPHAMIDE TREATED ALLOGENEIC MARROW INFILTRATING LYMPHOCYTES TO AUGMENT ANTI-TUMOR IMMUNITY | BORRELLO IVAN MARQUES | UNIV JOHNS HOPKINS |
| EP2925330 | PHARMACEUTICAL COMPOSITIONS FOR TREATING OBESITY | BIZZINI BERNARD | DIOPEITE SA |
| EP2925755 | NEUROPROTECTIVE AGENTS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | DUTTA ALOKE K | UNIV WAYNE STATE |
| EP2925771 | A PROCESS FOR THE PREPARATION OF SOLOMONAMIDE ANALOGUES | REDDY DUMBALA SRINIVASA | COUNCIL SCIENT IND RES |
| EP2926811 | ARTEMETHER-CONTAINING PHARMACEUTICAL COMPOSITION, PREPARATION, AND USE THEREOF | QING CHEN | KUNMING PHARMACEUTICAL CORP |
| EP2926824 | INHIBITOR OF INFLAMMATORY CONDITIONS | BLAIN EMMA JANE | COMPTON DEVELOPMENTS LTD |
| EP2927321 | CH3 DOMAIN VARIANT PAIR INDUCING FORMATION OF HETERODIMER OF HEAVY CHAIN CONSTANT REGION OF ANTIBODY AT HIGH EFFICIENCY, METHOD FOR PREPARING SAME, AND USE THEREOF | KIM YONG SUNG | AJOU UNIV IND ACAD COOP FOUND |
| EP2928456 | METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER | MANIAR MANOJ | ONCONOVA THERAPEUTICS INC |
| EP2928484 | COMPOUNDS USEFUL IN THE TREATMENT AND/OR CARE OF THE SKIN, HAIR AND/OR MUCOUS MEMBRANES AND THEIR COSMETIC OR PHARMACEUTICAL COMPOSITIONS | VAN DEN NEST WIM | LUBRIZOL ADVANCED MAT INC |
| EP2928498 | TRIAZINE FORMULATIONS WITH A SECOND ACTIVE INGREDIENT AND SURFACTANT(S) | LE MEUR ANNE CLAIRE | CEVA SANTé ANIMALE SA |
| EP2928898 | BETA-LACTAMASE INHIBITORS | BURNS CHRISTOPHER J | VENATORX PHARMACEUTICALS INC |
| EP2928921 | COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING EPO | GHOSH JOY | NOVARTIS AG |
| EP2929886 | COMPOSITION COMPRISING PHOSPHODIESTERASE TYPE 5 INHIBITOR FOR INHIBITING APOPTOSIS OF NERVE CELLS | KIM MYUNG HWA | ARIBIO INC |
| EP2930180 | DOUBLE-STRANDED RIBONUCLEIC ACID FOR ADJUVANTS | NAKANO TETSUO | KYOWA HAKKO BIO CO LTD |
| EP2931042 | ANTHRACYCLINE FORMULATIONS | GEYER SCOTT | CYTRX CORP |
| EP2931291 | XENON TREATMENT AS AN ADJUNCT TO PSYCHOTHERAPY FOR PSYCHIATRIC DISORDERS | MELONI EDWARD G | MCLEAN HOSPITAL CORP |
| EP2931304 | WT1 VACCINE | WEINER DAVID B | UNIV PENNSYLVANIA |
| EP2931775 | CHAIN-EXTENDING POLOXAMERS, THERMOREVERSIBLE HYDROGELS FORMED BY THEM WHICH INCLUDE BIOLOGICAL MATERIALS, AND MEDICINAL APPLICATIONS OF SAME | WIESE HINRICH | SCHIEKER MATTHIAS |
| EP2931903 | VIRAL VECTOR NANOCAPSULE FOR TARGETING GENE THERAPY AND ITS PREPARATION | LU YUNFENG | UNIV CALIFORNIA |
| EP2932962 | Stable powder formulation containing an anticholinergic agent | TRUNK MICHAEL | BOEHRINGER INGELHEIM INT |
| EP2932980 | MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION | PARK MAHN-HOON | SK CHEMICALS CO LTD |
| EP2932981 | Albumin-binding derivatives of GLP-1 | JOHANSEN NILS LANGELAND | NOVO NORDISK AS |
| EP2933251 | PHARMACEUTICAL COMPOSITION USABLE FOR THE TREATMENT OF A PATHOLOGY OF THE FOOT OF A HOOFED MAMMAL | WEYTS PETER M | WEYTS PETER |
| EP2933254 | NOVEL COMPOUND, PHARMACEUTICALLY ACCEPTABLE SALT OR OPTICAL ISOMER THEREOF, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF VIRAL DISEASES CONTAINING SAME AS ACTIVE INGREDIENT | JUNG YOUNG SIK | KOREA RES INST CHEM TECH |
| EP2934483 | DIALYSIS COMPOSITION | FORSBÄCK GUNITA | GAMBRO LUNDIA AB |
| EP2934505 | EICOSAPENTAENOIC ACID (EPA) FORMULATIONS | WAIBEL BRIAN J | QUALITAS HEALTH LTD |
| EP2934512 | USE OF CANNABINOIDS AND TERPENES FOR TREATMENT OF ORGANOPHOSPHATE AND CARBAMATE TOXICITY | MORGAN JOSEPH | KOTZKER CONSULTING LLC |
| EP2934519 | THERAPEUTIC THIAZOLIDINONE COMPOUNDS | SHAO PENCHENG PATRICK | MERCK SHARP & DOHME |
| EP2934538 | FACTOR IXA INHIBITORS | SMITH CAMERON JAMES | MERCK SHARP & DOHME |
| EP2934555 | METHODS FOR PRODUCTION OF PLATELETS FROM PLURIPOTENT STEM CELLS AND COMPOSITIONS THEREOF | FENG QIANG | OCATA THERAPEUTICS INC |
| EP2934589 | GLYCAN-MODIFIED ANTI-CD4 ANTIBODIES FOR HIV PREVENTION AND THERAPY | SONG RUIJIANG | UNIV ROCKEFELLER |
| EP2935303 | SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF | BEIGELMAN LEONID | ALIOS BIOPHARMA INC |
| EP2935313 | VACCINES AGAINST HEPATITIS B VIRUS | GEORGES BERTRAND VICTOR GILBERT | VAXIN UK LTD |
| EP2935611 | GLYCOENGINEERED ANTIBODY, ANTIBODY-CONJUGATE AND METHODS FOR THEIR PREPARATION | VAN DELFT FLORIS LOUIS | SYNAFFIX BV |
| EP2937077 | ORAL LIQUID FORMULATIONS COMPRISING HERBAL EXTRACTS | CIFTER üMIT | MONTERO GIDA SANAYI VE TICARET AS |
| EP2937087 | COMPOSITION AND FOOD OR DRINK | MASUZAKI HIROAKI | ADVANCED MEDICAL FRONTIER CO LTD |
| EP2937348 | CRYSTAL FORM OF COMPOUND USED AS MINERALOCORTICOID RECEPTOR ANTAGONIST AND PREPARATION METHOD THEREFOR | JIANG CHEN | KBP BIOSCIENCES CO LTD |
| EP2938326 | NOVEL VETERINARY PHARMACEUTICAL COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF | DELHOM NATHALIE | VIRBAC |
| EP2938335 | MULTI-POLYMER COMPOSITIONS FOR TRANSDERMAL DRUG DELIVERY | KULAKOFSKY JOSHUA | NOVEN PHARMA |
| EP2938355 | MONOVALENT AND POLYVALENT VACCINES AGAINST LEISHMANIA | PAPIEROK GéRARD-MARIE | VIRBAC SA |
| EP2938608 | SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 | PINKERTON ANTHONY | SANFORD BURNHAM MED RES INST |
| EP2939694 | DIALYSIS AGENT, AND METHOD FOR PRODUCING DIALYSIS AGENT | HARUTA YOSHIHISA | NIKKISO CO LTD |
| EP2939993 | COLORED LIGHT-TRANSMITTING ZIRCONIA SINTERED BODY AND USE THEREOF | KAWAMURA KIYOTAKA | TOSOH CORP |
| EP2940135 | HETERODIMERIZED POLYPEPTIDE | IGAWA TOMOYUKI | CHUGAI PHARMACEUTICAL CO LTD |
| EP2941253 | METHODS FOR REDUCING CELLULAR PROLIFERATION AND TREATING CERTAIN DISEASES | GENBERG CARL | UNIV BRIGHAM YOUNG |
| EP2941264 | A METHOD FOR TREATING TUMOR BY USING RECOMBINANT INTERFERON WITH CHANGED SPATIAL CONFIGURATION | WEI GUANGWEN | SUPERLAB FAR EAST LTD |
| EP2941265 | USES OF BT LIPOPEPTIDES AS THERAPEUTICS FOR OBESITY AND RELATED DISEASES | JIANG YIWEI | MYGALAXY LTD COMPANY |
| EP2941271 | C-TERMINAL HSP90 INHIBITORS TO TREAT PITUITARY ADENOMAS | PAEZ-PEREDA MARCELO | MAX PLANCK GES ZUR FÖRDERUNG DER WISSENSCHAFTEN E V |
| EP2941423 | DEOXYURIDINE TRIPHOSPHATASE INHIBITORS | LADNER ROBERT D | UNIV SOUTHERN CALIFORNIA |
| EP2941434 | MANGANESE-BASED MAGNETIC RESONANCE CONTRAST AGENTS | CARAVAN PETER | GEN HOSPITAL CORP |
| EP2941435 | MANNOSE-RECEPTOR SELECTIVE LYSINYLATED CATIONIC AMPHIPHILES AND A PROCESS FOR PREPARATION THEREOF | GARU ARUP | COUNCIL SCIENT IND RES |
| EP2941440 | POLYMERIC FORMS OF H-NOX PROTEINS | KAPP GREGORY | OMNIOX INC |
| EP2943189 | METHODS AND COMP0STIONS FOR TREATMENT OF DEMYELINATING DISEASES | BLITZER JEREMY | PATHOLOGICA LLC |
| EP2943192 | METHODS OF TREATING PANCREATIC CANCER | DESAI NEIL P | ABRAXIS BIOSCIENCE LLC |
| EP2943209 | DECELLULARIZED BIOMATERIAL FORM NON-MAMMALIAN TISSUE | EARLY RYANNE | ISE PROFESSIONAL TESTING & CONSULTING SERVICES INC |
| EP2943219 | VACCINE TO PREVENT MYCOPLASMAL INFECTION IN WATERFOWL | SZATHMARY DR SUSAN | SZATHMARY DR SUSAN |
| EP2943253 | COMPOSITIONS AND METHODS FOR THE REGULATION OF T REGULATORY CELLS USING TL1A-IG FUSION PROTEIN | SCHREIBER TAYLOR H | PODACK ECKHARD R |
| EP2943454 | TAPENTADOL MALEATE AND CRYSTALLINE FORMS THEREOF | KLJAJIC ALEN | FARMA GRS D O O |
| EP2943463 | FLUORINATED CBD COMPOUNDS, COMPOSITIONS AND USES THEREOF | MECHOULAM RAPHAEL | YISSUM RES DEV CO |
| EP2944306 | VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION | GRAHAM KENNETH S | REGENERON PHARMA |
| EP2944627 | NANOMETERSIZED METAL SALEN COMPLEX COMPOUNDS, THEIR PREPARATION AND THEIR USE AS SYSTEMIC ANTITUMOR AGENTS | ISHIKAWA YOSHIHIRO | IHI CORP |
| EP2945597 | GLASS CERAMIC MATERIAL AND METHOD | XIA WEI | HARRYSON CONSULTING GMBH |
| EP2945614 | GASTRO-RETENTIVE SUSTAINED-RELEASE ORAL DOSAGE FORM OF A BILE ACID SEQUESTRANT | SETHURAMAN VASU | IRONWOOD PHARMACEUTICALS INC |
| EP2945633 | USE OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS | FENDT MARKUS | NOVARTIS AG |
| EP2945637 | USE OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS | FENDT MARKUS | NOVARTIS AG |
| EP2945652 | METHODS OF TREATING CHOLANGIOCARCINOMA | MILLER VINCENT A | FOUNDATION MEDICINE INC |
| EP2945705 | FLEXIBLE SOLID COSMETIC COMPOSITION COMPRISING ANIONIC SURFACTANTS AND SOLID PARTICLES, AND COSMETIC TREATMENT PROCESS | THOMAS BéATRICE | ORéAL L |
| EP2945706 | FLEXIBLE SOLID COSMETIC COMPOSITION COMPRISING ANIONIC SURFACTANTS AND POLYMER CONDITIONING AGENTS, AND COSMETIC TREATMENT METHOD& xA; | THOMAS BEATRICE | ORéAL L |
| EP2945709 | COMPOSITION FOR INCREASING OF THE EFFECTIVENESS OF UV-B THERAPY, PROCESS FOR THE PREPARATION THEREOF, AND ITS USE | KEMéNY LAJOS | GLOBALDERM KOZMETOLóGIAI KORLáTOLT FELELOSSéG TáRSASáG |
| EP2946791 | Anti-CD277 antibodies and uses thereof | OLIVE DANIEL | INSERM INST NAT DE LA SANTé ET DE LA RECH MéDICALE |
| EP2948142 | COMBINATIONS WITH 2-AMINOETHANESULFONIC ACID | ZWICKL DR MARKUS | BOEHRINGER INGELHEIM INT |
| EP2948143 | USE OF PHENOXYPROPYLAMINE COMPOUNDS TO TREAT DEPRESSION | PELLEGRINI LORENZO | MINERVA NEUROSCIENCES INC |
| EP2948172 | GLYCOCONJUGATE VACCINES | WREN BRENDAN | LONDON SCHOOL HYGIENE & TROPICAL MEDICINE |
| EP2948188 | NEURONAL IMAGING AND TREATMENT | BEN-HAIM SHLOMO | TYLERTON INTERNAT HOLDINGS INC |
| EP2949315 | EXPANSION CARRIER WITH ACTIVE COMPONENT AND USE THEREOF | QIU MINGSHI | HARBIN OT PHARMACEUTICAL CO LTD |
| EP2949675 | HUMANIZED ANTI-HMGB1 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF | TAKADA KENZO | EVEC INC |
| EP2950777 | PERIODONTAL DISEASE TREATMENT | BERG MARIANNE | STRAUMANN HOLDING AG |
| EP2950784 | REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPOSOMES | HAYES MARK E | ZONEONE PHARMA INC |
| EP2950798 | PPAR AGONISTS FOR TREATMENT OF MULTIPLE SCLEROSIS | WEINSTEIN DAVID | INTEKRIN THERAPEUTICS INC |
| EP2951205 | ADMINISTRATION OF AN ANTI-ACTIVIN-A COMPOUND TO A SUBJECT | HAN HUIQUAN | SANTA MARIA BIOTHERAPEUTICS INC |
| EP2951292 | PLATELETS TRANSFECTED BY EXOGENOUS GENETIC MATERIAL AND PLATELET MICROPARTICLES OBTAINED BY SAID TRANSFECTED PLATELETS, METHOD FOR THE PREPARATION AND USES THEREOF | GRESELE PAOLO | GRESELE PAOLO |
| EP2952177 | COMPOSITIONS COMPRISING SPHINGOSINE I PHOSPHATE (SIP) RECEPTOR MODULATORS | RUEGGER COLLEEN | NOVARTIS AG |
| EP2952199 | USE OF ALLOGENEIC INTERSTITIAL VESSEL-LAYER CELL AND ALLOGENEIC MESENCHYMAL PROGENITOR CELL FOR PREVENTING OR TREATING OSTEOARTHRITIS | CAO WEI | CELLULAR BIOMEDICINE GROUP SHANGHAI LTD |
| EP2953463 | 3-ALKYL-5-FLUORO-4-SUBSTITUTED-IMINO-3,4-DIHYDROPYRIMIDIN-2(1H)-ONE DERIVATIVES AS FUNGICIDES | LORSBACH BETH | DOW AGROSCIENCES LLC |
| EP2953611 | USE OF A COMPOSITION COMPRISING AVOCADO PERSEOSE IN THE PROTECTION OF EPIDERMAL STEM CELLS | MSIKA PHILIPPE | EXPANSCIENCE LAB |
| EP2953622 | METHODS OF TREATING MELANOMA | DESAI NEIL P | ABRAXIS BIOSCIENCE LLC |
| EP2953623 | METHODS OF TREATING TOPICAL MICROBIAL INFECTIONS | PAGE STEPHEN | LUODA PHARMA PTY LTD |
| EP2953634 | METHODS FOR EXPANSION OR DEPLETION OF T-REGULATORY CELLS | FAUSTMAN DENISE L | GEN HOSPITAL CORP |
| EP2953639 | TREATMENT OF DNA DAMAGE AND MITOCHONDRIAL DYSFUNCTION USING PALM FRUIT JUICE | OSBORNE ADAM E | UNIV BRANDEIS |
| EP2953646 | BIODEGRADABLE AND CLINICALLY-COMPATIBLE NANOP ARTICLES AS DRUG DELIVERY CARRIERS | LI CHIANG J | 1GLOBE HEALTH INST LLC |
| EP2953648 | NANOPARTICLES CONTAINING A TAXANE AND THEIR USE | YIN RAY | ANP TECHNOLOGIES INC |
| EP2953682 | BIOSPECIFIC AGENTS FOR BONE | SANTIN MATTEO | ORTHOPAEDIC RES UK |
| EP2953926 | POSITION-SPECIFIC ASYMMETRIC DEUTERIUM ENRICHED CATECHOLAMINE DERIVATIVES AND MEDICAMENTS COMPRISING SAID COMPOUNDS | ALKEN RUDOLF-GIESBERT | IMPHAR AG |
| EP2953950 | COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES | HERTZ NICHOLAS T | UNIV CALIFORNIA |
| EP2953976 | SPECIFIC SITES FOR MODIFYING ANTIBODIES TO MAKE IMMUNOCONJUGATES | GEIERSTANGER BERNHARD HUBERT | IRM LLC |
| EP2955185 | POLYCYCLIC SUBSTITUTED PYRAZOLE KINASE ACTIVITY INHIBITORS AND USE THEREOF | LU TAO | UNIV CHINA PHARMA |
| EP2956122 | SUPRAMOLECULAR MAGNETIC NANOPARTICLES | CHEON JINWOO | UNIV CALIFORNIA |
| EP2956150 | SERUM FRACTION OF PLATELET-RICH FIBRIN | LACZA ZSOMBOR | LACERTA TECHNOLOGIES INC |
| EP2956185 | A POLYMERIC SYSTEM FOR RELEASE OF AN ACTIVE AGENT | KURISAWA MOTOICHI | AGENCY SCIENCE TECH & RES |
| EP2957282 | ORAL ANTISEPTIC COMPOSITION FOR TREATING ORAL MUCOSITIS | GALVáN GONZáLEZ TOMáS BERNARDO | GALVáN GONZáLEZ TOMáS BERNARDO |
| EP2957300 | MULTIVALENT MENINGOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE VACCINE | RYALL ROBERT | SANOFI PASTEUR INC |
| EP2958569 | SUGAR-ANALOG PHOSPHORUS-CONTAINING HETEROCYCLES HAVING AN ANTI-METASTATIC ACTIVITY | BAKALARA NORBERT | CENTRE NAT RECH SCIENT |
| EP2958590 | INACTIVE N-ACETYLATED-ALPHA-LINKED ACIDIC DIPEPTIDASE-LIKE PROTEIN 2 (NAALADL2) AS A THERAPEUTIC AND DIAGNOSTIC TARGET | HUDSON LINDSEY JANE | OXFORD BIO THERAPEUTICS LTD |
| EP2958593 | PHARMACEUTICAL COMPOSITION FOR TRANSMUCOSAL ADMINISTRATION OF BENZODIAZEPINES | SCHWARZ JOSEPH | EASTGATE PHARMACEUTICALS INC |
| EP2958624 | TREATMENT OF GRAFT VERSUS HOST DISEASE IN TRANSPLANT PATIENTS | GERGELY PETER | NOVARTIS AG |
| EP2959005 | COMPOUNDS, COMPOSITIONS, METHODS, AND KITS RELATING TO TELOMERE EXTENSION | RAMUNAS JOHN | UNIV LELAND STANFORD JUNIOR |
| EP2961415 | METHODS OF PRODUCING ENRICHED POPULATIONS OF TUMOR-REACTIVE T CELLS FROM TUMOR | GROS ALENA | US HEALTH |
| EP2961733 | DISULFIDE COMPOUNDS FOR DELIVERY OF PHARMACEUTICAL AGENTS | XU QIAOBING | UNIV TUFTS |
| EP2961774 | ALPHA-SYNUCLEIN ANTIBODIES AND USES THEREOF | EL-AGNAF OMAR | UNIV UNITED ARAB EMIRATES |
| EP2962698 | PHARMACEUTICAL COMPOSITION INCLUDING MIGRATORY FACTOR FOR GUIDING PLURIPOTENT STEM CELLS TO INJURY | DEZAWA MARI | CLIO INC |
| EP2964142 | WAX-BASED COMPOSITIONS, ARTICLES MADE THEREFROM, AND METHODS OF MANUFACTURE AND USE | JOHNSON STEVEN B | ULTRADENT PRODUCTS INC |
| EP2964209 | CO-ADMINISTRATION OF STEROIDS AND ZOLEDRONIC ACID TO PREVENT AND TREAT OSTEOARTHRITIS | DESAI KETAN | LEVOLTA PHARMACEUTICALS INC |
| EP2964233 | METHODS OF TREATING, REDUCING THE INCIDENCE OF, AND/OR PREVENTING ISCHEMIC EVENTS | ARCULUS-MEANWELL CLIVE ARTHUR | MEDICINES CO |
| EP2964238 | ABCB5(+) STEM CELLS FOR TREATING OCULAR DISEASE | FRANK MARKUS H | CHILDRENS MEDICAL CENTER |
| EP2964334 | COMPOSITIONS AND METHODS FOR TREATING DAMAGED HAIR | YANG SEN | AVON PROD INC |
| EP2966079 | PYRIDOPYRIMIDINE OR PYRIMIDOPYRIMIDINE COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF | SHEN JINGKANG | SHANGHAI INST MATERIA MEDICA |
| EP2967764 | DENTAL TREATMENT METHOD AND ABUTMENT USED THEREIN | ABBOUD MARCUS | UNIV NEW YORK STATE RES FOUND |
| EP2968071 | DEVICE FOR ORAL DELIVERY OF THERAPEUTIC COMPOUNDS | IMRAN MIR | RANI THERAPEUTICS LLC |
| EP2968083 | DENTAL COMPOSITION COMPRISING CHELATOR AND BASE | STEIN EMILY A | STEIN EMILY A |
| EP2968090 | METHOD OF REMOVING POLYMERIZED COATINGS FOR HUMAN NAILS, POLYMERIZED COATING FOR HUMAN NAILS HAVING IMPROVED REMOVABILITY, AND TWO PACKAGE SYSTEM | KOZACHECK JOSEPH | MYCONE DENTAL SUPPLY COMPANY INC |
| EP2968134 | AQUEOUS DELIVERY SYSTEM FOR LOW SURFACE ENERGY STRUCTURES | FREESE DONALD T | GORE & ASS |
| EP2968137 | EMULSION FORMULATIONS | DHINGRA OM | DIFFERENTIAL DRUG DEV ASSOCIATES LLC |
| EP2968155 | TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS | HERBIG SCOTT MAX | PFIZER |
| EP2968191 | METHODS OF TREATING BLADDER CANCER | DESAI NEIL P | ABRAXIS BIOSCIENCE LLC |
| EP2968193 | METHODS AND DEVICES FOR PREPARATION OF LIPID NANOPARTICLES | ZHU DE-MIN | CUREPORT INC |
| EP2968211 | PHENYL ALKYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING EPILEPSY OR EPILEPSY-RELATED SYNDROME | CHOI YONG MOON | BIO PHARM SOLUTIONS CO LTD |
| EP2968214 | NOVEL ANALGESIC COMPOSITIONS | SPAKEVICIUS DANGUOLE | VAPOGENIX INC |
| EP2968215 | THIOSACCHARIDE MUCOLYTIC AGENTS | OSCARSON STEFAN | UNIV CALIFORNIA |
| EP2968218 | METHOD FOR TREATMENT OF PARKINSON'S DISEASE | YACOBY-ZEEVI ORON | NEURODERM LTD |
| EP2968220 | METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION | SMITH GARDINER | AGENEBIO INC |
| EP2968245 | COMPOSITIONS AND METHODS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS | HARADA TSUYOSHI | MOCHIDA PHARM CO LTD |
| EP2968272 | USE OF INDOLE COMPOUNDS FOR FAT REDUCTION AND SKIN AND SOFT TISSUE TIGHTENING | DUNCAN DIANE | ALEVERE MEDICAL CORP |
| EP2968284 | ALKYL-AMINE HARMINE DERIVATIVES FOR PROMOTING BONE GROWTH | ELLIES DEBRA | OSTEOQC INC |
| EP2968299 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | LI ZHE | GLOBAL BLOOD THERAPEUTICS INC |
| EP2968330 | COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS | SCHULTZ PETER G | CALIFORNIA INST BIOMEDICAL RES |
| EP2968337 | HETEROARYL COMPOUNDS AND USES THEREOF | D AGOSTINO LAURA AKULLIAN | CELGENE AVILOMICS RES INC |
| EP2968359 | METHODS OF INHIBITING LEUKOTRIENE A4 HYDROLASE | SPRINGMAN ERIC B | CELTAXSYS INC |
| EP2968360 | METHODS AND COMPOSITIONS FOR INHIBITION OF BROMODOMAIN-CONTAINING PROTEINS | VANKAYALAPATI HARIPRASAD | CONVERGENE LLC |
| EP2968379 | ETOPOSIDE PRODRUGS FOR USE IN TARGETING CANCER STEM CELLS | UTKU NALAN | CELLACT PHARMA GMBH |
| EP2968414 | TREATMENT OF COLLAGEN DEFECTS USING PROTEIN SOLUTIONS | MATUSKA ANDREA | BIOMET BIOLOGICS LLC |
| EP2968443 | HEPCIDIN ANALOGUES AND USES THEREOF | SMYTHE MARK LESLIE | PROTAGONIST THERAPEUTICS INC |
| EP2968460 | PROTEIN FORMULATIONS | PARK SUNGAE | AMGEN INC |
| EP2968464 | IMPROVED METHODS OF USE FOR RECOMBINANT HUMAN SECRETOGLOBINS | PILON APRILE L | THERABRON THERAPEUTICS INC |
| EP2968465 | ANGIOGENIC COMPOSITIONS FOR WOUNDS, ARTICULAR JOINTS AND GRAFT MATERIALS | GARDNER VANCE | CARDIOVASCULAR BIOTHERAPEUTICS INC |
| EP2968468 | CHIMERIC CYTOKINE FORMULATIONS FOR OCULAR DELIVERY | ZARBIS-PAPASTOITSIS GREGORY | ELEVEN BIOTHERAPEUTICS INC |
| EP2968476 | METHOD OF ENHANCING DELIVERY OF THERAPEUTIC COMPOUNDS TO THE EYE | PAN ZHUO-HUA | UNIV WAYNE STATE |
| EP2968483 | SUBCUTANEOUS ADMINISTRATION OF ADAMTS13 | KOPIC ALEXANDRA NATHALIE | BAXALTA INC |
| EP2968492 | COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY | FEDOROV VICTOR D | SLOAN KETTERING INST CANCER |
| EP2968520 | BISPECIFIC MOLECULES THAT ARE IMMUNOREACTIVE WITH IMMUNE EFFECTOR CELLS THAT EXPRESS AN ACTIVATING RECEPTOR | KOENIG SCOTT | MACROGENICS INC |
| EP2968542 | BIOMARKERS FOR RADIATION TREATMENT | PARRY RENATE | VARIAN MED SYS INC |
| EP2968551 | FUSION PROTEINS AND METHODS THEREOF | IAVARONE ANTONIO | UNIV COLUMBIA |
| EP2968597 | POLYALKYLENE OXIDE VALERATE HEMOGLOBIN CONJUGATES | MALAVALLI ASHOK | SANGART INC |
| EP2968611 | IMMUNOPROTECTIVE PRIMARY MESENCHYMAL STEM CELLS AND METHODS | GARRY ROBERT F | UNIV TULANE |
| EP2968618 | IMAGEABLE EMBOLIC MICROSPHERE | DREHER MATTHEW R | DREHER MATTHEW R |
| EP2968619 | ENTERIC CT CONTRAST MATERIAL BASED ON LOW-Z ATOMS | YEH BENJAMIN M | UNIV CALIFORNIA |
| EP2968622 | ANTIGEN BINDING CONSTRUCTS TO CD8 | HO DAVID T | IMAGINAB INC |
| EP2968882 | DRUG DELIVERY DEVICE COMPRISING SILICON-BASED CARRIER PARTICLES | CANHAM LEIGH T | PSIVIDA INC |
| EP2968940 | MULTI-SITE TRANSCUTANEOUS ELECTRICAL STIMULATION OF THE SPINAL CORD FOR FACILITATION OF LOCOMOTION | GERASIMENKO YURY | UNIV CALIFORNIA |
| EP2969030 | A TOPICAL LIGHTENING COMPOSITION AND METHODS OF USE THEREOF | SHAH ARVIND N | AVON PROD INC |
| EP2970119 | NOVEL INDOLE DERIVATIVES USEFUL AS ANTI-DIABETIC AGENTS | ACTON JOHN J III | MERCK SHARP & DOHME |
| EP2970154 | TETRAHYDROXAMATE CHELATORS OF ZIRCONIUM89 AND NIOBIUM90 FOR USE IN DIAGNOSTIC APPLICATIONS | BRECHBIEL MARTIN W | US HEALTH |
| EP2970250 | SALT FORMS OF (S)-QUINUCLIDIN-3-YL (2-(2-(4-FLUOROPHENYL)THIAZOL-4-YL)PROPAN-2-YL)CARBAMATE | SIEGEL CRAIG | GENZYME CORP |
| EP2970277 | IMIDAZO(4,5-B) PYRIDIN-2-YL AMIDES AS KV7 CHANNEL ACTIVATORS | RESNICK LYNN | KNOPP BIOSCIENCES LLC |
| EP2970280 | METHODS FOR TREATING INFLAMMATION, AUTOIMMUNE DISORDERS AND PAIN | SAVAGE PAUL B | UNIV BRIGHAM YOUNG |
| EP2970308 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | METCALF BRIAN W | GLOBAL BLOOD THERAPEUTICS INC |
| EP2970315 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | LI ZHE | GLOBAL BLOOD THERAPEUTICS INC |
| EP2970358 | 3'-DEOXY NUCLEOSIDES FOR THE TREATMENT OF HCV | STEWART ALISTAIR JAMES | IDENIX PHARMACEUTICALS INC |
| EP2970359 | FLUORINATED PYRIMIDINE ANALOGS AND METHODS OF USE THEREOF | DAIFUKU RICHARD | EPIGENETICS PHARMA LLC |
| EP2970383 | INHIBITION OF PULMONARY FIBROSIS WITH NUTLIN-3A AND PEPTIDES | SHETTY SREERAMA | UNIV TEXAS |
| EP2970399 | PROTEIN PARTICLES COMPRISING DISULFIDE CROSSLINKERS AND USES RELATED THERETO | NEISH ANDREW S | UNIV EMORY |
| EP2970448 | HUMAN ANTIBODIES TO GREM 1 | ECONOMIDES ARIS | REGENERON PHARMA |
| EP2970456 | METHODS AND COMPOSITIONS FOR DELIVERING MRNA CODED ANTIBODIES | HEARTLEIN MICHAEL | SHIRE HUMAN GENETIC THERAPIES |
| EP2970824 | CLEANING COMPOSITION HAVING IMPROVED SOIL REMOVAL | WOLFF KELLY LAURA | KIMBERLY CLARK CO |
| EP2971166 | USE OF CD36 TO IDENTIFY CANCER SUBJECTS FOR TREATMENT | WATNICK RANDOLPH S | CHILDRENS MEDICAL CENTER |
| EP2974743 | CYCLODEXTRIN CARRIER-BASED ARTEANNUIN COMPOUND CONJUGATE AND PREPARING METHOD THEREOF | YANG BO | KUNMING PHARMACEUTICAL CORP |
| EP2975051 | READILY ISOLATED BISPECIFIC ANTIBODIES WITH NATIVE IMMUNOGLOBULIN FORMAT | DAVIS SAMUEL | REGENERON PHARMA |
| EP2976062 | INJECTABLE SUSTAINED RELEASE COMPOSITION AND METHOD OF USING THE SAME FOR TREATING INFLAMMATION IN JOINTS AND PAIN ASSOCIATED THEREWITH | HELLIWELL JAMES A | EUPRAXIA PHARMACEUTICALS USA LLC |
| EP2976067 | PHARMACEUTICAL COMPOSITION COMPRISING A FLUOROQUINOLONE ANTIBACTERIAL AGENT AND METHOD FOR THE PREPARATION THEREOF | KARAVAS EVANGELOS | PHARMATHEN SA |
| EP2976070 | ASTAXANTHIN ANTI-INFLAMMATORY SYNERGISTIC COMBINATIONS | LEVY RACHEL | LYCORED LTD |
| EP2976072 | EPINEPHRINE FINE PARTICLES AND METHODS FOR USE THEREOF FOR TREATMENT OF CONDITIONS RESPONSIVE TO EPINEPHRINE | RACHID OUSAMA | UNIV NOVA SOUTHEASTERN |
| EP2976088 | USE OF SEDOHEPTULOSE AS A NUTRITIONAL SUPPLEMENT | HASCHEMI ARVAND | MEDIZINISCHE UNIVERSITÄT WIEN |
| EP2976097 | COMPOSITIONS COMPRISING COLLAGEN AND PRP FOR TISSUE REGENERATION | GUETA RACHELI | COLLPLANT LTD |
| EP2976106 | COMBINATION THERAPY COMPRISING A B-RAF INHIBITOR AND A SECOND INHIBITOR | CAPONIGRO GIORDANO | NOVARTIS AG |
| EP2977064 | DRUG CARRIER HAVING SELF-ASSEMBLED 3-D NUCLEIC ACID NANOSTRUCTURE | AHN DAE RO | KOREA INST SCI & TECH |
| EP2977457 | IDNA VACCINES AND METHODS FOR USING THE SAME | PUSHKO PETER | MEDIGEN INC |
| EP2978449 | COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION | KING THOMAS H | GLOBEIMMUNE INC |
| EP2978456 | RADIOLABELLING PROCESS | WICKSTROM TORILD | GE HEALTHCARE LTD |
| EP2978502 | THREE-PHASE COSMETIC COMPOSITIONS COMPRISING NACRES | ARNAUD PASCAL | ORéAL L |
| EP2979690 | METHOD FOR MANUFACTURING EMULSION BEAD BY LOW-TEMPERATURE COOLING, AND EMULSION BEAD YIELDED THEREBY | JIANG YANFU | KPT LTD |
| EP2981169 | METHODS AND COMPOSITIONS FOR TREATING CANCERS HAVING ACQUIRED RESISTANCE TO CHEMOTHERAPEUTIC AND TARGETED DRUGS USING CARBOXYAMIDOTRIAZOLE OROTATE | KARMALI RASHIDA A | TACTICAL THERAPEUTICS INC |
| EP2981250 | CAPSULE WITH INTERNAL DIAPHRAGM | VAN ROOYEN JACQUES | BINUTRA INC |
| EP2981253 | COMPOSITIONS FOR USE IN STIMULATING BONE GROWTH | HORCAJADA MARIE NOËLLE | NESTEC SA |
| EP2981259 | A COMPOSITION FOR TREATING NEUROPATHY, A PROCESS AND A METHOD OF TREATMENT THEREOF | BHASKARAN SUNIL | INDUS BIOTECH PRIVATE LTD |
| EP2981260 | NOVEL ANALOGUES OF EPICATECHIN AND RELATED POLYPHENOLS | DUGAR SUNDEEP | SPHAERA PHARMA PRIVATE LTD |
| EP2981270 | ESTERS OF 2-DEOXY-MONOSACCHARIDES WITH ANTI PROLIFERATIVE ACTIVITY | PRIEBE WALDEMAR | UNIV TEXAS |
| EP2981526 | NAPHTHYLUREA DERIVATIVES USEFUL AS KINASE INHIBITORS | FYFE MATTHEW COLIN THOR | RESPIVERT LTD |
| EP2981529 | ORIDONIN ANALOGS, COMPOSITIONS, AND METHODS RELATED THERETO | ZHOU JIA | UNIV TEXAS |
| EP2981542 | 2',4'-FLUORO NUCLEOSIDES FOR THE TREATMENT OF HCV | MAYES BENJAMIN ALEXANDER | IDENIX PHARMACEUTICALS INC |
| EP2982380 | ANTIBODIES REACTIVE WITH B7-H3, IMMUNOLOGICALLY ACTIVE FRAGMENTS THEREOF AND USES THEREOF | LOO DERYK T | MACROGENICS INC |
| EP2983704 | FUSION POLYPEPTIDES AND VACCINES | SATO TAKANORI | CEVA SANTE ANIMALE |
| EP2983706 | USE OF IMMUNE SUPPRESSIVE DOMAINS AS MEDICAMENTS | BAHRAMI SHERVIN | SKAU APS |
| EP2983783 | CITRATE CONTAINING BEVERAGE | GOLDFARB DAVID S | UNIV NEW YORK |
| EP2983797 | COSMETIC, PHARMACEUTICAL OR FOOD COMPOSITION COMPRISING CAROTENOID CONTAINING EXTRACT OF ARTHROBACTER AGILIS | THOREL JEAN-NOËL | THOREL JEAN-NOËL |
| EP2985019 | Nasal composition having anti-viral properties | SAAID AMINA | CHURCH & DWIGHT CO INC |
| EP2985020 | TADALAFIL FREE BASE-CONTAINING FILM DOSAGE FORM CONTAINING POLYETHYLENE GLYCOL-BASED POLYMER AND/OR VINYL PYRROLIDONE-BASED POLYMER AS DISPERSION STABILIZER | JEON HONG RYEOL | CTC BIO INC |
| EP2985027 | Nasal composition comprising mixture of hyaluronic acids and saline solution | SAAID AMINA | CHURCH & DWIGHT CO INC |
| EP2985283 | ANTI-ANGIOGENESIS COMPOUND, INTERMEDIATE AND USE THEREOF | HOU RUI | GUANGZHOU HUI BO RUI BIOLOG PHARMACEUTICAL TECHNOLOGY CO LTD |
| EP2985284 | DICARBOXYLIC ACID BISAMIDE DERIVATIVES, USE THEREOF, PHARMACEUTICAL COMPOSITION BASED THEREON AND METHODS FOR PRODUCING DICARBOXYLIC ACID BISAMIDE DERIVATIVES | NEBOLSIN VLADIMIR EVGENIEVICH | OBSCHESTVO S OGRANICHENNOI OTVETSTENNOSTIYU PHARMENTPR |
| EP2986280 | SUSTAINED-RELEASE FORMULATIONS OF COLCHICINE AND METHODS OF USING SAME | RIEL SUSANNE | MURRAY & POOL ENTPR LTD |
| EP2986312 | CYTOKINE DERIVED TREATMENT WITH REDUCED VASCULAR LEAK SYNDROME | BECHARD DAVID | CYTUNE PHARMA |
| EP2986618 | ORGANIC ANION LITHIUM IONIC COCRYSTAL COMPOUNDS AND COMPOSITIONS | ZAWOROTKO MICHAEL JOHN | UNIV SOUTH FLORIDA |
| EP2988731 | COMPOSITION FOR USE IN REDUCING SCAB FORMATION AND PROMOTING HEALING | SVENSSON BIRGITTA | BIOGLAN AB |
| EP2988737 | METHODS AND COMPOSITIONS FOR TREATING DISEASES | KATSNELSON LLANA | NIZYME INC |
| EP2988768 | LYOPHILISATE CONTAINING A CYCLIC PEPTIDE OF FORMULA X1-GQRETPEGAEAKPWY-X2 | FISCHER BERNHARD | APEPTICO FORSCHUNG & ENTWICKLUNG GMBH |
| EP2988775 | IMMUNE MODULATION FOR TREATMENT OF AUTOIMMUNE DISEASE | NUSSENBLATT ROBERT | ENZO BIOCHEM INC |
| EP2988777 | NOVEL VACCINE FORMULATION FOR OCULAR IMMUNIZATION | BARISANI-ASENBAUER TALIN | MEDIZINISCHE UNIVERSITÄT WIEN |
| EP2988830 | COMPOSITION FOR STRAIGHTENING KERATIN FIBRES, COMPRISING A UREA AND/OR A UREA DERIVATIVE AND A NONIONIC, CATIONIC, AMPHOTERIC OR ANIONIC ASSOCIATIVE POLYMERIC THICKENER, PROCESS AND USE THEREOF | PLOS GRéGORY | ORéAL L |
| EP2989112 | MODIFIED G-QUADRUPLEX NANOPARTICLES | PHAN ANH TUAN | UNIV NANYANG TECH |
| EP2990476 | METHOD FOR PRODUCING PROTEIN | UENO TOMONORI | NIPPI INC |
| EP2991658 | ANTIMICROBIAL COMPOSITIONS AND METHODS OF MAKING THE SAME | KARANDIKAR BHALCHANDRA M | MEDICAL TECHNOLOGY RES INC |
| EP2991660 | COMPOSITIONS AND METHODS FOR PROMOTING NITRIC OXIDE PRODUCTION THROUGH AN ORAL DELIVERY SYSTEM | BRYAN NATHAN S | UNIV TEXAS |
| EP2991662 | MODULATORS OF THE SRC-KINASE ACTIVITY FOR PREVENTING OR TREATING METASTATIC CANCER | VAINIKKA SATU | CANCER REC TECH LTD |
| EP2991963 | INHIBITORS OF NHR2 AND/OR RUNX1/ETO-TETRAMERIZATION | METZ ALEXANDER | HEINRICH HEINE UNIVERSITÄT DüSSELDORF |
| EP2991968 | COMPOUNDS AND METHODS OF TREATING INFECTIONS | PAGE STEPHEN | NEOCULI PTY LTD |
| EP2992010 | FC-RECEPTOR BINDING MODIFIED ASYMMETRIC ANTIBODIES AND METHODS OF USE | REGULA JOERG THOMAS | HOFFMANN LA ROCHE |
| EP2992089 | USE OF ANTI-CD47 AGENTS TO ENHANCE IMMUNIZATION | TSENG DIANE | UNIV LELAND STANFORD JUNIOR |
| EP2992096 | COMPOUNDS AND METHODS FOR ENHANCED CELLULAR UPTAKE | BHAT BALKRISHEN | REGULUS THERAPEUTICS INC |
| EP2994134 | METHODS OF ADMINISTERING DANTROLENE FOR THE ACUTE TREATMENT OF CARDIAC ARRHYTHMIAS | NANTHAKUMAR KUMARASWAMY | UNIV HEALTH NETWORK |
| EP2994135 | NOVEL BIS-BENZYLIDINE PIPERIDONE PROTEASOME INHIBITOR WITH ANTICANCER ACTIVITY | RODEN RICHARD B | UNIV JOHNS HOPKINS |
| EP2994146 | METHODS AND TREATMENT FOR CERTAIN DEMYELINATION AND DYSMYELINATION-BASED DISORDERS AND/OR PROMOTING REMYELINATION | ZHANG ZHONGYAN | GR INTELLECTUAL RESERVE LLC |
| EP2994159 | PREDICTING IMMUNOGENICITY OF T CELL EPITOPES | SAHIN UGUR | BIONTECH AG |
| EP2994162 | VACCINE FOR PCV2 AND MYCOPLASMA | MA SHI JUN | PROTATEK INTERNAT INC |
| EP2994169 | LABELLED CARBOXYLIC ACIDS AND THEIR USES IN MOLECULAR IMAGING | ABOAGYE ERIC O | IMP INNOVATIONS LTD |
| EP2994197 | PHARMACEUTICAL COMPOSITION AND USES THEREOF | WU PEI-CHANG | |
| EP2994457 | RADIOMITIGATING PHARMACEUTICAL FORMULATIONS | MCBRIDE WILLIAM | UNIV CALIFORNIA |
| EP2994461 | METHODS OF TREATING SKIN CONDITIONS USING CYCLOLIGNAN COMPOUNDS | FEIN HOWARD | ALPHABET 1 LLC M |
| EP2995298 | STABILIZED PEMETREXED PREPARATION | SHIN MYUNG JIN | CJ HEALTHCARE CORP |
| EP2995299 | FUNCTIONAL POLYMER FILM-COATED PARTICLE HAVING HIGH DRUG CONTENT, TABLET CONTAINING SAME, AND METHODS FOR PRODUCTION THEREOF | HAYASHIDA TOMOHIRO | ZENSEI PHARMACEUTICAL IND CO LTD |
| EP2995310 | Compositions for the treatment of overtraining syndrome | WIKMAN KARL GEORG | SWEDISH HERBAL INST RES & DEV AB |
| EP2995311 | Compositions for the treatment of age related disorders | WIKMAN KARL GEORG | SWEDISH HERBAL INST RES & DEV AB |
| EP2996692 | MEANS AND METHODS FOR TREATING CANCER | HEUSER MICHAEL | HANNOVER MED HOCHSCHULE |
| EP2996699 | SALMONELLA STRAINS FOR USE IN THE TREATMENT AND/OR PREVENTION OF CANCER | NARDELLI HAEFLIGER DENISE | CT HOSPITALLER UNIVERSITAIRE VAUDOIS CHUV |
| EP2996704 | JOINT CARE COMPOSITION | SERISIER SAMUEL | MARS INC |
| EP2996710 | ACTIVE SUBSTANCE FOR TREATING SARCOPENIA | HAUSMANNS STEPHAN | GELITA AG |
| EP2996721 | METHODS AND COMPOSITIONS FOR PROGNOSIS, DIAGNOSIS AND TREATMENT OF ADAM8-EXPRESSING CANCER | SONENSHEIN GAIL | UNIV TUFTS |
| EP2997047 | HEPARAN SULPHATES | NURCOMBE VICTOR | AGENCY SCIENCE TECH & RES |
| EP2997958 | FORMULATION COMPRISING LIQUID ESTER QUATS AND/OR IMIDAZOLINIUM SALTS AND POLYMER THICKENER | SCHWAB PETER | EVONIK DEGUSSA GMBH |
| EP2999358 | SYNTHETIC MIXTURE OF OLIGOSACCHARIDES FOR T TREATING A MICROBIOTA OF A MAMMAL | DEKANY GYULA | GLYCOM AS |
| EP2999479 | HUMAN MONOCYTE SUB-POPULATION FOR TREATMENT OF EYE DISEASES AND DISORDERS | EISENBACH-SCHWARTZ MICHAL | YEDA RES & DEV |
| EP3000465 | T-TYPE CALCIUM CHANNEL INHIBITOR | KAWABATA ATSUFUMI | UNIV KINKI |
| EP3000482 | DOUBLE-ACYLATED GLP-1 DERIVATIVES | SAUERBERG PER | NOVO NORDISK AS |
| EP3000807 | MERCAPTONICOTINIC ACID COMPOUND AND PREPARATION METHOD AND USE THEREOF | WANG HUI | INST OF MICROBIOLOGY AND EPIDEMIOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES PR CHINA |
| EP3001814 | XANTHINE OXIDASE INHIBITOR FORMULATIONS | ALLEN DAVIDOFF | ALLEN DAVIDOFF |
| EP3002009 | TREATMENT OF IMATINIB RESISTANT LEUKEMIA USING 4-AMINOQUINOLINE-3-CARBONITRILES | HEWES BECKER | WYETH LLC |
| EP3003039 | METHYL/FLUORO-PYRIDINYL-METHOXY SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS AND FLUORO-PYRIMIDINYL-METHOXY SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS | HOCKERMAN SUSAN L | CONFLUENCE LIFE SCIENCES INC |
| EP3003206 | COMPOSITIONS AND METHODS FOR BIOACTIVE DENTAL COMPOSITES | WANG TONGXIN | UNIV HOWARD |
| EP3003214 | CONTAINER COMPRISING AN ANALYTE-SENSITIVE GEL | TAYLOR MARGARET JOAN | UNIV MONTFORT |
| EP3003287 | PRODUCTS CONTAINING CHARGED POLYMER COMPLEX MICROCAPSULES AND METHOD OF USE | SPEAKER TYCHO JOSEPH | CAPSULENT |
| EP3003290 | COMPOSITIONS AND METHODS FOR INDUCED TISSUE REGENERATION IN MAMMALIAN SPECIES | WEST MICHAEL | BIOTIME INC |
| EP3003299 | NOVEL N-3 IMMUNORESOLVENTS: STRUCTURES AND ACTIONS | SERHAN CHARLES N | BRIGHAM & WOMENS HOSPITAL |
| EP3003301 | NOVEL SUICIDAL LSD1 INHIBITORS TARGETING SOX2-EXPRESSING CANCER CELLS | ZHANG HUI | UNIV NEVADA |
| EP3003318 | USE OF SUSTAINED RELEASE DEXAMETHASONE IN POST-CATARACT SURGERY INFLAMMATION | WONG VERNON G | ICON BIOSCIENCE INC |
| EP3003328 | IRON SUPPLEMENT | BORTZ JONATHAN DAVID | AMIP LLC |
| EP3003358 | COMPOSITIONS, METHODS, AND DEVICES FOR DIALYSIS | MARGOLIN ALEXEY | ALLENA PHARMACEUTICALS INC |
| EP3003390 | ANTI-C10ORF54 ANTIBODIES AND USES THEREOF | LIPPINCOTT JOHN | IGENICA BIOTHERAPEUTICS INC |
| EP3003391 | ADENO-ASSOCIATED VIRUS VARIANTS AND METHODS OF USE THEREOF | SCHAFFER DAVID V | UNIV CALIFORNIA |
| EP3003489 | CYTOTOXIC AGENTS FOR THE TREATMENT OF CANCER | LEVITT DANIEL | CYTRX CORP |
| EP3004053 | A PROCESS FOR PREPARATION OF PYRROLES HAVING HYPOLIPIDEMIC HYPOCHOLESTEREMIC ACTIVITIES | DWIVEDI SHRIPRAKASH DHAR | CADILA HEALTHCARE LTD |
| EP3004171 | METHODS FOR INHIBITING ATHEROSCLEROSIS BY ADMINISTERING AN INHIBITOR OF PCSK9 | SASIELA WILLIAM J | REGENERON PHARMA |
| EP3006022 | OSMOLYTES FOR THE TREATMENT OF VIRAL RESPIRATORY DISEASES | KRUTMANN JEAN | BITOP AG |
| EP3006039 | ALK7 POLYPEPTIDES FOR USE IN PROMOTING FAT LOSS | KNOPF JOHN | ACCELERON PHARMA INC |
| EP3006454 | NEW COMPOUNDS HAVING TRIPLE ACTIVITIES OF THROMBOLYSIS, ANTITHROMBOTIC AND RADICAL SCAVENGING, AND SYNTHESIS, NANO-STRUCTURE AND USE THEREOF | PENG SHIQI | SHANGHAI LUMOSA THERAPEUTICS CO LTD |
| EP3006459 | METHOD AND COMPOSITIONS FOR ENHANCED ANTI-TUMOR EFFECTOR FUNCTIONING OF T CELLS | JENSEN MICHAEL | HOPE CITY |
| EP3007684 | A PROCESS FOR PRODUCING MICROCAPSULES COMPRISING AN ACTIVE COMPONENT ENCAPSULATED, PROTECTED AND STABILISED WITHIN A PROTEIN SHELL | DOHERTY SINEAD | ANABIO TECHNOLOGIES LTD |
| EP3007704 | COMBINATION THERAPY | TACHAS GEORGE | ANTISENSE THERAPEUTICS LTD |
| EP3007709 | LIPID-BASED PLATINUM COMPOUNDS AND NANOPARTICLES | SENGUPTA SHILADITYA | INVICTUS ONCOLOGY PVT LTD |
| EP3007710 | CELL POPULATIONS, METHODS OF TRANSDIFFERENTION AND METHODS OF USE THEREOF | FERBER SARAH | ORGENESIS LTD |
| EP3007719 | METHODS AND COMPOSITIONS FOR INCREASING NEUROGENESIS AND ANGIOGENESIS | RUBIN LEE L | HARVARD COLLEGE |
| EP3008173 | METHODS AND COMPOSITIONS FOR REDUCING IMMUNOSUPRESSION BY TUMOR CELLS | WUCHERPFENNIG KAI W | DANA FARBER CANCER INST INC |
| EP3009139 | COMPOSITION CONTAINING COMPOSITE EXTRACT OF REHMANNIA GLUTINOSA AND PUERARIA LOBATA FOR PREVENTING OR TREATING MENOPAUSAL SYMPTOMS | PARK JUYEON | UNIV KYUNG HEE UNIV IND COOP GROUP |
| EP3009146 | IMMUNOGENIC COMPOSITION | BIEMANS RALPH LEON | GLAXOSMITHKLINE BIOLOG SA |
| EP3009149 | CARRIER FOR TRANSPORTING SUBSTANCE TO MACROPHAGES | HIROSE YOSHITAKA | HOUSE WELLNESS FOODS CORP |
| EP3009466 | SILICONE MODIFIED BY LONG-CHAIN HYDROCARBON GROUP-CONTAINING DIGLYCERIN DERIVATIVE, AND USE THEREOF | SAWAYAMA SAYURI | DOW CORNING TORAY CO LTD |
| EP3010488 | STEREOSPECIFIC LIPIDS FOR LOCOREGIONAL THERAPY WITH LONG-TERM CIRCULATING STIMULI-SENSITIVE NANOCARRIER SYSTEMS | EIBL HANSJÖRG | THERMOSOME GMBH |
| EP3010495 | COMPOSITIONS AND METHODS FOR USE IN MEDICAL DIAGNOSIS | POUL LAURENCE | NANOBIOTIX |
| EP3010501 | ESTROGEN RECEPTOR MODULATOR AND USES THEREOF | KAHRAMAN MEHMET | SERAGON PHARMACEUTICALS INC |
| EP3010506 | USE OF HIGH DOSE PRIDOPIDINE FOR TREATING HUNTINGTON'S DISEASE | BASSAN MERAV | TEVA PHARMACEUTICALS INT GMBH |
| EP3010509 | FREE BASE CRYSTALS | ABE TAKASHI | INTRA CELLULAR THERAPIES INC |
| EP3010514 | DOUBLE-STRANDED ANTISENSE NUCLEIC ACID WITH EXON-SKIPPING EFFECT | YOKOTA TAKANORI | NAT UNIV CORP TOKYO MED & DENT |
| EP3010519 | TREATMENT OF BRAIN CANCER WITH ONCOLYTIC ADENOVIRUS | FUEYO JUAN | DNATRIX INC |
| EP3010522 | ENGINEERED HEME-BINDING COMPOSITIONS AND USES THEREOF | SUPER MICHAEL | HARVARD COLLEGE |
| EP3010547 | ENZYMATIC CONJUGATION OF POLYPEPTIDES | BREGEON DELPHINE | INNATE PHARMA |
| EP3010550 | CYCLIC PEPTIDES AS PROTEIN TARGETING AGENTS | HEATH JAMES R | CALIFORNIA INST OF TECHN |
| EP3011015 | ADIPOSE CELLS FOR CHONDROCYTE APPLICATIONS | O'HEERON PETE | SPINALCYTE LLC |
| EP3011949 | CURABLE DENTAL MATERIAL | WILLNER ALEXANDER | VOCO GMBH |
| EP3011971 | ANTIBODIES DIRECTED TO THE DELETION MUTANTS OF EPIDERMAL GROWTH FACTOR RECEPTOR AND USES THEREOF | WEBER RICHARD | AMGEN FREMONT INC |
| EP3011975 | SOLID COMPOSITION FOR THE ORAL ADMINISTRATION OF DYES AND DIAGNOSTIC USE THEREOF | MORO LUIGI | COSMO TECHNOLOGIES LTD |
| EP3012255 | STABILIZED CRYSTAL OF TIPIRACIL HYDROCHLORIDE, AND CRYSTALLIZATION METHOD FOR SAME | KAZUNO HIDEKI | TAIHO PHARMACEUTICAL CO LTD |
| EP3013342 | ADRENOCEPTORS ANTAGONISTS FOR THE PREVENTION AND TREATMENT OF NEURODEGENERATIVE CONDITIONS | TAGLIATI MICHELE | CEDARS SINAI MEDICAL CENTER |
| EP3013353 | NEW USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF VARIOUS DISEASES | COMBETTE JEAN-MARC | XIGEN INFLAMMATION LTD |
| EP3013361 | COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY | MCCREEDY BRUCE | NEXIMMUNE |
| EP3013362 | DENDRITIC CELL ASGPR TARGETING IMMUNOTHERAPEUTICS FOR MULTIPLE SCLEROSIS | OH SANGKON | BAYLOR RES INST |
| EP3013366 | COMBINATION THERAPY USING A FACTOR XII INHIBITOR AND A C1-INHIBITOR | NOLTE MARC | CSL BEHRING GMBH |
| EP3013818 | (S)-ENANTIOMER OF MEPAZINE AS PARACASPASE (MALT1) INHIBITOR FOR TREATING CANCER | KRAPPMANN DANIEL | HELMHOLTZ ZENTRUM MüNCHEN DEUTSCHES FORSCHUNGSZENTRUM FüR GESUNDHEIT UND UMWELT GMBH |
| EP3013857 | TRPM4 CHANNEL INHIBITORS FOR STROKE TREATMENT | LIAO PING | SINGAPORE HEALTH SERV PTE LTD |
| EP3013858 | IL-21 BINDING PROTEINS AND USES THEREOF | MACKAY CHARLES REAY | UNIV MONASH |
| EP3013866 | A PROCESS FOR PREPARING A CROSS-LINKED HYALURONIC ACID PRODUCT | KARLSSON MORGAN | GALDERMA SA |
| EP3015106 | COMPOSITION FOR PREVENTING OR TREATING RENAL DISEASES, CONTAINING DPP-IV INHIBITOR | CHA DAE RYONG | DONG A ST CO LTD |
| EP3015477 | HIGH-STABILITY T-CELL RECEPTOR AND PREPARATION METHOD AND APPLICATION THEREOF | LI YI | GUANGZHOU XIANGXUE PHARMACEUTICAL CO LTD |
| EP3016656 | BICYCLIC COMPOUNDS USEFUL FOR TREATING DISEASES CAUSED BY RETROVIRUSES | TAZI JAMAL | ABIVAX |
| EP3016669 | SECRETAGOGUES DERIVED FROM OXALOBACTER FORMIGENES | LINDNER ELISABETH | OXTHERA INTELLECTUAL PROPERTY AB |
| EP3016671 | ACTIVELY TRANSPORTED AND PROTEASE-RESISTANT PEPTIDES AS BBB SHUTTLES AND SHUTTLE-CARGO CONSTRUCTS | GIRALT LLEDó ERNEST | UNIV BARCELONA |
| EP3017810 | TRANSDERMAL DRUG DELIVERY SYSTEM HAVING MULTI-LAMELLAR EMULSION STRUCTURE | JEONG SE KYOO | NEOPHARM CO LTD |
| EP3019162 | DAN SHEN EXTRACTS AND COMPOUNDS | LUO GUOAN | UNIV TSINGHUA |
| EP3019167 | TREATING ELEVATED LEVELS OF EOSINOPHILS AND/OR BASOPHILS | BOZIK MICHAEL E | KNOPP BIOSCIENCES LLC |
| EP3019179 | USE OF GINGIVAL FIBROBLASTS IN THE TREATMENT OF ALOPECIA | LAFONT ANTOINE | ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS |
| EP3019190 | CATIONIC NEUROTOXINS | ANDERSON DINA BRADY | IPSEN BIOINNOVATION LTD |
| EP3019198 | COMPOSITIONS AND METHODS FOR IMPROVING REBAUDIOSIDE M SOLUBILITY | PRAKASH INDRA | COCA COLA CO |
| EP3019477 | HETEROCYCLIC COMPOUNDS AND METHODS OF THEIR USE | MCCARTHY THOMAS DAVID | NOVARTIS AG |
| EP3019484 | THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE | TRAVINS JEREMY M | AGIOS PHARMACEUTICALS INC |
| EP3019619 | COMPOSITIONS COMPRISING SYNTHETIC POLYNUCLEOTIDES ENCODING CRISPR RELATED PROTEINS AND SYNTHETIC SGRNAS AND METHODS OF USE | HOGE STEPHEN G | MODERNA THERAPEUTICS INC |
| EP3019854 | COMPOUNDS, SYSTEMS, AND METHODS FOR MONITORING AND TREATING A SURFACE OF A SUBJECT | EVANS CONOR L | GEN HOSPITAL CORP |
| EP3020395 | PREPARATION METHOD FOR TRADITIONAL CHINESE MEDICINE MICRO DROP PILL AND TRADITIONAL CHINESE MEDICINE MICRO DROP PILL PREPARED BY USING THE METHOD | YAN XIJUN | TASLY PHARMACEUTICAL GROUP CO |
| EP3020405 | COMPOSITION FOR PREVENTING AND TREATING LIVER FIBROSIS OR LIVER CIRRHOSIS,CONTAINING, AS ACTIVE INGREDIENT, MESENCHYMAL STEM CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS | LEE EUN JU | SEOUL NAT UNIV HOSPITAL |
| EP3020717 | P2X4 RECEPTOR ANTAGONIST | SAKUMA SHOGO | NIPPON CHEMIPHAR CO |
| EP3020829 | METHOD FOR SCREENING SUBSTANCE CAPABLE OF INHIBITING ABNORMAL SPLICING CAUSATIVE OF ONSET OR PROGRESS OF DISEASE | HAGIWARA MASATOSHI | UNIV KYOTO |
| EP3021669 | NOVEL SOLANIDINE-DERIVED COMPOUNDS | BEAULIEU RéMI | UNIVERSITé DE PICARDIE JULES VERNE |
| EP3021819 | ANTIPERSPIRANT SPRAY DEVICES AND COMPOSITIONS | MENON ELTON LUIS | PROCTER & GAMBLE |
| EP3021832 | PRESERVED ETHERIFIED CYCLODEXTRIN DERIVATIVES CONTAINING LIQUID AQUEOUS PHARMACEUTICAL COMPOSITION | AVEN MICHAEL | BOEHRINGER INGELHEIM VETMED |
| EP3021839 | METHODS AND COMPOSITIONS FOR TREATMENT OF FIBROSIS | TWEARDY DAVID J | BAYLOR COLLEGE MEDICINE |
| EP3021852 | NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF | MARTINEZ BOTELLA GABRIEL | SAGE THERAPEUTICS INC |
| EP3021858 | STRAIN FOR THE TREATMENT AND/OR PREVENTION OF CHRONIC INFLAMMATORY DISEASES | TAILLADE PATRICK | LESAFFRE & CIE |
| EP3022217 | COMPOSITIONS FOR MODULATING TAU EXPRESSION | KORDASIEWICZ HOLLY | IONIS PHARMACEUTICALS INC |
| EP3023094 | NOVEL FORMULATION OF CILOSTAZOL | CHEN FENGCHU | |
| EP3023108 | GLYCOSAMINOGLYCAN DERIVATIVE AND METHOD FOR PRODUCING SAME | MIYAMOTO KENJI | SEIKAGAKU KOGYO CO LTD |
| EP3024497 | METHODS AND COMPOSITIONS FOR TREATING BRAIN DISEASES | DAVIDSON BEVERLY L | UNIV IOWA RES FOUND |
| EP3026049 | METHOD FOR PREPARING BENZAMIDE DERIVATIVE, NOVEL INTERMEDIATE USED IN PREPARATION OF BENZAMIDE, AND METHOD FOR PREPARING NOVEL INTERMEDIATE | KWAK WOO YOUNG | DONG A ST CO LTD |
| EP3027165 | IMPACT MODIFIED DENTURE BASE COMPOSITIONS | SUN BENJAMIN JIEMIN | DENTSPLY INT INC |
| EP3027180 | COMPOSITIONS AND METHODS OF THE TREATMENT OF FATTY ACID METABOLISM DISORDERS | ISCHIROPOULOS HARRY | PHILADELPHIA CHILDREN HOSPITAL |
| EP3027225 | COMPOSITIONS AND METHODS FOR MODULATING THERMOGENESIS USING PTH-RELATED AND EGF-RELATED MOLECULES | SPIEGELMAN BRUCE M | DANA FARBER CANCER INST INC |
| EP3027650 | ANTI-GARP PROTEIN AND USES THEREOF | LUCAS SOPHIE | UNIVERSITé CATHOLIQUE DE LOUVAIN |
| EP3028691 | CERAMIDE DISPERSION COMPOSITION | KITAOKA HIROYUKI | FUJIFILM CORP |
| EP3028696 | AGENT FOR ALLEVIATING SIDE EFFECTS IN CANCER CHEMOTHERAPY | KURIHARA SHIGEKAZU | AJINOMOTO KK |
| EP3028704 | BOOSTING THE EFFECT OF METHOTREXATE THROUGH THE COMBINED USE WITH LIPOPHILIC STATINS | GARCíA CASTELLANO JOSé MANUEL | DALANA3 S L |
| EP3028714 | DIVALENT VACCINE COMPOSITIONS AND THE USE THEREOF FOR TREATING TUMOURS | SáNCHEZ RAMíREZ BELINDA | CENTRO INMUNOLOGIA MOLECULAR |
| EP3029114 | SYSTEM FOR COVERING A NAIL SURFACE | VU THONG H | CREATIVE NAIL DESIGN INC |
| EP3030214 | ALCOHOLIC SUNSCREEN GEL | BORCHERS KATHRIN | BEIERSDORF AG |
| EP3030231 | KETONE BODY AND KETONE BODY ESTER FOR REDUCING MUSCLE BREAKDOWN | CLARKE KIERAN | TDELTAS LTD |
| EP3030244 | POLYCONJUGATES FOR DELIVERY OF RNAI TRIGGERS TO TUMOR CELLS IN VIVO | CHENG WEIJUN | ARROWHEAD RES CORP |
| EP3030265 | POLYMERIC BIOMATERIALS DERIVED FROM MONOMERS COMPRISING HYDROXYACIDS AND PHENOL COMPOUNDS AND THEIR MEDICAL USES | BOLIKAL DURGADAS | UNIV RUTGERS |
| EP3030581 | ANTIBODY BINDING SITES SPECIFIC FOR EGFRvIII | ELLWANGER KRISTINA | AFFIMED GMBH |
| EP3030658 | COMPOUNDS AND METHODS FOR MODULATION OF DYSTROPHIA MYOTONICA-PROTEIN KINASE (DMPK) EXPRESSION | PANDEY SANJAY K | IONIS PHARMACEUTICALS INC |
| EP3031441 | CURABLE CALCIUM PHOSPHATE COMPOSITION FOR IN VIVO HARD TISSUE REPAIR, BONE REPAIR MATERIAL, AND VARIOUS DENTAL MATERIALS | HATANAKA KENJI | KURARAY NORITAKE DENTAL INC |
| EP3031907 | MATERIALS AND METHODS TO ENHANCE HEMATOPOIETIC STEM CELLS ENGRAFTMENT PROCEDURES | PELUS LOUIS M | UNIV INDIANA RES & TECH CORP |
| EP3031909 | IMMUNOMODULATION USING PLACENTAL STEM CELLS | PALUDAN CASPER | ANTHROGENESIS CORP |
| EP3031925 | METHOD FOR PREPARING A WAX-BASED CARRIER BY ENZYMATIC CATALYSIS | RODIER JEAN-DAVID | GATTEFOSSE SAS |
| EP3033081 | COMPOSITIONS AND METHODS FOR TREATING CHRONIC URTICARIA | BOZIK MICHAEL E | KNOPP BIOSCIENCES LLC |
| EP3033082 | TREATMENT OF COGNITIVE IMPAIRMENT WITH PDE4 INHIBITOR | PRICKAERTS JOS | UNIV MAASTRICHT |
| EP3033086 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | CHEN YAN | NOVARTIS AG |
| EP3033097 | FACTOR VIII-XTEN FUSIONS AND USES THEREOF | LIU TONGYAO | BIOGEN MA INC |
| EP3033108 | DESIGNED PEPTIDES FOR TIGHT JUNCTION BARRIER MODULATION | MILLER BENJAMIN L | UNIV ROCHESTER |
| EP3033350 | PROGESTERONE PHOSPHATE ANALOGS AND USES RELATED THERETO | GUTHRIE DAVID BRIAN | UNIV EMORY |
| EP3035910 | COMPOSITIONS AND METHODS FOR TREATING HAIR | TAN SILIU | OREAL |
| EP3035918 | SINGLE-LAYER ORAL DOSE OF NEURO-ATTENUATING KETAMINE | NIVOROZHKIN ALEX | AMORSA THERAPEUTICS INC |
| EP3035953 | FOWL ADENOVIRUS VACCINE | HESS MICHAEL | VETERINÄRMEDIZINISCHE UNIVERSITÄT WIEN |
| EP3035963 | FOWL ADENOVIRUS VACCINE | HESS MICHAEL | VETERINÄRMEDIZINISCHE UNIVERSITÄT WIEN |
| EP3037091 | COMPOSITION CONTAINING MONOACETYLDIACYLGLYCEROL COMPOUND AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING ASTHMA | OH SEI-RYANG | ENZYCHEM LIFESCIENCES CORP |
| EP3037105 | ANTIBODIES DIRECTED TO THE DELETION MUTANTS OF EPIDERMAL GROWTH FACTOR RECEPTOR AND USES THEREOF | WEBER RICHARD | AMGEN FREMONT INC |
| EP3038465 | ORAL PHARMACEUTICAL FORMULATION OF OMARIGLIPTIN | COOPER VINCENT BRETT | MERCK SHARP & DOHME |
| EP3038593 | ORAL COMPOSITION FOR IMPROVING HAIR QUALITY COMPRISING POLYINSATURATED FATTY ACIDS AND VITAMIN D | BRU CAROLE | NUTRICOS TECHNOLOGIES |
| EP3038609 | CYTOTOXIC T CELL RESPONSE MODIFIERS | BECKHOVE PHILIPP | DEUTSCHES KREBSFORSCH |
| EP3038644 | SITE-SPECIFIC ANTIBODY CONJUGATION METHODS AND COMPOSITIONS | ARATHOON WILLIAM ROBERT | STEMCENTRX INC |
| EP3038650 | ANTIBODIES AND ASSAYS FOR DETECTION OF FOLATE RECEPTOR 1 | AB OLGA | IMMUNOGEN INC |
| EP3038656 | COMPOUND OF GLYCOSAMINOGLYCAN, PREPARATION METHOD AND USE THEREOF | LIN HUA-YANG | HOLY STONE BIOTECH CO LTD |
| EP3039032 | METHODS AND COMPOSITIONS FOR TREATMENT OF CARTILAGE AND DISC TISSUE PATHOLOGIES | MWALE FACKSON | UNIV MCGILL |
| EP3039039 | ANTIBODIES NEUTRALIZING GM-CSF FOR USE IN THE TREATMENT OF RHEUMATOID ARTHRITIS OR AS ANALGESICS | WAGNER THOMAS | TAKEDA GMBH |
| EP3039040 | ANTI CD30 CHIMERIC ANTIGEN RECEPTOR AND ITS USE | CHMIELEWSKI MARKUS | UNIVERSITÄT ZU KÖLN |
| EP3039064 | EXTRACTION METHOD OF A POLYESTER POLYMER OR CUTIN FROM THE WASTED TOMATO PEELS AND POLYESTER POLIMER SO EXTRACTED | CIGOGNINI ILARIA | CHIESA VIRGINIO |
| EP3039148 | TRANSDUCTION BUFFER | GEIJSEN NIELS | KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN |
| EP3040068 | ADHESIVE SHEET FOR APPLICATION TO THE SKIN, AND PERCUTANEOUS ABSORPTION PREPARATION USING SAME | OGINO HIROYUKI | KM TRANSDERM LTD |
| EP3040078 | COMPOSITION FOR PREVENTING AND TREATING CANCER-RELATED FATIGUE, CONTAINING PROCESSED GINSENG POWDER OR PROCESSED GINSENG EXTRACT HAVING INCREASED GINSENOSIDE CONSTITUENT | YOO YOUNG-HYO | GREEN CROSS WELLBEING CORP |
| EP3040085 | OPHTHALMIC SOLUTION | SAKURAI SHUNSUKE | NOF CORP |
| EP3040343 | LOW MOLECULAR POLYPEPTIDE FOR PREVENTING AND TREATING INFLAMMATION AND USE THEREOF | XU XUN | SHANGHAI 1ST PEOPLES HOSPITAL |
| EP3041469 | TREATMENT AND/OR PREVENTION OF BONE METASTASIS | MEUILLET EMMANUELLE | UNIV ARIZONA STATE |
| EP3041482 | HIGH OSTEOCALCIN MICROCRYSTALLINE HYDROXYAPATITE FOR CALCIUM SUPPLEMENT | MCINTOSH CRAIG LACHLAN | WAITAKI BIOSCIENCES |
| EP3041483 | PRODUCTS COMPRISING AN EXTRACELLULAR MATRIX TISSUE MATERIAL AND OSTEOGENIC PROTEIN | WALLACE SHELLEY L | MUFFIN INC |
| EP3041484 | HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS WITH ALTERED GLYCOSYL GROUPS | WONG CHI-HUEY | |
| EP3041499 | REAGENTS AND METHODS FOR SCREENING MPS I, II, IIIA, IIIB, IVA, VI, AND VII | GELB MICHAEL H | UNIV WASHINGTON CT COMMERCIALI |
| EP3041500 | METHOD FOR INDUCING ANTITUMOR IMMUNITY USING SINDBIS VIRAL VECTORS AND TUMOR ASSOCIATED ANTIGENS | MERUELO DANIEL | UNIV NEW YORK |
| EP3041504 | THERMALLY STABLE VACCINE FORMULATIONS AND MICRONEEDLES | MISTILIS MATTHEW JOSEPH | GEORGIA TECH RES INST |
| EP3041507 | NUCLEIC ACIDS ENCODING HUMAN ANTIBODIES TO SIALYL-LEWIS A | SAWADA RITSUKO | MABVAX THERAPEUTICS INC |
| EP3041511 | COMPOSITIONS OF ELTROMBOPAG | PARTHASARADHI REDDY BANDI | HETERO RESEARCH FOUNDATION |
| EP3041516 | IMAGEABLE POLYMERS | HOHN STéPHANE | BIOCOMPATIBLES UK LTD |
| EP3041577 | TREATMENT AND PREVENTION OF AUTISM AND AUTISM SPECTRUM DISORDERS | WITTKOWSKI KNUT M | UNIV ROCKEFELLER |
| EP3041584 | METHOD OF ASSESSING HAIR COLOUR CHANGES | RICHARDS CLAIRE LOUISE | UNILEVER PLC |
| EP3041837 | CRYSTAL HAVING SPECIFIC CRYSTAL HABIT AND PHARMACEUTICAL COMPOSITION CONTAINING THE CRYSTAL AS ACTIVE INGREDIENT | MASUDA TAKAAKI | POLA PHARMA INC |
| EP3041949 | CELLS PRODUCING FC CONTAINING MOLECULES HAVING ALTERED GLYCOSYLATION PATTERNS AND METHODS AND USE THEREOF | CALLEWAERT NICO | VIB VZW |
| EP3042907 | DGAT1 INHIBITOR AND PREPARATION METHOD AND USE THEREOF | WU CHENGDE | MEDSHINE DISCOVERY INC |
| EP3042940 | LOW-TOXICITY SOPHOROLIPID-CONTAINING COMPOSITION AND USE THEREFOR | ITO HITOSHI | SARAYA CO LTD |
| EP3043773 | STABLE FIXED DOSE PHARMACEUTICAL COMPOSITION COMPRISING MOMETASONE AND OLOPATADINE | DHUPPAD ULHAS | GLENMARK SPECIALTY SA |
| EP3043785 | APPLICATION OF R-KETAMINE AND SALT THEREOF AS PHARMACEUTICALS | HASHIMOTO KENJI | UNIV CHIBA NAT UNIV CORP |
| EP3043790 | NOVEL ANTHRANILIC AMIDES AND THE USE THEREOF | CHAKRABARTY SURAVI | UNIV TULANE |
| EP3043793 | REHYDRATION OF MICRONIZED TECOVIRIMAT MONOHYDRATE | TYAVANAGIMATT SHANTAKUMAR R | SIGA TECHNOLOGIES INC |
| EP3043794 | COMBINATION OF EPIGENETIC FACTORS AND BISPECIFIC COMPOUNDS TARGETING CD33 AND CD3 IN THE TREATMENT OF MYELOID LEUKEMIA | WALTER ROLAND B | AMGEN INC |
| EP3043813 | PURIFICATION OF CHIMERIC FVIII MOLECULES | ZHU LILY | BIOGEN MA INC |
| EP3044163 | NANOPARTICLES FOR USE IN BIOADHESION | MARCELLAN ALBA | ESPCI PARISTECH |
| EP3044195 | COLLAGEN AND ELASTIN STIMULATING COMPOUND AND TOPICAL COMPOSITIONS COMPRISING SUCH COMPOUND | VAN TILBORG REINER | JOVENTIS S A |
| EP3044230 | CASPOFUNGIN DERIVATIVE | GROEN PAULUS BERNARDUS MARIA | DSM SINOCHEM PHARM NL BV |
| EP3045162 | OPIOID FORMULATIONS | TIBERG FREDRIK | CAMURUS AB |
| EP3045474 | THERAPEUTIC AGENTS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH UNDESIRED CELL PROLIFERATION | SEOANE SUáREZ JOAN | FUNDACIó PRIVADA INSTITUCIó CATALANA DE RECERCA I ESTUDIS AVANÇATS |
| EP3046537 | PHARMACEUTICAL PREPARATION OF CARBOHYDRATES FOR THERAPEUTIC USE | RAFALKO AGNES | GLYCOMINE INC |
| EP3046542 | SYNERGISTIC LIPOSOMAL FORMULATION FOR THE TREATMENT OF CANCER | ALI NAHID | COUNCIL SCIENT IND RES |
| EP3046560 | STEM CELL MODULATION II | RAO SUDHA | UNIV CANBERRA |
| EP3046585 | METHODS AND COMPOSITIONS FOR SYNTHESIZING IMPROVED SILK FIBERS | TURNER BRENDAN | BOLT THREADS INC |
| EP3046586 | METHODS OF TREATMENT USING BIS-POLYMER LIPID-PEPTIDE CONJUGATES AND NANOPARTICLES THEREOF | XU TING | UNIV CALIFORNIA |
| EP3046870 | SILICA MICRO- AND NANO-CAPSULES AND METHODS FOR MAKING THEM | MIDDELBERG ANTON PETER JACOB | UNIV QUEENSLAND |
| EP3046952 | POLYMER PARTICLES | CRUISE GREGORY M | TERUMO CORP |
| EP3047026 | MULTIFUNCTIONAL RNA NANOPARTICLES AND METHODS OF USE | SHAPIRO BRUCE ALLEN | US HEALTH |
| EP3049059 | INTRANASAL DHE FOR THE TREATMENT OF HEADACHE | HARUTA SHUNJI | SHIN NIPPON BIOMEDICAL LAB LTD |
| EP3049071 | PROPHYLAXIS AND TREATMENT OF A NEURODEGENERATIVE DISEASE NOT BASED ON A PROTEIN FOLDING DISORDER | UEFFING MARIUS | EBERHARD KARLS UNIVERSITÄT TüBINGEN MEDIZINISCHE FAKULTÄT |
| EP3049085 | INHIBITION OF SGK1 IN THE TREATMENT OF HEART CONDITIONS | ROSENZWEIG ANTHONY | BETH ISRAEL HOSPITAL |
| EP3049088 | PROSTAGLANDIN F2ALPHA AND ANALOGUES THEREOF FOR TREATING ATROPHIC CUTANEOUS SCARRING | SCHERER WARREN J | GALDERMA SA |
| EP3049114 | CARRIER-FREE BIOLOGICALLY-ACTIVE PROTEIN NANOSTRUCTURES | TANG LI | MASSACHUSETTS INST TECHNOLOGY |
| EP3049473 | DUALLY DERIVATIZED CHITOSAN NANOPARTICLES AND METHODS OF MAKING AND USING THE SAME FOR GENE TRANSFER IN VIVO | GAO JUN | ENGENE INC |
| EP3049526 | INTERLEUKIN-4 RECEPTOR-BINDING FUSION PROTEINS AND USES THEREOF | MERCHANT FAHAR | MEDICENNA THERAPEUTICS INC |
| EP3050576 | PEGYLATED RECOMBINANT HUMAN GROWTH HORMONE COMPOUNDS | RAU HARALD | ASCENDIS PHARMA GROWTH DISORDERS DIVISION AS |
| EP3050878 | NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF, OR METAL COMPLEX THEREOF | FUKUNAGA HIROFUMI | FUJIFILM CORP |
| EP3050896 | METHOD FOR PRODUCING POLYPEPTIDE HETEROMULTIMER | IGAWA TOMOYUKI | CHUGAI PHARMACEUTICAL CO LTD |
| EP3052076 | WATERY LOTION SKIN CARE COMPOSITIONS AND METHODS | YAROSH DANIEL B | ELC MAN LLC |
| EP3052109 | THERAPY WITH CELLS FROM HUMAN PLACENTA AND HEMATOPOIETIC CELLS | GURNEY JODI P | ANTHROGENESIS CORP |
| EP3052116 | METHODS FOR TREATING BREAST AND OTHER CANCERS BY TARGETING ARGININOSUCCINATE SYNTHETASE 1-DEFICIENCY | ANN DAVID K | ANN DAVID K |
| EP3052134 | GLUCOSE-RESPONSIVE INSULIN CONJUGATES | LIN SONGNIAN | MERCK SHARP & DOHME |
| EP3052194 | A VETERINARY METHOD FOR INDUCING EMESIS | LEVIJOKI JOUKO | ORION CORP |
| EP3052485 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | CASTRO ALFREDO C | INFINITY PHARMACEUTICALS INC |
| EP3052523 | METHODS OF TREATING AND DIAGNOSING ALPHA-V-BETA-6 OVEREXPRESSING CANCER | BARRY SIMON T | MEDIMMUNE LTD |
| EP3052548 | SILICONE-POLYETHER COPOLYMERS, ADHESIVES AND MEDICAL ARTICLES COMPRISING SAME, AND METHODS OF MAKING SAME | HANSEN RICHARD G | 3M INNOVATIVE PROPERTIES CO |
| EP3052625 | NOTCH 1 SPECIFIC SIRNA MOLECULE | SCHREIBER SÖREN | SOLUVENTIS GMBH |
| EP3053580 | METHOD OF PROVIDING PIRFENIDONE THERAPY TO A PATIENT | BRADFORD WILLIAMSON ZIEGLER | INTERMUNE INC |
| EP3053919 | CRYSTALLINE FORM OF 1-(BETA-D-GLUCOPYRANOSYL)-4-METHYL-3-[5-(4-FLUOROPHENYL)-2-THIENYLMETHYL]BENZENE AND PREPARATION METHOD THEREOF | WANG MENG | SHANGHAI DESANO PHARMACEUTICALS INVEST CO LTD |
| EP3054920 | DRY POWDER INHALER | DALVI MUKUL | TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D INC |
| EP3054942 | TREATMENTS FOR PROLIFERATIVE VITREORETINOPATHY | POLLACK AYALA | MOR RESEARCH APPLIC LTD |
| EP3054947 | CATHEPSIN CYSTEINE PROTEASE INHIBITORS | STACHEL SHAWN | MERCK SHARP & DOHME |
| EP3054965 | METHODS OF PREVENTING OR REDUCING PHOTORECEPTOR CELL DEATH | CONNOR KIP M | MASSACHUSETTS EYE & EAR INFIRM |
| EP3054969 | AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF OPIOID INDUCED DYSFUNCTIONS | SHAILUBHAI KUNWAR | SYNERGY PHARMACEUTICALS INC |
| EP3054971 | EPSTEIN-BARR VIRUS VACCINES | KANEKIYO MASARU | US OF AMERICA REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES |
| EP3055299 | PYRIMIDINE HYDROXY AMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS | YANG MIN | ACETYLON PHARMACEUTICALS INC |
| EP3055310 | DEUBIQUITINASE INHIBITORS AND METHODS FOR USE OF THE SAME | DONATO NICHOLAS J | UNIV MICHIGAN |
| EP3055331 | CONJUGATED ANTIBODIES AGAINST LY75 FOR THE TREATMENT OF CANCER | TERRETT JONATHAN ALEXANDER | OXFORD BIO THERAPEUTICS LTD |
| EP3055419 | ANALYZING IMMUNE SIGNALING NETWORKS FOR IDENTIFICATION OF THERAPEUTIC TARGETS IN COMPLEX CHRONIC MEDICAL DISORDERS, IDENTIFICATION OF A NATURAL KILLER CELL POPULATION AS A POTENTIAL THERAPEUTIC TARGET FOR GULF WAR ILLNESS&MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME, AND MODULATION OF NATURAL KILLER CELL FUNCTION BY STIMULATION WITH INTERLEUKIN 15 | FLETCHER MARY ANNE | UNIV NOVA SOUTHEASTERN |
| EP3056208 | IMMUNOPOTENTIATOR | KOSHI YOICHIRO | TORAY INDUSTRIES |
| EP3056217 | OSTEOARTHRITIS TREATMENT | HAMILTON JOHN ALLAN | UNIV MELBOURNE |
| EP3056492 | MEGUMINE SALT AND CRYSTALLINE FORMS THEREOF OF A DRUG (DELAFLOXACIN) | ZHANG GEOFF G | ABBVIE INC |
| EP3056564 | METHOD FOR PURIFICATION OF RETINAL PIGMENT EPITHELIAL CELLS | SAWADA MASANORI | HEALIOS KK |
| EP3056568 | METHODS FOR CONTROLLING BLOOD PHARMACOKINETICS OF ANTIBODIES | IGAWA TOMOYUKI | CHUGAI PHARMACEUTICAL CO LTD |
| EP3057563 | COSMETIC COMPOSITION WITH INCREASED OPACITY | HUDELIST FLORIAN | UNILEVER NV |
| EP3057575 | PRESERVATIVE FREE PHARMACEUTICAL COMPOSITIONS FOR OPHTHALMIC ADMINISTRATION | KARAVAS EVANGELOS | PHARMATHEN SA |
| EP3057580 | PHARMACEUTICAL DOSAGE FORMS CONTAINING SODIUM-1-[6-(MORPHOLIN-4-YL)PYRIMIDIN-4-YL]-4-(1H-1,2,3-TRIAZOL-1-YL)-1H-PYRAZOL-5-OLATE | NEUMANN HEIKE | BAYER PHARMA AG |
| EP3057591 | 4-[5-(3-CHLORO-PHENOXY)-OXAZOLO[5,4-D]PYRIMIDIN-2-YL]-2,6-DIMETHYL-PHENOXY}-ACETIC ACID FOR USE IN THE PREVENTION OR TREATMENT OF ACUTE KIDNEY INJURY | BRIAND VéRONIQUE | SANOFI SA |
| EP3057593 | TREATMENT FOR PANCREATIC CANCER | HEDLEY DAVID W | UNIV HEALTH NETWORK |
| EP3057604 | NANOPARTICLE COMPOSITIONS AND METHODS AS CARRIERS OF NUTRACEUTICAL FACTORS ACROSS CELL MEMBRANES AND BIOLOGICAL BARRIERS | KAUFMAN RICHARD CLARK | NANOSPHERE HEALTH SCIENCES LLC |
| EP3057610 | DRUG-CONJUGATES WITH A TARGETING MOLECULE AND TWO DIFFERENT DRUGS | MIAO ZHENWEI | SORRENTO THERAPEUTICS INC |
| EP3057615 | ANTI-RSPO ANTIBODIES AND METHODS OF USE | STORM ELAINE | HOFFMANN LA ROCHE |
| EP3057956 | POLYCYCLIC INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) | GRAY NATHANAEL | DANA FARBER CANCER INST INC |
| EP3057981 | THERAPEUTIC CANCER VACCINE BASED ON STRESS PROTEINS RENDERED IMMUNOGENIC | PINTEUR BENO脦T | GOLDFISH |
| EP3058085 | MICROBIOME RESPONSE TO AGENTS | ELINAV ERAN | YEDA RES & DEV |
| EP3058371 | USE OF ACAMPROSATE TO MODULATE ERK 1-2 ACTIVATION IN ANIMAL MODELS FOR FXS AND ASD AND INDIVIDUALS DIAGNOSED WITH FXS AND ASD | ERICKSON CRAIG | UNIV INDIANA RES & TECH CORP |
| EP3058938 | PLANT COMPOSITION HAVING MOISTURIZING, ANTI-WRINKLE, AND ANTI-ALLERGIC EFFICACIES, AND PREPARATION METHOD THEREOF | LIU GUANGRONG | INFINITUS CHINA CO LTD |
| EP3058989 | COMPOSITION FOR FORMING A FILM ON KERATIN FIBRES | HERRLEIN MATHIAS | PROCTER & GAMBLE |
| EP3059231 | CHROMENE DERIVATIVES AS INHIBITORS OF TCR-NCK INTERACTION | GAGETE MATEOS ANDRéS | ARTAX BIOPHARMA INC |
| EP3060200 | TYROSINE DERIVATIVES AND COMPOSITIONS COMPRISING THEM | HOFFMAN STEVEN | TYME INC |
| EP3060204 | BETA-CATENIN | AHMED AAMIR | UCL BUSINESS PLC |
| EP3060213 | PHARMACEUTICAL COMPOSITIONS COMPRISING ANTIBACTERIAL AGENTS | BHAGWAT SACHIN | WOCKHARDT LTD |
| EP3060229 | STABLE, AQUEOUS ANTIBODY FORMULATIONS | LEACH WILLIAM | MEDIMMUNE LLC |
| EP3060237 | METHODS, SYSTEMS AND COMPOSITIONS RELATING TO CELL CONVERSION VIA PROTEIN INDUCED IN-VIVO CELL REPROGRAMMING | WANG JIANJUN | UNIV WAYNE STATE |
| EP3060257 | LIPID FORMULATIONS FOR DELIVERY OF MESSENGER RNA | HEARTLEIN MICHAEL | SHIRE HUMAN GENETIC THERAPIES |
| EP3060562 | SUBSTITUTED PYRIMIDINE COMPOUNDS AND THEIR USE AS SYK INHIBITORS | LEE JAEKYOO | GENOSCO |
| EP3060580 | ANTI-PODOCALYXIN ANTIBODIES AND METHODS OF USING THE SAME | BABCOOK JOHN STEPHEN | CT FOR DRUG RES AND DEV |
| EP3060660 | RECOMBINANT GLYCOPROTEINS AND USES THEREOF | LEE KAREN | GENZYME CORP |
| EP3060671 | CNS DELIVERY OF MRNA AND USES THEREOF | DEROSA FRANK | SHIRE HUMAN GENETIC THERAPIES |
| EP3060908 | DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES | SEXTON DANIEL J | DYAX CORP |
| EP3061454 | PARASITICIDAL ORAL VETERINARY COMPOSITIONS COMPRISING SYSTEMICALLY-ACTING ACTIVE AGENTS, METHODS AND USES THEREOF | SOLL MARK D | MERIAL INC |
| EP3061747 | PYRIDIC KETONE DERIVATIVES, METHOD OF PREPARING SAME, AND PHARMACEUTICAL APPLICATION THEREOF | TU WANGYANG | SHANGHAI HENGRUI PHARM CO LTD |
| EP3062764 | STABILISED MULTIPLE EMULSIONS AS SKIN PROTECTION PRODUCT | HEISLER ECKHARD | DEB IP LTD |
| EP3062808 | TREATMENT OF METASTATIC PROSTATE CANCER | GAO ALLEN C | UNIV CALIFORNIA |
| EP3062819 | IONIC LIQUIDS FOR TRANSDERMAL DRUG DELIVERY | ZAKREWSKY MICHAEL | UNIV CALIFORNIA |
| EP3062820 | METHODS FOR ENCAPSULATION AND MICROCAPSULES PRODUCED THEREBY | GORECKA ELZBIETA | PROTEON PHARMACEUTICALS S A |
| EP3063159 | PROCESS FOR PURIFICATION OF A NEUTRAL HUMAN MILK OLIGOSACCHARIDE USING SIMULATED MOVING BED CHROMATOGRAPHY | JENNEWEIN STEFAN | JENNEWEIN BIOTECHNOLOGIE GMBH |
| EP3064578 | METHOD OF PRODUCING CELL POPULATION WITH HIGH TARGET CELL PURITY | NOGUCHI ERI | TERUMO CORP |
| EP3065701 | ELUTING MATRIX AND USES THEREOF | POZNANSKY MARK C | GEN HOSPITAL CORP |
| EP3065707 | MESOPOROUS DOSAGE FORMS FOR POORLY SOLUBLE DRUGS | PRINDERRE PASCAL | SIEGFRIED AG |
| EP3065741 | SESAME OIL BASED INJECTION FORMULATIONS | BEAURLINE JOSEPH | 3M INNOVATIVE PROPERTIES CO |
| EP3065744 | MEANS AND METHODS FOR THE TREATMENT OF NEPHROPATHY | EULBERG DIRK | NOXXON PHARMA AG |
| EP3065759 | IMMUNOSUPPRESSIVE AGENTS AND THEIR USE IN THERAPY | OTTERLEI MARIT | NORWEGIAN UNIV SCI & TECH NTNU |
| EP3065774 | ANTI-CCL17 ANTIBODIES | BOAKYE KEN | JANSSEN BIOTECH INC |
| EP3065782 | NANOSTRUCTURE CONJUGATES FOR MODULATION OF LOCATION-SPECIFIC SUBTYPES OF RECEPTORS AND ION CHANNELS | SAVTCHENKO ALEX | MOLOKANOVA ELENA |
| EP3065829 | COMPOSITIONS AND METHODS FOR TREATING MELANOMA | SLINGLUFF JR CRAIG L | UNIV VIRGINIA PATENT FOUND |
| EP3066068 | HYDROXYTYROSOL DERIVATIVES THEIR METHOD OF PREPARATION AND USE IN PERSONAL CARE | BOAZ NEIL WARREN | EASTMAN CHEM CO |
| EP3066072 | BIPHENYLAMIDE DERIVATIVE HSP90 INHIBITORS | BLAGG BRIAN S J | UNIV KANSAS |
| EP3066122 | PRE-HAPTOGLOBIN-2 MONOCLONAL ANTIBODIES AND USES THEREOF | FLANAGAN JOHN | BIO RAD LABORATORIES |
| EP3066124 | ANTICORPS ALLOSTERIQUES DE LA NEUREGULINE, DIRIG脡S CONTRE HER3 | CHARDES THIERRY | INSERM INST NAT DE LA SANTé ET DE LA RECH MéDICALE |
| EP3066937 | FOODSTUFF CONTAINING HISTIDINE AND APPLICATION THEREFOR | SHIBAKUSA TETSURO | AJINOMOTO KK |
| EP3068364 | SENESCENCE AND SENESCENCE ASSOCIATED SECRETORY PHENOTYPE | WU LINDSAY EDWARD | NEWSOUTH INNOVATIONS PTY LTD |
| EP3068373 | AQUEOUS BASED CAPSAICINOID FORMULATIONS AND METHODS OF MANUFACTURE AND USE | BIRBARA CHARLES A | VIZURI HEALTH SCIENCES LLC |
| EP3068392 | PROCESS OF PREPARING PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CFTR MEDIATED DISEASES | SWINNEY KELLY ANN | VERTEX PHARMA |
| EP3068399 | COMPOSITIONS AND METHODS FOR ASSESSING GUT FUNCTION | DORSHOW RICHARD B | DORSHOW RICHARD B |
| EP3068404 | COMPOSITIONS FOR USE IN THE PREVENTION OR TREATMENT OF URT INFECTIONS IN INFANTS OR YOUNG CHILDREN AT RISK | SPRENGER NORBERT | NESTEC SA |
| EP3068425 | METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS | MUMM JOHN BRIAN | ARMO BIOSCIENCES INC |
| EP3068803 | DOSING REGIMENS FOR USE WITH PCSK9 INHIBITORS | BACCARA-DINET MARIE | SANOFI SA |
| EP3069726 | AGENT AND METHOD FOR TREATING AUTOIMMUNE DISEASE | IWAKURA YOICHIRO | UNIV TOKYO SCIENCE FOUNDATION |
| EP3070095 | ADENO-ASSOCIATED VIRUS WITH SITE-DIRECTED MUTAGENESIS AND SITE-DIRECTED MODIFICATION, AND PREPARATION METHOD AND APPLICATION THEREFOR | ZHOU DEMIN | UNIV BEIJING |
| EP3070100 | HUMANIZED ANTIBODIES THAT SEQUESTER AMYLOID BETA PEPTIDE | HOLTZMAN DAVID M | UNIV ST LOUIS |
| EP3071181 | PHARMACEUTICAL COMPOSITION OF AN ANTI-VEGF ANTIBODY | SIGL RAINER | FORMYCON AG |
| EP3071206 | GASTRIN ANTAGONISTS (EG YF476, NETAZEPIDE) FOR TREATMENT AND PREVENTION OF OSTEOPOROSIS | MODLIN IRVIN MARK | CL BIOSCIENCES LLC |
| EP3071208 | COMPOSITIONS FOR USE IN THE PREVENTION OR TREATMENT OF NECROTIZING ENTEROCOLITIS IN INFANTS AND YOUNG CHILDREN | SANGILD PER TORP | NESTEC SA |
| EP3071223 | CELL | PULé MARTIN | UCL BUSINESS PLC |
| EP3071240 | METHOD FOR MONITORING EFFICACY OF TREATMENT OF ALZHEIMER'S DISEASE WITH AN APOE ISOFORM | DAVIDSON BEVERLY L | UNIV IOWA RES FOUND |
| EP3071561 | AUTOTAXIN INHIBITOR COMPOUNDS | HUTCHINSON JOHN HOWARD | PHARMAKEA INC |
| EP3071591 | ANTIMICROBIAL PEPTIDOMIMETICS | CHIA BRIAN CHENG SAN | AGENCY SCIENCE TECH & RES |
| EP3071592 | ARTIFICIAL DNA-BINDING PROTEINS AND USES THEREOF | SURACE ENRICO MARIA | FOND TELETHON |
| EP3072896 | TAXANE COMPOUND, AND PREPARATION METHOD AND USE THEREOF | ZHOU WEI | JIANGSU TASLY DIYI PHARMACEUTICAL CO LTD |
| EP3072906 | ANTIBODY FORMULATION | MOMM JOACHIM | NOVARTIS AG |
| EP3074021 | COMPOUND OF THE AVERMECTIN FAMILY OR OF THE MILBEMYCIN FAMILY FOR THE TREATMENT AND/OR PREVENTION OF ATOPIC DERMATITIS | HACINI-RACHINEL FERIEL | GALDERMA SA |
| EP3074385 | PIPERIDINE DERIVATIVES FOR USE IN THE TREATMENT OR PREVENTION OF PSYCHIATRIC AND NEUROLOGICAL CONDITIONS | GOLDBY ANNE | TAKEDA PHARMACEUTICAL |
| EP3074398 | A3 ADENOSINE RECEPTOR AGONISTS | JACOBSON KENNETH A | US HEALTH |
| EP3075377 | ORAL COMPOSITIONS COMPRISING POWDERED PLANT EXTRACTS | HÖBART HANS | HERMES ARZNEIMITTEL GMBH |
| EP3075841 | TISSUE PROCESSING APPARATUS AND METHOD FOR PROCESSING ADIPOSE TISSUE | CIMINO WILLIAM | GID GROUP INC |
| EP3076967 | NOVEL METHODS | VANOVER KIMBERLY | INTRA CELLULAR THERAPIES INC |
| EP3076969 | DOSAGE REGIMEN FOR AN ALPHA-ISOFORM SELECTIVE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR | DI TOMASO EMMANUELLE | NOVARTIS AG |
| EP3076971 | COMPOSITIONS AND METHODS FOR REDUCING MAJOR ADVERSE CARDIOVASCULAR EVENTS | KLASSEN PRESTON | OREXIGEN THERAPEUTICS INC |
| EP3076972 | CANCER TREATMENT WITH COMBINATION OF PLINABULIN AND TAXANE | HUANG LAN | BEYONDSPRING INC |
| EP3076977 | COMBINATION THERAPY FOR TREATING CANCER | KEILHACK HEIKE | EPIZYME INC |
| EP3077005 | COMPOSITION COMPRISING A URIDINE SOURCE AND AN OMEGA-3 PUFA FOR IMPROVING COORDINATION, BALANCE, GRIP STRENGTH OR FINE MOTOR SKILLS | ATTALI AMOS | NUTRICIA NV |
| EP3077396 | SYNTHESIS OF TRANS-8-CHLORO-5-METHYL-1 -[4-(PYRIDIN-2-YLOXY)-CYCLOHEXYL]-5,6-DIHYDRO-4H-2,3,5,10B-TETRAAZA-BENZO[E]AZULENE AND CRYTALLINE FORMS THEREOF | ROTHENHAEUSLER BENNO | HOFFMANN LA ROCHE |
| EP3077405 | ANTI-GANGLIOSIDE COMPOUND FOR TARGETING CANCER AND GENERATING ANTIBODIES | SARAGOVI H URI | UNIV MCGILL |
| EP3077410 | PROLINE-RICH PEPTIDES PROTECTIVE AGAINST S. PNEUMONIAE | GHASPARIAN ARIN | VIROMETIX AG |
| EP3077489 | DIHOMO-GAMMA-LINOLENIC ACID-CONTAINING MICROBIAL OIL AND DIHOMO-GAMMA-LINOLENIC ACID-CONTAINING MICROBIAL BIOMASS | SATO SEIZO | NIPPON SUISAN KAISHA LTD |
| EP3077519 | CMV VACCINES | ORLINGER KLAUS | HOOKIPA BIOTECH AG |
| EP3078375 | ANTI-FATIGUE COMPOSITION | SHIBAKUSA TETSURO | AJINOMOTO KK |
| EP3079660 | DRUG DELIVERY SYSTEM. | VERHOEVEN WILLY J H | MERCK SHARP & DOHME |
| EP3079661 | NALOXONE MONO-PRODUCT AND MULTI-LAYER TABLET | REY HéLèNE | DEVELCO PHARMA SCHWEIZ AG |
| EP3079666 | PHARMACEUTICAL COMPOSITIONS COMPRISING DIMETHYL FUMARATE | PLANELLS JIMENEZ MARIA | ALMIRALL SA |
| EP3079695 | GLUCOSYLCERAMIDE SYNTHASE INHIBITORS | LEONARD JOHN P | GENZYME CORP |
| EP3079697 | PROLYLHYDROXYLASE/ATF4 INHIBITORS FOR TREATING NEURAL CELL INJURY | RATAN RAJIV R | UNIV CORNELL |
| EP3079701 | SOLUBLE GUANYLATE CYCLASE ACTIVATORS | HAN XIAOQING | MERCK SHARP & DOHME |
| EP3079722 | METHOD FOR THIOETHER CONJUGATION OF PROTEINS | HUNNECHE CHARLOTTE SCHOU | NOVO NORDISK HEALTHCARE AG |
| EP3080270 | COMPLEMENT COMPONENT IRNA COMPOSITIONS AND METHODS OF USE THEREOF | BORODOVSKY ANNA | ALNYLAM PHARMACEUTICALS INC |
| EP3081221 | BOVINE COLOSTRUM ENZYME PROCESSED PRODUCT, PRODUCTION METHOD THEREFOR, COMPOSITION, AND FOOD OR BEVERAGE | UTO YOSHIHIRO | SAISEI PHARMA CO LTD |
| EP3081560 | TAXANES COMPOUNDS, PREPARATION METHOD THEREFOR, AND USES THEREOF | ZHOU WEI | JIANGSU TASLY DIYI PHARMACEUTICAL CO LTD |
| EP3082711 | COMPOSITION OF PICKERING EMULSION COMPRISING LOW AMOUNT OF ALCOHOL | MA SHOUWEI | ORéAL L |
| EP3082734 | HAIR FIXATIVES INCLUDING CELLULOSE ETHER BASED POLYGLUCOSE POLYMERS | BEVINAKATTI HANAMANTHSA | AKZO NOBEL CHEMICALS INT BV |
| EP3082757 | GEL-WIPE FOR PERSONAL CARE AND HOUSEHOLD CLEANSING | BRUNING ELIZABETH | JOHNSON & JOHNSON CONSUMER INC |
| EP3082762 | LONG-ACTING KETOPROFEN COMPOSITIONS | EWIN RICHARD ANDREW | ZOETIS SERVICES LLC |
| EP3082786 | ANTIDIABETIC SUBSTITUTED HETEROARYL COMPOUNDS | HAGMANN WILLIAM K | MERCK SHARP & DOHME |
| EP3082798 | BENZODIOXOL DERIVATIVES FOR USE IN THE TREATMENT OF ATTENTION DEFICIT AND/OR HYPERACTIVITY | VERLEYE MARC | BIOCODEX |
| EP3082799 | USE OF ISOFLAVONES FOR THE TREATMENT OF RETROVIRAL INFECTION | LIU LI | VERSITECH LTD |
| EP3082804 | NOVEL USE OF BIOTIN AND NATURAL ESSENTIAL OILS FOR BOVINE ANIMALS FOR THE PREVENTION AND TREATMENT OF KETOSIS | IMMIG IRMGARD | DSM IP ASSETS BV |
| EP3082809 | BTK INHIBITORS | LIU JIAN | MERCK SHARP & DOHME |
| EP3082829 | TREATMENT OF METABOLIC DISORDERS IN FELINE ANIMALS | REICHE DANIA BIRTE | BOEHRINGER INGELHEIM VETMED |
| EP3082831 | COMPOSITIONS BASED ON METHYL CYCLODEXTRINS FOR THE TREATMENT AND/OR PREVENTION OF DISEASES BY INCREASING THE HDL CHOLESTEROL LEVEL | SALOME MARC | ROQUETTE FRèRES |
| EP3082840 | METHODS AND ASSAYS RELATING TO CIRCULATING TUMOR CELLS | TING DAVID T | GEN HOSPITAL CORP |
| EP3082841 | METHODS FOR TREATING AN ANIMAL | CASEBOLT BRETT | PURETEIN BIOSCIENCE LLC |
| EP3082845 | METHODS AND COMPOSITIONS FOR TREATMENT OF PERIPHERAL NEUROPATHIES | FERNYHOUGH PAUL | UNIV MANITOBA |
| EP3082855 | COMPOSITION | TITBALL RICHARD WILLIAM | UNIV EXETER |
| EP3082858 | ADRENOMEDULLIN BINDER FOR USE IN THERAPY OF CANCER | BERGMANN ANDREAS | ANGIOBIOMED GMBH |
| EP3082865 | PREVENTION AND COUNTERACTION OF DIET-INDUCED THROMBOSIS RISK | VERMEER CEES | VITAK BV |
| EP3083616 | BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY | CHESSARI GIANNI | ASTEX THERAPEUTICS LTD |
| EP3083619 | P2X3 AND/OR P2X2/3 COMPOUNDS AND METHODS | THOMPSON SCOTT | ASANA BIOSCIENCES LLC |
| EP3083659 | VIRAL PEPTIDES | CARVALHO ISABEL MARIA FIDALGO DOS SANTOS SILVA | EQUIGERMINAL SA |
| EP3083960 | RAS EXON 2 SKIPPING FOR CANCER TREATMENT | ANDRESEN BRAGE | UNIV SYDDANSK |
| EP3083962 | DOUBLE-STRANDED POLYC:POLY(G/I) RNA FOR IMMUNOSTIMULATION AND CANCER TREATMENT | ROHAYEM JACQUES | RIBOXX GMBH |
| EP3085362 | COMPOSITIONS AND METHODS USING MICROSPHERES AND NON-IONIC CONTRAST AGENTS | REB PHILIPPE | BIOSPHERE MEDICAL S A |
| EP3085372 | COMBINATION OF PYRIDOXINE, FOLIC ACID AND MAGNESIUM IONS FOR TREATING CANCER | VERGARA CAMPILLO RAMIRO MOISES | VERGARA CAMPILLO RAMIRO MOISES |
| EP3085385 | PHARMACEUTICAL COMPOSITION COMPRISING ADALIMUMAB | FANG WEIJIE | ZHEJIANG HISUN PHARM CO LTD |
| EP3085388 | HYPERBRANCHED POLYMER CONJUGATES VIA NON-ENZYMATIC CLEAVABLE LINKER | HERSEL ULRICH | ASCENDIS PHARMA GROWTH DISORDERS DIVISION AS |
| EP3085783 | BISPECIFIC ANTIBODY SUBSTITUTING FOR FUNCTIONAL PROTEINS | HATTORI KUNIHIRO | CHUGAI PHARMACEUTICAL CO LTD |
| EP3086765 | USE OF SALICYLIC ACID DERIVATIVES AS PRODESQUAMATING ACTIVE AGENT | BROSSAT MAUDE | OREAL |
| EP3086787 | PHARMACEUTICAL COMBINATIONS | FERRETTI STEPHANE | NOVARTIS AG |
| EP3086803 | FGF-18 FORMULATION IN XYLOGLUCAN GELS | LO PRESTI CATERINA | ARES TRADING SA |
| EP3086858 | LIGHTENING PROCESS USING A SUBSTRATE BEARING AT LEAST ONE OXIDIZING AGENT AND AN AQUEOUS COMPOSITION | SAMAIN HENRI | ORéAL L |
| EP3087064 | PRODRUGS OF UROLITIHNS AND USES THEREOF | RINSCH CHRISTOPHER LAWRENCE | AMAZENTIS SA |
| EP3087087 | BETA-HAIRPIN PEPTIDOMIMETICS AS SELECTIVE ELASTASE INHIBITORS | GOMBERT FRANK OTTO | POLYPHOR AG |
| EP3087091 | VAR2CSA-DRUG CONJUGATES | RICH JAMES R | ZYMEWORKS INC |
| EP3087093 | PHARMACEUTICALLY RELEVANT AROMATIC-CATIONIC PEPTIDES | WILSON D TRAVIS | STEALTH BIOTHERAPEUTICS CORP |
| EP3087969 | PROTEASOME INHIBITORS AND USES THEREOF | ARBISER JACK L | ARBISER JACK L |
| EP3087984 | PROPHYLACTIC AND THERAPEUTIC AGENT FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | TOGASHI HIROKO | FUJIMOTO CO LTD |
| EP3088412 | PROTEIN PURIFICATION METHOD | TAKEDA KOZO | CHUGAI PHARMACEUTICAL CO LTD |
| EP3089707 | TISSUE GRAFTS AND METHODS OF MAKING AND USING THE SAME | MARIA DE PEPPO GIUSEPPE | NEW YORK STEM CELL FOUNDATION |
| EP3089737 | ORAL RAPAMYCIN NANOPARTICLE PREPARATIONS AND USE | VAIL NEAL K | RAPAMYCIN HOLDINGS LLC |
| EP3089741 | PHARMACEUTICAL COMPOSITIONS COMPRISING AZD9291 | WILSON DAVID | ASTRAZENECA AB |
| EP3089754 | SINGLE VIAL VACCINE FORMULATIONS | FOX CHRISTOPHER B | INFECTIOUS DISEASE RES INST |
| EP3089758 | COVALENTLY LINKED HELICAR-ANTI-HELICAR ANTIBODY CONJUGATES AND USES THEREOF | BRINKMANN ULRICH | HOFFMANN LA ROCHE |
| EP3089996 | BISPECIFIC ANTI-HAPTEN/ANTI-BLOOD BRAIN BARRIER RECEPTOR ANTIBODIES, COMPLEXES THEREOF AND THEIR USE AS BLOOD BRAIN BARRIER SHUTTLES | BRINKMANN ULRICH | HOFFMANN LA ROCHE |
| EP3090744 | PHARMACEUTICAL COMPLEX FORMULATION COMPRISING ANGIOTENSIN II RECEPTOR BLOCKER AND HMG-COA REDUCTASE INHIBITOR | LEE JAE WON | ALVOGEN KOREA CO LTD |
| EP3091978 | PHARMACEUTICAL COMPOSITIONS COMPRISING IMIQUIMOD FOR USE IN THE TREATMENT OF CARCINOMA IN SITU OF THE BLADDER | HOLLDACK JOHANNA | UROGEN PHARMA LTD |
| EP3091981 | COMPOSITIONS AND METHODS FOR TREATMENT OF ABNORMAL CELL GROWTH | PADVAL MAHESH | VERASTEM INC |
| EP3091990 | TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS/ACQUIRED IMMUNODEFICIENCY SYNDROME | HAR-NOY MICHAEL | IMMUNOVATIVE THERAPIES LTD |
| EP3091999 | IMPROVED CELL COMPOSITIONS AND METHODS FOR CANCER THERAPY | RUTENBERG ABRAHAM | HADASIT MED RES SERVICE |
| EP3092013 | STERILIZATION OF TOPICAL ANTISEPTIC SOLUTIONS | DEGALA SATISH | CAREFUSION 2200 INC |
| EP3092220 | VITAMIN C PRODRUGS AND USES THEREOF | SLOAN KENNETH B | UNIV FLORIDA |
| EP3093011 | METHOD FOR THE PREPARATION OF DIRECTLY TABLETTABLE MANNITOL | ERDMANN MARTIN | MERCK PATENT GMBH |
| EP3093017 | PHARMACEUTICAL COMPOSITION COMPRISING (S)-(3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL)METHANOL FOR USE IN TREATING MAMMALIAN CONDITIONS | DIBAS MOHAMMED I | ALLERGAN INC |
| EP3093019 | PHARMACEUTICAL COMPOSITION CONTAINING PYRIDYLAMINO ACETIC ACID COMPOUND | ENDO YOKO | SANTEN PHARMA CO LTD |
| EP3093021 | PYRIDYLAMINOACETIC ACID COMPOUND AND POLYOXYETHYLENE CASTOR OIL-CONTAINING PHARMACEUTICAL COMPOSITION | ENDO YOKO | SANTEN PHARMA CO LTD |
| EP3093338 | RECOMBINANT ANAEROBIC GRAM-POSITIVE BACTERIA | NISHIKAWA TAKESHI | TEIKYO HEISEI UNIVERSITY |
| EP3093339 | STEM CELLS DERIVED FROM PURE CHORIONIC TROPHOBLAST LAYER AND CELL THERAPY COMPRISING SAME | HA CHUL WON | SAMSUNG LIFE PUBLIC WELFARE FOUNDATION |
| EP3094314 | TARGETED NANOCARRIERS FOR THE ADMINISTRATION OF IMMUNOSUPPRESSIVE AGENTS | BROOME ANN-MARIE | MUSC FOUND FOR RES DEV |
| EP3094325 | HETEROARYLS AND USES THEREOF | BHARATHAN INDU T | MILLENNIUM PHARM INC |
| EP3094337 | PHOSPHOLIPID COMPOSITIONS AND THEIR PREPARATION | MYHREN FINN | AKER BIOMARINE ANTARCTIC AS |
| EP3094351 | IMMUNOMODULATORY AGENTS | WAKSAL SAMUEL D | KADMON CORP LLC |
| EP3094380 | METHODS OF TREATING METABOLIC SYNDROME RELATED CONDITIONS USING RETINOIC ACID RECEPTOR AGONISTS | GUDAS LORRAINE J | UNIV CORNELL |
| EP3094652 | NOVEL VACCINES AGAINST HPV AND HPV-RELATED DISEASES | OH SANGKON | BAYLOR RES INST |
| EP3094720 | COMPOSITIONS AND METHODS OF PREPARING AIRWAY CELLS | GHAEDI MAHBOOBE | UNIV YALE |
| EP3095447 | TREATING VITAMIN D INSUFFICIENCY AND DEFICIENCY WITH 25-HYDROXYVITAMIN D2 AND 25-HYDROXYVITAMIN D3 | BISHOP CHARLES W | OPKO RENAL LLC |
| EP3096739 | TOPICAL DELIVERY FORMULATION | PATE JAMES | MERIAL INC |
| EP3096745 | TRANSDERMAL DELIVERY SYSTEM COMPRISING DONEPEZIL OR ITS SALT | CHOI YO-HAN | DAE WOONG PHARMA |
| EP3096747 | ORALLY AVAILABLE COMPOUNDS, A PROCESS FOR PREPARING THE SAME AND THEIR USES AS ANTI-ADHESIVE DRUGS FOR TREATING E. COLI INDUCED INFLAMMATORY BOWEL DISEASES SUCH AS CROHN'S DISEASE | BOUCKAERT JULIE | CENTRE NAT RECH SCIENT |
| EP3096751 | 12-EPI-PLEUROMUTILINS | THIRRING KLAUS | NABRIVA THERAPEUTICS AG |
| EP3096774 | CELLULAR PLATFORM FOR RAPID AND COMPREHENSIVE T-CELL IMMUNOMONITORING | SEIDEL RONALD D III | EINSTEIN COLL MED |
| EP3096777 | GOBLET CELL REPLACEMENT THERAPY | YATES-BINDER CECELIA C | UNIV PITTSBURGH |
| EP3096783 | STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF | GU JIANXIN | PFIZER |
| EP3096786 | STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF | HAN MINGMING | PFIZER |
| EP3096839 | SCENTED BODY COMPOSITIONS | SHAVIT SHOVAL | MAORI S C LTD |
| EP3097079 | PROCESS FOR THE CYCLOADDITION OF A HETERO(ARYL) 1,3-DIPOLE COMPOUND WITH A (HETERO)CYCLOALKYNE | VAN DELFT FLORIS LOUIS | SYNAFFIX BV |
| EP3097089 | ARYL AND ARYLALKYL SUBSTITUTED PYRAZOLYL AND PYRIMIDINYL TRICYCLIC ENONES AS ANTIOXIDANT INFLAMMATION MODULATORS | ANDERSON ERIC | ABBVIE INC |
| EP3097180 | DEVICE FOR ULTRASOUND TESTS | BARBATO GAETANO | PROMEDICA BIOELECTRONICS S R L |
| EP3097913 | COSMETIC COMPOSITION CONTAINING HYDROXY PYRANONE DERIVATIVE COMPOUND FOR PROMOTING DIFFERENTIATION OF ADIPOCYTES | RHO HO SIK | AMOREPACIFIC CORP |
| EP3097916 | COMPOSITIONS AND METHODS FOR PROVIDING HEMATOPOIETIC FUNCTION | DELANEY COLLEEN | HUTCHINSON FRED CANCER RES |
| EP3097921 | COMPOSITION COMPRISING ACTIVE INGREDIENTS OF VEGETABLE ORIGIN | VALERII MARIA CHIARA | TARGETING GUT DIESEASE S R L |
| EP3098240 | ANTI-AXL ANTIBODIES AND METHODS OF USE | PEI LIN | HOFFMANN LA ROCHE |
| EP3099284 | OIL-IN-WATER EMULSION SUNSCREEN COMPOSITION | KENNEDY DIANNE M | ISP INVESTMENTS INC |
| EP3099313 | RETRO-INVERSO ANALOGS OF SPADIN DISPLAY INCREASED ANTIDEPRESSANT EFFECTS | GAUDRIAULT GEORGES | MEDINCELL |
| EP3099317 | NOVEL TREATMENTS | CLARSUND MATS PETER | ENZYMATICA AB |
| EP3099331 | TRANSMUCOSAL AND TRANSEPITHELIAL DRUG DELIVERY SYSTEM | STAMBOULIS ARTEMIS | UNIV BIRMINGHAM |
| EP3099380 | METHODS AND COMPOSITIONS FOR KILLING SENESCENT CELLS AND FOR TREATING SENESCENCE-ASSOCIATED DISEASES AND DISORDERS | LABERGE REMI-MARTIN | BUCK INST FOR RES ON AGING |
| EP3099704 | MHC CLASS I EPITOPE DELIVERING POLYPEPTIDES | POMA ERIC | MOLECULAR TEMPLATES INC |
| EP3100717 | COSMETIC | ALABATA ENRIQUE | RESTORSEA LLC |
| EP3101035 | BIFUNCTIONAL FUSION PROTEIN, PREPARATION METHOD THEREFOR, AND USE THEREOF | CHEN GUOQIANG | BEIJING HANMI PHARMACEUTICAL CO LTD |
| EP3101132 | ANTI-TRANSTHYRETIN HUMAN ANTIBODY | TORIKAI MASAHARU | THE CHEMO-SERO-THERAPEUTIC RES INST |
| EP3101138 | MICROBIAL OIL, METHOD FOR MANUFACTURING MICROBIAL OIL, CONCENTRATED MICROBIAL OIL, AND METHOD FOR MANUFACTURING CONCENTRATED MICROBIAL OIL | YAMAGUCHI HIDEAKI | NIPPON SUISAN KAISHA LTD |
| EP3102185 | NANOSUSPENSION OF NATURAL MATERIALS AND PREPARATION METHOD THEREOF | BRAND WERNER | APURANO PHARMACEUTICALS GMBH |
| EP3102186 | DONEPEZIL COMPOSITIONS AND METHOD OF TREATING ALZHEIMER'S DISEASE | DEDHIYA MAHENDRA G | FOREST LABORATORIES HOLDINGS LTD |
| EP3102195 | BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS | JANDELEIT BERND | QUADRIGA BIOSCIENCES INC |
| EP3102204 | HIGHLY SELECTIVE SIGMA RECEPTOR LIGANDS AND RADIOLIGANDS AS PROBES IN NOCICEPTIVE PROCESSING AND THE PATHPHYSIOLOGICAL STUDY OF MEMORY DEFICITS AND CONITIVE DISORDERS | MCCURDY CHRISTOPHER R | THE UNIV OF MISSISSIPPI |
| EP3102208 | CRYSTALLINE POLYMORPHS OF THE FREE BASE OF 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE | LI ZHE | GLOBAL BLOOD THERAPEUTICS INC |
| EP3102209 | USE OF FLAP INHIBITORS TO REDUCE NEUROINFLAMMATION MEDIATED INJURY IN THE CENTRAL NERVOUS SYSTEM | HEIDENREICH KIM A | BIOSCIENCE PHARMA PARTNERS LLC |
| EP3102215 | 4'-DIFLUOROMETHYL SUBSTITUTED NUCLEOSIDE DERIVATIVES AS INHIBITORS OF INFLUENZA RNA REPLICATION | SMITH MARK | RIBOSCIENCE LLC |
| EP3102230 | METHODS OF TREATING ALZHEIMER'S DISEASE | GRAHAM ROBERT | HOFFMANN LA ROCHE |
| EP3102234 | AIPA, OMPA, AND ASP14 IN VACCINE COMPOSITIONS AND DIAGNOSTIC TARGETS FOR ANAPLASMA PHAGOCYTOPHILUM INFECTION | CARLYON JASON | UNIV VIRGINIA COMMONWEALTH |
| EP3102245 | METHODS OF SCREENING, SELECTING, AND IDENTIFYING CYTOTOXIC RECOMBINANT POLYPEPTIDES BASED ON AN INTERIM DIMINUTION OF RIBOTOXICITY | POMA ERIC | MOLECULAR TEMPLATES INC |
| EP3102575 | NOVEL SALTS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS | SABOURAULT NICOLAS LUC | GALAPAGOS NV |
| EP3102613 | POLYMER PARTICLES AND USES THEREOF | REHM BERND HELMUT ADAM | REHM BERND HELMUT ADAM |
| EP3103442 | MICROSPHERES INCLUDING OXIDIZED CELLULOSE | BLASKOVICH PHILIP | COVIDIEN LP |
| EP3103443 | METHOD FOR TREATING PRIMARY INSOMNIA | ZISAPEL NAVA | NEURIM PHARMACEUTICALS (1991) LTD |
| EP3103807 | PEPTIDE/ -1,3-GLUCAN COMPLEX AND PRODUCTION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING PEPTIDE/ -1,3-GLUCAN COMPLEX | SAKURAI KAZUO | JAPAN SCIENCE & TECH AGENCY |
| EP3103809 | IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS | PETERS ROBERT T | BIOGEN HEMOPHILIA INC |
| EP3103866 | PORCINE PSEUDORABIES VIRUS ATTENUATING METHOD, VIRAL STRAINS ATTENUATED THEREBY, VACCINE COMPOSITION AND APPLICATION THEREOF | TIAN KEGONG | PULIKE BIOLOGICAL ENG INC |
| EP3104842 | SPRAYABLE COMPOSITION CONTAINING ZINC OXIDE AND A FLUORO-OLEFIN PROPELLANT | DANN THOMAS | MISSION PHARMA CO |
| EP3104889 | ACTIVATION OF INNATE IMMUNITY FOR ENHANCED NUCLEAR REPROGRAMMING OF SOMATIC CELLS WITH mRNA | COOKE JOHN P | UNIV LELAND STANFORD JUNIOR |
| EP3104919 | PRESSURISED METERED DOSE INHALERS AND METHOD OF MANUFACTURE | TAYLOR GLYN | CARDIFF SCINTIGRAPHICS LTD |
| EP3104940 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF SCHISTOSOMIASIS | HADLEY KEVIN | DSM IP ASSETS BV |
| EP3105230 | PYRIDOPYRAZINES MODULATORS OF GPR6 | HITCHCOCK STEPHEN | TAKEDA PHARMACEUTICALS CO |
| EP3105245 | PEPTIDES THAT BLOCK LEUKOCYTE RECRUITMENT AND METHODS OF USE | ROBBINS STEPHEN MARK | ARCH CANCER THERAPEUTICS INC |
| EP3105249 | ANTIBODY MOLEULES TO DENGUE VIRUS AND USES THEREOF | ROBINSON LUKE | VISTERRA INC |
| EP3105281 | MATERIALS AND METHODS RELATING TO STABILISED POLYMERIC SILICATE COMPOSITIONS | BASTOS CARLOS ANDRé PASSOS | MEDICAL RES COUNCIL |
| EP3105331 | KETOHEXOKINASE (KHK) IRNA COMPOSITIONS AND METHODS OF USE THEREOF | FITZGERALD KEVIN | ALNYLAM PHARMACEUTICALS INC |
| EP3106150 | IMPROVED PHARMACEUTICAL COMPOSITIONS OF PIMOBENDAN | PéTER LACZAY | BOEHRINGER INGELHEIM VETMEDICA GMBH |
| EP3106152 | ORALLY DISINTEGRATING TABLET COATED WITH FILM | OIKAWA MICHINORI | SAWAI SEIYAKU KK |
| EP3106158 | VITAMIN K2 AND MACULA DEGENERATION | WAGENAAR LOUIS JOHAN | WAGENAAR LOUIS JOHAN |
| EP3106169 | FORMULATION OF ORAL COMPOSITIONS COMPRISING ARSENIC TRIOXIDE AND METHODS OF USE THEREOF | KUMANA CYRUS RUSTAM | VERSITECH LTD |
| EP3106171 | CITRUS SEED EXTRACT-CONTAINING COMPOSITION, FOOD, DRUG, AND METHOD FOR PRODUCING CITRUS SEED EXTRACT-CONTAINING COMPOSITION | HORIBA TARO | KIKKOMAN CORP |
| EP3106206 | BODY INK COMPOSITIONS AND APPLICATORS | HANDLEY TYLER JAMES | INKBOX INK INC |
| EP3107543 | VACUOLIN-1 AS AN INHIBITOR OF AUTOPHAGYAND ENDOSOMAL TRAFFICKING AND THE USE THEREOF FOR INHIBITING TUMOR PROGRESSION | YUE JIANBO | UNIV HONG KONG |
| EP3107553 | METHODS AND COMPOSITIONS FOR INTESTINAL MICROENVIRONMENT TRANSFER | WÄTZIG GEORG | CONARIS RES INST AG |
| EP3107557 | HYDROPHILIC ANTIBODY-DRUG CONJUGATES | DORONINA SVETLANA | SEATTLE GENETICS INC |
| EP3107563 | GLYCOTARGETING THERAPEUTICS | HUBBELL JEFFREY A | ECOLE POLYTECHNIQUE FéDéRALE DE LAUSANNE (EPFL) EPFL-TTO |
| EP3107575 | METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST | PIROZZI GIANLUCA | SANOFI BIOTECHNOLOGY |
| EP3107590 | FREEZE-DRIED POLYMER COMPOSITIONS FOR MIXING WITH PLATELET RICH PLASMA TO FORM IMPLANTS FOR TISSUE REPAIR AND/OR COMPOSITIONS FOR THERAPEUTIC INTRA-ARTICULAR INJECTIONS | CHEVRIER ANIK | ORTHO REGENERATIVE TECH INC |
| EP3107898 | 1,2-SUBSTITUTED CYCLOPENTANES AS OREXIN RECEPTOR ANTAGONISTS | FIELDHOUSE CHARLOTTE | TAKEDA PHARMACEUTICALS CO |
| EP3107902 | COMPOUNDS AND METHODS FOR INHIBITING FASCIN | HUANG XIN-YUN | CORNELL UNIV CORNELL CENTER FOR TECH ENTPR & COMMERCIALIZATION ( CCTEC ) |
| EP3107909 | ANTIMITOTIC AMIDES FOR THE TREATMENT OF CANCER AND PROLIFERATIVE DISORDERS | SIDDIQUI-JAIN ADAM | FROST BIOLOGIC INC |
| EP3107919 | MACROCYCLIC THERAPEUTIC AGENTS, METHODS OF MANUFACTURE, AND METHODS OF TREATMENT | LUESCH HENDRIK | UNIV OF FLORIDA RES FOUND |
| EP3107923 | WATER-SOLUBLE O-CARBONYL PHOSPHORAMIDATE PRODRUGS FOR THERAPEUTIC ADMINISTRATION | GORDEEV MIKHAIL FEDOROVICH | MICURX PHARMACEUTICALS INC |
| EP3108891 | EYE DISEASE TREATMENT AGENT, SCREENING METHOD THEREFOR, AND METHOD FOR PREDICTING REJECTION RESPONSE ASSOCIATED WITH RETINAL PIGMENT EPITHELIAL CELL TRANSPLANT | TAKAHASHI MASAYO | HEALIOS KK |
| EP3108901 | COMPOSITION FOR IMAGING ATHEROSCLEROSIS AND METHOD FOR DIAGNOSING ATHEROSCLEROSIS BY USING SAME | SEO HONG SEOG | UNIV KOREA RES & BUS FOUND |
| EP3109257 | DIAGNOSIS AND THERAPY OF MULTIPLE SCLEROSIS | PATERNO' ROBERTO | PATERNO' ROBERTO |
| EP3109307 | PERFUME SYSTEMS | AMORELLI BENJAMIN | PROCTER & GAMBLE |
| EP3110407 | METAL-POLYMER COMPOSITE NANOPARTICLES | PRUD'HOMME ROBERT K | UNIV PRINCETON |
| EP3110446 | METHODS AND COMPOSITIONS FOR TREATING SIGLEC-8 ASSOCIATED DISEASES | BEBBINGTON CHRISTOPHER ROBERT | ALLAKOS INC |
| EP3110841 | PEPTIDES AND METHODS OF USE | DOCKAL MICHAEL | BAXALTA INC |
| EP3110946 | METHODS AND COMPOSITIONS FOR INDUCING DIFFERENTIATION OF HUMAN BROWN ADIPOCYTE PROGENITORS | BOSS OLIVIER B | ENERGESIS PHARMACEUTICALS INC |
| EP3111917 | LUBRICATING MEMBERS FOR RAZOR CARTRIDGES | STEPHENS ALISON FIONA | GILLETTE CO LLC |
| EP3111934 | AGENT FOR IMPROVING OR PREVENTING PROGRESSION OF CHRONIC KIDNEY DISEASE | IENAGA KAZUHARU | NIPPON ZOKI PHARMACEUTICAL CO |
| EP3111942 | COMPOSITIONS FOR USE IN THE PREVENTION OR TREATMENT OF URT INFECTIONS IN INFANTS OR YOUNG CHILDREN AT RISK | SPRENGER NORBERT | NESTEC SA |
| EP3111945 | PHARMACEUTICAL CONTAINING DENDRITIC CELLS, AND METHOD FOR PRODUCING SAME | TSUTSUI HIROYUKI | NAT UNIV CORP HOKKAIDO UNIV |
| EP3111950 | METHODS AND COMPOSITIONS RELATED TO GLUCOCORTICOID RECEPTOR ANTAGONISM AND PROSTATE CANCER | SZMULEWITZ RUSSELL Z | UNIV CHICAGO |
| EP3113748 | PROCESS FOR MANUFACTURING AN EMULSION | ÄCHTNER ANJA | KAO GERMANY GMBH |
| EP3113753 | AQUEOUS OXIDIZING COMPOSITION FOR HAIR | ÄCHTNER ANJA | KAO GERMANY GMBH |
| EP3113756 | ABRASIVE SKIN CLEANING PRODUCTS I | KÖNIG SYLVIA | BEIERSDORF AG |
| EP3113759 | VACCINE DELIVERY SYSTEMS USING YEAST CELL WALL PARTICLES | WAGNER THOMAS E | ORBIS HEALTH SOLUTIONS LLC |
| EP3113766 | FRACTIONATED RADIOTHERAPY AND CHEMOTHERAPY WITH AN OXYGEN THERAPEUTIC | UNGER EVAN C | UNGER EVAN C |
| EP3113776 | USE OF SHORT TERM STARVATION REGIMEN IN COMBINATION WITH KINASE INHIBITORS TO ENHANCE TRADITIONAL CHEMO-DRUG EFFICACY AND FEASIBILITY AND REVERSE SIDE EFFECTS OF KINASES IN NORMAL CELLS AND TISSUES | LONGO VALTER D | UNIV SOUTHERN CALIFORNIA |
| EP3113790 | PEPTIDES HORMONE ANALOGUES DERIVABLE FROM PREPROGLUCAGON | BLOOM STEPHEN ROBERT | IMP INNOVATIONS LTD |
| EP3114138 | IMPROVED MUTEINS OF CLOTTING FACTOR VIII | APGAR JAMES | PFIZER |
| EP3114227 | CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING USHER SYNDROME AND RETINITIS PIGMENTOSA | MAEDER MORGAN L | EDITAS MEDICINE INC |
| EP3115039 | METHOD FOR PRODUCING A FUSION MIXTURE FOR TRANSFERRING A CHARGED MOLECULE INTO AND/OR THROUGH A LIPID MEMBRANE | HOFFMANN BERND | BENIAG GMBH |
| EP3115046 | PET FOOD COMPOSITION COMPRISING AN ANTIOXIDANT COMPONENT | WARD SUSAN RUTH | IAMS EUROPE B V |
| EP3115064 | RNA-CODED ANTIBODY | HOERR INGMAR | CUREVAC AG |
| EP3116483 | CONTROLLED RELEASE COMPOSITION AND METHOD | YANG HUI S | FMC CORP |
| EP3116491 | PHARMACEUTICAL COMPOSITIONS OF THERAPEUTICALLY ACTIVE COMPOUNDS | GU CHONG-HUI | AGIOS PHARMACEUTICALS INC |
| EP3116507 | TREATMENT OF BRAIN AND CENTRAL NERVOUS SYSTEM TUMORS | WAKSAL SAMUEL D | KADMON CORP LLC |
| EP3116525 | TCO CONJUGATES AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS | ONETO JOSE MANUEL MEJIA | UNIV CALIFORNIA |
| EP3116529 | INTERLEUKIN-2 FOR TREATING FOOD ALLERGY | KLATZMANN DAVID | UNIVERSITé PIERRE ET MARIE CURIE (PARIS 6) |
| EP3116531 | PURIFYING INSULIN USING CATION EXCHANGE AND REVERSE PHASE CHROMATOGRAPHY IN THE PRESENCE OF AN ORGANIC MODIFIER AND ELEVATED TEMPERATURE | ORTIGOSA ALLISON D | MERCK SHARP & DOHME |
| EP3116548 | COMPOSITION | STOCKHAM MICHAEL ARTHUR | SHIELD TX (UK) LTD |
| EP3116579 | DRUG COMPOSITION AND COATING | DRUMHELLER PAUL D | GORE & ASS |
| EP3116887 | CARBOHYDRATE LIGANDS THAT BIND TO IGM ANTIBODIES AGAINST MYELIN-ASSOCIATED GLYCOPROTEIN | ERNST BEAT | UNIVERSITÄT BASEL |
| EP3117710 | BIOCIDE COMPOSITION FOR CONTROLLING PESTS AFFECTING EUROPEAN HONEY BEES, COMPRISING A WATER-SOLUBLE OLEA EUROPAEA EXTRACT | MARTINEZ ARENAS JESSICA ISABEL | UNIV DEL DESARROLLO |
| EP3117827 | COMPOSITION FOR VAGINA AND USE OF THE COMPOSITION | ZENG ZHONGMING | SINGAPORE ZE&Z INT PTE LTD |
| EP3119377 | PHOTOPOLYMERISABLE AND DUAL CURING DENTAL MATERIALS BASED ON THIOUREA DERIVATIVES | MOSZNER NORBERT | IVOCLAR VIVADENT AG |
| EP3119394 | COMPOSITIONS AND METHODS COMPRISING 2-(ACYLAMINO)IMIDAZOLES | LOOPER RYAN E | CURZA GLOBAL LLC |
| EP3119395 | POLYMERIC NANOPARTICLES AND METHODS OF MAKING AND USING SAME | SUNG YOUNG HO | MERCK SHARP & DOHME |
| EP3119396 | MUSCARINIC RECEPTOR AGONISTS | CONGREVE MILES STUART | HEPTARES THERAPEUTICS LTD |
| EP3119400 | MATERNAL VITAMIN B2 ADMINISTRATION FOR THE PREVENTION OF INCREASED ADIPOSITY, OVERWEIGHT OR OBESITY IN THE OFFSPRING | COOPER CYRUS | NESTEC SA |
| EP3119406 | METHODS FOR IMPROVING COGNITIVE FUNCTION VIA MODULATION OF QUINONE REDUCTASE 2 | ROSENBLUM KOBI | CARMEL-HAIFA UNIV ECONOMIC CORP LTD |
| EP3119413 | SUBLINGUAL DELIVERY OF GLATIRAMER ACETATE | SELA YORAM | MAPI PHARMA LTD |
| EP3119420 | DELIVERY SYSTEM COMPRISING A PROTEOLYTIC ENZYME OR EFFECTOR THEREOF FOR USE IN A METHOD FOR ORAL TREATMENT AND USES THEREOF | SCHROEDER AVRAHAM D | TECHNION RES & DEV FOUNDATION |
| EP3119438 | MAGNETIC AND FLUORESCENT REVERSE NANOASSEMBLIES | ISHOW ELéNA | UNIV NANTES |
| EP3119762 | BENZIMIDAZOLE DERIVATIVES AS ERBB TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER | LONG YUN | CAPELLA THERAPEUTICS INC |
| EP3119885 | ANTIBODY-FYNOMER CONJUGATES | NEWMAN ROLAND | MITSUBISHI TANABE PHARMA CORP |
| EP3119889 | STAT5 INHIBITORS AND USE OF SAME | AVALLE-BIHAN BéRANGèRE | CENTRE NAT DE LA RECH SCIENT (CNRS) |
| EP3119892 | BETA-HEXOSAMINIDASE PROTEIN VARIANTS AND ASSOCIATED METHODS FOR TREATING GM2 GANGLIOSDOSES | MAHURAN DON | HOSPITAL FOR SICK CHILDREN |
| EP3119901 | PROCESS FOR THE TREATMENT OF YEAST CELL WALLS WITH A LAMINARIPENTAOSE PRODUCING BETA-1,3-GLUCANASE | LANKHORST PETER PHILIP | DSM IP ASSETS BV |
| EP3120831 | TOPICAL DELIVERY OF SKIN COMPOSITIONS HAVING LOW PH | BRILLOUET ANNE-SOPHIE | JOHNSON & JOHNSON CONSUMER INC |
| EP3120835 | LIQUID PHARMACEUTICAL COMPOSITION | NAM BONG GIL | PHARMBIO KOREA CO LTD |
| EP3120853 | PHARMACEUTICAL COMPOSITION FOR TREATING STK11-MUTATION CANCER USING CARDIAC GLYCOSIDES | YOON SUK JOON | INDUSTRY-ACADEMIC COOP FOUND SOOKMYUNG WOMEN'S UNIV |
| EP3120857 | COMPOSITION FOR TREATING INFLAMMATORY BRAIN DISEASE COMPRISING STEM-CELL-DERIVED EXOSOME AS AN ACTIVE INGREDIENT | CHANG YUN SIL | SAMSUNG LIFE PUBLIC WELFARE FOUNDATION |
| EP3120872 | DUAL-PURPOSE PAT/ULTRASOUND CONTRAST AGENT BOUND WITH NANOPARTICLES CONTAINING DRUG AND METHOD FOR PREPARING SAME | KIM HYUN CHEOL | IMGT CO LTD |
| EP3122312 | CORROSIVE INGREDIENT (S) - CONTAINING COMPOSITIONS HAVING REDUCED TOXICITY AND METHOD OF OBTAINING | BOYD KEVIN N | JOHNSON & SON INC S C |
| EP3122349 | COMPOSITIONS FOR THE TREATMENT OF AUTODIGESTION | HALLAM THOMAS | LEADING BIOSCIENCES INC |
| EP3122363 | TREATMENT OF AUTISM | DAVIS BONNIE M | SYNAPTEC DEV LLC |
| EP3122375 | BREAST AND OVARIAN CANCER VACCINES | DISIS MARY L | UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION |
| EP3122752 | 4'-SUBSTITUTED NUCLEOSIDE-DERIVATIVES AS HIV REVERSE TRANSCRIPTASE INHIBITORS | GIRIJAVALLABHAN VINAY M | MERCK SHARP & DOHME |
| EP3122880 | CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING SICKLE CELL DISEASE | FRIEDLAND ARI E | EDITAS MEDICINE INC |
| EP3124034 | AGENT COMPRISING IMIDAZOLE DIPEPTIDE | HISATSUNE TATSUHIRO | UNIV TOKYO |
| EP3125866 | REFILLABLE DRUG DELIVERY DEVICES AND METHODS OF USE THEREOF | BRUDNO YEVGENY | HARVARD COLLEGE |
| EP3125867 | HYPEROSMOLAR COMPOSITION OF HYALURONIC ACID | ROULAND JEAN-FRANÇOIS | HORUS PHARMA |
| EP3125885 | COMBINATION OF EGFR INHIBITOR AND MEK INHIBITOR FOR USE IN THE TREATMENT OF NRAS MUTATED CANCER | CROSS DARREN ANTHONY EDWARD | ASTRAZENECA AB |
| EP3125906 | PEPTIDE FRAGMENTS OF NETRIN-1 AND COMPOSITIONS AND METHODS THEREOF | CAI HUA | UNIV CALIFORNIA |
| EP3125924 | METHODS OF USING PIGMENT EPITHELIUM DERIVED FACTOR (PEDF) FOR THE TREATMENT AND PREVENTION OF AGENT-INDUCED GONADAL OR UTERINE TOXICITY | SHALGI RUTH | RAMOT AT TEL-AVIV UNIV LTD |
| EP3125927 | METHODS AND COMPOSITIONS FOR IMMUNOMODULATION | MATA-FINK JORDI | RUBIUS THERAPEUTICS INC |
| EP3125942 | NEBULIZATION OF IMMUNOGLOBULIN | VONARBURG CéDRIC PIERRE | CSL BEHRING AG |
| EP3126380 | CHIMERIC ANTIGEN RECEPTOR (CAR) SIGNALLING SYSTEM | PULé MARTIN | UCL BUSINESS PLC |
| EP3126520 | BIOMARKERS AND USE OF MET INHIBITOR FOR TREATMENT OF CANCER | CAENEPEEL SEAN | AMGEN INC |
| EP3126528 | METHODS FOR DETERMINING RESPONSIVENESS TO MEK/ERK INHIBITORS | GUO SHENG | CROWN BIOSCIENCE INC (TAICANG) |
| EP3127544 | ANTI-TUMOR DRUG CONTAINING ANTI-TUMOR PLATINUM COMPLEX, AND ANTI-TUMOR EFFECT ENHANCER | OKABE HIROYUKI | TAIHO PHARMACEUTICAL CO LTD |
| EP3127553 | CALICHEAMICIN DERIVATIVE-CARRIER CONJUGATES | KUNZ ARTHUR | WYETH HOLDINGS LLC |
| EP3127869 | SILICON OXIDE-COATED ZINC OXIDE, METHOD FOR PRODUCING SAME, AND COMPOSITION AND COSMETIC INCLUDING SILICON OXIDE-COATED ZINC OXIDE | ITAGAKI TETSURO | SUMITOMO OSAKA CEMENT CO LTD |
| EP3127905 | HIGH-PURITY MAGNESIUM LITHOSPERMATE B AND PREPARATION METHOD THEREFOR | XUAN LIJIANG | SHANGHAI INST MATERIA MEDICA CAS |
| EP3127912 | TRIPEPTIDE EPOXYKETONE COMPOUND CONSTRUCTED BY HETEROCYCLE AND PREPARATION METHOD AND USE THEREOF | HU YONGZHOU | UNIV ZHEJIANG |
| EP3128005 | SIRP-ALPHA VARIANT CONSTRUCTS AND USES THEREOF | DEMING LAURA | ALEXO THERAPEUTICS INC |
| EP3128996 | Novel 7-Dehydrocholesterol Derivatives and Methods Using Same | SINGH RAKESH K | WOMEN AND INFANTS HOSPITAL OF RHODE ISLAND INC |
| EP3129006 | IMMUNOSUPPRESSANT FORMULATION | BOUILLOT PHILIPPE MICHEL RENE | NOVARTIS AG |
| EP3129014 | NOVEL ORGANOSELENIUM COMPOUNDS, METHOD FOR PRODUCING SAME, AND PHARMACEUTICAL USES THEREOF AS ANTITUMOUR AGENTS | YADAN JEAN-CLAUDE | TETRAHEDRON |
| EP3129015 | INOS-INHIBITORY COMPOSITIONS AND THEIR USE AS BREAST CANCER THERAPEUTICS | CHANG JENNY CHEE NING | THE METHODIST HOSPITAL SYSTEM |
| EP3129023 | POTENT SOLUBLE EPOXIDE HYDROLASE INHIBITORS | HAMMOCK BRUCE D | EICOSIS LLC |
| EP3129036 | YEAST-BASED IMMUNOTHERAPY AND TYPE I INTERFERON SENSITIVITY | BELLGRAU DONALD | GLOBEIMMUNE INC |
| EP3129042 | METHODS FOR PROTECTING AND TREATING TRAUMATIC BRAIN INJURY, CONCUSSION AND BRAIN INFLAMMATION WITH INTRANASAL INSULIN | FREY II WILLIAM H | HEALTHPARTNERS RES & EDUCATION |
| EP3129063 | ANTI-HER3 ANTIBODY-DRUG CONJUGATE | HETTMANN THORE | DAIICHI SANKYO CO LTD |
| EP3129104 | EYE-MAKEUP COSMETIC COMPOSITION | OKURA KOJI | LVMH RECH |
| EP3129366 | CARBAZOLE-CONTAINING AMIDES, CARBAMATES, AND UREAS AS CRYPTOCHROME MODULATORS | BERSOT ROSS | RESET THERAPEUTICS INC |
| EP3129368 | CYTOTOXIC COMPOUNDS WHICH ARE INHIBITORS OF THE POLYMERISATION OF TUBULIN | ALAMI MOUÂD | CENTRE NAT DE LA RECH SCIENT (C N R S ) |
| EP3129373 | HISTONE DEACETYLASE INHIBITORS | LIOU JING-PING | |
| EP3129405 | TRANSGENE GENETIC TAGS AND METHODS OF USE | JENSEN MICHAEL C | SEATTLE CHILDREN'S HOSPITAL (DBA SEATTLE CHILDREN'S RES INSTITUTE) |
| EP3129470 | TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR | BYRD JOHN | NOVARTIS AG |
| EP3130326 | COSMETIC CONTAINING FOAM AS CARRIER | CHOI JUNG SUN | AMOREPACIFIC CORP |
| EP3130331 | SKIN AGING INHIBITOR AND CONCENTRATE OF RESVERATROL 3-O- -GLUCOSIDE | SAMBE HARUYO | EZAKI GLICO CO |
| EP3130596 | NOVEL GLUCOSE DERIVATIVE, AND CELL IMAGING METHOD AND IMAGING AGENT USING SAID DERIVATIVE | YAMADA KATSUYA | UNIV HIROSAKI |
| EP3130597 | OLIGONUCLEOTIDE HAVING NON-NATURAL NUCLEOTIDE AT 5'-TERMINAL THEREOF | SHINOHARA FUMIKAZU | KYOWA HAKKO KIRIN CO LTD |
| EP3130606 | IMMUNOACTIVATING ANTIGEN-BINDING MOLECULE | IGAWA TOMOYUKI | CHUGAI PHARMACEUTICAL CO LTD |
| EP3131530 | VOLUMIZING MASCARA COMPOSITIONS | FAVA BEKISZ COLLETTE | AVON PROD INC |
| EP3131536 | BIOACTIVE OIL BASED POLYESTERAMIDE NANOFIBERS FOR WOUND HEALING APPLICATIONS | GUNDLOORI RATHNA VENKATA NAGA | COUNCIL SCIENT IND RES |
| EP3131550 | METHODS FOR TREATING CANCER USING TOR KINASE INHIBITOR COMBINATION THERAPY | TROWE TORSTEN BERNHARD | SIGNAL PHARM LLC |
| EP3131572 | USE OF APC ANALOGUE FOR WOUND HEALING | XUE MEILANG | ZZ BIOTECH LLC |
| EP3131576 | MEANS AND METHODS FOR PRODUCING NEISSERIA MENINGITIDIS CAPSULAR POLYSACCHARIDES OF LOW DISPERSITY | FIEBIG TIMM | MEDIZINISCHE HOCHSCHULE HANNOVER |
| EP3131908 | METHODS AND DEVICES FOR ISOLATING LEAD 203 | OLEWINE KEITH R | LANTHEUS MEDICAL IMAGING INC |
| EP3132803 | PREVENTIVE OR THERAPEUTIC AGENT FOR PAIN ASSOCIATED WITH HERPES ZOSTER IN ACUTE PHASE | INOUE KAZUHIDE | UNIV KYUSHU |
| EP3132804 | MEDICAL DEVICE INCLUDING ANIONIC DRUG | OBATA HARUKA | SEED CO LTD |
| EP3133400 | USE OF 15 MALE FERTILITY RELATED PROTEINS OR COMBINATION THEREOF | LI JIANYUAN | YANTAI JU JIE BIOENGINEERING LTD COMPANY |
| EP3133922 | IMPROVED BIOCIDE COMPOSITIONS BASED ON CALCIUM FLUORIDE AS WELL AS USES THEREOF | FLECHSIG FRANK | FLECHSIG PATENT COMPANY LLC |
| EP3134065 | COMPOSITION IN THE FORM OF NANO- OR MICRO- EMULSION | KOIDE MAKI | OREAL |
| EP3134068 | LONG-ACTING POLYMERIC DELIVERY SYSTEMS | OTTOBONI THOMAS B | HERON THERAPEUTICS INC |
| EP3134082 | MODIFICATION OF EXTRACORPOREAL PHOTOPHERESIS TECHNOLOGY WITH PORPHYRIN PRECURSORS | PENG QIAN | UNIV OSLO HF |
| EP3134084 | METHOD OF TREATING LUNG ADENOCARCINOMA | AFTAB DANA T | EXELIXIS INC |
| EP3134123 | IL-2RBETA-SELECTIVE AGONISTS IN COMBINATION WITH AN ANTI-CTLA-4 ANTIBODY OR AN AN ANTI-PD-1 ANTIBODY | ADDEPALLI MURALI KRISHNA | NEKTAR THERAPEUTICS (INDIA) PVT LTD |
| EP3134131 | NUCLEIC ACID VACCINES | CIARAMELLA GIUSEPPE | MODERNATX INC |
| EP3134389 | QUINAZOLINE SCAFFOLD BASED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF | GAVISH MOSHE | TECHNION RES & DEV FOUNDATION |
| EP3134410 | INHIBITING THE TRANSIENT RECEPTOR POTENTIAL A1 ION CHANNEL | LIPPA BLAISE S | HYDRA BIOSCIENCES INC |
| EP3134411 | PURINE DERIVATIVES AS CD73 INHIBITORS FOR THE TREATMENT OF CANCER | CACATIAN SALVACION | VITAE PHARMACEUTICALS INC |
| EP3134431 | LDLR VARIANTS AND THEIR USE IN COMPOSITIONS FOR REDUCING CHOLESTEROL LEVELS | WILSON JAMES M | UNIV PENNSYLVANIA |
| EP3135666 | (S)-OXIRACETAM CRYSTAL FORM III, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | YE LEI | CHONGQING RUNZE PHARMACEUTICAL |
| EP3137054 | COMPOSITIONS AND METHODS FOR ANTI-LYST IMMUNOMODULATION | BREUER CHRISTOPHER | THE RES INST AT NATIONWIDE CHILDREN'S HOSPITAL |
| EP3137096 | ENAMEL PRODUCTS AND METHODS OF USE | KYRKANIDES STEPHANOS | UNIV NEW YORK STATE RES FOUND |
| EP3137102 | TREATMENT OF ABNORMAL CUTANEOUS SCARRING | JACKSON CHRISTOPHER JOHN | ZZ BIOTECH LLC |
| EP3137103 | METHODS AND COMPOSITIONS FOR MODULATING THE IMMUNE SYSTEM WITH ARGINASE I | SCHABBAUER GERNOT | BIO-CANCER TREAT INT LTD |
| EP3137169 | INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1 | CHEN YOUNG K | CELGENE QUANTICEL RES INC |
| EP3137468 | COMPOUNDS AND COMPOSITIONS AS TOLL-LIKE RECEPTOR 7 AGONISTS | WU TOM YAO-HSIANG | NOVARTIS AG |
| EP3137470 | COMPOUNDS AND COMPOSITIONS AS TOLL-LIKE RECEPTOR 7 AGONISTS | LI YONGKAI | NOVARTIS AG |
| EP3137487 | POLYPEPTIDES FOR GENERATING ANTI-INFLUENZA ANTIBODIES AND USES THEREOF | VARADARAJAN RAGHAVAN | INDIAN INST SCIENT |
| EP3137494 | ISLET AMYLOID POLYPEPTIDES WITH IMPROVED SOLUBILITY | RALEIGH DANIEL | UNIV NEW YORK STATE RES FOUND |
| EP3137497 | AAV VECTORS FOR RETINAL AND CNS GENE THERAPY | SCARIA ABRAHAM | GENZYME CORP |
| EP3137532 | LIQUID TRIBLOCK COPOLYMER | MEIJBOOM RONALD | INGELL TECH HOLDING B V |
| EP3138575 | FREEZE-DRIED HGF PREPARATION | OHORI RYO | EISAI R&D MAN CO LTD |
| EP3138580 | COVALENTLY LINKED ANTIGEN-ANTIBODY CONJUGATES | BRINKMANN ULRICH | HOFFMANN LA ROCHE |
| EP3138833 | NOVEL KCNQ POTASSIUM CHANNEL AGONIST, AND PREPARATION METHOD THEREFOR AND USE THEREOF | NAN FAJUN | SHANGHAI INST MATERIA MEDICA CAS |
| EP3138837 | INDACATEROL FREE BASE IN SOLID FORM | LORENTE BONDE-LARSEN ANTONIO | CRYSTAL PHARMA SAU |
| EP3138853 | FC VARIANTS WITH ALTERED BINDING TO FCRN | CHAMBERLAIN AARON | XENCOR INC |
| EP3139901 | NON-PETROCHEMICALLY DERIVED CATIONIC EMULSIFIERS AND RELATED COMPOSITIONS AND METHODS | BURGO ROCCO | INOLEX INVESTMENT CORP |
| EP3139925 | VMAT2 INHIBITORS FOR THE TREATMENT OF HYPERKINETIC MOVEMENT DISORDERS | O'BRIEN CHRISTOPHER F | NEUROCRINE BIOSCIENCES INC |
| EP3139940 | THERAPY FOR USE IN THE TREATMENT OF TUMORS, ACQUIRED IMMUNODEFICIENCY SYNDROME AND LEUKEMIAS BY DUAL IMMUNE BIOSTIMULATION | MOGNA GIOVANNI | MOGNA GIOVANNI |
| EP3139947 | CONJUGATES OF AN IL-15 MOIETY AND A POLYMER | LIU XIAOFENG | NEKTAR THERAPEUTICS |
| EP3139958 | METHOD FOR TREATING CANCER | SODEN DECLAN | UNIV CORK |
| EP3139965 | CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO | MRSNY RANDALL J | APPLIED MOLECULAR TRANSP LLC |
| EP3140322 | MODIFIED FC GAMMA RECEPTOR TYPE III (FC III, HNA-1) POLYPEPTIDES AND THE USES THEREOF | LEE JAR-HOW | ONE LAMBDA INC |
| EP3141117 | IMMUNOMODULATING COMPOSITION | ELIAZ ISAAC | BETTER HEALTH PUBLISHING INC |
| EP3142648 | USE OF SEMI-FLUORINATED ALKANES IN TRANSDERMAL THERAPEUTIC SYSTEMS | WIEDERSBERG SANDRA | LTS LOHMANN THERAPIE-SYSTEME AG |
| EP3142652 | HETEROCYCLIC HYDROXAMIC ACIDS AS PROTEIN DEACETYLASE INHIBITORS AND DUAL PROTEIN DEACETYLASE-PROTEIN KINASE INHIBITORS AND METHODS OF USE THEREOF | LIU XUEDONG | UNIV COLORADO REGENTS |
| EP3142659 | HIV-1 PROTEASE INHIBITORS AND USES THEREOF | GHOSH ARUN K | PURDUE RESEARCH FOUNDATION |
| EP3142661 | METHOD FOR SUPPRESSING GLUCAGON SECRETION OF AN SGLT2 INHIBITOR | HIRSHBERG BOAZ | ASTRAZENECA AB |
| EP3142665 | MIF INHIBITORS FOR THE ACUTE OR CHRONIC TREATMENT OF PULMONARY HYPERTENSION | JALCE GAËL | MIFCARE |
| EP3142671 | COMBINATION OF BIOLOGICALLY ACTIVE SUBSTANCES FOR TREATMENT OF HYPERGLYCAEMIC DISORDERS | VOLLERT HENNING | BIOACTIVE FOOD GMBH |
| EP3142688 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING PANCREATITIS, RENAL INJURY AND CANCER | DESIR GARY | UNIV YALE |
| EP3142700 | MOLECULES WITH ALTERED NEONATE FC RECEPTOR BINDING HAVING ENHANCED THERAPEUTIC AND DIAGNOSTIC PROPERTIES | TSUI PING | MEDIMMUNE LLC |
| EP3142964 | PEPTIDE-POLYPEPTIDE CO-ASSEMBLED NANOPARTICLES FOR DRUG DELIVERY | RAPAPORT HANNA | B G NEGEV TECH AND APPLICATIONS LTD AT BEN-GURION UNIV |
| EP3143005 | CHEMOKINE CXCR4 AND CCR5 RECEPTOR MODULATORS AND USED RELATED THERETO | COX BRYAN D | UNIV EMORY |
| EP3143011 | DEUTERATED HETEROCYCLIC COMPOUNDS AND THEIR USE AS IMAGING AGENTS | MARIK JAN | HOFFMANN LA ROCHE |
| EP3143018 | CARBOXAMIDE DERIVATIVES | D'SOUZA ANNE-MARIE | NOVARTIS AG |
| EP3143037 | ALPHA4BETA7 INTEGRIN THIOETHER PEPTIDE ANTAGONISTS | BHANDARI ASHOK | PROTAGONIST THERAPEUTICS INC |
| EP3144001 | COMPOSITIONS OF SELENOORGANIC COMPOUNDS AND METHODS OF USE THEREOF | POWER RONAN | ALLTECH INC |
| EP3144015 | NOVEL LOW MOLECULAR WEIGHT CATIONIC LIPIDS FOR OLIGONUCLEOTIDE DELIVERY | STANTON MATTHEW G | SIRNA THERAPEUTICS INC |
| EP3145491 | COUGH MEDICINE CONTAINING AMBROXOL HYDROCHLORIDE | PLOHMANN BERND | BOEHRINGER INGELHEIM INT |
| EP3145510 | TREATMENT OF DISEASES USING COMBINATION OF ULTRAVIOLET BLOOD IRRADIATION AND ANTIBIOTICS | KUENSTNER JOHN TODD | KUENSTNER JOHN TODD |
| EP3145518 | A COMPOSITION FOR USE IN TREATING OR PREVENTING VIRAL OR BACTERIAL INFECTIONS IN A SUBJECT UNDERGOING ANTI-TUMOR CHEMOTHERAPY, LEUKEMIA TREATMENT OR AIDS THERAPY COMPRISING L. REUTERI LER03 AND/OR L. SALIVARIUS LS06. | MOGNA GIOVANNI | MOGNA GIOVANNI |
| EP3145519 | SYSTEMS AND METHODS FOR STORAGE AND DELIVERY OF AMMONIA OXIDIZING BACTERIA | HEYWOOD JAMES | AOBIOME LLC |
| EP3145527 | COMPOSITION AND METHOD FOR VANCOMYCIN ORAL LIQUID | MUNI INDU | CUTISPHARMA INC |
| EP3145530 | TRAIL RECEPTOR AGONISTS FOR TREATMENT OF FIBROTIC DISEASES | LEE KANG CHOON | THERALY PHARMACEUTICALS INC |
| EP3145536 | ENGINEERED TYROSINE AMMONIA LYASE | HUISMAN GJALT W | CODEXIS INC |
| EP3145588 | MULTI-COMPOSITION COSMETIC PRODUCTS AND METHOD FOR MANUFACTURING SAME | PERRIN LILY-ANN | LVMH RECH |
| EP3145929 | 5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS WHICH ARE JAK INHIBITORS | ZAK MARK EDWARD | HOFFMANN LA ROCHE |
| EP3145933 | NAMPT INHIBITORS AND METHODS | PAPOULIS ANDREW | GENZYME CORP |
| EP3146976 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETIC COMPLICATIONS AND ANGIOEDEMA, CONTAINING NATURAL MIXTURE EXTRACT AS ACTIVE INGREDIENT | KIM JIN SOOK | KOREA INST ORIENTAL MEDICINE |
| EP3147282 | OPTICAL RESOLUTION METHOD OF LENALIDOMIDE | TOJO YOSUKE | SHISEIDO CO LTD |
| EP3148517 | COMPOSITIONS AND METHODS TO PROMOTE BONE FORMATION | THAKUR NIKHIL A | UNIV NEW YORK STATE RES FOUND |
| EP3148526 | USE OF ERIBULIN IN THE TREATMENT OF CANCER | LITTLEFIELD BRUCE A | EISAI R&D MAN CO LTD |
| EP3148529 | COMPOUNDS FOR TREATING BRAIN CANCER | MEHRLING THOMAS | PURDUE PHARMACEUTICAL PRODUCTS L P |
| EP3148532 | PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF CANCER | ORWAR OWE | PIRAMAL ENTPR LTD |
| EP3148539 | HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF | DOMINGUEZ CELIA | CHDI FOUNDATION INC |
| EP3148551 | VOLATILE APPLICATIONS AGAINST PATHOGENS | MALEFYT TIM | AGROFRESH INC |
| EP3148571 | COMPOSITION FOR TREATING DIABETES MELLITUS COMPRISING INSULIN AND A GLP-1/GLUCAGON DUAL AGONIST | JUNG SUNG YOUB | HANMI PHARM IND CO LTD |
| EP3148574 | PURIFIED COMPOSITIONS OF IVIG AND KH PROTEINS FOR MODULATING LYMPHOCYTES AND TREATING HEPATITIS B VIRUS | HOANG KIEU | RARE ANTIBODY ANTIGEN SUPPLY INC |
| EP3148577 | NOVEL SEMI-SYNTHETIC MENINGOCOCCAL CONJUGATE VACCINE | GOEL AKSHAY | BIOLOGICAL E LTD |
| EP3148580 | TRI-SPECIFIC BINDING MOLECULES THAT SPECIFICALLY BIND TO MULTIPLE CANCER ANTIGENS AND METHODS OF USE THEREOF | BONVINI EZIO | MACROGENICS INC |
| EP3148584 | COMBINATION COMPRISING A GLUCOCORTICOID AND EDO-S101 | MEHRLING THOMAS JORG | EURO-CELTIQUE S A |
| EP3148587 | CARBONITRILE DERIVATIVES AS SELECTIVE ANDROGEN RECEPTOR MODULATORS | CHEKLER EUGENE LVOVICH PIATNITSKI | PFIZER |
| EP3148588 | N,N-BIS-2-MERCAPTOETHYL ISOPHTHALAMIDE FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | HALEY BOYD EUGENE | EMERAMED LTD |
| EP3148647 | COSMETIC TREATMENT OF KERATIN FIBRES | SAMAIN HENRI | OREAL |
| EP3149000 | IMPROVED FORMS OF A PI3K DELTA SELECTIVE INHIBITOR FOR USE IN PHARMACEUTICAL FORMULATIONS | VAKKALANKA SWAROOP KUMAR VENKATA SATYA | RHIZEN PHARMACEUTICALS S A |
| EP3149015 | MINIMAL SAPONIN ANALOGUES, SYNTHESIS AND USE THEREOF | GIN DAVID Y | MEMORIAL SLOAN-KETTERING CANCER CENTER |
| EP3149067 | WATER-MEDIATED PREPARATIONS OF POLYMERIC MATERIALS | NICHOLSON CHARLES BRENDAN | SECANT GROUP LLC |
| EP3149137 | FOAMING CLEANSER | MIZUNO HIROYASU | OREAL |
| EP3150189 | SUNSCREEN WITH REDUCED TEXTILE STAINING DUE TO DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE | WEINERT KATRIN | BEIERSDORF AG |
| EP3150198 | PHARMACEUTICAL COMPOSITIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIODIN-2-YL)BENZOIC ACID AND ADMINISTRATION THEREOF | VERWIJS MARINUS JACOBUS | VERTEX PHARMA |
| EP3150205 | TRANSDERMAL PREPARATION | KAWAKAMI SATOSHI | TEIKOKU SEIYAKU KK |
| EP3150218 | TARGETED INTERFERON DEMONSTRATES POTENT APOPTOTIC AND ANTI-TUMOR ACTIVITIES | MORRISON SHERIE L | UNIV CALIFORNIA |
| EP3150226 | BIOPHOTONIC COMPOSITIONS, KITS AND METHODS | LOUPIS NIKOLAOS | KLOX TECH INC |
| EP3150651 | CARBONATE POLYMER WITH DISULFUR FIVE-MEMBERED RING FUNCTIONAL GROUP ON SIDE CHAIN AND APPLICATION THEREOF | MENG FENGHUA | BRIGHT GENE BIO-MEDICAL TECH CO LTD |
| EP3151665 | METHODS AND SYSTEMS FOR DETERMINING AUTISM SPECTRUM DISORDER RISK | GEIGENMULLER UTE | LABORATORY CORP AMERICA HOLDINGS |
| EP3151809 | MICROENCAPSULATION TECHNIQUE AND PRODUCTS THEREOF | RAMACHANDRAN KARTHIK | LIKARDA LLC |
| EP3151810 | CONDITIONING HAIR PREPARATION, IN PARTICULAR SHAMPOO, CONTAINING SILICONS AND QUARTERNISED GUAR DERIVATIVES | NEMNICH JULIA | BEIERSDORF AG |
| EP3151817 | SULFUR(VI) FLUORIDE COMPOUNDS AND METHODS FOR THE PREPARATION THEREOF | DONG JIAJIA | SCRIPPS RESEARCH INST |
| EP3151832 | METHODS OF INCREASING TONIC INHIBITION AND TREATING SECONDARY INSOMNIA | DURING MATTHEW | OVID THERAPEUTICS INC |
| EP3151851 | ORNITHODOROS MOUBATA COMPLEMENT INHIBITOR FOR USE IN THE TREATMENT OF COMPLEMENT-MEDIATED DISEASES IN PATIENTS WITH C5 POLYMORPHISM | WESTON-DAVIES WYNNE H | VOLUTION IMMUNO PHARMACEUTICALS SA |
| EP3151855 | METHODS FOR TREATING TYPE 1 DIABETES USING GLUCAGON RECEPTOR ANTAGONISTIC ANTIBODIES | YAN HAI | REMD BIOTHERAPEUTICS INC |
| EP3151860 | THERMOSETTING BIOPHOTONIC COMPOSITIONS AND USES THEREOF | PIERGALLINI REMIGIO | KLOX TECH INC |
| EP3151865 | SITE-SPECIFIC CONJUGATION OF LINKER DRUGS TO ANTIBODIES AND RESULTING ADCS | ARIAANS GERARDUS JOSEPH ANDREAS | SYNTHON BIOPHARMACEUTICALS BV |
| EP3152231 | PEPTIDES, AND METHODS AND APPARATUS UTILISING SAME | BRENCHLEY PAUL | UNIV MANCHESTER |
| EP3153151 | SUNSCREEN HAVING REDUCED TENDENCY TO CAUSE 4-(TERT.-BUTYL)-4 - METHOXYDIBENZOYLMETHAN STAINS ON TEXTILES | WEINERT KATRIN | BEIERSDORF AG |
| EP3153155 | REFILLABLE DRUG DELIVERY DEVICES AND METHODS OF USE THEREOF | BRUDNO YEVGENY | HARVARD COLLEGE |
| EP3153160 | USE OF XANTHOPHYLLS FOR THE TREATMENT OF CANCERS | LU CHUEN WEI | |
| EP3153514 | QUINAZOLINONES AS INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA | FOWLER KERRY W | ICOS CORP |
| EP3154515 | IMPROVEMENTS TO NASAL COMPOSITIONS AND METHOD OF USE THEREOF | POPOV TODOR A | NASALEZE PATENTS LTD |
| EP3154521 | DISINTEGRATABLE CORE/SHELL SILICA PARTICLES FOR ENCAPSULATING AND RELEASING BIOACTIVE MACROMOLECULES | DE COLA LUISA | UNIVERSITé DE STRASBOURG |
| EP3154524 | EXTENDED-RELEASE DRUG DELIVERY COMPOSITIONS | DORMER NATHAN | ORBIS BIOSCIENCES INC |
| EP3154525 | PHARMACEUTICAL COMPOSITION COMPRISING A TRIAZOLE ANTIFUNGAL AGENT AND METHOD FOR PREPARATION THEREOF | KARAVAS EVANGELOS | PHARMATHEN SA |
| EP3154542 | METHODS AND COMPOSITIONS ADDRESSING DEPRESSED MOOD | MEYER JEFFREY H | CAMH |
| EP3154550 | SURFACE TREATMENT BY WATER-SOLUBLE POLYMERS AND LIPIDS/LIPOSOMES | KLEIN JACOB | YEDA RES & DEV |
| EP3154552 | DEVICE AND METHOD TO TREAT OR PREVENT JOINT DEGENERATION | EDWARDS JEFFREY D | INT SCIENT PTY LTD |
| EP3154557 | ACELLULAR AMNION DERIVED THERAPEUTIC COMPOSITIONS | WERBER BRUCE | AMNIO TECH LLC |
| EP3154559 | USE OF SERELAXIN TO REDUCE GDF-15 | PRESCOTT MARGARET FORNEY | NOVARTIS AG |
| EP3154569 | METHODS OF TREATING TTP WITH IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS AND USES THEREOF | DUBY CHRISTIAN | ABLYNX NV |
| EP3154583 | HUMAN MONOCLONAL ANTIBODIES TO GANGLIOSIDE GD2 | SCHOLZ WOLFGANG | MABVAX THERAPEUTICS INC |
| EP3154584 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING STAPHYLOCOCCUS AUREUS INFECTIONS | SIMARD JOHN | XBIOTECH INC |
| EP3154590 | COMBINATION THERAPY WITH GLUTAMINASE INHIBITORS | STEGGERDA SUSANNE M | CALITHERA BIOSCIENCES INC |
| EP3154634 | IMIDAZOL- OR 1,2,4-TRIAZOL-DERIVATIVES AND THEIR USE | CHARTON JULIE | UNIVERSITé DE LILLE 2 DROIT ET SANTé |
| EP3154669 | COMPOSITIONS OF MONO-ALKYL ETHERS OF MONOANHYDRO-HEXITOLS, PRODUCTION METHODS THEREOF AND USE OF SAME | GOZLAN CHARLOTTE | SYRAL BELGIUM NV |
| EP3154934 | COMPOUNDS, PHARMACEUTICAL COMPOSITION AND THEIR USE IN TREATING NEURODEGENERATIVE DISEASES | MELNYK PATRICIA | UNIVERSITé DE LILLE 2 DROIT ET SANTé |
| EP3154941 | SMALL MOLECULE LFA-1 INHIBITORS | BREITENSTEIN WERNER | ALLOCYTE PHARMACEUTICALS AG |
| EP3154980 | TETRAHYDROTRIAZOLOPYRIMIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND USES | ARMANI ELISABETTA | CHIESI FARM SPA |
| EP3154989 | BETA-LACTAMASE INHIBITORS | BURNS CHRISTOPHER J | VENATORX PHARMACEUTICALS INC |
| EP3155100 | ANTISENSE OLIGONUCLEOTIDES USEFUL IN TREATMENT OF POMPE DISEASE | BERGSMA ATZE JACOBUS | UNIV ERASMUS MED CT ROTTERDAM |
| EP3156068 | PHARMACEUTICAL COMPOSITIONS COMPRISING A POLYPEPTIDE COMPRISING AT LEAST ONE CXXC MOTIF AND HETEROLOGOUS ANTIGENS AND USES THEREOF | KLATZMANN DAVID | CNRS (CENTRE NAT DE LA RECH SCIENTIFIQUE) |
| EP3156411 | ARTIFICIAL CATALYST SYSTEM CAPABLE OF SUBSTITUTING FOR IN VIVO ACYLATION FUNCTION | KANAI MOTOMU | UNIV TOKYO |
| EP3156422 | HIGH AFFINITY HUMAN ANTIBODIES TO PCSK9 | SLEEMAN MARK W | REGENERON PHARMA |
| EP3157515 | PLATINUM COMPOUNDS, COMPOSITIONS, AND USES THEREOF | MOREAU BENO脦T | PLACON THERAPEUTICS INC |
| EP3157519 | METHODS AND SYSTEMS FOR TREATING CELL PROLIFERATION DISORDERS WITH PSORALEN DERIVATIVES | TOONE ERIC J | IMMUNOLIGHT LLC |
| EP3157529 | SHIP INHIBITION TO INDUCE ACTIVATION OF NATURAL KILLER CELLS | KERR WILLIAM | UNIV NEW YORK STATE RES FOUND |
| EP3157531 | METHODS AND COMPOSITIONS FOR STIMULATION OF THE INTESTINAL ENTEROENDOCRINE SYSTEM FOR TREATING DISEASES OR CONDITIONS RELATED TO THE SAME | ZASLOFF MICHAEL | ZASLOFF MICHAEL |
| EP3157532 | METHODS OF TREATING AND PREVENTING VASCULAR INSTABILITY DISEASES | GIBSON CHRISTOPHER C | THE UNIV OF UTAH RES FOUND |
| EP3157548 | THERAPY USING A FACTOR XII INHIBITOR IN A NEUROTRAUMATIC DISORDER | KLEINSCHNITZ CHRISTOPH | CSL BEHRING GMBH |
| EP3157571 | FATTY ACIDS AND THEIR USE IN CONJUGATION TO BIOMOLECULES | BARNES DAVID WENINGER | NOVARTIS AG |
| EP3157909 | LMP7 INHIBITORS | OWENS TIMOTHY | PRINCIPIA BIOPHARMA INC |
| EP3157952 | TREATMENT OF CONGESTIVE HEART FAILURE AND OTHER CARDIAC DYSFUNCTION USING A GDF15 MODULATOR | GYURIS JENO | AVEO PHARMACEUTICALS INC |
| EP3157953 | TREATMENT OF CHRONIC KIDNEY DISEASE AND OTHER RENAL DYSFUNCTION USING A GDF15 MODULATOR | GYURIS JENO | AVEO PHARMACEUTICALS INC |
| EP3158043 | COMPOSITIONS CONTAINING ONE OR MORE POLY ALPHA-1,3-GLUCAN ETHER COMPOUNDS | NAGY KEVIN D | DU PONT |
| EP3158059 | METHOD FOR RAPID GENERATION OF AN ATTENUATED RNA VIRUS | NOUGAIRèDE ANTOINE | UNIVERSITé D'AIX-MARSEILLE |
| EP3158991 | FORMULATIONS OF BENDAMUSTINE | PALEPU NAGESH R | EAGLE PHARMACEUTICALS INC |
| EP3159009 | APOPTOSIS INDUCER | NIITSU YOSHIRO | NITTO DENKO CORP |
| EP3159044 | LONG-LASTING POWDER ESSENCE COMPOSITION WITH IMPROVED COLORING AND SKIN FEELING AND PREPARATION METHOD THEREOF | BAE EUN-CHUL | C&C INT CO LTD |
| EP3159402 | TISSUE REGENERATION PROMOTER | NIITSU YOSHIRO | NITTO DENKO CORP |
| EP3160440 | COMBINATION PRODUCTS AND COSMETIC COMPOSITIONS FOR CONTROLLING SKIN DISORDERS AND SKIN AGING THAT AFFECT KERATINOCYTES AND/OR FIBROBLASTS AND THE DERMIS | MAHE YANN | NUTRICOS TECH |
| EP3160444 | A PHARMACEUTICAL OIL-IN-WATER NANO-EMULSION | MISRA AMBIKANANDAN | SYNERGIA BIO SCIENCES PRIVATE LTD |
| EP3160445 | MDI RELATED PRODUCTS AND METHODS OF USE | HARTMAN MICHAEL S | ISLAND BREEZE SYSTEMS CA LLC |
| EP3160451 | BUCCAL AND SUBLINGUAL CANNABINOID FORMULATIONS AND METHOD OF MAKING THE SAME | CROWLEY KENTON L | CROWLEY KENTON L |
| EP3160455 | ACTIVE PHARMACEUTICAL INGREDIENT (API) COMPRISING CANNABINOIDS FOR USE IN THE TREATMENT OF CANCER | STOTT COLIN | GW PHARMA LTD |
| EP3160467 | METHODS FOR RETREATING IRRITABLE BOWEL SYNDROME (IBS) | GOLDEN PAM | SALIX PHARMACEUTICALS INC |
| EP3160469 | METHODS OF MANAGING CONDITIONED FEAR WITH NEUROKININ RECEPTOR ANTAGONISTS | RESSLER KERRY J | UNIV EMORY |
| EP3160490 | METHOD OF TREATING PULMONARY HYPERTENSION BY ADMINISTRATION OF NATRIURETIC PEPTIDE RECEPTOR C SIGNALING PATHWAY ACTIVATORS | EGOM EMMANUEL EROUME | EGOM EMMANUEL EROUME |
| EP3160495 | A MEDICAMENT FOR USE IN A METHOD OF INDUCING OR EXTENDING A CELLULAR CYTOTOXIC IMMUNE RESPONSE | KROCZEK RICHARD | BUNDESREPUBLIK DEUTSCHLAND LETZTVERTRETEN DURCH DAS ROBERT KOCH-INSTITUT VERTRETEN DURCH SEINEN PRÄS |
| EP3160498 | IL-15-BASED MOLECULES AND METHODS OF USE THEREOF | LIU BAI | ALTOR BIOSCIENCE CORP |
| EP3160501 | INFLUENZA VIRUS HEMAGGLUTININ PROTEIN AS A VACCINE ANTIGEN | SACZYNSKA VIOLETTA | INST BIOTECHNOLOGII I ANTYBIOTYKOW |
| EP3160503 | INHIBITION OF SEROTONIN EXPRESSION IN GUT ENTEROENDOCRINE CELLS RESULTS IN CONVERSION TO INSULIN-POSITIVE CELLS | ACCILI DOMENICO | UNIV COLUMBIA |
| EP3160554 | METHODS, DEVICES AND SYSTEMS FOR PULMONARY DELIVERY OF ACTIVE AGENTS | DAVIDSON PERRY | SYQE MEDICAL LTD |
| EP3160958 | CRYSTALLINE SALTS OF (S)-6-((1-ACETYLPIPERIDIN-4-YL)AMINO)-N-(3-(3,4-DIHYDROISOQUINOLIN-2(1H)-YL)-2-HYDROXYPROPYL)PYRIMIDINE-4-CARBOXAMIDE | CLARK WILLIAM M | GLAXOSMITHKLINE IP DEV LTD |
| EP3160960 | PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS | EVARTS JERRY | GILEAD SCIENCES INC |
| EP3160961 | SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 | PINKERTON ANTHONY B | SANFORD-BURNHAM MEDICAL RES INST |
| EP3162353 | FLUOROALUMINOSILICATE GLASS POWDER | HOKII YUSUKE | G C DENTAL IND CORP |
| EP3162359 | OIL-IN-WATER EMULSION COMPOSITION | NAGARE YUKO | SHISEIDO CO LTD |
| EP3162372 | COMPOSITION FOR TREATING ISCHEMIC DISEASES OR NEUROGENIC INFLAMMATION, CONTAINING, AS ACTIVE INGREDIENT, NEURAL PROGENITOR CELLS OR SECRETOME THEREOF | KIM DONG WOOK | INDUSTRY-ACADEMIC COOP FOUND YONSEI UNIV |
| EP3162402 | NASAL SPRAY NOZZLE TO BE USED IN MEDICAL SYRINGE | KAMISHITA TAIZOU | TOKO YAKUHIN KOGYO KK |
| EP3162798 | 5-MEMBERED HETEROCYCLIC COMPOUND | NISHIDA HARUYUKI | TAKEDA PHARMACEUTICALS CO |
| EP3164118 | COATED PARTICLES | JACKSON PHILIP ROBERT | LUCIDEON LTD |
| EP3164126 | SUCCINATE DEHYDROGENASE INHIBITORS (SDHi's) | CHOUCHANI EDWARD | MEDICAL RES COUNCIL |
| EP3164138 | TREATMENT OF URINARY TRACT INFECTION | RADUTI CONSTANTIN | BIOMEDICALS SWEDEN AB |
| EP3164142 | METHOD FOR OBTAINING GLOBALLY ACTIVATED MONOCYTES | BAUER GüNTER | TRANSIMMUNE AG |
| EP3164144 | LACTOBACILLUS COMPOSITION ALLOWING THE STIMULATION OF HUMAN AND ANIMAL JUVENILE GROWTH IN CASES OF MALNUTRITION | LEULIER FRANÇOIS | ECOLE NORMALE SUPéRIEURE DE LYON |
| EP3164194 | Dickkopf2 (Dkk2) Inhibition Suppresses Tumor Formation | WU DIANQING | UNIV YALE |
| EP3164196 | TOPICAL FORMULATIONS FOR UV PROTECTION | QVIT-RAZ NOGA | TOPGENIX INC |
| EP3164251 | DEVICE FOR THE MANUFACTURE OF PHARMACEUTICAL PATCHES | GRADER LUDWIG | LUYE PHARMA AG |
| EP3164385 | NOVEL POLYMORPHIC FORM OF N-[2-(6-FLUORO-LH-INDOL-3-YL)ETHYL]-3-(2,2,3,3-TETRAFLUOROPROPOXY)BENZYLAMINE HYDROCHLORIDE FOR THE TREATMENT OF ALZHEIMER'S | ANDERSEN KRISTINE BIRKLUND | H LUNDBECK AS |
| EP3164413 | SELECTIVE INHIBITORS OF C-FOS AND THEIR ANTIPROLIFERATIVE PROPERTIES | VANHOUTTE PETER | INSERM - INST NAT DE LA SANTé ET DE LA RECH MéDICALE |
| EP3164509 | INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1 | CHEN YOUNG K | CELGENE QUANTICEL RES INC |
| EP3165233 | BIOMATERIAL FOR TREATMENT OF ACUTE AND CHRONIC SKIN WOUNDS | RAMATA-STUNDA ANNA | LATVIJAS UNIV |
| EP3165539 | IL-17 RECEPTOR A ANTIGEN BINDING PROTEINS | TOCKER JOEL | KIRIN-AMGEN INC |
| EP3166574 | COSMETIC COMPOSITIONS | MENDOZA RICKY | MARY KAY INC |
| EP3166581 | ANHYDROUS COMPOSITION BASED ON STYLING AND/OR SEBUM-ABSORBING POWDER AND ON PARTICLES ENCAPSULATING A BENEFICIAL AGENT | AUBERT LIONEL | OREAL |
| EP3166614 | COMPOSITION FOR THE PREVENTION AND THERAPY OF TUMOR DISEASES | SCHALLER GERHARD | SANOXSYS GMBH |
| EP3166616 | BETA-GLUCAN IN COMBINATION WITH ANTI-CANCER AGENTS AFFECTING THE TUMOR MICROENVIRONMENT | BOSE NANDITA | BIOTHERA INC |
| EP3166618 | COMBINATION THERAPY OF A CELLULAR PRO-TOLEROGENIC AND PRO-INFLAMMATORY PREPARATIONS FOR MODULATING THE IMMUNE SYSTEM | SCOTT MARK D | CANADIAN BLOOD SERVICES |
| EP3166626 | MATERIALS AND METHODS FOR TREATING DISORDERS ASSOCIATED WITH SULFATASE ENZYMES | RADIN DAVID N | BIOSTRATEGIES LC |
| EP3166634 | NOVEL VACCINE COMPOSITIONS FOR PORCINE EPIDEMIC DIARRHEA VIRUS AND PORCINE DELTACORONAVIRUS | MARX JACQUELINE GAYLE | ZOETIS SERVICES LLC |
| EP3166636 | PSGL-1 MODULATORS AND USES THEREOF | BRADLEY LINDA M | SANFORD-BURNHAM MEDICAL RES INST |
| EP3166645 | SITE SELECTIVE CONJUGATION OF AN OLIGONUCLEOTIDE CONJUGATE OR A SMALL MOLECULE TO A METAL BINDING PROTEIN | GOTHELF KURT VESTERAGER | AFFYCON APS |
| EP3166649 | AQUEOUS EXTRACT OF TRUFFLE AND COSMETIC COMPOSITION THEREOF | PORTOLAN FRéDéRIQUE | ISP INVESTMENTS LLC |
| EP3166650 | HYDROGEL COMPOSITIONS | MARCHANT NANCY S | LUBRIZOL ADVANCED MAT INC |
| EP3167876 | PHARMACEUTICAL TABLET FORMULATION FOR THE VETERINARY MEDICAL SECTOR, METHOD OF PRODUCTION AND USE THEREOF | FOLGER MARTIN | BOEHRINGER INGELHEIM VETMEDICA GMBH |
| EP3167887 | ARYL AMINE SUBSTITUTED QUINOXALINE USED AS ANTICANCER DRUGS | CHEN CHIHHUNG | |
| EP3167897 | STABILIZED LIQUID AND LYOPHILIZED ADAMTS13 FORMULATIONS | MATTHIESSEN H PETER | BAXALTA GMBH |
| EP3167899 | ISOLATED POLYPEPTIDE OF THE TOXIN A AND TOXIN B PROTEINS OF C.DIFFICILE AND USES THEREOF | ELLINGSWORTH LARRY | VALNEVA AUSTRIA GMBH |
| EP3168219 | PYRIDONE DERIVATIVE HAVING TETRAHYDROPYRANYL METHYL GROUP | HAGINOYA NORIYASU | DAIICHI SANKYO CO LTD |
| EP3169305 | A USE OF ISOSORBIDE MONOOLEATE | STOER CLAUDIA | BASF SE |
| EP3169308 | SUSPENSION COMPOSITIONS OF CYCLOSPORIN A FOR SUBCONJUNCTIVAL AND PERIOCULAR INJECTION | GORE ANURADHA V | ALLERGAN INC |
| EP3169325 | THERAPEUTIC INHIBITORY COMPOUNDS | MCDONALD ANDREW | LIFESCI PHARMACEUTICALS INC |
| EP3169326 | SUPPRESSION OF MYELOID DERIVED SUPPRESSOR CELLS AND IMMUNE CHECKPOINT BLOCKADE | ZHOU SHIBIN | UNIV JOHNS HOPKINS |
| EP3169334 | RNA FOR USE IN THE TREATMENT OF LIGAMENT OR TENDON LESIONS | HASENPUSCH GüNTHER | ETHRIS GMBH |
| EP3169344 | EPHA4 CYCLIC PEPTIDE ANTAGONISTS FOR NEUROPROTECTION AND NEURAL REPAIR | PASQUALE ELENA B | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST |
| EP3169368 | LINKERS AND THEIR APPLICATION TOWARDS ADC | LI CHUN SING | MEDSHINE DISCOVERY INC |
| EP3169670 | QUINOXALINE COMPOUNDS, METHOD FOR PREPARING THE SAME AND USE THEREOF | LIN NAN-HORNG | |
| EP3169674 | ARYL-TRIAZOLYL-PYRIDINES AS PESTICIDES | HALLENBACH WERNER | BAYER ANIMAL HEALTH GMBH |
| EP3170394 | HIGH QUALITY ANTIMICROBIAL PAINT COMPOSITION | GISSER KATHLEEN R | THE SHERWIN-WILLIAMS COMPANY |
| EP3170505 | PLATELET-DERIVED GROWTH FACTOR COMPOSITIONS AND METHOD OF USE THEREOF | LYNCH SAMUEL E | BIOMIMETIC THERAPEUTICS LLC |
| EP3170821 | COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACID LINKED DOLASTATIN DERIVATIVES | MIAO ZHENWEI | AMBRX INC |
| EP3170823 | ONE CLASS OF PYRAZOLONE COMPOUNDS AND USE THEREOF | NAN FAJUN | SHANGHAI INST MATERIA MEDICA CAS |
| EP3170901 | METHOD FOR IDENTIFYING EPITOPE OF PROTEIN | INOUE TOMOAKI | CHUGAI PHARMACEUTICAL CO LTD |
| EP3171851 | DUAL PHASE MOUTHWASH COMPOSITIONS | DILLON RENSL | COLGATE PALMOLIVE CO |
| EP3171869 | ACTIVE INGREDIENT COMPRISING A MIXTURE OF UNSATURATED DICARBOXYLIC FATTY ACIDS, COMPOSITIONS COMPRISING SAID INGREDIENT AND COSMETIC OR DERMATOLOGICAL USES | WELS BAS | SEDERMA SA |
| EP3171870 | PROTEIN PHOSPHATASE 2A INHIBITORS FOR TREATING MYELODYSPLASTIC SYNDROMES | LIST ALAN F | H LEE MOFFITT CANCER CT & RES |
| EP3171879 | PREVENTING AND TREATING INFLAMMATORY SKIN DISEASES | SIDI YECHEZKEL | TEL HASHOMER MEDICAL RES INFRASTRUCTURE & SERVICES LTD |
| EP3171892 | ANTI-PD-1 ANTIBODIES | QIU JUNZHUAN | CB THERAPEUTICS INC |
| EP3171894 | NEUROKININ-1 RECEPTOR ANTAGONIST COMPOSITION FOR TREATMENT OF DISEASES AND CONDITIONS OF THE RESPIRATORY TRACT | LARA RUIZ ANTONIO | PLUS VITECH S L |
| EP3171941 | N-METHYL-D-ASPARTATE RECEPTOR MODULATORS AND METHODS OF MAKING AND USING SAME | KHAN M AMIN | NAUREX INC |
| EP3172213 | MACROCYCLIC KINASE INHIBITORS AND USES THEREOF | GRAY NATHANAEL | DANA FARBER CANCER INST INC |
| EP3172318 | ATTENUATED STRAIN OF PRRS AND POTENTIAL USE IN IMMUNISING PREPARATIONS | FERRARI MAURA | ST ZOOPROFILATTICO SPERIMENTALE DELLA LOMBARDIA E DELL'EMILLIA ROMAGNA BRUNO UBERTINI - IZSLER |
| EP3173071 | MAROPITANT FORMULATION | BOEREN MARINUS MARIA MARTINUS | LE VET B V |
| EP3173076 | A PHARMACEUTICAL COMPOSITION COMPRISING SIMETHICONE AND OTILONIUM | FARSI FERHAD | ABDI IBRAHIM ILAC SANAYI VE TICARET A S |
| EP3173420 | POLYPEPTIDE AND POLYPEPTIDE COMPLEX FOR SUPPRESSING TUMOR METASTASIS AND TREATING LEUKEMIA AS WELL AS PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | WANG CHEN | NAT CT NANOSCIENCE & TECHNOLOGY CHINA |
| EP3174516 | KIT OF PARTS CONTAINING DENTAL MILL BLANK AND COLOURING SOLUTION | JAHNS MICHAEL | 3M INNOVATIVE PROPERTIES CO |
| EP3174519 | FORMULATIONS, METHODS AND DEVICES FOR PERIORBITAL SKIN REJUVENATION | SIDDIQUI MUKHTAR | YOUNIQUE LLC |
| EP3174527 | DOSAGE FORM OF SODIUM IBUPROFEN DIHYDRATE ON MESOPOROUS SILICA | LEE DER-YANG | JOHNSON & JOHNSON CONSUMER INC |
| EP3174537 | MONOCYCLIC ISOXAZOLINES AS INHIBITORS OF CHOLESTEROL ESTER TRANSFER PROTEIN | SHAO PENGCHENG PATRICK | MERCK SHARP & DOHME |
| EP3174868 | COMPOUNDS ACTIVE TOWARDS BROMODOMAINS | GERNER SEITZBERG JIMMI | NUEVOLUTION AS |
| EP3174886 | 2-OXA-5-AZABICYCLO[2.2.1]HEPTAN-3-YL DERIVATIVES | CECERE GIUSEPPE | HOFFMANN LA ROCHE |
| EP3174894 | COMPOSITIONS AND METHODS OF USE FOR TREATING METABOLIC DISORDERS | LINDHOUT DARRIN ANTHONY | NGM BIOPHARMACEUTICALS INC |
| EP3174908 | ANIONICALLY MODIFIED N-SULFONIC POLYALLYLAMINE DERIVATIVE, PHARMACEUTICAL COMPOSITION COMPRISING THE N-SULFONIC POLYALLYLAMINE DERIVATIVE AS THE ACTIVE SUBSTANCE AND USE OF THE N-SULFONIC POLYALLYLAMINE DERIVATIVE FOR THE PRODUCTION OF A MEDICINE | NOWAKOWSKA MARIA | UNIV JAGIELLONSKI |
| EP3175001 | PROGNOSTIC METHODS AND SYSTEMS OF TREATMENT FOR ACUTE LYMPHOBLASTIC LEUKEMIA | AVIGAD SMADAR | MOR RESEARCH APPLIC LTD |
| EP3175238 | DEVICES AND KITS FOR PRODUCTION OF PERSONALIZED, CONCENTRATED HUMAN MILK COMPOSITIONS, AND METHODS OF MAKING AND USING SAME | VERDI LESLEY KEANE | NESTEC SA |
| EP3175851 | USE OF BUTENYLPHTHALIDE, USAGE METHOD THEREOF AND METHOD FOR PREPARING SAME INTO PHARMACEUTICAL COMPOSITION | SU HONG-LIN | |
| EP3175863 | VARIANTS OF C-TYPE NATRIURETIC PEPTIDE | WENDT DANIEL J | BIOMARIN PHARM INC |
| EP3175888 | COMPOSITIONS CONTAINING POLYMERIC SULFUR AND USES THEREOF | DUNN KELLY | JOHNSON & JOHNSON CONSUMER INC |
| EP3176254 | USE OF ADIPOSE TISSUE-DERIVED STROMAL STEM CELLS IN TREATING FISTULA | FERNANDEZ MIGUEL MARIA GEMA | CELLERIX SL |
| EP3177282 | ANTIDIABETIC BICYCLIC COMPOUNDS | CHOBANIAN HARRY | MERCK SHARP & DOHME |
| EP3177293 | METHOD OF TREATING SKIN CONDITIONS | BUCKETT LINDA KAREN | ASTRAZENECA AB |
| EP3177297 | COMPOSITIONS RELATING TO VITAMIN D | TENG ZHU | SIEMENS HEALTHCARE DIAGNOSTICS INC |
| EP3177305 | EXTRACTS OF MICROALGAE AND PLANTS FOR REGULATING SEBUM PRODUCTION | ZANELLA LORENZO | CUTECH S R L |
| EP3177306 | COMPOSITIONS FOR THE INHIBITION OF GIARDIA LAMBLIA | BERMUDEZ-HUMARAN LUIS G | INST NAT DE LA RECH AGRONOMIQUE (INRA) |
| EP3177320 | HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE | IP NANCY YUK-YU | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPT OF HEALTH |
| EP3177332 | ARTICLE COATINGS INCLUDING OLIGOMERIZED POLYPHENOL LAYER AND BIOLOGICAL METHODS OF USE | BABCOCK DAVID E | SURMODICS INC |
| EP3177595 | ASYMMETRIC BISAMINOQUINOLINES AND BISAMINOQUINOLINES WITH VARIED LINKERS AS AUTOPHAGY INHIBITORS FOR CANCER AND OTHER THERAPY | AMARAVADI RAVI K | UNIV PENNSYLVANIA |
| EP3177611 | OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES | SCHRØDER GLAD SANNE | NUEVOLUTION AS |
| EP3177621 | NOVEL HDAC6 INHIBITORS AND THEIR USES | MAHBOOBI SIAVOSH | UNIVERSITÄT REGENSBURG |
| EP3177642 | ANGIOPOIETIN-LIKE 4 ANTIBODIES AND METHODS OF USE | TRAUGER JOHN | NOVARTIS AG |
| EP3177645 | SUBCUTANEOUSLY ADMINISTERED BISPECIFIC ANTIBODIES FOR USE IN THE TREATMENT OF CANCER | BUHMANN RAYMUND | LINDHOFER HORST DR |
| EP3177669 | AMPHIPHILIC BLOCKCOPOLYMERS COMPRISING REDUCTION SENSITIVE BIODEGRADABLE POLYESTERAMIDES | DIAS AYLVIN JORGE ANGELO ATHANASIUS | DSM IP ASSETS BV |
| EP3177720 | VIRUS LIKE PARTICLE COMPRISING MODIFIED ENVELOPE PROTEIN E3 | AKAHATA WATARU | VLP THERAPEUTICS LLC |
| EP3177726 | GENOME EDITING FOR THE TREATMENT OF HUNTINGTON's DISEASE | DEGLON NICOLE | CENTRE HOSPITALIER UNIV VAUDOIS (CHUV) |
| EP3178322 | AMIDE COMPOUND AND USE OF SAME FOR NOXIOUS ARTHROPOD CONTROL | MITSUDERA HIROMASA | SUMITOMO CHEMICAL CO |
| EP3178472 | ORAL FORMULATIONS OF METHYLNALTREXONE | SHAH SYED M | WYETH LLC |
| EP3178837 | URLC10-DERIVED PEPTIDE AND VACCINE CONTAINING SAME | TSUNODA TAKUYA | ONCOTHERAPY SCIENCE INC |
| EP3178847 | ANTI-TNF-ALPHA FULLY HUMAN MONOCLONAL ANTIBODIES WITH LOW IMMUNOGENICITY AND APPLICATION THEREOF | SUN LE | ABMAX BIOTECHNOLOGY CO LTD |
| EP3178850 | COMPOSITIONS COMPRISING CROSS-SPECIES-SPECIFIC ANTIBODIES AND USES THEREOF | KISCHEL ROMAN | AMGEN RES (MUNICH) GMBH |
| EP3178925 | METHOD FOR PRODUCING RETINAL GANGLION CELLS | AZUMA NORIYUKI | NAT CENTER FOR CHILD HEALTH AND DEV |
| EP3178929 | NEW ANTI-HUMAN IG(BETA) ANTIBODY | YAMAJUKU DAISUKE | ASTELLAS PHARMA INC |
| EP3178931 | ANTI-ORAI1 ANTIBODY | KOMAI TOMOAKI | DAIICHI SANKYO CO LTD |
| EP3179979 | NON-GREASY PERSONAL CARE COMPOSITIONS | LESNIAK EWELINA | COLGATE PALMOLIVE CO |
| EP3179991 | THERAPEUTIC COMBINATIONS OF A BTK INHIBITOR, A PI3K INHIBITOR, A JAK-2 INHIBITOR, AND/OR A BCL-2 INHIBITOR | HAMDY AHMED | ACERTA PHARMA BV |
| EP3179993 | ESKETAMINE FOR USE IN A METHOD FOR THE TREATMENT OF DEPRESSION | LI QINGQIN S | JANSSEN PHARMACEUTICA NV |
| EP3179997 | PALMITOLEIC ACID FOR USE IN INHIBITING THE ATTACHMENT OF SEA LICE TO FISH | PAGEAT PATRICK | INST DE RECH EN SEMIOCHIMIE ET ETHOLOGIE APPLIQUéE |
| EP3179998 | COMPOUNDS FOR THE TREATMENT OF HPV-INDUCED CARCINOMA | RAJENDRAN SENTHIL KUMAR | ÅBO AKADEMI |
| EP3180004 | CANCER THERAPEUTICS | BUSHWELLER JOHN H | UNIV VIRGINIA PATENT FOUNDATION |
| EP3180011 | IMMUNOTHERAPY FOR THE TREATMENT OF CANCER | ZHANG LI | UNIV HEALTH NETWORK |
| EP3180017 | PATHOGENIC CONTROL OF APOPTOSIS | SCHOLEFIELD JANINE | CSIR |
| EP3180317 | FACTOR XIa INHIBITORS | LIU WEIGUO | MERCK SHARP & DOHME |
| EP3180330 | 2,2,2-TRIFLUOROETHYL-THIADIAZINES | ANSELM LILLI | HOFFMANN LA ROCHE |
| EP3180335 | CYTOCHROME P450 INHIBITORS AND USES THEREOF | PANICKER BIJOY | ANGION BIOMEDICA CORP |
| EP3180353 | MYCOBACTERIUM TUBERCULOSIS PROTEINS | AMICOSANTE MASSIMO | OXFORD IMMUNOTEC LTD |
| EP3180365 | NOVEL POTASSIUM CHANNEL BLOCKERS AND USE THEREOF IN THE TREATMENT OF AUTOIMMUNE DISEASES | NORTON RAYMOND S | UNIV MONASH |
| EP3180373 | BIOMATERIAL WITH REDUCED INFLAMMATORY RESPONSE | SANTERRE PAUL | GOVERNING COUNCIL UNIV TORONTO |
| EP3181556 | MICROMOLECULE COMPOUND, METHOD OF SYNTHESIS AND APPLICATION THEREOF | WANG ZENGQUAN | TECHNODERMA MEDICINES PTE LTD |
| EP3181575 | CELLULAR LIBRARIES OF PEPTIDE SEQUENCES (CLIPS) AND METHODS OF USING THE SAME | DAUGHERTY PATRICK SEAN | UNIV CALIFORNIA |
| EP3181616 | CELLULOSE MICROPOWDER | YOSHIDA NAOYA | ASAHI CHEMICAL IND |
| EP3181682 | REDUCED COLONIZATION OF MICROBES AT THE MUCOSA | STEIDLER LOTHAR | INTREXON ACTOBIOTICS NV |
| EP3182967 | METHOD FOR TREATING HYPERHIDROSIS | BENCHERIF MEROUANE | ATACAMA THERAPEUTICS INC |
| EP3182969 | A COMPOSITION HAVING A MUSCLE-RELAXANT AND ANTI-INFLAMMATORY ACTIVITY | BIJNO DOMENICO | KOLINPHARMA S P A |
| EP3182977 | LANOSTEROL FOR USE IN TREATING VISION DISORDERS | HOU RUI | UNIV CALIFORNIA |
| EP3182982 | A COMPOSITION FOR THE TREATMENT AND PREVENTION OF URINARY TRACT INFECTIONS | BIJNO DOMENICO | KOLINPHARMA S P A |
| EP3182989 | METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DISEASE | WILSON D TRAVIS | STEALTH BIOTHERAPEUTICS CORP |
| EP3182999 | ANTI-LAG3 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS | LIANG LINDA | MERCK SHARP & DOHME |
| EP3183002 | MONOCLONAL ANTIBODIES FOR TREATMENT OF MICROBIAL INFECTIONS | ZURAWSKI DANIEL V | US ARMY |
| EP3183242 | SUBSTITUTED BICYCLIC COMPOUNDS | XIAO HAI-YUN | BRISTOL MYERS SQUIBB CO |
| EP3183249 | 1,4,7,10-TETRAZACYCLODODECANE BASED AGENTS TO TARGET BACTERIA AND ITS USE | BROENSTRUP MARK | HELMHOLTZ-ZENTRUM FüR INFEKTIONSFORSCHUNG GMBH |
| EP3183345 | BIOCOMPATIBLE INFINITE COORDINATION POLYMER NANOPARTICLE-NUCLEIC ACID CONJUGATES FOR ANTISENSE GENE REGULATION | MIRKIN CHAD A | UNIV NORTHWESTERN |
| EP3184098 | FOAMING COMPOSITION FOR DIAPER RASH | PATEL JIGER | JOHNSON & JOHNSON CONSUMER INC |
| EP3184521 | INDAZOLE COMPOUNDS AS FGFR KINASE INHIBITOR, PREPARATION AND USE THEREOF | GENG MEIYU | SHANGHAI HAIHE PHARMACEUTICAL CO LTD |
| EP3185843 | GEL COMPOSITION AND GEL COMPRISING A UV FILTER | ROUDOT ANGELINA | L'ORéAL |
| EP3185854 | INJECTABLE SLURRIES AND METHODS OF MANUFACTURING AND USING THE SAME | GARIBYAN LILIT | MASSACHUSETTS GEN HOSPITAL |
| EP3185857 | BONDABLE MICROCAPSULES AND SURFACE FUNCTIONALIZED FILLERS | GROSS STEPHEN M | PREMIER DENTAL PRODUCTS CO |
| EP3185867 | CRYSTALLIZATION PROCESS OF ARIPIPRAZOLE DERIVATIVES IN EXTENDED RELEASE FORMULATIONS FOR TREATMENT OF SCHIZOPHRENIA | MORALES WILFREDO JR | ALKERMES PHARMA IRELAND LTD |
| EP3185872 | FORMULATIONS OF TESTOSTERONE AND METHODS OF TREATMENT THEREWITH | JOSEPHS ROBERT A | UNIV TEXAS |
| EP3185874 | METHOD OF IMPROVING OR ENHANCING GROWTH AT AN ADULT AGE OF AN OFFSPRING BY ADMINISTRATION OF FOS | APPER EMMANUELLE | BEGHIN MEIJI SA |
| EP3185887 | METHOD FOR PREPARING CRYSTALLINE INSULIN OR INSULIN ANALOG COMPOSITIONS | WATSON DOUGLAS S | MERCK SHARP & DOHME |
| EP3185890 | TOPICAL COMPOSITION CONTAINING RANPIRNASE | SULLEY JAMIE | TAMIR BIOTECHNOLOGY INC |
| EP3186224 | SUBSTITUTED AZETIDINE DERIVATIVES AS TAAR LIGANDS | CECERE GIUSEPPE | HOFFMANN LA ROCHE |
| EP3186227 | NOVEL SULFONYLAMINOBENZAMIDE COMPOUNDS AS ANTHELMINTICS | GAUVRY NOËLLE | NOVARTIS TIERGESUNDHEIT AG |
| EP3186242 | INHIBITORS OF -AMINO- -CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE | PELLICCIARI ROBERTO | TES PHARMA S R L |
| EP3186243 | GLYCOSIDASE INHIBITORS | QUATTROPANI ANNA | ASCENEURON SA |
| EP3186245 | MAPK INHIBITORS | KRUM HENRY | WANG BING HUI |
| EP3186247 | PROTEIN KINASE INHIBITORS | YU CHUNRONG | ASTAR BIOTECH LLC |
| EP3186274 | INTRACELLULAR OSTEOPONTIN REGULATES THE LINEAGE COMMITMENT OF LYMPHOID SUBSETS | CANTOR HARVEY | DANA FARBER CANCER INST INC |
| EP3187166 | THICKENING AND/OR SHEAR-THINNING POLYESTER | PEETERS HILDE | OLEON N V |
| EP3187175 | SUPPLEMENTARY THERAPEUTIC FORMULATIONS FOR THE SEQUENTIAL OR SEPARATE ADMINISTRATION OF BUTYRIC ACID AND PROBIOTICS | MISCIOSCIA MARIO | EURO-PHARMA S R L |
| EP3187182 | PHARMACEUTICAL COMPOSITION COMPRISING EICOSAPENTAENOIC ACID AND NICOTINIC ACID AND METHODS OF USING SAME | MANKU MEHAR | AMARIN PHARMACEUTICALS IE LTD |
| EP3187551 | ANTHOCYANIN-BASED PIGMENT COMPOSITION | ISHIDA MASAHIKO | SAN-EI GEN F F I INC |
| EP3188720 | TADALAFIL ORAL DISPERSIBLE FILM AND PREPARING METHOD THEREOF | CHO YONG HEE | SEOUL PHARMA CO LTD |
| EP3188722 | METHODS FOR TREATING PROTOZOAN INFECTIONS | PAGE STEPHEN | NEOCULI PTY LTD |
| EP3188723 | FORMULATION FOR TREATING CHRONIC WOUNDS | BASARA MICHAEL | EPIEN MEDICAL INC |
| EP3188724 | LIPOSOME ENCAPSULATED AFFINITY DRUG | NIYIKIZA CLET | L E A F HOLDINGS GROUP LLC |
| EP3188740 | ACTIVATION OF MARROW INFILTRATING LYMPHOCYTES IN HYPOXIC ALTERNATING WITH NORMOXIC CONDITIONS | BORRELLO IVAN M | UNIV JOHNS HOPKINS |
| EP3188747 | ELEVATED INTRACRANIAL PRESSURE TREATMENT | SINCLAIR ALEX | UNIV BIRMINGHAM |
| EP3188803 | TRANSPARENT MULTI-PHASE SYSTEM | TREU JENS | BEIERSDORF AG |
| EP3189041 | TETRAHYDROISOQUINOLINE DERIVED PRMT5-INHIBITORS | BERGMAN YLVA ELISABET | CTXT PTY LTD |
| EP3189042 | TETRAHYDROISOQUINOLINE DERIVED PRMT5-INHIBITORS | FOITZIK RICHARD CHARLES | CTXT PTY LTD |
| EP3189048 | AMINOINDANE-, AMINOTETRAHYDRONAPHTHALENE- AND AMINOBENZOCYCLOBUTANE-DERIVED PRMT5-INHIBITORS | BERGMAN YLVA ELISABET | CTXT PTY LTD |
| EP3189052 | CaMKII INHIBITORS AND USES THEREOF | LEVY DANIEL E | ALLOSTEROS THERAPEUTICS INC |
| EP3189067 | RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE | KWONG PETER | US HEALTH |
| EP3189074 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING INFLAMMATION | SAPIEHA PRZEMYSLAW | RSEM LTD PARTNERSHIP |
| EP3189135 | RETINAL GANGLION CELLS AND PROGENITORS THEREOF | WANG WEI | ASTELLAS INST FOR REGENERATIVE MEDICINE |
| EP3189153 | COMPOUND TARGETING IL-23A AND TNF-ALPHA AND USES THEREOF | BARRETT RACHEL REBECCA | BOEHRINGER INGELHEIM INT |
| EP3189840 | METHYLPHENIDATE-PRODRUGS, PROCESSES OF MAKING AND USING THE SAME | GUENTHER SVEN | KEMPHARM INC |
| EP3189852 | BISPHOSPHONATE-CONTAINING PHARMACEUTICAL VACCINE COMPOSITION FOR HUMORAL IMMUNITY | SHISHIDO TAKUYA | NITTO DENKO CORP |
| EP3189859 | COMPOSITION FOR TREATMENT OF CARTILAGE DISEASE | IWASAKI NORIMASA | MOCHIDA PHARM CO LTD |
| EP3190104 | QUINOLINONE COMPOUND AND USE THEREOF | ZUO YINGLIN | SUNSHINE LAKE PHARMA CO LTD |
| EP3190108 | HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS | OSLOB JOHAN D | 3-V BIOSCIENCES INC |
| EP3190113 | PYRROLOPYRIMIDINE COMPOUNDS USED AS TLR7 AGONIST | DING ZHAOZHONG | CHAI TAI TIANQING PHARMACEUTICAL GROUP CO LTD |
| EP3190115 | SALT OF CEPHALOSPORIN DERIVATIVE, CRYSTALLINE SOLID FORM OF SAME AND METHOD FOR PRODUCING SAME | MATSUBARA FUMIHIKO | SHIONOGI & CO |
| EP3190413 | METHOD FOR PREDICTING DEPRESSION TREATMENT DRUG ALTERNATIVES | KAWAMURA NORIYUKI | HUMAN METABOLOME TECH INC |
| EP3190893 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING BACTERIAL INFECTIONS | MATLICK JOHN | K10 TECH INC |
| EP3191083 | GELATIN/PECTIN PARTICLES | DOLPHIN JOHN M | GELITA AG |
| EP3191085 | ABUSE RESISTANT PHARMACEUTICAL COMPOSITIONS | REKHI GURVINDER SINGH | RECRO GAINESVILLE LLC |
| EP3191086 | THYMOL AND CARVACOL FOR USE IN MEDICINE | SAH RAJAN | UNIV IOWA RES FOUND |
| EP3191103 | COMPOSITIONS AND METHODS FOR TREATMENT OF PRE-CANCEROUS SKIN LESIONS | CORNELIUS LYNN | UNIV WASHINGTON |
| EP3191114 | OCCIDIOFUNGIN FORMULATIONS AND USES THEREOF | SMITH JAMES | SMITH JAMES |
| EP3191186 | COMPOSITIONS AND METHODS OF USING INTERLEUKIN-4 INDUCED GENE 1 (IL4I1) | HUANG JEFFREY | UNIV GEORGETOWN |
| EP3191187 | COMBINATION THERAPIES WITH ANTI-CD38 ANTIBODIES | LOKHORST HENK M | JANSSEN BIOTECH INC |
| EP3191188 | COMPOSITIONS FOR KERATIN FIBERS | ABDO MOHANNAD | AVON PROD INC |
| EP3191461 | CRYSTALLINE SOLID FORMS OF 6-CARBOXY-2-(3,5-DICHLOROPHENYL)-BENZOXAZOLE | GIRARD KEVIN PAUL | PFIZER |
| EP3191489 | PYRROLOPYRIMIDINES FOR USE IN INFLUENZA VIRUS INFECTION | JONCKERS TIM HUGO MARIA | JANSSEN SCIENCES IRELAND UC |
| EP3191502 | TARGETED DELIVERY OF TERTIARY AMINE-CONTAINING DRUG SUBSTANCES | BURKE PATRICK J | SEATTLE GENETICS INC |
| EP3191809 | SYSTEM AND METHOD FOR PREPARING A PHARMACEUTICAL COMPOUND | SANDMANN CHRISTIAN | BECTON DICKINSON CO |
| EP3192509 | REMIFENTANIL INJECTION | HORIUCHI AIKO | TERUMO CORP |
| EP3192511 | PHARMACEUTICAL CONTAINING SODIUM-DEPENDENT PHOSPHATE TRANSPORTER INHIBITOR | OHTAKE YOSHIHITO | CHUGAI PHARMACEUTICAL CO LTD |
| EP3192518 | ANTI-INFLAMMATORY AGENT | IZUMI HIROHISA | MORINAGA MILK INDUSTRY CO LTD |
| EP3192524 | HGF PREPARATION SUITABLE FOR TREATMENT OF NERVOUS DISEASES | FUKUTA KAZUHIRO | KRINGLE PHARMA INC |
| EP3192565 | ORAL CARE COMPOSITION COMPRISING A PROTEIN FOR BALANCING THE BACTERIAL FLORA OF THE MOUTH | ADAMS SUZANNE ELIZABETH | UNILEVER PLC |
| EP3192815 | HIGH-RECOVERABILITY RESIN PARTICLES AND USE THEREOF | KUSAKA AKIYOSHI | SEKISUI PLASTICS |
| EP3192862 | BIOMATRIX SCAFFOLDS | WANG YUNFANG | UNIV NORTH CAROLINA CHAPEL HILL |
| EP3193817 | COMPOSITIONS COMPRISING A SILICONE SURFACTANT, A SILICONE ELASTOMER POWDER AND AN ORGANO-MODIFIED CLAY | ARNAUD PASCAL | L'ORéAL |
| EP3193829 | OPHTHALMIC DRUG COMPOSITIONS | YAMAMOTO RONALD K | OXULAR LTD |
| EP3193840 | ARIMOCLOMOL FORMULATION | HINSBY ANDERS MØRKEBERG | ORPHAZYME APS |
| EP3193855 | BICYCLIC COMPOUNDS | BUNKER KEVIN DUANE | KALYRA PHARMACEUTICALS INC |
| EP3193856 | FORMULATION | BREKKE STIAN | PHARMAQ AS |
| EP3193867 | OCULAR FORMULATIONS FOR DRUG-DELIVERY AND PROTECTION OF THE ANTERIOR SEGMENT OF THE EYE | BINGAMAN DAVID P | PANOPTICA INC |
| EP3193871 | CED OF SN-38-LOADED MICELLES AGAINST BRAIN TUMOR | SAITO RYUTA | NIPPON KAYAKU KK |
| EP3193878 | COMPOUNDS AND METHODS | LI PENG | INTRA-CELLULAR THERAPIES INC |
| EP3193898 | EURYCOMA LONGIFOLIA EXTRACT AND ITS USE IN ENHANCING AND/OR STIMULATING IMMUNE SYSTEM | GEORGE ANNIE | BIOTROPICS MALAYSIA BERHAD |
| EP3193914 | ORGAN PROTECTION IN PSMA-TARGETED RADIONUCLIDE THERAPY OF PROSTATE CANCER | BABICH JOHN W | MOLECULAR INSIGHT PHARM INC |
| EP3193917 | VACCINE COMPOSITIONS COMPRISING TRYPTOPHAN 2,3-DIOXYGENASE OR FRAGMENTS THEREOF | ANDERSEN MADS HALD | HERLEV HOSPITAL |
| EP3193933 | ANTI-CD276 ANTIBODIES (B7H3) | DIMITROV DIMITER S | US HEALTH |
| EP3193934 | COMPOSITIONS FOR IMPROVING THE HEALTH RELATED QUALITY OF LIFE OF RHEUMATOID ARTHRITIS PATIENTS | JOSEPH GEORGE JOHNY | SANOFI BIOTECHNOLOGY |
| EP3193944 | METHODS OF TREATING CELLS CONTAINING FUSION GENES | LUO JIANHUA | UNIV OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION |
| EP3194032 | TOPICAL PTEROSTILBENE COMPOSITIONS FOR USE IN TREATING UV-INDUCED LOSS OF BARRIER FUNCTION IN SKIN | MEYSKENS JR FRANK L | UNIV CALIFORNIA |
| EP3194367 | TETRAHYDROISOQUINOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT OF OBESITY AND DIABETES | ROTH GERALD JUERGEN | BOEHRINGER INGELHEIM INT |
| EP3194382 | PYRAZOLE DERIVATIVES AS SGC STIMULATORS | BARDEN TIMOTHY CLAUDE | IRONWOOD PHARMACEUTICALS INC |
| EP3194421 | CYTOTOXIC AND ANTI-MITOTIC COMPOUNDS, AND METHODS OF USING THE SAME | WINTERS GEOFFREY C | ZYMEWORKS INC |
| EP3194437 | ANGIOPOETIN-LIKE 4 (ANGPTL4) ANTIBODIES AND METHODS OF USE | TRAUGER JOHN | NOVARTIS AG |
| EP3194447 | ANTIBODIES CAPABLE OF BINDING TWO EPITOPES ON TISSUE FACTOR PATHWAY INHIBITOR (1-161) | PETERSEN HELLE HEIBROCH | NOVO NORDISK AS |
| EP3194597 | ALLELE-SPECIFIC THERAPY FOR HUNTINGTON DISEASE HAPLOTYPES | SOUTHWELL AMBER L | UNIV BRITISH COLUMBIA |
| EP3194601 | ADENO-ASSOCIATED VIRAL VECTORS FOR TREATING MYOCILIN (MYOC) GLAUCOMA | PECHAN PETER | GENZYME CORP |
| EP3194970 | IMMUNOGENIC MUTANT PEPTIDE SCREENING PLATFORM | DELAMARRE LELIA | HOFFMANN LA ROCHE |
| EP3194972 | A METHOD OF TREATING BONE METASTASIS DISEASES, MEDICAMENTS THEREFORE, AND A METHOD OF PREDICTING THE CLINICAL OUTCOME OF TREATING BONE METASTASIS DISEASES | STRAUB JOSEF | MERCK PATENT GMBH |
| EP3195331 | NANOPARTICLES FOR MAGNETIC RESONANCE IMAGING APPLICATIONS | WEI HE | MASSACHUSETTS INST TECHNOLOGY |
| EP3195849 | UV BLOCKING FUNCTIONAL COMPOSITE POWDER PREPARED BY DOUBLY COATING INORGANIC POWDER WITH INORGANIC UV BLOCKING AGENT AND ORGANIC UV ABSORBER, AND UV BLOCKING COSMETIC COMPOSITION USING SAME | LEE BEOM ZOO | CHEMLAND CO LTD |
| EP3195852 | KERATIN SOFTENING PATCH | NAM TACK SOO | WOOSHIN MEDICS CO LTD |
| EP3195869 | METHOD OF PROMOTING WOUND HEALING | SAMPATH PRABHA | AGENCY FOR SCIENCE TECH AND RES (A*STAR) |
| EP3195870 | AGENT FOR PROMOTING GROWTH OF NONPATHOGENIC ORAL INDIGENOUS BACTERIA OR AGENT FOR IMPROVING ORAL BACTERIAL FLORA, AND COMPOSITION FOR ORAL USE | MARUYAMA MASATO | LION CORP |
| EP3195871 | WHITENING COMPOSITION COMPRISING UMBEL EXTRACT | PARK PIL JOON | AMOREPACIFIC CORP |
| EP3196201 | POLYCYCLIC PYRIDONE DERIVATIVE HAVING INTEGRASE-INHIBITING ACTIVITY | YOSHINAGA TOMOKAZU | SHIONOGI & CO |
| EP3196213 | ANTIBODIES DIRECTED TO HER-3 AND USES THEREOF | ROTHE MIKE | DAIICHI SANKYO EUROPE GMBH |
| EP3196305 | SCHWANN CELLS AND METHOD FOR PREPARING SAME | SOWA YOSHIHIRO | KYOTO PREFECTURAL PUBLIC UNIV CORP |
| EP3196313 | MICROALGAE EXTRACT CONTAINING OMEGA3-POLYUNSATURATED FATTY ACIDS AND METHOD FOR EXTRACTING OIL FROM MICRO-ORGANISMS | GONZALEZ RAMON NIEVES | GONZALEZ RAMON NIEVES |
| EP3197427 | O/W EMULSIONS | MENDROK-EDINGER CHRISTINE | DSM IP ASSETS BV |
| EP3197445 | PROLINE OR PROLINE DERIVATIVES FOR THE TREATMENT OF DEMENTIA | SALAMA ZOSER B | SALAMA ZOSER B |
| EP3197454 | CONTINUOUS FLOW CARBOXYLATION REACTION | TWEEDIE SCOTT | SARCODE BIOSCIENCE INC |
| EP3197458 | DERMOCOSMETIC OR PHARMACEUTICAL USE OF A COMPOSITION CONTAINING AT LEAST ONE INHIBITOR OF CERTAIN CHEMOATTRACTANT CYTOKINES | BERNARD PHILIPPE | GREENPHARMA S A |
| EP3197466 | A COMBINATION OF KYNURENINE AND ANTIGEN PRESENTING CELLS (APC) AS THERAPEUTICS AND METHODS FOR THEIR USE IN IMMUNE MODULATION | GHAHARY AZIZ | UNIV BRITISH COLUMBIA |
| EP3197470 | CIS-GNETIN H AND TRANS-GNETIN H AS THERAPEUTIC AGENTS | GAO YING | MIDDLE TENNESSEE STATE UNIV |
| EP3197472 | RECOMBINANT PHE-FREE PROTEINS FOR USE IN THE TREATMENT OF PHENYLKETONURIA | LI QINGSHAN | NEXTTOBE AB |
| EP3197473 | PROTEINS INCREASING PANCREATIC BETA CELL NUMBER AND METHODS OF USE | HAMPTON JENNIFER | UNIV OREGON |
| EP3197489 | METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST HUMAN IMMUNODEFICIENCY VIRUS INFECTION | BAROUCH DAN | BETH ISRAEL DEACONESS MEDICAL CT INC |
| EP3197493 | METHODS OF REVERSING CACHEXIA AND PROLONGING SURVIVAL COMPRISING ADMINISTERING A GDF15 MODULATOR AND AN ANTI-CANCER AGENT | GYURIS JENO | AVEO PHARMACEUTICALS INC |
| EP3197496 | ARTICULAR CARTILAGE REPAIR | GUILAK FARSHID | CYTEXX THERAPEUTICS INC |
| EP3197920 | TARGETING OF MELANOCYTES FOR DELIVERING THERAPEUTIC OR DIAGNOSTIC AGENTS USING PROTEIN NANOCAGES | LIM SIERIN | UNIV NANYANG TECH |
| EP3198009 | ONCOLYTIC TUMOR VIRUSES AND METHODS OF USE | O'SHEA CLODAGH | SALK INST FOR BIOLOGICAL STUDI |
| EP3199037 | SLOWLY-DIGESTIBLE LONG-ACTING ENERGY-SUPPLYING AGENT | AIZAWA KENTA | JAPAN MAIZE PROD |
| EP3199152 | ANTI-CANCER AGENT AND METHOD FOR KILLING CANCER CELLS | ISHIKAWA YOSHIHIRO | IHI CORP |
| EP3199155 | CORNEAL THICKNESS ADJUSTMENT AGENT | TAKAHASHI HIROYUKI | KOWA CO |
| EP3199161 | PHARMACEUTICAL PREPARATION | ODA HIROSHI | KOWA CO |
| EP3199170 | SALACIA FOR REDUCING THE NUMBER OF INTESTINAL BACTERIA, FOOD, AND PHARMACEUTICAL PRODUCT THEREOF | ODA YURIKO | FUJIFILM CORP |
| EP3199179 | RECOMBINANT FUSION PROTEIN FORMULATION | WANG YINJUE | INNOVENT BIOLOGICS INC |
| EP3199529 | SALT OF DICARBOXYLIC ACID COMPOUND | YOKOYAMA MIZUKA | DAIICHI SANKYO CO LTD |
| EP3199613 | CLEANSING COMPOSITIONS | JOLLIFF SAM | IMERYS MINERALS LTD |
| EP3199627 | TUMOR ANTIGEN PEPTIDES | TORIGOE TOSHIHIKO | UNIV SAPPORO MEDICAL |
| EP3200748 | COMPOSITIONS AND METHODS FOR THE TREATMENT AND PROPHYLAXIS OF SURGICAL SITE INFECTIONS | EMANUEL NOAM | POLYPID LTD |
| EP3200751 | STABLE LOTION EMULSION COMPOSITION AND WET WIPE | MARSH RANDALL GLENN | PROCTER & GAMBLE |
| EP3200761 | PROMOTING MUSCLE BUILDING AND REPAIR AND TREATING DISORDERS RELATED TO COLLAGEN AND PERTINENT PROTEINS BY USING SHILAJIT | SEN CHANDAN K | NATREON INC |
| EP3200776 | BETA LACTAMASE INHIBITORS | BREM JüRGEN | UNIV OXFORD INNOVATION LTD |
| EP3200782 | NEW COMPOSITION FOR PREVENTING GASTROINTESTINAL DISORDERS | ATTALI AMOS | NUTRICIA NV |
| EP3200807 | ANALYSIS OF T-CELL MONOTYPIA | OGG GRAHAM | UNIV OXFORD INNOVATION LTD |
| EP3200813 | PULMONARY ADMINISTRATION OF PYOCINS FOR TREATING BACTERIAL RESPIRATORY INFECTIONS | WALKER DANIEL | UNIV GLASGOW COURT |
| EP3200815 | METHODS AND COMPOSITIONS FOR TREATING CANCER | PERALES-PUCHALT ALFREDO | WISTAR INST |
| EP3200822 | BINDING MOLECULES, ESPECIALLY ANTIBODIES, BINDING TO L1CAM (CD171) | ALTEVOGT PETER | DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS |
| EP3200826 | PHARMACEUTICAL COMPOSITIONS FOR TREATING EBOLA VIRUS DISEASE | VECHT-LIFSHITZ SUSAN EVE | VECHT-LIFSHITZ SUSAN EVE |
| EP3200880 | LOW VISCOSITY CELLULOSICS IN HAIR CARE COMPOSITIONS | GREYSON ANDREA | ROHM & HAAS |
| EP3201193 | BENZENECARBOTHIOCCYCLOPENTA[C]PYRROLE-1,3-DIONE COMPOUNDS AND PROCESS FOR SYNTHESIS THEREOF | REDDY DUMBALA SRINIVASA | COUNCIL SCIENT IND RES |
| EP3201196 | FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES | DE HARO GARCIA TERESA | UCB BIOPHARMA SPRL |
| EP3201203 | CRYSTALLINE FORM OF 1-(1-METHYL-1H-PYRAZOL-4-YL)-N-((1R,5S,7S)-9-METHYL-3-OXA-9-AZABICYCLO[3.3.1]NONAN-7-YL)-1H-INDOLE-3-CARBOXAMIDE | ZHAO YUXIN | TAKEDA PHARMACEUTICALS CO |
| EP3201207 | BORONIC ACID DERIVATIVES | KLEIN MARKUS | MERCK PATENT GMBH |
| EP3201208 | BORONIC ACID DERIVATIVES | KLEIN MARKUS | MERCK PATENT GMBH |
| EP3201336 | METHODS FOR EXTRACTING AND PURIFYING NON-DENATURED PROTEINS | KALE ANIKET | IMPOSSIBLE FOODS INC |
| EP3201338 | COMPOSITIONS AND METHODS FOR SILENCING HEPATITIS B VIRUS GENE EXPRESSION | CROSS JENNIFER L | PROTIVA BIOTHERAPEUTICS INC |
| EP3202392 | ORAL DOSAGE FORMS COMPRISING LICARBAZEPINE ACETATE | VASCONCELOS TéOFILO CARDOSO DE | BIAL - PORTELA & CA S A |
| EP3202415 | C1ORF32 FUSED TO THE FC FRAGMENT FOR THE TREATMENT OF MULTIPLE SCLEROSIS, RHEUMATOID ARTHRITIS AND OTHER AUTOIMMUNE DISORDERS | HECHT IRIS | COMPUGEN LTD |
| EP3202459 | ACTRIIB ANTAGONISTS AND DOSING AND USES THEREOF FOR REGULATING BODY FAT CONTENT | SEEHRA JASBIR | ACCELERON PHARMA INC |
| EP3202713 | POROUS SILICA-BASED PARTICLES, METHOD FOR PRODUCING SAME, AND CLEANSING COSMETIC MATERIAL INCLUDING POROUS SILICA-BASED PARTICLES | WATANABE SATOSHI | JGC CATALYSTS & CHEMICALS LTD |
| EP3202891 | USES OF BACTEROIDES IN TREATMENT OR PREVENTION OF OBESITY-RELATED DISEASES | NING GUANG | RUIJIN HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG U |
| EP3203976 | ORAL CARE COMPOSITIONS COMPRISING A PEROXIDE SOURCE, A POLYHYDRIC ALCOHOL AND A SURFACTANT | FEI LIN | COLGATE PALMOLIVE CO |
| EP3203988 | REDUCED FOAMING VACCINE COMPOSITIONS | GENIN NOEL YVES HENRI JEAN | MERIAL INC |
| EP3203993 | ANTIOXIDANT EYE DROPS | KADOR PETER F | KADOR PETER F |
| EP3203998 | SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DIABETES | GAGNON LYNE | PROMETIC PHARMA SMT LTD |
| EP3204002 | PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF TUMORS | RAPPOSELLI SIMONA | INT SOC FOR DRUG DEV S R L |
| EP3204015 | COMPOSITIONS AND METHODS FOR INHIBITION OF HAO1 (HYDROXYACID OXIDASE 1 (GLYCOLATE OXIDASE)) GENE EXPRESSION | QUERBES WILLIAM | ALNYLAM PHARMACEUTICALS INC |
| EP3204016 | COMPOSITIONS COMPRISING SULFATED POLYSACCHARIDES AND USES THEREOF | KLEIN RONNIE | ALGAMED THERAPEUTICS (A M T) LTD |
| EP3204018 | NEOADJUVANT USE OF ANTIBODY-DRUG CONJUGATES | GOLDENBERG DAVID M | IMMUNOMEDICS INC |
| EP3204040 | TREATMENT OF CANCER USING TLR9 AGONIST WITH CHECKPOINT INHIBITORS | WANG DAQING | IDERA PHARMACEUTICALS INC |
| EP3204052 | NANO PARTICLE DETECTION WITH X-RAY CAPSULE | KIMCHY YOAV | CHECK-CAP LTD |
| EP3204119 | MULTIPLE-VARIABLE IL-2 DOSE REGIMEN FOR TREATING IMMUNE DISORDERS | KORETH JOHN | DANA FARBER CANCER INST INC |
| EP3204120 | METHODS AND COMPOSITIONS FOR INCREASING THE POTENCY OF ANTIFUNGAL AGENTS | LUDLOW CATHERINE | PACIFIC NORTHWEST RES INST |
| EP3204382 | HETEROARYL COMPOUNDS AS BTK INHIBITORS AND USES THEREOF | GAILLARD PASCALE | MERCK PATENT GMBH |
| EP3204410 | BIPHASIC SINGLE-CHAIN INSULIN ANALOGUES | WEISS MICHAEL | UNIV CASE WESTERN RESERVE |
| EP3205335 | EMULSION COMPOSITION FOR AEROSOL PREPARATION, AND AEROSOL AGENT | TAJIMA KAZUO | UNIV KANAGAWA |
| EP3205353 | RAPID AND PROLONGED IMMUNOLOGIC-THERAPEUTIC | TANG DE-CHU C | ALTIMMUNE INC |
| EP3205650 | EGFR INHIBITOR, AND PREPARATION AND APPLICATION THEREOF | WEI MINGSONG | SHANGHAI HANSOH BIOMEDICAL CO LTD |
| EP3205661 | HSP70-DERIVED PEPTIDE, AND METHOD OF MANUFACTURING PHARMACEUTICAL COMPOSITION, IMMUNITY INDUCER, AND ANTIGEN-PRESENTING CELL FOR CANCER TREATMENT OR PREVENTION USING THE SAME | MIYAKAWA TOMOYA | CYTLIMIC INC |
| EP3205717 | METHOD FOR PROLIFERATING NEURAL PROGENITOR CELLS AND COMPOSITION FOR TREATING NERVE DISORDERS CONTAINING PROLIFERATED NEURAL PROGENITOR CELLS | MOON JI-SOOK | COLLEGE OF MEDICINE POCHON CHA UNIV IND |
| EP3206660 | MALODOR REDUCING COMPOSITIONS | FADEL ADDI | GIVAUDAN SA |
| EP3206669 | FORMULATIONS HAVING ANTI-INFLAMMATORY ACTIVITY AND ANTIMICROBIAL ACTIVITY AGAINST GRAM-POSITIVE BACTERIA | JAMES-MEYER LYNN S | NATUREZA INC |
| EP3206680 | USE OF CANNABIDIOL IN THE TREATMENT OF NOCTURNAL SNORING | GUY GEOFFREY | GW PHARMA LTD |
| EP3206689 | INHIBITORS OF LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE AND USES THEREOF | BOTTINI NUNZIO | LA JOLLA INST OF ALLERGY & IMMUNOLOGY |
| EP3206703 | PEPTIDE-BASED METHODS FOR TREATING PANCREATIC CANCER | RUDLOFF UDO | US HEALTH |
| EP3206749 | USE OF CDK9 AND BRD4 INHIBITORS TO INHIBIT INFLAMMATION | HAUDENSCHILD DOMINIK | UNIV CALIFORNIA |
| EP3207029 | TRYPTAMIDE COMPOSITIONS AND METHODS OF USE | STOCK JEFFRY | SIGNUM BIOSCIENCES INC |
| EP3207926 | OXIDIZED LIPIDS IN THE TREATMENT OF CHRONIC OR NEUROPATHIC PAIN | SISSIGNANO MARCO | FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E V |
| EP3207928 | COMPOSITE PREPARATION, CONTAINING NOVEL 3-(4-(BENZYLOXY)PHENYL)HEX-4-INOIC ACID DERIVATIVE AND ANOTHER ACTIVE INGREDIENT, FOR PREVENTING OR TREATING METABOLIC DISEASES | YANG JIN | HYUNDAI PHARM CO LTD |
| EP3207929 | COLCHICINE DERIVATIVES | YANG LI-XI | CALIFORNIA PACIFIC MEDICAL CENTER |
| EP3207936 | STABLE PEPTIDE COMPOSITION | MURAKAMI TAKASHI | SHIONOGI & CO |
| EP3207945 | SUSTAINED RELEASE FORMULATION OF METFORMIN AND METHOD FOR PREPARING SAME | PARK JUN HONG | CJ HEALTHCARE CORP |
| EP3208269 | INHIBITORS OF C-FMS KINASE | ILLIG CARL R | JANSSEN PHARMACEUTICA NV |
| EP3208279 | MINI-HEPCIDIN PEPTIDES AND METHODS OF USING THEREOF | GANZ TOMAS | UNIV CALIFORNIA |
| EP3209265 | MILLING BLANK FOR PRODUCTION OF MEDICAL MOULDED PARTS | KLARE MARTIN | PRO3DURE MEDICAL GMBH |
| EP3209314 | A PHARMACEUTICAL COMPOSITION AND THE USE THEREOF | CHANTALAT LAURENT | GALDERMA SA |
| EP3209317 | METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 | JAMIL KHURRAM | MALLINCKRODT HOSPITAL PRODUCTS IP LTD |
| EP3209319 | A METHOD OF TREATMENT | VAN DER WEERDEN NICOLE LOUISE | HEXIMA LTD |
| EP3209321 | TREATMENT OF CANCER WITH IMMUNE STIMULATORS | KING ROBERT S | SCICLONE PHARMACEUTICALS INC |
| EP3209328 | INHIBITORS OF LACTATE TRANSPORTERS FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES | MAURO CLAUDIO | UNIV LONDON QUEEN MARY |
| EP3209332 | REDUCING VISCOSITY OF PHARMACEUTICAL FORMULATIONS | SLOEY CHRISTOPHER JAMES | AMGEN INC |
| EP3209337 | STRONTIUM PHOSPHATE MICROPARTICLE FOR RADIOLOGICAL IMAGING AND THERAPY | DAY DELBERT E | MO-SCI CORP |
| EP3209383 | A PERSONAL CARE COMPOSITION AND METHOD OF MAKING | GULBIN TIMOTHY CHARLES | PROCTER & GAMBLE |
| EP3209649 | CRYSTAL MODIFICATIONS OF ELOBIXIBAT | YMéN INGVAR | ELOBIX AB |
| EP3209696 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF GLIOBLASTOMA | SAHIN UGUR | BIONTECH RNA PHARMACEUTICALS GMBH |
| EP3209783 | PERMANENT EPIGENETIC GENE SILENCING | NALDINI LUIGI | OSPEDALE SAN RAFFAELE SRL |
| EP3210602 | COMPOSITION FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES, CONTAINING RAMALIN | YIM JOUNG HAN | KOREA INST OF OCEAN SCIENCE AND TECH |
| EP3210969 | KCNQ2-5 CHANNEL ACTIVATOR | YASHIRO KENTARO | ONO PHARMACEUTICAL CO |
| EP3211005 | THERAPEUTIC USE OF SPECIFIC LIGAND IN MSRV ASSOCIATED DISEASES | BERNARD CORINNE | GENEURO SA |
| EP3211007 | PHARMACEUTICAL COMPOSITION FOR TREATING CROHN'S DISEASE | YASUDA NOBUYUKI | EISAI R&D MAN CO LTD |
| EP3211071 | PRODUCTION METHOD FOR RETINAL TISSUE | KUWAHARA ATSUSHI | SUMITOMO DAINIPPON PHARMA CO LTD |
| EP3211082 | MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY | BHAT BALKRISHEN | REGULUS THERAPEUTICS INC |
| EP3211085 | ADENO-ASSOCIATED VIRUS (AAV) CLADES, SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR | GAO GUANGPING | UNIV PENNSYLVANIA |
| EP3212160 | CREAM TO POWDER COSMETIC COMPOSITIONS | SCOTLAND SHAUNA-KAYE LECAINE DOMINIQUE | L'ORéAL |
| EP3212169 | PROCESS FOR FORMING ACTIVE DOMAINS DISPERSED IN A MATRIX | VODAK DAVID THOMAS | BEND RES INC |
| EP3212175 | METHODS FOR THE PREPARATION OF RIBOSIDES | AXT STEVEN DONALD | GILEAD SCIENCES INC |
| EP3212200 | USE OF A REVERSE-TRANSCRIPTASE INHIBITOR IN THE PREVENTION AND TREATMENT OF DEGENERATIVE DISEASES | PROCHIANTZ ALAIN | CENTRE NAT RECH SCIENT |
| EP3212208 | USE OF L. REUTERI FOR RECOVERY OF MICROBIOTA DYSBIOSIS IN EARLY LIFE | GARCIA-RODENAS CLARA LUCIA | BIOGAIA AB |
| EP3212213 | METHODS AND COMPOSITIONS USING GDF15 POLYPEPTIDES FOR INCREASING RED BLOOD CELLS | KUMAR RAVINDRA | ACCELERON PHARMA INC |
| EP3212218 | GIP AGONIST COMPOUNDS AND METHODS | SHELTON PERNILLE TOFTENG | ZEALAND PHARMA AS |
| EP3212223 | COMPOSITIONS AND METHODS FOR BOOSTING THE EFFICACY OF ADOPTIVE CELLULAR IMMUNOTHERAPY | BERGER SUSANNA CAROLINA | HUTCHINSON FRED CANCER RES |
| EP3212230 | DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES | GARDAI SHYRA | SEATTLE GENETICS INC |
| EP3212231 | ANTI-TIM-3 ANTIBODIES | WANG CHENG-I | AGENCY SCIENCE TECH & RES |
| EP3212292 | POLYMER COMPRISING ALKOXYSILANE GROUPS AND USE IN COSMETICS | GIUSTINIANI PASCAL | OREAL |
| EP3212294 | COMPOSITION BASED ON STYLING POWDER AND/OR SEBUM-ABSORBING POWDER AND AN ALUMINIUM SALT | AUBERT LIONEL | OREAL |
| EP3212634 | COMPOUNDS AND METHODS TO SUPPRESS AUTOIMMUNE RESPONSE | KERKVLIET NANCY I | UNIV OREGON STATE |
| EP3212637 | DOPAMINE D3 RECEPTOR ANTAGONISTS COMPOUNDS | CREMONESI SUSANNA | INDIVIOR UK LTD |
| EP3212644 | DERIVATIVES OF 2-(1,2,4-TRIAZOL-3-YLSULFANYL)-N-1,3,4-THIADIAZOL-2-YL ACETAMIDE WHICH ARE USEFUL FOR THE TREATMENT OF INTER ALIA DIABETES | RüTZLER MICHAEL | APOGLYX AB |
| EP3212652 | RIPK2 INHIBITORS AND METHOD OF TREATING CANCER WITH SAME | LAUFER RADOSLAW | UNIV HEALTH NETWORK |
| EP3212773 | EFFICIENT DELIVERY OF THERAPEUTIC MOLECULES TO CELLS OF THE INNER EAR | CHEN ZHENG-YI | MASSACHUSETTS EYE & EAR INFIRMARY |
| EP3212794 | POLYNUCLEOTIDE AGENTS TARGETING SERPINC1 (AT3) AND METHODS OF USE THEREOF | HINKLE GREGORY | ALNYLAM PHARMACEUTICALS INC |
| EP3213745 | GALENICAL FORMULATION OF NSAIDS | HEYDT-LOTTER SILKE | CHEMISCHE FABRIK KREUSSLER & CO GMBH |
| EP3213748 | CANNABINOIDS (THC:CBD RATIO) IN COMBINATION WITH AN ALKYLATING AGENT FOR USE IN TREATING BRAIN TUMOUR | VELASCO DIEZ GUILLERMO | GW PHARMA LTD |
| EP3213761 | NOVEL TREATMENT OF RETINA AND NERVE USING LAMININ | KOIZUMI NORIKO | KYOTO PREFECTURAL PUBLIC UNIV CORP |
| EP3213764 | MICRONEEDLE DEVICE CONTAINING RECOMBINANT FOLLICLE STIMULATING HORMONE | NISHIMURA SHINPEI | HISAMITSU PHARMACEUTICAL CO |
| EP3213770 | IMMUNE REGULATORY OLIGONUCLEOTIDE (IRO) COMPOUNDS TO MODULATE TOLL-LIKE RECEPTOR BASED IMMUNE RESPONSE | KANDIMALLA EKAMBAR R | IDERA PHARMACEUTICALS INC |
| EP3214086 | SUBSTITUTED DIHYDROPYRROLOPYRAZOLE COMPOUND | AGA YASUHIRO | UBE INDUSTRIES |
| EP3215118 | DRUG-DEVICE UNIT CONTAINING QUINAGOLIDE | HALLIDAY JANET | FERRING BV |
| EP3215119 | OCULAR DELIVERY OF DRUGS | UCHEGBU IJEOMA | NANOMERICS LTD |
| EP3215132 | METHODS OF ADMINISTERING AMANTADINE COMPOSITIONS | WENT GREGORY T | ADAMAS PHARMACEUTICALS INC |
| EP3215136 | ANTIVIRAL AGENTS DIRECTED AGAINST RESPIRATORY SYNCYTIAL VIRUS | SIZUN CHRISTINA | CENTRE NAT DE LA RECH SCIENT (C N R S ) |
| EP3215142 | IMMUNOREGULATORY AGENTS | BECK HILARY PLAKE | FLEXUS BIOSCIENCES INC |
| EP3215143 | COMBINATION COMPRISING SPIRULINA AND PALMITOYLETHANOLAMIDE AND/OR SALTS OR PHARMACEUTICALLY ACCEPTABLE DERIVATIVES THEREOF AND THEIR FORMULATIONS, FOR USE IN THE PREVENTION AND/OR IN THE TREATMENT OF HYPERACTIVATED TISSUE CONDITIONS | MIGLIACCIO RAFFAELE | MIGLIACCIO RAFFAELE |
| EP3215144 | ORNITHINE AMINOTRANSFERASE INHIBITION WITH GABA ANALOGUES FOR TREATMENT OF HEPATOCELLULAR CARCINOMA | SILVERMAN RICHARD B | UNIV NORTHWESTERN |
| EP3215146 | BLT2 AGONISTS FOR THE TREATMENT OF PAIN | SCHOLICH KLAUS | FRAUNHOFER GES FORSCHUNG |
| EP3215159 | APILIMOD FOR USE IN THE TREATMENT OF COLORECTAL CANCER | BEEHARRY NEIL | LAM THERAPEUTICS INC |
| EP3215163 | BETA-GLUCAN METHODS AND COMPOSITIONS THAT AFFECT THE TUMOR MICROENVIRONMENT | BOSE NANDITA | BIOTHERA INC |
| EP3215184 | THERAPEUTIC MULTI-PEPTIDES T SPECIFIC IMMUNE THERAPY FOR TREATMENT OF BRAIN METASTASIS | COSTANTINI DOMINIQUE | OSE IMMUNOTHERAPEUTICS |
| EP3215192 | METHODS AND COMPOSITIONS RELATED TO SYNTHETIC NANOCARRIERS WITH RAPAMYCIN IN A STABLE, SUPER-SATURATED STATE | O'NEIL CONLIN | SELECTA BIOSCIENCES INC |
| EP3215353 | STEREOLITHOGRAPHIC METHOD AND COMPOSITION | HAGIWARA TSUNEO | DWS SRL |
| EP3215499 | IMINOSUGARS USEFUL FOR THE TREATMENT OF VIRAL DISEASES | RAMSTEDT URBAN | EMERGENT VIROLOGY LLC |
| EP3215518 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR MT1-MMP | TEUFEL DANIEL PAUL | BICYCLE THERAPEUTICS LTD |
| EP3215522 | T CELL RECEPTORS DIRECTED AGAINST BOB1 AND USES THEREOF | HEEMSKERK MIRJAM H M | LEIDEN UNIV MEDICAL CENTER |
| EP3215524 | FC-REGION VARIANTS WITH MODIFIED FCRN- AND PROTEIN A-BINDING PROPERTIES | SCHLOTHAUER TILMAN | HOFFMANN LA ROCHE |
| EP3215634 | IDENTIFICATION OF NOVEL DISEASE STATES USING VISCOELASTIC ANALYSIS IN THE PRESENCE OF A THROMBOLYTIC AGENT | CHAPMAN MICHAEL P | UNIV COLORADO REGENTS |
| EP3216447 | USE OF EDARAVONE IN PREPARING DRUG FOR PREVENTING AND TREATING CEREBRAL AMYLOID ANGIOPATHY (CAA) | WANG YANJIANG | THE THIRD AFFILIATED HOSPITAL THIRD MILITARY MEDICAL UNIV PLA |
| EP3216450 | PHARMACEUTICAL PREPARATION COMPRISING CYCLIN INHIBITOR AND PREPARATION METHOD THEREOF | ZENG JIN | JIANGSU HANSOH PHARMACEUTICAL CO LTD |
| EP3216782 | IRON AMINO ACID COMPOUNDS, METHOD FOR PREPARING IRON AMINO ACID COMPOUNDS, COMPOSITIONS CONTAINING IRON AMINO ACID COMPOUNDS, AND USES THEREOF | SERCHELI RICARDO DA SILVA | NPA - NúCLEO DE PESQUISAS APLICADAS LTDA |
| EP3216786 | PYRIMIDINE OR PYRIDINE COMPOUNDS, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USES THEREOF | JIANG YUEHENG | SHANGHAI SHALETECH TECH CO LTD |
| EP3216860 | LYSATES OF MESENCHYMAL STEM CELLS FOR THE TREATMENT OF SKELETAL MUSCLE INJURIES | MUÑOZ CASTAÑEDA JUAN RAFAEL | SERVICIO ANDALUZ DE SALUD |
| EP3218009 | PROCESS FOR THE CONJUGATION OF A PEPTIDE OR PROTEIN WITH A REAGENT COMPRISING A LEAVING GROUP INCLUDING A PORTION OF PEG | GODWIN ANTONY | POLYTHERICS LTD |
| EP3218059 | CAPSAICINOIDS FOR USE IN TREATING ACRAL LICK GRANULOMA | CAMPBELL JAMES N | CENTREXION THERAPEUTICS CORP |
| EP3218358 | DIFLUOROMETHYL-AMINOPYRIDINES AND DIFLUOROMETHYL-AMINOPYRIMIDINES | CMILJANOVIC VLADIMIR | PIQUR THERAPEUTICS AG |
| EP3218374 | SUBSTITUTED PYRROLOPYRIDINES AS INHIBITORS OF BROMODOMAIN | ALBRECHT BRIAN K | GENENTECH INC |
| EP3218380 | CRYSTALLINE FORM OF (S)-N-(5-((R)-2-(2,5-DIFLUOROPHENYL)-PYRROLIDIN-1-YL)-PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE HYDROGEN SULFATE | ARRIGO ALISHA B | ARRAY BIOPHARMA INC |
| EP3218404 | HUMAN ANTI-THYROGLOBULIN T CELL RECEPTORS | HANADA KENICHI | US HEALTH |
| EP3218406 | BINDING MOLECULES SPECIFIC FOR CD73 AND USES THEREOF | MINTER RALPH | MEDIMMUNE LTD |
| EP3218487 | HEPATITIS D VIRUS (HDV) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | HINKLE GREGORY | ALNYLAM PHARMACEUTICALS INC |
| EP3218721 | COMPOUNDS FOR USE AS IMAGING AGENTS | EL-AGNAF OMAR M ALI | UNIV UNITED ARAB EMIRATES |
| EP3219307 | NANOLIPIDIC PARTICLES | FOUNTAIN MICHAEL W | DERMAZONE SOLUTIONS INC |
| EP3219323 | PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF HEPATITIS C | KOHARA MICHINORI | TOKYO METROPOLITAN INST MEDICAL SCIENCE |
| EP3219712 | COUMARIN DYES AND CONJUGATES THEREOF | JANSEN THOMAS PAUL | CYANAGEN SRL |
| EP3219723 | TARGETING TISSUE FACTOR TO ACTIVATED PLATELETS | HILDEN IDA | NOVO NORDISK AS |
| EP3219790 | MYOCARDIAL CELL SHEET | ISEOKA HIROKO | TERUMO CORP |
| EP3220875 | HIGH SALT TOOTHPASTE AND METHODS FOR USING SAME | XU YUN | COLGATE PALMOLIVE CO |
| EP3220886 | COMPOSITION COMPRISING AN ORTHO-DIPHENOL DERIVATIVE, AN ALKALI METAL (BI)CARBONATE, A WATER-SOLUBLE ORGANIC SOLVENT AND A REDUCING AGENT | WAHLER ARNO | L'ORéAL |
| EP3220888 | EPRINOMECTIN PARENTERAL COMPOSITIONS | GUIMBERTEAU FLORENCE | CEVA SANTé ANIMALE SA |
| EP3220892 | LONG-ACTING GROWTH HORMONE DOSAGE FORMS | SPROGØE KENNETT | ASCENDIS PHARMA ENDOCRINOLOGY DIV AS |
| EP3220894 | NANOSUSPENSION FORMULATION | MAO SHIRUI | FMC CORP |
| EP3220913 | NOVEL NANOPARTICLE-BASED VACCINE TARGETING CANCER/TESTIS ANTIGENS (CTA) AND ITS USE IN SOLID AND HEMATOLOGICAL MALIGNANCIES | CHIRIVA-INTERNATI MAURIZIO | KIROMIC LLC |
| EP3220924 | TOPICAL MEDICAMENT FOR SKIN AND MUCOSAL INJURIES ASSOCIATED WITH EPIDERMOLISIS BULLOSA | VASQUEZ RAMON EFRAIN | REV PHARMA CORP |
| EP3220939 | THERAPEUTIC HOMODIMER AND USES THEREOF | ARPI MATOSSIAN-ROGERS | ARPI MATOSSIAN-ROGERS |
| EP3220940 | COMPOSITIONS AND METHODS FOR MODULATING AT2R ACTIVITY | GAVINI MADHAVI P | NOVOPYXIS INC |
| EP3220946 | COMPOSITIONS AND METHODS FOR TREATING GLUTEN INTOLERANCE AND DISORDERS ARISING THEREFROM | SCHRIEMER DAVID | NEPETX LLC |
| EP3220952 | METHOD OF TREATING OR PREVENTING STROKE | ERIKSSON ULF | CSL LTD |
| EP3221006 | DENTAL FLOSS COATING COMPOSITION | FOCASSIO PAULO | COLGATE PALMOLIVE CO |
| EP3221295 | MONOCARBOXYLATE TRANSPORT MODULATORS AND USES THEREOF | SANDANAYAKA VINCENT | NIROGYONE THERAPEUTICS INC |
| EP3221318 | FUSED IMIDAZOLE DERIVATIVES AS TGF-BETA INHIBITORS | SINGH RAJINDER | RIGEL PHARMACEUTICALS INC |
| EP3221321 | FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE | PRATT BENJAMIN ANTHONY | AKARNA THERAPEUTICS LTD |
| EP3221337 | MULTIVALENT LIGAND-LIPID CONSTRUCTS | BOVIN NICOLAI VLADIMIROVICH | BOVIN NICOLAI VLADIMIROVICH |
| EP3221358 | CD47 ANTIBODIES, METHODS, AND USES | DONG JIANYING | JANSSEN PHARMACEUTICA NV |
| EP3221361 | ANTI-TRANSFERRIN RECEPTOR / ANTI-BACE1 MULTISPECIFIC ANTIBODIES AND METHODS OF USE | LIU YICHIN | GENENTECH INC |
| EP3221448 | PROCESS FOR PRODUCING RECOMBINANT TRYPSIN | SLEEVI MARK C | MERCK SHARP & DOHME |
| EP3222272 | PHARMACEUTICAL COMPOSITION | NILSSON ANDERS | FERRING BV |
| EP3222276 | PHARMACEUTICAL COMPOSITION FOR TREATING CANCER AND BIOMARKER FOR DRUG SCREENING | CHA TAI-LUNG | NAT DEFENSE MEDICAL CENTER |
| EP3222279 | ORAL PHARMACEUTICAL FORMULATION OF MONTELUKAST AND LEVOCETIRIZINE AND METHOD FOR ITS PRODUCTION | ZWOLINSKA-OBARSKA ANNA | INVEST BIELANY SPOLKY Z OGRANICZONA ODPOWIEDZIALNOSCIA |
| EP3222280 | INCREASING DRUG BIOAVAILABILITY IN NALTREXONE THERAPY | FLANAGAN SHAWN | OREXIGEN THERAPEUTICS INC |
| EP3223016 | PEPTIDES FOR TARGETING GASTRIC CANCER, AND MEDICAL USE THEREOF | CHOI EUN KYUNG | UNIV ULSAN FOUND FOR IND COOP |
| EP3223773 | ORAL CARE COMPOSITIONS AND METHODS OF USE | JOSIAS WILBENS | COLGATE PALMOLIVE CO |
| EP3223781 | MOUTHRINSE FORMULATIONS COMPRISING FLUORIDE AND A METAL SALT OF PYRROLIDONE CARBOXYLIC ACID | HINRICHS RUTH | GABA INT HOLDING GMBH |
| EP3223783 | COSMETIC COMPOSITION COMPRISING AN ORGANOSILANE, A CATIONIC SURFACTANT AND A CATIONIC POLYMER HAVING CHARGE DENSITY GREATER THAN OR EQUAL TO 4 MEQ/G | JAOUANI KARIMA | L'ORéAL |
| EP3223785 | ORAL COMPOSITION FOR TOOTH WHITENING | MALONEY VENDA | COLGATE PALMOLIVE CO |
| EP3223795 | FORMULATION FOR EFFECTIVE TOCOTRIENOL DELIVERY | FONG CHEE WAI | KL-KEPONG OLEOMAS SDN BHD |
| EP3223796 | PHARMACEUTICAL COMPOSITIONS, PREPARATION AND USES THEREOF | POTTIER AGNèS | NANOBIOTIX |
| EP3223805 | PRODRUGS OF PHENOLIC TRPV1 AGONISTS | HUSFELD CRAIG | CONCENTRIC ANALGESICS INC |
| EP3223807 | METHOD OF PREVENTING OR TREATING A PULMONARY DISEASE OR CONDITION | HARIJITH ANANTHA | UNIV ILLINOIS |
| EP3223815 | COMBINATION OF IBUDILAST AND RILUZOLE AND METHODS OF USING SAME | MATSUDA KAZUKO | MEDICINOVA INC |
| EP3223824 | OXIDIZED LIPIDS AND TREATMENT OR PREVENTION OF FIBROSIS | MENDEL ITZHAK | VASCULAR BIOGENICS LTD |
| EP3223845 | HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS | MOORE GREGORY | XENCOR INC |
| EP3223867 | RADIOEMBOLIC PARTICLES | BOYD DANIEL | ABK BIOMEDICAL INC |
| EP3223906 | METHODS AND COMPOSITIONS FOR POTENTIATING THE ACTION OF OPIOID ANALGESICS USING IBOGA ALKALOIDS | MAILLET EMELINE | DEMERX INC |
| EP3223911 | STABLE WHITENING DENTIFRICE COMPOSITION WITH SUPERIOR AESTHETICS | FEI LIN | COLGATE PALMOLIVE CO |
| EP3223913 | ZINC PHOSPHATE COMPLEX | QIAO BAOHUA | COLGATE PALMOLIVE CO |
| EP3223915 | ORAL CARE COMPOSITION | XU YUN | COLGATE PALMOLIVE CO |
| EP3224238 | NOVEL CYSTOBACTAMIDES | BAUMANN SASCHA | HELMHOLTZ-ZENTRUM FüR INFEKTIONSFORSCHUNG GMBH |
| EP3224248 | CERTAIN PROTEIN KINASE INHIBITORS | ZHAO XINGDONG | SHANGHAI FOCHON PHARMACEUTICAL CO LTD |
| EP3225112 | PHOTOSENSITISER DISPERSION AND USE OF THE SAME | BÄUMLER WOLFGANG | UNIVERSITÄTSKLINIKUM REGENSBURG |
| EP3225238 | COMPOSITION FOR INDUCING FACILITATION OF CELL REJUVENATION COMPRISING GENISTEIN OR EPIGALLOCATECHIN GALLATE | LEE EUN KYUNG | AMOREPACIFIC CORP |
| EP3225627 | TRIPEPTIDE COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | ZHENG XIAOHUI | UNIV NORTHWEST |
| EP3226745 | CAPSULE COATING FOR IMAGE CAPTURE CONTROL | TROLLSAS MIKAEL | CAPSOVISION INC |
| EP3226831 | COMPOSITIONS COMPRISING AN AUTOASSOCIATIVE POLYURETHANE, A FATTY ALCOHOL OR ACID, A NONIONIC SURFACTANT, AND A PIGMENT | BRUN GAËLLE | L'ORéAL |
| EP3226843 | ANTICANCER COMPOSITIONS | VERRECK GEERT | ARAGON PHARMACEUTICALS INC |
| EP3226858 | IMIDAZOLE-BASED ANTIMICROBIAL AGENTS | ÖNDER KAMIL | PROCOMCURE BIOTECH GMBH |
| EP3226873 | COMPOSITIONS COMPRISING 15-HEPE AND METHODS OF TREATING OR PREVENTING FIBROSIS USING SAME | ROWE JONATHAN | AFIMMUNE LTD |
| EP3226877 | SYSTEMS AND METHODS FOR FACILITATING PLACEMENT OF LABWARE COMPONENTS | ALLEN STEPHEN | PERKINELMER HEALTH SCI INC |
| EP3226884 | METHOD OF REMOVING ACETALDEHYDE FROM RADIOACTIVE PHARMACEUTICALS | ENGELL TORGRIM | GE HEALTHCARE LTD |
| EP3226888 | ADMINISTRATION OF A SELECTIVE IL-6-TRANS-SIGNALLING INHIBITOR | COTTINGHAM IAN | FERRING BV |
| EP3226897 | ANTIBODIES TARGETING B-CELL MATURATION ANTIGEN AND METHODS OF USE | BRENTJENS RENIER J | MEMORIAL SLOAN KETTERING CANCER CENTER |
| EP3226905 | HYALURONAN CONJUGATES WITH PHARMACEUTICALLY ACTIVE SUBSTANCES, METHODS AND COMPOSITIONS | LINDQVIST BENGT | SYNARTRO AB |
| EP3226912 | MESSENGER RNA THERAPY FOR TREATMENT OF ARTICULAR DISEASE | DEROSA FRANK | RANA THERAPEUTICS INC |
| EP3226977 | GLASS COMPOSITES FOR TISSUE AUGMENTATION, BIOMEDICAL AND COSMETIC APPLICATIONS | WEINBERGER PAUL M | AUGUSTA UNIV RES INST INC |
| EP3227272 | BIFUNCTIONAL do2pa DERIVATIVES, CHELATES WITH METALLIC CATIONS AND USE THEREOF | OUKHATAR FATIMA | CENTRE NAT DE LA RECH SCIENT (CNRS) |
| EP3227276 | COMBINATIONS FOR THE TREATMENT OF NEUROBLASTOMA | HORNBY ZACHARY DOLPH | IGNYTA INC |
| EP3227297 | 4,6-SUBSTITUTED-PYRAZOLO[1,5-A]PYRAZINES AS JANUS KINASE INHIBITORS | ALLEN SHELLEY | ARRAY BIOPHARMA INC |
| EP3227299 | FORMULATION INHIBITING EFFECTS OF LOW ACID ENVIRONMENT | ZHU LEI | MERCK SHARP & DOHME |
| EP3227441 | CAMKK1 AS A NOVEL REGENERATIVE THERAPEUTIC | PENN MARC S | SUMMA HEALTH |
| EP3228310 | METHYLGLYOXAL BIS(GUANYL-HYDRAZONE) FOR REGULATING OSTEOPONTIN IN A SUBJECT | HADLOCK KENNETH | PATHOLOGICA LLC |
| EP3228323 | ADJUVANT COMPOSITION CONTAINING AT LEAST ONE INFLUENZA VIRUS NEUTRALIZING AND BINDING MOLECULE AND VACCINE COMPOSITION CONTAINING SAME | CHANG SHIN JAE | CELLTRION INC |
| EP3228615 | DIHYDRONAPHTHALENE DERIVATIVE | KUSUMI KENSUKE | ONO PHARMACEUTICAL CO |
| EP3228628 | NOVEL DERMATOPHAGOIDES FARINAE PROTEIN | ASAKA NAOMASA | TAIHO PHARMACEUTICAL CO LTD |
| EP3228706 | COEXPRESSION PLASMID | KOSEKI KOICHI | ANAEROPHARMA SCIENCE INC |
| EP3229779 | HYDROGEL DRUG DELIVERY IMPLANTS | JARRETT PETER | INCEPT LLC |
| EP3229808 | METHODS FOR TREATING FUNGAL INFECTIONS | GENBERG CARL A | UNIV BRIGHAM YOUNG |
| EP3229811 | PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS | CHATURVEDI VIPIN KUMAR | GRI BIO INC |
| EP3229813 | TREATMENT OF HMGB1-MEDIATED INFLAMMATION | TRACEY KEVIN J | THE FEINSTEIN INST MEDICAL RES |
| EP3229823 | CHEMOTHERAPEUTIC COMBINATIONS OF CATIONIC ANTIMICROBIAL PEPTIDES AND CHEMOTHERAPEUTICS | EIKE LIV MARIE | LYTIX BIOPHARMA AS |
| EP3230254 | COMPOSITIONS AND METHODS FOR TREATING DISEASES AND CONDITIONS | CHEN BEIBEI | UNIV OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION |
| EP3230281 | 1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES | DAVENPORT ADAM JAMES | BAYER AG |
| EP3230298 | 3-SUBSTITUTED 5-AMINO-6H-THIAZOLO[4,5-D]PYRIMIDINE-2,7-DIONE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION | CHEN DONGDONG | HOFFMANN LA ROCHE |
| EP3230300 | INHIBITORS FOR INHIBITING TUMOR METASTASIS | KüHNE RONALD | FORSCHUNGSVERBUND BERLIN EV |
| EP3230461 | LENTIVIRAL VECTOR-BASED JAPANESE ENCEPHALITIS IMMUNOGENIC COMPOSITION | CHARNEAU PIERRE | PASTEUR INSTITUT |
| EP3231411 | AQUEOUS DENTAL GLASS IONOMER COMPOSITION | LICHKUS ANDREW MURRAY | DENTSPLY DETREY GMBH |
| EP3231429 | NOVEL AQUEOUS COMPOSITION | SAWAI ISAMU | KOWA CO |
| EP3231432 | AGENT FOR HYPODERMIC INJECTIONS AND PRODUCTION METHOD FOR SYRINGES CONTAINING AGENT FOR HYPODERMIC INJECTIONS | KANAUCHI ATSUSHI | MOTEJO LTD |
| EP3231443 | STEM CELLS CONTAINING STATIN-ENCAPSULATED NANOPARTICLES | II MASAAKI | EDUCATIONAL FOUND OF OSAKA MEDICAL AND PHARMACEUTICAL UNIV |
| EP3231802 | PYRIDINECARBOXAMIDE DERIVATIVES, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USES THEREOF | LI XIN | JIANGSU HENGRUI MEDICINE CO |
| EP3231804 | COMPOUNDS AND COMPOSITIONS FOR THE DETECTION AND TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISORDERS | ELMALEH DAVID R | MASSACHUSETTS GEN HOSPITAL |
| EP3231866 | NUCLEIC ACID COMPLEX, METHOD FOR FORMING NUCLEIC ACID HYBRIDIZATION, PHARMACEUTICAL COMPOSITION, NUCLEIC ACID PROBE, AND COMPLEMENTARY-STRAND NUCLEIC ACID COMPLEX | KOMATSU YASUO | NAT INST ADVANCED IND SCIENCE & TECH |
| EP3233022 | PERFUME COMPOSITIONS | QUELLET CHRISTIAN | GIVAUDAN SA |
| EP3233027 | COMPOSITIONS FOR PROVIDING IMPROVED SUNSCREEN PROTECTION | AU VAN | UNILEVER PLC |
| EP3233038 | DYE COMPOSITION COMPRISING A PARA-PHENYLENEDIAMINE OXIDATION BASE AND A PARTICULAR COUPLER | NICOU VALéRIE | L'ORéAL |
| EP3233054 | FORMULATIONS OF A PI3K/MTOR-INHIBITOR FOR INTRAVENOUS ADMINISTRATION | BACK KEVIN RICHARD | PFIZER |
| EP3233066 | A MODIFIED RELEASE COMPOSITION OF ORLISTAT AND ACARBOSE FOR THE TREATMENT OF OBESITY AND RELATED METABOLIC DISORDERS | ALDERBORN GÖRAN | EMPROS PHARMA AB |
| EP3233068 | A PROCESS FOR PREPARATION OF BIOAVAILABLE WHITE CURCUMIN - A UNIQUE BLEND OF HYDROGENATED CURCUMINOIDS | GOPI SREERAJ | AUREA BIOLABS PRIVATE LTD |
| EP3233079 | (S)-N-(3-(6-ISOPROPOXYPYRIDIN-3-YL)-1H-INDAZOL-5-YL)-1-(2-(4-(4-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)-3,6-DIHYDROPYRIDIN-1(2H)-YL)-2-OXOETHYL)-3-(METHYLTHIO)PYRROLIDINE-3-CARBOXAMIDE COMPOSITIONS FOR PHARMACEUTICAL PREPARATIONS | BAHL DEEPAK | MERCK SHARP & DOHME |
| EP3233081 | TRANSDERMAL DRUG DELIVERY DEVICE INCLUDING FENTANYL | PRESZLER PRINCE AMY | 3M INNOVATIVE PROPERTIES CO |
| EP3233084 | GSK3B AND USES THEREOF IN THE DIAGNOSTIC AND TREATMENT OF HYPOPIGMENTATION DISORDERS | PASSERON THIERRY | INST NAT DE LA SANTé ET DE LA RECH MéDICALE (INSERM) |
| EP3233100 | SINGLE HERB EXTRACT FOR THE TREATMENT OF PCOS (POLY CYSTIC OVARIAN SYNDROME) | SHARMA ASHOK | GOEL PAWAN KUMAR |
| EP3233107 | NBP158 AND USES THEREOF | ZHANG WENTAO | ZHANG WENTAO |
| EP3233115 | METHODS AND COMPOSITIONS RELATED TO TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY | JODELE SONATA | CHILDREN'S HOSPITAL MEDICAL CENTER |
| EP3233130 | NUCLEIC ACID CONSTRUCTS AND GENE THERAPY VECTORS FOR USE IN THE TREATMENT OF WILSON DISEASE | MURILLO SAUCA OIHANA | FUND PARA LA INVESTIG MEDICA APLICADA |
| EP3233190 | ANTIBACTERIAL COMPOSITION COMPRISING AN ACETAL OR A LONG-CHAIN ALKYL HEXITANE ETHER | GOZLAN CHARLOTTE | TEREOS STARCH & SWEETENERS BELGIUM |
| EP3233192 | COMPOSITIONS AND METHODS FOR TARGETED CYTOKINE DELIVERY | KRUPNICK ALEXANDER SASHA | UNIV WASHINGTON |
| EP3233200 | COMPOSITIONS PROVIDING DELAYED RELEASE OF ACTIVES | BAXTER ELAINE ALICE MARIE | PROCTER & GAMBLE |
| EP3233203 | DYEING PROCESS STARTING FROM ORTHO-DIPHENOL | WAHLER ARNO | OREAL |
| EP3233206 | ZINC PHOSPHATE COMPLEX FOR ORAL CARE | QIAO BAOHUA | COLGATE PALMOLIVE CO |
| EP3233207 | PERSONAL CARE COMPOSITIONS WITH ZINC PHOSPHATE ACTIVE | PAN LONG | COLGATE PALMOLIVE CO |
| EP3233257 | TWO-COMPONENT PRODUCTS IN BAGS FOR THE OXIDATIVE DYEING OF KERATIN FIBRES | MüLLER BURKHARD | HENKEL AG & CO KGAA |
| EP3233265 | COATED MICROCAPSULES | HITCHCOCK JAMES PAUL | PROCTER & GAMBLE |
| EP3233267 | COATED MICROCAPSULES | TASKER ALISON LOUISE | PROCTER & GAMBLE |
| EP3233492 | METHODS OF HANDLING ADHESIVE LAMINATE PATCHES | KNUTSON GORDON P | 3M INNOVATIVE PROPERTIES CO |
| EP3233806 | NOVEL COMPOUNDS, SYNTHESIS METHOD THEREOF AND USE OF SAME IN MEDICINE AND IN COSMETICS | PORTAL THIBAUD | GALDERMA RES & DEV |
| EP3233866 | PYRAZOLOPYRIDINAMINES AS MKNK1 AND MKNK2 INHIBITORS | GIESE ANJA | BAYER PHARMA AG |
| EP3234116 | METHODS OF TREATING TISSUE CALCIFICATION | QUINN ANTHONY | ALEXION PHARMA INC |
| EP3235503 | COMPOSITION CONTAINING MIXED EXTRACT OF MULBERRY AND PORIA COCOS BARK FOR PREVENTING, IMPROVING OR TREATING NEURODEGENERATIVE DISORDERS | CHOI SANG ZIN | DONG-A ST CO LTD |
| EP3235906 | SINGLE-STRANDED NUCLEIC ACID MOLECULE FOR INHIBITING TGF- BETA 1 EXPRESSION | MATSUMOTO TAKAHIRO | BONAC CORP |
| EP3236945 | THERAPEUTIC COMPOSITIONS AND METHODS FOR MALIGNANT TUMORS WITH RNAI MOLECULES TARGETED TO HSP47 AND P21 | YING WENBIN | NITTO DENKO CORP |
| EP3236972 | N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTI-VIRAL USES RELATED THERETO | PAINTER GEORGE R | UNIV EMORY |
| EP3236976 | RNA INTERFERENCE AGENTS FOR P21 GENE MODULATION | YING WENBIN | NITTO DENKO CORP |
| EP3237003 | NANOPARTICLE COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY | MCCREEDY BRUCE | NEXIMMUNE INC |
| EP3237011 | COMPOSITION COMPRISING VANCOMYCIN AND ORLISTAT | FONTAINE VéRONIQUE | UNIVERSITé LIBRE DE BRUXELLES |
| EP3237071 | SKIN CARE FORMULATIONS CONTAINING COPOLYMERS WITH PHOSPHATE GROUPS AND INORGANIC METAL OXIDE PARTICLES | COOPER BETH | ROHM & HAAS |
| EP3237385 | MUTANT IDH1 INHIBITORS USEFUL FOR TREATING CANCER | BOXER MATTHEW BRIAN | US HEALTH |
| EP3237419 | FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE | MOHAN RAJU | AKARNA THERAPEUTICS LTD |
| EP3237450 | ANTI-MERTK AGONISTIC ANTIBODIES AND USES THEREOF | TAVAZOIE SOHAIL | UNIV ROCKEFELLER |
| EP3237622 | METHODS FOR WOUND HEALING | VÅGESJÖ EVELINA | ILYA PHARMA AB |
| EP3238654 | MASTICATORY ORTHODONTIC CORRECTION DEVICE AND METHOD FOR MAKING THE SAME | HUNG CHENG-HSIANG | |
| EP3238692 | HYDROGEL COMPOSITION | KAKINUKI KENICHI | KAO CORP |
| EP3238695 | ZINC PHOSPHATE CONTAINING COMPOSITIONS | REGE AARTI | COLGATE PALMOLIVE CO |
| EP3238697 | CLEANING AGENT COMPOSITION CONTAINING ACYL BASIC AMINO ACID DERIVATIVE | KOBAYASHI SHUN | AJINOMOTO KK |
| EP3238707 | COMPOSITIONS AND METHODS FOR TREATING INTESTINAL HYPERPERMEABILITY | HOFFMAN STEVE | HOFFMAN STEVE |
| EP3238731 | YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS | PALENA CLAUDIA | GLOBEIMMUNE INC |
| EP3239149 | CRYSTAL FORM I OF CANAGLIFLOZIN AND PREPARATION METHOD THEREOF | WANG FEI | CHONGQING PHARMACEUTICAL IND RES INST CO LTD |
| EP3239167 | CONOTOXIN PEPTIDE KAPPA-CPTX-BTL01, PREPARATION METHOD THEREFOR, AND USES THEREOF | LIU JIE | BGI SHENZHEN |
| EP3239168 | CONOTOXIN PEPTIDE -CPTX-BTL02, PREPARATION METHOD THEREFOR, AND USES THEREOF | LIU JIE | BGI SHENZHEN |
| EP3239177 | NOVEL EGFRVIII ANTIBODY AND COMPOSITION COMPRISING SAME | YOON JAE BONG | PHARMABCINE INC |
| EP3239297 | NATURALLY OCCURING miRNA FOR CONTROLLING GENE EXPRESSION, AND USE OF SAME | AOKI ERIKO | BONAC CORP |
| EP3240525 | AQUEOUS OXIDIZING COMPOSITION | PRATT DOMINIC | KAO GERMANY GMBH |
| EP3240538 | USE OF MASITINIB FOR TREATMENT OF AN AMYOTROPHIC LATERAL SCLEROSIS PATIENT SUBPOPULATION | MOUSSY ALAIN | AB SCIENCE |
| EP3240555 | MULTI-SUPPLEMENT COMPOSITIONS | RABOVSKY ALEXANDER B | MELALEUCA INC |
| EP3240556 | BACTERIAL COMPOSITIONS | NAYAK SUBHENDU | MELALEUCA INC |
| EP3240772 | COMPOUNDS FROM ANTRODIA CAMPHORATA, METHOD FOR PREPARING THE SAME AND USE THEREOF | LIU CHIUNG-LIN | |
| EP3240785 | SMALL MOLECULE INHIBITORS OF LACTATE DEHYDROGENASE AND METHODS OF USE THEREOF | MALONEY DAVID J | US HEALTH |
| EP3240802 | GLUCAGON DERIVATIVES | JUNG SUNG YOUB | HANMI PHARM IND CO LTD |
| EP3240803 | METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS | BEDOYA FELIPE | NOVARTIS AG |
| EP3240890 | ASSESSING RETINAL PIGMENT EPITHELIAL CELL POPULATIONS | BOHANA-KASHTAN OSNAT | CELL CURE NEUROSCIENCES LTD |
| EP3240893 | METHODS TO IMPROVE CELL THERAPY | SACKSTEIN ROBERT | THE BRIGHAM AND WOMEN'S HOSPITAL INC |
| EP3241545 | SILICON DIOXIDE NANOPARTICLES AND THEIR USE FOR VACCINATION | WEIGANDT MARKUS | MERCK PATENT GMBH |
| EP3241546 | POLYMER NANOPARTICLE FREEZE-DRIED PRODUCT, AND PREPARATION METHOD THEREFOR | LEE SA WON | SAMYANG BIOPHARMACEUTICALS |
| EP3241556 | ACTIVATION AND AGGREGATION OF HUMAN PLATELETS AND FORMATION OF PLATELET GELS BY NANOSECOND PULSED ELECTRIC FIELDS | HARGAVE BARBARA Y | EASTERN VIRGINIA MEDICAL SCHOOL |
| EP3241558 | HIGHLY SOLUBLE LEPTINS | ERICKSON MARY | AEGERION PHARMACEUTICALS INC |
| EP3241822 | URAT1 INHIBITOR | ENDO TSUYOSHI | NIPPON CHEMIPHAR CO |
| EP3241824 | TRIFLUOROACETHYDRAZIDE COMPOUND AS WELL AS PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN PREPARING MEDICAMENT | WANG YUQIANG | GUANGZHOU MAGPIE PHARMACEUTICALS CO LTD |
| EP3241844 | ANTIBODY AGAINST NEUROPILIN 1 AND USE THEREOF | NAM DO-HYUN | SAMSUNG LIFE PUBLIC WELFARE FOUNDATION |
| EP3242552 | GAS DELIVERY DEVICE COMPRISING A GAS RELEASING MOLECULE AND A GAS PERMEABLE MEMBRANE | MEINEL LORENZ | JULIUS-MAXIMILIANS-UNIVERSITAET WUERZBURG |
| EP3242651 | COMPOSITION, IN PARTICULAR A COSMETIC MAKEUP AND/OR CARE COMPOSITION, COMPRISING A LIPOPHILIC CLAY, FROM 1% TO 10% BY WEIGHT OF MICA AND AT LEAST ONE NON-CYCLIC SILICONE OIL | RICARD AUDREY | L'ORéAL |
| EP3242658 | ALLOSTERIC ACTIVATORS FOR TREATMENT OF PHENYLKETONURIA | BRITZ-MCKIBBIN PHILIP | UNIV MCMASTER |
| EP3242674 | COMPOSITIONS CONTAINING CURCUMIN HAVING IMPROVED BIOAVAILABILITY | FRESU ANTONELLO | SOLUVEG SA |
| EP3242680 | NOVEL THERAPY | SVANBORG CATHARINA | LINNANE PHARMA AB |
| EP3242723 | RESTORING PHYSIOLOGY IN IRON-DEFICIENT ORGANISMS USING SMALL MOLECULES | BURKE MARTIN D | UNIV ILLINOIS |
| EP3242869 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATION AND PAIN | KANDULA MAHESHA | CELLIX BIO PRIVATE LTD |
| EP3242884 | CATIONIC NEUROTOXINS | ANDERSON DINA BRADY | IPSEN BIOINNOVATION LTD |
| EP3242892 | ALTERED APRIL BINDING ANTIBODIES | VAN EENENNAAM HANS | ADURO BIOTECH HOLDINGS EUROPE B V |
| EP3242903 | COMPOSITIONS FOR INTRODUCING NUCLEIC ACID INTO CELLS | DOHMEN CHRISTIAN | ETHRIS GMBH |
| EP3242934 | FACTORS AND CELLS THAT PROVIDE FOR INDUCTION OF BONE, BONE MARROW, AND CARTILAGE | CHAN CHARLES K F | UNIV LELAND STANFORD JUNIOR |
| EP3242945 | SINGLE-VECTOR GENE CONSTRUCT COMPRISING INSULIN AND GLUCOKINASE GENES | BOSCH TUBERT FàTIMA | UNIV AUT脪NOMA DE BARCELONA |
| EP3243501 | COSMETICS WITH EXCELLENT ULTRAVIOLET SCREENING EFFECT AND MANUFACTURING METHOD THEREOF | KIM KI-JUNG | CQV CO LTD |
| EP3243512 | SILYBIN INJECTION AND PREPARATION METHOD THEREFOR | CHEN JIANMING | TASLY PHARMACEUTICAL GROUP CO |
| EP3244870 | EXPANDED POLYMER POWDERS | CARTIER LAURENT B | ARKEMA INC |
| EP3244872 | ORAL CARE COMPOSITIONS AND METHODS OF USE | THOMSON PAUL | COLGATE PALMOLIVE CO |
| EP3244886 | INDOLE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS | KESTELEYN BART RUDOLF ROMANIE | JANSSEN PHARMACEUTICALS INC |
| EP3244899 | PROSTAGLANDIN TRANSPORTER INHIBITORS FOR INHIBITING OVULATION | HOURVITZ ARIEL | TEL HASHOMER MEDICAL RES INFRASTRUCTURE & SERVICES LTD |
| EP3244912 | TREATMENT OF PEDIATRIC TYPE 2 DIABETES MELLITUS PATIENTS WITH LIXISENATIDE | BERGMANN KARIN | SANOFI AVENTIS DEUTSCHLAND |
| EP3244924 | METHODS OF INCREASING DELIVERY OF ANTI-CANCER AGENTS TO TARGETS | MADIYALAKAN RAGUPATHY | ONCOQUEST INC |
| EP3244950 | RESPIRATORY INTERFACE | GULKA NOEL | TRUDELL MEDICAL INT |
| EP3245193 | HETEROCYCLIC COMPOUNDS FOR CANCER IMAGING AND TREATMENT AND METHODS FOR THEIR USE | SADAR MARIANNE DOROTHY | BRITISH COLUMBIA CANCER AGENCY BRANCH |
| EP3245200 | 2-(PYRAZIN-2-YLCARBONYLAMINOMETHYL)BENZIMIDAZOLIUM COMPOUNDS AS EPITHELIAL SODIUM CHANNEL INHIBITORS | HECKEL ARMIN | BOEHRINGER INGELHEIM INT |
| EP3245225 | COMPOSITIONS AND METHODS FOR TREATMENT AND DETECTION OF CANCERS | WONG CHI HUEY | |
| EP3245289 | DIFFERENTIATION OF MACROPHAGES FROM PLURIPOTENT STEM CELLS | LIM HWEI-IN SHAWN | AGENCY SCIENCE TECH & RES |
| EP3246003 | MULTI-PART DENTAL BLEACHING SYSTEMS AND METHOD FOR BLEACHING TEETH USING SUCH SYSTEMS | ALLRED PETER M | ULTRADENT PRODUCTS INC |
| EP3246017 | STABLE LIQUID FORMULATION OF AMG 416 HCL (ETELCALCETIDE) | MACLEAN DEREK | AMGEN INC |
| EP3246018 | PHARMACEUTICAL COMPOSITION | NILSSON ANDERS | FERRING BV |
| EP3246019 | RABIES GLYCOPROTEIN VIRUS-LIKE PARTICLES (VLPS) | SMITH GALE | NOVAVAX INC |
| EP3246032 | PHARMACEUTICAL COMPOSITIONS COMPRISING ZOLEDRONIC ACID, CALCIUM AND VITAMIN D, SUITABLE FOR THE TREATMENT AND/OR PROPHYLAXIS OF DISEASES RELATED TO BONE METABOLISM AND OF TREATMENT-RELATED SIDE EFFECTS SUCH AS HYPOCALCAEMIA | KARL CHRISTOPH | KARL CHRISTOPH |
| EP3246036 | MEDICINE FOR IMPROVING STATE OF PREGNANCY, AND USE THEREOF | YAMAGUCHI KOUSHI | YAMAGUCHI KOUSHI |
| EP3246038 | COMPOSITIONS COMPRISING DECELLULARIZED EXTRACELLULAR MATRIX OBTAINED FROM CARDIAC TISSUE | CHRISTMAN KAREN | UNIV CALIFORNIA |
| EP3246322 | FUROXAN COMPOUND, AND MANUFACTURING METHOD FOR SAME | MATSUBARA RYOSUKE | NAT UNIV CORP KOBE UNIV |
| EP3246324 | PHENYL C-GLUCOSIDE DERIVATIVE CONTAINING DEOXYGLUCOSE STRUCTURE, PREPARATION METHOD AND USES THEREOF | ZHAO GUILONG | TIANJIN INST OF PHARMACEUTICAL RES |
| EP3246357 | COMPOSITE COMPOSITION | HEIKKILA KURT | TUNDRA COMPOSITES LLC |
| EP3247323 | CHLOROPHYLL COMPOSITION | SAVANGIKAR CHITRA VASANT | SAVANGIKAR CHITRA VASANT |
| EP3247329 | INJECTABLE PHARMACEUTICAL COMPOSITION COMPRISING DEXAMETHASONE SODIUM PHOSPHATE | SHAH MAHENDRA G | SEMNUR PHARMACEUTICALS INC |
| EP3247333 | VERSATILE TOPICAL DRUG DELIVERY VEHICLE AND MULTIFACTORIAL TISSUE MOISTURIZER THAT PROVIDES MUCOSAL AND SKIN BARRIER RESTORATION | SKÖLD THOMAS | TETRADERM GROUP LLC |
| EP3247350 | LIQUID FORMULATION OF CABAZITAXEL | PATEL HIREN PRAVINBHAI | EMCURE PHARMACEUTICALS LTD |
| EP3247360 | HETEROCYCLIC INHIBITORS OF MONOCARBOXYLATE TRANSPORTERS | BANNISTER THOMAS D | SCRIPPS RESEARCH INST |
| EP3247370 | CONIFEROUS RESIN FOR TREATING AND PREVENTING STERILE INFLAMMATION | SIPPONEN PENTTI | REPOLAR PHARMACEUTICALS OY |
| EP3247375 | ANTI-SENESCENCE COMPOUNDS AND USES THEREOF | DE KEIZER PETERUS LEONARDUS JOSEPHUS | UNIV ERASMUS MED CT ROTTERDAM |
| EP3247376 | METHOD FOR TREATING CANCER | KLOTZ LAURENCE H | SUNNYBROOK RES INST |
| EP3247394 | PHARMACEUTICAL FORMULATION COMPRISING ANTI-EGFR ANTIBODY | CHOI YONG WOON | GREEN CROSS CORP |
| EP3247397 | METAL-GLYCOPROTEIN COMPLEXES AND THEIR USE AS CHEMOTHERAPEUTIC COMPOUNDS | MANDEL ARKADY | THERALASE TECH INC |
| EP3247410 | METHODS AND COMPOSITIONS FOR INCREASING SUSCEPTIBILITY TO RADIATION TREATMENT BY INHIBITING SUPPRESSION OF NUMERICAL CHROMOSOMAL INSTABILITY OF CANCER CELLS | BAKHOUM SAMUEL F | MEMORIAL SLOAN-KETTERING CANCER CENTER |
| EP3247701 | ANTHELMINTIC COMPOUNDS, COMPOSITIONS AND METHOD OF USING THEREOF | LONG ALAN | MERIAL INC |
| EP3248567 | FIXED HYBRID DENTAL ATTACHMENT DEVICE | MULLALY SCOTT | ZEST IP HOLDINGS LLC |
| EP3248611 | NOVEL LONG-ACTING GLUCAGON CONJUGATE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME FOR THE PREVENTION AND TREATMENT OF OBESITY | WOO YOUNG EUN | HANMI SCIENCE CO LTD |
| EP3248613 | BETA-GLUCURONIDE DRUG LINKER CONJUGATES | JEFFREY SCOTT | SEATTLE GENETICS INC |
| EP3248946 | EXTRACORPOREAL DEVICES AND METHODS OF TREATING COMPLICATIONS OF PREGNANCY | KARUMANCHI ANANTH S | BETH ISRAEL DEACONESS MEDICAL CT INC |
| EP3248979 | NOVEL INHIBITOR OF FLT3 KINASE AND USE THEREOF | LIU JING | HEFEI INST OF PHYSICAL SICENCE CHINESE ACAD OF SCIENCES |
| EP3250193 | USE OF A MIXTURE OF MODIFIED GLUCOSE POLYMERS FOR REDUCING TUMOR METASTASIS | SUNDERMANN BERND | FRESENIUS KABI DEUTSCHLAND GMBH |
| EP3250202 | COMPOSITION FOR USE IN INCREASING ENGRAFTMENT EFFICACY OF HAEMATOPOETIC STEM CELLS AFTER TRANSPLANTATION | FREISSMUTH MICHAEL | SCIPHARM SàRL |
| EP3250211 | NOVEL PROCESS FOR PREPARATION OF GLUCOCORTICOID STEROIDS | TRIPATHI VINAYAK | CORAL DRUGS PVT LTD |
| EP3250214 | HIGH SURFACE-AREA LYOPHILIZED COMPOSITIONS COMPRISING ARSENIC FOR ORAL ADMINISTRATION IN PATIENTS | VADDI KRISHNA | ORSENIX HOLDINGS BV |
| EP3250218 | METHODS FOR TREATING OBESITY | XIE ZIJIAN | MARSHALL UNIV RES CORP |
| EP3250230 | MODULATORS OF COMPLEMENT ACTIVITY | HOARTY MICHELLE DENISE | RA PHARMACEUTICALS INC |
| EP3250237 | HEMIASTERLIN DERIVATIVES FOR CONJUGATION AND THERAPY | KLINE TONI | SUTRO BIOPHARMA INC |
| EP3250293 | PROCESS FOR TREATING THE HAIR WITH AT LEAST ONE SILICONE FUNCTIONALIZED WITH AT LEAST ONE ALKOXYSILANE UNIT, AND STEAM | CHAMPEAUX MéLISSA | OREAL |
| EP3250549 | CYCLOPROPYLMETHANAMINES AS SELECTIVE 5-HT(2C) RECEPTOR AGONISTS | KOZIKOWSKI ALAN | UNIV ILLINOIS |
| EP3250555 | PROCESS FOR THE PRODUCTION OF CONDENSED IMIDAZOLO DERIVATIVES | BERTOGG ANDREAS | NOVARTIS AG |
| EP3250564 | DESIGN SYNTHESIS AND METHODS OF USE OF ACYCLIC FLEXIMER NUCLEOSIDE ANALOGUES HAVING ANTI-CORONAVIRUS ACTIVITY | RADTKE KATHERINE L | UNIV MARYLAND |
| EP3250581 | ALPHA-D-GALACTOSIDE INHIBITORS OF GALECTINS | BRIMERT THOMAS | GALECTO BIOTECH AB |
| EP3250584 | MULTI-EPITOPIC CONSTRUCT | LU XINJIE | THROMBOSIS RES INST |
| EP3250586 | NOVEL PROTEINS SPECIFIC FOR ANGIOGENESIS | BEL AIBA RACHIDA SIHAM | PIERIS PHARMACEUTICALS GMBH |
| EP3250590 | COMPOSITIONS AND METHODS RELATING TO UNIVERSAL GLYCOFORMS FOR ENHANCED ANTIBODY EFFICACY | WONG CHI HUEY | |
| EP3250594 | ANTI-TRANSTHYRETIN ANTIBODIES | NIJJAR TARLOCHAN S | PROTHENA BIOSCIENCES LTD |
| EP3250599 | BIOMARKER | WEST NATHANIEL RICHARD | UNIV OXFORD INNOVATION LTD |
| EP3250604 | mAb-DRIVEN CHIMERIC ANTIGEN RECEPTOR SYSTEMS FOR SORTING/DEPLETING ENGINEERED IMMUNE CELLS | SASU BARBRA JOHNSON | CELLECTIS |
| EP3251658 | LIPOSOME COMPOSITION USING SUGAR ALCOHOL WITH ADJUSTED SURFACE AREA AND/OR POROSITY AS CARRIER AND METHOD FOR PREPARING SAME | SONG KEON-HYOUNG | UNIV SOONCHUNHYANG IND ACAD COOP FOUND |
| EP3251675 | PREVENTION OR TREATMENT OF URIC ACID OR GOUT DISEASE | ZHANG QIAN | SHANTON PHARMA CO LTD |
| EP3251678 | BENZOXABOROLE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS | HERNANDEZ VINCENT S | ANACOR PHARMACEUTICALS INC |
| EP3251740 | METHOD OF PRODUCING NANOPARTICLE-IN-OIL DISPERSION | SHIMIZU MASATAKA | MIYAZAKI PREFECTURE |
| EP3252039 | COMPOUND CONTAINING INDOLEACETIC ACID CORE STRUCTURE AND USE THEREOF | BEIJING AN JIAN XI BIO-MEDICAL TECHNOLOGY CO LTD | BEIJING AN JIAN XI BIO-MEDICAL TECHNOLOGY CO LTD |
| EP3252053 | POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF HIV INFECTIONS | JI MINGZHE | GILEAD SCIENCES INC |
| EP3252058 | POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF HIV INFECTIONS | JI MINGZHE | GILEAD SCIENCES INC |
| EP3252161 | GENE THERAPY FOR LYSOSOMAL STORAGE DISEASES | DODGE JAMES | GENZYME CORP |
| EP3252171 | METHODS OF TREATING CANCER | BELLOVIN DAVID | FIVE PRIME THERAPEUTICS INC |
| EP3253371 | NANOEMULSIONS | RANNARD STEVE | UNIV LIVERPOOL |
| EP3253377 | MONOMETHYLFUMARATE PRODRUG COMPOSITIONS | MANSER DAVID S | ALKERMES PHARMA IRELAND LTD |
| EP3253382 | PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY | PRUZANSKI MARK | INTERCEPT PHARMACEUTICALS INC |
| EP3253384 | MEBENDAZOLE POLYMORPH FOR TREATMENT AND PREVENTION OF TUMORS | BAI REN-YUAN | UNIV JOHNS HOPKINS |
| EP3253391 | AQUEOUS SOLUTION FORMULATIONS OF VANCOMYCIN | CHEN ANDREW XIAN | LATITUDE PHARMACEUTICALS INCORPORATED |
| EP3253399 | COMPOSITIONS AND METHODS FOR IMPROVED MUSCLE METABOLISM | BILY ANTOINE CHARLES | NATUREX SA |
| EP3253403 | METHODS AND COMPOSITIONS FOR IMPROVED COGNITION | DUBAL DENA | UNIV CALIFORNIA |
| EP3253456 | METHODS FOR THE PRODUCTION OF BIOPOLYMERS WITH SPECIFIC MOLECULAR WEIGHT DISTRIBUTION | KUNZ MICHAEL | MEDSKIN SOLUTIONS DR SUWELACK AG |
| EP3253457 | COSMETIC USE OF A PEPPERMINT EXTRACT | DUMAS MARC | LVMH RECH |
| EP3253745 | COMPOUNDS CONTAINING CARBON-CARBON LINKER AS GPR120 AGONISTS | SHARMA RAJIV | PIRAMAL ENTPR LTD |
| EP3253749 | COMPOUNDS WITH ANTI-TUMORAL ACTIVITY | MOUSSY ALAIN | AB SCIENCE |
| EP3253754 | 2-PHENYL-3H-IMIDAZO[4,5-B]PYRIDINE DERIVATES USEFUL AS INHIBITORS OF MAMMALIAN TYROSINE KINASE ROR1 ACTIVITY | MELLSTEDT HÅKAN | KANCERA AB |
| EP3253756 | FLUORINATED IMIDAZO[4,5-C]QUINOLINE DERIVATIVES AS INHIBITORS OF BROMODOMAIN CONTAINING PROTEINS | SLASSI ABDELMALIK | TRILLIUM THERAPEUTICS INC |
| EP3253762 | 9H-PYRROLO-DIPYRIDINE DERIVATIVES | MERCIER JOËL | UCB BIOPHARMA SPRL |
| EP3253764 | MACROCYCLIC COMPOUNDS AS IRAK1/4 INHIBITORS AND USES THEREOF | CHEN XIAOLING | MERCK PATENT GMBH |
| EP3253777 | RVG DERIVED PEPTIDES | EL-AGNAF OMAR M ALI | UNIV UNITED ARAB EMIRATES |
| EP3253781 | MODIFIED DKK2 PROTEIN, NUCLEIC ACID ENCODING THE SAME, PREPARATION METHOD THEREOF, AND USE THEREOF | HA IL HO | MEDPACTO INC |
| EP3253783 | SIGNALLING SYSTEM | PULé MARTIN | UCL BUSINESS PLC |
| EP3254677 | ADHESIVE PATCH | NAKASHIMA KENTARO | HISAMITSU PHARMACEUTICAL CO |
| EP3254680 | PHARMACEUTICAL COMPOSITION FOR INHIBITING GROWTH OF CANCER STEM CELLS, CONTAINING ALDEHYDE INHIBITOR AND BIGUANIDE-BASED COMPOUND | KANG SEOK GU | INDUSTRY-ACADEMIC COOPERATION FOUNDATION YONSEI UNIV |
| EP3254693 | LACTIC-ACID-BACTERIA-CONTAINING COMPOSITION, ORAL PHARMACEUTICAL COMPOSITION FOR TREATING HPV INFECTION AND/OR HPV-ASSOCIATED TUMORS, AND MUCOSAL IMMUNITY-INDUCING AGENT | KAWANA KEI | UNIV TOKYO |
| EP3255031 | COMPOUND, AND SEPARATION METHOD, SYNTHESIS METHOD AND USE THEREOF | DUAN ZHENWEN | BEIJING PEKING UNIV WBL BIOTECH CO LTD |
| EP3255043 | N-(6-((2R,3S)-3,4-DIHYDROXYBUTAN-2-YLOXY)-2-(4-FLUOROBENZYLTHIO)PYRIMIDIN-4-YL)-3- METHYLAZETIDINE-1-SULFONAMIDE AS CHEMOKINE RECEPTOR MODULATOR | CONNOLLY STEPHEN | ASTRAZENECA AB |
| EP3255047 | PYRIMIDO-DIAZEPINONE KINASE SCAFFOLD COMPOUNDS AND METHODS OF TREATING DISORDERS | GRAY NATHANAEL S | DANA FARBER CANCER INST INC |
| EP3255061 | SELECTIVE IMMUNODEPLETION OF ENDOGENOUS STEM CELL NICHE FOR ENGRAFTMENT | WEISSMAN IRVING L | UNIV LELAND STANFORD JUNIOR |
| EP3256109 | PHARMACEUTICAL COMPOSITIONS COMPRISING N-(3,5-DIMETHOXYPHENYL)-N'-(1-METHYLETHYL)-N-[3-(1-METHYL-1H-PYRAZOL-4-YL)QUINOXALIN-6-YL]ETHANE-1,2-DIAMINE | BROGGINI DIEGO FERNANDO DOMENICO | ASTEX THERAPEUTICS LTD |
| EP3256144 | PEPTIDE INHIBITION OF CCR3-MEDIATED DISEASES OR CONDITIONS | ACKERMAN STEVEN J | UNIV ILLINOIS |
| EP3256165 | ANTIBODY THERAPEUTICS THAT BIND CTLA4 | GRAY JOHN DIXON | SORRENTO THERAPEUTICS INC |
| EP3256177 | METHOD OF MAKING INJECTABLE CEMENTS | REN WEIPING | UNIV WAYNE STATE |
| EP3256219 | CHLAMYDIA-ACTIVATED B CELL PLATFORMS AND METHODS THEREOF | CHERPES THOMAS | OHIO STATE INNOVATION FOUNDATION |
| EP3256451 | IMIDAZOLYL TRICYCLIC ENONES AS ANTIOXIDANT IFLAMMATION MODULATORS | JIANG XIN | REATA PHARMACEUTICALS INC |
| EP3256465 | BLOCKERS OF THE GROWTH HORMONE RECEPTOR IN DISEASE PREVENTION AND TREATMENT | LONGO VALTER D | UNIV SOUTHERN CALIFORNIA |
| EP3256484 | NON-MEMBRANE DISRUPTIVE p53 ACTIVATING STAPLED PEPTIDES | TAN YAW SING | AGENCY SCIENCE TECH & RES |
| EP3256569 | ALVEOLAR-LIKE MACROPHAGES AND METHOD OF GENERATING SAME | POST MARTIN | HOSPITAL FOR SICK CHILDREN |
| EP3256570 | RETARGETED HERPESVIRUS WITH A GLYCOPROTEIN H FUSION | CAMPADELLI MARIA GABRIELLA | ALMA MATER STUDIORUM - UNIVERSITà DI BOLOGNA |
| EP3256594 | ENHANCED DELIVERY OF VIRAL PARTICLES TO THE STRIATUM AND CORTEX | STANEK LISA M | GENZYME CORP |
| EP3257510 | LACTATE DEHYDROGENASE INHIBITOR AND ANTIEPILEPTIC DRUG CONTAINING SAME | INOUE TSUYOSHI | NAT UNIV CORPORATION OKAYAMA UNIV |
| EP3258797 | VITAMIN A COMPOSITION | SAGALOWICZ LAURENT | NESTEC SA |
| EP3258927 | HOST DEFENSE PROTEIN (HDP) MIMETICS FOR PROPHYLAXIS AND/OR TREATMENT OF INFLAMMATORY DISEASES OF THE GASTROINTESTINAL TRACT | MENON KRISHNA | INNOVATION PHARMACEUTICALS INC |
| EP3258935 | ILOPERIDONE FOR THE TREATMENT OF SCHIZOPHRENIA | POLYMEROPOULOS MIHAEL H | VANDA PHARMACEUTICALS INC |
| EP3258942 | COSMETIC AND TOPICAL COMPOSITIONS COMPRISING CANNABIGEROL | CHANGOER LEKHRAM | AXIM BIOTECHNOLOGIES INC |
| EP3258943 | COMBINATION IMMUNE THERAPY AND CYTOKINE CONTROL THERAPY FOR CANCER TREATMENT | NOVIK SHAI | ENLIVEX THERAPEUTICS LTD |
| EP3258958 | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING RHINOVIRUS INFECTIONS | WOODFOLK JUDITH ANN | UNIV VIRGINIA PATENT FOUNDATION |
| EP3258960 | LEPTOSPIRA IMMUNOPROTECTIVE PROTEINS AND METHODS OF IDENTIFICATION AND USE THEREOF | BOMCHIL NATALIA INES | MERIAL INC |
| EP3258970 | PROCESS FOR THE PURIFICATION OF GA-68 FROM ELUATE DERIVING FROM 68GE/ 68GA GENERATORS AND CHROMATOGRAPHIC COLUMNS FOR USE IN SAID PROCESS | FUGAZZA LORENZA | ADVANCED ACCELERATOR APPLICATIONS INT S A |
| EP3259271 | FLUORINATED TETRAHYDRONAPHTHYRIDINYL NONANOIC ACID DERIVATIVES AND USES THEREOF | ASKEW BEN C | SCIFLUOR LIFE SCIENCES INC |
| EP3260118 | METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION | GALLAGHER MICHELA | UNIV JOHNS HOPKINS |
| EP3260130 | METHODS FOR TREATING FATTY LIVER DISEASE | KONCAREVIC ALAN | ACCELERON PHARMA INC |
| EP3260140 | METHODS AND PRODUCTS FOR TRANSFECTING CELLS | ANGEL MATTHEW | FACTOR BIOSCIENCE INC |
| EP3260453 | OXAZOLE SUBSTITUTED INDAZOLES AS PI3-KINASE INHIBITORS | HAMBLIN JULIE NICOLE | GLAXO GROUP LTD |
| EP3260454 | CONDENSED PYRIMIDINE COMPOUND OR SALT THEREOF | MIYAZAKI ISAO | TAIHO PHARMACEUTICAL CO LTD |
| EP3261459 | MINERAL ENRICHED NATURAL SUPPLEMENTS | WICKING J BRUCE | CURA GLOBAL HEALTH (BVI) LTD |
| EP3261582 | METHODS AND COMPOSITIONS RELATING TO LEPTIN ANTAGONISTS | SCHNEIDERMAN JACOB | SCHNEIDERMAN JACOB |
| EP3261608 | COMPOSITIONS COMPRISING COMBINATIONS OF ORGANIC ACIDS | FOURRE TARA | JOHNSON & JOHNSON CONSUMER INC |
| EP3261609 | COMPOSITIONS COMPRISING COMBINATIONS OF ORGANIC ACIDS | FOURRE TARA | JOHNSON & JOHNSON CONSUMER INC |
| EP3261635 | COMPOUNDS FOR TREATING OCULAR DISEASES | LIAO CHICHOU | SPRINGSKY BIOMED COMPANY LTD |
| EP3261637 | PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS AND THEIR THERAPEUTICAL APPLICATIONS | TAO CHUNLIN | NANTBIOSCIENCE INC |
| EP3261642 | QUINOLINE DERIVATIVES FOR USE IN THE TREATMENT OR PREVENTION OF VIRAL INFECTION | SCHERRER DIDIER | ABIVAX |
| EP3261644 | COMPOSITIONS AND METHODS FOR TREATING RETINAL DEGRADATION | AMBATI JAYAKRISHNA | UNIV KENTUCKY RES FOUND |
| EP3261645 | STIMULATION OF APPETITE, MANAGEMENT OF WEIGHT LOSS, AND TREATMENT OF ANOREXIA IN DOGS AND CATS | BUHLES WILLIAM | KINDRED BIOSCIENCES INC |
| EP3261647 | COMPOSITIONS AND METHODS OF TREATING FANCONI ANEMIA | D'ANDREA ALAN | DANA FARBER CANCER INST INC |
| EP3261654 | NON-SPECIFIC DELAYED-TYPE HYPERSENSITIVITY RESPONSE TO TREAT HERPES SIMPLEX VIRUS INFECTION | MCTAVISH HUGH | SQUAREX LLC |
| EP3261660 | A GM-CSF NEGATIVE MODULATOR FOR USE IN TREATING, PREVENTING OR AMELIORATING AORTOPATHY | SUZUKI TORU | UNIV LEICESTER |
| EP3261662 | CARBAPENEMASES FOR USE WITH ANTIBIOTICS FOR THE PROTECTION OF THE INTESTINAL MICROBIOME | KALEKO MICHAEL | SYNTHETIC BIOLOGICS INC |
| EP3261673 | COMBINED VACCINATION/RADIOTERAPY FOR CANCER TREATMENT | DEUTSCH ERIC | INST CURIE |
| EP3261722 | COMPOSITIONS COMPRISING PREGNANCY SPECIFIC GLYCOPROTEINS AND METHODS OF USE THEREOF | DVEKSLER GABRIELA | HENRY M JACKSON FOUND ADVANCEMENT MILITARY MEDICINE INC |
| EP3261723 | PROBIOTIC STRAINS FOR URINARY TRACT INFECTIONS | SANTAS GUTIéRREZ JONATHAN | AB-BIOTICS S A |
| EP3261724 | FRAGRANCE DISPERSION FOR DETERGENT COMPOSITIONS | SIEGEL SVEN | SYMRISE AG |
| EP3261725 | ENHANCED PERFUME COMPOSITIONS | LOMBARDO LOUIS J | TAKASAGO PERFUMERY CO LTD |
| EP3261741 | CPC DISTRIBUTION CHROMATOGRAPHY OF CANNABINOIDS | RUTZ ANDREAS | BIONORICA ETHICS GMBH |
| EP3262021 | TREATMENT METHOD, COMPOUNDS, AND METHOD OF INCREASING TRPV2 ACTIVITY | GULKO PERCIO S | FEINSTEIN INST MEDICAL RES |
| EP3262028 | N-(4-HYDROXY-4-METHZL-CYCLOHEXYL)-4-PHENYL-BENZENESULFONAMIDE AND N-(-4HYDROXY-4-METHYL-CYCLOHEXYL)-4-(2-PYRIDYL)-BENZENESULFONAMIDE COMPOUNDS AND THEIR THERAPEUTIC USE | SMITH STEPHEN ALLAN | PIMCO 2664 LTD |
| EP3262047 | IMIDAZOPYRIMIDINE AND IMIDAZOTRIAZINE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | PARK CHUN EUNG | SK BIOPHARMACEUTICALS CO LTD |
| EP3263097 | ADHESIVE SKIN POULTICE | TSURU SEIICHIRO | HISAMITSU PHARMACEUTICAL CO |
| EP3263098 | DELIVERY SYSTEM FOR PERCUTANEOUS ABSORPTION DRUG AND METHOD FOR MANUFACTURING SAME | HAMAMOTO HIDETOSHI | MEDRX CO LTD |
| EP3263134 | COMPOSITION FOR PREVENTING OR TREATING VALVE CALCIFICATION, CONTAINING DPP-4 INHIBITOR | CHANG EUN-JU | ASAN FOUND |
| EP3263140 | DECELLULARIZED TISSUE | NEGISHI JUN | ADEKA CORP |
| EP3263525 | SILICON OXIDE-COATED ZINC OXIDE, SILICON OXIDE-COATED ZINC OXIDE-CONTAINING COMPOSITION, AND COSMETIC PRODUCT | SUMA SYUNSUKE | SUMITOMO OSAKA CEMENT CO LTD |
| EP3263568 | BENZAMIDES | YU HENRY | MERCK PATENT GMBH |
| EP3263601 | COMBINATION OF ANTI-KIR ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TREAT CANCER | GRAZIANO ROBERT F | BRISTOL MYERS SQUIBB CO |
| EP3263714 | METHOD FOR DIAGNOSING, PREVENTING AND TREATING CANCER BRAIN METASTASIS, AND DRUG DELIVERY SYSTEM FOR ENABLING PASSAGE THROUGH BLOOD-BRAIN BARRIER | OCHIYA TAKAHIRO | GENE TECHNO SCIENCE CO LTD |
| EP3265048 | CARTRIDGE HAVING COMPOSITE MATERIAL | SCHAUFELBERGER MARTIN | COLTèNE/WHALEDENT AG |
| EP3265057 | TOPICAL FORMULATION | DAVIS ADRIAN | DAVIS ADRIAN |
| EP3265061 | PROCESS FOR PRODUCING POLYMERIC MICROSPHERES | BIODVERY PHARMATECH LTD | JIN TUO |
| EP3265073 | DUAL FUNCTION MOLECULES FOR HISTONE DEACETYLASE INHIBITION AND ATAXIA TELANGIECTASIA MUTATED ACTIVATION AND METHODS OF USE THEREOF | GRINDROD SCOTT | SHUTTLE PHARMACEUTICALS LLC |
| EP3265089 | NEW USE OF ISOQUINOLINE DERIVATIVES FOR DIABETIC WOUND HEALING | LEE SHOEI-SHENG | |
| EP3265116 | SYSTEMIC AND TOPICAL APPLICATION OF PLATELET MICROPARTICLES TO TREAT BLEEDING IN TRAUMA PATIENTS | REFAAI MAJED A | UNIV ROCHESTER |
| EP3265126 | TESOFENSINE, BETA BLOCKER COMBINATION FORMULATION | NIELSEN PETER G | SANIONA AS |
| EP3265134 | METHODS FOR CELL LABELING AND MEDICAL IMAGING | BANSAL ADITYA | MAYO FOUND MEDICAL EDUCATION & RES |
| EP3265140 | TRANSMUCOSAL AND TRANSDERMAL DELIVERY SYSTEMS | HALL SEAN MICHAEL | MEDLAB CLINICAL U S INC |
| EP3265445 | LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF | ROWBOTTOM MARTIN W | PHARMAKEA INC |
| EP3265448 | RILUZOLE PRODRUGS AND THEIR USE | WROBEL JAY EDWARD | BIOHAVEN PHARM HOLDING CO LTD |
| EP3265560 | HOMOLOGOUS RECOMBINATION FACTORS | DUROCHER DANIEL | SINAI HEALTH SYS |
| EP3265570 | RETROVIRAL AND LENTIVIRAL VECTORS | PULé MARTIN | UCL BUSINESS PLC |
| EP3265575 | CD20 BINDING MOLECULES AND USES THEREOF | KEYT BRUCE | IGM BIOSCIENCES INC |
| EP3266447 | PRODUCTION PROCESS FOR FORMULATIONS CONTAINING TICAGRELOR | UNLU SERDAR | ALI RAIF ILAC SAN A S |
| EP3266456 | COMBINATIONS OF LIPOSOMAL IRINOTECAN, 5-FU AND LEUCOVORIN FOR THE TREATMENT OF PANCREATIC CANCER | BAYEVER ELIEL | IPSEN BIOPHARM LTD |
| EP3266767 | METHOD FOR PREPARING AN ANTIFIBROTIC AGENT | ATTOLINO EMANUELE | DIPHARMA FRANCIS SRL |
| EP3266777 | QUINUCLIDINE DERIVATIVE | MIZUSHIMA TOHRU | LTT BIO-PHARMA CO LTD |
| EP3266865 | CELL THERAPEUTIC AGENT FOR CANCER TREATMENT AND COMBINATION THERAPY WITH SAME | SUH HAE YOUNG | AJOU UNIV INDUSTRY-ACADEMIC COOPERATION FOUNDATION |
| EP3266871 | METHOD FOR STABILIZING DNA APTAMER | HIRAO ICHIRO | TAGCYX BIOTECHNOLOGIES |
| EP3267964 | PEG FREE STABLE LOW VISCOSITY OIL-IN-WATER EMULSION AND USE THEREOF | GU YINGHUA | EVONIK SPECIALTY CHEMICALS (SHANGHAI) CO LTD |
| EP3267977 | SOLID DISPERSIONS | GUAN JIAN | FMC CORP |
| EP3267978 | TOPICAL COMPOSITIONS COMPRISING A CORTICOSTEROID | KANDAVILLI SATEESH | PROMIUS PHARMA LLC |
| EP3267981 | TRANSDERMAL THERAPEUTIC SYSTEM WITH AN OVERTAPE COMPRISING TWO ADHESIVE LAYERS | SCHURAD BJÖRN | LUYE PHARMA AG |
| EP3267984 | 1,2,4-OXADIAZOLE AND THIADIAZOLE COMPOUNDS AS IMMUNOMODULATORS | SASIKUMAR POTTAYIL GOVINDAN NAIR | AURIGENE DISCOVERY TECH LTD |
| EP3268000 | PYRAZOLO[1,5-A][1,3,5]TRIAZINE AND PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AS CDK INHIBITORS | SAMAJDAR SUSANTA | AURIGENE DISCOVERY TECH LTD |
| EP3268010 | COMPOSITIONS AND METHODS FOR TREATING BACTERIAL INFECTION | HASSETT DANIEL J | UNIV CINCINNATI |
| EP3268013 | IL-10-PRODUCING CD4+ T CELLS AND USES THEREOF | GREGORI SILVIA ADRIANA | FOND TELETHON |
| EP3268016 | PANCREATIC ENDOCRINE PROGENITOR CELL THERAPIES FOR THE TREATMENT OF OBESITY AND TYPE 2 DIABETES (T2D) | KIEFFER TIMOTHY J | PETUNIA RESOURCES LTD |
| EP3268023 | COMBINATION OF BACTERICIDAL AGENT WITH A LYSOSOMOTROPIC ALKALINISING AGENT FOR THE TREATMENT OF A BACTERIAL INFECTION | EICHENSEHER FRITZ | MICREOS HUMAN HEALTH BV |
| EP3268038 | ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO FLT3 PROTEINS | RUDRA-GANGULY NANDINI | AGENSYS INC |
| EP3268052 | PREPARATIONS OF META-IODOBENZYLGUANDINE AND PRECURSORS THEREOF | MOSS JASON | MOLECULAR INSIGHT PHARM INC |
| EP3268092 | PRODUCT AND METHOD FOR THE TEMPORARY SHAPING OF KERATIN-CONTAINING FIBERS | LANGE JULIA BIBIANE | HENKEL AG & CO KGAA |
| EP3268356 | HETEROCYCLIC COMPOUNDS AND METHODS FOR THEIR USE | BROWN JANE | NOVARTIS AG |
| EP3268362 | SUBSTITUTED PYRIDINES AND USES THEREOF | WEHN PAUL | PELOTON THERAPEUTICS INC |
| EP3268386 | FUSION PROTEIN COMPRISING A LIGAND BINDING DOMAIN OF VEGF AND PDGF | ZEN KEVIN | |
| EP3268391 | METHODS OF REDUCING SERUM LEVELS OF FC-CONTAINING AGENTS USING FCRN ANTAGONSITS | ONGENAE NICOLAS G H | ARGENX BVBA |
| EP3268414 | SELF-SUPPORTING, BIODEGRADABLE FILM BASED ON HYDROPHOBIZED HYALURONIC ACID, METHOD OF PREPARATION AND USE THEREOF | FOGLAROVA MARCELA | CONTIPRO AS |
| EP3269347 | AEROSOL PRODUCT FOR FORMING COOL-FEELING GEL COMPOSITION FOR HUMAN BODY | NAKAJIMA YASUTOMO | TOYO AEROSOL IND CO |
| EP3269349 | TOPICALLY APPLIED COSMETIC REDUCTIVE COMPOSITION CONTAINING KERATIN AND SULPHUR | MORALES MONTECINOS JUAN PABLO | RODRIGUEZ CERDA PATRICIO ALFREDO |
| EP3269390 | CHIMPANZEE ADENOVIRUS VACCINE CARRIERS | CIRILLO AGOSTINO | MSD ITALIA SRL |
| EP3269721 | BICYCLIC PYRIDINE COMPOUND | KAWAGUCHI KENICHI | ASTELLAS PHARMA INC |
| EP3270693 | METHODS FOR STABILIZING ATHEROSCLEROTIC PLAQUES USING LIPOXINS, RESOLVINS, AND ANALOGS THEREOF | VAN DYKE THOMAS E | FORSYTH DENTAL INFIRMARY FOR CHILDREN |
| EP3270876 | NITRONE INHIBITION OF OXIDATION OF UNSATURATED FATS | FHANER CASSIE | DOW GLOBAL TECHNOLOGIES LLC |
| EP3270893 | STABLE GRANULES WITH LOW INTERNAL WATER ACTIVITY | BECKER NATHANIEL T | DANISCO US INC |
| EP3270894 | MRNA THERAPY FOR POMPE DISEASE | DEROSA FRANK | TRANSLATE BIO INC |
| EP3270898 | METHODS FOR THE TREATMENT OF BLADDER CANCER | GABIZON ALBERTO | LIPOMEDIX PHARMACEUTICALS LTD |
| EP3270901 | COMPOSITIONS COMPRISING DIHYDROQUERCETIN FOR USE IN METHODS FOR TREATING HERPES | AUCLAIR CHRISTIAN | BIONOOX SUISSE SA |
| EP3270912 | PHARMACEUTICAL COMPOSITIONS CONTAINING TAXANE-CYCLODEXTRIN COMPLEXES, METHOD OF MAKING AND METHODS OF USE | ZHAO WILLIAM W | MERIDIAN LAB |
| EP3270923 | THERAPEUTIC AGENT FOR FRONTAL LOBE DYSFUNCTION | HORITA TAKAKO | KYOWA HAKKO KIRIN CO LTD |
| EP3270925 | ANTIBACTERIAL COMPOSITIONS | NANDANWAR MANOHAR BABURAO | THE WOCKHARDT LTD |
| EP3270926 | TRIAZOLYL PYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS | SHEN DONG-MING | MERCK SHARP & DOHME |
| EP3270930 | PREECLAMPSIA | CAI MENG | UNIV ASTON |
| EP3270941 | COMPOSITIONS CONTAINING SILYMARIN AND SULFOALKYL ETHER CYCLODEXTRIN AND METHODS OF USING THE SAME | PIPKIN JAMES D | CYDEX PHARMACEUTICALS INC |
| EP3270942 | USE OF HYLOCEREUS UNDATUS FRUIT EXTRACT AS FLUORESCENT COLORANT OF SKIN | VON OPPEN-BEZALEL LIKI | IBR - ISRAELI BIOTECHNOLOGY RES LTD |
| EP3270950 | ISOLATED PEPTIDES AND FRAGMENTS THEREOF FROM FIBRINOGEN FOR USE AS DRUGS, PARTICULARLY IN SKIN INFLAMMATORY DISEASES | DUPIN NICOLAS | UNIV PARIS DESCARTES |
| EP3270953 | NOVEL TREATMENT METHOD | ERICSSON PETER | IDOGEN AB |
| EP3270985 | POLYPEPTIDE COMPOSITIONS AND METHODS OF USING THE SAME | ANNABI NASIM | THE BRIGHAM AND WOMEN'S HOSPITAL INC |
| EP3271329 | NOVEL HYDROPHILIC LINKERS AND LIGAND-DRUG CONJUGATES THEREOF | SUN SANXING | HANGZHOU DAC BIOTECH CO LTD |
| EP3271337 | METHOD FOR PRODUCING (4S)-4-[4-CYANO-2-(METHYLSULFONYL)PHENYL]-3,6-DIMETHYL-2-OXO-1-[3-(TRIFLUOROMETHYL)PHENYL]-1,2,3,4-TETRAHYDRO PYRIMIDINE-5-CARBONITRILE | SCHIRMER HEIKO | BAYER PHARMA AG |
| EP3271352 | PIPERAZINE CARBAMATES AND METHODS OF MAKING AND USING SAME | CISAR JUSTIN S | ABIDE THERAPEUTICS INC |
| EP3271392 | AGENTS FOR USE IN THE THERAPEUTIC OR PROPHYLACTIC TREATMENT OF MYOPIA OR HYPEROPIA | JONAS SHEFALI BRINDA | JONAS SHEFALI BRINDA |
| EP3271397 | NOVEL MONOCLONAL ANTIBODY INHIBITORS TARGETING POTASSIUM CHANNEL KCNK9 | LATERRA JOHN J | UNIV JOHNS HOPKINS |
| EP3271402 | ANTIBODIES TOWARDS AN EXTRACELLULAR REGION OF NBCN1 | BØDTKJER EBBE BRIGGS | UNIV AARHUS |
| EP3271483 | METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER | POCKAJ BARBARA A | MAYO FOUND MEDICAL EDUCATION & RES |
| EP3272330 | COMPOSITION AND COSMETIC METHOD FOR REDUCING CELLULITE BLEMISHES | CAVALLO GIOVANNI | ITALFARMACIA S R L |
| EP3272342 | METHODS AND COMPOSITIONS FOR TREATMENT OF ATTENTION DEFICIT DISORDER | LICKRISH DAVID | IRONSHORE PHARMACEUTICALS & DEV INC |
| EP3272713 | MULTIPOLAR MICROKINETIC DRINKING WATER, PREPARATION METHOD FOR SAME, AND USES THEREOF | WANG WEIXING | HAPPY OCEAN (BEIJING) WATER TECH CO LTD |
| EP3272750 | MORPHINAN DERIVATIVE | NAGASE HIROSHI | UNIV TSUKUBA |
| EP3273942 | MICRONEEDLE PATCH FOR DELIVERING AN ACTIVE INGREDIENT TO SKIN | PETERSSON KARSTEN | LEO PHARMA AS |
| EP3273983 | NOVEL CYTOTOXIC AGENTS THAT PREFERENTIALLY TARGET LEUKEMIA INHIBITORY FACTOR (LIF) FOR THE TREATMENT OF MALIGNANCIES AND AS NEW CONTRACEPTIVE AGENTS | NAIR HAREESH | EVESTRA INC |
| EP3273984 | USE OF KIT INHIBITORS TO CONDITION SUBJECTS FOR A HEMATOPOIETIC STEM CELL (HSC) TRANSPLANTATION | MALIK PUNAM | CHILDREN'S HOSPITAL MEDICAL CENTER |
| EP3273991 | ANTI-CD89 CYTOTOXIC COMPLEX | STEIN CHRISTOPH | FRAUNHOFER GES FORSCHUNG |
| EP3273994 | CAR T-CELL THERAPY DIRECTED TO LHR FOR THE TREATMENT OF SOLID TUMORS | EPSTEIN ALAN L | UNIV SOUTHERN CALIFORNIA |
| EP3273995 | USE OF ALGINATE OLIGOMERS AND CFTR MODULATORS IN THE TREATMENT OF CONDITIONS ASSOCIATED WITH CFTR DYSFUNCTION | DESSEN ARNE | ALGIPHARMA AS |
| EP3274339 | 2-HOMOPIPERAZINE-1-YL-4H-1,3-BENZOTHIAZINE-4-ONE DERIVATIVES AND PROCESS FOR THE PREPARATION OF 2- (HOMO)PIPERAZINE 1,3-BENZOTHIAZINE-4-ONE HYDROCHLORIDES | STEWART COLE | ECOLE POLYTECHNIQUE FéDéRALE DE LAUSANNE (EPFL) |
| EP3274364 | ENGINEERED BOTULINUM NEUROTOXIN | DONG MIN | HARVARD COLLEGE |
| EP3275425 | HAIR STYLING COMPOSITION | SCHMID SABINE | KAO GERMANY GMBH |
| EP3275436 | INSECT PROTEIN-CONTAINING PREPARATION AND METHOD FOR TREATING ANDROGEN DEFICIENCY IN WOMEN | STRUKOV VILLORIJ IVANOVICH | OBSHESTVO S OGRANICHENNOJ OTVETSTVENNOSTJU PARAFARM |
| EP3275442 | THERAPEUTIC AGENT FOR BILE DUCT CANCER | SHIBATA TATSUHIRO | NAT CANCER CT |
| EP3275450 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES, CONTAININGLACTOCOCCUS CHUNGANGENSIS | KIM WON YONG | CHUNG-ANG UNIV INDUSTRY-ACADEMIC COOPERATION FOUNDATION |
| EP3275452 | PHARMACEUTICAL COMPOSITION CONTAINING SILIBININ | WU NAIFENG | TASLY PHARMACEUTICAL GROUP CO |
| EP3275453 | PHARMACEUTICAL COMPOSITION CONTAINING SILYBIN AND VE | SUN HE | TASLY PHARMACEUTICAL GROUP CO |
| EP3275454 | PHARMACEUTICAL COMPOSITION CONTAINING SILYBIN, VE AND L-CARNITINE | SUN HE | TASLY PHARMACEUTICAL GROUP CO |
| EP3275455 | PHARMACEUTICAL COMPOSITION CONTAINING SILYBIN AND L-CARNITINE | SUN HE | TASLY PHARMACEUTICAL GROUP CO |
| EP3275456 | PHARMACEUTICAL COMPOSITION CONTAINING SILIBININ AND PUERARIA ROOT EXTRACT | YAN XIJUN | TASLY PHARMACEUTICAL GROUP CO |
| EP3275457 | PHARMACEUTICAL COMPOSITION CONTAINING SILYBIN | WU NAIFENG | TASLY PHARMACEUTICAL GROUP CO |
| EP3275881 | COMPOUND OF 5-HYDROXYL-1,7-NAPHTHYRIDINE SUBSTITUTED BY ARYLOXY OR HETEROOXY, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE THEREOF | ZHOU YUNLONG | SHENYANG SUNSHINE PHARMACEUTICAL CO LTD |
| EP3275883 | METHOD FOR PRODUCING NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF, AND PRODUCTION INTERMEDIATE OF SAME | FUKUNAGA HIROFUMI | FUJIFILM CORP |
| EP3275895 | NEUROPILIN-1 SPECIFIC BINDING PEPTIDE, FUSION PROTEIN FUSED WITH SAME, AND USE THEREOF | KIM YONG SUNG | AJOU UNIV INDUSTRY-ACADEMIC COOPERATION FOUNDATION |
| EP3276010 | METHOD FOR PREDICTING A TREATMENT RESPONSE TO A V1B RECEPTOR ANTAGONIST IN A PATIENT WITH DEPRESSIVE SYMPTOMS AND/OR ANXIETY SYMPTOMS | STRUCK JOACHIM | BRAHMS GMBH |
| EP3277253 | COMPOSITION AND PROCESS FOR SHAPING OR ALTERING THE SHAPE OF HAIR | BIATO CAMILA MACIEL | L'ORéAL |
| EP3277260 | ERODIUM CRASSIFOLIUM L'HER PLANT EXTRACTS AND USES THEREOF | KOLTAI HINANIT | THE STATE OF ISRAEL MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT AGRICULTURAL RES ORGANIZATION (ARO) |
| EP3277266 | ORAL SOLID DOSAGE FORM OF AMLODIPINE AND VETERINARY USES THEREOF | CHARLES ROMAIN | CEVA SANTé ANIMALE |
| EP3277267 | ENTERIC-COATED PELLETS CONTAINING A PROTON PUMP INHIBITOR | ATILIO LOS MARIO | LABORATORIOS BAGó S A |
| EP3277270 | COMPOSITIONS AND METHODS FOR TREATING ANEMIA | SMITH ALEXANDER | AKEBIA THERAPEUTICS INC |
| EP3277271 | ANTIVIRAL ACTIVITY FROM MEDICINAL MUSHROOMS AND THEIR ACTIVE CONSTITUENTS | STAMETS PAUL EDWARD | STAMETS PAUL EDWARD |
| EP3277272 | METHODS OF STRATIFYING PATIENTS FOR TREATMENT WITH RETINOIC ACID RECEPTOR- AGONISTS | CHEN MEI WEI | SYROS PHARMACEUTICALS INC |
| EP3277277 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS | BRIAS JULIE | MUTABILIS |
| EP3277283 | SILDENAFIL SUBLINGUAL SPRAY FORMULATIONS | POTTA THRIMOORTHY | INSYS DEV CO INC |
| EP3277286 | BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF | WANG GUOQIANG | ENANTA PHARM INC |
| EP3277295 | COMPOSITION FOR THE TREATMENT OF A PATHOGENIC METABOLIC STATE OF THE INTESTINAL MICROBIOTA AND OF DERIVED DISEASES | VINCENT CLAUDE | INTERNATIONAL NUTRITION RES COMPANY |
| EP3277297 | METHODS AND COMPOSITIONS FOR STIMULATION OF CELL PROLIFERATION AND PROVISION OF BIOLOGICALLY ACTIVE MIXTURES OF FGF2 ISOFORMS | AIZMAN IRINA | SANBIO INC |
| EP3277304 | PROTOXIN-II VARIANTS AND METHODS OF USE | FLINSPACH MACK | JANSSEN BIOTECH INC |
| EP3277305 | ANTIGEN BINDING MOLECULES COMPRISING A TRIMERIC TNF FAMILY LIGAND | AMANN MARIA | HOFFMANN LA ROCHE |
| EP3277307 | POWDER COMPOSITIONS FOR GENERATING CROSS-LINKED PROTEIN FOAMS AND METHODS OF USING THEREOF | ATTAR ISHAY | ATTAR ISHAY |
| EP3277313 | AGENTS AND COMPOSITIONS FOR ELICITING AN IMMUNE RESPONSE | RALPH STEPHEN | CANCURE LTD |
| EP3277379 | ALDEHYDE COMPOUNDS FOR TREATING PULMONARY FIBROSIS, HYPOXIA, AND CONNECTIVE TISSUE AND AUTOIMMUNE DISEASE | LI ZHE | GLOBAL BLOOD THERAPEUTICS INC |
| EP3277384 | SOLID ORAL CARE COMPOSITIONS | ADAMS SUZANNE ELIZABETH | UNILEVER PLC |
| EP3277677 | 1-CYANO-PYRROLIDINE COMPOUNDS AS USP30 INHIBITORS | JONES ALISON | MISSION THERAPEUTICS LTD |
| EP3277685 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS | BRIAS JULIE | MUTABILIS |
| EP3277718 | DOSAGE REGIMEN FOR ANTI-MIF ANTIBODIES | KERSCHBAUMER RANDOLF | BAXALTA GMBH |
| EP3277722 | ANTIBODIES TO CANINE INTERLEUKIN-4 RECEPTOR ALPHA | MORSEY MOHAMAD | INTERVET INT BV |
| EP3277815 | OLIGONUCLEOTIDE COMPOUNDS FOR TREATMENT OF PREECLAMPSIA AND OTHER ANGIOGENIC DISORDERS | KHVOROVA ANASTASIA | UNIV MASSACHUSETTS |
| EP3278112 | A COMPOSITION COMPRISING PROSTACYCLIN OR ANALOGUES THEREOF FOR TREATMENT OF ACUTE CRITICALLY ILL PATIENTS | OSTROWSKI SISSE RYE | OSTROWSKI SISSE RYE |
| EP3278790 | ANTI-OXIDATIVE OR ANTI-AGING COMPOSITION CONTAINING 5-ADAMANTAN-1-YL-N-(2,4-DIHYDROXYBENZYL)-2,4-DIMETHOXYBENZAMIDE | JOO YUNG HYUP | AMOREPACIFIC CORP |
| EP3278814 | THERAPEUTIC COMPOSITION CONTAINING ANTITHROMBIN GAMMA | MUKAI MAYUMI | KYOWA HAKKO KIRIN CO LTD |
| EP3279182 | ACETYLSALICYLIC ACID DERIVATIVE CRYSTAL AND PREPARATION METHOD AND USE THEREOF | ZHANG JING | ZHEJIANG YUEJIA PHARMACEUTICALS CO LTD |
| EP3279183 | MONOCYCLIC COMPOUND | MIZOJIRI RYO | TAKEDA PHARMACEUTICALS CO |
| EP3279187 | 9-MEMBERED FUSED RING DERIVATIVE | OHYABU NAOKI | SHIONOGI & CO |
| EP3279236 | BIODEGRADABLE POLYETHYLENE GLYCOL DERIVATIVE HAVING CYCLIC BENZYLIDENE ACETAL LINKER | TSUBUSAKI TAKUMA | NOF CORP |
| EP3279324 | EXON SKIPPING THERAPY FOR DYSTROPHIC EPIDERMOLYSIS BULLOSA | HOVNANIAN ALAIN | INSTITUT NATIONAL DE LA SANTE ET DE LA RECH MEDICALE (INSERM) |
| EP3279663 | USE OF GELSOLIN TO DIAGNOSE AND TREAT INFLAMMATORY DISEASES | STOSSEL THOMAS P | THE BRIGHAM AND WOMEN'S HOSPITAL INC |
| EP3280272 | EXTRACTS FROM PLANTS OF THE MORINGACEAE FAMILY AND METHODS OF MAKING | RASKIN ILYA | UNIV RUTGERS |
| EP3280385 | FOAMING DENTIFRICE WITH DESENSITIZING AGENTS | POTH TILO | COLGATE PALMOLIVE CO |
| EP3280390 | METHOD OF COSMETIC TREATMENT TO PROTECT THE SKIN FROM POLLUTION AND IMPROVE SKIN REGENERATION | PORTOLAN FRéDéRIQUE | ISP INVESTMENTS LLC |
| EP3280392 | COMBINATIONS OF AMISULPRIDE AND ANOTHER ANTI-EMETIC FOR TREATING NAUSEA AND VOMITING | GILBERT JULIAN CLIVE | ACACIA PHARMA LTD |
| EP3280396 | GLYCOSAMINOGLYCAN ESTERS, PROCESSES FOR THEIR PREPARATION AND THEIR USE IN FORMULATIONS FOR OPHTHALMIC USE | BARICORDI NIKLA | HYALBLUE S R L |
| EP3280401 | COMPOSITIONS FOR TREATING AND/OR PREVENTING CELL OR TISSUE NECROSIS SPECIFICALLY TARGETING CATHEPSIN C AND/OR CELA1 AND/OR CELA3A AND/OR STRUCTURALLY RELATED ENZYMES THERETO | NATHAN ILANA | ELA PHARMA LTD |
| EP3280404 | METHODS FOR SELECTING PHOSPHATASE SELECTIVE AND NON-SELECTIVE PHOSPHATASE INHIBITORS | BERTOLOTTI ANNE | MEDICAL RES COUNCIL |
| EP3280405 | INHIBITORS AND THEIR USES | BERTOLOTTI ANNE | MEDICAL RES COUNCIL |
| EP3280432 | DE NOVO BINDING DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF | LAFLEUR DAVID WILLIAM | SUBDOMAIN LLC |
| EP3280433 | DE NOVO BINDING DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF | LAFLEUR DAVID WILLIAM | SUBDOMAIN LLC |
| EP3280435 | TGF-BETA SUPERFAMILY TYPE I AND TYPE II RECEPTOR HETEROMULTIMERS AND USES THEREOF | KUMAR RAVINDRA | ACCELERON PHARMA INC |
| EP3280441 | ANTI-SORTILIN ANTIBODIES AND METHODS OF USE THEREOF | ROSENTHAL ARNON | ALECTOR LLC |
| EP3280456 | NANOPARTICLE-BASED ANTIGEN SPECIFIC IMMUNOTHERAPY | MCATEER MARTINA | MIDATECH LTD |
| EP3280705 | PYRONE DERIVATIVES FOR USE AS ANTIVIRAL AGENTS | BRACK WERNER RUTH | HELMHOLTZ ZENTRUM MüNCHEN DEUTSCHES FORSCHUNGSZENTRUM FüR GESUNDHEIT UND UMWELT (GMBH) |
| EP3280723 | BACKBONE-CYCLIZED PEPTIDOMIMETICS | OBRECHT DANIEL | POLYPHOR AG |
| EP3280726 | ALK4:ACTRIIB HETEROMULTIMERS AND USES THEREOF | KUMAR RAVINDRA | ACCELERON PHARMA INC |
| EP3280727 | SINGLE-ARM TYPE I AND TYPE II RECEPTOR FUSION PROTEINS AND USES THEREOF | KUMAR RAVINDRA | ACCELERON PHARMA INC |
| EP3280795 | COMBINATION OF CHIMERIC ANTIGEN RECEPTOR THERAPY AND AMINO PYRIMIDINE DERIVATIVES | BYRD JOHN | NOVARTIS AG |
| EP3281614 | MULTIFUNCTIONAL FORMULATION COMPRISED OF NATURAL INGREDIENTS AND METHOD OF PREPARATION/MANUFACTURING THEREOF | DATT RAJAN | DATT MEDIPRODUCTS PVT LTD |
| EP3281619 | SHAMPOO CONTAINING A GEL NETWORK | WELLS ROBERT LEE | PROCTER & GAMBLE |
| EP3281622 | CLEANING CREAM CONTAINING PVA PARTICLES AND PRODUCING METHOD THEREOF | YAN HONG-CHANG | |
| EP3281693 | CONTAINER FOR BUBBLE PRODUCTION | TACHIBANA KATSURO | SONOCORE INC |
| EP3283044 | SURFACE TREATING CONDITIONING COMPOSITION | LYNCH MATTHEW LAWRENCE | PROCTER & GAMBLE |
| EP3283045 | ONE-STEP METHOD FOR PRODUCTION OF ULTRA-SMALL LIPID STRUCTURES | FOUNTAIN MICHAEL | FOUNTAIN TECH INTERNATIONAL LLC |
| EP3283049 | ORAL CARE COMPOSITIONS AND METHODS OF USE | PRENCIPE MICHAEL | COLGATE PALMOLIVE CO |
| EP3283057 | COMPOSITION AND KITS FOR PSEUDOPLASTIC MICROGEL MATRICES | SALAMONE JOSEPH CHARLES | ROCHAL IND LLC |
| EP3283077 | BROMODOMAIN INHIBITORS | BENNETT MICHAEL JOHN | CELGENE QUANTICEL RES INC |
| EP3283106 | THERAPEUTIC ANTIBODIES AND THEIR USES | KUO TRACY CHIA-CHIEN | PFIZER |
| EP3283125 | LYOPHILIZATION OF RNA | KETTERER THOMAS | CUREVAC AG |
| EP3283171 | DERIVATIVES OF AMPHOTERICIN B | BURKE MARTIN D | REVOLUTION MEDICINES INC |
| EP3283179 | SOLID SKIN CARE EMULSION COMPRISING SOLID AND LIQUID LIPIDS | HALLMANN MARITA | BEIERSDORF AG |
| EP3283463 | DIMERIC QUINACRINE DERIVATIVES AS AUTOPHAGY INHIBITORS FOR CANCER THERAPY | AMARAVADI RAVI K | UNIV PENNSYLVANIA |
| EP3283465 | CRYSTALLINE FGFR4 INHIBITOR COMPOUND AND USES THEREOF | MONIZ GEORGE | EISAI R&D MAN CO LTD |
| EP3283484 | QUINOLINE DERIVATIVES AS INHIBITORS OF HEAT SHOCK FACTOR 1 PATHWAY ACTIVITY | JONES KEITH | CANCER RESEARCH TECH LTD |
| EP3283492 | ANTIVIRAL AND ANTIBACTERIA AGENTS BASED ON QUATERNARY AMMONIUM COMPOUND COMPLEXED WITH BORIC ACID AND ITS DERIVATIVES | LE TIEN CANH | B-ORGANIC FILMS CORP |
| EP3283527 | COMBINATION THERAPY FOR CANCER | MASTELLER EMMA | FIVE PRIME THERAPEUTICS INC |
| EP3283606 | IMPROVED METHOD AND APPARATUS FOR EXTRACTING BOTANICAL OILS | THOMAS C RUSSELL | NATURAL EXTRACTION SERVICES LLC |
| EP3284458 | PRODUCTION PROCESS FOR NSAID-CONTAINING LOZENGES, THEIR COMPOSITIONS, THEIR MEDICINAL USE | FANFARILLO MICHAEL | RECKITT BENCKISER HEALTHCARE (UK) LTD |
| EP3284459 | PHARMACEUTICAL COMPOSITIONS COMPRISING A LOCAL ANAESTHETIC SUCH AS BUPIVACAINE FOR LOCAL ADMINISTRATION TO THE MOUTH OR THROAT | ANDERSEN OVE | MOBERG PHARMA AB |
| EP3284472 | HOT FLASH-SUPPRESSING AGENT | UCHIDA MASAYUKI | MEIJI CO LTD |
| EP3284506 | SOLUBLE MICRONEEDLE CONTAINING INGREDIENT FOR CONTROLLING RELEASE OF NEUROTRANSMITTERS | KANG NAE-GYU | LG HOUSEHOLD & HEALTH CARE LTD |
| EP3284744 | INDAZOLE INHIBITORS OF THE WNT SIGNAL PATHWAY AND THERAPEUTIC USES THEREOF | HOOD JOHN | SAMUMED LLC |
| EP3284756 | GENERATION AND PROFILING OF FULLY HUMAN HUCAL GOLD-DERIVED THERAPEUTIC ANTIBODIES SPECIFIC FOR HUMAN CD38 | TESAR MICHAEL | MORPHOSYS AG |
| EP3284823 | METHOD FOR EFFICIENT EXON (44) SKIPPING IN DUCHENNE MUSCULAR DYSTROPHY AND ASSOCIATED MEANS | PLATENBURG GERARD JOHANNES | BIOMARIN TECH BV |
| EP3284825 | METHODS OF PRODUCING HYBRID POLYPEPTIDES WITH MOVING PARTS | CAPON DANIEL J | CAPON DANIEL J |
| EP3285581 | PYRAZOLYL PYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS | SHEN DONG-MING | MERCK SHARP & DOHME |
| EP3285594 | DELIVERY SYSTEMS AND METHODS OF PREPARING THE SAME | POPPLEWELL LEWIS MICHAEL | INT FLAVORS & FRAGRANCES INC |
| EP3285734 | COMPOSITION | CONSTANTINE MARK | COSMETIC WARRIORS LTD |
| EP3285735 | DELIVERY OF SURFACTANT SOLUBLE ANTI-DANDRUFF AGENT | CHANG DEBORA W | PROCTER & GAMBLE |
| EP3285739 | COMPOSITION | CONSTANTINE MARK | COSMETIC WARRIORS LTD |
| EP3285743 | ENCAPSULATED GAS OR PARTIAL VACUUM CT CONTRAST MATERIAL | YEH BENJAMIN M | UNIV CALIFORNIA |
| EP3285755 | COMPOSITIONS AND METHODS FOR NEUROPROTECTION AND TREATMENT OF NEURODEGENERATION | FAULKNER MARK C | VIREO SYSTEMS INC |
| EP3285757 | SELECTIVE ANDROGEN RECEPTOR DEGRADER (SARD) LIGANDS AND METHODS OF USE THEREOF | NARAYANAN RAMESH | GTX INC |
| EP3285761 | PARTHENOLIDE AND ITS DERIVATIVES FOR USE IN THE TREATMENT OF AXONAL DAMAGE | GOBRECHT PHILIPP LUDWIG ALEXANDER | HEINRICH HEINE UNIVERSITÄT DüSSELDORF |
| EP3285777 | GLYCAN THERAPEUTICS AND METHODS OF TREATMENT | VON MALTZAHN GEOFFREY A | KALEIDO BIOSCIENCES INC |
| EP3285782 | METHODS OF TISSUE REPAIR AND REGENERATION | KANG YUJIAN JAMES | INNOLIFE CO LTD |
| EP3285802 | EMULSIONS FOR INJECTABLE FORMULATIONS | ONDEI ROBERTA | CRODA INT PLC |
| EP3285805 | THERAPEUTIC ANTIBODIES AND USES THEREOF | WALSH BRADLEY | MINOMIC INT LTD |
| EP3285871 | VECTORS AND METHODS FOR REGENERATIVE THERAPY | MACLELLAN W ROBB | UNIV WASHINGTON |
| EP3285874 | COMPOSITIONS AND METHODS FOR TREATING MYCOBACTERIA INFECTIONS AND LUNG DISEASE | LU RUYING | MATINAS BIOPHARMA NANOTECHNOLOGIES INC |
| EP3286139 | APYROGENIC PREPARATION CONTAINING NANOPARTICLES SYNTHESISED BY MAGNETOTACTIC BACTERIA FOR MEDICAL OR COSMETIC APPLICATIONS | ALPHANDéRY EDOUARD | NANOBACTERIE |
| EP3286181 | PYRAZOLE COMPOUNDS AND METHOD FOR MAKING AND USING THE COMPOUNDS | KELLEY RYAN | RIGEL PHARMACEUTICALS INC |
| EP3286183 | ISOXAZOLYL SUBSTITUTED BENZIMIDAZOLES | PEGG NEIL ANTHONY | CELLCENTRIC LTD |
| EP3286189 | CRYSTALLINE COMPOUND AS SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) ENZYME INHIBITOR | SAVORY EDWARD | PROXIMAGEN LTD |
| EP3286206 | NOVEL HYBRID ACTRIIB LIGAND TRAP PROTEINS FOR TREATING MUSCLE WASTING DISEASES | HAN HQ | ALIVEGEN USA INC |
| EP3286212 | POLYPEPTIDES TARGETING HIV FUSION | KRYSTAL MARK R | VIIV HEALTHCARE UK (NO 5) LTD |
| EP3286301 | GENERATION OF MUSCLE-LINEAGE CELLS FROM STEM CELLS | SCHMIDT ULI | GENEA IP HOLDINGS PTY LTD |
| EP3286311 | METHOD FOR THE TREATMENT OF MALIGNANCIES | PIERCE ROBERT H | ONCOSEC MEDICAL INC |
| EP3286315 | METHODS OF IDENTIFYING BACTERIA COMPRISING BINDING POLYPEPTIDES | LOMBANA TWYLA NOELLE | GENENTECH INC |
| EP3287118 | MULTILAYER-COLOR COMPOSITE MATERIAL FOR USE IN DENTAL DEPARTMENT, AND PREPARATION METHOD THEREFOR | WANG HONGJUAN | SHENZHEN UPCERA DENTAL TECH CO LTD |
| EP3287137 | METHOD FOR DISRUPTING EXOSOMES, EXOSOME DISRUPTION KIT, AND METHOD FOR SEPARATING EXOSOMES DERIVED FROM NORMAL CELLS | FUJII RYOTA | MITSUI CHEMICALS INC |
| EP3287139 | NERVE GROWTH FACTOR COMPOSITION AND POWDER INJECTION | TAN JIANPING | STAIDSON BEIJING BIOPHARMACEUTICALS CO LTD |
| EP3287140 | NERVE GROWTH FACTOR COMPOSITION AND POWDER INJECTION | TAN JIANPING | STAIDSON BEIJING BIOPHARMACEUTICALS CO LTD |
| EP3287141 | NERVE GROWTH FACTOR COMPOSITION AND POWDER INJECTION | TAN JIANPING | STAIDSON BEIJING BIOPHARMACEUTICALS CO LTD |
| EP3287142 | METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION | DEMOPULOS GREGORY A | UNIV LEICESTER |
| EP3287436 | COMPOSITIONS FOR USE IN THE TREATMENT OF BCAT1-MEDIATED DISEASES | PAPATHANASSIU ADONIA E | ERGON PHARMACEUTICALS LLC |
| EP3287441 | HETEROCYCLIC COMPOUND | ASANO YASUTOMI | TAKEDA PHARMACEUTICALS CO |
| EP3287443 | 6-MEMBERED HETEROCYCLIC DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | TANAKA SATORU | SHIONOGI & CO |
| EP3287460 | HEMISULFATE SALT OF 5,10-METHYLENE-(6R)-TETRAHYDROFOLIC ACID | MOSER RUDOLF | MERCK & CIE |
| EP3287518 | METHOD FOR FREEZE DRYING A BACTERIA-CONTAINING CONCENTRATE | GEORGIEVA TANIA IVANOVA | CHR HANSEN AS |
| EP3288379 | PEPTIDE COMPOSITIONS AND METHODS OF USE | BESIRLI CAGRI G | ONL THERAPEUTICS INC |
| EP3288532 | POLYMERS FOR STABILISING PEROXIDE COMPOUNDS | SCHADE CHRISTIAN | BASF SE |
| EP3288542 | COMPOSITIONS AND METHODS FOR ADMINISTERING ANTIBODIES | VOELCKER NICOLAS HANS | UNIV SOUTH AUSTRALIA |
| EP3288546 | OXIDIZED CAROTENOIDS AND COMPONENTS THEREOF FOR PREVENTING NECROTIC ENTERITIS | BURTON GRAHAM W | AVIVAGEN INC |
| EP3288561 | METHODS AND PHARMACEUTICAL COMPOSITIONS COMPRISING A SGLT2 INHIBITOR FOR TREATING OR IMPROVING ERECTILE DYSFUNCTION | MAYOUX ERIC WILLIAMS | BOEHRINGER INGELHEIM INT |
| EP3288577 | ADIPONECTIN PEPTIDOMIMETICS FOR TREATING OCULAR DISORDERS | HSU HENRY | ALLYSTA PHARMACEUTICALS INC |
| EP3288582 | NUCLEIC ACID CONSTRUCT | PULé MARTIN | UCL BUSINESS PLC |
| EP3288590 | MIXED DISULFIDE CONJUGATES OF THIENOPYRIDINE COMPOUNDS AND USES THEREOF | ZHANG HAOMING | UNIV MICHIGAN REGENTS |
| EP3288604 | TRIGGERABLE SHAPE MEMORY INDUCTION DEVICES | ZHANG SHIYI | MASSACHUSETTS INST TECHNOLOGY |
| EP3288644 | COSMETIC USE OF EXTRACTS DERIVED FROM SOMATIC EMBRYO ENRICHED PLANT CELL CULTURES AND COSMETIC COMPOSITIONS CONTAINING THOSE EXTRACTS | TITO ANNALISA | VITALAB S R L |
| EP3288918 | GUANIDINE COMPOUNDS AND USE THEREOF | KIM SUNG WUK | IMMUNOMET THERAPEUTICS INC |
| EP3288925 | REAGENTS AND METHODS FOR BIOORTHOGONAL LABELING OF BIOMOLECULES IN LIVING CELLS | MEHL RYAN A | UNIV OREGON STATE |
| EP3288926 | N-ARALKYLCARBONYL-PIPERAZINE AND -HOMOPIPERAZINE COMPOUNDS AND PERSONAL CARE COMPOSITIONS COMPRISING THE SAME | ROSA JOSE GUILLERMO | UNILEVER PLC |
| EP3288940 | AZABENZIMIDAZOLES AND THEIR USE AS AMPA RECEPTOR MODULATORS | BERRY CYNTHIA G B | JANSSEN PHARMACEUTICA NV |
| EP3288942 | RSV ANTIVIRAL PYRAZOLO- AND TRIAZOLO-PYRIMIDINE COMPOUNDS | LANÇOIS DAVID FRANCIS ALAIN | JANSSEN SCIENCES IRELAND UC |
| EP3288960 | SHORT SYNTHETIC PEPTIDE FOR TREATMENT AND/OR PROPHYLAXIS OF AUTOIMMUNE AND INFLAMMATORY DISORDERS | TSAO YEOU-PING | |
| EP3288961 | SHORT SYNTHETIC PEPTIDE FOR TREATING DISEASES AND/OR CONDITIONS RELATED TO ANGIOGENESIS | TSAO YEOU-PING | |
| EP3288977 | METHODS OF MEDIATING CYTOKINE EXPRESSION WITH ANTI CCR4 ANTIBODIES | MARASCO WAYNE A | DANA FARBER CANCER INST INC |
| EP3288980 | TREATMENT OF PD-L1-POSITIVE MELANOMA USING AN ANTI-PD-1 ANTIBODY | YANG ARVIN | BRISTOL MYERS SQUIBB CO |
| EP3289080 | GENE THERAPY FOR AUTOSOMAL DOMINANT DISEASES | WU WEN-HSUAN | UNIV COLUMBIA |
| EP3290020 | MILD PREPARATIONS CONTAINING ALKOXYLATED FATTY ACID AMIDES | #VALUE! | RICHLI REMO |
| EP3290023 | RIVASTIGMINE-CONTAINING SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITION | PARK SANG GEUN | NAVIPHARM CO LTD |
| EP3290053 | EXTERNAL AGENT FOR TREATING HYPERHIDROSIS | IMAMURA KANA | HISAMITSU PHARMACEUTICAL CO |
| EP3290405 | MESYLIC ACID SALT OF ACYLTHIOUREA COMPOUND, CRYSTAL THEREOF, AND PRODUCTION PROCESSES THEREFOR | SATO AYAKO | TAIHO PHARMACEUTICAL CO LTD |
| EP3290423 | OPTICALLY ACTIVE 2-HYDROXY TETRAHYDROTHIENOPYRIDINE DERIVATIVES, PREPARATION METHOD AND USE IN MANUFACTURE OF MEDICAMENT THEREOF | SUN HONGBIN | JIANGSU VCARE PHARMATECH CO LTD |
| EP3290428 | TABLET COMPRISING CRYSTALLINE (S)-ISOPROPYL 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1 (2H)-YL)-4-FLUORO-3-HYDROXY-4-METHYLTETRAHYDROFURAN-2-YL)METHOXY)(PHENOXY)PHOSPHORYL)AMINO)PROPANOATE | ROSS BRUCE S | GILEAD PHARMASSET LLC |
| EP3291679 | ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA | CLUBE JASPER | SNIPR TECH LTD |
| EP3291801 | RIBOFLAVIN FOR THE TREATMENT OF ISCHEMIC STROKE AND/OR OTHER GLUTAMATE EXCITOTOXICITY-ASSOCIATED DISEASES | BREA FLORIANI JOSE MANUEL | UNIV SANTIAGO COMPOSTELA |
| EP3291809 | HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF | DOMINGUEZ CELIA | CHDI FOUNDATION INC |
| EP3291812 | INJECTABLE DEPOT FORMULATIONS | ASHTON PAUL | PSIVIDA INC |
| EP3291830 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS THEREOF FOR USE IN IMMUNOTHERAPY AGAINST COLORECTAL CARCINOMA (CRC) AND OTHER CANCERS | MAHR ANDREA | IMMATICS BIOTECHNOLOGIES GMBH |
| EP3291841 | ONCOLYTIC HSV1 VECTOR AND METHODS OF USE | NAKASHIMA HIROSHI | BRIGHAM & WOMENS HOSPITAL INC |
| EP3292101 | TRICYCLIC SULFONES AS ROR MODULATORS | DUAN JINGWU | SQUIBB BRISTOL MYERS CO |
| EP3292116 | 3-ARYL-4-AMIDO-BICYCLIC [4,5,0]HYDROXAMIC ACIDS AS HDAC INHIBITORS | ZHENG XIAOZHANG | FORMA THERAPEUTICS INC |
| EP3292138 | PRODUCTION OF LARGE-SIZED MICRODYSTROPHINS IN AN AAV-BASED VECTOR CONFIGURATION | DICKSON GEORGE | ROYAL HOLLOWAY & BEDFORD NEW COLLEGE |
| EP3292149 | ANTI-CD71 ANTIBODIES, ACTIVATABLE ANTI-CD71 ANTIBODIES, AND METHODS OF USE THEREOF | SAGERT JASON GARY | CYTOMX THERAPEUTICS INC |
| EP3292154 | ANTI-HUMAN-HER3 ANTIBODIES AND USES THEREOF | CHARDES THIERRY | GAMAMABS PHARMA |
| EP3292206 | GLUCOCEREBROSIDASE GENE THERAPY FOR PARKINSON'S DISEASE | PARK YUNG HEE | SHIRE HUMAN GENETIC THERAPIES |
| EP3292869 | KAL1 PROTEIN CONTROLLING CELL CYCLE OF HEMATOPOIETIC STEM CELL, AND USE THEREOF | KIM HYO SOO | SEOUL NAT UNIV R&DB FOUNDATION |
| EP3292871 | NANOREACTOR USING POLYION COMPLEX POLYMERSOMES, AND METHOD FOR PRODUCING SAME | KATAOKA KAZUNORI | UNIV TOKYO |
| EP3293202 | ANTI HUMAN INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN (IL1RAP) ANTIBODIES AND USES THEREOF | ÅGERSTAM HELENA | CANTARGIA AB |
| EP3294263 | HOT RESHAPING PROCESS | KOMURE NATSUMI | OREAL |
| EP3294264 | COMPOSITION FOR KERATIN FIBERS | PLOS GREGORY | OREAL |
| EP3294277 | FUNCTIONAL CURE OF RETROVIRAL INFECTION | CHRIST FRAUKE | UNIV LEUVEN KATH |
| EP3294288 | HUMAN PAPILLOMA VIRUS REPLICATION INHIBITORS | USTAV MART SR | ICOSAGEN CELL FACTORY Oü |
| EP3294291 | RADIOTRACER DERIVATIVES OF TRIMETHOPRIM FOR DIAGNOSTIC IMAGING | SELLMYER MARK | UNIV PENNSYLVANIA |
| EP3294295 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS IN PATIENTS SUFFERING FROM CIRRHOSIS | PERIANIN AXEL JOSEPH | INST NAT SANTE RECH MED |
| EP3294323 | ADENO-ASSOCIATED FOR THERAPEUTIC DELIVERY TO CENTRAL NERVOUS SYSTEM | MCIVOR R SCOTT | MCIVOR R SCOTT |
| EP3294326 | PRIME-BOOST REGIMENS INVOLVING ADMINISTRATION OF AT LEAST ONE MRNA CONSTRUCT | FOTIN MLECZEK MARIOLA | CUREVAC AG |
| EP3294417 | COMPOSITIONS AND METHODS FOR TREATMENT OF GLIOMA | QUAIL DANIELA FRANCIS | MEMORIAL SLOAN KETTERING CANCER CENTER |
| EP3294735 | INHIBITORS OF INFLUENZA VIRUSES REPLICATION | FARMER LUC J | VERTEX PHARMA |
| EP3294746 | NOVEL SUBSTITUTED AMINOTHIAZOLOPYRIMIDINEDIONE FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION | WANG BAOXIA | HOFFMANN LA ROCHE |
| EP3294760 | BACTERIA ENGINEERED TO REDUCE HYPERPHENYLALANINEMIA | FALB DEAN | SYNLOGIC INC |
| EP3294769 | TREATMENT FOR MULTIPLE MYELOMA (MM) | LECLAIR STEPHANE | MORPHOSYS AG |
| EP3294891 | POLYNUCLEOTIDES, VECTORS AND METHODS FOR INSERTION AND EXPRESSION OF TRANSGENES | KEIMEL JOHN G | NEW HOPE RES FOUNDATION |
| EP3294900 | ALBUMIN-BASED NON-COVALENT COMPLEXES AND METHODS OF USE THEREOF | VERMA RAVI | SPECTRAL PLATFORMS INC |
| EP3295949 | TOPICAL DRUG FOR TREATING BREAST CANCER AND PREPARATION METHOD THEREOF | MA JIAN | MA JIAN |
| EP3295952 | PHARMACEUTICAL FORMULATION COMPRISING GLP-1 ANALOGUE AND PREPARATION METHOD THEREOF | LIU XIAONI | HANGZHOU JIUYUAN GENE ENG CO LTD |
| EP3295955 | BOTULINUM NANOEMULSIONS | EDELSON JONATHAN | UNIV MASSACHUSETTS LOWELL |
| EP3295962 | TETRAPYRROLES CONJUGATES AS MRI CONTRAST AGENT | KIESSLING FABIAN | NANO4IMAGING GMBH |
| EP3296284 | HYDROXYBUTYRATE ESTER AND MEDICAL USE THEREOF | CLARKE KIEREN | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRES BY THE SECRETARY OF HEALTH AND HUMAN SERVIC |
| EP3296319 | METHODS FOR TREATING COLORECTAL CANCER | PANNEQUIN JULIE | CENTRE NAT RECH SCIENT |
| EP3296395 | MULTIPLE ANTIGEN BINDING MOLECULAR FUSION, PHARMACEUTICAL COMPOSITION, METHOD FOR IDENTIFYING LINEAR EPITOPE, AND METHOD FOR PREPARING MULTIPLE ANTIGEN BINDING MOLECULAR FUSION | IGAWA TOMOYUKI | CHUGAI PHARMACEUTICAL CO LTD |
| EP3297612 | PHARMACEUTICAL COMPOSITION COMPRISING ATOMOXETINE AND METHOD FOR THE PREPARATION THEREOF | KARAVAS EVANGELOS | PHARMATHEN SA |
| EP3297624 | A PHARMACEUTICAL CO-CRYSTAL AND USE THEREOF | LIU XIAOZHONG | SYN NAT PRODUCTS ENTPR LLC |
| EP3297626 | OPHTHALMIC COMPOSITION COMPRISING LIPOIC ACID AND A MUCOMIMETIC POLYMER | CLARET MARTINE | OPHTALMIS MONACO |
| EP3297628 | CALCINEURIN INHIBITORS OF THE SETRON FAMILY FOR THE TREATMENT OF HEARING LOSS | DYHRFJELD JOHNSEN JONAS | SENSORION |
| EP3297636 | PHARMACEUTICAL COMPOSITION OF CARBOPLATIN BASED CO-CRYSTALS AND USE THEREOF | LIU XIAOZHONG | SYN NAT PRODUCTS ENTPR LLC |
| EP3297637 | BENZENE-1,3,5-TRICARBOXAMIDE DERIVATIVES AND USES THEREOF | DONG YIZHOU | OHIO STATE INNOVATION FOUNDATION |
| EP3297638 | SINGLE-STEP DNA PREPARATION FOR POLYMERASE CHAIN REACTION USING MAGNETIC CHITOSAN MICROPARTICLES | WHITE IAN M | CANON US LIFE SCIENCES INC |
| EP3297653 | TREATMENT OF POST-BARIATRIC HYPOGLYCEMIA WITH GLP-1 ANTAGONISTS | MCLAUGHLIN TRACEY L | UNIV LELAND STANFORD JUNIOR |
| EP3297654 | TREATMENT OF POST-BARIATRIC HYPOGLYCEMIA WITH EXENDIN(9-39) | MCLAUGHLIN TRACEY L | UNIV LELAND STANFORD JUNIOR |
| EP3297661 | METHOD OF IMPROVING CHARACTERISTICS OF PROTEINS | DUBRIDGE ROBERT B | FULL SPECTRUM GENETICS INC |
| EP3297668 | COMBINATION OF ANTI-FGFR4-ANTIBODY AND BILE ACID SEQUESTRANT | ABRAHAM REIMAR | DAIICHI SANKYO EUROPE GMBH |
| EP3297672 | TRISPECIFIC BINDING PROTEINS AND METHODS OF USE | BAEUERLE PATRICK | HARPOON THERAPEUTICS INC |
| EP3297678 | AN IMPROVED PROCESSES FOR THE PREPARATION OF CARFILZOMIB OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | DEHURY SANJAY KUMAR | LAURUS LABS PRIVATE LTD |
| EP3297682 | DRY POWDER COMPOSITION COMPRISING LONG-CHAIN RNA | EBER FABIAN JOHANNES | CUREVAC AG |
| EP3297685 | RADIOACTIVE NANOPARTICLES AND METHODS OF MAKING AND USING THE SAME | SUN XIANKAI | UNIV TEXAS |
| EP3298004 | COMPOUNDS TARGETING PROTEINS, COMPOSITIONS, METHODS, AND USES THEREOF | CHAN KYLE W H | BIOTHERYX INC |
| EP3298011 | QUINOLONE DERIVATIVES AS FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITORS | BRAMELD KENNETH ALBERT | PRINCIPIA BIOPHARMA INC |
| EP3298038 | ANTI-PRE-S1 HBV ANTIBODIES | SUI JIANHUA | HUAHUI HEALTH LTD |
| EP3298047 | PROCESS FOR THE PREPARATION OF POLYSACCHARIDES | DE FERRA LORENZO | CHEMI SPA |
| EP3298139 | METHOD FOR REDUCING OR INACTIVATING VIRAL AND MICROBIAL CONTENT IN THE PROCESSES FOR THE MANUFACTURE OF PANCREATIN | MANNING KENNETH S | SCIENT PROTEIN LABORATORIES LLC |
| EP3298142 | DRY POWDER COMPOSITION COMPRISING LONG-CHAIN RNA | EBER FABIAN JOHANNES | CUREVAC AG |
| EP3299011 | HYPOTONIC COMPOSITION FOR FAT DECOMPOSITION AND METHOD FOR PREPARING SAME | LEE KYOUNG LACK | LEE KYOUNG LACK |
| EP3299356 | PROCESS FOR THE PREPARATION OF PLEUROMUTILINS | RIEDL ROSEMARIE | NABRIVA THERAPEUTICS AG |
| EP3299370 | CRYSTALLINE FORMS OF DIAZABICYCLOOCTANE DERIVATIVE AND PRODUCTION PROCESS THEREOF | ABE TAKAO | MEIJI SEIKA PHARMA CO LTD |
| EP3299371 | HYDROXYL PURINE COMPOUNDS AND USE THEREOF | WU LINGYUN | GUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD |
| EP3299384 | TRUNCATED ROTAVIRUS VP4 PROTEIN AND APPLICATION THEREOF | GE SHENGXIANG | UNIV XIAMEN |
| EP3299810 | METHOD FOR DETERMINING APPLICATION OF NOVEL THERAPY TO MULTIPLE SCLEROSIS (MS) PATIENT | YAMAMURA TAKASHI | NAT CENTER NEUROLOGY & PSYCHIATRY |
| EP3300482 | USE OF PRG4 TO IMPROVE DYNAMIC VISUAL ACUITY AND HIGHER ORDER ABERRATIONS | SULLIVAN BENJAMIN D | LUBRIS LLC |
| EP3300736 | COMPOSITION COMPRISING ANTIBIOTIC COMPOUND AND AN HETEROCYCLIC COMPOUND AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS | BONNARD DAMIEN | MUTABILIS |
| EP3300795 | A PROCESS FOR OBTAINING MICROCAPSULES | BERNARDINI MARCO | SIPCAM SPA |
| EP3301178 | THE MIRNA-212/132 FAMILY AS A THERAPEUTIC TARGET | THUM THOMAS | MAX PLANCK GESELLSCHAFT |
| EP3302263 | HEAT SUBSTRATE AND/OR IMAGE ENHANCEMENT COMPOSITIONS AND ENHANCED TISSUE ABLATION METHODS | DUPUY DAMIAN E | UNIV BROWN |
| EP3302289 | METHOD AND DEVICE FOR COLLECTING MYCOBACTERIUM COMPLEX SPECIES FROM THE ORAL CAVITY OF A PATIENT | GROBLER ANNE FREDERICA | UNIV NORTHWEST |
| EP3302347 | PROCESS FOR TAKING A DENTAL IMPRESSION AND CURABLE COMPOSITION FOR USE IN A DENTAL IMPRESSIONING AND RETRACTION PROCESS | MAURER ANDREAS R | 3M INNOVATIVE PROPERTIES CO |
| EP3302409 | PROCESS FOR STIMULATING HYALURONIC ACID SYNTHESIS | THOMAS BERTRAND | CAUDALIE IP LTD |
| EP3302418 | ANTI-DANDRUFF AGENTS | KERR RUSSELL GREIG | CRODA INT PLC |
| EP3302421 | COMPOSITIONS COMPRISING AT LEAST ONE DISPERSED ACTIVE PRINCIPLE AND LIPID MICROCAPSULES | DUBAYLE CAROLE | GALDERMA RES & DEV |
| EP3302440 | MODIFIED OR TARGETED RELEASE FORMULATIONS OF LINACLOTIDE | HASHASH AHMAD | IRONWOOD PHARMACEUTICALS INC |
| EP3302454 | COMPOSITIONS FOR USE IN TREATING PARKINSON'S DISEASE AND RELATED DISORDERS | AFONSO NUNO | TECHNOPHAGE INVESTIG E DESENVOLVIMENTO EM BIOTECNOLOGIA SA |
| EP3302471 | TETRASUBSTITUTED ALKENE COMPOUNDS AND THEIR USE | BOCK MARK | EISAI R&D MAN CO LTD |
| EP3302474 | COMPOSITIONS FOR TREATMENT OF ATROPHIC VAGINITIS, PERI-AND POST-MENOPAUSAL DYSPAREUNIA, AND/OR OOPHORECTOMIZED FEMALES AND TREATMENT METHODS THEREWITH | CHRISTOPHER ANASTASIA M | DURGA ENTPR LLC |
| EP3302478 | PAC-1 COMBINATION THERAPY | HERGENROTHER PAUL J | UNIV ILLINOIS |
| EP3302492 | HALOGENATED SALICYLANILIDES FOR TREATING CLOSTRIDIUM INFECTIONS | SOMMER MORTEN OTTO ALEXANDER | ANTIBIOTX APS |
| EP3302493 | NEW USE OF INHIBITOR OF CYSTINE-GLUTAMATE TRANSPORTER | HSIEH CHIA-HUNG | |
| EP3302496 | DOTMP KIT FORMULATIONS FOR RADIOISOTOPES | FRANK R KEITH | ISOTHERAPEUTICS GROUP LLC |
| EP3302501 | COMBINATION OF A PD-1 ANTAGONIST AND CPG-C TYPE OLIGONUCLEOTIDE FOR TREATING CANCER | YU YING | MERCK SHARP & DOHME |
| EP3302519 | ORNITHODOROS MOUBATA COMPLEMENT INHIBITOR FOR USE IN THE TREATMENT OF ACUTE GRAFT VERSUS HOST DISEASE | WESTON-DAVIES WYNNE H | VOLUTION IMMUNO PHARMACEUTICALS SA |
| EP3302531 | IMMUNE TOLERANT AND NON-IMMUNE TOLERANT ELASTIN-LIKE RECOMBINANT PEPTIDES AND METHODS OF USE | CHEN MINGNAN | UNIV UTAH RES FOUND |
| EP3302570 | TRIMALEIMIDE LINKERS AND USES THEREOF | HAN NIANHE | NEWBIO THERAPEUTICS INC |
| EP3302576 | MULTIVALENT TARGETING FLUORESCENT TRACER IN THE NEAR INFRARED RANGE FOR OPTICAL IMAGING | GAYET PASCAL | FLUOPTICS |
| EP3302580 | COMPOSITIONS AND METHODS FOR REDUCING THE RISK OF POST-IMAGING PANCREATITIS | HUSAIN SOHAIL | UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION |
| EP3302581 | DIAGNOSTIC IMAGING AGENT FOR EARLY BONE METASTASIS FROM CANCER | OKA SHUNTARO | NIHON MEDIPHYSICS CO LTD |
| EP3302703 | METHODS AND COMPOSITIONS TO MODULATE THE GUT MICROBIOTA AND TO MANAGE WEIGHT | CELIKER HASAN | XENO BIOSCIENCES INC |
| EP3302709 | METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION | KHALILI KAMEL | UNIV TEMPLE |
| EP3303283 | FTO INHIBITORS | HUANG NIU | NAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING |
| EP3303317 | METHODS AND COMPOSITIONS FOR INHIBITING THE INTERACTION OF MENIN WITH MLL PROTEINS | GREMBECKA JOLANTA | KURA ONCOLOGY INC |
| EP3303334 | TYROSINE KINASE INHIBITORS | GOLDSTEIN DAVID | PRINCIPIA BIOPHARMA INC |
| EP3303335 | HETEROCYCLIC COMPOUNDS FOR TREATING PSORIASIS | ZHANG JINTAO | JS INNOPHARM SHANGHAI LTD |
| EP3303339 | PDE9 INHIBITORS WITH IMIDAZO TRIAZINONE BACKBONE AND IMIDAZO PYRAZINONE BACKBONE FOR TREATMENT OF PERIPHERAL DISEASES | SVENSTRUP NIELS | H LUNDBECK AS |
| EP3303340 | POLYKETIDES, METHODS OF USE AND PREPARATION | WU CHANGSHENG | UNIV LEIDEN |
| EP3303342 | IMIDAZO-PYRAZINYL DERIVATIVES USEFUL AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS | GARFUNKLE JOIE | MERCK SHARP & DOHME |
| EP3303357 | VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE SEROTYPE 5 | ANISH CHAKKUMKAL | MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WSS |
| EP3303378 | INHIBITORS OF PROTOTYPIC GALECTIN DIMERIZATION AND USES THEREOF | CHATENET DAVID | INST NAT RECH SCIENT |
| EP3303384 | NEUTRALIZING ANTI-INFLUENZA BINDING MOLECULES AND USES THEREOF | KALLEWAARD-LELAY NICOLE | MEDIMMUNE LLC |
| EP3303570 | METHODS FOR CULTURING AND/OR DIFFERENTIATING HEMATOPOIETIC STEM CELLS INTO PROGENITORS AND USES THEREOF | LAGANIèRE JOSéE | HEMA QUEBEC |
| EP3305276 | SKIN ADHESIVE SHEET, AND SHEET-LIKE EXTERNAL PREPARATION FOR SKIN | KITAGAWA RUMIKO | TORAY INDUSTRIES |
| EP3305279 | ULTRAVIOLET RADIATION ABSORBING POLYMER COMPOSITION | EHLIS THOMAS | JOHNSON & JOHNSON CONSUMER INC |
| EP3305291 | USES OF BENZIMIDAZOLE DERIVATIVE FOR NOCTURNAL ACID BREAKTHROUGH | LEE HA JIN | CJ HEALTHCARE CORP |
| EP3305305 | SILICATE CONTAINING COMPOSITIONS AND METHODS OF TREATMENT | STANLEY RICHARD THOMAS | HS PHARMACEUTICALS LLC |
| EP3305323 | HUMAN ANTIBODIES AND SPECIFIC BINDING SEQUENCES THEREOF FOR USE IN STROKE AND ISCHEMIA OR ISCHEMIC CONDITIONS | RODRIGUEZ MOSES | MAYO FOUND MEDICAL EDUCATION & RES |
| EP3305341 | METHOD FOR PREPARING DENTAL COMPOSITE RESIN MATERIAL, AND PRODUCT PREPARED USING DENTAL COMPOSITE RESIN MATERIAL | QIU YUEXIU | LIAONING UPCERA DENTAL CO LTD |
| EP3305370 | ALGAE AUTOPHAGY ACTIVATOR | HOFMEISTER DIRK | CHEMISCHES LABORATORIUM DR KURT RICHTER GMBH |
| EP3305785 | PYRIDO[3,4-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | MIZUNO TSUYOSHI | TEIJIN PHARMA LTD |
| EP3305802 | NOVEL PEPTIDE AND COMPOSITION CONTAINING THE SAME | KIM SANG JAE | GEMVAX & KAEL CO LTD |
| EP3307235 | EMULSIONS FOR ENHANCED REDUCTIVE DECOLORATION OF KERATIN FIBERS | SCHÖPGENS JüRGEN | HENKEL AG & CO KGAA |
| EP3307251 | FLUOROCYCLOPENTENYLCYTOSINE USES AND PROCESSES OF PREPARATION | LEE YOUNG BOK | REXAHN PHARMACEUTICALS INC |
| EP3307262 | COMPOUNDS FOR USE IN TREATING NEUROMUSCULAR DISORDERS | HOLM PEDERSEN THOMAS | NMD PHARMA APS |
| EP3307268 | SUBSTITUTED PHENYLOXAZOLIDINONES FOR ANTIMICROBIAL THERAPY | COOPER CHRISTOPHER B | THE GLOBAL ALLIANCE FOR TB DRUG DEV INC |
| EP3307275 | INJECTABLE ANTIBIOTIC FORMULATIONS AND USE THEREOF | HEPLER DOUGLAS I | PIEDMONT ANIMAL HEALTH LLC |
| EP3307280 | TREATMENT OF SEXUAL DYSFUNCTION | GOREN OFER A | REJOY |
| EP3307289 | MICROBIOTA RESTORATION THERAPY (MRT) COMPOSITIONS AND METHODS OF MANUFACTURE | JONES LEE A | REBIOTIX INC |
| EP3307296 | METHODS AND COMPOSITIONS FOR TREATING AGING-ASSOCIATED CONDITIONS | WYSS-CORAY ANTON | UNIV LELAND STANFORD JUNIOR |
| EP3307315 | METHOD FOR PREPARATION OF ALUMINIUM PHOSPHATE GEL FOR APPLICATION IN VACCINE FORMULATIONS | RAVI GANAPATHY | BIOLOGICAL E LTD |
| EP3307322 | HUMANIZED ANTI-CD40 ANTIBODIES AND USES THEREOF | YU BO | PRIMATOPE THERAPEUTICS INC |
| EP3307330 | METHOD OF TREATMENT USING ONCOLYTIC VIRUSES | MOHR IAN J | UNIV NEW YORK |
| EP3307428 | MICROCAPSULES MODIFIED WITH NANOMATERIAL FOR CONTROLLED RELEASE OF ACTIVE AGENT AND PROCESS FOR PREPARATION THEREOF | SHUKLA PARSHURAM GAJANAN | COUNCIL SCIENT IND RES |
| EP3307722 | SOLID FORMS OF (Z)-4-(5-((3-BENZYL-4-OXO-2-THIOXOTHIAZOLIDIN-5-YLIDENE)METHYL)FURAN-2-YL)BENZOIC ACID | BARBOSA ANTONIO J | ADHAERE PHARMACEUTICALS INC |
| EP3307733 | MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS | GALLANT MICHEL | VERTEX PHARMA |
| EP3307752 | TERNARY MIXTURES OF 6'-SL, LNnT and LST c | CHAMPION ELISE | GLYCOM AS |
| EP3307784 | CARBONIC ANHYDRASE IX-SPECIFIC ANTIBODIES AND USES THEREOF | LENFERINK ANNE E G | NAT RES COUNCIL CANADA |
| EP3307875 | METHODS FOR THE PRODUCTION OF TCR GAMMA DELTA+ T CELLS | ANJOS DIOGO ANTONIO REMECHIDO | LYMPHACT LYMPHOCYTE ACTIVATION TECH S A |
| EP3308772 | INHALABLE EPINEPHRINE | BATYCKY RICHARD P | CIVITAS THERAPEUTICS INC |
| EP3308783 | USE OF COMPOSITION FOR PREPARING A MEDICAMENT FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS | YANG SHIBAO | JIANGSU SIMCERE PHARM CO LTD |
| EP3308796 | ACTIVIN-ACTRII ANTAGONISTS AND USES FOR TREATING BONE AND OTHER DISORDERS | SCHORR SLOAN VICTOR | CELGENE CORP |
| EP3308800 | ADJUVANT FOR VACCINES, VACCINE, AND IMMUNITY INDUCTION METHOD | UEMATSU SATOSHI | UNIV TOKYO |
| EP3309150 | (R)-3-(4'-(2-(2-METHYLPYRROLIDIN-1-YL)ETHYL)BIPHENYL-4-YL)PROPANOIC ACID AS HISTAMINE H3 RECEPTOR MODULATORS FOR THE TREATMENT OF COGNITIVE DISORDERS | COVEL JONATHAN A | ARENA PHARM INC |
| EP3309171 | BLOOD-BRAIN BARRIER PERMEABLE PEPTIDE COMPOSITIONS | BHATT RAM S | ICB INT INC |
| EP3309172 | HUMANIZED ANTIBODY AGAINST AMYLOID BETA | PFEIFER ANDREA | AC IMMUNE SA |
| EP3310326 | MULTI-LAYER TOPICALLY-APPLIED ARTICLE FOR PROVIDING A BENEFIT TO SKIN | BINNER CURT | JOHNSON & JOHNSON CONSUMER INC |
| EP3310337 | IMPLANTS INCLUDING AN OXYSTEROL AND METHODS OF USE | REVES BENJAMIN T | WARSAW ORTHOPEDIC INC |
| EP3310345 | ORODISPERSIBLE TABLET CONTAINING ESTETROL | JASPART SéVERINE FRANCINE ISABELLE | MITHRA PHARMACEUTICALS S A |
| EP3310346 | ORODISPERSIBLE TABLET CONTAINING ESTETROL | JASPART SéVERINE FRANCINE ISABELLE | MITHRA PHARMACEUTICALS S A |
| EP3310347 | LONG-ACTING COAGULATION FACTORS AND METHODS OF PRODUCING SAME | FIMA UDI EYAL | OPKO BIOLOGICS LTD |
| EP3310349 | COMPOSITIONS AND METHODS FOR ENHANCING NEUROGENESIS IN ANIMALS | PAN YUANLONG | NESTEC SA |
| EP3310364 | IRON CARBOHYDRATE COMPLEX FOR TREATMENT OF IRON DEFICIENCY OF A FETUS OR AN INFANT | THOMSEN LARS LYKKE | PHARMACOSMOS HOLDING AS |
| EP3310386 | COMBINATION THERAPIES FOR HEME MALIGNANCIES WITH ANTI-CD38 ANTIBODIES AND SURVIVIN INHIBITORS | DOSHI PARUL | JANSSEN BIOTECH INC |
| EP3310388 | CONDITIONING PROTOCOLS AND USE OF SAME FOR TISSUE REGENERATION | REISNER YAIR | YEDA RES & DEV |
| EP3310769 | TREPROSTINIL DERIVATIVES AND COMPOSITIONS AND USES THEREOF | ZHANG XIAOMING | CORSAIR PHARMA INC |
| EP3310782 | IMIDAZO-PYRAZINYL DERIVATIVES USEFUL AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS | GARFUNKLE JOIE | MERCK SHARP & DOHME |
| EP3310786 | DRUG DELIVERY AND IMAGING CHEMICAL CONJUGATE, FORMULATIONS AND METHODS OF USE THEREOF | ADELMAN STEVEN JAY | NANOPHAGIX LLC |
| EP3310800 | DELIVERY SYSTEMS FOR CONTROLLED DRUG RELEASE | KRATZ FELIX | CYTRX CORP |
| EP3310801 | TGR5 MODULATORS AND METHODS OF USE THEREOF | PELLICCIARI ROBERTO | INTERCEPT PHARMACEUTICALS INC |
| EP3310919 | VECTORS FOR USE IN AN INDUCIBLE COEXPRESSION SYSTEM | MCCLAIN SEAN | ABSCI LLC |
| EP3310931 | CRISPR/CAS9 COMPLEX FOR INTRODUCING A FUNCTIONAL POLYPEPTIDE INTO CELLS OF BLOOD CELL LINEAGE | TOWNES TIM | UAB RES FOUND |
| EP3311666 | DIKETONES AND HYDROXYKETONES AS CATENIN SIGNALING PATHWAY ACTIVATORS | KC SUNIL KUMAR | SAMUMED LLC |
| EP3311808 | ADHESIVE PREPARATION CONTAINING BISOPROLOL | ABE ERIKO | TOA EIYO LTD |
| EP3311828 | MODIFIED VASOACTIVE INTESTINAL PEPTIDES | SADEGHI HOMAYOUN | PHASEBIO PHARMACEUTICALS INC |
| EP3311835 | ADMINISTRATION OF HYPOXIA ACTIVATED PRODRUGS AND ANTIANGIOGENIC AGENTS FOR THE TREATMENT OF CANCER | KROLL STEWART | THRESHOLD PHARMACEUTICALS INC |
| EP3311840 | TREATMENT-RESISTANCE REDUCING AGENT FOR TREATMENT-RESISTANT CANCER | BAGHDADI MUHAMMAD | UNIV HOKKAIDO NAT UNIV CORP |
| EP3311841 | ANTICANCER AGENT | ODAGAMI TAKENAO | PRISM PHARMA CO LTD |
| EP3312163 | DEUTERIUM-SUBSTITUTED DEHYDROPHENYLAHISTIN-LIKE COMPOUND, PREPARATION METHOD THEREOF AND USE IN PREPARATION OF ANTITUMOR DRUG | LI WENBAO | MARINE BIOMEDICAL RES INST QINGDAO CO LTD |
| EP3312169 | 5-HT3 RECEPTOR ANTAGONISTS | HITCHCOCK STEPHEN | TAKEDA PHARMACEUTICALS CO |
| EP3312173 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | KANAI TOSHIMI | KYOWA HAKKO KIRIN CO LTD |
| EP3312177 | TRICYCLIC DERIVATIVE COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | LEE HYUNHO | JEIL PHARMACEUTICAL CO LTD |
| EP3313286 | METHOD AND APPARATUS FOR DETERMINING BIOMETRIC INDICATORS USING MULTIPLE FLUORESCENT MARKERS | MEIER DANIEL J | PHARMACOPHOTONICS INC D/B/A FAST BIOMEDICAL |
| EP3313385 | AZIRIDINE CONTAINING DNA ALKYLATING AGENTS | MATTEUCCI MARK | THRESHOLD PHARMACEUTICALS INC |
| EP3313396 | G PROTEIN-COUPLED RECEPTOR KINASE INHIBITORS AND METHODS FOR USE OF THE SAME | LARSEN SCOTT D | UNIV MICHIGAN REGENTS |
| EP3313401 | METHODS OF TREATING EPITHELIOID CELL TUMORS | DESAI NEIL P | ABRAXIS BIOSCIENCE LLC |
| EP3313415 | COMPOSITION FOR THE PREVENTION OF MICROBIAL GROWTH | RODRIGUEZ INGRID | EIKONIC R&D PTY LTD |
| EP3313429 | IMMUNOMODULATION FOR THE LONG TERM PREVENTION AND TREATMENT OF AUTOIMMUNE DISEASES AND FOREIGN TISSUE REJECTION | SHIRWAN HAVAL | UNIV LOUISVILLE RES FOUND INC |
| EP3313453 | METHOD FOR IMAGING ARTHRITIS | GARROOD TOBY | GUYS AND ST THOMAS NHS FOUND TRUST |
| EP3313527 | ANTICANCER DRUG-CONTAINING PLANT VIRUS PARTICLES | STEINMETZ NICOLE F | UNIV CASE WESTERN RESERVE |
| EP3313528 | IMMUNOTHERAPEUTIC DOSING REGIMENS COMPRISING POMALIDOMIDE AND AN ANTI-CS1 ANTIBODY FOR TREATING CANCER | MULLIGAN CHRISTOPHER LEE | SQUIBB BRISTOL MYERS CO |
| EP3313831 | N-SUBSTITUTED HYDROXAMIC ACIDS WITH CARBON-BASED LEAVING GROUPS AS EFFICIENT HNO DONORS AND USES THEREOF | TOSCANO JOHN P | UNIV JOHNS HOPKINS |
| EP3313832 | 3-TETRAZOLYL-BENZENE-1,2-DISULFONAMIDE DERIVATIVES AS METALLO-BETA-LACTAMASE INHIBITORS | BENNETT FRANK | MERCK SHARP & DOHME |
| EP3313833 | COMPOUNDS AND THEIR USE AS INHIBITORS OF N-MYRISTOYL TRANSFERASE | BELL ANDREW SIMON | IMP INNOVATIONS LTD |
| EP3313857 | POLYMER-CYCLODEXTRIN-LIPID CONJUGATES | WU NIAN | WU NIAN |
| EP3313864 | PRRSV MINOR PROTEIN-CONTAINING RECOMBINANT VIRAL VECTORS AND METHODS OF MAKING AND USE THEREOF | MEBATSION TESHOME | MERIAL INC |
| EP3313865 | SYNTHETIC PEPTIDE COMPOUNDS AND METHODS OF USE | KRISHNA NEEL K | EASTERN VIRGINIA MEDICAL SCHOOL |
| EP3315116 | TOPICAL SUNSCREEN COMPOSITION, METHOD OF PREPARATION, AND USE THEREOF | DUDLEY DENIS | CYBERDERM LABORATORIES INC |
| EP3315121 | PHARMACEUTICAL COMPOSITIONS | FRASER SCOTT | WARNEFORD HEALTHCARE LTD |
| EP3315124 | BILAYER TABLET FORMULATIONS | ABEBE ADMASSU | ASTRAZENECA AB |
| EP3315128 | DOSING REGIMEN OF THERAPEUTIC AGENT FOR ATAXIA ASSOCIATED WITH SPINOCEREBELLAR DEGENERATION | SHIMIZU YOSHITAKA | KISSEI PHARMACEUTICAL |
| EP3315136 | CANCER THERAPEUTIC DRUG AND CANCER TREATMENT METHOD | NIIMORI KANAKO | UNIV KUMAMOTO NAT UNIV CORP |
| EP3315139 | A DELIVERY SYSTEM FOR TARGETED DELIVERY OF A THERAPEUTICALLY ACTIVE PAYLOAD | TEMME ACHIM | UNIV DRESDEN TECH |
| EP3315499 | CRYSTAL OF (6S,9aS)-N-BENZYL-6-[(4-HYDROXYPHENYL)METHYL]- 4,7-DIOXO-8-({6-[3-(PIPERAZIN-1-YL)AZETIDIN-1-YL]PYRIDIN- 2-YL}METHYL)-2-(PROP-2-EN-1-YL)-OCTAHYDRO-1H-PYRAZINO[2,1-c][1,2,4]TRIAZINE-1-CARBOXAMIDE COMPOUND | KUSHIDA IKUO | EISAI R&D MAN CO LTD |
| EP3315509 | POLYMERIZED PEPTIDE AND GEL HAVING COLLAGEN-LIKE STRUCTURE | KOIDE TAKAKI | UNIV WASEDA |
| EP3316856 | BLENDED FORMULATIONS | HENRY WILLIAM | SEQUESSOME TECH HOLDINGS LIMITED |
| EP3316857 | MULTIPHASIC COMPOSITIONS | GARRAWAY RICHARD WOLF | SEQUESSOME TECH HOLDINGS LIMITED |
| EP3316867 | IMMEDIATE-RELEASE TABLETS CONTAINING A DRUG AND PROCESSES FOR FORMING THE TABLETS | KOTHARI SANJEEV | GENENTECH INC |
| EP3316873 | DEVICE FOR ORAL DELIVERY OF ACTIVE AGENTS | BONNER DANIEL | ENTREGA INC |
| EP3316875 | METHODS TO DIAGNOSE AND TREAT ACUTE RESPIRATORY INFECTIONS | TSALIK EPHRAIM L | UNIV DUKE |
| EP3316880 | THIRD GENERATION TAXOIDS AND METHODS OF USING SAME | OJIMA IWAO | UNIV NEW YORK STATE RES FOUND |
| EP3316885 | ANTIBODY-SN-38 IMMUNOCONJUGATES WITH A CL2A LINKER | GOVINDAN SERENGULAM V | IMMUNOMEDICS INC |
| EP3316900 | AMMONIA OXIDIZING BACTERIA FOR TREATMENT OF ACNE | WHITLOCK DAVID R | AOBIOME LLC |
| EP3316972 | MICROCAPSULES | AUSSANT EMMANUEL | GIVAUDAN SA |
| EP3317255 | ARYL SULFONAMIDE COMPOUNDS AS CARBONIC ANHYDRASE INHIBITORS AND THEIR THERAPEUTIC USE | ZHANG ZAIHUI | SIGNALCHEM LIFESCIENCES CORP |
| EP3317273 | INHIBITORS OF EGFR AND METHODS OF USE THEREOF | GRAY NATHANAEL | DANA FARBER CANCER INST INC |
| EP3317277 | SOMATOSTATIN MODULATORS AND USES THEREOF | ZHU YUNFEI | CRINETICS PHARMACEUTICALS INC |
| EP3317278 | SOMATOSTATIN MODULATORS AND USES THEREOF | ZHAO JIAN | CRINETICS PHARMACEUTICALS INC |
| EP3317279 | TRIAZA-SPIRODECANONES AS DDR1 INHIBITORS | BUETTELMANN BERND | HOFFMANN LA ROCHE |
| EP3317289 | NOVEL SUBSTITUTED AMINOTHIAZOLOPYRIMIDINEDIONE FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION | WANG LISHA | HOFFMANN LA ROCHE |
| EP3317301 | COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO LAG-3 | DRANOFF GLENN | NOVARTIS AG |
| EP3317410 | DISCONTINUOUS OLIGONUCLEOTIDE LIGANDS | GOLDECK MARION | UNIV BONN RHEINISCHE FRIEDRICH WILHELMS |
| EP3318245 | UV-BLOCKING COSMETIC COMPOSITION | JUNG HA JIN | AMOREPACIFIC CORP |
| EP3318246 | WHITENING COSMETIC COMPOSITION COMPRISINGCARAGANA SINICA | PARK SUNG MIN | CELLTRION INC |
| EP3318251 | COMPOSITION FOR PREVENTING OR TREATING OBESITY OR LIPID-RELATED METABOLIC DISEASE | CHUNG MYUNG JUN | CELL BIOTECH CO LTD |
| EP3318254 | AZELAIC ACID COMPOSITION HAVING ADIPOSE TISSUE TRIGLYCERIDE DEGRADATION EFFECT | LEE SUNG-JOON | UNIV KOREA RES & BUS FOUND |
| EP3318255 | COMPOSITIONS AND METHODS FOR LOWERING TRIGLYCERIDES WITHOUT RAISING LDL-C LEVELS IN A SUBJECT ON CONCOMITANT STATIN THERAPY | OSTERLOH IAN | AMARIN PHARMACEUTICALS IE LTD |
| EP3318257 | DRUG FOR PREVENTING OR TREATING INFLAMMATORY BOWEL DISEASE | KAKUTA HIROKI | NAT UNIV CORPORATION OKAYAMA UNIV |
| EP3318263 | ANTIOXIDANT COMPOSITION AND COMPOSITION FOR IMPROVEMENT OF SKIN CONDITIONS | CHUNG MYUNG JUN | CELL BIOTECH CO LTD |
| EP3318265 | PEPTIDE HAVING ANTI-VIRAL EFFECT AND COMPOSITION CONTAINING SAME | KIM SANG JAE | GEMVAX & KAEL CO LTD |
| EP3318267 | HUNTER SYNDROME THERAPEUTIC AGENT AND TREATMENT METHOD | LEE JIN-KYUNG | GREEN CROSS CORP |
| EP3318268 | ROSEBURIA FLAGELLIN AND IMMUNE MODULATION | KELLY DENISE | 4D PHARMA RES LTD |
| EP3318561 | HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF | CAMPBELL JOHN EMMERSON | SUNOVION PHARMACEUTICALS INC |
| EP3318564 | BICYCLIC HETEROCYCLES AS FGFR INHIBITORS | SUN YAPING | INCYTE HOLDINGS CORP |
| EP3318565 | PYRROLO[2,3-D]PYRIMIDINYL, PYRROLO[2,3-B]PYRAZINYL AND PYRROLO[2,3-D]PYRIDINYL ACRYLAMIDES | BROWN MATTHEW FRANK | PFIZER |
| EP3318572 | COMPOSITION COMPRISING AMINO ACID AND CYCLIC DIPEPTIDE | FUKIZAWA SHINYA | SUNTORY HOLDINGS LTD |
| EP3318575 | ALBUMIN-SUGAR CHAIN COMPLEX | TANAKA KATSUNORI | GLYTECH INC |
| EP3319597 | COMPOSITIONS COMPRISING ANTIBODY-DUOCARMYCIN DRUG CONJUGATES | OSINGA NIELS JAAP | SYNTHON BIOPHARMACEUTICALS BV |
| EP3319599 | COMBINATIONS OF A NEONICOTINOID AND A PYRETHROID FOR CONTROLLING THE SPREAD OF DIROFILARIOSIS | VARLOUD MARIE | CEVA SANTE ANIMALE |
| EP3319603 | PRE-FRONTAL CORTEX PROCESSING DISORDER, GAIT AND LIMB IMPAIRMENT TREATMENT | ROSEMAN BRUCE | GILROSE PHARMACEUTICALS LLC |
| EP3319611 | OXYSTEROLS AND METHODS OF USE THEREOF | SALITURO FRANCESCO G | SAGE THERAPEUTICS INC |
| EP3319612 | OXYSTEROLS AND METHODS OF USE THEREOF | SALITURO FRANCESCO G | SAGE THERAPEUTICS INC |
| EP3319618 | PROCESS FOR PRODUCING EGG YOLK WITH HIGH CONTENT OF AF-16 | LANGE STEFAN | LANTMAENNEN AS FAKTOR AB |
| EP3319635 | A CHECKPOINT INHIBITOR AND A WHOLE CELL MYCOBACTERIUM FOR USE IN CANCER THERAPY | AKLE CHARLES | IMMODULON THERAPEUTICS LTD |
| EP3319640 | COMPOSITION AND METHODS OF TREATMENT | RIDDEN JOHN | BLUEBERRY THERAPEUTICS LTD |
| EP3319641 | NOVEL PSMA-SPECIFIC BINDING PROTEINS | SKERRA ARNE | UNIV MUENCHEN TECH |
| EP3319692 | NANOASSEMBLED COMPLEXES OF NUCLEIC ACIDS, AVIDIN AND BIOTINYLATED COMPOUNDS FOR USE AS DRUG CARRIERS | MORPURGO MARGHERITA | JOINTHERAPEUTICS S R L |
| EP3319694 | SOLID STICK ANTIPERSPIRANT COMPOSITIONS HAVING NON-VOLATILE SILICONES | MENON ELTON LUIS | PROCTER & GAMBLE |
| EP3319945 | 2-ARYL- AND 2-ARYLALKYL-BENZIMIDAZOLES AS MIDH1 INHIBITORS | PANKNIN OLAF | BAYER PHARMA AG |
| EP3319950 | VICINAL PRIMARY DIAMINES ASSOCIATED WITH METAL AND/OR FREE RADICAL CHELATION MOTIFS, AND ACTIVE AGAINST CARBONYL AND OXIDATIVE STRESS, AND USE THEREOF | SASAKI NOBUMICHI ANDRé | UNIV AMIENS PICARDIE JULES VERNE |
| EP3319956 | SUBSTITUTED OXOPYRIDINE DERIVATIVES | JIMENEZ NUNEZ ELOISA | BAYER PHARMA AG |
| EP3319959 | HETERO-HALO INHIBITORS OF HISTONE DEACETYLASE | JEFSON MARTIN R | RODIN THERAPEUTICS INC |
| EP3319976 | COMPOSITIONS AND METHODS FOR TREATING LUNG DISEASES AND LUNG INJURY | CHEN KUAN-JU | INSMED INC |
| EP3319980 | FORMULATIONS FOR IMPROVING THE EFFICACY OF HYDROPHOBIC DRUGS | HOMAN REYNOLD | PEPTINOVO BIOPHARMA LLC |
| EP3320101 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR EXPRESSING A POLYNUCLEOTIDE OF INTEREST IN THE PERIPHERAL NERVOUS SYSTEM OF A SUBJECT | AUBOURG PATRICK | INST NAT SANTE RECH MED |
| EP3320891 | HAIR COSMETIC | MORIOKA TOMOKI | KAO CORP |
| EP3320895 | RAPID-ACTING, BLOOD-ARGININE-LEVEL-INCREASABLE ORAL PREPARATION COMPRISING CITRULLINE AND ARGININE | OCHIAI MASAYUKI | KYOWA HAKKO BIO CO LTD |
| EP3320902 | METHODS FOR TREATING DISEASES USING ISOINDOLINE COMPOUNDS | SCHAFER PETER H | CELGENE CORP |
| EP3320903 | PHARMACEUTICAL COMPOSITION CONTAINING AMLODIPINE, VALSARTAN, AND ROSUVASTATIN | JUNG YOON SEOK | CJ HEALTHCARE CORP |
| EP3320911 | ACTIVIN-ACTRII ANTAGONISTS AND USES FOR INCREASING RED BLOOD CELL LEVELS | SHERMAN MATTHEW L | ACCELERON PHARMA INC |
| EP3320912 | INDOLEAMINE 2, 3-DIOXYGENASE BASED IMMUNOTHERAPY | ANDERSEN MADS HALD | IO BIOTECH APS |
| EP3320916 | A MEDICAMENT FOR USE IN A METHOD OF INDUCING OR EXTENDING A CELLULAR CYTOTOXIC IMMUNE RESPONSE | KROCZEK RICHARD | BUNDESREPUBLIK DEUTSCHLAND LETZTVERTRETEN DURCH DAS ROBERT KOCH INST VERTRETEN DURCH SEINEN PRAESIDE |
| EP3321262 | SERINE/THREONINE KINASE INHIBITORS | BLAKE JAMES F | ARRAY BIOPHARMA INC |
| EP3321286 | BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES | AST OLIVER | ROCHE GLYCART AG |
| EP3321355 | METHODS AND COMPOSITIONS FOR THE CLINICAL DERIVATION OF AN ALLOGENIC CELL AND THERAPEUTIC USES | PATEL AMIT | PATEL AMIT |
| EP3322412 | USE OF AMITRIPTYLINE FOR BLOCKING BRAIN HEMICHANNELS AND METHOD FOR POTENTIATING ITS EFFECT IN VIVO | JEANSON TIFFANY | THERANEXUS |
| EP3322420 | BICYCLIC HETEROCYCLES AS INHIBITORS OF CHOLESTEROL ESTER TRANSFER PROTEIN | SHAO PENGCHENG PATRICK | MERCK SHARP & DOHME |
| EP3322432 | PEPTIDES FOR USE IN PROMOTING TRANSPORT OF GLUCOSE | KHALDI NORA | NURITAS LTD |
| EP3322438 | IL-8 INHIBITORS FOR USE IN THE TREATMENT OF CERTAIN UROLOGICAL DISORDERS | ALLEGRETTI MARCELLO | DOMPE FARM SPA |
| EP3322454 | COMPOSITE MATERIAL FOR IMPLANTS, ITS USE AND METHOD OF ITS PRODUCTION | BALOG MARTIN | USTAV MATERIALOV A MECH STROJOV SAV |
| EP3322484 | COMPOSITIONS AND METHODS FOR TREATING CANCER | VAN VLERKEN-YSLA LILIAN EMILIA | MEDIMMUNE LLC |
| EP3322486 | COMPOSITIONS FOR PROVIDING FRIZZ-FREE WAVY HAIRSTYLES USING LOW HEAT | WHITE ANGIE | KAO USA INC |
| EP3322487 | MAGNOLIA BARK EXTRACT AS A HYDROPHOBIC LIGAND FOR PREFERENTIAL REMOVAL OF GRAM NEGATIVE BACTERIA FROM THE ORAL CAVITY | BUSSCHER HENK J | WRIGLEY W M JUN CO |
| EP3322711 | HPK1 INHIBITORS AND METHODS OF USING SAME | SAMPSON PETER BRENT | UNIV HEALTH NETWORK |
| EP3322713 | CYCLIC PURINE DINUCLEOTIDES AS MODULATORS OF STING | ADAMS JERRY LEROY | GLAXOSMITHKLINE IP DEV LTD |
| EP3322724 | IL-26 INHIBITORS | GILLIET MICHEL | CENTRE HOSPITALIER UNIV VAUDOIS CHUV |
| EP3322731 | METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR | MANEKAS DEMETRIOS | SQUIBB BRISTOL MYERS CO |
| EP3322733 | HIDE1 COMPOSITIONS AND METHODS | DICKEN YOSEF | COMPUGEN LTD |
| EP3322736 | FUSION POLYPEPTIDES AND METHODS OF USE | LIU HONGYU | PROSIT SOLE BIOTECHNOLOGY BEIJING CO LTD |
| EP3322804 | NUCLEASE-INDEPENDENT TARGETED GENE EDITING PLATFORM AND USES THEREOF | JIN SHENGKAN | UNIV RUTGERS |
| EP3323409 | ULTRAVIOLET-RAY SCREENING AGENT AND COSMETIC | YAGYU TOSHIHIRO | SHODOSHIMA HEALTHY LAND CO LTD |
| EP3323419 | AGENT FOR TREATMENT OF MYOTONIC DYSTROPHY | NAKAMORI MASAYUKI | UNIV OSAKA |
| EP3323421 | OLIVE LEAF EXTRACT AND METHOD FOR PRODUCING SAME | YAGYU TOSHIHIRO | SHODOSHIMA HEALTHY LAND CO LTD |
| EP3323427 | HUMAN IMMUNODEFICIENCY VIRUS (HIV)-NEUTRALIZING ANTIBODIES | CHAN-HUI PO-YING | THERACLONE SCIENCES INC |
| EP3323431 | DIAGNOSTIC FOR CANCER | URANO YASUTERU | UNIV TOKYO |
| EP3323885 | CHIMERIC NOROVIRUS P PARTICLE AND PREPARATION AND USE THEREOF | KONG WEI | CHANGCHUN BCHT BIOTECHNOLOGY CO |
| EP3324932 | COMPOSITIONS AND METHODS FOR NANOPARTICLE LYOPHILE FORMS | YING WENBIN | NITTO DENKO CORP |
| EP3324938 | TOPICAL FORMULATIONS AND TREATMENTS | ALUR HEMANT H | TRILOGIC PHARMA LLC |
| EP3324943 | MANNITOL GRANULES FOR DIRECT COMPRESSION | BOIT BAPTISTE | ROQUETTE FRERES |
| EP3324951 | PERITONEAL THERAPEUTIC FLUID | GRENTZMANN GUIDO | OPTERION HEALTH AG |
| EP3324958 | SALTS AND PRODRUGS OF 1-METHYL-D-TRYPTOPHAN | MAUTINO MARIO | NEWLINK GENETICS CORP |
| EP3324964 | AMPHIPHILIC PYRIDINIUM COMPOUNDS TO TREAT EPILEPSY AND OTHER DISORDERS OF THE NERVOUS SYSTEM | POLLARD BETTE SILVER | POLLARD BETTE SILVER |
| EP3324980 | MULTI-TARGETED SINGLE ENTITY CONJUGATES | JADHAV VASANT | ALNYLAM PHARMACEUTICALS INC |
| EP3324986 | MATERIALS AND METHODS FOR IMPROVING IMMUNE RESPONSES AND THE SKIN AND/OR MUCOSAL BARRIER FUNCTION | BERKES EVA A | QUORUM INNOVATIONS LLC |
| EP3324988 | USE OF ONCOLYTIC HERPES SIMPLEX VIRUS, ALONE OR IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITOR, IN THE TREATMENT OF CANCER | CONNER JOE | VIRTTU BIOLOGICS LTD |
| EP3324994 | METHODS OF REDUCING THE NEED FOR SURGERY IN PATIENTS SUFFERING FROM BENIGN PROSTATIC HYPERPLASIA | AVERBACK PAUL | NYMOX CORP |
| EP3325014 | METHODS FOR TREATING CANCER USING APILIMOD | LICHENSTEIN HENRI | LAM THERAPEUTICS INC |
| EP3325015 | LIPOSOMAL ADJUVANT COMPOSITIONS | DOMINOWSKI PAUL JOSEPH | ZOETIS SERVICES LLC |
| EP3325094 | COMPOSITIONS COMPRISING 15-HEPE FOR USE IN TREATING OR PREVENTING CANCER AND NEUROLOGIC DISEASE | CLIMAX JOHN | AFIMMUNE LTD |
| EP3325097 | COMPOSITIONS AND AGENTS AGAINST HEPATITIS B VIRUS AND USES THEREOF | LIMPHONG PATTRARANEE | ARCTURUS THERAPEUTICS INC |
| EP3325449 | HETEROCYCLIC COMPOUNDS, PARTICULARLY PYRIMIDINYLINDAZOLE COMPOUNDS FOR TREATING PARKINSON'S DISEASE | DING XIAO | GLAXOSMITHKLINE IP DEV LTD |
| EP3326606 | METHODS FOR FIXING HAIR AND SKIN | PRESSLY ERIC D | LIQWD INC |
| EP3326616 | LIPOSOMAL MITIGATION OF DRUG-INDUCED LONG QT SYNDROME AND POTASSIUM DELAYED-RECTIFIER CURRENT | HELSON LAWRENCE | SIGNPATH PHARMA INC |
| EP3326622 | MODIFIED AXL PEPTIDES AND THEIR USE IN INHIBITION OF AXL SIGNALING IN ANTI-METASTATIC THERAPY | GIACCIA AMATO J | UNIV LELAND STANFORD JUNIOR |
| EP3326626 | DERMATOMYCOSIS TREATMENT AGENT | YOSHIZAKI SHIRO | YOSHIZAKI SHIRO |
| EP3326631 | COMPOUND PAC-1 OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | WANG ZHIMIN | WANG ZHIMIN |
| EP3326632 | COMBINED ANTICANCER DRUG SENSITIVITY-DETERMINING MARKER | TANIGAWARA YUSUKE | UNIV KEIO |
| EP3326635 | TREATMENT AND PREVENTION OF THE COMMON COLD USING POVIDONE-IODINE | GOODALL STEPHEN | FIREBRICK PHARMA PTY LTD |
| EP3326637 | USE OF MANGOSTEEN RIND EXTRACT IN PREPARATION OF MEDICINE FOR TREATING SKIN DISEASES | CHANG JIA-MING | |
| EP3326640 | APPLICATIONS OF MUSSEL ADHESIVE PROTEIN PRODUCT IN TREATMENT AND PREVENTION OF DISEASES RELATED TO MELANIN | JANSON JAN CHRISTER | BENGT I SAMUELSSON INSTITUTE OF LIFE SCIENCE RES |
| EP3326643 | FACTOR VIII-FC CHIMERIC AND HYBRID POLYPEPTIDES, AND METHODS OF USE THEREOF | DUMONT JENNIFER A | BIOVERATIV THERAPEUTICS INC |
| EP3326648 | PHARMACEUTICAL COMPOSITIONS COMPRISING HUMAN ANTIBODIES TO PCSK9 | HANOTIN CORINNE | SANOFI BIOTECHNOLOGY |
| EP3326651 | ACETAMINOPHEN AND TRAMADOL COMPOUND ORAL SOLUTION | CHEN SHIH-MIN | |
| EP3326652 | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION COMPRISING HIGH CONCENTRATION TAXANE | LEE IN-HYUN | DAE HWA PHARMA CO LTD |
| EP3327012 | CRYSTALLINE FORMS OF BILASTINE AND PREPARATION METHODS THEREOF | DEL RíO PERICACHO JOSé LUIS | DISPROQUIMA S A |
| EP3327030 | VACCINES AND VACCINE COMPONENTS FOR INHIBITION OF MICROBIAL CELLS | ALTERMANN ERIC HEINZ | PASTORAL GREENHOUSE GAS RES LTD |
| EP3327036 | TUMOR-SPECIFIC ANTI-EGFR ANTIBODY AND APPLICATION THEREOF | WANG HUAMAO | CARSGEN THERAPEUTICS CO LTD |
| EP3327039 | HUMANIZED MONOCLONAL ANTIBODIES AND METHODS OF USE | SUI JIANHUA | DANA FARBER CANCER INST INC |
| EP3327040 | MULTIMERIC IL-15 SOLUBLE FUSION MOLECULES AND METHODS OF MAKING AND USING SAME | WONG HING C | ALTOR BIOSCIENCE CORP |
| EP3327118 | METHOD FOR INDUCING VASCULAR ENDOTHELIAL CELLS | NAKAHATA TATSUTOSHI | UNIV KYOTO |
| EP3327441 | METHOD FOR ASSISTING DIAGNOSIS OF CONDITIONS OF MYELOFIBROSIS, METHOD FOR ASSISTING PREDICTION OF PROGNOSIS, METHOD FOR MONITORING THERAPEUTIC EFFECT, AND MARKER AND DEVICE TO BE USED THEREIN | TANAKA YASUHITO | UNIV NAGOYA CITY PUBLIC UNIV CORP |
| EP3328345 | SHEET PACKS FOR TREATING FACIAL OR BODY SURFACES | CARULLO ANNE | ELC MAN LLC |
| EP3328355 | IMPLANT COMPOSITIONS FOR THE UNIDIRECTIONAL DELIVERY OF THERAPEUTIC COMPOUNDS TO THE BRAIN | MCGINITY MICHAEL J | UNIV TEXAS |
| EP3328361 | DRUG LOADED NANORESIN PARTICLES | KHOPADE AJAY JAYSINGH | SUN PHARMA ADVANCED RES CO LTD |
| EP3328366 | AQUEOUS FORMULATION COMPRISING SDS, TCA AND A COLLOIDAL SUSPENSION OF IRON(II) FOR USE IN THE TOPICAL TREATMENT OF MICRO-ORGANISMS AND PARASITES | MAGRO MASSIMILIANO | AINT S R L |
| EP3328379 | BIS-HETEROARYL DERIVATIVES AS MODULATORS OF PROTEIN AGGREGATION | WRASIDLO WOLFGANG | UCB BIOPHARMA SPRL |
| EP3328390 | CHOLECALCIFEROL SULFATE SALTS AND THEIR USE FOR THE TREATMENT OF VITAMIN D DEFICIENCY | SALAMI OYEWOLE TAYE | CFSO GMBH |
| EP3328395 | NEW USE OF DEXTRAN SULFATE | BRUCE LARS | TX MEDIC AB |
| EP3328396 | OPHTHALMIC FORMULATIONS COMPRISING COOPERATIVE COMPLEXES OF LOW- AND HIGH-MOLECULAR-WEIGHT HYALURONIC ACID | DE ROSA MARIO | ALTERGON SA |
| EP3328419 | PD-1-BINDING MOLECULES AND METHODS OF USE THEREOF | SHAH KALPANA | MACROGENICS INC |
| EP3328423 | ENHANCED IMMUNE RESPONSE IN AQUATIC SPECIES | WEISS CHRISTIAN | BAYER ANIMAL HEALTH GMBH |
| EP3328425 | COMBINED USE OF ANTI PD-1 AND ANTI M-CSF ANTIBODIES IN THE TREATMENT OF CANCER | FJAELLSKOG MARIE-LOUISE | NOVARTIS AG |
| EP3328426 | TREATMENT OF PATIENTS DIAGNOSED WITH PANCREATIC DUCTAL ADENOCARCINOMA USING MONOCLONAL ANTIBODIES AGAINST THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) | STRUMBERG DIRK | INNOCIMAB PTE LTD |
| EP3328498 | HERBAL COMBINATIONS FOR TREATING PSORIASIS | SHRAIBOM NADAV | SIRBAL LTD |
| EP3328813 | SINTERED ALUMINA-BASED AND ZIRCONIA-BASED PRODUCT | PERIE THOMAS | SAINT GOBAIN CT RECHERCHES |
| EP3328832 | FUCOSIDASE INHIBITORS | ZANKEL TODD C | HORIZON ORPHAN LLC |
| EP3328837 | INHIBITOR OF THE MUTATED ISOCITRATE DEHYDROGENASE IDH1 R132H | SCHIRMER HEIKO | BAYER PHARMA AG |
| EP3328852 | FACTOR XIA NEW MACROCYCLE BEARING A NON-AROMATIC P2' GROUP | ZHU YEHENG | SQUIBB BRISTOL MYERS CO |
| EP3328887 | ANTI-GM-CSF ANTIBODIES AND USES THEREOF | WANG ZHENGYI | I MAB |
| EP3329483 | MRI-CT COMPATIBLE DYNAMIC MOTION PHANTOM | YUE YONG | CEDARS SINAI MEDICAL CENTER |
| EP3329775 | PROCESSES FOR THE SYNTHESIS OF DIARYLTHIOHYDANTOIN AND DIARYLHYDANTOIN COMPOUNDS | THOMPSON ANDREW | MEDIVATION PROSTATE THERAPEUTICS LLC |
| EP3329909 | FENFLURAMINE FOR USE IN THE TREATMENT OF DRAVET SYNDROME | CEULEMANS BERTEN | KATHOLIEKE UNIV LEUVEN KU LEUVEN RESEARCH & DEVELOPMENT |
| EP3329913 | COMPOSITION FOR INHIBITING FORMATION OF SNARE COMPLEX, CONTAINING MYRICETIN DERIVATIVES | KWEON DAE HYUK | RESEARCH & BUSINESS FOUND SUNGKYUNKWAN UNIV |
| EP3329924 | DSRNA THERAPY FOR TRANSTHYRETIN (TTR) RELATED OCULAR AMYLOIDOSIS | ALVAREZ RENE | ALNYLAM PHARMACEUTICALS INC |
| EP3329925 | POLYION COMPLEX CAPABLE OF EFFICIENTLY DELIVERING MRNA INTO LIVING BODY, AND DRUG AND METHOD FOR TREATING ARTHROPATHY IN WHICH SAID COMPLEX IS USED | ITAKA KEIJI | ACCURNA INC |
| EP3329934 | ANTITUMOR IMMUNITY ENHANCING COMPOSITION CONTAINING ADENOVIRUS SIMULTANEOUSLY EXPRESSING IL-12 AND SHVEGF | YUN CHAE OK | UNIV HANYANG IND UNIV COOP FOUND |
| EP3329938 | CHROMOPHORE COMBINATIONS FOR BIOPHOTONIC USES | LOUPIS NIKOLAOS | KLOX TECH INC |
| EP3329966 | METHODS OF INDUCING ANESTHESIA | BROSNAN ROBERT J | UNIV CALIFORNIA |
| EP3330256 | HETEROCYCLIC DERIVATIVE HAVING TrkA-INHIBITING ACTIVITY | YUKIMASA AKIRA | SHIONOGI & CO |
| EP3330258 | 1, 3, 5-TRIAZINE DERIVATIVE AND METHOD OF USING SAME | ZHAO NA | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD |
| EP3330272 | FUSED TRICYCLIC HETEROCYCLIC COMPOUNDS AS HIV INTEGRASE INHIBITORS | COLEMAN PAUL J | MERCK SHARP & DOHME |
| EP3330379 | APTAMER AGAINST INSULIN RECEPTOR AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | RYU SUNG HO | POSCO |
| EP3331383 | NUTRITIONAL COMPOSITIONS AND INFANT FORMULAS COMPRISING BIFIDOBACTERIUM ANIMALIS SSP. LACTIS AND OPTIONALLY A MIX OF OLIGOSACCHARIDES FOR INDUCING A GUT MICROBIOTA CLOSE TO THE ONE OF BREAST FED INFANTS | GARCIA-RODENAS CLARA LUCIA | NESTEC SA |
| EP3331494 | COMPOSITION INTENDED TO VECTORISE AN ANTI-CANCER AGENT | ROBIC CAROLINE | GUERBET SA |
| EP3331496 | ANTIMICROBIAL COMPOSITIONS COMPRISING MUPIROCIN AND NEOMYCIN | DUNMAN PAUL M | UNIV ROCHESTER |
| EP3331497 | A LUBRICANT FORMULATION OF CARBAMOYLETHYL KATIRA AND A PROCESS FOR PREPARATION THEREOF | RANA VIKAS | COUNCIL SCIENT IND RES |
| EP3331502 | CONTROLLED RELEASE PROPIVERINE FORMULATIONS | BAS KAAN | SANTA FARMA ILAC SANAYI A S |
| EP3331513 | HYDROALCOHOLIC SOLUTIONS COLOURED WITH CHLORHEXIDINE, METHODS FOR THE PRODUCTION THEREOF, AND USES OF SAME | PIROT FABRICE | UNIV CLAUDE BERNARD LYON |
| EP3331523 | USE OF 2-(5S-METHYL-2-OXO-4R-PHENYL-PYRROLIDIN-1-YL)-ACETAMIDE IN THE TREATMENT OF SEIZURES | ZVEJNIECE LIGA | LATVIAN INST ORGANIC SYNTHESIS |
| EP3331528 | MUSCARINIC AGONISTS | BROWN GILES ALBERT | HEPTARES THERAPEUTICS LTD |
| EP3331529 | MUSCARINIC AGONISTS | BROWN GILES ALBERT | HEPTARES THERAPEUTICS LTD |
| EP3331533 | SYNTHESIS AND BIOLOGICAL ACTIVITY OF 2-METHYLENE ANALOGS OF CALCITRIOL AND RELATED COMPOUNDS | DELUCA HECTOR F | WISCONSIN ALUMNI RES FOUND |
| EP3331540 | ENGINEERED PLATFORMS TO STABILIZE BOTH HEPATOCYTES AND ENDOTHELIAL CELLSIN VITRO | KHETANI SALMAN R | UNIV COLORADO STATE RES FOUND |
| EP3331545 | HEMICHANNEL EXTRACELLULAR-DOMAIN SPECIFIC AGENTS FOR TREATING SEPSIS | WANG HAICHAO | FEINSTEIN INST MEDICAL RES |
| EP3331551 | METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE AND NEUROINFLAMMATORY CONDITIONS | FU KIT YU | UNIV HONG KONG SCI & TECH |
| EP3331552 | MODIFIED YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS | KING THOMAS H | GLOBEIMMUNE INC |
| EP3331557 | GENETICALLY ENCODED INTRINSICALLY DISORDERED STEALTH POLYMERS FOR DELIVERY AND METHODS OF USING SAME | CHILKOTI ASHUTOSH | UNIV DUKE |
| EP3331568 | SOLID SOLUTION COMPOSITIONS FOR NSAIDs | BANNISTER ROBIN MARK | INFIRST HEALTHCARE LTD |
| EP3331610 | AGENTS FOR USE IN THE TREATMENT OF GLIOMA | OSSWALD MATTHIAS | UNIV HEIDELBERG RUPRECHT KARLS |
| EP3331611 | 1H-PYRROL-3-AMINES | GRAHAM KEITH | BAYER PHARMA AG |
| EP3331617 | EXFOLIATING COSMETIC COMPOSITION INCLUDING PIECES OF CANDIED CITRUS FRUIT | KURFURST CHANTAL | LVMH RECH |
| EP3331864 | 1,3,4-OXADIAZOLE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | LEE JAEKWANG | CHONG KUN DANG PHARMACEUTICAL CORP |
| EP3331870 | 2-(HET)ARYL-SUBSTITUTED CONDENSED HETEROCYCLIC DERIVATIVES AS PEST CONTROL AGENTS | FISCHER RüDIGER | BAYER CROPSCIENCE AG |
| EP3331877 | PYRAZOLE PYRIMIDINE DERIVATIVE AND USES THEREOF | BEN NERIAH YINON | YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD |
| EP3331880 | N-(PYRIDIN-2-YL)-4-(THIAZOL-5-YL)PYRIMIDIN-2-AMINE DERIVATIVES AS THERAPEUTIC COMPOUNDS | WANG SHUDONG | UNIV SOUTH AUSTRALIA |
| EP3331891 | CHIRAL REAGENTS FOR PREPARATION OF HOMOGENEOUS OLIGOMERS | ENDO ATSUSHI | EISAI R&D MAN CO LTD |
| EP3331894 | NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND THEIR USES | KREMSKY JONATHAN N | METRO INT BIOTECH LLC |
| EP3331897 | PHENYL UREA ANALOGS AS FORMYL PEPTIDE REPCEPTOR 1 (FPR1) SELECTIVE AGONISTS | DUONG TIEN T | ALLERGAN INC |
| EP3331900 | PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS | MAHR ANDREA | IMMATICS BIOTECHNOLOGIES GMBH |
| EP3331902 | CONSTRUCTS HAVING A SIRP-ALPHA DOMAIN OR VARIANT THEREOF | PONS JAUME | ALEXO THERAPEUTICS INC |
| EP3331915 | IMMUNE-CHECKPOINT INHIBITORS FOR USE IN THE TREATMENT OF BLOOD-BORNE CANCERS | FIEDLER WALTER | AMGEN RES MUNICH GMBH |
| EP3331921 | INULIN PRODUCT | MERTENS LINDA | TIENSE SUIKERRAFFINADERIJ NV |
| EP3332762 | TOPICAL COMPOSITION CONTAINING GLYCERIN AND YEAST EXTRACT | RANDHAWA MANPREET | JOHNSON & JOHNSON CONSUMER INC |
| EP3332774 | COMPOSITION FOR SOFT CAPSULE COATING | KONDO YOSUKE | FUJI CAPSULE CO LTD |
| EP3332803 | GENETICALLY ENGINEERED SWINE INFLUENZA VIRUS AND USES THEREOF | PALESE PETER | ICAHN SCHOOL MED MOUNT SINAI |
| EP3332810 | FAST-ACTING INSULIN FORMULATION COMPRISING A SUBSTITUTED ANIONIC COMPOUND | SOULA OLIVIER | ADOCIA |
| EP3333177 | MULTI-TARGET COMPOUND WITH ANTICOAGULATION AND ANTIPLATELET ACTIVITY, PREPARATION METHOD THEREFOR, AND USE THEREOF | DING WEI | SHAANXI MICOT TECH LIMITED COMPANY |
| EP3333192 | ANTIBODY AGAINST GLYPICAN-3 AND APPLICATION THEREOF | WANG HUAMAO | CARSGEN THERAPEUTICS LTD |
| EP3333264 | CHIMERIC ANTIGEN RECEPTOR, AND T CELLS IN WHICH CHIMERIC ANTIGEN RECEPTOR IS EXPRESSED | KONG SEOGKYOUNG | YOO YOUNG PHARM CO LTD |
| EP3334401 | SUNSCREEN COMPOSITION CONTAINING HIGH LEVELS OF LIPOSOLUBLE UV FILTERS | YOUSSEF ROBYN MUENZ | OREAL |
| EP3334403 | TOPICAL COMPOSITIONS | CARLE TIFFANY | MARY KAY INC |
| EP3334405 | SKIN PENETRATING DELIVERY SYSTEM BASED ON POSITIVELY CHARGED SUGAR EMULSIFIERS | MUNK CHRISTIAN | EVONIK SCHLUECHTERN GMBH |
| EP3334411 | INJECTABLE LIQUID COMPOSITION FOR USE IN THE INTRA-ARTICULAR INFILTRATION THERAPY | FERRARI ALESSIO | ALFAKJN S R L |
| EP3334412 | A PHARMACEUTICAL COMPOSITION COMPRISING ELECTROHYDRODYNAMICALLY OBTAINED FIBRES, THE COMPOSITION HAVING IMPROVED RESIDENCE TIME ON THE APPLICATION SITE | HANSEN JENS | DERMTREAT APS |
| EP3334441 | COMPOSITIONS DERIVED FROM COHN FRACTION PASTE AND USE THEREOF | COOPER AYELET | KAMADA LTD |
| EP3334444 | COMPOSITION OF LACTIC BACTERIA FOR USE IN THE TREATMENT OF INFECTIONS DUE TO PROPIONIBACTERIUM ACNES AND IN PARTICULAR FOR ACNE | MOGNA GIOVANNI | PROBIOTICAL SPA |
| EP3334449 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR IMPROVING WOUND HEALING USING CD24 | ARBER NADIR | MEDICAL RES INFRASTRUCTURE & HEALTH SERVICES FUND TEL AVIV MEDICAL CT |
| EP3334500 | MULTI-LIGAND DRUG CONJUGATES AND USES THEREOF | HUANG BAOHUA ROBERT | COHERENT BIOPHARMA |
| EP3334705 | CETYLATED FATTY ACIDS, SYSTEM FOR THE PREPARATION THEREOF AND USE THEREOF | LACORTE ANDREA | PHARMANUTRA S P A |
| EP3334713 | PHENYLSULFONAMIDO-BENZOFURAN DERIVATIVES AND USES THEREOF IN THE TREATMENT OF PROLIFERATIVE DISEASES | CHENG EMILY H | MEMORIAL SLOAN KETTERING CANCER CENTER |
| EP3334719 | SUBSTITUTED BENZIMIDAZOLES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS | POURASHRAF MEHRNAZ | NEOMED INST |
| EP3334721 | CGRP RECEPTOR ANTAGONISTS | COATES DAVID ANDREW | LILLY CO ELI |
| EP3334746 | CONNEXIN 45 INHIBITION FOR THERAPY | KIZANA EDDY | UNIV SYDNEY |
| EP3334824 | PD-1 ANTIBODIES | BARUAH HEMANTA | INNOVENT BIOLOGICS SUZHOU CO LTD |
| EP3335043 | METHOD FOR DIFFERENTIALLY DIAGNOSING ACTH-DEPENDENT CUSHING'S SYNDROME | MORAITIS ANDREAS G | CORCEPT THERAPEUTICS INC |
| EP3335744 | LEUKOCYTE PREPARATION AND METHOD FOR PRODUCING A LEUKOCYTE PREPARATION | DR ALTRICHTER JENS | ARTCLINE GMBH |
| EP3335760 | NITROGEN-BASED, LOW-TEMPERATURE ATMOSPHERIC PRESSURE PLASMA FOR TREATING MUSCLE DAMAGE | KIM CHUL HO | UNIV AJOU IND ACADEMIC COOP FOUND |
| EP3336084 | 6-(5-HYDROXY-1H-PYRAZOL-1-YL)NICOTINAMIDE DERIVATIVES AND THEIR USE AS PHD INHIBITORS | BROWN JASON W | TAKEDA PHARMACEUTICALS CO |
| EP3336088 | CRYSTAL FORM OF OREXIN RECEPTOR ANTAGONIST COMPOUND, AND PREPARATION METHOD AND APPLICATION THEREOF | WU SONGLIANG | SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD |
| EP3336098 | SKIN PERMEABLE PEPTIDE AND METHOD FOR USING SAME | CHOI JE-MIN | IUCF HYU |
| EP3336100 | PEPTIDE HAVING EFFECT OF PREVENTING OR TREATING CENTRAL NERVOUS SYSTEM DISEASES AND PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING CENTRAL NERVOUS SYSTEM DISEASES, CONTAINING SAME AS ACTIVE INGREDIENT | CHOI JE-MIN | IUCF HYU |
| EP3336103 | ANTIBODIES COMPRISING MULTIPLE SITE-SPECIFIC NON-NATURAL AMINO ACID RESIDUES, METHODS OF THEIR PREPARATION AND METHODS OF THEIR USE | THANOS CHRISTOPHER | SUTRO BIOPHARMA INC |
| EP3336185 | ANTIBODY | HOSEN NAOKI | UNIV OSAKA |
| EP3336190 | METHODS, SYSTEMS, AND COMPOSITIONS FOR CELL-DERIVED/VESICLE-BASED MICRORNA DELIVERY | KATAKOWSKI MARK E | FORD HENRY HEALTH SYSTEM |
| EP3336192 | RNA TRANSCRIPTION VECTOR AND USES THEREOF | HEIRMAN CARLO | UNIV BRUSSEL VRIJE |
| EP3336548 | METHOD FOR PROVIDING INFORMATION ON CHRONIC MYELOID LEUKEMIA | KIM DONG WOOK | CATHOLIC UNIV KOREA IND ACADEMIC COOPERATION FOUNDATION |
| EP3337465 | COMPOSITIONS AND METHODS FOR USE IN COMBINATION FOR THE TREATMENT AND DIAGNOSIS OF AUTOIMMUNE DISEASES | HAKONARSON HAKON | CHILDRENS HOSPITAL PHILADELPHIA |
| EP3337485 | CRYSTALLINE FORMS OF IBRUTINIB | SANTRA RAMKINKAR | SUN PHARMACEUTICAL IND LTD |
| EP3337487 | HONOKIOL AND MAGNOLOL FORMULATIONS WITH INCREASED STABILITY AND IMPROVED UPTAKE, AND METHODS OF USE THEREOF | FRAMROZE BOMI P | ST IP HOLDING AG |
| EP3337506 | COMBINATIONS AND USES THEREOF | ENDELL JAN | MORPHOSYS AG |
| EP3337519 | COMPOSITIONS COMPRISING MACROCYCLE DERIVATIVES INCORPORATING BRIDGED MACROCYCLES AND METHODS OF PRODUCING AND USING SAME | HUBIN TIMOTHY J | SOUTHWESTERN OKLAHOMA STATE UNIV |
| EP3337567 | HIV-1 PROTEASE INHIBITORS AND USES THEREOF | GHOSH ARUN K | PURDUE RESEARCH FOUNDATION |
| EP3337568 | PHTHALOCYANINE DYE CONJUGATES AND THEIR STORAGE | MAKINGS LEWIS R | ASPYRIAN THERAPEUTICS INC |
| EP3337571 | ANHYDROUS TOOTH WHITENING COMPOSITIONS COMPRISING CETYLPYRIDINIUM CHLORIDE | ROBBINS KYLE | COLGATE PALMOLIVE CO |
| EP3337604 | METHODS FOR MAKING LOW REMNANT FREE FORMALDEHYDE MICROCAPSULES AND MICROCAPSULES MADE BY SAME | LENTZ CARL M | MICROTEK LABORATORIES INC |
| EP3337787 | PYRAZOLO FUSED HETEROCYCLIC COMPOUNDS AS ERK INHIBITORS | ZHANG JINTAO | CHANGZHOU JIEKAI PHARMATECH CO LTD |
| EP3337900 | METHODS AND COMPOSITIONS TO TREAT LIVER DISEASES AND CONDITIONS | MARTíNEZ CHANTAR MARíA LUZ | ASOCIACION CENTRO DE INVESTIG COOPERATIVA EN BIOCIENCIAS CIC BIOGUNE |
| EP3338592 | COSMETIC | YAMANAKA REIKO | TAIKI CORP LTD |
| EP3338763 | USE OF RHAMNOLIPIDS FOR THE COSMETIC TREATMENT OF REACTIVE SKIN | GENICHE AUDREY | OREAL |
| EP3338779 | TUMOR THERAPEUTIC AGENT | OKAMOTO KIYOSHI | EISAI R&D MAN CO LTD |
| EP3338792 | CORNEAL DAMAGE PREVENTION/TREATMENT COMPOSITION COMPRISING THYMOSIN BETA 4 AND CITRIC ACID AS ACTIVE INGREDIENTS | KANG SIN WOOK | G TREEBNT CO LTD |
| EP3338799 | ANTIBODIES TO IL-6 AND USE THEREOF | GARCIA-MARTINEZ LEON | ALDERBIO HOLDINGS LLC |
| EP3339294 | PHARMACEUTICAL COMPOSITION AND APPLICATION REPLACING QUINOLONE DERIVATIVE, PHARMACEUTICAL ACCEPTABLE SALT, OR STEREOISOMER | DING KE | UNIV JINAN |
| EP3339299 | NOVEL CATECHOL DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | KIM HWAN MOOK | AUTOPHAGYSCIENCES INC |
| EP3339321 | MODULATORS OF MYC, METHODS OF USING THE SAME AND METHODS OF IDENTIFYING AGENTS THAT MODULATE MYC | REFAELI YOSEF | TAIGA BIOTECHNOLOGIES INC |
| EP3340962 | ENHANCED PHOTOSTABILITY, EXTENDED RANGE UVA FILTERING AND CAMOUFLAGING POTENTIAL OF AVOBENZONE-DEFECT RICH ZNO NANOCRYSTALS COMPLEX | ADERSH ASOK | INDIAN INST TECHNOLOGY BOMBAY |
| EP3340969 | PHARMACEUTICAL COMPOSITIONS COMPRISING 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)-PIPERIDINE-2,6-DIONE | WALTERS COLIN | CELGENE CORP |
| EP3340974 | METHODS FOR TREATMENT OF DISEASES | GELBER COHAVA | SERPIN PHARMA LLC |
| EP3340982 | COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS | WILES JASON ALLAN | ACHILLION PHARMACEUTICALS INC |
| EP3341001 | COMPOSITION AND METHOD FOR TREATMENT AND PROPHYLAXIS OF INTESTINAL INFECTION AND INFLAMMATION | AGHAIBEIK-LAVASANI SHAHRAM | IMMUNEBIOTECH MEDICAL SWEDEN AB |
| EP3341015 | ENHANCED DEPLETION OF TARGETED CELLS WITH CD47 BLOCKADE AND AN IMMUNE COSTIMULATORY AGONIST | SCHNORR PETER | UNIV LELAND STANFORD JUNIOR |
| EP3341083 | OIL-IN-WATER EMULSION COMPOSITION | TOKUNAGA EMIKO | OREAL |
| EP3341367 | BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS AS IRAK4 MODULATORS | LEE KATHERINE LIN | PFIZER |
| EP3341368 | NOVEL 6-6 BICYCLIC AROMATIC RING SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS | WU TONGFEI | JANSSEN PHARMACEUTICA NV |
| EP3341370 | CGRP RECEPTOR ANTAGONISTS | COATES DAVID ANDREW | LILLY CO ELI |
| EP3341389 | PEPTIDE INHIBITORS OF TELOMERASE TRANSLOCATION AND THERAPEUTIC USES THEREOF | EBBEN JOHNATHAN D | MEDICAL COLLEGE WISCONSIN INC |
| EP3341393 | MODIFIED ANTHRAX TOXIN PROTECTIVE ANTIGEN | LIU SHI-HUI | US HEALTH |
| EP3341394 | IMPROVED CELL-PERMEABLE (ICP)-SOCS3 RECOMBINANT PROTEIN AND USES THEREOF | JO DAEWOONG | CELLIVERY THERAPEUTICS INC |
| EP3341396 | IMPROVED CELL-PERMEABLE (ICP)-SOCS3 RECOMBINANT PROTEIN AND USES THEREOF | JO DAEWOONG | CELLIVERY THERAPEUTICS INC |
| EP3341410 | CHIMERIC ANTIGEN RECEPTORS WITH INTEGRATED CONTROLLABLE FUNCTIONS | JUILLERAT ALEXANDRE | CELLECTIS |
| EP3341481 | MICRORNA-328 ANTI-SENSE COMPOSITION AND THERAPEUTIC USE | JUO SUH-HANG H | |
| EP3341725 | METHODS FOR DETECTING PHOSPHORYLATED ALPHA-SYNUCLEIN | BARBOUR ROBIN | PROTHENA BIOSCIENCES LTD |
| EP3342417 | COMPOSITION FOR BODY SLIMMING AND SKIN CARE AND PREPARATION METHOD THEREOF | LIU XIAOYING | INFINITUS CHINA CO LTD |
| EP3342423 | TRANSDERMALLY ABSORPTIVE COMPOSITION | MIWA YASUSHI | MEDRX CO LTD |
| EP3342765 | CATHEPSIN K INHIBITOR AND APPLICATION THEREOF | WANG XIAOJUN | SUNSHINE LAKE PHARMA CO LTD |
| EP3342767 | PYRAZOLYL SUBSTITUTED CARBONIC ACID DERIVATIVES AS MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | TRAN THUY-ANH | ARENA PHARM INC |
| EP3342786 | ANTI-DLL3 ANTIBODY | YOSHIDA KENJI | CHUGAI PHARMACEUTICAL CO LTD |
| EP3342853 | INTESTINAL BACTERIABUTYRIBACTERINTESTINI | FENG QIANG | BGI SHENZHEN |
| EP3342866 | POLYPEPTIDE CARRIER FOR PRESENTING TARGET POLYPEPTIDE AND USES THEREOF | ZHANG TIANYING | UNIV XIAMEN |
| EP3344215 | ORAL CARE COMPOSITIONS AND METHODS OF USE | THOMSON PAUL | COLGATE PALMOLIVE CO |
| EP3344234 | POLYMERS AND MICROSPHERES | HEAYSMAN CLARE LOUISE | BIOCOMPATIBLES UK LTD |
| EP3344251 | A COMBINATION THERAPY COMPRISING VARLITINIB AND AN ANTICANCER AGENT | LINDMARK BERTIL | ASLAN PHARMACEUTICALS PTE LTD |
| EP3344259 | COMPOSITION AND MEDICAL DEVICE COMPRISING ACETYLSALICYLIC ACID FOR THE TREATMENT OF HUMAN PAPILLOMA VIRUS SKIN INFECTIONS | POLI ELENA | POLI ELENA |
| EP3344280 | FORMATION OF BONE | DEHGHANI FARIBA | ELASTAGEN PTY LTD |
| EP3344286 | OVARIAN CANCER VACCINES | TUOHY VINCENT K | CLEVELAND CLINIC FOUND |
| EP3344287 | ANTI-SURVIVIN ANTIBODIES FOR CANCER THERAPY | FENSTERMAKER ROBERT A | HEALTH RESEARCH INC |
| EP3344304 | BIOACTIVE POLYMER FOR BONE REGENERATION | FATHI ALI | UNIV SYDNEY |
| EP3344343 | SILICONES FOR HEAT PROTECTION | BRUNI ANTONIO | DOW SILICONES CORP |
| EP3344622 | GUANIDINE SUBSTITUTED IMIDAZO[4,5-c]RING COMPOUNDS | GRIESGRABER GEORGE W | 3M INNOVATIVE PROPERTIES CO |
| EP3344623 | IMIDAZO[4,5-c]RING COMPOUNDS CONTAINING SUBSTITUTED GUANIDINE GROUPS | GRIESGRABER GEORGE W | 3M INNOVATIVE PROPERTIES CO |
| EP3344649 | ANALOGUES OF VDAC1-DERIVED PEPTIDES | SHOSHAN-BARMATZ VARDA | B G NEGEV TECHNOLOGIES AND APPLICATIONS LTD AT BEN GURION UNIV |
| EP3345545 | FUNCTIONALIZED MAGNETIC NANOPARTICLES AND USE IN IMAGING AMYLOID DEPOSITS AND NEUROFIBRILLARY TANGLES | AKHTARI MASSOUD | UNIV CALIFORNIA |
| EP3345594 | SOLUBILIZED FLAVONOID COMPOSITION | BIRBARA PHILIP J | VIZURI HEALTH SCIENCES LLC |
| EP3345596 | INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER | WANDS JACK R | RHODE ISLAND HOSPITAL |
| EP3345612 | USE OF BACTERIORHODOPSIN AS A COSMETIC AND/OR THERAPEUTIC AGENT IN THE COMPREHENSIVE TREATMENT OF DERMATOSES | GRISHKOVA ELIZAVETA SERGEEVNA | GRISHKOVA ELIZAVETA SERGEEVNA |
| EP3345627 | COMPOSITIONS AND METHODS FOR TRANSPORT ACROSS THE BLOOD BRAIN BARRIER | WALZ ANDREAS | OPHIDION INC |
| EP3345894 | COMPOUND HAVING PROTEIN TYROSINE PHOSPHATASE SHP-1 AGONIST ACTIVITY | CHEN KUENFENG | |
| EP3345905 | DEUTERATED BENZOQUINOLIZINE DERIVATIVES AS INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 | GANT THOMAS G | AUSPEX PHARMACEUTICALS INC |
| EP3345929 | FUSION POLYPEPTIDE IN WHICH ANTI-INFLAMMATORY POLYPEPTIDE AND FERRITIN MONOMER FRAGMENT ARE BOUND AND PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING INFLAMMATORY DISEASES, CONTAINING SAME AS ACTIVE INGREDIENT | BAE JONG-SUP | KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND |
| EP3346969 | RADICALLY POLYMERIZABLE DENTAL MATERIAL | BECKER OLAV-SVEN | MUEHLBAUER TECH GMBH |
| EP3346972 | PROCESS FOR TREATING HAIR | NÖCKER BERND | KAO GERMANY GMBH |
| EP3346974 | PROCESS FOR SEMIPERMANENT STRAIGHTENING AND PERMANENT SHAPING HAIR | NÖCKER BERND | KAO GERMANY GMBH |
| EP3346980 | LIPOPHILIC COSMETIC COMPOSITIONS CONTAINING PELARGONIC ACID ESTERS | CAPUZZI LUIGI | NOVAMONT SPA |
| EP3347005 | SYNERGISTIC ANTIBACTERIAL EFFECTS OF MAGNOLIA BARK EXTRACT AND L-ARGININE, N-ALPHA-LAUROYL ETHYL ESTER ON PLAQUE BIOFILM | DODDS MICHAEL W | WRIGLEY W M JUN CO |
| EP3347009 | COMPOSITION COMPRISING RESVERATROL AND MELATONIN FOR REDUCING HAIR LOSS AND/OR INCREASING HAIR REGROWTH | SEKHAVAT HOUFAR | TRIPLE HAIR INC |
| EP3347014 | METHODS OF DIAGNOSING AND TREATING TOURETTE SYNDROME | HAKONARSON HAKON | CHILDRENS HOSPITAL PHILADELPHIA |
| EP3347015 | METHODS OF DIAGNOSING AND TREATING CONDUCT DISORDER | HAKONARSON HAKON | CHILDRENS HOSPITAL PHILADELPHIA |
| EP3347016 | METHODS OF DIAGNOSING AND TREATING ANXIETY DISORDER | HAKONARSON HAKON | CHILDRENS HOSPITAL PHILADELPHIA |
| EP3347018 | INHIBITORS OF CYCLIN-DEPENDENT KINASES | HAO MINGFENG | DANA FARBER CANCER INST INC |
| EP3347019 | PSMA-TARGETED NIR DYES AND THEIR USES | KULARATNE SUMITH A | ON TARGET LABORATORIES LLC |
| EP3347030 | USE OF PASTEURIZED AKKERMANSIA FOR TREATING METABOLIC DISORDERS | CANI PATRICE | UNIV LOUVAIN |
| EP3347031 | A COMPOSITION COMPRISING A PROTEIN AND A POLYALKOXY FATTY COMPOUND | KATZ JOSHUA S | DOW GLOBAL TECHNOLOGIES LLC |
| EP3347039 | IMMUNE CHECKPOINT INTERVENTION IN CANCER | MCGRANAHAN NICHOLAS | CANCER RESEARCH TECH LTD |
| EP3347054 | DOSING REGIMENS FOR ANTI-TF-ANTIBODY DRUG-CONJUGATES | LISBY STEEN | GENMAB AS |
| EP3347097 | SUBSTITUTED HETEROARYL COMPOUNDS AND METHODS OF USE | XI NING | SUNSHINE LAKE PHARMA CO LTD |
| EP3347101 | OIL-IN-WATER EMULSION COMPOSITION | DU YAO | OREAL |
| EP3347102 | PROCESS FOR PERMANENT SHAPING HAIR | NÖCKER BERND | KAO GERMANY GMBH |
| EP3347356 | TRICYCLIC FUSED PYRIDIN-2-ONE DERIVATIVES AND THEIR USE AS BRD4 INHIBITORS | VADIVELU SARAVANAN | JUBILANT BIOSYS LTD |
| EP3347377 | THYMIC STROMAL LYMPHOPOIETIN (TSLP)-BINDING ANTIBODIES AND METHODS OF USING THE ANTIBODIES | RONDEAU JEAN-MICHEL RENE | NOVARTIS AG |
| EP3347487 | NON-INVASIVE METHODS FOR ASSESSING GENETIC INTEGRITY OF PLURIPOTENT STEM CELLS | DE VOS JOHN | INST NAT SANTE RECH MED |
| EP3348252 | OIL-IN-WATER TYPE COSMETIC AND SUNSCREEN COSMETIC | NAKATSUKA AKIO | SUMITOMO SEIKA CHEMICALS |
| EP3348255 | EXTRACTS OF TETRASELMIS SP. FOR COSMETIC AND THERAPEUTIC PURPOSES | PERTILE PAOLO | SYMRISE AG |
| EP3348257 | TOOTH-ATTACHABLE PATCH CAPABLE OF BEING REMOVED BY TOOTHBRUSHING | KIM JONG-HOON | LG HOUSEHOLD & HEALTH CARE LTD |
| EP3348260 | PHARMACEUTICAL TRAMADOL COMPOSITION FOR OPHTHALMIC USE | SANZ MENENDEZ NURIA | FARMALIDER SA |
| EP3348276 | CANCER TREATMENT COMPOSITION COMBINING ANTI-CD26 ANTIBODY AND OTHER ANTICANCER AGENT | YAMADA TAKETO | YS AC CO LTD |
| EP3348279 | MEDICINAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY RESPIRATORY DISEASE | KANEHIRO ARIHIKO | NAT UNIV CORPORATION OKAYAMA UNIV |
| EP3348632 | METHOD FOR PRODUCING KIDNEY PROGENITOR CELLS | KAWAMOTO TATSUYA | ASTELLAS PHARMA INC |
| EP3348635 | NOVEL HUMAN SERUM ALBUMIN MUTANT | TAKAHASHI KENICHI | JAPAN CHEM RES |
| EP3348668 | USES OF RUTHENIUM(0)-OLEFIN COMPLEXES | DOPPIU ANGELINO | UMICORE AG & CO KG |
| EP3349582 | NOVEL INSECT INHIBITORY PROTEINS | BOWEN DAVID J | MONSANTO TECHNOLOGY LLC |
| EP3349656 | SYSTEMS AND METHODS FOR POLARIZED NUCLEAR IMAGING AND SPECTROSCOPY | CATES GORDON D | UNIV VIRGINIA PATENT FOUNDATION |
| EP3349720 | BIOSOURCED EMOLLIENT COMPOSITION COMPRISING ISOPARAFFINS | SWOBODA BENJAMIN | TOTAL MARKETING SERVICES |
| EP3349724 | DURABLE DENTAL FILM-FORMING COMPOSITION AND USES THEREOF | DONG RONG | COLGATE PALMOLIVE CO |
| EP3349740 | CO-THERAPY COMPRISING CANAGLIFLOZIN AND PHENTERMINE FOR THE TREATMENT OF OBESITY AND OBESITY RELATED DISORDERS | ROSENTHAL NORMAN R | JANSSEN PHARMACEUTICA NV |
| EP3349747 | NO-DONORS FOR THE TREATMENT OF CEREBROVASCULAR VASOSPASMS AFTER BRAIN HEMORRHAGE | EHLERT ANGELIKA | EHLERT ANGELIKA |
| EP3349752 | METHOD OF WOUND HEALING | JAGANNATH M R | CONNEXIOS LIFE SCIENCES PVT LTD |
| EP3349762 | CO-CRYSTALS OF SGLT2 INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF | CHIVUKULA KAMESWAR RAO | LAURUS LABS PRIVATE LTD |
| EP3349763 | SYNTHETIC COMPOSITION FOR MICROBIOTA MODULATION | VIGSNÆS LOUISE KRISTINE | GLYCOM AS |
| EP3349769 | IN VIVO PRIMING OF NATURAL KILLER CELLS | TESI RAYMOND J | IMMUNE VENTURES LLC |
| EP3349775 | SOLID PHASE PEPTIDE SYNTHESIS METHODS AND ASSOCIATED SYSTEMS | THOMAS DALE ARLINGTON III | MASSACHUSETTS INST TECHNOLOGY |
| EP3349778 | PHARMACEUTICAL ASSOCIATION OF GROWTH FACTOR RECEPTOR AGONIST AND ADHESION PROTEIN INHIBITOR FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF | ZOUANI OMAR F | HISTIDE AG |
| EP3349793 | ANTI-S100A8 FOR TREATING LEUKEMIA | TESSIER PHILIPPE | UNIV LAVAL |
| EP3349795 | DUAL VARIABLE DOMAIN IMMUNOCONJUGATES AND USES THEREOF | RADER CHRISTOPH | SCRIPPS RESEARCH INST |
| EP3349802 | LIPOCATIONIC DENDRIMERS AND USES THEREOF | SIEGWART DANIEL J | UNIV TEXAS |
| EP3349857 | STABLE DISPERSIONS CONTAINING DROPS COMPRISING A GELLING AGENT | GOUTAYER MATHIEU | CAPSUM |
| EP3349891 | METHOD FOR PREPARING MICROCAPSULES BY DOUBLE EMULSION | WALTERS JAMIE | CALYXIA |
| EP3350162 | MONO- OR DI-SUBSTITUTED INDOLE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS | KESTELEYN BART RUDOLF ROMANIE | JANSSEN PHARMACEUTICALS INC |
| EP3350176 | NOVEL OXAZOLE DERIVATIVES THAT INHIBIT SYK | MOUSSY ALAIN | AB SCIENCE |
| EP3350177 | HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USES THEREOF | JORAND-LEBRUN CATHERINE | MERCK PATENT GMBH |
| EP3350178 | NOVEL IMIDAZO [4,5-C]QUINOLINE AND IMIDAZO [4,5-C][1,5]NAPHTHYRIDINE DERIVATIVES AS LRRK2 INHIBITORS | GALATSIS PAUL | PFIZER |
| EP3350179 | CRYSTALLINE FORMS | AISSAOUI HAMED | IDORSIA PHARMACEUTICALS LTD |
| EP3350186 | NANO- AND MICRO-SIZED PARTICLES OF 20-CAMPTOTHECIN OR DERIVATIVE THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, AND TREATMENT OF CANCERS THEREWITH | CHEN WENHAO | CAO PHARMACEUTICALS INC |
| EP3350213 | T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS | TRAN ERIC | US HEALTH |
| EP3350220 | ANTI-PRO/LATENT-MYOSTATIN ANTIBODIES AND USES THEREOF | CARVEN GREGORY J | SCHOLAR ROCK INC |
| EP3350308 | USE OF A LYOCELL FIBRE | OPIETNIK MARTINA | CHEMIEFASER LENZING AG |
| EP3350322 | A NOVEL ENDOLYSIN POLYPEPTIDE | LOESSNER MARTIN JOHANNES | MICREOS HUMAN HEALTH BV |
| EP3350333 | POLYNUCLEOTIDES CONTAINING A STABILIZING TAIL REGION | BUTORA GABOR | MODERNATX INC |
| EP3350341 | METHODS FOR DIAGNOSING AND EVALUATING NON-ALCOHOLIC STEATOHEPATITIS | DARTEIL RAPHAËL | GENFIT |
| EP3351248 | COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS | CHARMOT DOMINIQUE | ARDELYX INC |
| EP3351253 | METHOD FOR MAKING AN AUTOLOGOUS PROTEIN SOLUTION | O'SHAUGHNESSEY KRISTA | BIOMET BIOLOGICS LLC |
| EP3351257 | MOLDED PLACENTAL TISSUE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | KOOB THOMAS J | MIMEDX GROUP INC |
| EP3351261 | COMBINATION MEDICAMENT COMPRISING IL-12 AND AN AGENT FOR BLOCKADE OF T-CELL INHIBITORY MOLECULES FOR TUMOUR THERAPY | BECHER BURKHARD | UNIV ZUERICH |
| EP3351264 | COMPOSITION COMPRISING PROTEASE, AMYLASE AND LIPASE | FALLON JOAN M | GALENAGEN LLC |
| EP3351542 | NEW CRYSTAL OF PIPERAZINE COMPOUND | AOKI SHINICHI | TAIHO PHARMACEUTICAL CO LTD |
| EP3351552 | 2'- SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT | CLARKE MICHAEL O' NEIL HANRAHAN | GILEAD SCIENCES INC |
| EP3351554 | GLUTEN-RELATED DISORDERS | FASANO FRANCESCA ROMANA | HEINZ CO BRANDS H J LLC |
| EP3351580 | POLYMER CONJUGATE OF HEXA-COORDINATED PLATINUM COMPLEX | NAKAMURA MASAHARU | NIPPON KAYAKU KK |
| EP3352584 | COMPOSITIONS AND METHODS FOR SYNTHESIZING 5'-CAPPED RNAS | HOGREFE RICHARD I | TRILINK BIOTECHNOLOGIES INC |
| EP3352739 | LIPOIC ACID CHOLINE ESTER COMPOSITIONS AND METHODS TO GENERATE BIOCOMPATIBLE OPHTHALMIC FORMULATIONS | BARMAN SHIKHA P | ENCORE VISION INC |
| EP3352741 | INHIBITORS OF PLASMINOGEN FOR TREATING, REDUCING OR PREVENTING RADIATION-INDUCED INJURIES | NY TOR | OMNIO AB |
| EP3352742 | COMPOSITIONS COMPRISING TRITERPENOIDS | HAZAN ZADIK | REGENERA PHARMA LTD |
| EP3352747 | COMPOSITIONS FOR TREATMENT OF PAIN IN PATIENTS WHO UNDERWENT ELECTIVE ARTHROPLASTY | GIORGETTI PAOLO LUCA MARIA | PROFESSIONAL DIETETICS INT S R L IN FORMA ABBREVIATA P D INT S R L |
| EP3352752 | DETECTING AND TREATING GROWTH HORMONE DEFICIENCY | THORNER MICHAEL | AMMONETT PHARM LLC |
| EP3352766 | HIGH ELASTICITY HYALURONAN COMPOSITIONS AND METHODS OF USE THEREOF | BELMONTE CARLOS | MATRIX BIOLOGY INST |
| EP3352771 | UMBILICAL TISSUE COMPOSITIONS AND METHODS OF USE | DANILKOVITCH ALLA | OSIRIS THERAPEUTICS INC |
| EP3352777 | HOMEOPROTEINS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISORDERS | PROCHIANTZ ALAIN | CENTRE NAT RECH SCIENT |
| EP3352782 | IMPROVED METHODS AND COMPOUNDS FOR ELIMINATING IMMUNE RESPONSES TO THERAPEUTIC AGENTS | SAINT-REMY JEAN-MARIE | IMCYSE SA |
| EP3352783 | VACCINATION WITH IMMUNO-ISOLATED CELLS PRODUCING AN IMMUNOMODULATOR | MACH NICOLAS | MAXIVAX SA |
| EP3352823 | CRYSTALLINE SALTS OF NALOXONE AND NALTREXONE | ZAMLOOT MICHAEL | PAIN THERAPEUTICS INC |
| EP3352856 | METHODS OF TREATING INTRAOCULAR PRESSURE WITH ACTIVATORS OF TIE-2 | PETERS KEVIN GENE | AERPIO THERAPEUTICS INC |
| EP3352857 | SYD985 TREATMENT OF T-DM1 REFRACTORY CANCER PATIENTS | VOORTMAN GERRIT | SYNTHON BIOPHARMACEUTICALS BV |
| EP3353161 | TRIAZOLE DERIVATIVES AS P2Y14 RECEPTOR ANTAGONISTS | JACOBSON KENNETH A | US HEALTH |
| EP3353164 | BI-HETEROARYL SUBSTITUTED 1,4-BENZODIAZEPINES AND USES THEREOF FOR THE TREATMENT OF CANCER | ANGIBAUD PATRICK RENé | JANSSEN PHARMACEUTICA NV |
| EP3353178 | NEW BICYCLIC COMPOUNDS AS DUAL ATX/CA INHIBITORS | DI GIORGIO PATRICK | HOFFMANN LA ROCHE |
| EP3353181 | NEW BICYCLIC COMPOUNDS AS DUAL ATX/CA INHIBITORS | HERT JéRÔME | HOFFMANN LA ROCHE |
| EP3353184 | NOVEL BRANCHED AMPHIPHILIC LIPIDS | JAFFRèS PAUL-ALAIN | UNIV BRETAGNE OCCIDENTALE |
| EP3353190 | C4-MODIFIED OLEANOLIC ACID DERIVATIVES FOR INHIBITION OF IL-17 AND OTHER USES | VISNICK MELEAN | REATA PHARMACEUTICALS INC |
| EP3353214 | AGENTS INHIBITING KALLIKREIN-8 FOR USE IN THE PREVENTION OR TREATMENT OF ALZHEIMER'S DISEASE | HERRING ARNE | UNIV DUISBURG ESSEN |
| EP3354257 | COMPOSITION, FOR IMPROVING SKIN AND PREVENTING HAIR LOSS, COMPRISING PLANT EXTRACT-DERIVED EXTRACELLULAR VESICLES | LEE WON JONG | PROSTEMICS CO LTD |
| EP3354264 | PROPHYLAXIS AND TREATMENT OF NEISSERIA GONORRHOEAE EYE INFECTION | SNYDER LORI A | KINGSTON UNIV HIGHER EDUCATION CORPORATION |
| EP3354272 | LIGHTENING COMPOSITION COMPRISING GINSENG-DERIVED EXOSOME-LIKE VESICLES | CHOI SUH-YEON | AMOREPACIFIC CORP |
| EP3354273 | MELANOCORTIN RECEPTOR LIGANDS | DONG ZHENG XIN | IPSEN PHARMA |
| EP3354277 | COMPOSITIONS AND METHODS FOR TREATING GAUCHER DISEASE | DANIEL PETER F | SHIRE HUMAN GENETIC THERAPIES |
| EP3354320 | COMPOSITION FOR USE IN ORAL CARE AND RELATED APPARATUS FOR THE TREATMENT OF THE ORAL CAVITY | SERGI CHIARA | 32 LABS S R L |
| EP3354656 | RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA) | MCSWIGGEN JAMES | SIRNA THERAPEUTICS INC |
| EP3355849 | ORAL CARE COMPOSITIONS AND METHODS OF USING THE COMPOSITIONS | REGE AARTI | COLGATE PALMOLIVE CO |
| EP3355855 | COMPOSITION FOR DUST PARTICLE REDUCTION | BONNER PATRICIA | JOHNSON & JOHNSON CONSUMER INC |
| EP3355870 | PROCESS FOR THE PRODUCTION OF COMPRESSED TABLETS | ACHKAR JIHANE | DSM IP ASSETS BV |
| EP3355875 | COMBINATION OF A BTK INHIBITOR AND A CHECKPOINT INHIBITOR FOR TREATING CANCERS | VENKATARAMAN SRIRAM | GILEAD SCIENCES INC |
| EP3355881 | ORAL TAXANE COMPOSITIONS AND METHODS | CHAN DENISE S B | ATHENEX HK INNOVATIVE LTD |
| EP3355884 | TETRAHYDRO-1H-PYRIDO[3,4-b]INDOLE ANTI-ESTROGENIC DRUGS | MYLES DAVID C | OLEMA PHARMACEUTICALS INC |
| EP3355890 | HUMAN PLASMA KALLIKREIN INHIBITORS | KOTIAN PRAVIN L | BIOCRYST PHARM INC |
| EP3355891 | METHODS OF TREATING TRANSPLANT REJECTION | BETTS BRIAN C | CTI BIOPHARMA CORP |
| EP3355897 | AN ANTI-METASTATIC MARINE BACTERIAL EXOPOLYSACCHARIDE DERIVATIVE AND USES THEREOF | COLLIEC-JOUAULT SYLVIA | INSTITUT FRANCAIS DE RECH POUR LEXPLOITATION DE LA MER IFREMER |
| EP3355900 | A GYNURA PROCUMBENS OIL EXTRACT FOR THE TREATMENT OF SEVERAL DERMATOLOGICAL DISEASES AND ITS PROCESS THEREOF | KOSTAS GRIGORIOU M D | KOSTAS GRIGORIOU M D |
| EP3355907 | BI-SPECIFIC THERAPEUTIC PROTEINS FOR TISSUE REPAIR | ANTIPOV LAURA D J | SILVER CREEK PHARMACEUTICALS INC |
| EP3355918 | BIOFUNCTIONALIZED NANOPARTICLES AND USES THEREOF IN ADOPTIVE CELL THERAPY | SICARD ANTOINE | INST NAT SANTE RECH MED |
| EP3355927 | DEVICES FOR SUPPORTING REGENERATION OF BODY TISSUES, AND METHODS OF MAKING AND USING THEM | DASHTI DEREK C | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND |
| EP3355993 | ORAL CARE COMPOSITIONS | AHMED RABAB | COLGATE PALMOLIVE CO |
| EP3355995 | SOFT-PACKAGED COSMETIC PREPARATION | ALANYA-ROUSSEAU ESMA | BEIERSDORF AG |
| EP3356348 | 2-AMINOQUINAZOLINE DERIVATIVES AS P70S6 KINASE INHIBITORS | BOYLE ROBERT GEORGE | SENTINEL ONCOLOGY LTD |
| EP3356356 | COMPOUNDS USEFUL AS MODULATORS OF TRPM8 | PATRON ANDREW P | SENOMYX INC |
| EP3356359 | INHIBITORS OF KRAS G12C MUTANT PROTEINS | LI LIANSHENG | ARAXES PHARMA LLC |
| EP3356370 | 11,13-MODIFIED SAXITOXINS FOR THE TREATMENT OF PAIN | MULCAHY JOHN | SITEONE THERAPEUTICS INC |
| EP3356390 | METHODS AND COMPOSITIONS FOR ANTIBODY-EVADING VIRUS VECTORS | ASOKAN ARAVIND | UNIV NORTH CAROLINA CHAPEL HILL |
| EP3356407 | BISPECIFIC ANTI-CD19XCD3 T CELL ACTIVATING ANTIGEN BINDING MOLECULES | BACAC MARINA | HOFFMANN LA ROCHE |
| EP3356410 | BISPECIFIC ANTI-CEAXCD3 T CELL ACTIVATING ANTIGEN BINDING MOLECULES | BACAC MARINA | HOFFMANN LA ROCHE |
| EP3356412 | TARGETING METASTASIS STEM CELLS THROUGH A FATTY ACID RECEPTOR (CD36) | AZNAR BENITAH SALVADOR | FUNDACIO INST DE RECERCA BIOMEDICA IRB BARCELONA |
| EP3356416 | PD-1 ANTIBODIES AND USES THEREOF | GU NANA | ASIA BIOTECH PTE LTD |
| EP3356519 | EXOSOME PACKAGING OF NUCLEIC ACIDS | GIBBINGS DERRICK | UNIV OTTAWA |
| EP3357483 | SUNSCREEN COSMETIC | NAGAI KOUICHI | SHISEIDO CO LTD |
| EP3357486 | HAIR RESTORATION AND/OR HAIR GROWTH PROMOTING COMPOSITION CONTAINING SOYASAPONIN | KANG YOUNG GYU | AMOREPACIFIC CORP |
| EP3357491 | PHARMACEUTICAL COMPOSITION CONTAINING ANIONIC DRUG, AND PREPARATION METHOD THEREFOR | NAM HYE YEONG | SAMYANG BIOPHARMACEUTICALS |
| EP3357509 | TREATMENT OF CANCER WITH THERAPEUTIC MONOCLONAL ANTIBODY SPECIFIC FOR A TUMOR ASSOCIATED ANTIGEN AND AN IMMUNE ADJUVANT | NICODEMUS CHRISTOPHER F | ONCOQUEST INC |
| EP3357514 | LIPID DERIVATIVE IN WHICH HYDROPHILIC POLYMERS ARE BOUND VIA CYCLIC BENZYLIDENE ACETAL LINKERS | OTA MASAKI | NOF CORP |
| EP3357541 | METHYLSULFONYLMETHANE COMPOSITION FOR REDUCING BLOOD ALCOHOL CONTENT | GIAMMARTINI ENRICO | ITALFARMACIA S R L |
| EP3357925 | SALT TYPE AND CRYSTAL TYPE OF 4H-PYRAZOLO [1, 5-ALPHA]BENZIMIDAZOLE COMPOUND AND PREPARATION METHOD AND INTERMEDIATE THEREOF | WANG XUEHAI | HUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC |
| EP3358351 | ADAM12 INHIBITORS AND THEIR USE AGAINST INFLAMMATION-INDUCED FIBROSIS | PEDUTO LUCIE | PASTEUR INSTITUT |
| EP3359119 | DENTAL COMPOSITION | KLEE JOACHIM E | DENTSPLY DETREY GMBH |
| EP3359154 | WNT SIGNALING PATHWAY INHIBITORS AND THERAPEUTIC APPLICATIONS THEREOF | ZHANG XIAOHU | SUZHOU YUNXUAN YIYAO KEJI YOUXIAN GONGSI |
| EP3359160 | FARNESOID X RECEPTOR MODULATORS | PELLICCIARI ROBERTO | INTERCEPT PHARMACEUTICALS INC |
| EP3359186 | INHIBITION OF AUTISM SPECTRUM DISORDER USING DECOY ANTIGENS TO MATERNAL BRAIN-REACTIVE ANTIBODIES | DIAMOND BETTY A | FEINSTEIN INST MEDICAL RES |
| EP3359189 | HUMANIZED ANTI PSA (5A10) ANTIBODIES | TRAN AMANDA THUY | FREDAX AB |
| EP3359197 | METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING CANCER | SCHIFFMAN JOSHUA | UNIV UTAH RES FOUND |
| EP3359241 | FORMULATIONS OF PTHRP ANALOGUES, TRANSDERMAL PATCHES THEREOF, AND USES THEREOF | HATTERSLEY GARY | RADIUS HEALTH INC |
| EP3359533 | QUINOXALINE AND PYRIDOPYRAZINE DERIVATIVES AS PI3KBETA INHIBITORS | ANGIBAUD PATRICK RENé | JANSSEN PHARMACEUTICA NV |
| EP3359536 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CFTR | MUNOZ BENITO | PROTEOSTASIS THERAPEUTICS INC |
| EP3359542 | SPIRO[3H-INDOLE-3,2 虂-PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORS | GOLLNER ANDREAS | BOEHRINGER INGELHEIM INT |
| EP3359556 | MODULATING GAMMA - C -CYTOKINE ACTIVITY | AZIMI NAZLI | BIONIZ LLC |
| EP3359559 | GLYCOSYLATED YGHJ POLYPEPTIDES FROM ENTEROTOXIGENIC ESCHERICHIA COLI (ETEC) | BOYSEN ANDERS | UNIV SYDDANSK |
| EP3359671 | DNA VECTORS, TRANSPOSONS AND TRANSPOSASES FOR EUKARYOTIC GENOME MODIFICATION | MINSHULL JEREMY | DNA2 0 INC |
| EP3359676 | TRANSPOSON SYSTEM, KIT COMPRISING THE SAME, AND USES THEREOF | WU SAREINA CHIUNG-YUAN | GENOMEFRONTIER THERAPEUTICS INC |
| EP3359677 | COMPOSITIONS AND METHODS FOR TREATING FRAGILE X SYNDROME AND RELATED SYNDROMES | DAVIDSON BEVERLY L | CHILDRENS HOSPITAL PHILADELPHIA |
| EP3360534 | SPRAYABLE SUNSCREEN COSMETIC | YAMAKI SATOSHI | SHISEIDO CO LTD |
| EP3360537 | OIL-IN-WATER TYPE ORGANOPOLYSILOXANE EMULSION AND METHOD FOR PRODUCING SAME, COSMETIC RAW MATERIAL, AND COSMETIC PRODUCT | KOJIMA KAZUHIKO | DOW CORNING TORAY CO LTD |
| EP3360550 | MOLECULES AND PHARMACEUTICAL COMPOSITIONS, IN PARTICULAR FOR TREATING A GENETIC BLOOD DISORDER | GARDEBIEN FABRICE | UNIV DE LA REUNION |
| EP3360553 | MOLECULES AND PHARMACEUTICAL COMPOSITIONS, IN PARTICULAR FOR TREATING A GENETIC BLOOD DISORDER | GARDEBIEN FABRICE | UNIV DE LA REUNION |
| EP3360554 | ANTI-HEPATITIS B VIRUS AGENT | SHIMANE KAZUKI | TOYAMA CHEMICAL CO LTD |
| EP3360574 | MEDICINAL COMPOSITION FOR AMELIORATING AND TREATING INTERVERTEBRAL DISC DEGENERATION AND LOW BACK PAIN, AND METHOD FOR SCREENING THERAPEUTIC AGENT | MATSUMOTO MORIO | UNIV KEIO |
| EP3360579 | PERITONEAL DIALYSIS FLUID | NISHITANI HIROSHI | TERUMO CORP |
| EP3360580 | METHOD FOR GENETIC TREATMENT USING THE AAV-XBP1S/GFP VIRUS AND USE THEREOF IN THE PREVENTION AND TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS | HETZ FLORES CLAUDIO ANDRéS | UNIV CHILE |
| EP3360600 | NATURAL SILICONE REPLACEMENTS FOR SILICONE FLUIDS IN PERSONAL CARE FORMULATIONS | BURGO ROCCO | INOLEX INVESTMENT CORP |
| EP3360864 | PYRIMIDINE COMPOUND | KIMURA HIDENORI | SUMITOMO DAINIPPON PHARMA CO LTD |
| EP3360877 | 1,6- DIAZABICYCLO [3,2,1]OCTAN- 7- ONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS | PATIL VIJAYKUMAR JAGDISHWAR | WOCKHARDT LTD |
| EP3360893 | HIGH-AFFINITY AND SOLUBLE PDL-1 MOLECULE | LI YI | GUANGZHOU INST BIOMED & HEALTH |
| EP3361250 | PHARMACEUTICAL COMPOSITION FOR INDUCING EXERCISE-LIKE EFFECTS | SEO HONG SEOG | CELLVERTICS CO LTD |
| EP3362050 | AMPHIPHILIC MOLECULES LAYERS | KENAAN AHMAD | CENTRE NAT RECH SCIENT |
| EP3362054 | PREGABALIN COMPOSITIONS | RUIZ AMENOS ANNA | LESVI LABORATORIOS SL |
| EP3362056 | AMINOTHIOLESTER COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, FOR USE IN THE TREATMENT OF CANCER | CEYLAN ISMAIL | ADVANCED BIODESIGN |
| EP3362058 | 5-HYDROXYTRYPTAMINE 1B RECEPTOR-STIMULATING AGENT FOR THE TREATMENT OF MYOCARDIAL INFARCTION | CHRETIEN FABRICE BRUNO | PASTEUR INSTITUT |
| EP3362066 | COMBINATION THERAPY FOR TREATING MALIGNANCIES | AGRESTA SAMUEL V | AGIOS PHARMACEUTICALS INC |
| EP3362070 | COMBINATION THERAPY FOR TREATING MALIGNANCIES | CHOPRA VIVEK SAROJ KUMAR | CELGENE CORP |
| EP3362081 | TREATMENT OF LEARNING DISABILITIES AND OTHER NEUROLOGICAL DISORDERS WITH SK CHANNEL INHIBITOR(S) | HASHIMOTO-TORII KAZUE | CHILDRENS NAT MEDICAL CT |
| EP3362094 | COMBINATION COMPRISING AN AMINOTHIOLESTER COMPOUND OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A COMPOUND ABLE TO INCREASE THE H2O2 LEVEL IN CANCER CELLS OF A SUBJECT | CEYLAN ISMAIL | ADVANCED BIODESIGN |
| EP3362097 | A PROCESS FOR PREPARING A STABLE EMULSION COMPRISING ONE OR MORE AVERMECTINS | MALLARD CLAIRE | GALDERMA SA |
| EP3362101 | PROMOTER FOR THE SPECIFIC EXPRESSION OF GENES IN RETINAL ENDOTHELIAL CELLS | JUETTNER JOSEPHINE | FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RES |
| EP3362443 | COMPOUNDS USEFUL AS IMMUNOMODULATORS | YEUNG KAP-SUN | SQUIBB BRISTOL MYERS CO |
| EP3362444 | COMPOUNDS | BATES DAVID | EXONATE LTD |
| EP3362448 | NEW COMPOUNDS INHIBITORS OF THE YAP/TAZ-TEAD INTERACTION AND THEIR USE IN THE TREATMENT OF MALIGNANT MESOTHELIOMA | BARTH MARTINE | INVENTIVA |
| EP3362449 | SIBIRILINE DERIVATIVES FOR USE FOR PREVENTING AND/OR TREATING DISORDERS ASSOCIATED WITH CELLULAR NECROPTOSIS | DIMANCHE-BOITREL MARIE-THéRèSE | INST NAT SANTE RECH MED |
| EP3362454 | EP4 ANTAGONISTS | ZHENG WANJUN | EISAI R&D MAN CO LTD |
| EP3362459 | ACETATE COMPLEXES AND METHODS FOR ACETATE QUANTIFICATION | LEACH ANDREW | GEN ELECTRIC |
| EP3362470 | CHIMERIC ANTIGEN RECEPTORS CONTAINING A CHLOROTOXIN DOMAIN | BARISH MICHAEL | HOPE CITY |
| EP3362480 | ANTIBODY SPECIFICALLY BINDING TO ERBB3 AND USE THEREOF | BAE DONG GOO | ISU ABXIS CO LTD |
| EP3362569 | CXCR6-TRANSDUCED T CELLS FOR TARGETED TUMOR THERAPY | KOBOLD SEBASTIAN | UNIV MUENCHEN LUDWIG MAXIMILIANS |
| EP3362754 | PROTEASOME INHIBITORS AND USES THEREOF | LIN GANG | UNIV CORNELL |
| EP3363426 | COMPOSITION FOR SKIN WHITENING CONTAINING AMORPHIGENI AS ACTIVE INGREDIENT | KIM KWANG DONG | NAT UNIV GYEONGSANG IACF |
| EP3363437 | AMINOINDANE COMPOUNDS AND USE THEREOF IN TREATING PAIN | THOMPSON SCOTT KEVIN | ENDO PHARMACEUTICALS SOLUTIONS |
| EP3363450 | TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING PSORIASIS | LU CHUANJIAN | GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE |
| EP3363783 | COMPOSITION FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE AND ATOPIC DERMATITIS | KANG IN CHEOL | INNOPHARMASCREEN INC |
| EP3363789 | PYRAZINE COMPOUND AND ARTHROPOD PEST CONTROL AGENT CONTAINING SAME | ORIMOTO KOHEI | SUMITOMO CHEMICAL CO |
| EP3363808 | PROCESS FOR THE PREPARATION OF A STEVIA COMPOSITION COMPRISING REBAUDIOSIDE B | MARKOSYAN AVETIK | PURECIRCLE USA INC |
| EP3363893 | IDENTIFICATION OF CD8+ T CELLS THAT ARE CD161HI AND/OR IL18RALPHAHI AND HAVE RAPID DRUG EFFLUX CAPACITY | TURTLE CAMERON J | HUTCHINSON FRED CANCER RES |
| EP3364188 | BLOOD BIOMARKER FOR USE IN EVALUATION OF EFFECT OF DRUG THERAPY ON KIDNEY CANCER | NAKAIGAWA NOBORU | PUBLIC UNIV CORP YOKOHAMA CITY UNIV |
| EP3364941 | USE OF GLYCOSIDES TO INCREASE HAIR MASS | THIBAUT SéBASTIEN | OREAL |
| EP3364943 | FORMULATIONS WITH A CONTROLLED RELEASE OF PERFUMES FOR DERMAL APPLICATION | KOLTER KARL | BASF SE |
| EP3364947 | AQUEOUS COMPOSITION COMPRISING DANTROLENE | SCHWEBEL HERVé JEAN | BRAUN MELSUNGEN AG |
| EP3364952 | LIPOSOMES CONTAINING CELL PENETRATING PEPTIDES AND TETRAETHERLIPIDS FOR THE ORAL DELIVERY OF MACROMOLECULES | UHL PHILIPP | UNIV HEIDELBERG |
| EP3364962 | METHOD FOR IMPROVING RECOGNITION AND/OR WORKING MEMORY IN HYPERPHENYLALANIMENIA AND PHENYLKETONURIA PATIENTS | DE WILDE MATTHEUS CORNELIS | NUTRICIA NV |
| EP3364975 | COMBINATION OF TRAZODONE AND GABAPENTIN FOR THE TREATMENT OF PAIN | GARRONE BEATRICE | ACRAF |
| EP3364984 | COMPOUNDS AND COMPOSITIONS INCLUDING PHOSPHOROTHIOATED OLIGODEOXYNUCLEOTIDE, AND METHODS OF USE THEREOF | KORTYLEWSKI MARCIN TOMASZ | HOPE CITY |
| EP3364988 | WOUND CARE COMPOSITION | KARAMAN OZLU ZEYNEP | KARAMAN OZLU ZEYNEP |
| EP3364990 | A PROCESS TO ENHANCE THE BIOACTIVITY OF ASHWAGANDHA EXTRACTS | ANTONY BENNY | ANTONY BENNY |
| EP3364995 | SINGLE-CHAIN CD27-RECEPTOR AGONIST PROTEINS | GIEFFERS CHRISTIAN | APOGENIX AG |
| EP3364996 | PROSTATE-TARGETING ADENO-ASSOCIATED VIRUS SEROTYPE VECTORS | GAO GUANGPING | UNIV MASSACHUSETTS LOWELL |
| EP3365026 | ANTI-CANCER AND ANTI-INFLAMMATORY THERAPEUTICS AND METHODS THEREOF | LEONARD JACK L | UNIV MASSACHUSETTS |
| EP3365347 | BORON COMPOUNDS AS INHIBITORS OF LIPOXYGENASE AND THE LIPOXYGENASE PATHWAY, AND PREPARATION AND USE THEREOF | HEY-HAWKINS EVAMARIE | UNIV LEIPZIG |
| EP3365366 | TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS FOR PREVENTION OR TREATMENT OF HIV INFECTION | YANG ZHI-YONG | SANOFI SA |
| EP3365421 | SOLID SOLUTIONS OF ODORIFEROUS SUBSTANCES AND FLAVORING AGENTS WITH VINYL LACTAM POLYMERS | KOLTER KARL | BASF SE |
| EP3366270 | METHOD FOR PRODUCING COATING FILM | AMARI NAOMI | KAO CORP |
| EP3366277 | PEELABLE NAIL LACQUER | ROSSEL BART | OYSTERSHELL NV |
| EP3366283 | DIRECT COMPRESSION FORMULATION AND PROCESS | KOWALSKI JAMES | NOVARTIS AG |
| EP3366285 | ALPHA-DERIVATIVES OF CIS-MONOUNSATURATED FATTY ACIDS FOR USE AS MEDICINES | ESCRIBá RUIZ PABLO VICENTE | UNIV ILLES BALEARS |
| EP3366294 | METHYLENE BLUE COMPLEX FOR TREATING SKIN DISEASE AND ITS USE THEREOF | LEE YONG-DEOK | D R NANO CO LTD |
| EP3366302 | PROTECTION OF CELLS FROM ALU-RNA-INDUCED DEGENERATION AND INHIBITORS FOR PROTECTING CELLS | AMBATI JAYAKRISHNA | UNIV KENTUCKY RES FOUND |
| EP3366306 | USE OF SOME PEPTIDES IN DIAGNOSIS AND TREATMENT OF DIABETES, OBESITY AND METABOLIC DISEASES ASSOCIATED THERETO | OKTAYOGLU SELDA | ISTANBUL UNIV REKTORLUGU |
| EP3366307 | COMPOSITIONS AND METHODS OF INHIBTING MASP-1 AND/OR MASP-3 FOR THE TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA | SCHWAEBLE HANS-WILHELM | OMEROS CORP |
| EP3366679 | HETEROCYCLIC COMPOUND | SUGIMOTO TAKAHIRO | TAKEDA PHARMACEUTICALS CO |
| EP3366695 | SAPOSIN-A DERIVED PEPTIDES AND USES THEREOF | RANDOLPH WATNICK | CHILDRENS MEDICAL CENTER |
| EP3367994 | METHOD FOR INHIBITING OR MASKING FISHY ODOURS | HATT HANNS | SYMRISE AG |
| EP3368002 | ORAL CARE PRODUCTS AND METHODS COMPRISING ANTIFREEZE PROTEINS | SCHNEIDER NINA | BASF SE |
| EP3368012 | LISINOPRIL FORMULATIONS | MOSHER GEROLD L | SILVERGATE PHARMACEUTICALS INC |
| EP3368020 | METHODS OF GENERATING MICROPARTICLES AND POROUS HYDROGELS USING MICROFLUIDICS | OAKEY JOHN | UNIV WYOMING |
| EP3368023 | DERIVATIVES OF PORPHYRINS, THEIR PROCESS OF PREPARATION AND THEIR USE FOR TREATING VIRAL INFECTIONS | AMRANE SAMIR | INST NAT SANTE RECH MED |
| EP3368043 | FUROSTAN-3-OL DERIVATIVES AS SKELETAL MUSCLE HYPERTROPHIC AGENTS | TALLEY JOHN J | EMMYON INC |
| EP3368044 | TREATMENT OF HEPATIC STEATOSIS RELATED OLIGO-OVULATION | IBáÑEZ LOURDES | UNIV LEUVEN KATH |
| EP3368052 | USE OF MAPK INHIBITORS TO REDUCE LOSS OF HEMATOPOIETIC STEM CELLS DURING EX VIVO CULTURE AND/OR GENETIC MANIPULATION | MALIK PUNAM | CHILDRENS HOSPITAL MED CT |
| EP3368064 | METHOD TO IMPROVE SAFETY AND EFFICACY OF ANTI-CANCER THERAPY | GENKIN DMITRY | CLS THERAPEUTICS LTD |
| EP3368067 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF HER2-EXPRESSING SOLID TUMORS | WOOD LAUREN V | US HEALTH |
| EP3368161 | COSMETIC COMPOSITION IMPARTING A NATURAL COMPLEXION AND A HEALTHY-LOOKING APPEARANCE EFFECT | CHABRILLANGEAS MATHIEU | OREAL |
| EP3368205 | MICROCAPSULES AND COMPOSITIONS PROVIDING CONTROLLED RELEASE OF ACTIVES | BAXTER ELAINE ALICE MARIE | NOXELL CORP |
| EP3368207 | ENCAPSULATION | ZHANG HANWEI | ENCAPSYS LLC |
| EP3368522 | PYRIDINE OR PYRIMIDINE DERIVATIVES | HOENER MARIUS | HOFFMANN LA ROCHE |
| EP3368524 | HETEROARYLCARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS | FRATTINI SARA | BOEHRINGER INGELHEIM INT |
| EP3368527 | PALBOCICLIB SALTS | LUKáCS GYULA | EGYT GYOGYSZERVEGYESZETI GYAR |
| EP3368534 | VALBENAZINE SALTS AND POLYMORPHS THEREOF | MCGEE KEVIN | NEUROCRINE BIOSCIENCES INC |
| EP3368538 | WEE 1 KINASE INHIBITORS AND METHODS OF MAKING AND USING THE SAME | REIGAN PHILIP | UNIV COLORADO REGENTS |
| EP3368678 | GENETIC CONSTRUCT | WIDDOWSON PETER | QUETHERA LTD |
| EP3369411 | MULTICOMPONENT MESO THREAD CONTAINING HYALURONIC ACID AND METHOD FOR PRODUCING SAME (VARIANTS) | MIHAJLOVA NATAL'YA PAVLOVNA | MARTINEX INTERNATIONAL RES AND DEVELOPMENT |
| EP3369412 | METHOD FOR PRODUCING PRESSED MAKE-UP POWDER | ROH YOUNG HEA | AMOREPACIFIC CORP |
| EP3369418 | COMPOSITION | HOSOKAWA KINYA | SHISEIDO CO LTD |
| EP3369425 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | GRANT GEORGE | 4D PHARMA RES LTD |
| EP3369427 | SYNERGISTIC ANTIPARASITIC COMPOSITIONS AND SCREENING METHODS | ENAN ESSAM | TYRATECH INC |
| EP3369430 | ACUTE RESPIRATORY DISTRESS SYNDROME THERAPEUTIC AGENT | MIZUSHIMA TORU | LTT BIO PHARMA CO LTD |
| EP3369745 | ANTI-PD-L1 NANOBODY AND USE THEREOF | SHEN XIAONING | INNOVENT BIOLOGICS SUZHOU CO LTD |
| EP3369809 | METHOD FOR OBTAINING LEYDIG CELLS BY CARRYING OUT INDUCED DIFFERENTIATION ON HUMAN INDUCED PLURIPOTENT STEM CELLS, AND USE OF LEYDIG CELLS | XIANG PENG | UNIV SUN YAT SEN |
| EP3369818 | MIRNA FOR TREATING HEAD AND NECK CANCER | BRAKENHOFF RUDOLF HENRIKUS | INTERNA TECH B V |
| EP3369820 | DNA APTAMER CAPABLE OF BONDING TO VWF | HIRAO ICHIRO | TAGCYX BIOTECHNOLOGIES |
| EP3370697 | PHYSICALLY AND CHEMICALLY STABLE ORAL SUSPENSIONS OF GIVINOSTAT | COLOMBO GIUSEPPE | ITALFARMACO SPA |
| EP3370700 | ORAL COMPOSITION IN GEL FORM COMPRISING CHITOSAN, PECTIN WITH A HIGH DEGREE OF METHOXYLATION, A SUGARY SUBSTANCE, L-CARNITINE AND N-ACETYLCYSTEINE | FRATTER ANDREA | LABOMAR S R L |
| EP3370717 | COMPOSITIONS FAVORING WOUND REPAIR | GUERIN SYLVAIN | UNIV LAVAL |
| EP3370718 | LOCAL AND REGIONAL ANESTHESIA AND ANALGESIA | PETRUSKA JEFFREY C | UNIV LOUISVILLE RES FOUND INC |
| EP3370733 | METHODS OF CD40 ACTIVATION AND IMMUNE CHECKPOINT BLOCKADE | OVERWIJK WILLEM W | UNIV TEXAS |
| EP3370737 | ANTI-AGING COMPOSITIONS AND METHODS FOR USING SAME | IDELEVICH PAVEL | PRESCIENT PHARMA LLC |
| EP3370739 | SYSTEMS AND METHODS FOR ANTI-MICROBIAL EFFECT FOR BONES | RABINER ROBERT A | ILLUMINOSS MEDICAL INC |
| EP3370746 | COMPOSITION COMPRISING LACTOBACILLUS PLANTARUM 2830 (ECGC 13110402) | O'HARA STEPHEN PATRICK | OPTIBIOTIX LTD |
| EP3370755 | ACTIVATION OF RESIDENT MEMORY T CELLS FOR CANCER IMMUNOTHERAPY | MASOPUST JR DAVID B | UNIV MINNESOTA |
| EP3370757 | USE OF ANGIOPOIETINS IN PROMOTING BLOOD COAGULATION AND IN THE TREATMENT OF BLOOD COAGULATION DISORDERS | DALY CHRISTOPHER | REGENERON PHARMA |
| EP3370770 | SUBCUTANEOUS FORMULATIONS OF ANTI-CD38 ANTIBODIES AND THEIR USES | JANSSON RICHARD | JANSSEN BIOTECH INC |
| EP3371150 | PROCESS FOR PREPARING BRIVARACETAM | DEFRANCE THIERRY | UCB BIOPHARMA SPRL |
| EP3371172 | TETRAHYDROINDAZOLES AND MEDICAL USES THEREOF | DRUMMOND CATHERINE | LAIN SONIA |
| EP3371174 | INDOLIN-2-ONE DERIVATIVES | GAUFRETEAU DELPHINE | HOFFMANN LA ROCHE |
| EP3371195 | SELECTIVE HDAC8 INHIBITORS AND THEIR USES | MEYER-ALMES FRANZ-JOSEF | HOCHSCHULE DARMSTADT |
| EP3371196 | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF PLATELET AGGREGATION | MARTEL ALAIN | UNIV MONTREAL |
| EP3372229 | METHODS OF INCREASING TONIC INHIBITION AND TREATING SECONDARY INSOMNIA | DURING MATTHEW | OVID THERAPEUTICS INC |
| EP3372231 | PHARMACEUTICAL COMPOSITION FOR CANCER IMMUNOTHERAPY PURPOSES AND/OR IMMUNOSTIMULATION PURPOSES WHICH CONTAINS DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND AS ACTIVE INGREDIENT | EGUCHI TOMOHIRO | ASTELLAS PHARMA INC |
| EP3372232 | TUMOR THERAPEUTIC AGENT COMPRISING GEMCITABINE LIPOSOME COMPOSITION AND KIT | KITAHASHI TSUKASA | FUJIFILM CORP |
| EP3372233 | PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING CANCER | MIYANO ATSUKO | TORAY INDUSTRIES |
| EP3372234 | COMPLEX COMPRISING RNAI MOLECULE AND N-ACETYLATED CHITOSAN | YONEYAMA HIROYUKI | STELIC INST & CO INC |
| EP3372246 | PERITONEAL DIALYSIS FLUID | USAMI HIROKAZU | TERUMO CORP |
| EP3372281 | POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITY | JOHNS BRIAN ALVIN | VIIV HEALTHCARE CO |
| EP3372588 | PYRIMIDINE COMPOUND | ORIMOTO KOHEI | SUMITOMO CHEMICAL CO |
| EP3372589 | PYRIMIDINE DERIVATIVE | OKADA MAKOTO | ASKA PHARM CO LTD |
| EP3372591 | CADHERIN-11 INHIBITORS AND METHODS OF USE THEREOF | BYERS STEPHEN W | UNIV GEORGETOWN |
| EP3372594 | PYRIMIDINE DERIVATIVE AND USE THEREOF | WANG XUEHAI | HUMANWELL HEALTHCARE GROUP CO LTD |
| EP3372600 | FUSED HETEROCYCLIC COMPOUND DERIVATIVE AND APPLICATION THEREOF | ZHANG GUISEN | NHWA PHARMA CORP |
| EP3372605 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS | HAAS JULIA | ARRAY BIOPHARMA INC |
| EP3372607 | CRYSTALLINE FORM OF BTK KINASE INHIBITOR AND PREPARATION METHOD THEREOF | WU GUAILI | JIANGSU HENGRUI MEDICINE CO |
| EP3373892 | DENTIFRICE COMPOSITIONS WITH DUAL FLUORIDE SOURCE WITH IMPROVED FLUORIDE UPTAKE | YANG HONGMEI | PROCTER & GAMBLE |
| EP3373904 | TOOTH WHITENING COMPOSITIONS COMPRISING PEROXIDE COMPLEX AND PERCARBONATE SALT | EVANS LAUREN | COLGATE PALMOLIVE CO |
| EP3373905 | DENTIFRICE COMPOSITIONS WITH IMPROVED CONSUMER EXPERIENCE | BASA SWAPNA | PROCTER & GAMBLE |
| EP3373906 | COMPOSITIONS AND METHODS FOR APPLICATION OVER SKIN | AKTHAKUL ARIYA | SHISEIDO AMERICAS CORP |
| EP3373917 | PROCESS FOR RECOVERY OF WASTE GEL-MASS FROM SOFTGEL MANUFACTURING PROCESS | FULPER LESTER DAVID | SCHERER TECHNOLOGIES LLC R P |
| EP3373928 | NOVEL FORMULATIONS | SHALVIRI ALIREZA | GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS US LLC |
| EP3373935 | CYANOPYRIDINE DERIVATIVES AS LIVER X RECEPTOR BETA AGONISTS, COMPOSITIONS, AND THEIR USE | RUDD MICHAEL T | MERCK SHARP & DOHME |
| EP3373937 | ANTI-CD22 ANTIBODY-MAYTANSINE CONJUGATES AND METHODS OF USE THEREOF | RABUKA DAVID | SCHERER TECHNOLOGIES LLC R P |
| EP3373951 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF EPIDERMOLYSIS BULLOSA | FRANKLIN RICHARD | TARIX PHARMACEUTICALS LTD |
| EP3374027 | RATIONAL DRUG DESIGN TARGETING RESISTANT GRAM-NEGATIVE BACTERIAL INFECTIONS TO POLYMYXIN-CLASS ANTIBIOTICS | MANCIA FILIPPO | UNIV COLUMBIA |
| EP3374028 | SPHINGAMIDE COMPOUNDS AND METHODS FOR BINDING INKT CELLS | ZAJONC DIRK | LA JOLLA INST ALLERGY & IMMUNOLOGY |
| EP3374358 | AZETIDINE DERIVATIVES FOR TAU IMAGING | ATTARDO GIORGIO | LILLY CO ELI |
| EP3375454 | RNA COMPOSITION FOR TREATING NON-SMALL LUNG CANCER (NSCLC) | BARNER MARIJKE | CUREVAC AG |
| EP3375866 | STEM CELL WITH SUPPRESSED SOCS AND IMPROVED IMMUNOSUPPRESSIVE ABILITY AND USE THEREOF | YOO KEON HEE | SAMSUNG LIFE PUBLIC WELFARE FOUNDATION |
| EP3376859 | MICROORGANISMS FOR THE PRODUCTION OF INSECT PHEROMONES AND RELATED COMPOUNDS | LEONARD EFFENDI | PROVIVI INC |
| EP3377028 | INK SET AND METHOD FOR INK JET PRINTING | EDAKA KEIICHI | FUNAI ELECTRIC CO |
| EP3377033 | MASCARA COMPOSITION AND METHOD | LEE WILSON A | ELC MAN LLC |
| EP3377044 | IBUPROFEN COMPOSITIONS FOR DIRECT ORAL ADMINISTRATION | HAALA JOSEF | HERMES ARZNEIMITTEL GMBH |
| EP3377049 | CRYSTALLINE FORMS OF TAPENTADOL SALTS AND PROCESS FOR PREPARATION THEREOF | THIRUMALAI RAJAN SRINIVASAN | MSN LABORATORIES PRIVATE LTD |
| EP3377055 | GLYCOLIC ACID PROTECTS AGAINST ISCHEMIC INSULTS | PAN-MONTOJO FRANCISCO | PAN MONTOJO FRANCISCO |
| EP3377066 | AMIDO-SUBSTITUTED PYRIDOTRIAZINE DERIVATIVES USEFUL AS HIV INTEGRASE INHIBITORS | GRAHAM THOMAS H | MERCK SHARP & DOHME |
| EP3377090 | METHODS FOR TREATMENT OF BILE ACID-RELATED DISORDERS | LING LEI | NGM BIOPHARMACEUTICALS INC |
| EP3377094 | VIRULENCE ATTENUATED BACTERIA FOR TREATMENT OF MALIGNANT SOLID TUMORS | ITTIG SIMON | UNIV BASEL |
| EP3377103 | FUNCTIONAL ANTIBODY FRAGMENT COMPLEMENTATION FOR A TWO-COMPONENTS SYSTEM FOR REDIRECTED KILLING OF UNWANTED CELLS | COBBOLD MARK | REVITOPE LTD |
| EP3377110 | NANOPARTICLES BASED ON OPTIONALLY ALKOXYLATED POLY(ALKYL CYANOACRYLATES) HAVING A DEFINED DEGREE OF POLYMERIZATION | CURIC ANAMARIJA | ABBVIE DEUTSCHLAND |
| EP3377176 | METHOD OF TREATING PATIENTS COADMINISTERED A FACTOR Xa INHIBITOR AND VERAPAMIL | PATEL MAULIK | MORGANDANE SCIENT LLC |
| EP3377178 | B-1A LYMPHOCYTE AND/OR MACROPHAGE TARGETING AND ACTIVATION TO TREAT MEDICAL CONDITIONS WITH INFLAMMATORY OR AUTOIMMUNE COMPONENTS | STEINMAN LAWRENCE | UNIV LELAND STANFORD JUNIOR |
| EP3377179 | DEUTERATED EPI-743 | LIU JULIE F | CONCERT PHARMACEUTICALS INC |
| EP3377483 | N-SUBSTITUTED INDOLE DERIVATIVES AS PGE2 RECEPTOR MODULATORS | FRETZ HEINZ | IDORSIA PHARMACEUTICALS LTD |
| EP3377494 | PYRROPYRIMIDINE COMPOUNDS AS MNKS INHIBITORS | WINTER-HOLT JON JAMES | LIFEARC |
| EP3377501 | FUSED THIAZOLOPYRIMIDINE DERIVATIVES AS MNKS INHIBITORS | WINTER-HOLT JON JAMES | LIFEARC |
| EP3377509 | NEW MOLECULES FROM SEAWEEDS WITH ANTI-CANCER ACTIVITY | BOBBITT JUDITH | OCEANS LTD |
| EP3377519 | LABYRINTHOPEPTINS AS ANTI-VIRAL AGENTS | BRÖNSTRUP MARK | HELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH |
| EP3377623 | PROCESS FOR OBTAINING AN AQUEOUS EXTRACT ENRICHED WITH SMALL RNAS FROM A PLANT MATERIAL AND EXTRACTS RESULTING FROM THE PROCESS | PORTOLAN FRéDéRIQUE | ISP INVESTMENTS LLC |
| EP3377624 | TOPICAL COMPOSITION COMPRISING A SMALL RNA TIGER LILY EXTRACT AND METHOD OF COSMETIC CARE TO REDUCE SKIN SIGNS OF AGING | OGER ELODIE | ISP INVESTMENTS LLC |
| EP3378465 | SUNSCREEN AGENT COMPRISING POLYGLYCERYL-10 STEARATE AND POLYGLYCERYL-2 CAPRATE | SPROCK SARAH | BEIERSDORF AG |
| EP3378483 | STRO-1BRIGHT CELLS FOR USE IN TREATING LOW BACK PAIN | GHOSH PETER | MESOBLAST INC |
| EP3378486 | STABILIZED ANTIBODY-CONTAINING LIQUID FORMULATIONS | IGAWA TOMOYUKI | CHUGAI PHARMACEUTICAL CO LTD |
| EP3378493 | NOVEL ANTI-CANCER DRUG NANO-PREPARATION AND PREPARATION METHOD THEREFOR | YU BO | HANGZHOU PUSH KANG BIOTECHNOLOGY CO LTD |
| EP3378861 | ACRYLIC ACID DERIVATIVE, PREPARATION METHOD AND USE IN MEDICINE THEREOF | GUAN DONGLIANG | ZHEJIANG HISUN PHARM CO LTD |
| EP3378870 | NOVEL ANTIMICROBIAL PEPTIDE AND USE THEREOF | LEE TAE HOON | NOVACELL TECH INC |
| EP3378873 | ANTI-CLAUDIN 1 MONOCLONAL ANTIBODIES FOR THE PREVENTION AND TREATMENT OF HEPATOCELLULAR CARCINOMA | BAUMERT THOMAS | INSTITUT HOSPITALIER UNIV DE STRASBOURG |
| EP3378937 | PEPTIDE HAVING ACCUMULATION SPECIFIC TO PANCREATIC CANCER, AND USE OF SAID PEPTIDE | KONDO EISAKU | UNIV NIIGATA |
| EP3380062 | COMPOSITIONS FOR TREATING THE HAIR | DREHER KIMBERLY CHRISTINE | OREAL |
| EP3380066 | ORAL CARE COMPOSITIONS | NAWROCKI SHIRI | COLGATE PALMOLIVE CO |
| EP3380068 | STRIPED DENTIFRICE COMPOSITION COMPRISING ZINC | MOURAO MARCELLA F | COLGATE PALMOLIVE CO |
| EP3380069 | CLEANSING COMPOSITIONS | HARDY EUGENE | COLGATE PALMOLIVE CO |
| EP3380072 | BIOTECHNOLOGICALLY-PRODUCED CELLULOSE-CONTAINING ARTICLE FOR DERMATOLOGICAL USE | HESSLER NADINE | JENACELL GMBH |
| EP3380078 | COMPOSITION COMPRISING POLYELETROLYTE COMPLEXES, METHODS AND USES THEREOF | CRISTINA ARAúJO VIEIRA SíLVIA | ASSOCIATION FOR THE ADVANCEMENT OF TISSUE ENGINEERING AND CELL BASED TECH & THERAPIES A4TEC ASSOCIAC |
| EP3380080 | TOPICAL FILM-FORMING SPRAY | KOTTAYIL S GEORGE | GRACE THERAPEUTICS LLC |
| EP3380081 | METHOD FOR PREPARING A STABLE CONTROLLED-RELEASE PROPOLIS COLLOIDAL DISPERSION SYSTEM FOR VARIOUS USES | GARDIKIS KONSTANTINOS | APIVITA S A |
| EP3380085 | ORAL PREPARATIONS WITH OMEPRAZOLE OR PANTOPRAZOLE | HANS JOACHIM | SYMRISE AG |
| EP3380086 | USE OF CYP26-RESISTANT RAR ALPHA SELECTIVE AGONISTS IN THE TREATMENT OF CANCER | GHIAUR GABRIEL | IO THERAPEUTICS INC |
| EP3380092 | COMPOSITION OF OLIVETOL AND METHOD OF USE REDUCE OR INHIBIT THE EFFECTS OF TETRAHYDROCANNABINOL IN THE HUMAN BODY | CARBERRY JAMES J | UNDOO LLC |
| EP3380093 | BETA-HYDROXY KETONES AS TOPICAL AGENTS FOR THE PROPHYLAXIS OR TREATMENT OF PHOTODERMATOSES | CAROLA CHRISTOPHE | MERCK PATENT GMBH |
| EP3380101 | EIF4-A-INHIBITING COMPOUNDS AND METHODS RELATED THERETO | ERNST JUSTIN T | EFFECTOR THERAPEUTICS INC |
| EP3380112 | PEPTIDES AND THEIR USE IN THE TREATMENT OF HAIR | IDKOWIAK BALDYS JOLANTA | AVON PROD INC |
| EP3380117 | GENETICALLY MODIFIED CELLS AND USES THEREOF | BOYD RICHARD | CARTHERICS PTY LTD |
| EP3380119 | FMDV AND E2 FUSION PROTEINS AND USES THEREOF | AUDONNET JEAN-CHRISTOPHE | MERIAL INC |
| EP3380120 | IMMUNOSTIMULATORY COMPOSITIONS | CARPENTIER ANTOINE | HOPITAUX PARIS ASSIST PUBLIQUE |
| EP3380122 | ANTI-5T4 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES | VAN DER LEE MIRANDA MARIA CORNELIA | SYNTHON BIOPHARMACEUTICALS BV |
| EP3380467 | HETEROCYCLIC INDOLES FOR USE IN INFLUENZA VIRUS INFECTION | JONCKERS TIM HUGO MARIA | JANSSEN SCIENCES IRELAND UC |
| EP3380495 | PEPTIDE COMPOUNDS AND PEPTIDE CONJUGATES FOR THE TREATMENT OF CANCER THROUGH RECEPTOR-MEDIATED CHEMOTHERAPY | BéLIVEAU RICHARD | TRANSFERT PLUS SEC |
| EP3380615 | IL-34 ANTISENSE OLIGONUCLEOTIDES AND METHODS OF USING SAME | MCNULTY MARIE | NOGRA PHARMA LTD |
| EP3381435 | DENTAL ADHESIVE AGENT AND METHOD OF MANUFACTURING THEREOF | KAKINUMA HIROAKI | G C DENTAL IND CORP |
| EP3381441 | ANTIAGING COMPOSITION FOR EXTERNAL PREPARATION FOR SKIN, CONTAINING EXTRACT OF GERMINATEDGLYCINE GRACILIS | KANG YOUNG GYU | AMOREPACIFIC CORP |
| EP3381444 | SYRINGE | SIGG JUERGEN | NOVARTIS AG |
| EP3381457 | PHYSIOLOGICALLY ACTIVE COMPOSITION COMPRISING N-ACETYLGLUCOSAMINE FOR THE TREATMENT OF BACK PAIN | SCHANTL JOSEF | NATURAL PRODUCTS & DRUGS GMBH |
| EP3381461 | PEPTIDES AND METHODS OF USING SAME | MOGELSVANG SOREN | SERPIN PHARMA LLC |
| EP3381469 | ANTI-ERBB2 ANTIBODY-DRUG CONJUGATE AND COMPOSITION THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | XUE TONGTONG | SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD |
| EP3381904 | NOVEL NITROGEN-CONTAINING AROMATIC HETEROCYCLIC COMPOUND | SAKAKIBARA RYO | MITSUBISHI TANABE PHARMA CORP |
| EP3381910 | 4-OXO-4,5-DIHYDROTHIAZOLE DERIVATIVE, PREPARATION METHOD AND USE THEREOF | LI SONG | INST PHARMACOLOGY & TOXICOLOGY ACADEMY MILITARY MEDICAL SCIENCES PLA CHINA |
| EP3381913 | NOVEL IMIDAZOLE COMPOUND AND USE THEREOF AS MELANOCORTIN RECEPTOR AGONIST | SATO ATSUSHI | MITSUBISHI TANABE PHARMA CORP |
| EP3381917 | IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF | BUON CHRISTOPHE | NEOMED INST |
| EP3381921 | GINKGOLIDE B DERIVATIVE AND PREPARATION METHOD AND USE THEREOF | LI DAXIONG | CHENGDU BAIYU GINKGOLIDE PHARMACEUTICALS CO LTD |
| EP3381942 | A METHOD FOR TREATING MELANOMA USING A HERPES SIMPLEX VIRUS AND AN IMMUNE CHECKPOINT INHIBITOR | VANDERWALDE ARI | AMGEN INC |
| EP3382006 | MODIFIED GRAM POSITIVE BACTERIA AND USES THEREOF | STEIDLER LOTHAR | INTREXON ACTOBIOTICS NV |
| EP3382009 | CHIMERIC ANTIGEN RECEPTOR-MODIFIED IMMUNE EFFECTOR CELL CARRYING PD-L1 BLOCKING AGENT | LI ZONGHAI | CARSGEN THERAPEUTICS LTD |
| EP3383357 | HYDROGEN PEROXIDE BOOSTER SYSTEM FOR ENHANCED TEETH WHITENING | DOGO-ISONAGIE CAJETAN | COLGATE PALMOLIVE CO |
| EP3383358 | CLEANSING BARS | DUBOVOY VIKTOR | COLGATE PALMOLIVE CO |
| EP3383361 | OLIGONUCLEOTIDES IN FOOD, BEVERAGE, COSMETIC AND MEDICINAL FORMULATIONS | KABISCH JOHANNES | DNA ESSENCE GMBH |
| EP3383363 | TOPICAL PHARMACEUTICAL FORMULATIONS FOR TREATING INFLAMMATORY-RELATED CONDITIONS | CORONADO DINA JEAN | ANACOR PHARMACEUTICALS INC |
| EP3383370 | EXTENDED DURATION LOCAL ANESTHETIC FORMULATION | POULSEN JEREMY | VENTIS PHARMA |
| EP3383376 | METHODS FOR INHIBITING CONVERSION OF CARNITINE TO TRIMETHYLAMINE (TMA) | HAZEN STANLEY LEON | PROCTER & GAMBLE |
| EP3383379 | COCOA POLYPHENOLS AND SOLUBLE DIETARY FIBER FOR USE IN THE TREATMENT OR PREVENTION DISORDERS ASSOCIATED WITH AN ABOVE-NORMAL NUMBER OF GRANULOCYTES IN A TISSUE | BLANCHARD CARINE | NESTEC SA |
| EP3383388 | ARYL ACYLSULFONAMIDES AS BLT1 ANTAGONISTS | HAN YONGXIN | MERCK SHARP & DOHME |
| EP3383389 | ARYL ACYLSULFONAMIDES AS BLT1 ANTAGONISTS | HAN YONGXIN | MERCK SHARP & DOHME |
| EP3383397 | PHARMACEUTICAL COMPOSITIONS CONTAINING DORAVIRINE, TENOFOVIR DISOPROXIL FUMARATE AND LAMIVUDINE | PANMAI SANTIPHARP | MERCK SHARP & DOHME |
| EP3383402 | PHARMACEUTICAL COMPOSITION COMPRISING DARUNAVIR AND METHOD FOR THE PREPARATION THEREOF | KARAVAS EVANGELOS | PHARMATHEN SA |
| EP3383406 | COMPOSITIONS CONTAINING DECITABINE, 5AZACYTIDINE AND TETRAHYDROURIDINE AND USES THEREOF | SAUNTHARARAJAH YOGEN | EPIDESTINY INC |
| EP3383415 | USE OF MITOCHONDRIAL IRON CHELATORS FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | CHOI AUGUSTINE M K | UNIV CORNELL |
| EP3383418 | SLC45A2 PEPTIDES FOR IMMUNOTHERAPY | LIZEE GREGORY | UNIV TEXAS |
| EP3383421 | STAPLED HELICAL PEPTIDES AND METHODS OF SYNTHESIS | LI XUECHEN | UNIV HONG KONG |
| EP3383422 | CIRCULAR TANDEM REPEAT PROTEINS | BRADLEY PHILIP | HUTCHINSON FRED CANCER RES |
| EP3383434 | TRANSDUCTION BUFFER | GEIJSEN NIELS | KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN |
| EP3383440 | SYNP162, A PROMOTER FOR THE SPECIFIC EXPRESSION OF GENES IN ROD PHOTORECEPTORS | HARTL DOMINIK | FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RES |
| EP3383493 | C5-C6-CARBOCYCLIC FUSED IMINOTHIADIAZINE DIOXIDES AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE | SCOTT JACK D | MERCK SHARP & DOHME |
| EP3383495 | CHEMICAL REPROGRAMMING OF HUMAN GLIAL CELLS INTO NEURONS WITH SMALL MOLECULE COCKTAIL | CHEN GONG | PENN STATE RES FOUND |
| EP3383851 | DEXTRORPHAN-DERIVATIVES WITH SUPPRESSED CENTRAL NERVOUS ACTIVITY | LAMMERT ECKHARD | HEINRICH HEINE UNIV DUESSELDORF |
| EP3383860 | APELIN RECEPTOR AGONISTS AND METHODS OF USE | MENG WEI | SQUIBB BRISTOL MYERS CO |
| EP3383867 | COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY | RANCATI FABIO | CHIESI FARM SPA |
| EP3383957 | CELLULOSE-BASED ORGANIC PIGMENTS | ANDREWS MARK P | ANOMERA INC |
| EP3383958 | METHOD FOR THE PRODUCTION OF GRANULES COMPRISING SURFACE-REACTED CALCIUM CARBONATE | DIAZ QUIJANO CAROLINA | OMYA INT AG |
| EP3384028 | MONOCARBOXYLATE TRANSPORTER 4 (MCT4) ANTISENSE OLIGONUCLEOTIDE (ASO) INHIBITORS FOR USE AS THERAPEUTICS IN THE TREATMENT OF CANCER | WANG YUZHUO | UNIV BRITISH COLUMBIA |
| EP3384917 | METHOD FOR PRODUCING HYALURONIDASE CONJUGATE WITH POLYETHYLENEPIPERAZINE DERIVATIVES AND THE USE OF THE CONJUGATE PRODUCED | NEKRASOV ARKADII VASILEVICH | OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU NPO PETROVAKS FARM |
| EP3384929 | METHOD FOR USING SMALL MOLECULE COMPOUNDS TO INDUCE HUMAN TUMOR CELLS TO BE DIRECTLY REPROGRAMMED INTO NON-ONCOGENIC CELLS | ZHANG PEILIN | TRANSCEND CYTOTHERAPY CO LTD |
| EP3385253 | CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING | CASEBIER DAVID S | LANTHEUS MEDICAL IMAGING INC |
| EP3385274 | MUTANT OF HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN | LI SHAOWEI | UNIV XIAMEN |
| EP3385383 | ANTI-IL-17 APTAMER HAVING IMPROVED RETENTION IN BLOOD | HARUTA KAZUHIKO | ZENYAKU KOGYO CO LTD |
| EP3385387 | SIMIAN ADENOVIRUS NUCLEIC ACID- AND AMINO ACID-SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREOF | COLLOCA STEFANO | GLAXOSMITHKLINE BIOLOGICALS SA |
| EP3386463 | TREATMENT COMPOSITIONS, APPARATUS AND METHODS FOR MODIFYING KERATINOUS SURFACES | LINGOES JANETTE VILLALOBOS | PROCTER & GAMBLE |
| EP3386465 | HAIR CARE COMPOSITION | CHANG SHAO KUN | UNILEVER NV |
| EP3386490 | FILM INCLUDING A POLYSULFATED OLIGOSACCHARIDE AND A POLYCATION AND METHOD FOR MANUFACTURING SAME | BOULMEDAIS FOUZIA | URGO RECH INNOVATION ET DEVELOPPEMENT |
| EP3386491 | RUFINAMIDE FOR USE IN THE TREATMENT OF MYOTONIA | PEDERSEN THOMAS HOLM | UNIV AARHUS |
| EP3386511 | METHODS FOR TREATING HUNTINGTON'S DISEASE | BABU SURESH | PTC THERAPEUTICS INC |
| EP3386519 | SIRNA STRUCTURES FOR HIGH ACTIVITY AND REDUCED OFF TARGET | YING WENBIN | NITTO DENKO CORP |
| EP3386527 | COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING NEUROINFLAMMATION, NEURODEGENERATION, NEUROPATHIC PAIN, AND MIGRAINE | MILLER YURY | UNIV CALIFORNIA |
| EP3386531 | USE OF C-TYPE NATRIURETIC PEPTIDE VARIANTS TO TREAT OSTEOARTHRITIS | O'NEILL CHARLES A | BIOMARIN PHARM INC |
| EP3386537 | MATERIALS AND METHODS FOR DELIVERING NUCLEIC ACIDS TO COCHLEAR AND VESTIBULAR CELLS | STANKOVIC KONSTANTINA | MASSACHUSETTS EYE & EAR INFIRMARY |
| EP3386543 | CONDITIONING REGIMENS AND METHODS FOR INDUCING MIXED CHIMERISM | ZENG DEFU | HOPE CITY |
| EP3386548 | INOSITOL DERIVATIVES FOR USE IN PATHOLOGICAL CRYSTALLIZATION | IVARSSON MATTIAS | ETH ZUERICH |
| EP3386550 | METHODS AND COMPOSITIONS FOR THE MAKING AND USING OF GUIDE NUCLEIC ACIDS | GOURGUECHON STEPHANE B | ARC BIO LLC |
| EP3386590 | BICYCLIC INHIBITORS OF PAD4 | DEVRAJ RAJESH | PADLOCK THERAPEUTICS INC |
| EP3386596 | TOPICAL SKIN CARE COMPOSITIONS COMPRISING MYRSINE AFRICANA EXTRACTS | LALL NAMRITA | UNIV PRETORIA |
| EP3386956 | FUMAGILLOL DERIVATIVES AND POLYMORPHS THEREOF | PETERSEN JOHN S | SYNDEVRX INC |
| EP3386978 | BRIDGED PIPERIDINE DERIVATIVES | BARTELS BJOERN | HOFFMANN LA ROCHE |
| EP3386980 | COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR | WU GUOXIAN | PLEXXIKON INC |
| EP3386981 | HETEROCYCLES USEFUL AS ANTI-CANCER AGENTS | ZHANG HANCHENG | HANGZHOU INNOGATE PHARMA CO LTD |
| EP3386984 | HEXAHYDROPYRAZINOTRIAZINONE DERIVATIVES AS KINASE INHIBITORS | HORSLEY HELEN TRACEY | UCB BIOPHARMA SPRL |
| EP3386986 | GOLD PORPHYRIN-PEG CONJUGATES AND METHODS OF USE | CHE CHI MING | UNIV HONG KONG |
| EP3386988 | NOVEL DIHYDROPYRANOPYRIMIDINONE DERIVATIVES, AND USE THEREOF | KIM KYUNGJIN | ST PHARM CO LTD |
| EP3386997 | MONOMALEIMIDE-FUNCTIONALIZED PLATINUM COMPOUNDS FOR CANCER THERAPY | KOWOL CHRISTIAN | UNIV WIEN MED |
| EP3387004 | CYCLIC PEPTIDES TARGETING ALPHA4 BETA7 INTEGRIN | VAZQUEZ MANUEL PEREZ | ENCYCLE THERAPEUTICS INC |
| EP3387015 | TYPE II ANTI-CD20 ANTIBODY FOR REDUCING FORMATION OF ANTI-DRUG ANTIBODIES | BACAC MARINA | HOFFMANN LA ROCHE |
| EP3387019 | RELAXIN IMMUNOGLOBULIN FUSION PROTEINS AND METHODS OF USE | WANG FENG | THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RES |
| EP3388055 | METHOD FOR PREPARING LIPOSOME | ZHANG XIQUAN | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD |
| EP3388064 | 2,4-THIAZOLIDINEDIONE DERIVATIVES IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | GARCíA COLLAZO ANA MARíA | MINORYX THERAPEUTICS S L |
| EP3388067 | PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING CANCER | MIYANO ATSUKO | TORAY INDUSTRIES |
| EP3388111 | ORGANOARSENIC COMPOUND FOR THE TREATMENT OF CANCER | SCHWARTZ BRIAN ERIC | SOLASIA PHARMA K K |
| EP3388428 | FIVE-MEMBERED HETEROCYCLIC AMIDES WNT PATHWAY INHIBITOR | WANG YONGHUI | SUZHOU SINOVENT PHARMACEUTICALS COMPANY |
| EP3388446 | IMPROVED ANGIOGENESIS-INHIBITING PEPTIDE AND COMPOSITION FOR PREVENTING AND TREATING ANGIOGENESIS-RELATED DISEASE COMPRISING SAME AS ACTIVE INGREDIENT | KIM YOUNG MYEONG | AVIXGEN INC |
| EP3388450 | HIV VACCINE BASED ON TARGETING MAXIMIZED GAG AND NEF TO DENDRITIC CELLS | BANCHEREAU JACQUES F | BAYLOR RES INSTITUTE |
| EP3388504 | SURFACTANT COMPOSITION | DOI YASUHIRO | KAO CORP |
| EP3388506 | SURFACTANT COMPOSITION | DOI YASUHIRO | KAO CORP |
| EP3389380 | SPIROCYCLIC QUINOLIZINE DERIVATIVES USEFUL AS HIV INTEGRASE INHIBITORS | ZHANG YONGLIAN | MERCK SHARP & DOHME |
| EP3389596 | PROCESS FOR PRODUCING A COSMETIC COMPOSITION | GIRON FRANCK | OREAL |
| EP3389618 | PROCESS FOR TREATING KERATIN FIBRES USING AN AQUEOUS COMPOSITION COMPRISING A COMBINATION OF PARTICULAR ALKOXYSILANES | SAMAIN HENRI | OREAL |
| EP3389625 | QUICK DISSOLVING DIPHENHYDRAMINE ORAL DOSAGE FORM | DANSEREAU RICHARD JOHN | PROCTER & GAMBLE |
| EP3389629 | LIQUID COMPOSITION FOR USE AS A NASAL SOLUTION | DERAIN NATHALIE | URGO RECH INNOVATION ET DEVELOPPEMENT |
| EP3389633 | PHARMACEUTICAL COMPOSITIONS COMPRISING PHENYLAMINOPYRIMIDINE DERIVATIVE | PARVATANENI DURGA MAHESWARI | NATCO PHARMA LTD |
| EP3389634 | METHODS FOR TREATING CANCER | RAGAN PAULA MARIE | X4 PHARMACEUTICALS INC |
| EP3389662 | PROCESS FOR THE PREPARATION OF TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS FOR USING THE SAME FOR THE TREATMENT OF CANCER | STUMPF ANDREAS | GENENTECH INC |
| EP3389673 | METHODS AND COMPOSITIONS FOR DELIVERY OF POLYNUCLEOTIDES | MORGENSTERN DAVID A | MONSANTO TECHNOLOGY LLC |
| EP3389682 | GROUP B ADENOVIRUS ENCODING AN ANTI-TCR-COMPLEX ANTIBODY OR FRAGMENT | CHAMPION BRIAN ROBERT | PSIOXUS THERAPEUTICS LTD |
| EP3389688 | NOVEL USE | CAMPICHE REMO | DSM IP ASSETS BV |
| EP3389689 | NOVEL USE | CAMPICHE REMO | DSM IP ASSETS BV |
| EP3389690 | FORMULATIONS AND METHODS FOR CONTROLLING THE REPRODUCTIVE CYCLE AND OVULATION | COLMAN JUAN ANDRES | PROINVET INNOVATIONS S A |
| EP3389694 | AN ANTIMICROBIAL COMPOSITION | AGARWAL KHUSHBU | UNILEVER NV |
| EP3389719 | PEPTIDE OLIGONUCLEOTIDE CONJUGATES | HANSON GUNNAR J | SAREPTA THERAPEUTICS INC |
| EP3389734 | SELF-ASSEMBLING PEPTIDES COMPRISING NON-IONIC POLAR AMINO ACIDS FOR ANTI-ADHESION | GIL EUN SEOK | 3 D MATRIX LTD |
| EP3389781 | INHIBITORS OF TNF SUPERFAMILY COSTIMULATORY INTERACTIONS AND METHODS FOR USES OF THE SAME | BUCHWALD PETER | UNIV MIAMI |
| EP3389790 | OXIDATION AGENT PREPARATIONS | GROSJACQUES CAMILLE | HENKEL AG & CO KGAA |
| EP3389795 | OCCLUSIVE PERSONAL CARE COMPOSITION | DUBOVOY VIKTOR | COLGATE PALMOLIVE CO |
| EP3389796 | COMBINATION OF POLYION COMPLEX PARTICLE AND HYDROPHILIC OR WATER-SOLUBLE UV FILTER | KASAI TAKEHIKO | OREAL |
| EP3390060 | PROCESS FOR COLOURING A BASE COSMETIC COMPOSITION | GIRON FRANCK | OREAL |
| EP3390357 | BIARYL MONOBACTAM COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF BACTERIAL INFECTIONS | TANG HAIFENG | MERCK SHARP & DOHME |
| EP3390359 | (R)-N-(ADAMANTYL-2-YL)PYRROLIDINE-2-CARBOXAMIDE DERIVATIVES FOR COSMETIC USE | BOUDON STEPHANIE | DSM IP ASSETS BV |
| EP3390370 | BIS-TRIAZOLE COMPOUNDS WITH ANTI-BIOFILM AND ANTI-CORROSION PROPERTIES | ANDJOUH SOFYANE | UNIV DE TOULON |
| EP3390382 | SUBSTITUTED 4-PHENYL PYRIDINE COMPOUNDS AS NON-SYSTEMIC TGR5 AGONISTS | LEWIS JASON G | ARDELYX INC |
| EP3390384 | QUINOLINE-3-CARBOXAMIDES AS H-PGDS INHIBITORS | CADILLA RODOLFO | ASTEX THERAPEUTICS LTD |
| EP3390387 | HETEROARYLBENZIMIDAZOLE COMPOUNDS | SCHULZE VOLKER | BAYER PHARMA AG |
| EP3390389 | POLYCYCLIC TLR7/8 ANTAGONISTS AND USE THEREOF IN THE TREATMENT OF IMMUNE DISORDERS | SHERER BRIAN A | MERCK PATENT GMBH |
| EP3390390 | BIPYRAZOLYL DERIVATIVES USEFUL FOR THE TREATMENT OF AUTOIMMUNE DISEASES | BOSANAC TODD | BOEHRINGER INGELHEIM INT |
| EP3390392 | ALKYL DIHYDROQUINOLINE SULFONAMIDE COMPOUNDS | WEISS MATTHEW | AMGEN INC |
| EP3390400 | HETEROARYLHYDROXYPYRIMIDINONES AS AGONISTS OF THE APJ RECEPTOR | MYERS MICHAEL C | SQUIBB BRISTOL MYERS CO |
| EP3390404 | TRICYCLIC COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS | AVERSA ROBERT JOHN | NOVARTIS AG |
| EP3390412 | WATER-SOLUBLE DERIVATIVES OF 3,5-DIPHENYL-DIAZOLE COMPOUNDS | GIESE ARMIN | MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WSS |
| EP3390441 | HUMAN IMMUNODEFICIENCY VIRUS NEUTRALIZING ANTIBODIES | BALAKRISHNAN MINI | GILEAD SCIENCES INC |
| EP3390450 | ANTI-CD28 HUMANIZED ANTIBODIES FORMULATED FOR ADMINISTRATION TO HUMANS | VANHOVE BERNARD | OSE IMMUNOTHERAPEUTICS |
| EP3390541 | A COATED BISMUTH OXY HALIDE-BASED PIGMENT | VERSPAILLE GRETA | CAPPELLE PIGMENTS NV |
| EP3390613 | HERBAL EXTRACTION AND MANUFACTURING PROCESS | OZAYMAN NURI MURAT | BIOARGE BITKISEL KOZMETIK ARASTIRMA GELISTIRME MUHENDISLIK LTD STI |
| EP3390623 | WILSON'S DISEASE GENE THERAPY | NATHWANI AMIT | UCL BUSINESS PLC |
| EP3390638 | MENINGOCOCCAL INFECTION AND MODIFIEDNEISSERIA LACTAMICA | LAVER JAY ROBERT | UNIV SOUTHAMPTON |
| EP3391875 | METHOD FOR PREPARING POLYMERIC MICELLE CONTAINING ANIONIC DRUG | NAM HYE YEONG | SAMYANG BIOPHARMACEUTICALS |
| EP3391876 | LIPID CONSTRUCT FOR DELIVERY OF INSULIN TO A MAMMAL | LAU JOHN R | SDG INC |
| EP3391885 | THERAPEUTIC AGENT FOR BREAST CANCER | MIYANO SAORI | EISAI R&D MAN CO LTD |
| EP3391890 | POSACONAZOLE INTRAVENOUS SOLUTION FORMULATIONS STABILIZED BY SUBSTITUTED BETA-CYCLODEXTRIN | HEIMBECHER SUSAN K | MERCK SHARP & DOHME |
| EP3391897 | HEMOSTATIC COMPOSITION AND HEMOSTATIC METHOD USING HEMOSTATIC COMPOSITION | NAGANO KEIJI | 3 D MATRIX LTD |
| EP3391910 | OXYSTEROL-THERAPEUTIC AGENT DERIVATIVE FOR BONE HEALING | HARRINGTON ROGER | WARSAW ORTHOPEDIC INC |
| EP3391913 | A BONE REGENERATION AGENT COMPRISING GELATIN | HIRATSUKA TAKAHIRO | FUJIFILM CORP |
| EP3392249 | MACROCYCLES WITH HETROCYCLIC P2' GROUPS AS FACTOR XIA INHIBITORS | CORTE JAMES R | SQUIBB BRISTOL MYERS CO |
| EP3392253 | MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES | STEADMAN VICTORIA ALEXANDRA | GILEAD SCIENCES INC |
| EP3392261 | STEROIDAL COMPOUND, COMPOSITION CONTAINING THE SAME AND USE THEREOF | WANG YIHAN | SHENZHEN TARGETRX INC |
| EP3392262 | CYCLOPEPTIDE, PHARMACEUTICAL OR COSMETIC COMPOSITION COMPRISING THE SAME AND METHOD FOR PREPARING THE SAME | CHEN CHIEN-TIEN | |
| EP3392271 | METHOD OF PRODUCING RECOMBINANT ADAMTS13 IN CELL CULTURE | GRILLBERGER LEOPOLD | BAXALTA GMBH |
| EP3393427 | METHOD OF REDUCING PERSPIRATION | GROTHEER ELKE | BEIERSDORF AG |
| EP3393430 | COSMETIC PROCESS FOR TREATING KERATIN MATERIALS WITH A MALEIC ANHYDRIDE ETHYLENIC POLYMER | LION BERTRAND | OREAL |
| EP3393439 | COMPOSITION SPRAYABLE IN MOUSSE FORM COMPRISING A VINYLFORMAMIDE/VINYLAMINE COPOLYMER, A PARTICULAR SURFACTANT AND A PROPELLANT | PASQUET DOROTHéE | OREAL |
| EP3393441 | DYEING COMPOSITION COMPRISING A DIRECT DYE OF TRIARYLMETHANE STRUCTURE, AND A SILICONE | GUERIN FRéDéRIC | OREAL |
| EP3393442 | COMPOSITION FOR DYEING THE HAIR, COMPRISING AN OXIDATION BASE OF PARA-PHENYLENEDIAMINE TYPE AND A 2-AMINO-5-ETHYLPHENOL COUPLER | NICOU VALéRIE | OREAL |
| EP3393449 | NON-DYEING COMPOSITION COMPRISING A CATIONIC ACRYLIC COPOLYMER AND A CONDITIONING AGENT | RONCHARD GUILLAUME | OREAL |
| EP3393452 | METHOD FOR MANUFACTURING A DRUG DELIVERY DEVICE AND A DRUG DELIVERY DEVICE MANUFACTURED ACCORDING TO THE METHOD | HOLMBERG SVANTE | BAYER OY |
| EP3393455 | INJECTABLE FORMULATION OF A MACROCYCLIC LACTONE AND LEVAMISOLE | VETTORATO LUIS FERNANDO | INTERVET INT BV |
| EP3393463 | Suplatast tosilate for treating cough associated with interstitial lung disease | HANSEN JOHN BONDO | CONRIG PHARMA APS |
| EP3393466 | COMPOUNDS FOR TARGETING THYROID HORMONE RECEPTOR ALPHA ISOFORMS AND METHODS OF USE THEREOF | DHESY-THIND SUKHBINDER | UNIV MCMASTER |
| EP3393470 | METABOLISM RESISTANT FENFLURAMINE ANALOGS AND METHODS OF USING THE SAME | FARR STEPHEN J | ZOGENIX INTERNATIONAL LTD |
| EP3393489 | SYNTHETIC LUNG SURFACTANT WITH ENHANCED STABILITY AND EFFECTIVENESS | WALTHER FRANS J | LOS ANGELES BIOMEDICAL RES INST HARBOR UCLA MEDICAL CT |
| EP3393500 | POLYMER CONJUGATES HAVING REDUCED ANTIGENICITY AND METHODS OF USING THE SAME | GANSON NANCY J | UNIV DUKE |
| EP3393505 | RECOMBINANT ZIKA VACCINES | TAUBER ERICH | THEMIS BIOSCIENCE GMBH |
| EP3393513 | CHROMATOGRAPHY BASED PURIFICATION STRATEGIES FOR VIRUSES | MüLLNER MATTHIAS | THEMIS BIOSCIENCE GMBH |
| EP3393517 | TREATMENT OF MODERATE TO SEVERE INFLUENZA | NOCKER KARLHEINZ | VENTALEON GMBH |
| EP3393521 | NANOSYSTEMS FOR CONTROLLED TRANSPORT OF ACTIVE MOLECULES FOR DIAGNOSTIC, PROGNOSTIC AND THERAPEUTIC PURPOSES | SANCHEZ MARTIN ROSARIO MARIA | FIDIA FARM SPA |
| EP3393522 | IMPROVED HYBRID DUAL RECOMBINANT AAV VECTOR SYSTEMS FOR GENE THERAPY | KALATZIS VASILIKI | INST NAT SANTE RECH MED |
| EP3393592 | A PROCESS FOR TREATING KERATIN SUBSTANCES USING A COMPOSITION COMPRISING A MODIFIED PHOTO-DIMERIZABLE POLYMER | VIC GABIN | OREAL |
| EP3393595 | METHOD FOR MULTI-TONAL COLOR MODIFICATION OF KERATINOUS FIBERS | MANNECK HARTMUT | HENKEL AG & CO KGAA |
| EP3394030 | COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF AGENTS | BENENATO KERRY E | MODERNATX INC |
| EP3394045 | COCRYSTAL, PRODUCTION METHOD THEREOF, AND MEDICAMENT CONTAINING COCRYSTAL | KIMOTO KOYA | TAKEDA PHARMACEUTICALS CO |
| EP3394049 | CYANOPYRROLIDINE DERIVATIVES AS INHIBITORS FOR DUBS | KEMP MARK IAN | MISSION THERAPEUTICS LTD |
| EP3394052 | BICYCLIC HYDROXAMIC ACIDS USEFUL AS INHIBITORS OF MAMMALIAN HISTONE DEACETYLASE ACTIVITY | HAMMER KRISTIN | KANCERA AB |
| EP3394056 | COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE | HADARI YARON R | SHY THERAPEUTICS LLC |
| EP3394065 | TETRAHYDROPYRANYL AMINO-PYRROLOPYRIMIDINONE AND METHODS OF USE THEREOF | LAPIERRE JEAN-MARC | ARQULE INC |
| EP3394071 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS | BRIAS JULIE | MUTABILIS |
| EP3394084 | PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST BREAST CANCER AND OTHER CANCERS | MAHR ANDREA | IMMATICS BIOTECHNOLOGIES GMBH |
| EP3394236 | CLEANSING COMPOSITIONS | RUAN YANG | COLGATE PALMOLIVE CO |
| EP3394247 | NOVEL GENERATION OF ANTIGEN-SPECIFIC TCRS | MILOSEVIC SLAVOLJUB | MEDIGENE IMMUNOTHERAPIES GMBH |
| EP3394260 | MATERIALS AND METHODS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTAL TEMPORAL LOBULAR DEGENERATION | COWAN CHAD ALBERT | CRISPR THERAPEUTICS AG |
| EP3394266 | NUCLEIC ACIDS ENCODING REPETITIVE AMINO ACID SEQUENCES RICH IN PROLINE AND ALANINE RESIDUES THAT HAVE LOW REPETITIVE NUCLEOTIDE SEQUENCES | BINDER ULI | XL PROTEIN GMBH |
| EP3395323 | HAIR TREATMENT METHOD | NIWANO YU | KAO CORP |
| EP3395324 | ANTI-AGING AGENT AND ANTI-AGING COMPOSITION FOR SKIN | NAKAGAMI YUKO | SHOWA DENKO KK |
| EP3395356 | COMPOSITION CONTAINING INDUCER OF SIRT1 EXPRESSION FOR PREVENTING OR TREATING SEPSIS OR SEPTIC SHOCK | HAN MYUNG KWAN | STEMDR INC |
| EP3395364 | CASPASE INHIBITOR-CONTAINING DRUG FOR TREATING OR PREVENTING DISORDER CAUSED BY TGF- , AND APPLICATION THEREOF | KOIZUMI NORIKO | THE DOSHISHA |
| EP3395370 | LIPOSOME AND LIPOSOME COMPOSITION | YAMADA NAOKI | FUJIFILM CORP |
| EP3395371 | DRUG INCLUSION COMPOUND, PREPARATION THEREOF, AND PREPARATION METHOD THEREFOR | SHI SHUIPING | GUANGZHOU XIANGXUE PHARMACEUTICAL CO LTD |
| EP3395410 | A COSMETIC COMPOSITION, METHOD AND PROCESS OF APPLICATION THEREOF | BEATO MERINO RAQUEL | REVLON |
| EP3395832 | ANTI P2X7 RECEPTOR ANTIBODIES AND FRAGMENTS THEREOF | BARDEN JULIAN ALEXANDER | BIOSCEPTRE INTERNATIONAL LTD |
| EP3395835 | ANTIBODY HAVING ENHANCED ACTIVITY, AND METHOD FOR MODIFYING SAME | IGAWA TOMOYUKI | CHUGAI PHARMACEUTICAL CO LTD |
| EP3395836 | HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS | HANOTIN CORINNE | SANOFI BIOTECHNOLOGY |
| EP3395857 | POLYMER CONJUGATE OF SULFOXIDE DERIVATIVE-COORDINATED PLATINUM(II) COMPLEX | NAKAMURA MASAHARU | NIPPON KAYAKU KK |
| EP3397233 | COSMETIC COMPOSITIONS HAVING MECHANICALLY ACTIVATED WARMING ENHANCEMENT | GEORGE KELLY MARIE | OREAL |
| EP3397242 | LIPOPHILIC FORMULATIONS | MOLINARI CLAUDIO GIUSEPPE | NOIVITA S R L S |
| EP3397244 | TREATMENT OF BREAST CANCER USING A COMBINATION OF A CATIONIC LIPOSOMAL FORMULATION OF TAXANE, A NON-LIPOSOMAL FORMULATION OF TAXANE AND A FURTHER ACTIVE AGENT | LIN SIH-TING | SYNCORE BIOTECHNOLOGY CO LTD |
| EP3397249 | ENTERIC COATED ORAL PHARMACEUTICAL PREPARATION COMPRISING DIMETHYL FUMARATE | DROZD ALEKSANDRA | ZAKL FARMACEUTYCZNE POLPHARMA SA |
| EP3397252 | PERSONAL CARE COMPOSITIONS | REED JESSE | COLGATE PALMOLIVE CO |
| EP3397254 | TRYPTAMINE-BASED SHIP INHIBITORS FOR THE TREATMENT OF CANCER | KERR WILLIAM G | UNIV NEW YORK STATE RES FOUND |
| EP3397271 | COMPOSITIONS AND METHODS FOR TREATING RETINOPATHY | XIE ZIJIAN | MARSHALL UNIV RESEARCH CORPORATION |
| EP3397272 | METHOD OF TREATING A MAMMAL, INCLUDING HUMAN, AGAINST CANCER USING METHIONINE AND ASPARAGINE DEPLETION | AGUERA KARINE | ERYTECH PHARMA |
| EP3397273 | AUGMENTED ACID ALPHA-GLUCOSIDASE FOR THE TREATMENT OF POMPE DISEASE | DO HUNG V | AMICUS THERAPEUTICS INC |
| EP3397348 | HAIR GROWTH COMPOSITION AND METHOD | WU JEFFREY M | JOHNSON & JOHNSON CONSUMER INC |
| EP3397352 | DEODORANT COMPOSITIONS | ABUELHAIGA MOHAMMED | DEAD SEA BROMINE CO LTD |
| EP3397378 | MICROCAPSULE COMPRISING A MEMBRANE OBTAINED BY MICROENCAPSULATION USING COMPLEX COACERVATION, AND OBTENTION METHOD | ONGMAYEB GISèLE | CAPSULAE |
| EP3397631 | SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANES AS KETOHEXOKINASE INHIBITORS | DOWLING MATTHEW | PFIZER |
| EP3397640 | XANTHINE DERIVATIVE INHIBITORS OF BET PROTEINS | MORELLI XAVIER | INST NAT SANTE RECH MED |
| EP3398454 | WHEY PROTEIN MICELLES AGAINST MUSCLE ATROPHY AND SARCOPENIA | BREUILLE DENIS | NESTEC SA |
| EP3398589 | PHARMACEUTICAL COMPOSITE PREPARATION | RYU JEI-MAN | SHIN POONG PHARMACEUTICAL CO LTD |
| EP3398591 | MICROENCAPSULATION OF BETA-ALANINE | WU WENZHONG | INNOBIO CORPORATION LTD |
| EP3398605 | MEDICINAL COMPOSITION FOR IMPROVING PROGNOSIS AFTER RESTART OF PATIENT'S OWN HEARTBEAT | SUZUKI MASARU | UNIV KEIO |
| EP3398606 | MICROALGAE-DERIVED COMPOSITIONS FOR IMPROVING THE HEALTH AND APPEARANCE OF SKIN | DILLON HARRISON F | TERRAVIA HOLDINGS INC |
| EP3398614 | AGENT FOR PREVENTING AND/OR TREATING ALZHEIMER'S DISEASE | INOUE HARUHISA | UNIV KYOTO |
| EP3398638 | DRY POWDER INHALER | ARP JAN | PHARMACHEMIE BV |
| EP3398942 | SUBSTITUTED OXADIAZOLE CHEMICAL COMPOUND AND COMPOSITION CONTAINING SAID CHEMICAL COMPOUND AND USE THEREOF | WANG YIHAN | SHENZHEN TARGETRX INC |
| EP3398949 | USES OF COMPOUND IN PREPARATION OF DRUGS FOR TREATING BRAIN GLIOMA | JIANG TAO | BEIJING PEARL BIOTECHNOLOGY LLC |
| EP3398950 | NOVEL KINASE INHIBITOR AGAINST WILD-TYPE EGFR AND MUTATED EGFR | LIU QINGSONG | PRECEDO PHARMACEUTICALS CO LTD |
| EP3398951 | SALT OF QUINOLONE COMPOUND, POLYMORPHS THEREOF, PREPARATION METHOD THEREFOR, COMPOSITION, AND APPLICATIONS | YU JIANXIN | SHANGHAI PHARMACEUTICALS HOLDING CO LTD |
| EP3398956 | NOVEL RIG-I LIGANDS AND METHODS FOR PRODUCING THEM | GOLDECK MARION | UNIV BONN RHEINISCHE FRIEDRICH WILHELMS |
| EP3398963 | CHEMICALLY MODIFIED MRNA FOR USE IN THE TREATMENT OF A DISEASE ASSOCIATED WITH THE CFTR GENE | KORMANN MICHAEL | UNIV TUEBINGEN MEDIZINISCHE FAKULTAET |
| EP3399039 | COMPOUNDS FOR TREATMENT OF ISCHEMIC INJURY | FERDINáNDY PéTER | PHARMAHUNGARY 2000 KFT |
| EP3399040 | METHOD OF PREPARING PORCINE CIRCOVIRUS TYPE 2 CAPSID PROTEIN AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | LIN JIUNN-HORNG | |
| EP3399044 | METHOD FOR PRODUCING HEPARAN SULFATE HAVING ANTICOAGULANT ACTIVITY | TOKURA YURIKO | AJINOMOTO KK |
| EP3399968 | SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE | SONG YUNTAO | CS PHARMATECH LTD |
| EP3399972 | LOW DOSE THERAPEUTIC TREATMENT | DAVIDSON PERRY | SYQE MEDICAL LTD |
| EP3399993 | METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | WILSON D TRAVIS | WILSON D TRAVIS |
| EP3399998 | TREATMENT WITH GDF11 PREVENTS WEIGHT GAIN, IMPROVES GLUCOSE TOLERANCE AND REDUCES HEPATOSTEATOSIS | BARRANDON ORNELLA | HARVARD COLLEGE |
| EP3400024 | A COMBINATION THERAPY USING REIC/DKK-3 GENE AND A CHECKPOINT INHIBITOR | KUMON HIROMI | MOMOTARO GENE INC |
| EP3400066 | TREATMENTS AND PREVENTION OF OPIOID NEONATAL ABSTINENCE SYNDROME | SADEE WOLFGANG | OHIO STATE INNOVATION FOUNDATION |
| EP3400074 | COMPOSITIONS AND METHODS FOR GENERATING IMMUNOTOLERANT RESPONSES | COHEN SMADAR | B G NEGEV TECHNOLOGIES AND APPLICATIONS LTD AT BEN GURION UNIV |
| EP3400209 | ASCOCHLORIN DERIVATIVE AND USE THEREOF AS AMPK ACTIVATOR | SHIMMA NOBUO | NRL PHARMA INC |
| EP3400210 | MULTI-TARGET" COMPOUNDS WITH INHIBITORY ACTIVITY TOWARDS HISTONE DEACETYLASES AND TUBULIN POLYMERISATION, FOR USE IN THE TREATMENT OF CANCER | ALAMI MOUÂD | UNIV PARIS SUD |
| EP3400220 | PYRAZOLE DERIVATIVES | CHEN LI | HUA MEDICINE SHANGHAI LTD |
| EP3400222 | ZWITTERIONIC PROPARGYL-LINKED ANTIFOLATES USEFUL FOR TREATING BACTERIAL INFECTIONS | WRIGHT DENNIS | UNIV CONNECTICUT |
| EP3400225 | FUNCTIONALIZED PENTANOIC ACIDS FOR USE IN INFLUENZA VIRAL INFECTIONS | GUILLEMONT JéRÔME éMILE GEORGES | JANSSEN SCIENCES IRELAND UC |
| EP3400227 | QUINOLINE ANALOGS AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS | HAO XIAOLIN | HOU XIAOLIN |
| EP3400238 | MUTATED VON WILLEBRAND FACTOR | ANDREWS ARNA | CSL BEHRING RECOMBINANT FACILITY AG |
| EP3400239 | TETRAVALENT ANTI-PSGL-1 ANTIBODIES AND USES THEREOF | LIN RONG-HWA | BIOALLIANCE CV |
| EP3400244 | ANTI-CD37 CHIMERIC ANTIGEN RECEPTORS AND IMMUNE CELLS EXPRESSING THEM | SMELAND ERLEND | UNIV OSLO HF |
| EP3400941 | ANTITUMOR AGENT | SAYA HIDEYUKI | UNIV KEIO |
| EP3400946 | ANTIVIRAL COMPOSITION AND METHOD FOR USING SAME | IVACHTCHENKO ALEXANDR VASILIEVICH | ALLA CHEM LLC |
| EP3400949 | COMPOSITION FOR TOPICAL USE, IN PARTICULAR FOR BLADDER INSTILLATION | SODHA FRANK | FARCO GMBH |
| EP3400952 | ANTITUMOR AGENT | FUJIYA MIKIHIRO | NATIONAL UNIV CORPORATION ASAHIKAWA MEDICAL UNIV |
| EP3400958 | COMPOSITIONS AND METHODS FOR TREATING CELIAC SPRUE DISEASE | SIEGEL JUSTIN | UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION |
| EP3400961 | ANTI-LAMP1 ANTIBODIES AND ANTIBODY DRUG CONJUGATES, AND USES THEREOF | BAUDAT YVES | SANOFI SA |
| EP3400969 | IMPLANTED DEVICE | ZHANG DEYUAN | LIFETECH SCIENT SHENZHEN CO |
| EP3401327 | DIFFERENTIAL IN TUMOUR GENE PRODUCTS AND USE OF SAME | TüRECI ÖZLEM | ASTELLAS PHARMA INC |
| EP3401333 | ANTI-HUMAN FOLATE RECEPTOR BETA ANTIBODIES AND METHODS OF USE | LOW PHILIP S | PURDUE RESEARCH FOUNDATION |
| EP3401685 | DIAGNOSTIC AGENT AND MEDICINE COMPRISING ADAMTS13 AS MAIN INGREDIENT | HATA KOICHIRO | UNIV KYOTO |
| EP3402455 | COSMETIC PREPARATIONS CONTAINING BENZETHONIUM CHLORIDE AND DIOLS | MEIRING UTA | BEIERSDORF AG |
| EP3402461 | NAIL COMPOSITION WITH CAPPED OLIGOMERS | VALIA DAVE | REVLON CONSUMER PROD CORP |
| EP3402463 | FORMULATIONS OF VANCOMYCIN | PALEPU NAGESH R | SCIDOSE LLC |
| EP3402469 | P2X7 RECEPTOR ANTAGONISTS FOR RESTORING T-CELL LYMPHOPOIESIS IN SUBJECTS INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS (HIV) | LEVY YVES | INST NAT SANTE RECH MED |
| EP3402474 | IL-8 INHIBITORS FOR USE IN THE TREATMENT OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY | BRANDOLINI LAURA | DOMPE FARM SPA |
| EP3402475 | METHODS AND FORMULATIONS FOR TREATMENT OF AND/OR PROTECTION AGAINST ACUTE LIVER FAILURE AND OTHER HEPATOTOXIC CONDITIONS | NÄSSTRÖM JACQUES | PLEDPHARMA AB |
| EP3402480 | COMPOSITIONS AND METHODS FOR INTRAVENOUS ADMINISTRATION OF 2-BROMO-1-(3,3-DINITROAZETIDIN-1-YL)ETHANONE | ORONSKY BRYAN T | EPICENTRX INC |
| EP3402488 | SOLID ORAL DOSAGE FORMS OF ESLICARBAZEPINE | NITHIYANANDAM RAVIKUMAR | JUBILANT GENERICS LTD |
| EP3402489 | SDC-2 EXOSOME COMPOSITIONS AND METHODS OF ISOLATION AND USE | ELLIMAN STEPHEN J | ORBSEN THERAPEUTICS LTD |
| EP3402491 | COMPOSITIONS AND METHODS RELATED TO MULTIMODAL THERAPEUTIC CELL SYSTEMS FOR CANCER INDICATIONS | KAHVEJIAN AVAK | RUBIUS THERAPEUTICS INC |
| EP3402494 | CHIMERIC PROTEINS AND METHODS OF IMMUNOTHERAPY | QI LEI S | UNIV LELAND STANFORD JUNIOR |
| EP3402499 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF TYPE 1 DIABETES | ROTTIERS PIETER | INTREXON ACTOBIOTICS NV |
| EP3402511 | COMPOSITIONS AND METHODS FOR TREATMENT OF OCULAR DISEASES | WEINBERGER DOV | MOR RESEARCH APPLIC LTD |
| EP3402515 | IMPROVED METHODS FOR MONITORING IMMUNE STATUS OF A SUBJECT | BERENSON JAMES R | BERENSON JAMES R |
| EP3402526 | NEW IMPROVED COMPOSITION COMPRISING AT LEAST ONE CADOTRIL | MUHAMMED SALIH MUHSIN | JOHNSON & JOHNSON CONSUMER INC |
| EP3402533 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROLOGIC DISEASE | DEKELVER RUSSELL | SANGAMO THERAPEUTICS INC |
| EP3402535 | ULTRAFINE NANOPARTICLES AS AN IMAGING AGENT FOR DIAGNOSING A RENAL DISORDER | MIGNET NATHALIE | INST NAT SANTE RECH MED |
| EP3402537 | QUANTITATIVE PET IMAGING OF TISSUE FACTOR EXPRESSION USING 18F-LABLED ACTIVE SITE INHIBITED FACTOR VII | KJAER ANDREAS | RIGSHOSPITALET |
| EP3402543 | CARDIOSPHERE-DERIVED CELLS AND EXOSOMES SECRETED BY SUCH CELLS IN THE TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION | MARBAN EDUARDO | CEDARS SINAI MEDICAL CENTER |
| EP3402576 | NOREUGENIN GLYCOSIDE DERIVATIVES | CAROLA CHRISTOPHE | UNIV HAMBURG |
| EP3402790 | SPIROHEPTANE SALICYLAMIDES AND RELATED COMPOUNDS AS INHIBITORS OF ROCK | SMITH II LEON M | SQUIBB BRISTOL MYERS CO |
| EP3402792 | QUINOLIN-2-ONE DERIVATIVES | DORSCH DIETER | MERCK PATENT GMBH |
| EP3402798 | COMPOUNDS ANTAGONIZING A3 ADENOSINE RECEPTOR, METHOD FOR PREPARING THEM, AND MEDICAL-USE THEREOF | LEE JINHWA | HANDOK INC |
| EP3402876 | VASCULAR EXTRACELLULAR MATRIX HYDROGEL | BADYLAK STEPHEN F | UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION |
| EP3403639 | PHOSPHATE-BASED DENTAL INVESTMENT MATERIAL | KITAMURA TOSHIO | SHOFU INC |
| EP3403642 | COSMETIC | TAKIGAMI SHOJI | LITTLE SCIENTIST CO LTD |
| EP3403657 | USE OF OLIGOURONATES FOR TREATING MUCUS HYPERVISCOSITY | TAYLOR CATHERINE | NORWEGIAN UNIV SCI & TECH NTNU |
| EP3403661 | MARINE ORGANISM-DERIVED EXTRACT, COMPOUND, AND MEDICAL COMPOSITION HAVING NICHE FORMATION SUPPRESSING ACTIVITY OF LEUKEMIC STEM CELLS | NAKAO YOICHI | UNIV WASEDA |
| EP3403664 | USE OFCISTANCHE TUBULOSA | WANG CHAO-JIH | SINPHAR TIAN LI PHARMACEUTICAL CO LTD HANGZHOU |
| EP3403674 | PHARMACEUTICAL COMPOSITIONS FOR TREATING PAIN | ZHUO MIN | FOREVER CHEER INTERNATIONAL LTD |
| EP3403675 | ADENO-ASSOCIATED VIRUS VIRION FOR USE IN TREATMENT OF EPILEPSY | MURAMATSU SHIN-ICHI | UNIV JICHI MEDICAL |
| EP3404102 | BONE DELIVERY CONJUGATES AND METHOD OF USING SAME TO TARGET PROTEINS TO BONE | CRINE PHILIPPE | ALEXION PHARMA INC |
| EP3404103 | NUCLEIC ACID COMPRISING OR CODING FOR A HISTONE STEM-LOOP AND A POLY(A) SEQUENCE OR A POLYADENYLATION SIGNAL FOR INCREASING THE EXPRESSION OF AN ENCODED ALLERGENIC ANTIGEN OR AN AUTOIMMUNE SELF-ANTIGEN | THESS ANDREAS | CUREVAC AG |
| EP3404106 | SELECTIVE GENE THERAPY EXPRESSION SYSTEM | BUJ BELLO ANA MARIA | GENETHON |
| EP3405041 | A LIQUID PROBIOTIC COMPOSITION STABLE AT AMBIENT TEMPERATURE | MEHTA DILIP | SYNERGIA LIFE SCIENCES PVT LTD |
| EP3405169 | PRODUCTS FOR PROTECTING KERATIN FIBRES AND METHOD FOR OXIDATIVE HAIR DYEING | MANNECK HARTMUT | HENKEL AG & CO KGAA |
| EP3405198 | DEVICE FOR DETECTION OF VITAMIN D METABOLITES | WANG KEVIN C | AFFIMEDIX INC |
| EP3405209 | NOVEL BIOMOLECULE CONJUGATES AND USES THEREFOR | HAMZAH JULIANA BINTI | UNIV WESTERN AUSTRALIA |
| EP3405213 | BACTERIAL GHOSTS FOR THE TREATMENT OF CANCER | LUBITZ WERNER | BIRD C GMBH |
| EP3405263 | NOVEL PROBIOTIC BACTERIAL STRAIN OF LACTOBACILLUS PLANTARUM AND COMPOSITIONS AND USES THEREOF IN THE TREATMENT OF INFLAMMATION | FISCHER JÖRG THILO | PROBI AB |
| EP3405429 | FORMATION OF FUNCTIONALIZED NANOPARTICLES BY SUPRAMOLECULAR CO-ASSEMBLY | SHEKHTER ZAHAVI TALIA | UNIV RAMOT |
| EP3405454 | INDOLINE DERIVATIVES, COMPOSITIONS COMPRISING THEM AND USES THEREOF | WEINSTOCK-ROSIN MARTA | YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD |
| EP3405461 | NOVEL MOLECULE WITH ANTI-CANCER ACTIVITY | BOBBITT JUDITH | OCEANS LTD |
| EP3405465 | IRAK4 INHIBITING AGENTS | CHAN TIMOTHY | BIOGEN MA INC |
| EP3405469 | N-((1-PHENYL-9H-PYRIDO[3,4-B]INDOL-3-YL)METHYL)CINNAMAMIDES AS ANTICANCER AGENTS AND PREPARATION THEREOF | KAMAL AHMED | COUNCIL SCIENT IND RES |
| EP3405487 | IgY ANTIBODIES FOR THE PREVENTION OF SEA LICE INFESTATION AND INFECTION | MORLANDSTØ JAN OVE | NORIFISH AS |
| EP3405490 | MONO AND BISPECIFIC ANTIBODIES FOR EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III AND CD3 AND THEIR USES | CHOU JOYCE CHING | PFIZER |
| EP3405495 | NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES | ANDRE PASCALE | INNATE PHARMA |
| EP3406239 | PALATABLE KETOPROFEN LYSINE SALT SOLUTIONS | IRIANNI GUSEPPE | EPIFARMA SRL |
| EP3406240 | LIPOSOME FORMULATION AND MANUFACTURE | RICHTER YORAM | BIOREST LTD |
| EP3406262 | MONOCLONAL ANTIBODIES SPECIFIC FOR THE PIII ANTIGEN OF HUMAN ADENOVIRUS (ADV), PRODUCED AND SECRETED BY CELL HYBRIDOMAS, USEFUL FOR DETECTION AND DIAGNOSIS OF ADV INFECTION | BUENO RAMíREZ SUSAN MARCELA | UNIV PONTIFICIA CATOLICA CHILE |
| EP3406293 | BALLOON CATHETER, PRODUCTION METHOD FOR BALLOON CATHETER, AND TREATMENT METHOD | GOTO HIROSHI | TERUMO CORP |
| EP3406600 | TRPM8 RECEPTOR AGONIST COMPOUNDS AND USES THEREOF | FERRER MONTIEL ANTONIO VICENTE | UNIV MIGUEL HERNANDEZ DE ELCHE |
| EP3406611 | FLAVANONE DERIVATIVES AND PREPARATION METHOD AND USE THEREOF | LI LIN | XUANWU HOSPITAL OF CAPITAL MEDICAL UNIV |
| EP3406612 | CARBOLINE DERIVATIVE SERVING AS BROMODOMAIN INHIBITOR | WANG NENGHUI | NINGBO WENDA PHARMA TECH LTD |
| EP3406625 | WALNUT OLIGOPEPTIDE POWDER, AND PREPARATION METHOD AND APPLICATION THEREOF | WANG ZHAORI | SINPHAR TIAN LI HANGZHOU PHARMACY COMPANY LTD |
| EP3406627 | IGG4 FC FRAGMENT COMPRISING MODIFIED HINGE REGION | JUNG SUNG YOUB | HANMI PHARM IND CO LTD |
| EP3407846 | SEMAPHORIN 3C VARIANTS, COMPOSITIONS COMPRISING SAID VARIANTS AND METHODS OF USE THEREOF IN TREATING EYE DISEASES | TOLEDANO SHIRA | TECHNION RES & DEV FOUNDATION |
| EP3407856 | ACTIVE COMBINATIONS OF PERILLIC ACID AND ACTIVITY ENHANCING SUBSTANCES | REHDORF JESSICA | BRAIN BIOTECHNOLOGY RES & INFORMATION NETWORK AG |
| EP3407858 | A METHOD FOR TREATING THE APPEARANCE OF THINNING HAIR | PAWLUS ALISON | ELC MAN LLC |
| EP3407859 | COMPOSITION FOR ENHANCING HAIR FIBER PROPERTIES | CARBALLADA JOSE ANTONIO | PROCTER & GAMBLE |
| EP3407866 | COSMETIC AGENT CONSISTING OF GALACTOMANNANS OBTAINED FROM CAESALPINIA SPINOSA AND CROSS-LINKED SULPHATED GALACTANS OBTAINED FROM KAPPAPHYCUS ALVAREZII | PAUFIQUE JEAN | SOC IND LIMOUSINE DAPPLICATION BIOLOGIQUE |
| EP3407879 | OPHTHALMIC GABAPENTIN FOR THE TREATMENT OF CORNEAL ULCERS | BIONDI PIERO | SOOFT ITALIA S P A |
| EP3407883 | FORMULATION FOR TREATING MIGRAINE | DALLA VOLTA GIORGIO | GOTHAM S R L |
| EP3407887 | CLINCAL REGIMEN FOR TREATING MYELODYSPLASTIC SYNDROME WITH PHOSPHATASE INHIBITOR | LIST ALAN F | LIXTE BIOTECHNOLOGY INC |
| EP3407889 | ORGANIC COMPOUNDS | YAO WEI | INTRA CELLULAR THERAPIES INC |
| EP3407898 | NEW METHOD OF TREATING BACTERIAL INFECTIONS | ÖBERG BO | ULTUPHARMA AB |
| EP3407901 | EXPANSION AND DIFFERENTIATION OF INNER EAR SUPPORTING CELLS AND METHODS OF USE THEREOF | EDGE ALBERT | MASSACHUSETTS EYE & EAR INFIRMARY |
| EP3407903 | METHOD TO REDUCE MICROBIAL BLOOM IN POULTRY HATCHERY | WOLFENDEN ROSS | NOVOZYMES AS |
| EP3407904 | BOTANICAL COMPOSITIONS OF SALVIA OFFICINALIS WITH ACTIVITY IN EXTENDING CHRONOLOGICAL LIFESPAN AND METHODS OF USE | LEYLAND PETER ANTHONY | SIBELIUS LTD |
| EP3407905 | METHODS FOR MODULATING INTESTINAL MICROBIOTA | NORDKILD PETER | DEFENSIN THERAPEUTICS APS |
| EP3407975 | USE OF PROSTACYCLIN ANTAGONISTS FOR TREATING OCULAR SURFACE NOCICEPTION | WOODWARD DAVID FREDERICK | JENIVISION INC |
| EP3408260 | CRYSTALLINE(2S,4R)-5-(5'-CHLORO-2'-FLUORO-[1,1'-BIPHENYL]-4-YL)-2-(ETHOXYMETHYL)-4-(3-HYDROXYISOXAZOLE-5-CARBOXAMIDO)-2-METHYLPENTANOIC ACID AND USES THEREOF | HUGHES ADAM D | THERAVANCE BIOPHARMA R&D IP LLC |
| EP3408268 | BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF ROR-GAMMA | CLAREMON DAVID A | VITAE PHARMACEUTICALS INC |
| EP3408276 | 5'-PHOSPHOROTHIOLATE MRNA 5'-END (CAP) ANALOGS, MRNA COMPRISING THE SAME, METHOD OF OBTAINING AND USES THEREOF | JEMIELITY JACEK | UNIV WARSZAWSKI |
| EP3408381 | ATTENUATED INFECTIOUS BRONCHITIS VIRUS | BICKERTON ERICA | THE PIRBRIGHT INST |
| EP3409270 | DRY POWDER FORMULATION COMPRISING AN ANTICHOLINERGIC, A CORTICOSTEROID AND A BETA-ADRENERGIC FOR ADMINISTRATION BY INHALATION | MUSA ROSSELLA | CHIESI FARM SPA |
| EP3409280 | COMPOSITIONS COMPRISING A SULFORAPHANE AND MILK THISTLE EXTRACT OR POWDER | CORNBLATT BRIAN | NUTRAMAX LAB INC |
| EP3409287 | ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 191P4D12 PROTEINS | SATPAEV DAULET | AGENSYS INC |
| EP3409292 | STABILIZED AQUEOUS COMPOSITION COMPRISING CHONDROITIN SULFATE AND HYALURONIC ACID | NOGAMI EIJI | SEIKAGAKU KOGYO CO LTD |
| EP3409293 | COMPLEXES COMPRISING PHOSPHOLIPIDS, WATER-SOLUBLE DEXTRIN FIBERS AND ANTIOXIDANT ACTIVE PRINCIPLES OF NATURAL ORIGIN, THEIR PREPARATION AND USE IN ORAL FORMULATIONS | MANCONI MARIA | UNIV DEGLI STUDI CAGLIARI |
| EP3409664 | APPLICATION OF SUBSTITUTED CINNAMAMIDE DERIVATIVES IN PREPARATION OF ANTI-ANXIETY MEDICATIONS | HAN MIN | TASLY PHARMACEUTICAL GROUP CO |
| EP3409667 | AMIDE COMPOUNDS FOR THE TREATMENT OF HIV INFECTIONS | BRIZGYS GEDIMINAS | GILEAD SCIENCES INC |
| EP3409671 | ISOTHIAZOLE DERIVATIVES AS GPR120 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES | ILLIG CARL R | JANSSEN PHARMACEUTICA NV |
| EP3409672 | PARAZOLE CONDENSED-RING DERIVATIVES AND PREPARATION METHOD THEREOF AND APPLICATION THEREOF IN TREATMENT OF CANCERS, INFLAMMATION AND IMMUNE DISEASES | CHEN XIANGYANG | BEIJING INNOCARE PHARMA TECH CO LTD |
| EP3409673 | PYRROLOPYRIMIDINE FIVE-MEMBERED AZACYCLIC DERIVATIVE AND APPLICATION THEREOF | YIN JIANMING | HANGZHOU HUADONG MEDICINE GROUP BIOPHARMACEUTICAL CO LTD |
| EP3409682 | COMPOUND AND USE THEREOF AND PLATINUM COMPLEX AND LIPIDOSOME THEREOF | YANG LI | UNIV SHENYANG PHARMACEUTICAL |
| EP3409703 | WATER ABSORBENT RESIN HAVING SILOXANE SKELETON, AND COSMETIC INCLUDING SAME | IYOKU HIROOMI | SHINETSU CHEMICAL CO |
| EP3409765 | KETOREDUCTASE-MEDIATED STEREOSELECTIVE ROUTE TO ALPHA CHLOROALCOHOLS | BONG YONG KOY | CODEXIS INC |
| EP3409780 | NUCLEIC ACID COMPLEX | UEHARA KEIJI | KYOWA HAKKO KIRIN CO LTD |
| EP3411004 | PROCESS OF MANUFACTURING A STABLE, READY TO USE INFUSION BAG FOR AN OXIDATION SENSITIVE FORMULATION | HINGORANI TUSHAR | INNOPHARMA INC |
| EP3411014 | NEW TOPICAL COMPOSITIONS COMPRISING USNIC ACID AND THEIR USE IN THERAPY | PIZZONI ANGELO | APHARM SRL |
| EP3411022 | Particles for Targeted Delivery and Uses in Managing Bleeding or Blood Clotting | LAM WILBUR A | UNIV EMORY |
| EP3411028 | COMBINATION PRODUCTS FOR THE TREATMENT OF RSV | YSEBAERT NINA | JANSSEN SCIENCES IRELAND UC |
| EP3411036 | 3,5-DISUBSTITUTED PYRAZOLES USEFUL AS CHECKPOINT KINASE 1 (CHK1) INHIBITORS, AND THEIR PREPARATIONS AND APPLICATIONS | CAI XIONG | |
| EP3411037 | COMPOUNDS, COMPOSITIONS AND METHODS FOR CANCER PATIENT STRATIFICATION AND CANCER TREATMENT | WENGNER ANTJE MARGRET | BAYER PHARMA AG |
| EP3411047 | CONTROLLED-RELEASE AND STRATIFIED CYCLODEXTRIN INCLUSION COMPLEX VEHICLES | CZAP AL | CZAP RES AND DEVELOPMENT LLC |
| EP3411060 | USE OF AAC-11 INHIBITORS FOR THE TREATMENT OF VIRAL INFECTION | POYET JEAN-LUC | INST NAT SANTE RECH MED |
| EP3411065 | CLEC9A BINDING AGENTS | KLEY NIKOLAI | ORIONIS BIOSCIENCES NV |
| EP3411067 | ANTI-C-MET ANTIBODIES AND USES THEREOF | YU SEUNG SHIN | VIROMED CO LTD |
| EP3411076 | ANTIBODY-DRUG CONJUGATES TARGETING uPARAP | NIELSEN CHRISTOFFER | RIGSHOSPITALET |
| EP3411358 | SUBSTITUTED PIPERIDINE COMPOUND AND USE THEREOF | FUJIMOTO TATSUHIKO | TAKEDA PHARMACEUTICALS CO |
| EP3411381 | C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS | CHEN JIE | VIIV HEALTHCARE UK NO 5 LTD |
| EP3411388 | TRUNCATED GLYCOPROTEIN G OF HERPES SIMPLEX VIRUS 2 | LILJEQVIST JAN-ÅKE | SIMPLEXIA AB |
| EP3411391 | UBIQUITIN VARIANTS AND USES THEREOF AS 53BP1 INHIBITORS | DUROCHER DANIEL | GOVERNING COUNCIL UNIV TORONTO |
| EP3411392 | NON-HUMAN ANIMALS HAVING AN ENGINEERED ANGPTL8 GENE | GUSAROVA VIKTORIA | REGENERON PHARMA |
| EP3411393 | ADMINISTRATION OF ENGINEERED T CELLS FOR TREATMENT OF CANCERS IN THE CENTRAL NERVOUS SYSTEM | BADIE BENHAM | HOPE CITY |
| EP3411410 | PD-1 ANTIBODIES | BARUAH HEMANTA | INNOVENT BIOLOGICS SUZHOU CO LTD |
| EP3411411 | BENZOPYRAZOLE COMPOUNDS AND ANALOGUES THEREOF | KOTIAN PRAVIN L | BIOCRYST PHARM INC |
| EP3412273 | ROOT CANAL TREATMENT MATERIAL AND KIT FOR ROOT CANAL TREATMENT | AMAO AKIHITO | FUJIFILM CORP |
| EP3412275 | PEPTIDE HAVING SKIN WHITENING ACTIVITY AND USE THEREOF | CHUNG YONG JI | CAREGEN CO LTD |
| EP3412279 | NANOSTRUCTURED GELS CAPABLE OF CONTROLLED RELEASE OF ENCAPSULATED AGENTS | KARP JEFFREY M | BRIGHAM & WOMENS HOSPITAL INC |
| EP3412290 | ANDROGEN RECEPTOR MODULATOR FOR THE TREATMENT OF PROSTATE CANCER AND ANDROGEN RECEPTOR-ASSOCIATED DISEASES | JUNG MICHAEL E | UNIV CALIFORNIA |
| EP3412291 | CRYSTAL FORM OF IMIDAZOLONE TYPE COMPOUNDS, AND PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF | JI QI | FORELAND PHARMA CO LTD |
| EP3412302 | MODIFIED FGF-21 POLYPEPTIDES AND USES THEREOF | MORIN PAUL E | SQUIBB BRISTOL MYERS CO |
| EP3412305 | TREATMENT OF COAGULATION DISEASE BY ADMINISTRATION OF RECOMBINANT VWF | SCHEIFLINGER FRIEDRICH | BAXALTA GMBH |
| EP3412312 | COATING LIQUID FOR MICRONEEDLES, MICRONEEDLE-COATING SUBSTANCE, AND MICRONEEDLE ARRAY | QUAN YING-SHU | COSMED PHARMACEUTICAL CO LTD |
| EP3412657 | NOVEL IRREVERSIBLE BRUTON'S TYROSINE KINASE INHIBITOR | LIU JING | HEFEI INST OF PHYSICAL SICENCE CHINESE ACADEMY OF SCIENCES |
| EP3412667 | COCRYSTAL | IWATA KENTARO | TAKEDA PHARMACEUTICALS CO |
| EP3413867 | EXOTHERMIC TOPICAL DEVICES FOR DELIVERING PHARMACEUTICALS AND COSMETICS TO THE SKIN | LUEBCKE PETER | AMAPHASE LTD |
| EP3413870 | IGMESINE FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | ROMAN FRANÇOIS J | SIGMATHERA SAS |
| EP3413877 | ORAL CHOLESTYRAMINE FORMULATION AND USE THEREOF | GILLBERG PER-GÖRAN | ALBIREO AB |
| EP3413878 | ORAL CHOLESTYRAMINE FORMULATION AND USE THEREOF | GILLBERG PER-GÖRAN | ALBIREO AB |
| EP3413881 | COMPOSITIONS AND METHODS FOR TREATING CHRONIC WOUNDS | ASLAM RUMMANA | UNIV HACKENSACK MEDICAL CENTER |
| EP3413887 | INTERMEDIATES IN THE SYNTHESIS OF ERIBULIN AND RELATED METHODS OF SYNTHESIS | BARAN PHIL S | EISAI R&D MAN CO LTD |
| EP3413895 | C5-C6-OXACYLIC FUSED IMINOTHIADIAZINE DIOXIDE COMPOUNDS BEARING AN ETHER LINKER AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE | WALSH SHAWN P | MERCK SHARP & DOHME |
| EP3413896 | VCN ENHANCER COMPOSITIONS AND METHODS OF USING THE SAME | BONNER MELISSA | BLUEBIRD BIO INC |
| EP3413906 | CANCER TREATMENT COMBINATION COMPOSITIONS, METHODS AND USES | CARDELLI JAMES | THE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIV & AGRICULTURAL & MECHANICAL COLLEGE |
| EP3413907 | BLOOD TREATMENT WITH INACTIVATION OF CIRCULATING NUCLEIC ACIDS | LAUBROCK ANDREAS | FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH |
| EP3413913 | PHARMACEUTICAL COMPOSITIONS COMPRISING AN ANTI-RETROVIRAL DRUG AND A PHARMACOKINETIC ENHANCER | MALHOTRA GEENA | CIPLA LTD |
| EP3414227 | PIPERIDINONE FORMYL PEPTIDE 2 RECEPTOR AND FORMYL PEPTIDE 1 RECEPTOR AGONISTS | WURTZ NICHOLAS R | SQUIBB BRISTOL MYERS CO |
| EP3414229 | QUINOLINONE LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF | ROWBOTTOM MARTIN W | PHARMAKEA INC |
| EP3414247 | SPIROINDOLINONES AS DDR1 INHIBITORS | BUETTELMANN BERND | HOFFMANN LA ROCHE |
| EP3414249 | PDE1 INHIBITOR | JESUDASON CYNTHIA DARSHINI | LILLY CO ELI |
| EP3414333 | REPLICATIVE TRANSPOSON SYSTEM | BUERCKSTUEMMER TILMANN | HORIZON DISCOVERY LTD |
| EP3415146 | INFLAMMASOME ACTIVATION INHIBITOR | WATANABE SHIMPEI | KRACIE HOLDINGS LTD |
| EP3415150 | TREATMENT OF VASCULOPATHY WITH PROSTACYCLIN AND MESENCHYMAL STEM CELLS | JEFFS ROGER | UNITED THERAPEUTICS CORP |
| EP3415160 | POLYPEPTIDES DERIVED FROM ENTEROCOCCUS AND THEIR USE FOR VACCINATION AND THE GENERATION OF THERAPEUTIC ANTIBODIES | HARTKE AXEL | UNIV FREIBURG ALBERT LUDWIGS |
| EP3415516 | HAPTENS OF RISPERIDONE AND PALIPERIDONE | HASPESLAGH PIETER RIK | JANSSEN PHARMACEUTICA NV |
| EP3415620 | ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE | CHOU JANICE J | US HEALTH |
| EP3416616 | COMPOSITIONS OF MULTIPLE ARIPIPRAZOLE PRODRUGS | ZEIDAN TAREK A | ALKERMES PHARMA IRELAND LTD |
| EP3416623 | lPA-3-LOADED LIPOSOMES AND METHODS OF USE THEREOF | SHENOY SOMANATH RAMMOHAN | UNIV GEORGIA |
| EP3416643 | METHODS OF INCREASING HAIR GROWTH AND IMPROVING HAIR APPEARANCE | WILLIAMS JONNIE R | MYMD PHARMACEUTICALS INC |
| EP3416654 | METHODS FOR THE USE OF 5'-ADENOSINE DIPHOSPHATE RIBOSE (ADPR) | SHALWITZ ROBERT | INVIRSA INC |
| EP3416656 | ANTI-VIRUS AGENT AND METHOD FOR TREATMENT OF VIRAL INFECTION | MELROSE GRAHAM JOHN HAMILTON | RECCE PHARMACEUTICALS LTD |
| EP3416663 | GENERATING GABAergic NEURONS IN BRAINS | CHEN GONG | PENN STATE RES FOUND |
| EP3416666 | VELDOREOTIDE WITH POOR SOLUBITLIY IN PHYSIOLOGICAL CONDITIONS FOR USE IN THE TREATMENT OF ACROMEGALY, ACROMEGALY CANCER, SST-R5 EXPRESSING TUMORS, TYPE 2 DIABETES, HYPERGLYCEMIA, AND HORMONE-RELATED TUMORS | AFARGAN MICHAEL | STRONGBRIDGE IRELAND LTD |
| EP3416675 | TREATMENT OF HEPATITIS DELTA VIRUS INFECTION WITH INTERFERON LAMBDA | MARTINS EDUARDO BRUNO | EIGER BIOPHARMACEUTICALS INC |
| EP3416676 | DOSING AND USE OF LONG-ACTING CLR/RAMP AGONISTS | HSU SHEAU YU TEDDY | ADEPTHERA LLC |
| EP3416730 | DERMATOLOGICAL COSMETIC COMPOSITION COMPRISING AN SDKP PEPTIDE OR AN ANALOG THEREOF | RIVIERE NICOLAS | RPM DERMATOLOGIE |
| EP3416946 | TETRACYCLIC PYRIDONE COMPOUNDS AS ANTIVIRALS | FU JIPING | NOVARTIS AG |
| EP3416960 | NOVEL COMPOUNDS | GIBSON KARL RICHARD | MISSION THERAPEUTICS LTD |
| EP3416962 | 6,7-DIHYDRO-5H-BENZO[7]ANNULENE DERIVATIVES AS ESTROGEN RECEPTOR MODULATORS | BOUABOULA MONSIF | SANOFI SA |
| EP3416963 | HISTONE METHYLTRANSFERASE INHIBITORS | YU MING | GLOBAL BLOOD THERAPEUTICS INC |
| EP3416969 | FUSED 1,4-OXAZEPINES AND RELATED ANALOGS AS BET BROMODOMAIN INHIBITORS | WANG SHAOMENG | UNIV MICHIGAN REGENTS |
| EP3416983 | ANTIBODIES FOR IL-17C | HAAS JAN DOMINIK | MORPHOSYS AG |
| EP3416984 | CHIMERIC CANINE ANTI-CD20 ANTIBODY | PANCOOK JAMES DAVID | ELANCO US INC |
| EP3417046 | NATURAL SOAP COMPOSITION WITH CONTROLLED ZETA POTENTIAL AND MANUFACTURING PROCESS | OZAYMAN NURI MURAT | BIOARGE BITKISEL KOZMETIK ARASTIRMA GELISTIRME MUHENDISLIK LTD STI |
| EP3417294 | METHODS COMPRISING FIXED INTERMITTENT DOSING OF CEDIRANIB | BARRY SIMON | ASTRAZENECA AB |
| EP3417296 | EPIGENOMIC PROFILING REVEALS THE SOMATIC PROMOTER LANDSCAPE OF PRIMARY GASTRIC ADENOCARCINOMA | TAN PATRICK | AGENCY SCIENCE TECH & RES |
| EP3417701 | GENETICALLY MODIFIED MICE AND ENGRAFTMENT | STEVENS SEAN | REGENERON PHARMA |
| EP3417844 | SUNSCREEN WITH A REDUCED TENDENCY TO STAIN TEXTILES IV | WEINERT KATRIN | BEIERSDORF AG |
| EP3417845 | ALPHA-GEL FORMATION COMPOSITION AND ALPHA-GEL COMPOSITION | MIYAHARA REIJI | SHISEIDO CO LTD |
| EP3417862 | ENHANCED BRAIN BIOAVAILABILITY OF GALANTAMINE BY SELECTED FORMULATIONS AND TRANSMUCOSAL ADMINISTRATION OF LIPOPHILIC PRODRUGS | MAELICKE ALFRED | NEURODYN LIFE SCIENCES INC |
| EP3417867 | COMPOSITION CONTAINING MEDICINAL HERB EXTRACT AS ACTIVE INGREDIENT FOR PREVENTING, ALLEVIATING, OR TREATING STRESS OR DEPRESSION | LEE MI YOUNG | KOREA INST ORIENTAL MEDICINE |
| EP3417876 | INJECTABLE PREFORMED MACROSCOPIC 3-DIMENSIONAL SCAFFOLDS FOR MINIMALLY INVASIVE ADMINISTRATION | BENCHERIF SIDI A | HARVARD COLLEGE |
| EP3417887 | CONSTRUCTION OF MICRORNA GENE-MEDIATED NOVEL TISSUE ENGINEERED NERVE AND APPLICATIONS THEREOF IN REPAIRING NERVE DEFECT | GU XIAOSONG | UNIV NANTONG |
| EP3418275 | NOVEL 2,3,5-SUBSTITUTED THIOPHENE COMPOUND AS PROTEIN KINASE INHIBITOR | SIM TAE BO | KOREA INST SCI & TECH |
| EP3418279 | AROMATIC HETEROCYCLIC COMPOUNDS AS ANTIINFLAMMATORY COMPOUNDS | LONGSHAW ALISTAIR IAN | RESPIVERT LTD |
| EP3418291 | PEPTIDE HAVING HAIR GROWTH-PROMOTING ACTIVITY AND USE THEREOF | CHUNG YONG JI | CAREGEN CO LTD |
| EP3418304 | RECOGNITION OF MEMBRANE TYPE MUCIN-LIKE PROTEIN AND CLINICAL APPLICATION THEREOF | TSUJI SHOUTARO | KANAGAWA PREFECTURAL HOSPITAL ORGANIZATION |
| EP3418386 | COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION OF HEPATITIS B VIRUS | CHIN DANIEL | ARROWHEAD PHARMACEUTICALS INC |
| EP3418739 | METHOD FOR SCREENING ANTICANCER AGENT INHIBITING BINDING OF AIMP2-DX2 AND HSP70 | KIM SUNGHOON | MEDICINAL BIOCONVERGENCE RES CT |
| EP3419590 | HYALURONIC ACID CONJUGATE | BARICORDI NIKLA | RIBOHYAL S R L |
| EP3419592 | PROCESS FOR PREPARING A SILICONE ELASTOMER WITH HYDROPHILIC ACTIVES AND A PERSONAL CARE COMPOSITION CONTAINING THE ELASTOMER | LIMER ADAM JOHN | UNILEVER PLC NO 41424 |
| EP3419595 | STABLE LIQUID GONADOTROPIN FORMULATION | SJÖGREN HELEN ULRIKA | FERRING BV |
| EP3419623 | METHODS FOR USING FXR AGONISTS | LAFFITTE BRYAN | NOVARTIS AG |
| EP3419624 | METHODS FOR USING FXR AGONISTS | LAFFITTE BRYAN | NOVARTIS AG |
| EP3419625 | METHODS FOR USING FXR AGONISTS | LAFFITTE BRYAN | NOVARTIS AG |
| EP3419637 | COMPOSITIONS AND METHODS FOR PREVENTING AND/OR TREATING VITAMIN B12 DEFICIENCY | DE VOS WILLEM MEINDERT | CAELUS PHARMACEUTICALS B V |
| EP3419650 | LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE | NGUYEN PHUONG M | PORTOLA PHARM INC |
| EP3419671 | HIGH BIOAVAILABILITY OROMUCOSAL PHARMACEUTICAL PREPARATIONS BASED ON CYCLODEXTRIN AND SUCRALOSE | BELLORINI LORENZO | ALTERGON SA |
| EP3419683 | NITRIC OXIDE GENERATING FORMULATIONS AND KITS | MEYERHOFF MARK E | UNIV MICHIGAN REGENTS |
| EP3419695 | COMPACT PLATFORM FOR ACCURATE DRUG DELIVERY | IORDANOV VENTZESLAV PETROV | PROGENITY INC |
| EP3419975 | IMINOTHIADIAZINANE DIOXIDE DERIVATIVES AS PLASMEPSIN V INHIBITORS | DE HARO GARCIA TERESA | UCB BIOPHARMA SPRL |
| EP3419976 | ACID ADDITION SALTS OF PIPERAZINE DERIVATIVES | QUATTROPANI ANNA | ASCENEURON SA |
| EP3420001 | BINDING MEMBERS TO PD-L1 | SHAMSHIEV ABDIJAPAR | CELL MEDICA SWITZERLAND AG |
| EP3420003 | MONOLITHIC COMPOSITION FOR DUAL-RATE RELEASE WITH HIGH DRUG LOADING | LE TIEN CANH | MATRIPHARM INT INC |
| EP3420084 | NOVEL APPROACH FOR TREATING INFLAMMATORY DISORDERS | JASCHINSKI FRANK | SECARNA PHARMACEUTICALS GMBH & CO KG |
| EP3421039 | DRUG FOR CANCER THERAPY CHARACTERIZED BY ADMINISTERING COMBINATION BETWEEN AXL INHIBITOR AND IMMUNE CHECKPOINT INHIBITOR | TANAKA KOHEI | ONO PHARMACEUTICAL CO |
| EP3421043 | USE OF FENUGREEK EXTRACT TO ENHANCE FEMALE LIBIDO | BHASKARAN SUNIL | GE NUTRIENTS INC |
| EP3421047 | METHOD FOR IMPROVING THE EFFICACY OF A SURVIVIN VACCINE IN THE TREATMENT OF CANCER | MANSOUR MARC | IMMUNOVACCINE TECHNOLOGIES INC |
| EP3421447 | FATTY ACID COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | NAN FAJUN | SHANGHAI INST MATERIA MEDICA CAS |
| EP3421457 | PYRIMIDINE FGFR4 INHIBITORS | REYNOLDS DOMINIC | EISAI R&D MAN CO LTD |
| EP3421470 | SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES IN CRYSTALLINE FORM | FEY PETER | ADVERIO PHARMA GMBH |
| EP3421471 | PURINE AND DEAZAPURINE DERIVATIVES AS PHARMACEUTICAL COMPOUNDS | DAVIES THOMAS GLANMOR | ASTEX THERAPEUTICS LTD |
| EP3421475 | CONDENSED HETEROCYCLIC COMPOUND HAVING BONDED HETEROCYCLES AND SALTS THEREOF, AGRICULTURAL/HORTICULTURAL INSECTICIDE CONTAINING SAID COMPOUND, AND METHOD FOR USING SAID INSECTICIDE | YAMAUCHI CHIAKI | NIHON NOHYAKU CO LTD |
| EP3421590 | MODIFIED NATURAL KILLER CELLS AND NATURAL KILLER CELL LINES HAVING INCREASED CYTOTOXICITY | O'DWYER MICHAEL EAMON PETER | ONKIMMUNE LTD |
| EP3421594 | NOVEL HIGHLY-STABLE RECOMBINANT SUPEROXIDE DISMUTASE AND APPLICATION THEREOF | MENG FANGUO | HANGZHOU REDOX PHARMATECH CO LTD |
| EP3421603 | GENE THERAPY FOR NEURODEGENERATIVE DISORDERS | PASSINI MARCO A | GENZYME CORP |
| EP3423031 | AEROSOL ANTIDANDRUFF COMPOSITION | RENOCK SEAN MICHAEL | PROCTER & GAMBLE |
| EP3423060 | IMATINIB FOR USE IN THE TREATMENT OF STROKE | ERIKSSON ULF | HAMRA INVEST AB |
| EP3423065 | BORON-CONTAINING SMALL MOLECULES | LI XIANFENG | ANACOR PHARMACEUTICALS INC |
| EP3423081 | COMPOSITIONS FOR USE IN THE TREATMENT OF NEUROLOGICAL DISEASE | MCCLEAN PAULA | UNIV ULSTER |
| EP3423082 | LIRAGLUTIDE IN CARDIOVASCULAR CONDITIONS | RASMUSSEN SØREN | NOVO NORDISK AS |
| EP3423084 | COMPOSITION COMPRISING BOTULINUM TOXIN | FINK KLAUS | MERZ PHARMA GMBH & CO KGAA |
| EP3423105 | ERIBULIN-BASED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE | ALBONE EARL F | EISAI R&D MAN CO LTD |
| EP3423110 | CLOSED-ENDED LINEAR DUPLEX DNA FOR NON-VIRAL GENE TRANSFER | KOTIN ROBERT M | UNIV MASSACHUSETTS |
| EP3423440 | 5-METHYL-6-PHENYL-4,5-DIHYDRO-2H-PYRIDAZIN-3-ONE DERIVATIVE | KATOH TAKAHIRO | OTSUKA PHARMA CO LTD |
| EP3423441 | IODINATED ANALOGS OF CHOLINE, METHODS OF PREPARATION THEREOF, AND USE THEREOF AS MEDICAMENTS | SVEC PAVEL | UNIVERZITA PALACKEHO V OLOMOUCHI |
| EP3423449 | SUBSTITUTED AURONE ALKALOIDS AS ANTI-MYCOBACTERIAL AGENTS | GUDUP SATISH SONBARAO | COUNCIL SCIENT IND RES |
| EP3423467 | NEW DIFLUOROKETAMIDE DERIVATIVES AS HTRA1 INHIBITORS | MAERKI HANS P | HOFFMANN LA ROCHE |
| EP3423470 | IMMUNOMODULATORS | ALLEN MARTIN PATRICK | SQUIBB BRISTOL MYERS CO |
| EP3423495 | ANTIBODIES SPECIFIC TO HUMAN POLIOVIRUS RECEPTOR (PVR) | MANDELBOIM OFER | YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD |
| EP3423497 | MONOCLONAL ANTIBODIES THAT SPECIFICALLY RECOGNIZE CANINE DLA-DR ANTIGEN AND THEIR USES | MIAZEK ARKADIUSZ | INST IMMUNOLOGII I TERAPII DOSWIADCZALNEJ POLSKIEJ AKADEMII NAUK |
| EP3424486 | SILICA-INCLUDING MICROCAPSULE RESIN PARTICLES, METHOD FOR PRODUCING SAME, AND APPLICATION THEREOF | KUSAKA AKIYOSHI | SEKISUI PLASTICS |
| EP3424487 | NETWORKED DISPERSION OF BIOCELLULOSE MICROFIBRILS IN WATER | JUN SEUNG-HYUN | LG HOUSEHOLD & HEALTH CARE LTD |
| EP3424498 | TUMOUR THERAPEUTIC MONOCLONAL ANTIBODY NANO-CAPSULE AND PREPARATION METHOD AND USE THEREOF | YUAN XUBO | TIANJIN NANUO BIO TECH CO LTD |
| EP3424506 | PHARMACEUTICAL COMPOSITION FOR TREATING FUNCTIONAL PSYCHIATRIC DISORDERS | MOROZOVA MARGARITA ALEKSEEVNA | OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTYU VALENTEK |
| EP3424508 | USE OF SODIUM DEOXYCHOLATE FOR THE NON-SURGICAL REMOVAL OF FAT | KOLODNEY MICHAEL S | LOS ANGELES BIOMEDICAL RES INST HARBOR UCLA MEDICAL CT |
| EP3424518 | IMMUNITY INDUCER | KURIHARA AKIRA | TORAY INDUSTRIES |
| EP3424532 | INFLUENZA VIRUS ANTIBODY COMPOSITIONS | HUFTON SIMON | THE SEC DEP FOR HEALTH |
| EP3424534 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MEDIATED DISEASES | PHENIX BRIAN DEAN | VERTEX PHARMA |
| EP3424536 | ANAESTHETIC SOLUTION AND METHOD OF USE THEREOF FOR ANAESTHETISING, STUNNING AND SLAUGHTERING FISH | GARCIA AYALA ALFONSA | UNIV CARTAGENA POLITECNICA |
| EP3424537 | SMALL MOLECULE DRUG CONJUGATES | KRALL NIKOLAUS | EIDGENOESSICHE TECHNISCHE HOCHSCHULE ZUERICH |
| EP3424932 | BORONOPHTHALIDES FOR THERAPEUTIC USE | BAKER STEPHEN | ANACOR PHARMACEUTICALS INC |
| EP3424946 | A FUSION PROTEIN HAVING TRANSCRIPTION MODULATING DOMAIN AND A PROTEIN TRANSDUCTION DOMAIN, AND AN INHIBITOR FOR TRANSCRIPTION FACTOR FUNCTION COMPRISING THE SAME | PARK TAE YOON | UNIV YONSEI IACF |
| EP3426017 | HYDROPONIC TILIACORA TRIANDRA AND USE THEREOF | HWANG CHENG S | AVON PROD INC |
| EP3426232 | A MAZINDOL IR/SR MULTILAYER TABLET AND ITS USE FOR THE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD) | ZWYER ALEXANDER C | NLS 1 PHARMA AG |
| EP3426243 | 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF | MAINOLFI NELLO | RAZE THERAPEUTICS INC |
| EP3426265 | BLOOD PLASMA AND PLASMA FRACTIONS AS THERAPY FOR TUMOR GROWTH AND PROGRESSION | BRAITHWAITE STEVEN P | ALKAHEST INC |
| EP3426273 | SUBLINGUAL COMPOSITIONS COMPRISING NATURAL EXTRACTS AND USES THEREOF | KARABOGA ARNAUD SINAN | HARMONIC PHARMA |
| EP3426348 | 3-DESOXY DERIVATIVE AND PHARMACEUTICAL COMPOSITIONS THEREOF | PELLICCIARI ROBERTO | INTERCEPT PHARMACEUTICALS INC |
| EP3426355 | FAT AND/OR WAX ACTIVATED BY MEANS OF THE WATER-INSULUBLE FRACTION OF CARICA PAPAYA SAP | COQUET CORINNE | ISP INVESTMENTS LLC |
| EP3426401 | SYSTEMS AND METHODS FOR PREPARING A THROMBIN SERUM | BARE CHRISTOPHER | ARTHREX INC |
| EP3426626 | RESVERATROL GLYCOLATE AND TARTRATE DERIVATIVES AND SYNTHETIC METHODS THEREFOR | MOHAMMADI FATEMEH | ELC MAN LLC |
| EP3426635 | 3-OXA-8-AZABICYCLO[3.2.1]OCTANE DERIVATIVES AND THIER USE IN THE TREATMENT OF CANCER AND HEMOGLOBINOPATHIES | STUPPLE PAUL ANTHONY | CTXT PTY LTD |
| EP3426636 | SUBSTITUTED HETEROCYCLES AS C-MYC TARGETING AGENTS | SCHILTZ GARY E | UNIV NORTHWESTERN |
| EP3426641 | IMMUNOPROTEASOME INHIBITOR ANALOGS | PIRRUNG MICHAEL C | UNIV CALIFORNIA |
| EP3426648 | TETRAHYDROISOQUINOLINES AS PRMT5 INHIBITORS | BERGMAN YLVA ELISABET | CTXT PTY LTD |
| EP3426652 | NOVEL INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE GAMMA | MOGEMARK MICKAEL | ASTRAZENECA AB |
| EP3426653 | BICYCLIC COMPOUNDS FOR DIAGNOSIS AND THERAPY | MOLETTE JéRÔME | AC IMMUNE SA |
| EP3426656 | TRICYCLIC COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS | JAIN RAMA | NOVARTIS AG |
| EP3426661 | 4BETA-AMIDOTRIAZOLE LINKED PODOPHYLLOTOXIN DERIVATIVES AS POTENTIAL ANTICANCER AGENTS | KAMAL AHMED | COUNCIL SCIENT IND RES |
| EP3426664 | SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS | BERTHELOT DIDIER JEAN-CLAUDE | JANSSEN PHARMACEUTICA NV |
| EP3426717 | COMPOSITION COMPRISING ORGANOSILOXANE NANO LATEX AND PREPARATION OF ORGANOSILOXANE NANO LATEX | PHUKAN MONJIT | MOMENTIVE PERFORMANCE MAT INC |
| EP3427715 | DENTAL MATERIALS BASED ON LOW VISCOSITY RADICALLY POLYMERIZABLE MONOMERS HAVING A HIGH REFRACTIVE INDEX | MOSZNER NORBERT | IVOCLAR VIVADENT AG |
| EP3427716 | PHOTOPOLYMERIZATION INITIATOR AND PHOTOCURABLE COMPOSITION | FURUHASHI KOJI | TOKUYAMA DENTAL CORP |
| EP3427728 | PHARMACEUTICAL COMPOSITIONS COMPRISING NITROXYL DONORS | KALISH VINCENT JACOB | CARDIOXYL PHARMACEUTICALS INC |
| EP3427731 | AMELIORATING AGENT FOR FEMALE-SPECIFIC PHYSICAL AND/OR MENTAL UNPLEASANT SYMPTOM | UENO TOMOMI | OTSUKA PHARMA CO LTD |
| EP3427738 | INHIBITORS OF INFLUENZA VIRUSES REPLICATION | CHARIFSON PAUL | VERTEX PHARMA |
| EP3427743 | ANTI-HEPATOMA-VIRUS AGENT | IKEDA MASANORI | UNIV KAGOSHIMA |
| EP3427752 | STABILIZED FORMULATIONS CONTAINING ANTI-NGF ANTIBODIES | WALSH SCOTT | REGENERON PHARMA |
| EP3428159 | CRYSTALLINE FORMS OF MESYLATE SALT OF PYRIDINYL AMINO PYRIMIDINE DERIVATIVE, PREPARATION METHODS THEREFOR, AND APPLICATIONS THEREOF | LUO HUIBING | SHANGHAI ALLIST PHARMACEUTICAL AND MEDICAL TECH CORPORATIONS |
| EP3428169 | 6,6A-DIHYDRO FURO[3,2-B]FURAN-2-(5H)ONE DERIVATIVES, THEIR PREPARATION AND USE FOR TREATING TUMORS | GABRIELE BARTOLO | UNIV DELLA CALABRIA |
| EP3428170 | ANTI-INFLUENZA POLYCYCLIC PYRIDONE DERIVATIVE AND PRODRUG THEREOF | KAWAI MAKOTO | SHIONOGI & CO |
| EP3428177 | PEPTIDE EXHIBITING HAIR GROWTH PROMOTING ACTIVITY AND/OR MELANIN PRODUCTION PROMOTING ACTIVITY AND USE THEREOF | CHUNG YONG JI | CAREGEN CO LTD |
| EP3428195 | MODIFIED STARCH | DR HEINZE FRIEDRICH | CORN PRODUCTS DEV INC |
| EP3429565 | PROLONGED RELEASE PHARMACEUTICAL COMPOSITION COMPRISING CYSTEAMINE OR SALT THEREOF | GAZZANIGA ANDREA | RECORDATI IND CHIMICA E FARMACEUTICA SPA |
| EP3429566 | AMBRISENTAN FOR USE IN THE TREATMENT OF ACUTE RENAL FAILURE | NAVARRO IKER | NOORIK BIOPHARMACEUTICALS AG |
| EP3429572 | COMBINATION THERAPY FOR PROLIFERATIVE DISEASES | JOHANSEN BERIT | AVEXXIN AS |
| EP3429577 | N-LIPOIC -AMINO ACID OR PEPTIDE, DERIVATIVES AND THEIR USES | YU RUEY J | NEOSTRATA COMPANY INC |
| EP3429582 | COMBINATION THERAPY FOR PROLIFERATIVE DISEASES | JOHANSEN BERIT | AVEXXIN AS |
| EP3429585 | BRIDGED BICYCLIC INHIBITORS OF MENIN-MLL AND METHODS OF USE | WU TAO | KURA ONCOLOGY INC |
| EP3429600 | NEW IMMUNOBIOLOGICAL PRODUCTS | POLYAKOV IGOR | POLYAKOV IGOR |
| EP3429603 | METHODS AND COMPOSITIONS RELATING TO HEMATOPOIETIC STEM CELL EXPANSION | ROSSI DERRICK J | CHILDRENS MEDICAL CENTER |
| EP3429607 | COMPOSITIONS USEFUL IN THE PREVENTION AND/OR TREATMENT OF DISORDERS OF THE ORAL CAVITY, UPPER AIRWAYS AND ESOPHAGUS | BOMBARDELLI EZIO | INDENA SPA |
| EP3429616 | COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF HOOF AND CLAW DISEASES | POLYAKOV IGOR | POLYAKOV IGOR |
| EP3429622 | TREATMENT OF SEVERE COMMUNITY ACQUIRED PNEUMONIA | LANGOHR PATRICK | BIOTEST AG |
| EP3429633 | A METHOD OF ENGINEERING DRUG-SPECIFIC HYPERSENSITIVE T-CELLS FOR IMMUNOTHERAPY BY GENE INACTIVATION | VALTON JULIEN | CELLECTIS |
| EP3429689 | ACELLULAR PLACENTAL PREPARATIONS | WASHBURN SCOTT A | PLAKOUS THERAPEUTICS INC |
| EP3429694 | SKIN-BRIGHTENING COSMETIC | KEIMES JÖRG | OCEAN RES & DEVELOPMENT GMBH |
| EP3429993 | DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS; METHOD OF MAKING; AND USE THEREOF | NEWMAN AMY HAUCK | US HEALTH |
| EP3429994 | 2-CYANOISOINDOLINE DERIVATIVES FOR TREATING CANCER | GIBSON KARL RICHARD | MISSION THERAPEUTICS LTD |
| EP3429998 | PROCESS FOR PREPARING QUINOLIN-2-YL-PHENYLAMINE DERIVATIVES AND THEIR SALTS | RABE SEBASTIAN | RATIOPHARM GMBH |
| EP3430005 | COMPOUNDS AND METHODS FOR KINASE MODULATION AND INDICATIONS THEREFORE | LIN JACK | PLEXXIKON INC |
| EP3430012 | 4,6 DIHYDROPYRROLO [3,4-C]PYRAZOLE-5 (1H)-CARBONITRILE DERIVATES FOR TREATING CANCER | JONES ALISON | MISSION THERAPEUTICS LTD |
| EP3430038 | COMPOSITIONS AND METHODS FOR CD20 IMMUNOTHERAPY | PRESS OLIVER | HUTCHINSON FRED CANCER RES |
| EP3430054 | METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND ANTI-GPC3 ANTIBODIES | ENDO MIKA | CHUGAI PHARMACEUTICAL CO LTD |
| EP3430143 | INHIBITORS OF SRSF1 TO TREAT NEURODEGENERATIVE DISORDERS | HAUTBERGUE GUILLAUME | UNIV SHEFFIELD |
| EP3430168 | METHODS AND KITS TO IDENTIFY KLEBSIELLA STRAINS | BOWERS JOLENE | TRANSLATIONAL GENOMICS RES INST |
| EP3431076 | IMPROVED LIPID FORMULATION | AKINC AKIN | ARBUTUS BIOPHARMA CORP |
| EP3431078 | NON-PULSATILE PROLONGED-RELEASE BETAHISTINE ORAL SOLID COMPOSITIONS | PATEL HIMANSHUKUMAR DASHARATHLAL | INTAS PHARMACEUTICALS LTD |
| EP3431082 | ANTI-AGING COMPOSITION | JEONG SE KYOO | NEOPHARM CO LTD |
| EP3431100 | COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR INFLUENZA | ROSS TED M | UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION |
| EP3431103 | TARGETING ABCB5 FOR CANCER THERAPY | FRANK MARKUS H | BRIGHAM & WOMENS HOSPITAL INC |
| EP3431141 | THREE-DIMENSIONAL PRINTING METHOD | JACOB JULES | APRECIA PHARMACEUTICALS LLC |
| EP3431460 | NOVEL FORMULATION AND METHOD OF SYNTHESIS | WICKSTROM TORILD | GE HEALTHCARE LTD |
| EP3431468 | USE OF ADIPONECTIN RECEPTOR AGONISTS IN TREATING DEPRESSION, ANXIETY AND NEUROINFLAMMATION | NICOLAS SARAH | CENTRE NAT RECH SCIENT |
| EP3431475 | SOLID FORMS OF A SELECTIVE CDK4/6 INHIBITOR | CHEKAL BRIAN PATRICK | PFIZER |
| EP3431478 | MICROMOLECULAR LUNG-TARGETING DRUG | ZHANG ZHIRONG | YAOPHARMA CO LTD |
| EP3431487 | CRYSTAL OF REDUCED-FORM GLUTATHIONE AND METHOD FOR PRODUCING SAME | FUKUMOTO KAZUNARI | KYOWA HAKKO BIO CO LTD |
| EP3431583 | METHOD FOR DIFFERENTIATING INDUCED PLURIPOTENT STEM CELLS INTO RENAL PROXIMAL TUBULAR CELL-LIKE CELLS | ZINK DANIELE | AGENCY SCIENCE TECH & RES |
| EP3432854 | USE OF GEL BEADS TO CONTROL DROPLET DISPERSION | UTADA ANDREW | BIO RAD LABORATORIES |
| EP3432859 | COSMETIC COMPOSITIONS AND USES THEREOF | DURKEE BARBARA | MARY KAY INC |
| EP3432865 | ORAL DOSAGE FORM | VERVAET CHRIS | UNIV GENT |
| EP3432872 | COMPOSITIONS AND METHODS FOR USE OF EFLORNITHINE AND DERIVATIVES AND ANALOGS THEREOF TO TREAT CANCERS, INCLUDING GLIOMAS | LEVIN VICTOR A | ORBUS THERAPEUTICS INC |
| EP3432874 | METHODS AND COMPOSITIONS FOR TREATMENT OF PRADER-WILLI SYNDROME | MECHOULAM RAPHAEL | YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD |
| EP3432879 | USING FATTY ACID SYNTHASE INHIBITORS TO TREAT FIBROSIS | LEOF EDWARD B | MAYO FOUND MEDICAL EDUCATION & RES |
| EP3432881 | USE OF DDX3 INHIBITORS AS ANTIPROLIFERATIVE AGENTS | BRAI ANNALAURA | AZIENDA OSPEDALIERA UNIV SENESE |
| EP3432882 | METHODS OF TREATING FABRY DISEASE IN PATIENTS HAVING THE G9331A MUTATION IN THE GLA GENE | BENJAMIN ELFRIDA | AMICUS THERAPEUTICS INC |
| EP3432883 | METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS | GUALBERTO ANTONIO | KURA ONCOLOGY INC |
| EP3432886 | PIM KINASE INHIBITORS IN COMBINATION WITH RNA SPLICING MODULATORS/INHIBITORS FOR TREATMENT OF CANCERS | BIEBERICH CHARLES J | UNIV MARYLAND |
| EP3432895 | PREPARATION OF PLATELET PELLET LYSATE AND ITS USE FOR TREATING NEUROLOGICAL DISORDERS | DEVOS DAVID | CENTRE HOSPITALIER REGIONAL ET UNIV DE LILLE |
| EP3432899 | USE OF PROBIOTICS IN THE TREATMENT AND/OR PREVENTION OF PSORIASIS | NAVARRO LóPEZ VICENTE MANUEL | BIONOU RES S L |
| EP3432901 | SEQUENTIAL ANTI-CANCER TREATMENT | BIGNER DARELL D | UNIV DUKE |
| EP3432970 | IN VIVO DRUG DELIVERY DEVICES AND METHODS FOR DRUG DELIVERY | LEE HEEJIN | TARIS BIOMEDICAL LLC |
| EP3433238 | PROSTATE-SPECIFIC MEMBRANE ANTIGEN TARGETED HIGH-AFFINITY AGENTS FOR ENDORADIOTHERAPY OF PROSTATE CANCER | RAY SANGEETA | UNIV JOHNS HOPKINS |
| EP3433243 | NOVEL DERIVATIVES AND THEIR USE AS SELECTIVE INHIBITORS OF CASPASE-2 | JACOTOT ETIENNE | INST NAT SANTE RECH MED |
| EP3433247 | 6-HYDROXY-4-OXO-1,4-DIHYDROPYRIMIDINE-5-CARBOXAMIDES AS APJ AGONISTS | PI ZULAN | SQUIBB BRISTOL MYERS CO |
| EP3433259 | CONJUGATES OF TACROLIMUS, THEIR COMPOSITIONS, AND THEIR USES | FUSELIER JOSEPH | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND |
| EP3433273 | BINDING MOLECULES TO CD38 AND PD-L1 | ZHUKOVSKY EUGENE | BIOMUNEX PHARMACEUTICALS |
| EP3433276 | EARLY INTERVENTION METHODS TO PREVENT OR AMELIORATE TOXICITY | JENSEN MICHAEL | SEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENS RES INST |
| EP3433368 | TRANS-REPLICATING RNA | BEISSERT TIM | BIONTECH RNA PHARMACEUTICALS GMBH |
| EP3434265 | PHARMACEUTICAL COMPOSITION CONTAINING RIFAXIMIN ALPHA & DELTA | RANEBURGER JOHANNES | SANDOZ AG |
| EP3434278 | USE OF ANTIPLATELET THROMBOLYSIN IN THE PREPARATION OF MEDICINE FOR TREATING THROMBOTIC THROMBOCYTOPENIC PURPURA | LI XIAOYI | ZHAOKE PHARMACEUTICAL HEFEI COMPANY LTD |
| EP3434285 | PHARMACEUTICAL COMPOSITION AND USE THEREOF | LIU XIAOYU | WATERSTONE PHARMACEUTICALS WUHAN CO LTD |
| EP3434287 | SHORT AND ULTRA-SHORT ANTIMICROBIAL LIPOPEPTIDES AND USE THEREOF | ROMANI ANTONELLO | ARTA PEPTIDION S R L S |
| EP3434329 | COSMETIC USE OF A TULIP EXTRACT ON HAIR | BERNARD PHILIPPE | CASTER |
| EP3434673 | EGFR INHIBITOR FREE BASE OR ACID SALT POLYCRYSTALLINE FORM, PREPARATION METHOD THEREFOR, AND APPLICATION | CHEN ZHONGKE | JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD |
| EP3434674 | COMPOUND HAVING MUTANT IDH INHIBITORY ACTIVITY, PREPARATION METHOD AND USE THEREOF | JIANG LEI | SHANGHAI HAIHE PHARMACEUTICAL CO LTD |
| EP3434678 | SALT FORM OF DPPIV INHIBITOR AND PREPARATION METHOD FOR SALT FORM | LIU HONG | SHANGHAI INST MATERIA MEDICA CAS |
| EP3434685 | URIDINE PHOSPHORAMIDE PRODRUG, PREPARATION METHOD THEREFOR, AND MEDICINAL USES THEREOF | WANG GUOCHENG | JIANGSU TASLY DIYI PHARMACEUTICAL CO LTD |
| EP3434687 | NOVEL OXYNTOMODULIN DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR TREATING OBESITY COMPRISING THE SAME | JUNG SUNG YOUB | HANMI SCIENCE CO LTD |
| EP3434762 | MODIFIED NATURAL KILLER CELLS AND NATURAL KILLER CELL LINES HAVING INCREASED CYTOTOXICITY | O'DWYER MICHAEL EAMON PETER | ONKIMMUNE LTD |
| EP3435788 | BILAYER TABLETS OF VITAMIN AND PROCESS FOR PREPARING THE SAME | CHANG DAVID S | ACCESS BUSINESS GROUP INT LLC |
| EP3435966 | CARBOXYLATED POLYPHENOL DERIVATIVES AND THEIR COSMETIC USE | HITCE JULIEN | OREAL |
| EP3435967 | HAIR CONDITIONING COMPOSITION CONTAINING PENTAERYTHRITOL ESTER AND PPG ALKYL ETHER | FENG JI | BEIERSDORF AG |
| EP3435975 | INJECTABLE COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREOF | RAYBIN SAMUEL | BOSTON SCIENT SCIMED INC |
| EP3435976 | ANTIBACTERIAL COMPOSITIONS | CHAUHAN BHASKAR | WOCKHARDT LTD |
| EP3435985 | GRANULATE FORMULATION OF 5-METHY!-1-PHENY!-2(1H)-PYRIDONE AND METHOD OF MAKING THE SAME | MUJUMDAR SIDDHARTHYA KRISHNACHANDAN | HOFFMANN LA ROCHE |
| EP3435988 | DRUG-CONTAINING PARTICULATE COMPOSITION WITH CATIONIC AGENT, ASSOCIATED MEDICAL DEVICES, AND METHODS FOR TREATMENT | SLAGER JORAM | SURMODICS INC |
| EP3435990 | STABLE PHARMACEUTICAL COMPOSITIONS FOR TOPICAL ADMINISTRATION AND USES THEREOF | SALAMA PAUL | VIDAC PHARMA LTD |
| EP3435999 | FERRIC MALTOL COMPOSITIONS FOR USE IN THE TREATMENT OR PREVENTION OF CANCER AND TUMOURS | POWELL JONATHAN JOSEPH | SHIELD TX UK LTD |
| EP3436010 | 5-HT2A SEROTONIN RECEPTOR INVERSE AGONISTS OR ANTAGONISTS FOR USE IN REDUCING AMYLOID-BETA PEPTIDES AND ACCUMULATION OF AMYLOID PLAQUES | BURSTEIN ETHAN | ACADIA PHARM INC |
| EP3436019 | SOLID FORMS OF (1S,4S)-4-(2-(((3S4R)-3-FLUOROTETRAHYDRO-2H-PYRAN-4-YL) AMINO)-8-((2,4,6-TRICHLOROPHENYL) AMINO)-9H-PURIN-9-YL)-1-METHYLCYCLOHEXANE-1-CARBOXAMIDE AND METHODS OF THEIR USE | CHEN ZHENG | SIGNAL PHARM LLC |
| EP3436025 | METHODS FOR THE SEPARATION AND DETECTION OF AN OXYSTEROL | HARRINGTON ROGER E | WARSAW ORTHOPEDIC INC |
| EP3436038 | BETA-CASEINS AND COGNITIVE FUNCTION | CLARKE ANDREW JOHN | A2 MILK CO LTD |
| EP3436051 | COLUMN-BASED FULLY SCALABLE RAAV MANUFACTURING PROCESS | QU GUANG | SPARK THERAPEUTICS INC |
| EP3436073 | A COMPOSITION COMPRISING PIC FOR TREATMENT OF CANCER | ZHANG YI | YISHENG BIOPHARMA SINGAPORE PTE LTD |
| EP3436078 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALS | MACLENNAN ALEXANDER JOHN | UNIV CINCINNATI |
| EP3436079 | CHIMERIC ANTIGEN AND T CELL RECEPTORS AND METHODS OF USE | WILTZIUS JED | KITE PHARMA INC |
| EP3436080 | METHOD TO PREPARE SPERM | VISCONTI PABLO E | UNIV MASSACHUSETTS |
| EP3436110 | PRE-FILLED SYRINGE | LOBRUTTO ROSARIO | TEVA PHARMA |
| EP3436155 | TOOTHPASTE COMPOSITION | CHANDRASEKARAN SEMBIAN | UNILEVER NV |
| EP3436158 | TOPICAL COMPOSITION COMPRISING PLANT EXTRACTS | PACCHETTI BARBARA | LINNEA SA |
| EP3436435 | SUBSTITUTED INDOLE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS | BARDIOT DOROTHéE ALICE MARIE-EVE | JANSSEN PHARMACEUTICALS INC |
| EP3436437 | SUBSTITUTED INDOLINE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS | KESTELEYN BART RUDOLF ROMANIE | JANSSEN PHARMACEUTICALS INC |
| EP3436447 | ISOQUINOLINYL TRIAZOLONE COMPLEXES | CHEN RONGLIANG | TAKEDA PHARMACEUTICALS CO |
| EP3436451 | SPHINGOSINE KINASE INHIBITOR AMIDOXIME PRODRUGS | THORPE STEVEN BRANDON | UNIV VIRGINIA PATENT FOUNDATION |
| EP3436453 | INHIBITORS OF THE UNCONVENTIONAL SECRETION OF FIBROBLAST GROWTH FACTOR 2 (FGF2) BY TUMOR CELLS AND USES THEREOF | NICKEL WALTER | UNIV HEIDELBERG |
| EP3436456 | FUSED HEXACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | DE HARO GARCIA TERESA | UCB BIOPHARMA SPRL |
| EP3436458 | FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | HEER JAG PAUL | UCB BIOPHARMA SPRL |
| EP3436459 | FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | DELIGNY MICHAËL LOUIS ROBERT | UCB BIOPHARMA SPRL |
| EP3436460 | FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | DELIGNY MICHAËL LOUIS ROBERT | UCB BIOPHARMA SPRL |
| EP3436478 | MULTISPECIFIC ANTIBODIES FOR USE IN THE TREATMENT OF A NEOPLASM OF THE URINARY TRACT | BAUER HARTWIG-WILHELM | LINDHOFER HORST DR |
| EP3436481 | DUAL FUNCTION ANTIBODIES SPECIFIC TO GLYCOSYLATED PD-L1 AND METHODS OF USE THEREOF | YOO STEPHEN S | STCUBE INC |
| EP3436483 | ERBB2-TARGETING ANTIBODY | SIBILIO LEONARDO | ST BIOCHIMICO ITALIANO GIOVANNI LORENZINI S P A |
| EP3436582 | BETA-CATENIN NUCLEIC ACIDS AND USES THEREOF | HUANG HANHUA | AVIDITY BIOSCIENCES LLC |
| EP3436584 | EGFR NUCLEIC ACIDS AND USES THEREOF | HUANG HANHUA | AVIDITY BIOSCIENCES LLC |
| EP3436586 | MYC NUCLEIC ACIDS AND USES THEREOF | HUANG HANHUA | AVIDITY BIOSCIENCES LLC |
| EP3436587 | PHOSPHATIDYLINOSITOL-3-KINASE NUCLEIC ACIDS AND USES THEREOF | HUANG HANHUA | AVIDITY BIOSCIENCES LLC |
| EP3437531 | TISSUE-PAPER | YASUI SHUTA | DAIO SEISHI KK |
| EP3437622 | CEMENT FOR DENTAL USE | YOSHIMITSU RYOSUKE | G C DENTAL IND CORP |
| EP3437623 | GLASS POWDER FOR DENTAL USE | YOSHIMITSU RYOSUKE | G C DENTAL IND CORP |
| EP3437640 | SYNUCLEINOPATHY THERAPEUTIC MEDICATION | FUKUNAGA KOHJI | UNIV TOHOKU |
| EP3437644 | MEDICINE | KATO JURAN | TAKEDA PHARMACEUTICALS CO |
| EP3437645 | FILM-COATED TABLET HAVING HIGH CHEMICAL STABILITY OF ACTIVE INGREDIENT | MATONO MITSUHIRO | INTERCEPT PHARMACEUTICALS INC |
| EP3437657 | ANTIBODY MODIFIED BY SUBSTITUTING CYSTEINE AT AMINO ACID POSITIONS 80 AND 171 OF KABAT NUMBERING | IDE NOBUYUKI | SYSMEX CORP |
| EP3437662 | IL-12 IMMUNOCONJUGATE | WULHFARD SARAH | PHILOGEN SPA |
| EP3438103 | GRISEOFULVIN COMPOUND | SAITO KEIJI | DAIICHI SANKYO CO LTD |
| EP3438109 | HETEROCYCLIC COMPOUND | IKEDA SHUHEI | TAKEDA PHARMACEUTICALS CO |
| EP3438159 | ORGANOPOLYSILOXANE, COSMETIC MATERIAL, AND METHOD FOR PRODUCING ORGANOPOLYSILOXANE | KAMEI MASANAO | SHINETSU CHEMICAL CO |
| EP3439617 | USE OF KAOLIN AS AN OPACIFIER | PAGIS LAURE | IMERTECH SAS |
| EP3439618 | UV-PROTECTIVE COMPOSITIONS AND THEIR USE | LANDA BENZION | LANDA LABS 2012 LTD |
| EP3439621 | AQUEOUS FOAMING CLEANSING COMPOSITIONS COMPRISING N-ACYL SALTS OF POLYCARBOXLIC ACIDS AND PLANT MICROFIBERS | VELIKOV KRASSIMIR PETKOV | UNILEVER PLC |
| EP3439622 | A PROCESS FOR SYNTHESIZING AN AMIDO ALKYL BETAINE STARTING FROM AN ALCOHOL, AN AMIDO ALKYL BETAINE PREPARED BY THE PROCESS WITH INCREASED VISCOSITY, AND USE THEREOF AS A VISCOELASTIC SURFACTANT | BACK OLIVIER | RHODIA OPERATIONS |
| EP3439623 | COMPOSITIONS WITH ACYLISETHIONATE SURFACTANT AND METHODS OF USE | CLARK PETER | INNOSPEC LTD |
| EP3439633 | GLUCONO DELTA-LACTONE FOR TREATMENT OF VAGINAL FUNGAL INFECTIONS | ELLERVIK ULF | GEDEA BIOTECH AB |
| EP3439641 | COMPOSITIONS, KITS AND METHODS FOR MAINTAINING EYELID HYGIENE | ADKINS NAT JR | OCUSOFT INC |
| EP3439646 | METHOD FOR IMPROVING LANGUAGE SKILLS IN CHILDREN WITH SUSPECTED OR CONFIRMED CEREBRAL PALSY OR CHILDREN AT INCREASED RISK THEREOF | VOS ARJEN PAUL | NUTRICIA NV |
| EP3439653 | REDUCING TUMOR BURDEN BY ADMINISTERING CCR1 ANTAGONISTS IN COMBINATION WITH PD-1 INHIBITORS OR PD-L1 INHIBITORS | CHARO ISRAEL | CHEMOCENTRYX INC |
| EP3439655 | RING-FUSED THIAZOLINO 2-PYRIDONES, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF TUBERCULOSIS | STALLINGS CHRISTINA L | QURETECH BIO AB |
| EP3439658 | SOLUBLE C5aR ANTAGONISTS | FAN PINGCHEN | CHEMOCENTRYX INC |
| EP3439661 | METHODS OF TREATING OCULAR CONDITIONS | ACKERMANN DOUGLAS MICHAEL | OYSTER POINT PHARMA INC |
| EP3439676 | FISH OIL TOPICAL COMPOSITION | BETTLE GRISCOM III | OMEZA LLC |
| EP3439689 | METHODS FOR TREATING HYPERLIPIDEMIA WITH AN ANGPTL8 INHIBITOR AND AN ANGPTL3 INHIBITOR | GROMADA JESPER | REGENERON PHARMA |
| EP3439742 | COSMETIC COMPOSITIONS FOR PROTECTION AGAINST AIR POLLUTANTS | MARAMALDI GIADA | INDENA SPA |
| EP3440015 | HIGHLY POROUS MAGNESIUM CARBONATE AND METHOD OF PRODUCTION THEREOF | CHEUNG OCEAN | DISRUPTIVE MAT AB |
| EP3440054 | PYRROLE DERIVATIVES | CHEN LI | HUA MEDICINE SHANGHAI LTD |
| EP3440057 | SILICONE ATOMS CONTAINING IVACAFTOR ANALOGUES | MUNOZ BENITO | PROTEOSTASIS THERAPEUTICS INC |
| EP3440062 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY ENRICHED ISOXAZOLINE COMPOUNDS - CRYSTALLINE TOLUENE SOLVATE OF (S)-AFOXOLANER | YANG CHUNHUA | MERIAL INC |
| EP3440067 | TETRAHYDROISOQUINOLINE ESTROGEN RECEPTOR MODULATORS AND USES THEREOF | LABADIE SHARADA | HOFFMANN LA ROCHE |
| EP3441063 | THIOUREYLENE LIQUID COMPOSITIONS | REYNOLDS LOUISE | NORBROOK LAB LTD |
| EP3441064 | EXTENDED RELEASE LIQUID COMPOSITIONS OF GUAIFENESIN | VATS SANDEEP KUMAR | SUN PHARMACEUTICAL IND LTD |
| EP3441074 | NOVEL VEHICLES FOR THE TRANSFECTION OF miRNAS | SáNCHEZ BARREIRO ALEJANDRO | UNIV SANTIAGO COMPOSTELA |
| EP3441075 | ORALLY ADMINISTERED ESSENTIAL OIL COMPOSITION AND USE THEREOF | LAI LILY | LAI LILY |
| EP3441086 | ANTI-PD-1 MONOCLONAL ANTIBODY | XIA YU | AKESO BIOPHARMA INC |
| EP3441106 | MICRONEEDLE STRUCTURE FOR EFFICIENT SKIN PERFORATION | SHIM WOO-SUN | LG HOUSEHOLD & HEALTH CARE LTD |
| EP3441389 | PYRAZOLE-OXAZOLIDINONE COMPOUND FOR ANTI-HEPATITIS B VIRUS | CHEN HUANMING | SHANGHAI ZHIMENG BIOPHARMA CO LTD |
| EP3441392 | A PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | REN PINGDA | INTELLIKINE LLC |
| EP3441460 | EX VIVO EXPANSION METHOD FOR CORD BLOOD NK CELL, AND KIT AND APPLICATION THEREOF | WU XIAOYUN | BEIJING JINGMENG STEM CELL TECH CO LTD |
| EP3442358 | INFANT NUTRITION DELIVERING METABOLIC BENEFITS | ACHESON KEVIN JOHN | NESTEC SA |
| EP3442491 | SURFACE-MODIFIED EFFECT PIGMENT AND NAIL VARNISH COMPOSITION | GEBHARD ANN-KATRIN | ECKART GMBH |
| EP3442497 | ACTIVE COMBINATIONS, COMPOSITIONS AND METHODS FOR ENHANCING HAIR GROWTH | CABELLO ESCRIBANO JOSé MIGUEL | GRATIA MUNDI GMBH |
| EP3442513 | USE OF CANNABIDIOLIC ACID IN THE TREATMENT OF AUTISM SPECTRUM DISORDER AND ASSOCIATED DISORDERS | GUY GEOFFREY | GW RES LTD |
| EP3442514 | INHIBITORS OF GLUCOSYLCERAMIDE DEGRADATION IN THE TREATMENT OF DISEASES OF THE MOTOR UNITS | SPEDDING MICHAEL | SPEDDING RES SOLUTIONS |
| EP3442528 | COMBINATION THERAPY WITH NOTCH AND PI3K/MTOR INHIBITORS FOR USE IN TREATING CANCER | PATEL BHARVIN KUMAR | LILLY CO ELI |
| EP3442529 | COMBINATION THERAPY WITH NOTCH AND CDK4/6 INHIBITORS FOR THE TREATMENT OF CANCER | BECKMANN RICHARD PAUL | LILLY CO ELI |
| EP3442541 | METHODS FOR TREATING CANCER AND INHIBITING GRAFT REJECTION | LIU YUAN | UNIV GEORGIA STATE RES FOUND |
| EP3442581 | USE OF CANNABIDIVARIN IN THE TREATMENT OF AUTISM SPECTRUM DISORDER, ASSOCIATED DISORDERS AND SCHIZOPHRENIA | GUY GEOFFREY | GW RES LTD |
| EP3442584 | COMBINATIONS OF PBD-BASED ANTIBODY DRUG CONJUGATES WITH BCL-2 INHIBITORS | ARTHUR WILLIAM | SEATTLE GENETICS INC |
| EP3442587 | MULTI-DOSE COMPOSITIONS CONTAINING AN ANTIMICROBIAL POLYAMIDE OR OCTENIDINE PRESERVATIVE | RIGAUT GUILLAUME | MERIAL INC |
| EP3442955 | SELECTIVE D3 DOPAMINE RECEPTOR AGONISTS AND METHODS OF THEIR USE | SIBLEY DAVID R | US HEALTH |
| EP3442965 | NOVEL N-[(HETEROARYLOXY)PROPANYL]HETEROARYL CARBOXAMIDES | RIETHER DORIS | BOEHRINGER INGELHEIM INT |
| EP3442980 | HETEROCYCLIC COMPOUNDS AS RET KINASE INHIBITORS | JORDAN ALLAN | CANCER RESEARCH TECH LTD |
| EP3443009 | ANTI-TIM-3 ANTIBODIES AND COMPOSITIONS | LINDSTED TRINE | SYMPHOGEN AS |
| EP3443123 | METHODS AND COMPOSITIONS FOR DETECTING SINGLE T CELL RECEPTOR AFFINITY AND SEQUENCE | JIANG NING | UNIV TEXAS |
| EP3443955 | NOOTROPIC COMPOSITIONS FOR IMPROVING MEMORY PERFORMANCE | COHEN DANIEL | PHARNEXT |
| EP3443969 | BRAIN FUNCTION-IMPROVING COMPOSITION FOR NEWBORNS | KUSUDA SATOSHI | MEIJI CO LTD |
| EP3443981 | LLT-1 ANTIBODIES WITH NEW FUNCTIONAL PROPERTIES | SPEE PETRUS JOHANNES LOUIS | CENTRE NAT RECH SCIENT |
| EP3444238 | PROCESS FOR PREPARING DIFLUOROMETHYLENE COMPOUNDS | NAGAI KEITA | SATO PHARMA |
| EP3444261 | 2,2-DIFLUOROPROPIONAMIDE DERIVATIVE OF BARDOXOLONE METHYL, PHARMACEUTICAL COMPOSITIONS AND POLYMORPHS THEREOF FOR USE IN TREATING CERTAIN CONDITIONS | ANDERSON ERIC | REATA PHARMACEUTICALS INC |
| EP3444268 | STAPHYLOCOCCUS AUREUS LEUKOCIDINS, THERAPEUTIC COMPOSITIONS, AND USES THEREOF | TORRES VICTOR J | UNIV NEW YORK |
| EP3444281 | IMPROVED PEPTIDE PHARMACEUTICALS | NESTOR JOHN J | EUMEDERIS PHARMACEUTICALS INC |
| EP3444334 | METHOD FOR INDUCING CD8+ T CELLS | KAWAMOTO HIROSHI | UNIV KYOTO |
| EP3444349 | METHODS AND COMPOSITIONS FOR PREVENTING ISCHEMIA REPERFUSION INJURY IN ORGANS | SQUIERS ELIZABETH C | QUARK PHARMACEUTICALS INC |
| EP3444350 | METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF ALPHA-1 ANTITRYPSIN BY DOUBLE-STRANDED RNA | BROWN BOB D | DICERNA PHARMACEUTICALS INC |
| EP3444353 | MICROBIAL FERMENTATION OF BOTANICALS | WANG LEI | CHANGSHA OMICS BIO TECH CO LTD |
| EP3444356 | METHOD FOR ASSESSING OR SELECTING SEBACEOUS-GLAND- OR HAIR-FOLLICLE-SELECTIVE ANDROGEN RECEPTOR ACTIVITY CONTROLLING AGENT | INOUE TAKAYOSHI | KAO CORP |
| EP3445314 | ORAL CARE COMPOSITION | BLASCO ALESSANDRO | UNILEVER PLC |
| EP3445337 | TWIN-SCREW DRY GRANULATION FOR PRODUCING SOLID FORMULATIONS | REPKA MICHAEL ANDREW | UNIV MISSISSIPPI |
| EP3445356 | FAST-ACTING PLANT-BASED MEDICINAL COMPOUNDS AND NUTRITIONAL SUPPLEMENTS | LEONE-BAY ANDREA | RECEPTOR LIFE SCIENCES INC |
| EP3445357 | BIFUNCTIONAL MOLECULES FOR DEGRADATION OF EGFR AND METHODS OF USE | GRAY NATHANAEL | DANA FARBER CANCER INST INC |
| EP3445362 | COMPOSITION AND METHOD FOR TREATING METABOLIC DISORDERS | CINCOTTA ANTHONY H | VEROSCIENCE LLC |
| EP3445370 | METHODS FOR THE PREPARATION OF OBETICHOLIC ACID AND DERIVATIVES THEREOF | LIST BENJAMIN | INTERCEPT PHARMACEUTICALS INC |
| EP3445377 | COMPOSITIONS FOR THE SKIN | ESCAICH FERRER JOSé | BIOIBERICA S A U |
| EP3445406 | COMPOSITIONS AND METHODS FOR ENHANCED GENE EXPRESSION OF PKLR | SEGOVIA JOSE C | CENTRO DE INVESTIG ENERGETICAS MEDIOAMBIENTALES Y TECNOLOGICAS |
| EP3445451 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF LYSOSOMAL STORAGE DISORDERS AND DISORDERS CHARACTERIZED BY LYSOSOMAL DYSFUNCTION | SARDIELLO MARCO | BAYLOR COLLEGE MEDICINE |
| EP3445455 | METHOD FOR DETERMINING THE UV PROTECTION OF SUNCREEN ON THE SKIN WHEN UNDER WATER | BATZER JAN | BEIERSDORF AG |
| EP3445456 | COSMETIC COMPOSITION COMPRISING WATER DEPLETED IN 2H AND 18O ISOTOPS | MAYER WOLFGANG | MEDENA AG |
| EP3445558 | A FRACTIONAL LOBE PROCESSOR | BHUSHAN INDU | STEERLIFE INDIA PRIVATE LTD |
| EP3445743 | PRODRUG OF AMINO ACID DERIVATIVE | OTAKE NORIKAZU | TAISHO PHARMA CO LTD |
| EP3445744 | NOVEL INHIBITORS OF MEPRIN ALPHA AND BETA | WERMANN MICHAEL | FRAUNHOFER GES FORSCHUNG |
| EP3445763 | NOVEL CRYSTALLINE SALT FORMS OF 3-(1,2,4-TRIAZOLO[4,3-A]PYRIDINE-3-YLETHYNYL)-4-METHYL-N-(4-((4-METHYLPIPERAZIN-1-YL)METHYL)-3-TRIFLUOROMETHYLPHENYL)BENZAMIDE FOR MEDICAL APPLICATION | CHILOV GERMES GRIGORIEVICH | LLC 芦FUSION PHARMA禄 |
| EP3445766 | NEW ANTIMICROBIAL COMPOUND | SLETTA HÅVARD | SINTEF TTO AS |
| EP3445799 | RENEWABLY DERIVED POLYESTERS AND METHODS OF MAKING AND USING THE SAME | NELSON ASHLEY M | ELEVANCE RENEWABLE SCIENCES |
| EP3446682 | OPHTHALMIC COMPOSITION | MATSUMURA YASUKO | ROHTO PHARMA |
| EP3446683 | COENZYME Q10 SOLUBILIZING COMPOSITION AND METHOD FOR PREPARING SAME | CHUNG SANG JEON | ABTIS CO LTD |
| EP3446684 | ORALLY DISINTEGRATING TABLET | SAEKI ISAMU | TOWA PHARMACEUTICAL CO LTD |
| EP3446705 | [6R]-MTHF AN EFFICIENT FOLATE ALTERNATIVE IN 5-FLUOROURACIL BASED CHEMOTHERAPY | LINDBERG PER LENNART | ISOFOL MEDICAL AB |
| EP3446706 | [6R]-MTHF MULTIPLE BOLUS ADMINISTRATION IN 5-FLUOROURACIL BASED CHEMOTHERAPY | LINDBERG PER LENNART | ISOFOL MEDICAL AB |
| EP3446714 | ANTI-NUCLEOLIN AGENT-CONJUGATED NANOPARTICLES | BATES PAULA | UNIV LOUISVILLE RES FOUND INC |
| EP3447045 | 1-(1-HYDROXY-2,3-DIHYDRO-1H-INDEN-5-YL)-UREA DERIVATIVES AND RELATED COMPOUNDS KCNQ 2-5 CHANNEL ACTIVATORS FOR TREATING DYSURIA | YASHIRO KENTARO | ONO PHARMACEUTICAL CO |
| EP3447054 | COMPOUND AND PREPARATION METHOD THEREFOR, COMPOSITION AND APPLICATION THEREOF | LEI SIJUN | WUHAN LL SCIENCE AND TECH DEVELOPMENT CO LTD |
| EP3447061 | PHARMACEUTICAL FORMULATION COMPRISING A PHOSPHORAMIDATE DERIVATIVE OF 5-FLUORO-2'-DEOXYURIDINE FOR USE IN THE TREATMENT OF CANCER | MCGUIGAN CHRISTOPHER | NUCANA PLC |
| EP3447067 | GLP-1R/GCGR DUAL TARGET AGONIST POLYPEPTIDE FOR TREATING FATTY LIVER, HYPERLIPIDEMIA, AND ATHEROSCLEROSIS | JIANG XIANXING | SHENZHEN TURIER BIOTECH CO LTD |
| EP3447070 | COMPOUNDS FOR TREATING THE REMYELINATION BLOCKADE IN DISEASES ASSOCIATED WITH THE EXPRESSION OF HERV-W ENVELOPE PROTEIN | PERRON HERVé | GENEURO SA |
| EP3447125 | T CELL RECEPTOR-DEFICIENT T CELL COMPOSITIONS | SENTMAN CHARLES L | DARTMOUTH COLLEGE |
| EP3447131 | INFLUENZA A VIRUS MUTANTS | BILSEL PAMUK | FLUGEN INC |
| EP3448352 | CLEANSING COMPOSITIONS AND METHODS | RANIERI-CHAMBERLAIN ALAINE | ELC MAN LLC |
| EP3448358 | FILM-LIKE FORM OF ADMINISTRATION FOR THE TRANSMUCOSAL DELIVERY OF ANTIDIABETIC PEPTIDES | MüLLER MARKUS | LTS LOHMANN THERAPIE SYSTEME AG |
| EP3448372 | FORMULATIONS FOR USE IN THE TREATMENT OR IN THE PREVENTION OF UROLOGICAL DISEASES | CASTELLI SIMONE | INPHA DUEMILA S R L |
| EP3448380 | 1,5-DISUBSTITUTED 1,2,3-TRIAZOLES ARE INHIBITORS OF RAC/CDC42 GTPASES | VLAAR CORNELIS P | UNIV PUERTO RICO |
| EP3448386 | ISOQUINOLIN-3-YL CARBOXAMIDES AND PREPARATION AND USE THEREOF | KC SUNIL KUMAR | SAMUMED LLC |
| EP3448389 | QUINAZOLINE AND INDOLE COMPOUNDS TO TREAT MEDICAL DISORDERS | WILES JASON ALLAN | ACHILLION PHARMACEUTICALS INC |
| EP3448401 | HSV VECTORS WITH ENHANCED REPLICATION IN CANCER CELLS | JIA WILLIAM | VIROGIN BIOTECH CANADA LTD |
| EP3448421 | METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF SURGICAL ADHESIONS | TSAI JONATHAN | UNIV LELAND STANFORD JUNIOR |
| EP3448429 | HUMANIZED AFFINITY MATURED ANTI-FCRN ANTIBODIES | BLUMBERG LAURENCE J | SYNTIMMUNE INC |
| EP3448437 | EVASION OF NEUTRALIZING ANTIBODIES BY A RECOMBINANT ADENO-ASSOCIATED VIRUS | KERAVALA ANNAHITA | ADVERUM BIOTECHNOLOGIES INC |
| EP3448493 | MICRONEEDLE ARRAY ASSEMBLY, DRUG DELIVERY DEVICE AND METHOD FOR ADMINISTERING LIQUID ACROSS A BROAD AREA AT LOW PRESSURE | BAKER ANDREW T | SORRENTO THERAPEUTICS INC |
| EP3448494 | MICRONEEDLE ARRAY ASSEMBLY AND FLUID DELIVERY APPARATUS HAVING SUCH AN ASSEMBLY | BAKER ANDREW T | SORRENTO THERAPEUTICS INC |
| EP3448522 | NOVEL SUBSTITUTED IMIDAZOPYRIDINE COMPOUNDS AS INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN-2,3-DIOXYGENASE | COWLEY PHILLIP M | IOMET PHARMA LTD |
| EP3448528 | CROSSLINKED POLYORGANOSILOXANE AND PERSONAL CARE COMPOSITION CONTAINING SAME | XING ZHIMIN | MOMENTIVE PERFORMANCE MAT INC |
| EP3448838 | ISOQUINOLIN-3-YL CARBOXAMIDES AND PREPARATION AND USE THEREOF | KC SUNIL KUMAR | SAMUMED LLC |
| EP3448840 | MOFEZOLAC DERIVATIVES AS MULTI-FUNCTIONS SELECTIVE COX-1 INHIBITORS | SCILIMATI ANTONIO | UNIV DEGLI STUDI DI BARI ALDO MORO |
| EP3448843 | ARYL BETA DIKETONES AND THEIR USE A ODORANTS | FLACHSMANN FELIX | GIVAUDAN SA |
| EP3448846 | SYNTHESIS OF INDAZOLES | THALER TOBIAS | BAYER PHARMA AG |
| EP3448853 | COMPOUNDS FOR MODULATING AQUAPORINS | EVENÄS JOHAN | APOGLYX AB |
| EP3448861 | A PROCESS FOR THE PREPARATION OF 2-PYRAZOLO[1,5-A]PYRAZIN-2-YLPYRIDO[1,2-A]PYRIMIDIN-4-ONE | DOTT PASCAL | HOFFMANN LA ROCHE |
| EP3448864 | SILSESQUINOXANES AS TRANSPORT COMPOUNDS | KNAUER SASCHA | UNIV DARMSTADT TECH |
| EP3449003 | REOVIRIDAE VACCINE | ROY POLLY | LONDON SCHOOL OF HYGIENE & TROPICAL MEDICINE |
| EP3449004 | POLY(HISTIDINE)-BASED MICELLES FOR COMPLEXATION AND DELIVERY OF PROTEINS AND NUCLEIC ACIDS | GHOROGHCHIAN PAIMAN PETER | VINDICO NANOBIOTECHNOLOGY LLC |
| EP3449017 | TARGETED MEASURE OF TRANSCRIPTIONAL ACTIVITY RELATED TO HORMONE RECEPTORS | SYMMANS WILLIAM FRASER | UNIV TEXAS |
| EP3449896 | OIL-IN-WATER SOLID COSMETIC | KUBOTA SHUN | SHISEIDO CO LTD |
| EP3449924 | COMPOSITION, CROCINS ACTIVE SITE, AND USES THEREOF | YAO XINSHENG | UNIV JINAN |
| EP3449925 | URIDINE NUCLEOSIDE DERIVATIVES, COMPOSITIONS AND METHODS OF USE | HAYDON PHILIP G | UNIV TUFTS |
| EP3449927 | PHARMACEUTICAL FORMULATIONS COMPRISING CHONDROITIN SULFATE AND HYALURONIC ACID DERIVATIVES | CAMPISI MONICA | FIDIA FARM SPA |
| EP3450433 | SUBSTITUTED PURINE DERIVATIVE | TOJO SHINGO | SUMITOMO DAINIPPON PHARMA CO LTD |
| EP3450434 | DEUTERATED DERIVATIVES OF RUXOLITINIB | SILVERMAN I ROBERT | CONCERT PHARMACEUTICALS INC |
| EP3450448 | THERAPEUTIC PEPTIDE FOR EXCITATORY NEUROTOXICITY-RELATED INJURIES | LU YING | BIOCELLS BEIJING BIOTECH CO LTD |
| EP3450458 | HUMAN ANTIBODIES TO GFR 3 AND METHODS OF USE THEREOF | CROLL SUSAN D | REGENERON PHARMA |
| EP3450459 | ANTI-CDH3 ANTIBODIES AND USES THEREOF | SHIBA YASUHIRO | ONCOTHERAPY SCIENCE INC |
| EP3452006 | ANTIPERSPIRANT COMPOSITION | BRUNNER THOMAS JR | THOMAS BRUNNER HYGIENE GMBH |
| EP3452012 | NUTRACEUTICAL OR PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF POLYCYSTIC OVARY SYNDROME OR OF DISEASES OR DISORDERS RELATED THERETO | FIORETTI BERNARD | S&R FARM S P A |
| EP3452013 | COATED IMPLANTS FOR LONG-TERM CONTROLLED RELEASE OF ANTIBODY THERAPEUTICS | SCHWENDEMAN STEVEN P | UNIV MICHIGAN REGENTS |
| EP3452019 | USE OF SUGAR-ALCOHOLS IN TIBOLONE COMPOSITIONS | JASPART SéVERINE | MITHRA PHARMACEUTICALS S A |
| EP3452021 | ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE | JOWETT JAMES | PHASEBIO PHARMACEUTICALS INC |
| EP3452035 | POLYMORPHIC FORMS OF 3-[2-BUTYL-1-(2-DIETHYLAMINO-EHTYL)-1H-BENZOIMIDAZOL-5-YL]-N-HYDROXY-ACRYLAMIDE AND USES THEREOF | DUNCAN DAVID | MEI PHARMA INC |
| EP3452047 | COMPOSITIONS FOR THE TREATMENT OF CHRONIC VULVAL AND PERINEAL PAIN AND SYMPTOMS AND CONDITIONS ASSOCIATED THEREWITH | VANCAILLIE THIERRY | T&A PHARMA PTY LTD |
| EP3452071 | CHIMERIC NEUROTOXINS | LIU SAI MAN | IPSEN BIOPHARM LTD |
| EP3452075 | OPHTHALMIC PHARMACEUTICAL COMPOSITION | IM GUANG-JIN | SAM CHUN DANG PHARM CO LTD |
| EP3452093 | OPHTHALMIC COMPOSITIONS | SHABTO URI | SACSH CORP |
| EP3452094 | BINARY SELF ASSEMBLED GELS FOR CONTROLLED DELIVERY OF ENCAPSULATED AGENTS TO CARTILAGE | KARP JEFFREY | BRIGHAM & WOMENS HOSPITAL INC |
| EP3452095 | SIMMONDSIN FORMULATION | VAN DEN DRIESSCHE HERMAN | VAN DEN DRIESSCHE HERMAN |
| EP3452105 | TREATMENT OF ROSACEA WITH P38 AND ERK KINASE PATHWAY INHIBITORS | ADAM ALEJANDRO P | ALBANY MEDICAL COLLEGE |
| EP3452118 | POLYPEPTIDE AND HYALURONIC ACID COATINGS | LAVALLE PHILIPPE | INST NAT SANTE RECH MED |
| EP3452174 | HAIR RELAXER COMPOSITIONS AND METHOD | SYED ALI N | AVLON IND INC |
| EP3452176 | SAXIFRAGA EXTRACTS FOR COSMETIC OR THERAPEUTIC USE ON THE SKIN | MUTEL VINCENT | TAUDERMA SA |
| EP3452461 | PIPERIDINES AS MENIN INHIBITORS | WANG SHAOMENG | THE REGENTS OF THE UNIV OF MICHIGAN OFFICE OF TECHNOLOGY TRANSFER |
| EP3452463 | AMIDE-SUBSTITUTED PYRIDINYLTRIAZOLE DERIVATIVES AND USES THEREOF | COLLIN MARIE-PIERRE | BAYER PHARMA AG |
| EP3452464 | PYRAZOLE DERIVATIVES, COMPOSITIONS AND THERAPEUTIC USE THEREOF | CRAWFORD JAMES | HOFFMANN LA ROCHE |
| EP3452495 | ADENO-ASSOCIATED VIRUS POLYNUCLEOTIDES, POLYPEPTIDES AND VIRIONS | HALLWIRTH CLAUS | CHILDRENS MEDICAL RES INSTITUTE |
| EP3452583 | ENGINEERED NUCLEASES USEFUL FOR TREATMENT OF HEMOPHILIA A | JANTZ DEREK | PREC BIOSCIENCES INC |
| EP3452827 | METHOD FOR THE ANALYSIS OF GLYCOSAMINOGLYCANS, HEPARINS AND THEIR DERIVATIVES BY NUCLEAR MAGNETIC RESONANCE | FRANCO GUILLERMO | FARM ROVI LAB SA |
| EP3453399 | FORMULATIONS COMPRISING LIPID SYSTEMS CARRYING BIOACTIVE COMPOUNDS, FOR USE AS IMMUNOTHERAPY POTENTIATORS OR ADJUVANTS FOR PATIENTS WITH CANCER OR IMMUNOLOGICAL DISORDERS | TORRES OLIVARES CARLOS | UNIV MADRID AUTONOMA |
| EP3453400 | METHODS FOR PREVENTING OR TREATING CERTAIN DISORDERS BY INHIBITING BINDING OF IL-4 AND/OR IL-13 TO THEIR RESPECTIVE RECEPTORS | HOHLBAUM ANDREAS | PIERIS PHARMACEUTICALS GMBH |
| EP3453402 | REDUCING IMMUNOGENICITY AGAINST FACTOR VIII IN INDIVIDUALS UNDERGOING FACTOR VIII THERAPY | JIANG HAIYAN | BIOVERATIV THERAPEUTICS INC |
| EP3453404 | CORE-SHELL STRUCTURE, PREPARATION, MEDICINE FOR EXTERNAL APPLICATION, TAPE AGENT AND COSMETIC PRODUCT | KAWAMURA DAICHI | SEKISUI CHEMICAL CO LTD |
| EP3453406 | ROR1 (NTRKR1) SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR CANCER IMMUNOTHERAPY | SCHIFFER-MANNIOUI CèCILE | CELLECTIS |
| EP3453698 | NOVEL ORGANOLEPTIC COMPOUNDS | NARULA ANUBHAV P S | INT FLAVORS & FRAGRANCES INC |
| EP3453704 | PHENOL COMPOUND AND COMBINATION OF SAME WITH A BENZODIAZEPINE FUSED TO 1,4-DIHYDROPYRIDINE FOR TREATING DISEASES OF THE CENTRAL NERVOUS AND VASCULAR SYSTEMS | OCHOA RODRíGUEZ ESTAEL | UNIV LA HABANA |
| EP3453708 | PROCESS FOR THE PREPARATION OF 5-CHLORO-N-(2-ISOPROPOXY-5-METHYL-4-PIPERIDIN-4-YL-PHENYL)-N-2-(ISOPROPYLSULFONYL)PHENYL)-2,4-DIAMINE DI-HYDROCHLORIDE | FENG LILI | NOVARTIS AG |
| EP3453711 | LLP2A- BISPHOSPHONATE CONJUGATES FOR OSTEOPOROSIS TREATMENT | LAM KIT S | UNIV CALIFORNIA |
| EP3453713 | BUFADIENOLIDE COMPOUNDS SUBSTITUTED IN POSITION 3 BY AN AMINE GROUP FOR USE IN THE TREATMENT OF CANCER | QIAN XIANGPING | NEUPHARMA INC |
| EP3453716 | POLYETHYLENE GLYCOL-MODIFIED ANGIOGENESIS INHIBITOR HM-1 AND APPLICATION THEREOF | XU HANMEI | NANJING ANJI BIOLOGICAL TECH CO LTD |
| EP3453718 | LACTIC ACID BACTERIA-DERIVED PROTEIN AND PREPARATION METHOD THEREFOR | CHUNG MYUNG JUN | CELL BIOTECH CO LTD |
| EP3453723 | ANTI-ASIC1 ANTIBODIES AND USES THEREOF | MACDONALD LYNN | REGENERON PHARMA |
| EP3454737 | TUMOR BED IMPLANT FOR MULTIMODALITY TREATMENT OF AT RISK TISSUE SURROUNDING A RESECTION CAVITY | STAUFFER PAUL | UNIV JEFFERSON |
| EP3454820 | MICRO-EMULSION CONCENTRATES WITH AMPHOTERIC SURFACTANTS | HLOUCHA MATTHIAS | BASF SE |
| EP3454827 | METHOD FOR STABILIZING RETINOIC ACID PRECURSORS AND A SKIN BENEFIT COMPOSITION WITH STABILIZED RETINOIC ACID PRECURSORS | LOU ANJING | UNILEVER PLC |
| EP3454829 | COMPOSITION FOR REDUCTION OF HAIR SPLIT ENDS, USE AND PROCESS THEREOF | LIPINSKI NORMEN | KAO GERMANY GMBH |
| EP3454830 | OIL-IN-WATER EMULSIONS HAVING A CONCENTRATION OF PLANT EXTRACTS CONTAINING ISOFLAVONES AND ONE OR MORE MICA PIGMENTS | FEY SVEN | BEIERSDORF AG |
| EP3454835 | LIPID NANOPARTICLES COMPRISING LIPOPHILIC ANTI-INFLAMMATORY AGENTS AND METHODS OF USE THEREOF | LINDFORS LENNART | ASTRAZENECA AB |
| EP3454854 | PROCESS FOR SYNTHESIZING 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)-PYRIDIN-3-YL)METHOXY)BENZALDEHYDE | LI ZHE | GLOBAL BLOOD THERAPEUTICS INC |
| EP3454859 | METHODS OF TREATING CIRCADIAN RHYTHM SLEEP DISORDERS | BEUCKMANN CARSTEN T | EISAI R&D MAN CO LTD |
| EP3454867 | FASTING MIMICKING DIET (FMD) AS AN IMMUNOREGULATORY TREATMENT FOR GASTROINTESTINAL AUTOIMMUNE/INFLAMMATORY DISEASES. | LONGO VALTER D | UNIV SOUTHERN CALIFORNIA |
| EP3454879 | NEW COMPOUNDS AND PHARMACEUTICAL USE THEREOF IN THE TREATMENT OF CANCER | SUSIN SANTOS A | INST NAT SANTE RECH MED |
| EP3454887 | TARGETED MUTANT INTERFERON-BETA AND USES THEREOF | KLEY NIKOLAI | ORIONIS BIOSCIENCES NV |
| EP3454888 | BROTH MICRODILUTION METHOD FOR EVALUATING AND DETERMINING MINIMAL INHIBITORY CONCENTRATION OF ANTIBACTERIAL POLYPEPTIDES | SCHUCH RAYMOND | CONTRAFECT CORP |
| EP3454898 | DRUG COMBINATIONS FOR REDUCING CELL VIABILITY AND/OR CELL PROLIFERATION | SELVARAJ ANAND | EISAI R&D MAN CO LTD |
| EP3455203 | VINYLOGOUS PHENETHYLAMINES AS NEUROTRANSMITTER RELEASERS | BLOUGH BRUCE | RES TRIANGLE INST |
| EP3455229 | NOVEL CRYSTALLINE FORMS | HANNA MAZEN | GRUENENTHAL GMBH |
| EP3455248 | ANTIGEN BINDING MOLECULES COMPRISING A TNF FAMILY LIGAND TRIMER AND PD1 BINDING MOIETY | FERRARA KOLLER CLAUDIA | HOFFMANN LA ROCHE |
| EP3455253 | C-TERMINALLY FUSED TNF FAMILY LIGAND TRIMER-CONTAINING ANTIGEN BINDING MOLECULES | BRUENKER PETER | HOFFMANN LA ROCHE |
| EP3455257 | ANTI-PD-L1 ANTIBODIES | KEYT BRUCE | IGM BIOSCIENCES INC |
| EP3455761 | METHODS AND MATERIALS FOR STAGING AND TREATING SKIN CANCER | MEVES ALEXANDER | MAYO FOUND MEDICAL EDUCATION & RES |
| EP3456311 | COSMETIC | FUNABIKI YUHEI | SUMITOMO SEIKA CHEMICALS |
| EP3456330 | CORTEXOLONE 17ALPHA-VALERATE FOR USE IN THE TREATMENT OF TUMOURS | GERLONI MARA | COSMO TECHNOLOGIES LTD |
| EP3456331 | GENE THERAPY FOR NIEMANN-PICK DISEASE TYPE A | PASSINI MARCO A | GENZYME CORP |
| EP3456336 | COMPOUND CELERY SEED AND SOPHORA FLOWER BUD EXTRACT AND MEDICAL USE THEREOF | GAO YONGLIANG | BEIJING HUMANWELL JUNWEI PHARMACEUTICAL TECH CO LTD |
| EP3456339 | NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER INCLUDING NSCLC | FRITSCHE JENS | IMMATICS BIOTECHNOLOGIES GMBH |
| EP3456346 | PD-1 AND LAG-3 BINDING MOLECULES AND METHODS OF USE THEREOF | SHAH KALPANA | MACROGENICS INC |
| EP3456359 | NEUTRON CAPTURE THERAPY COMPOSITION FORMED USING ION IMPLANTATION | NIU HUAN | |
| EP3456710 | NOVEL PROSTAGLANDIN DERIVATIVE | YASUDA ARATA | AGC INC |
| EP3456717 | TABLETS CONTAINING 4,6-DIAMINO-QUINOLINE-3-CARBONITRILE DERIVATIVES AS CANCER OSAKA THYROID (COT) MODULATORS FOR TREATING CANCER | BACON ELIZABETH M | GILEAD SCIENCES INC |
| EP3456718 | ISATIN-DERIVED COMPOUNDS, USE OF THE COMPOUNDS FOR THE TREATMENT OF AIDS AND METHOD OF TREATMENT USING THESE COMPOUNDS | BOECHAT NUBIA | FUND OSWALDO CRUZ FIOCRUZ SUPERINTENDENCIA DE PLANEJAMENTO |
| EP3456720 | NOVEL CRYSTALLINE SALT FORM OF 2,2-DIMETHYL-6-((4-((3,4,5-TRIMETHOXYPHENYL)AMINO)-1,3,5-TRIAZIN-2-YL)AMINO)-2H-PYRIDO[3,2-B][1,4]OXAZIN-3(4H)-ONE FOR MEDICAL APPLICATION | NEBOLSIN VLADIMIR EVGENIEVICH | LIMITED MOLECULAR TECH |
| EP3456721 | METHOD OF PRODUCING COMPOUNDS HAVING HIV INTEGRASE INHIVITORY ACTIVITY | SUMINO YUKIHITO | SHIONOGI & CO |
| EP3456745 | HYALURONIC ACID DERIVATIVE HAVING CATIONIC GROUP AND HYDROPHOBIC GROUP INTRODUCED THEREIN | NAKAI TAKASHI | CHUGAI PHARMACEUTICAL CO LTD |
| EP3457851 | DERIVATIVES OF SOBETIROME | SCANLAN THOMAS | UNIV OREGON HEALTH & SCIENCE |
| EP3458017 | ORAL CARE COMPOSITIONS AND METHODS OF USE | CHEN DANDAN | COLGATE PALMOLIVE CO |
| EP3458018 | COSMETIC COMPOSITION COMPRISING ANIONIC SURFACTANTS, AMPHOTERIC SURFAC-TANTS, CATIONIC POLYMERS AND LIQUID FATTY SUBSTANCES CHOSEN FROM FATTY ALCO-HOLS AND FATTY ESTERS, AND COSMETIC TREATMENT PROCESS | THOMAS BéATRICE | OREAL |
| EP3458019 | PRODUCT FOR THE THERAPY AND PREVENTION OF BURNOUT SYNDROME OF THE SCALP AND THE SKIN | LUTZ BEAT | APOMEDICA SAGL |
| EP3458024 | AQUEOUS SURFACTANT COMPOSITIONS | BRUNN CLAUDIA | BASF SE |
| EP3458030 | LACRIMAL DRUG DELIVERY DEVICE | SCHIEBER ANDY | UNIV COLORADO REGENTS |
| EP3458040 | COMBINATION OF PURE 5-HT6 RECEPTOR ANTAGONISTS WITH NMDA RECEPTOR ANTAGONIST | NIROGI RAMAKRISHNA | SUVEN LIFE SCIENCES LTD |
| EP3458053 | USE OF RILUZOLE, RILUZOLE PRODRUGS OR RILUZOLE ANALOGS WITH IMMUNOTHERAPIES TO TREAT CANCERS | CORIC VLADIMIR | BIOHAVEN PHARM HOLDING CO LTD |
| EP3458057 | PHARMACEUTICAL FORMULATIONS CONTAINING CANNABIDIOL AND NICOTINE FOR TREATING SMOKELESS TOBACCO ADDICTION | WILLIAMS JONNIE R | CV SCIENCES INC |
| EP3458091 | COMBINATION THERAPY WITH NOTCH AND PD-1 OR PD-L1 INHIBITORS | BENDER MARK HARRATH | LILLY CO ELI |
| EP3458109 | OLFACTORY MEANS FOR THE DIAGNOSIS OF NEUROLOGICAL COMPLICATIONS OF NERVOUS SYSTEM INFECTION | LAZARINI-SERANDOUR FRANÇOISE | PASTEUR INSTITUT |
| EP3458111 | PET-IMAGING IMMUNOMODULATORS | DONNELLY DAVID J | SQUIBB BRISTOL MYERS CO |
| EP3458445 | KRAS G12C INHIBITORS | FISCHER JOHN P | MIRATI THERAPEUTICS INC |
| EP3458455 | NOVEL PYRAZINE COMPOUNDS WITH OXYGEN, SULFUR AND NITROGEN LINKER FOR THE TREATMENT OF INFECTIOUS DISEASES | HU TAISHAN | HOFFMANN LA ROCHE |
| EP3458478 | ANTI PD-1 AND ANTI-LAG3 ANTIBODIES FOR CANCER TREATMENT | ZETTL MARKUS | BOEHRINGER INGELHEIM INT |
| EP3458480 | ANTIBODY DIRECTED AGAINST THE ENDOTHELIN RECEPTOR BETA SUB-TYPE | BOQUET DIDIER | COMMISSARIAT ENERGIE ATOMIQUE |
| EP3458485 | TETHERED INTERLEUKIN-2 TO ITS RECEPTOR IL-2RBETA, A PLATFORM TO ENHANCE NATURAL KILLER AND REGULATORY T CELL ACTIVITY | JOUNAIDI YOUSSEF | MASSACHUSETTS GEN HOSPITAL |
| EP3458558 | AQUEOUS SURFACTANT COMPOSITIONS | BRUNN CLAUDIA | BASF SE |
| EP3458594 | VSV/NDV HYBRID VIRUSES FOR ONCOLYTIC THERAPY OF CANCER | EBERT OLIVER | KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIV MUENCHEN |
| EP3459369 | PHARMACEUTICAL COMPOSITION USING LACTOBACILLUS SP. KCCM 11826P STRAIN FOR PREVENTING HYPERPHOSPHATEMIA AND FOR TREATING CHRONIC KIDNEY DISEASE AND HEALTH FUNCTIONAL FOOD | KIM HYO JIN | KOREA FOOD RES INST |
| EP3459522 | USE OF EGG CELLULAR EXTRACTS FOR WOUND TREATMENT | GAMMELSAETER RUNHILD | REGENICS AS |
| EP3459526 | BIOAVAILABLE DITHIOCARBAMATE-METAL COMPLEX NANOPARTICLES, METHOD OF PREPARATION AND USE THEREOF | SKROTT ZDENEK | PALACKY UNIV IN OLOMOUC |
| EP3459537 | APPLICATION OF CLOFOCTOL FOR MANUFACTURING PHARMACEUTICAL PRODUCT FOR TREATING HUMAN NEUROGLIOMA | PENG XIAOZHONG | INST BASIC MEDICAL SCIENCES CAMS |
| EP3459539 | PHARMACEUTICAL FORMULATION FOR DELAYING INCIDENCE AND/OR TREATMENT OF PULMONARY FIBROSIS | SU HONG-LIN | |
| EP3459541 | USE OF CARBAMATE COMPOUND IN ORDER TO PREVENTATIVELY TREAT HEADACHES | SHIN HYE WON | SK BIOPHARMACEUTICALS CO LTD |
| EP3459542 | USE OF CARBAMATE COMPOUND FOR PREVENTING OR TREATING TRIGEMINAL NEURALGIA | JO MIN JAE | SK BIOPHARMACEUTICALS CO LTD |
| EP3459550 | INJECTION COMPOSITION COMPRISING AN IRON DEXTRAN COMPLEX AND VITAMINS FOR PREVENTING AND TREATING ANEMIA | CHERNYSHOVA MARINA PAVLOVNA | OBSHESTVO S OGRANICHENNOJ OTVETSTVENNOSTJU VIKZDOROVE ZHIVOTNYH |
| EP3459554 | YEAST EXTRACT HAVING DIABETES PREVENTION EFFECT | SAIKI TOMOMI | KOHJIN LIFE SCIENCES CO LTD |
| EP3459560 | ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III CHIMERIC ANTIGEN RECEPTORS AND USE OF SAME FOR THE TREATMENT OF CANCER | ROSENBERG STEVEN A | US HEALTH |
| EP3459564 | PLASMA KALLIKREIN BINDING PROTEINS | SEXTON DANIEL J | DYAX CORP |
| EP3459926 | PHENYLATE DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND USES THEREOF | FENG ZHIQIANG | INST MATERIA MEDICA CAMS |
| EP3459937 | THIAZOLE DERIVATIVE AND APPLICATIONS | LI HONGLIN | UNIV EAST CHINA SCIENCE & TECH |
| EP3459944 | AZEPANYL-DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME WITH ANTIPARASITIC ACTIVITY | SPANGENBERG THOMAS | MERCK PATENT GMBH |
| EP3459948 | FLUORINE-CONTAINING TRIAZOLOPYRIDINE, AND MANUFACTURING METHOD, PHARMACEUTICAL COMPOSITION, AND APPLICATION THEREOF | LIU HONG | SHANGHAI INST MATERIA MEDICA CAS |
| EP3459953 | NOVEL 5H-PYRROLO[2,3-D]PYRIMIDIN-6(7H)-ONE DERIVATIVE | SUGIMOTO TETSUYA | TAIHO PHARMACEUTICAL CO LTD |
| EP3459954 | NOVEL POLYMORPH OF TRIAZOLO PYRAZINE DERIVATIVE AND METHOD FOR PREPARING SAME | JEONG SEONG-HOON | ABION INC |
| EP3459978 | COSMETIC FOR CORRECTING BUMPS AND DIPS | MORI RIKAKO | NIKKO CHEMICALS |
| EP3460476 | BIOMARKER COMPOSITION COMPRISING LRP-1 AS ACTIVE INGREDIENT, FOR DIAGNOSIS OF RADIATION-RESISTANT CANCER OR PREDICTION OF RADIATION THERAPY PROGNOSIS | CHOI EUN KYUNG | UNIV ULSAN FOUND IND COOP |
| EP3461472 | SENSITIVE SKIN CLEANSER WITH ENHANCED CLEANING EFFECT | STOLZ HERMANN JOSEF | PETER GREVEN PHYSIODERM GMBH |
| EP3461477 | GASTROINTESTINAL SITE-SPECIFIC ORAL VACCINATION FORMULATIONS ACTIVE ON THE ILEUM AND APPENDIX | SCHENTAG JEROME J | THERABIOME LLC |
| EP3461479 | NUTRACEUTICAL AND PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF FOR PRESERVING COGNITIVE FUNCTIONS | BLIVET JULIE | BLIVET JULIE |
| EP3461812 | N-(5-(BIPHEN-4-YLMETHYLOXY)PENTYL)-SUBSTITUTED IMINOSUGARS AS INHIBITORS OF GLUCOSYLCERAMIDE SYNTHASE | OVERKLEEFT HERMAN STEVEN | ACAD MEDISCH CT |
| EP3461816 | FIVE-MEMBERED HETEROCYLIC COMPOUNDS USEFUL AS MODULATORS OF TRPM8 | CHUMAKOVA LYUDMYLA | SENOMYX INC |
| EP3461824 | BRUTON'S TYROSINE KINASE INHIBITORS | ERLANSON DANIEL A | BIOGEN MA INC |
| EP3461834 | NEUROACTIVE STEROIDS | MARTINEZ BOTELLA GABRIEL | SAGE THERAPEUTICS INC |
| EP3463255 | CERAMIC BLANK FILLED WITH AN ORGANIC COMPOUND AND WITH IMPROVED MACHINING PROPERTIES | WOLDEGERGIS YOHANNES | KULZER & CO GMBH |
| EP3463256 | BIOMIMETIC MINERAL BASED ENDODONTIC CEMENT COMPOSITION AND USES THEREOF | GUZMAN JASON EDWARD | ESSENTIAL DENTAL SYSTEMS INC |
| EP3463268 | BIOPHOTONIC COMPOSITIONS AND USES THEREOF | LOUPIS NIKOLAOS | KLOX TECH LIMITED |
| EP3463269 | HAND DISINFECTANT | ALMAS GEIR HERMOD | WIAB WATER INNOVATION AB |
| EP3463285 | ANTIPERSPIRANT PREPARATION | DÖRING THOMAS | HENKEL AG & CO KGAA |
| EP3463293 | INJECTABLE SOLUTION AT PH 7, COMPRISING AT LEAST ONE BASAL INSULIN WHOSE PI IS BETWEEN 5.8 AND 8.5, A PRANDIAL INSULIN AND/OR A GASTROINTESTINAL HORMONE, AND A COPOLYAMINO ACID BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS | GEISSLER ALEXANDRE | ADOCIA |
| EP3463298 | METRONOMIC ORAL GEMCITABINE FOR CANCER THERAPY | HAO WEI-HUA | |
| EP3463308 | FORMULATIONS OF POLYALKYLENE OXIDE-ASPARAGINASE AND METHODS OF MAKING AND USING THE SAME | FORNASINI GIANFRANCO | SERVIER IP UK LTD |
| EP3463323 | SOLID ORAL DOSAGE FORMS OF 2R,6R-HYDROXYNORKETAMINE OR DERIVATIVES THEREOF | RANDS PETER | SMALL PHARMA LTD |
| EP3463332 | COMPOSITION FOR USE IN THE PROPHYLAXIS OF ALLERGIC DISEASE | ECKHARDT ERIK | NESTEC SA |
| EP3463335 | CANNABIDIOL COMPOSITIONS AND USES THEREOF | AESCHBACH RODIN | PHARMOTECH SA |
| EP3463349 | USE OF SIROLIMUS TO TREAT EXUDATIVE AGE-RELATED MACULAR DEGENERATION WITH PERSISTENT EDEMA | MATURI RAJ K | SANTEN PHARMA CO LTD |
| EP3463365 | ANTIFUNGAL PHARMACEUTICAL FORMULATION | LAW DEREK | F2G LTD |
| EP3463387 | MEDICAMENT FOR THE TREATMENT OF ACUTE LIVER FAILURE | SHARMA AMAR | MEDIZINISCHE HOCHSCHULE HANNOVER |
| EP3463402 | METHODS OF USING PULMONARY CELLS FOR TRANSPLANTATION AND INDUCTION OF TOLERANCE | REISNER YAIR | YEDA RES & DEV |
| EP3463426 | USE OF LA1-LIKE PEPTIDE ISOLATED FROM MAURUS PALMATUS VENOM AS AN ACTIVATOR OF SPERM MOTILITY IN MAMMALS | ARNOULT CHRISTOPHE | IMV TECH |
| EP3463435 | ANTIBODIES TO ALPHA-SYNUCLEIN AND USES THEREOF | PERKINTON MICHAEL | MEDIMMUNE LTD |
| EP3463482 | COMPOSITIONS AND METHODS RELATING TO T PERIPHERAL HELPER CELLS IN AUTOANTIBODY-ASSOCIATED CONDITIONS | BRENNER MICHAEL B | BRIGHAM & WOMENS HOSPITAL INC |
| EP3463574 | COMPOSITIONS AND METHODS FOR TREATING PULMONARY VASCULAR DISEASE | CHAN STEPHEN Y | UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION |
| EP3463583 | PASTE-LIKE HAIR BLEACHING AGENTS | ANDERHEGGEN BERND | HENKEL AG & CO KGAA |
| EP3464248 | 3-OXO-2,6-DIPHENYL-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDES | SCHMEES NORBERT | BAYER PHARMA AG |
| EP3464249 | SUBSTITUTED CARBONUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS | KUMPF ROBERT ARNOLD | PFIZER |
| EP3464260 | UREA MOTIF CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS ANTIBACTERIAL DRUGS | KLEINER PHILIPP | UNIV MUENCHEN TECH |
| EP3464266 | SUBSTITUTED INDAZOLES USEFUL FOR TREATMENT AND PREVENTION OF ALLERGIC AND/OR INFLAMMATORY DISEASES IN ANIMALS | BEDDIES GERALD | BAYER ANIMAL HEALTH GMBH |
| EP3464272 | NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS | MA CUNBO | JACOBIO PHARMACEUTICALS CO LTD |
| EP3464276 | NEW CRYSTALLINE FORM OF N-[5-(3,5-DIFLUORO-BENZYL)-1H-INDAZOL-3-YL]-4-(4-METHYL-PIPERAZIN-1-YL)-2-(TETRAHYDRO-PYRAN-4-YLAMINO)-BENZAMIDE | CANDIANI ILARIA | NERVIANO MEDICAL SCIENCES SRL |
| EP3464278 | XANTHONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE | CHEN DONGDONG | HOFFMANN LA ROCHE |
| EP3464279 | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | LU LIANG | INCYTE CORP |
| EP3464280 | SILVESTROL ANTIBODY-DRUG CONJUGATES AND METHODS OF USE | PILLOW THOMAS | HOFFMANN LA ROCHE |
| EP3464286 | PYRAZOLOPYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER | CYR PATRICK | GENENTECH INC |
| EP3464289 | ULTRA-POTENT VINCA ALKALOIDS: ADDED MOLECULAR COMPLEXITY FURTHER DISRUPTS THE TUBULIN DIMER-DIMER INTERFACE | BOGER DALE L | SCRIPPS RESEARCH INST |
| EP3464318 | GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF | MCPHERSON MICHAEL J | ABBVIE INC |
| EP3464338 | MODIFIED RNA ENCODING VEGF-A POLYPEPTIDES, FORMULATIONS, AND USES RELATING THERETO | PARINDER LEIF KARLSSON | MODERNATX INC |
| EP3464354 | ANTIBODIES THAT BIND TO HUMAN ANTI-M脺LLERIAN HORMONE (AMH) AND THEIR USES | KOHLMANN ANGELICA | KOHLMANN ANGELICA |
| EP3464361 | ANTI-CD40 ANTIBODIES AND THEIR USES | HOLLENBAUGH DIANE | ABBVIE BIOTHERAPEUTICS INC |
| EP3464373 | USE OF ANTI-PD-1 ANTIBODY IN THE TREATMENT OF PATIENTS WITH COLORECTAL CANCER | AXELSON MICHAEL | SQUIBB BRISTOL MYERS CO |
| EP3464563 | ALTERED ADHERENT STROMAL CELLS AND METHODS OF PRODUCING AND USING SAME | ABRAHAM EYTAN | PLURISTEM LTD |
| EP3464571 | METHODS FOR ISOLATING ADENO-ASSOCIATED VIRUS USING A POLYDIALLYLDIALKYLAMMONIUM SALT | DONG WENLING | LONZA HOUSTON INC |
| EP3466264 | METHODS FOR DRUG DELIVERY COMPRISING UNFOLDING AND FOLDING PROTEINS AND PEPTIDE NANOPARTICLES | HU YIQIAO | UNIV NANJING |
| EP3466399 | LIQUID DISPERSION AND USES THEREOF | ASHIDA TAKURO | SAKAI CHEMICAL INDUSTRY CO |
| EP3466400 | COMPOSITION FOR ORAL CAVITY | TAKAHASHI NORITAKA | KAO CORP |
| EP3466414 | USE OF NOOTKATONE | DAI HAOFU | INST OF TROPICAL BIOSCIENCE AND BIOTECHNOLOGY |
| EP3466423 | TREATMENT OF CANCER WITH TOR KINASE INHIBITORS | XU SHUICHAN | SIGNAL PHARM LLC |
| EP3466437 | PERINATAL DISEASE PREVENTIVE OR THERAPEUTIC AGENT FOR RUMINANT | KANEDA KOICHI | IDEMITSU KOSAN CO |
| EP3466939 | NEW DAPAGLIFLOZIN CRYSTAL FORM AND PREPARATION METHOD AND USE THEREOF | LI XIANG | JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD |
| EP3466940 | CRYSTAL FORM OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR | SHU CHUTIAN | HAINAN XUANZHU PHARMA CO LTD |
| EP3466948 | FUSED PYRIMIDINOPIPERIDINE DERIVATIVE, AND MANUFACTURING METHOD AND APPLICATION THEREOF | KUANG RONGREN | SHANGHAI ALLIST PHARMACEUTICAL AND MEDICAL TECH CORPORATIONS |
| EP3466950 | NOVEL BETA-LACTAMASE INHIBITORS | HU BOYU | MEDSHINE DISCOVERY INC |
| EP3466952 | NOVEL INHIBITOR FOR FLT3 KINASE AND USES THEREOF | LIU QINGSONG | PRECEDO PHARMACEUTICALS CO LTD |
| EP3466953 | PYRROLO[2,3-D]PYRIMIDINE DERIVATIVE AS JANUS KINASE INHIBITOR | RODGERS JAMES D | INCYTE HOLDINGS CORP |
| EP3466976 | ANTI-HER2 ANTIBODY-DRUG CONJUGATE | NAITO HIROYUKI | DAIICHI SANKYO CO LTD |
| EP3467102 | COMPOSITION COMPRISING FUSION PROTEIN OF RV2299C AND ESAT-6 FOR PROMOTING MATURATION OF DENDRITIC CELL | KIM HWA-JUNG | QURATIS INC |
| EP3467111 | LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHY | THUM THOMAS | MEDIZINISCHE HOCHSCHULE HANNOVER |
| EP3468526 | FRAGRANCE MATERIAL | LANKIN MICHAEL E | TAKASAGO PERFUMERY CO LTD |
| EP3468527 | FRAGRANCE MATERIAL | LOMBARDO LOUIS J | TAKASAGO PERFUMERY CO LTD |
| EP3468528 | PERSONAL CARE COMPOSITION | MENG SHENG | UNILEVER NV |
| EP3468529 | SUNBLOCK FORMULATION COMPRISING HIGH LINOLEIC ACID NATURAL OILS AND METHOD OF PREPARING | FICKO MAJDA | FICKO MAJDA |
| EP3468533 | NANOSTRAW WELL INSERT DEVICES FOR IMPROVED CELL TRANSFECTION AND VIABILITY | SWOBODA RYAN T | UNIV LELAND STANFORD JUNIOR |
| EP3468541 | ACTIVE AGENTS AGAINST PROTOZOA | BEITZ PROF DR ERIC | UNIV KIEL CHRISTIAN ALBRECHTS |
| EP3468542 | SELF EMULSIFYING AND GASTRO-RESISTANT FAT BASED MATRIX AND PREPARATION METHOD THEREOF | BERTIN WALTER | LABOMAR S R L |
| EP3468547 | NOVEL BENZENESULFONAMIDE COMPOSITIONS FOR TREATMENT OF MALIGNANT PLEURAL EFFUSIONS | YANG CHUAN-CHING | WU LESTER |
| EP3468548 | METHODS OF TREATING PANCREATIC CANCER | BEKKER PETRUS | CHEMOCENTRYX INC |
| EP3468577 | PRION PROTEIN-DENDRIMER CONJUGATES FOR USE IN TREATMENT OF ALZHEIMER DISEASE | NIEZNANSKI KRZYSZTOF | INST BIOLOGII DOSWIADCZALNEJ IM MARCELEGO NENCKIEGO |
| EP3468583 | COMPOSITION COMPRISING AT LEAST ONE ENZYME AND AT LEAST ONE MICROBICIDAL MOLECULE FOR THE PREVENTION OR TREATMENT OF POST-IMPLANT INFECTIONS | SIALA M WAFI | ONELIFE S A |
| EP3468604 | PHARMACEUTICAL COMBINATIONS FOR TREATING CANCER | BAUSCH ALEXANDER | SUPPORT VENTURE GMBH |
| EP3468620 | 18 F-LABELED BISPHOSPHONATES FOR PET IMAGING | MCKENNA CHARLES E | UNIV SOUTHERN CALIFORNIA |
| EP3468949 | CRYSTALLINE PHARMACEUTICAL CO-CRYSTALS OF GLYCOPYRRONIUM BROMIDE WITH LACTOSE | MENDES ZITA | HOVIONE SCIENTIA LTD |
| EP3468955 | 5-[3-[PIPERAZIN-1-YL]-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAMTS 4 AND 5 INHIBITORS FOR TREATING E.G. OSTEOARTHRITIS | LABéGUèRE FRéDéRIC GILBERT | GALAPAGOS NV |
| EP3468956 | 6-HYDROXY-5-(PHENYL/HETEROARYLSULFONYL)PYRIMIDIN-4(1H)-ONE AS APJ AGONISTS | TORA GEORGE O | SQUIBB BRISTOL MYERS CO |
| EP3468963 | DIHYDROPYRIMIDINYL BENZAZEPINE CARBOXAMIDE COMPOUNDS | DEY FABIAN | HOFFMANN LA ROCHE |
| EP3468977 | FXR (NR1H4) MODULATING COMPOUNDS | GEGE CHRISTIAN | GILEAD SCIENCES INC |
| EP3469070 | HERPESVIRUS WITH MODIFIED GLYCOPROTEIN B | CAMPADELLI MARIA GABRIELLA | UNIV BOLOGNA ALMA MATER STUDIORUM |
| EP3469072 | HERPESVIRUS WITH MODIFIED GLYCOPROTEIN H FOR PROPAGATION IN A CELL | NICOSIA ALFREDO | UNIV BOLOGNA ALMA MATER STUDIORUM |
| EP3469907 | SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS | SELNESS SHAUN R | ACLARIS THERAPEUTICS INC |
| EP3470048 | PHOTOCURABLE DENTAL COMPOSITION | SZILLAT FLORIAN | DENTSPLY DETREY GMBH |
| EP3470057 | CATIONIC DRY POWDERS COMPRISING MAGNESIUM SALT | LIPP MICHAEL M | PULMATRIX OPERATING CO INC |
| EP3470070 | METHODS AND MATERIALS FOR TREATING CALCIFIC AORTIC VALVE STENOSIS | MILLER JORDAN D | MAYO FOUND MEDICAL EDUCATION & RES |
| EP3470373 | ZINC OXIDE POWDER, DISPERSION, AND COSMETICS | SUMA SYUNSUKE | SUMITOMO OSAKA CEMENT CO LTD |
| EP3470402 | CRYSTALLINE FORMS OF NEUROTROPHIN MIMETIC COMPOUNDS AND THEIR SALTS | MUNIGETI RAJGOPAL | PHARMATROPHIX INC |
| EP3470408 | PREPARATION METHOD FOR 2-AMINO-3-SUBSTITUTED MERCAPTOPROPIONATE DERIVATIVE AND USE THEREOF | ZHONG JUN | JIANGSU TASLY DIYI PHARMACEUTICAL CO LTD |
| EP3470432 | METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST | ARDELENAU MARIUS | SANOFI BIOTECHNOLOGY |
| EP3471544 | MODIFIED DYSTROPHIN PROTEINS | DUAN DONGSHENG | UNIV MISSOURI |
| EP3471687 | APPLICATOR FOR PERSONAL CARE | SUTTON SIMON NICHOLAS | AVON PROD INC |
| EP3471691 | MIXTURE COMPRISING AT LEAST DIHYDRO-5-PENTYL-2(3H)-FURANONE AND 2,4-DIMETHYL-4-PHENYLTETRAHYDROFURAN AND USE THEREOF FOR MASKING UNPLEASANT ODOURS | MARIN CHRISTOPHE | EXPRESSIONS PARFUMEES |
| EP3471702 | THERMOSTABLE FORMULATION OF BIOLOGICALLY ACTIVE SUBSTANCES | GIZURARSON SVEINBJORN | CAPRETTO EHF |
| EP3471721 | TREATMENT OF VASCULAR CALCIFICATION | DUER MELINDA | CAMBRIDGE ENTPR LTD |
| EP3471730 | PHARMACEUTICAL SALTS OF N-(2-(2-(DIMETHYLAMINO)ETHOXY)-4-METHOXY-5-((4-(1-METHYL-1H-INDOL-3-YL)PYRIMIDIN-2-YL)AMINO)PHENYL)ACRYLAMIDE AND CRYSTALLINE FORMS THEREOF | GRECO MICHAEL NICHOLAS | BETA PHARMA INC |
| EP3472153 | PYRIMIDIN-2-YLAMINO-1H-PYRAZOLS AS LRRK2 INHIBITORS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISORDERS | ESTRADA ANTHONY A | DENALI THERAPEUTICS INC |
| EP3472160 | BICYCLIC PYRIDINE, PYRAZINE, AND PYRIMIDINE DERIVATIVES AS PI3K BETA INHIBITORS | BERTHELOT DIDIER JEAN-CLAUDE | JANSSEN PHARMACEUTICA NV |
| EP3472162 | HETEROARYL ESTROGEN RECEPTOR MODULATORS AND USES THEREOF | GOODACRE SIMON CHARLES | HOFFMANN LA ROCHE |
| EP3472207 | BINDING MOLECULES BINDING PD-L1 AND LAG-3 | CAMPBELL JAMIE | F STAR DELTA LTD |
| EP3473236 | MICROGELS FOR THE DELIVERY OF COSMETIC ACTIVE ORGANIC SUBSTANCES | ALARD VALéRIE | LVMH RECH |
| EP3473238 | POWDER HAIR DYE COMPOSITION | FUTATSUGI SHIZUKA | HOYU KK |
| EP3473258 | DIARRHEA-PREVENTING NUTRITIONAL COMPOSITION | HINO KAZUO | OTSUKA PHARMA FACTORY INC |
| EP3473263 | COMBINED PREPARATIONS FOR THE TREATMENT OF CANCER OR INFECTION | TRIEBEL FRéDéRIC | IMMUTEP SAS |
| EP3473264 | USE OF THE BASIC FORM OF RECOMBINANT HUMAN ERYTHROPOIETIN IN THE TREATMENT OF PATIENTS WITH SPINOCEREBELLAR ATAXIA WITH CAG REPEAT MUTATIONS | AMARO GONZáLEZ DANIEL ENRIQUE | CT INMUNOLOGIA MOLECULAR |
| EP3473267 | INDIVIDUALIZED VACCINES FOR CANCER | SAHIN UGUR | BIONTECH RNA PHARMACEUTICALS GMBH |
| EP3473611 | TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF | HEYES JAMES | ARBUTUS BIOPHARMA CORP |
| EP3473626 | PYRROLOPYRIMIDINE CRYSTAL FOR PREPARING JAK INHIBITOR | ZHOU ZHOU | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD |
| EP3473630 | BORON-BASED PRODRUG STRATEGY FOR INCREASED BIOAVAILABILITY AND LOWER-DOSAGE REQUIREMENTS FOR DRUG MOLECULES CONTAINING AT LEAST ONE PHENOL (OR AROMATIC HYDROXYL) GROUP | WANG GUANGDI | XAVIER UNIV OF LOUISIANA |
| EP3473648 | HUMAN ANTIBODIES TO PD-L1 | PAPADOPOULOS NICHOLAS J | REGENERON PHARMA |
| EP3473708 | ONCOLYTIC VIRUS THERAPY FOR RESISTANT TUMORS | SHAH KHALID | MASSACHUSETTS GEN HOSPITAL |
| EP3474825 | SUSTAINED RELEASE FORMULATION COMPRISING TIZANIDINE | ILHAN DOGA | SANTA FARMA ILAC SANAYI A S |
| EP3474858 | TWO-COMPONENT COMPOSITION | FREDRIKSON JOHN BJØRN | ASAMEDIC AS |
| EP3474860 | ANTIMICROBIAL COMPOUNDS AND METHODS OF USE | BURZELL CYNTHIA K | AEQUOR INC |
| EP3474886 | METHODS FOR TREATING HYPOPHOSPHATASIA IN CHILDREN AND ADOLESCENTS | FUJITA KENJI | ALEXION PHARMA INC |
| EP3474891 | VACCINE COMPOSITIONS COMPRISING AN ATTENUATED MUTANT ZIKA VIRUS | DESPRES PHILIPPE | INST NAT SANTE RECH MED |
| EP3474897 | CILASTATIN FOR USE IN THE TREATMENT OF SEPSIS | TEJEDOR JORGE ALBERTO | FUNDACION PARA LA INVESTIG BIOMEDICA DEL HOSPITAL GREGORIO MARANON |
| EP3474902 | PHARMACEUTICAL COMPOSITION COMPRISING FLUORINE-18 LABELLED GASES | LLOP ROIG JORDI | ASOCIACION CENTRO DE INVESTIG COOPERATIVA EN BIOMATERIALES CIC BIOMAGUNE |
| EP3474947 | MAGNETIC FIELD OSCILLATING AT SEVERAL FREQUENCIES FOR IMPROVING EFFICACY AND/OR REDUCING TOXICITY OF MAGNETIC HYPERTHERMIA | ALPHANDéRY EDOUARD | NANOBACTERIE |
| EP3474952 | COMPOSITIONS CONTAINING LATEX PARTICLES AND UV ABSORBERS | SHULMAN INNA | ROHM & HAAS |
| EP3475262 | BICYCLIC IMIDAZOLE DERIVATIES USEFUL FOR THE TREATMENT OF RENAL DISEASE, CARDIOVASCULAR DISEASES AND FIBROTIC DISORDERS | MCKIBBEN BRYAN P | BOEHRINGER INGELHEIM INT |
| EP3475276 | THIAZOLE DERIVATIVES USEFUL AS MUTANT IDH1 INHIBITORS FOR TREATING CANCER | BOXER MATTHEW BRIAN | US HEALTH |
| EP3475277 | ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF | KIRSEBOM LEIF | BIOIMICS AB |
| EP3475279 | TRIAZOLOPYRIDINES AS GAMMA-SECRETASE MODULATORS | BARTELS BJOERN | HOFFMANN LA ROCHE |
| EP3475283 | NOVEL[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES | GOBBI LUCA | HOFFMANN LA ROCHE |
| EP3475303 | ANTI-CD19 ANTIBODY FORMULATIONS | GARIDEL PATRICK | MORPHOSYS AG |
| EP3475425 | TREATMENTS OF NON-ALCOHOLIC STEATOHEPATITIS (NASH) | HEIKENWÄLDER MATHIAS | DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS |
| EP3475433 | ADENOVIRAL VECTOR | GILBERT SARAH C | UNIV OXFORD INNOVATION LTD |
| EP3476381 | EXTERNAL PREPARATION FOR SKIN FOR WRINKLE IMPROVEMENT | HINOKITANI TOSHIHIRO | POLA CHEM IND INC |
| EP3476382 | AGENT FOR TREATING POWDER FOR COSMETIC, POWDER FOR COSMETIC, AND COSMETIC FORMULATED USING SAID POWDER | KISHIMOTO NORIHISA | DOW CORNING TORAY CO LTD |
| EP3476388 | COMPOSITION COMPRISING COENZYME Q10 AND PIPERINE | MARINI DANIELE | DIFASS INT S R L |
| EP3476391 | PHARMACEUTICAL COMPOSITION | NAGAI YOSHITAKA | JAPAN SCIENCE & TECH AGENCY |
| EP3476395 | COMPOSITION FOR INJECTION WHICH CAN BE USED FOR TREATMENT OF HEART DISEASES AND CONTAINS FIBROBLASTS, AND METHOD FOR PRODUCING FIBROBLAST FOR THERAPY USE | IWAMIYA TAKAHIRO | METCELA INC |
| EP3476397 | NOVEL COMPOSITION AND METHOD OF USING THE SAME | RATH MATTHIAS | RATH MATTHIAS W |
| EP3476398 | PREVENTATIVE AND/OR THERAPEUTIC AGENT FOR OSTEOGENESIS IMPERFECTA AND THE LIKE | SUZUKI CHIHIRO | PHARMA FOODS INT CO LTD |
| EP3476410 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING TISSUE INJURY AND DISEASE | PETERSON DALE R | MICROVASCULAR TISSUES INC |
| EP3476829 | BIARYL UREA DERIVATIVE OR SALT THEREOF, AND MANUFACTURING AND APPLICATION OF SAME | WANG YONGHUI | UNIV FUDAN |
| EP3476831 | CRYSTAL FORM OF 9-AMINOMETHYL SUBSTITUTED TETRACYCLINE COMPOUNDS AND PREPARATION METHOD THEREFOR | HUANG ZHENHUA | KBP BIOSCIENCES CO LTD |
| EP3476854 | LIVER DELIVERY-BASED ANTIVIRAL PRECURSOR DRUG NUCLEOSIDE CYCLOPHOSPHATE COMPOUND AND USE THEREOF | XI ZHIJIAN | ZHEJIANG PALOALTO PHARMACEUTICAL TECH CO LTD |
| EP3478276 | METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA) | HAZEN STANLEY LEON | PROCTER & GAMBLE |
| EP3478277 | ANTI-ACNE COMPOSITIONS AND METHODS OF USE | ROBERT VALERIE A | OREAL |
| EP3478309 | NOVEL SILYBUM MARIANUM ACHENE EXTRACT AND USES THEREOF IN DERMATOLOGY AND DERMO-COSMETICS | SAURAT JEAN-HILAIRE | FABRE PIERRE DERMO COSMETIQUE |
| EP3478326 | BIOCOMPATIBLE POLYMERIC NANOPARTICLES CONTAINING FUNCTIONAL METAL NANOSTRUCTURES, PREPARATION PROCESS AND RELATIVE USE IN THE DIAGNOSTIC AND/OR THERAPEUTIC FIELD | COMES FRANCHINI MAURO | BIO ON SPA |
| EP3478658 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR POTENTIATING GENE SILENCING | LEE DONGKI | OLIX PHARMACEUTICALS INC |
| EP3478677 | 1 H-PYRAZOL-1 -YL-THIAZOLES AS INHIBITORS OF LACTATE DEHYDROGENASE AND METHODS OF USE THEREOF | MALONEY DAVID J | US HEALTH |
| EP3478679 | 5,7-DIHYDRO-PYRROLO-PYRIDINE DERIVATIVES FOR TREATING NEUROLOGICAL AND NEURODEGENERATIVE DISEASES | ZHANG LEI | PFIZER |
| EP3478682 | [1,2,4]TRIAZOLO[1,5-A]PYRIDINYL SUBSTITUTED INDOLE COMPOUNDS | DYCKMAN ALARIC J | SQUIBB BRISTOL MYERS CO |
| EP3478683 | DIAZEPINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF HEPATITIS B INFECTIONS | KUDUK SCOTT | NOVIRA THERAPEUTICS INC |
| EP3478693 | BORONIC ACID DERIVATIVES AND THERAPEUTIC USES THEREOF | HECKER SCOTT | QPEX BIOPHARMA INC |
| EP3478710 | FUSION PROTEIN FOR USE IN THE TREATMENT OF HVG DISEASE | JÄCKEL ELMAR | MEDIZINISCHE HOCHSCHULE HANNOVER |
| EP3478719 | USE OF ANTI-SCLEROSTIN ANTIBODIES IN THE TREATMENT OF OSTEOGENESIS IMPERFECTA | JUNKER UWE | MEREO BIOPHARMA 3 LTD |
| EP3478843 | OLIGONUCLEOTIDES COMPRISING MODIFIED NUCLEOSIDES | CARTER JEFF | SOMALOGIC INC |
| EP3478893 | MULTI-DENSITY PAPER PRODUCTS COMPRISING CELLULOSE NANOFILAMENTS | ZIEGENBEIN TOBIAS | MERCER INT INC |
| EP3479820 | THERMOSENSITIVE NANO-CAPSULE AND PREPARATION METHOD THEREFOR | LU XIHUA | ANHUI MICRODELIVERY SMART MICROCAPSULE SCI & TECH CO LTD |
| EP3479825 | PDE1 INHIBITORS FOR USE IN THE TREATMENT AND/OR PREVENTION OF CNS OR PNS DISEASES OR DISORDERS | WENNOGLE LAWRENCE | INTRA CELLULAR THERAPIES INC |
| EP3479826 | APPLICATION OF METHYL 4-[9-(6-AMINOPURYL)]-2(S)-HYDROXYBUTYRATE IN PREPARATION OF MEDICAMENT FOR TREATING PSORIASIS AND VITILIGO | ZUO JIANPING | SHANGHAI INST MATERIA MEDICA CAS |
| EP3479863 | COMPOSITIONS, METHODS AND ARTICLES CONCERNING PHARMACEUTICAL NITRIC OXIDE AND CONTROLLED PATIENT DELIVERY SYSTEMS THEREOF | DUMPIT RONALD | INO THERAPEUTICS LLC |
| EP3480167 | TITANIUM OXIDE PARTICLES, AND TITANIUM OXIDE PARTICLE DISPERSION AND COSMETICS USING SAME | YAKUBO TEPPEI | SUMITOMO OSAKA CEMENT CO LTD |
| EP3480198 | NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | YOSHIDA MINORU | RIKEN |
| EP3480199 | IMIDAZOPYRIDINAMINE PHENYL DERIVATIVE AND USE THEREOF | YIN JIANMING | HANGZHOU SANYINTAI PHARMACEUTICAL TECH CO LTD |
| EP3480215 | ANTI-HER2 ANTIBODY AND CONJUGATE THEREOF | FANG JIANMIN | REMEGEN LTD |
| EP3480307 | NEW GENETICALLY-MODIFIED VACCINIA VIRUS | NAKAO SHINSUKE | ASTELLAS PHARMA INC |
| EP3481182 | PROBIOTIC BACTERIA FOR FISH | SØRUM HENNING | PREVIWO AS |
| EP3481365 | SOLUBILIZING AGENTS FOR UV FILTERS IN COSMETIC FORMULATIONS | BEHLER ANSGAR | BASF SE |
| EP3481370 | PHARMACEUTICAL COMPOSITION COMPRISING BENZYDAMINE | FAZIO ANTONELLO | ACRAF |
| EP3481392 | ACC INHIBITORS FOR USE IN TREATING MYCOBACTERIAL DISEASES | REILING NORBERT | FORSCHUNGSZENTRUM BORSTEL LEIBNIZ ZENTRUM FUER MEDIZIN UND BIOWISSENSCHAFTEN |
| EP3481393 | COMBINATION OF A PD-l ANTAGONIST AND A RAF INHIBITOR FOR TREATING CANCER | SONG JING | BEIGENE LTD |
| EP3481414 | FORMULATIONS OF ABALOPARATIDE, TRANSDERMAL PATCHES THEREOF, AND USES THEREOF | HATTERSLEY GARY | RADIUS HEALTH INC |
| EP3481428 | ADHESIVE ORAL DISSOLVED FILMS IN MANAGING ORAL CARE | RUBIN YORAM | PHARMEDICA LTD |
| EP3481507 | COSMETIC COMPOSITION COMPRISING A PARTICULAR COMBINATION OF SURFACTANTS, A SILICONE, A CATIONIC POLYMER, A FATTY ALCOHOL AND A CLAY | ROY DHIMOY | OREAL |
| EP3481815 | 1,3-DIHYDROXY-PHENYL DERIVATIVES USEFUL AS IMMUNOMODULATORS | YEUNG KAP-SUN | SQUIBB BRISTOL MYERS CO |
| EP3481824 | 2-PHENYLIMIDAZO[4,5-B]PYRIDIN-7-AMINE DERIVATES USEFUL AS INHIBITORS OF MAMMALIAN TYROSINE KINASE ROR1 ACTIVITY | MELLSTEDT HÅKAN | KANCERA AB |
| EP3481826 | TYROSINE KINASE INHIBITORS | HOLLAND SACHA | RIGEL PHARMACEUTICALS INC |
| EP3481827 | IMIDAZO[1,2-A]PYRIDINE DERIVATIVES, METHODS FOR PREPARING THE SAME AND USE THEREOF | KIM JEONGMIN | JEIL PHARMACEUTICAL CO LTD |
| EP3481829 | FUSED PYRIMIDINE DERIVATIVES | BARTELS BJOERN | HOFFMANN LA ROCHE |
| EP3481846 | OXYSTEROLS AND METHODS OF USE THEREOF | SALITURO FRANCESCO G | SAGE THERAPEUTICS INC |
| EP3482652 | COSMETIC | YAMANAKA REIKO | TAIKI CORP LTD |
| EP3482753 | COMPOSITIONS, METHODS AND USES FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS BY CONTROLLING BLOOD GLUCOSE LEVEL | COHEN DANIEL | PHARNEXT |
| EP3482760 | COMBINATION COMPRISING EP4 ANTAGONIST AND IMMUNE CHECKPOINT INHIBITOR | YOSHIDA TAKAO | ONO PHARMACEUTICAL CO |
| EP3482764 | INSECT AND/OR SPIDER REPELLENT COMPRISING BLACK CUMIN OIL | GALLREIN ANDREAS | ANTON HUEBNER GMBH & CO KG |
| EP3482767 | DOSE ESCALATION ENZYME REPLACEMENT THERAPY FOR TREATING ACID SPHINGOMYELINASE DEFICIENCY | SCHUCHMAN EDWARD H | ICAHN SCHOOL MED MOUNT SINAI |
| EP3483149 | BENZO[D]THIAZOLE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME | OH SE-WOONG | YUHAN CORP |
| EP3483162 | N-ALKYLSULFONYL-FUSED HETEROCYCLIC COMPOUND OR SALT THEREOF, PESTICIDE CONTAINING SAID COMPOUND, AND METHOD FOR USING SAID PESTICIDE | ABE YUTAKA | NIHON NOHYAKU CO LTD |
| EP3483163 | TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES AS CB2 RECEPTOR ANTAGONISTS | ROEVER STEPHAN | HOFFMANN LA ROCHE |
| EP3483169 | CRYSTAL OF CYCLIC PHOSPHONIC ACID SODIUM SALT AND METHOD FOR MANUFACTURING SAME | YUASA HIROAKI | OTSUKA CHEMICAL CO LTD |
| EP3483183 | IMMUNOCONJUGATE COMPRISING HUMANISED RS7 ANTIBODIES | GOVINDAN SERENGULAM V | IMMUNOMEDICS INC |
| EP3483192 | N-VINYL LACTAM-BASED CROSSLINKED POLYMER, COSMETIC, ABSORBENT AGENT FOR INK, AND ABSORBENT COMPOSITE | IKEMOTO YUI | NIPPON CATALYTIC CHEM IND |
| EP3483262 | SMALL MOLECULE COMPOUND COMBINATION FOR REPROGRAMMING DIGESTIVE TRACT DERIVED EPITHELIAL CELLS TO ENDODERMAL STEM/PROGENITOR CELLS, REPROGRAMMING METHOD AND APPLICATION | WANG YUNFANG | INST OF TRANSFUSION MEDICINE ACADEMY OF MILITARY MEDICAL SCIENCES PEOPLES LIBERATION ARMY OF CHINA |
| EP3484437 | DENTIFRICE INCLUDING ZINC AND BLUE DYE OR PIGMENT | KOCINSKA AGNIESZKA | COLGATE PALMOLIVE CO |
| EP3484445 | FORMULATION FOR ADMINISTRATION OF RNA | SAHIN UGUR | BIONTECH RNA PHARMACEUTICALS GMBH |
| EP3484454 | BI-DOTA COMPLEX-LOADED DENDRITIC POLYMER NANOPARTICLES | PEREZ JESUS MANUEL | UNIV CENTRAL FLORIDA RES FOUND INC |
| EP3484471 | METHOD FOR PRODUCING A POLYMORPHIC FORM OF 3-[5-AMINO-4-(3- CYANOBENZOYL)-PYRAZOL-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMIDE | SULEIMAN OSAMA | MEREO BIOPHARMA 1 LTD |
| EP3484476 | MECLOZINE DERIVATIVES AND DICLAZURIL DERIVATIVES FOR USE IN THE PREVENTION AND/OR THE TREATMENT OF DISORDERS ASSOCIATED TO THE INFLAMMATION INDUCED BY P. ACNES | DUPIN NICOLAS | UNIV PARIS DESCARTES |
| EP3484480 | THE USE OF HOMOSALATE AND OCTYL SALICYLATE TO TREAT MULTIPLE SCLEROSIS | DELUCA HECTOR F | WISCONSIN ALUMNI RES FOUND |
| EP3484481 | METHODS FOR TREATMENT OFCLOSTRIDIUM DIFFICILE | JANDA KIM D | SCRIPPS RESEARCH INST |
| EP3484495 | NOVEL FATTY ACID MODIFIED UROCORTIN-2 ANALOGS FOR THE TREATMENT OF DIABETES AND CHRONIC KIDNEY DISEASE | ALSINA-FERNANDEZ JORGE | LILLY CO ELI |
| EP3484502 | BLOOD PLASMA FRACTIONS AS A TREATMENT FOR AGING-ASSOCIATED COGNITIVE DISORDERS | BELL DAVID | ALKAHEST INC |
| EP3484521 | POLY(L-LYSINE ISOPHTHALAMIDE) (PLP) POLYMERS WITH HYDROPHOBIC PENDANT CHAINS | CHEN RONGJUN | IMP INNOVATIONS PLC |
| EP3484585 | USE OF PROBIOTICS IN THE TREATMENT AND/OR PREVENTION OF ATOPIC DERMATITIS | NAVARRO LóPEZ VICENTE MANUEL | BIONOU RES S L |
| EP3484587 | COMBINATION COMPRISING ZIDOVUDINE AND A CARBAPENEM | COATES ANTHONY | HELPERBY THERAPEUTICS LTD |
| EP3484589 | AQUEOUS ORAL CARE FLUORIDE TREATMENT COMPOSITIONS, AND METHODS | WANG YIZHONG | 3M INNOVATIVE PROPERTIES CO |
| EP3484853 | METHOD FOR PRODUCING A POLYMORPHIC FORM OF 3-[5-AMINO-4-(3-CYANOBENZOYL)-PYRAZOL-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMIDE | SULEIMAN OSAMA | MEREO BIOPHARMA 1 LTD |
| EP3484854 | APOPTOSIS INHIBITORS | ZHANG ZHIYUAN | NAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING |
| EP3484859 | NEW DIFLUOROKETAMIDE DERIVATIVES AS HTRA1 INHIBITORS | MAERKI HANS P | HOFFMANN LA ROCHE |
| EP3484862 | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING A SYMPTON ASSOCIATED WITH GOUT OR HYPERURICEMIA | YAN SHUNQI | ARTHROSI THERAPEUTICS INC |
| EP3484867 | INHIBITORS OF TRYPTOPHAN 2,3-DIOXYGENASE | DE MAN ADRIANUS PETRUS ANTONIUS | NETHERLANDS TRANSLATIONAL RES CENTER B V |
| EP3484875 | PYRAZOLYLAMINOBENZIMIDAZOLE DERIVATIVES AS JAK INHIBITORS | BASTIAN JOLIE ANNE | LILLY CO ELI |
| EP3484884 | FUSED PYRIMIDINE DERIVATIVES | BARTELS BJOERN | HOFFMANN LA ROCHE |
| EP3484909 | ANTISECRETORY FACTOR 17 | LANGE STEFAN | LANTMAENNEN AS FAKTOR AB |
| EP3484916 | ANTIBODIES SPECIFIC FOR HYPERPHOSPHORYLATED TAU AND METHODS OF USE THEREOF | PEDERSEN JAN TORLEIF | H LUNDBECK AS |
| EP3485040 | B-CELL-MIMETIC CELLS | FUSSENEGGER MARTIN | ETH ZUERICH |
| EP3485869 | USE OF PHYTANTRIOL AS AN ANTIMICROBIAL AGENT | MENDROK-EDINGER CHRISTINE | DSM IP ASSETS BV |
| EP3485886 | ORAL PHARMACEUTICAL COMPOSITION OF TECOVIRIMAT AND PREPARATION METHOD THEREFOR | ZHONG WU | INST PHARMACOLOGY & TOXICOLOGY ACADEMY MILITARY MEDICAL SCIENCES PLA CHINA |
| EP3485887 | INJECTABLE PHARMACEUTICAL COMPOSITION OF TECOVIRIMAT AND PREPARATION METHOD THEREOF | ZHONG WU | INST PHARMACOLOGY & TOXICOLOGY ACADEMY MILITARY MEDICAL SCIENCES PLA CHINA |
| EP3485892 | COMPOSITION FOR PREVENTION OR TREATMENT OF MILD COGNITIVE IMPAIRMENT OR DEMENTIA CONTAINING HYDROGEN AS ACTIVE INGREDIENT | ASADA TAKASHI | MITOS CO LTD |
| EP3485894 | COMBINATION OF OFFICINAL PLANTS AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF SLEEP DISORDERS | PIZZONI ANGELO | ITALFARMACO SPA |
| EP3485901 | EGFR AND C-MET-FIBRONECTIN TYPE III DOMAIN BINDING MOLECULES | ANDERSON MARK | JANSSEN BIOTECH INC |
| EP3485908 | THERAPEUTIC COMBINATION AND USE OF DLL4 ANTAGONIST ANTIBODIES AND ANTI-HYPERTENSIVE AGENTS | STAGG ROBERT JOSEPH | ONCOMED PHARM INC |
| EP3485914 | TELOMERASE REVERSE TRANSCRIPTASE-BASED THERAPIES | BOBADILLA MARIA | FUNDACION CENTRO NAC DE INVESTIGACIONES ONCOLOGICAS CARLOS III |
| EP3486233 | POORLY SOLUBLE COMPLEX OR SOLVATE THEREOF, PHARMACEUTICAL COMPOSITION, AND APPLICATION THEREOF | ZHANG SHANCHUN | FRUITHY HOLDINGS LTD |
| EP3486234 | ARYL- OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS | CHESWORTH RICHARD | EPIZYME INC |
| EP3486242 | OXOPICOLINAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF | YANG FANGLONG | JIANGSU HENGRUI MEDICINE CO |
| EP3486245 | 2-AMINO-N-(PIPERIDIN-1-YL-PYRIDIN-3-YL) PYRAZOLO[1,5ALPHA]PYRIMIDINE-3-CARBOXAMID AS INHIBITOR OF ATR KINASE | AHMAD NADIA | VERTEX PHARMA |
| EP3486249 | 99MTC-EDDA/HYNIC-IPSMA AS A RADIOPHARMACEUTICAL FOR DETECTING THE OVEREXPRESSION OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN | FERRO FLORES GUILLERMINA | INSTITUTO NAC DE INVESTIGACIONES NUCLEARES |
| EP3486322 | METHOD FOR PRODUCING VACCINIA VIRUS EXPRESSING FOREIGN GENE | NAKAMURA TAKAFUMI | NAT UNIV CORP TOTTORI UNIV |
| EP3487474 | COSMETIC TREATMENT METHOD FOR THE SKIN | BEDOS PHILIPPE | SYNTIVIA |
| EP3487476 | SERIES OF CAPSULES AND METHOD OF MANUFACTURE, COSMETIC COMPOSITION AND COSMETIC TREATMENT | PAFUMI YAN ERIC | CAPSUM |
| EP3487493 | OXYTOCIN ANTAGONIST DOSING REGIMENS FOR PROMOTING EMBRYO IMPLANTATION AND PREVENTING MISCARRIAGE | LOUMAYE ERNEST | OBSEVA SA |
| EP3487497 | AR ANTAGONISTS OR INHIBITORS FOR USE IN TREATING GLIOBLASTOMA | LAVON BEN MOSHE IRIS | HADASIT MED RES SERVICE |
| EP3487840 | CYCLOHEXYL BENZAMIDE COMPOUNDS | HU ZHILONG | LILLY CO ELI |
| EP3487851 | AMINOPYRIDINE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS | LI JIALIANG | NOVARTIS AG |
| EP3487857 | PURINE AND 3-DEAZAPURINE ANALOGUES AS CHOLINE KINASE INHIBITORS | CASALE ELENA | NERVIANO MEDICAL SCIENCES SRL |
| EP3487859 | ANTIMETASTATIC 2H-SELENOPHENO[3,2-H]CHROMENES, SYNTHESIS THEREOF, AND METHODS OF USING SAME AGENTS | ARSENJANS PAVELS | LATVIAN INST ORGANIC SYNTHESIS |
| EP3488443 | SELECTING NEOEPITOPES AS DISEASE-SPECIFIC TARGETS FOR THERAPY WITH ENHANCED EFFICACY | TADMOR ARBEL D | BIONTECH RNA PHARMACEUTICALS GMBH |
| EP3488842 | POWDER-LIQUID TYPE DENTAL PLATE LINER | HITOMI MIKI | TOKUYAMA DENTAL CORP |
| EP3488899 | HAIR CARE COMPOSITION | LANGELLA VALENTINA | LAMBERTI SPA |
| EP3489220 | LIPIDS FOR THERAPEUTIC AGENT DELIVERY FORMULATIONS | PAYNE JOSEPH E | NITTO DENKO CORP |
| EP3489230 | CHEMICAL COMPOUND OF ISOCITRATE DEHYDROGENASE INHIBITOR, AND APPLICATION THEREOF | WANG YONG | NANJING SANHOME PHARMACEUTICAL CO LTD |
| EP3489231 | PIPERAZINE DERIVATIVE | SUGANE TAKASHI | ASTELLAS PHARMA INC |
| EP3489238 | PHARMACEUTICAL COMPOSITIONS OF 6H-PYRIDO[3,2-E][1,2,4]TRIAZOLO[1,5-C]PYRIMIDIN-5-ONE AND [1,2,4]TRIAZOLO[1,5-C]PTERIDIN-5(6H)-ONE DERIVATIVES AS PDE1 INHIBITORS FOR TREATING E.G. NEUROLOGICAL DISORDERS | ALLAN AMY | DART NEUROSCIENCE CAYMAN LTD |
| EP3489252 | PEPTIDE HAVING ANTICANCER ACTIVITY, AND CANCER PREVENTING AND TREATING PHARMACEUTICAL COMPOSITION, FUNCTIONAL HEALTH FOOD COMPOSITION AND FUNCTIONAL COSMETIC COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT | KIM CHUL GEUN | UNIV HANYANG IND UNIV COOP FOUND |
| EP3489255 | MUTANT INTERLEUKIN-2 POLYPEPTIDES | AST OLIVER | ROCHE GLYCART AG |
| EP3489256 | ANTIGEN BINDING MOLECULES COMPRISING A TNF FAMILY LIGAND TRIMER | AMANN MARIA | HOFFMANN LA ROCHE |
| EP3489350 | BIFIDOBACTERIUM ANIMALIS AMT30 STRAIN AND COMPOSITION CONTAINING THE STRAIN OF BIFIDOBACTERIUM ANIMALIS AMT30 | SOSNOWSKA-TUREK EWELINA | SOSNOWSKA TUREK EWELINA |
| EP3490524 | PERSONAL CARE COMPOSITIONS COMPRISING FATTY ACID AMIDE DERIVATIVES | AU VAN | UNILEVER PLC |
| EP3490535 | SUSTAINED RELEASE COMPOSITION COMPRISING MICRONIZED TOLCAPONE | NARDI RICART ANNA | SOM INNOVATION BIOTECH S L |
| EP3490577 | SKIN COMPOSITIONS COMPRISING TURMERONES | MAJKA ZBIGNIEW | ADAMED PHARMA S A |
| EP3490580 | METHOD OF PREVENTING OR REDUCING THE INCIDENCE OF ACUTE URINARY RETENTION | AVERBACK PAUL | NYMOX CORP |
| EP3490584 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF MELANOMA | REFAELI YOSEF | TAIGA BIOTECHNOLOGIES INC |
| EP3490587 | PROPHYLACTIC PROTECTION AGAINST VIRAL INFECTIONS | SQUIQUERA LUIS | SQUIQUERA LUIS |
| EP3490609 | POLYMER | STOLNIK-TRENKIC SNJEZANA | VECTURA LTD |
| EP3490973 | POLYMORPHIC FORMS OF BELINOSTAT AND PROCESSES FOR PREPARATION THEREOF | MALE SRIDHAR REDDY | FRESENIUS KABI ONCOLOGY LTD |
| EP3490975 | O-SUBSTITUTED HYDROXAMIC ACIDS | TOSCANO JOHN P | UNIV JOHNS HOPKINS |
| EP3490983 | DIMETHOXYPHENYL SUBSTITUTED INDOLE COMPOUNDS AS TLR7, TLR8 OR TLR9 INHIBITORS | DYCKMAN ALARIC J | SQUIBB BRISTOL MYERS CO |
| EP3490986 | PIPERIDINE CXCR7 RECEPTOR MODULATORS | AISSAOUI HAMED | IDORSIA PHARMACEUTICALS LTD |
| EP3490991 | COELENTERAZINE ANALOGUES | HALL MARY | PROMEGA CORP |
| EP3491004 | DIAGNOSTIC METHODS, THERAPEUTIC AGENTS AND USES THEREOF | ZHANG QIBO | METABOLON INC |
| EP3491109 | COMPOSITION COMPRISING ALCOHOL ETHOXYLATE AND GLUCAMIDE | SIENKIEWICZ ALEKSANDRA | CLARIANT INT LTD |
| EP3491929 | AMELIORATIVE EFFECTS OF A WHOLE COFFEE FRUIT EXTRACT ON AGE-RELATED NEURODEGENERATIVE DISEASE | CHANG WILLIAN TIENHUNG | |
| EP3492084 | TREATMENT OF PULMONARY ARTERIAL HYPERTENSION WITH PROSTACYCLIN-TREATED ENDOTHELIAL PROGENITOR CELLS | JEFFS ROGER | UNITED THERAPEUTICS CORP |
| EP3492086 | USE OF EPIGENETIC INHIBITOR 1-(BETA-D-RIBOFURANOSYL)-2(1H)-PYRIMIDINONE (ZEBULARINE) FOR PROMOTING WOUND HEALING, COMPLEX TISSUE AND ORGAN REGENERATION | SACHADYN PAWEL | UNIV GDANSKI |
| EP3492088 | MEDICINAL COMPOSITION FOR IMPROVING AND/OR STABILIZING CIRCULATORY DYNAMICS AFTER ONSET OF HEMORRHAGIC SHOCK | SUZUKI MASARU | UNIV KEIO |
| EP3492089 | DERMATOLOGICAL COMPOSITION CONTAINING ESCHERICHIA COLI AND ENTEROCOCCUS FAECALIS | MüLLER HANS-JÖRG | SYMBIOGRUPPE GMBH & CO KG |
| EP3492091 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR VASCULAR DISORDER | SAIKI YOSHIKATSU | UNIV TOHOKU |
| EP3492100 | ANTIBODIES TO OPGL | BOYLE WILLIAM | AMGEN INC |
| EP3492106 | COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT | CHARMOT DOMINIQUE | ARDELYX INC |
| EP3492143 | LOW VISCOSITY DENTAL CARE COMPOSITION | SÖRGEL NORBERT | BLBR GMBH |
| EP3492465 | S1P1 AGONIST AND APPLICATION THEREOF | WU LINGYUN | SHIJIAZHUANG SAGACITY NEW DRUG DEV CO LTD |
| EP3492469 | COMPOUND AS SELECTIVE JAK INHIBITOR, AND SALT AND THERAPEUTIC USE THEREOF | ZHANG WENYAN | TIANJIN LONGBOGENE PHARMACEUTICAL CO LTD |
| EP3492593 | NUCLEASE-MEDIATED REGULATION OF GENE EXPRESSION | ORKIN STUART H | CHILDRENS MEDICAL CENTER |
| EP3493786 | ACTIVE AGENT AND METHOD FOR REDUCING MALODOR | FAN AIXING | COLGATE PALMOLIVE CO |
| EP3493848 | HETEROCYCLIC DIAMIDINES | RAMMING ANDREAS | UNIV FRIEDRICH ALEXANDER ER |
| EP3493849 | NEW USE OF N,N-BIS-2-MERCAPTOETHYL ISOPHTHALAMIDE | HALEY BOYD EUGENE | EMERAMED LTD |
| EP3494110 | PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATING OR PREVENTING A RESPIRATORY SYNCYTIAL VIRUS INFECTION | COCKERILL STUART | REVIRAL LTD |
| EP3494120 | OXADIAZOLOPYRIDINE DERIVATES FOR USE AS GHRELIN O-ACYL TRANSFERASE (GOAT) INHIBITORS | GODBOUT CéDRICKX | BOEHRINGER INGELHEIM INT |
| EP3494206 | LACTIC BACTERIA AND THE USE THEREOF FOR THE PREVENTIVE, INHIBITORY AND/OR REDUCTIVE TREATMENT OF THE FORMATION OF BACTERIAL BIOFILMS | MOGNA GIOVANNI | PROBIOTICAL SPA |
| EP3494955 | COSMETIC COMPOSITION FOR PROMOTING HAIR GROWTH | KOZIAK KATARZYNA | UNIV WARSZAWSKI MEDYCZNY |
| EP3494962 | LIQUID INHALATION FORMULATION COMPRISING RPL554 | SPARGO PETER LIONEL | VERONA PHARMA PLC |
| EP3494964 | LIPOSOME AND METHOD FOR PRODUCING LIPOSOME | ISODA TAKESHI | KONICA MINOLTA HOLDINGS INC |
| EP3494965 | AN IMPROVED PROCESS FOR THE PREPARATION OF PIRFENIDONE | MANDADAPU VENKATA PRAMOD KUMAR | LAURUS LABS LTD |
| EP3494973 | COMPOSITIONS COMPRISING GENISTEIN PHOSPHATES FOR TREATING THE LOSS OF BONE MASS | WANG SHANG-TA | |
| EP3494985 | VACCINE COMPOSITION COMPRISING MUTANT CALRETICULIN | KRALOVICS ROBERT | CEMM FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GMBH |
| EP3495324 | ZINC-OXIDE-CONTAINING COMPOSITE PARTICLES, COMPOSITION FOR UV SHIELDING, AND COSMETIC | DOSHITA KAZUHIRO | NIPPON SHEET GLASS CO LTD |
| EP3495350 | COMPOUND INHIBITING FORMATION OF C-MYC/MAX/DNA COMPLEX | JEONG KYUNG CHAE | NAT CANCER CT |
| EP3495352 | CRYSTAL FORM OF ANDROGEN RECEPTOR ANTAGONIST MEDICATION, PREPARATION METHOD THEREFOR, AND USE | CHEN MINHUA | CRYSTAL PHARMACEUTICAL SUZHOU CO LTD |
| EP3495357 | 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE | PETRUKHIN KONSTANTIN | UNIV COLUMBIA |
| EP3495362 | IMIDAZOPYRIDINE THIOGLYCOLIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | LIU XINYONG | UNIV SHANDONG |
| EP3495369 | USE OF SALTS OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-1H- PYRAZOL-1-YL)-3- CYCLOPENTYLPROPANENITRILE | LI HUI-YIN | INCYTE HOLDINGS CORP |
| EP3495372 | BORONATED DERIVATIVES FOR THE TREATMENT OF DISEASES AND CONDITIONS ASSOCIATED TO OXIDATIVE STRESS | DI STEFANO ANTONIO | UNIV DEGLI STUDI G D ANNUNZIO CHIETI PESCARA |
| EP3495387 | BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES AND THEIR USE IN THE TREATMENT OF OCULAR VASCULAR DISEASES | DUERR HARALD | ROCHE GLYCART AG |
| EP3495392 | ANTI-CGRP COMPOSITIONS AND USE THEREOF | KOVACEVICH BRIAN ROBERT | ALDERBIO HOLDINGS LLC |
| EP3495502 | BIOMARKERS FOR PREMATURE BIRTH | CHIM SIU-CHUNG STEPHEN | UNIV HONG KONG CHINESE |
| EP3496703 | MOXIDECTIN TOPICAL LIQUID FORMULATIONS | REYNOLDS LOUISE | NORBROOK LAB LTD |
| EP3496715 | COMPOUNDS USEFUL FOR ALTERING THE LEVELS OF BILE ACIDS FOR THE TREATMENT OF DIABETES AND CARDIOMETABOLIC DISEASE | CALDWELL JOHN P | MERCK SHARP & DOHME |
| EP3496716 | COMPOUNDS USEFUL FOR ALTERING THE LEVELS OF BILE ACIDS FOR THE TREATMENT OF DIABETES AND CARDIOMETABOLIC DISEASE | CUMMING JARED N | MERCK SHARP & DOHME |
| EP3496724 | PROTEIN KINASE REGULATORS | IWANOWICZ EDWIN J | NANJING GATOR MEDITECH COMPANY LTD |
| EP3496728 | COMPOSITIONS COMPRISING NANOSILICA PARTICLES AND THEIR USE IN METHODS OF ACTIVATING T LYMPHOCYTES FOR THERAPY | POWELL JONATHAN JOSEPH | RES & INNOVATION UK |
| EP3496734 | INSULIN GLARGINE | GERRING DAVID | ARECOR LTD |
| EP3496737 | APOM-FC FUSION PROTEINS, COMPLEXES THEREOF WITH SPHINGOSINE L-PHOSPHATE (SIP), AND METHODS FOR TREATING VASCULAR AND NON-VASCULAR DISEASES | HLA TIMOTHY T | CHILDRENS MEDICAL CT CORP |
| EP3496739 | COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION | KUMAR RAVINDRA | ACCELERON PHARMA INC |
| EP3496818 | HAIR DYE AGENT HAVING UNILAMELLAR AND MULTILAMELLAR VESICLES | MüLLER BURKHARD | HENKEL AG & CO KGAA |
| EP3497086 | AMINO PYRIMIDINE SSAO INHIBITORS | COATES DAVID ANDREW | LILLY CO ELI |
| EP3497087 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | QIAN XIANGPING | NEUPHARMA INC |
| EP3497093 | SULFONYL PYRIDYL TRP INHIBITORS | VERMA VISHAL | HOFFMANN LA ROCHE |
| EP3497095 | COMPOUNDS | RONGVED PÅL | UNIV OSLO |
| EP3497096 | AN ANTIMICROBIAL COMPOUND | COCKERILL STUART | THE UNIV OF DURHAM |
| EP3497103 | PYRIDOPYRIMDINONE CDK2/4/6 INHIBITORS | BEHENNA DOUGLAS CARL | PFIZER |
| EP3497130 | COMBINATION THERAPY FOR CANCER | LO KIN-MING | MERCK PATENT GMBH |
| EP3497192 | ORGANIC COMPOUNDS | ZOU YUE | GIVAUDAN SA |
| EP3497457 | SYSTEM AND METHOD FOR MICROFLUIDIC PARAHYDROGEN INDUCED POLARIZATION HYPERPOLARIZER FOR MAGNETIC RESONANCE IMAGING (MRI) AND NUCLEAR MAGNETIC RESONANCE (NMR) APPLICATIONS | ALSOP DAVID | BETH ISRAEL DEACONESS MEDICAL CT INC |
| EP3498253 | VESICLES FOR DELAYED DELIVERY OF FRAGRANCE THEIR PREPARATION AND USE THEREOF | DAHMS GERD | CLARIANT INT LTD |
| EP3498258 | APPLICATION FOR WATER EXTRACT OF PLANT OF GRACILARIACEAE OR FERMENT THEREOF AND PHARMACEUTICAL COMPOSITION AND/OR HEALTH FOOD FOR TREATING AND/OR ALLEVIATING NERVOUS DISEASES | PAN I-HONG | |
| EP3498262 | USE OF A GEL OF NATURAL POLYSACCHARIDE(S) FOR THE PREPARATION OF AN INJECTABLE FORMULATION FOR TREATING JOINT DEGENERATION | GAVARD MOLLIARD SAMUEL | APTISSEN SA |
| EP3498277 | PHARMACEUTICAL COMPOSITION FOR STROKE TREATMENT BASED ON AMPK INHIBITION | KIM YANG HEE | UNIV SEJONG IND ACAD COOP FOUD |
| EP3498284 | PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING CANCER | MIYANO ATSUKO | TORAY INDUSTRIES |
| EP3498292 | USPA2 PROTEIN CONSTRUCTS AND USES THEREOF | BLAIS NORMAND | GLAXOSMITHKLINE BIOLOGICALS SA |
| EP3498705 | 2-ACETYL-6-(2-(2-(4-BROMOBENZYLIDENE)HYDRAZINYL)THIAZOLE-4-YL)-3,7,9-TRIHYDROXY-8,9B-DIMETHYLDIBENZO[B,D]FURAN-1(9BH)-ONE EXHIBITING AN INHIBITORY EFFECT ON HUMAN TYROSYL-DNA-PHOSPHODIESTERASE 1 ENZYME | LUZINA OLGA ANATOLYEVNA | OBSHESTVO S OGRANICHENNOI OTVETSTVENNOSTJU INNOVATIE PHARMACOLOGY RES IPHAR |
| EP3498708 | DEUTERATED 3-(4,5-SUBSTITUTED PYRIMIDINAMINE) PHENYL DERIVATIVES AND APPLICATIONS THEREOF | ZHU YONGQIANG | NANJING CHUANGTE PHARMACEUTICAL TECH CO LTD |
| EP3498715 | ANTI-HCMV VIRUS COMPOUND | XIONG JIAN | MEDSHINE DISCOVERY INC |
| EP3498725 | 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID FOR USE IN THERAPY | BOTELLA GABRIEL MARTINEZ | SAGE THERAPEUTICS INC |
| EP3498734 | COMBINATION OF A PD-1 ANTAGONIST AND A VEGFR INHIBITOR FOR TREATING CANCER | MARTINI JEAN-FRANCAIS ANDRE | PFIZER |
| EP3498843 | ENDONUCLEASE TARGETING BLOOD COAGULATION FACTOR VIII GENE AND COMPOSITION FOR TREATING HEMOPHILIA COMPRISING SAME | KIM DONG WOOK | UNIV YONSEI IACF |
| EP3500207 | CARRIER BASED DENTAL ROOT CANAL OBTURATOR | LI NATHAN Y | LI NATHAN Y |
| EP3500246 | ANTIPARKINSON TABLET FORMULATION WITH IMPROVED DISSOLUTION PROFILE | ÖNCEL HATICE | ILKO ILAC SANAYI VE TICARET ANONIM SIRKETI |
| EP3500281 | USE OF IAP INHIBITOR AND ONCOLYTIC VIRUS IN PREPARATION OF ANTI-TUMOR DRUG | YAN GUANGMEI | GUANGZHOU VIROTECH PHARMACEUTICAL CO LTD |
| EP3500307 | USE OF VCP INHIBITOR AND ONCOLYTIC VIRUS IN THE PREPARATION OF AN ANTI-TUMOR DRUG | YAN GUANGMEI | GUANGZHOU VIROTECH PHARMACEUTICAL CO LTD |
| EP3500363 | GALLIUM-68 GENERATORS AND METHODS FOR MAKING SUCH GENERATORS | BARBOSA LUIS ANTONIO M M | CURIUM US LLC |
| EP3500550 | CROSS-LINKED POLYGLYCEROL ESTERS | VON HOF JAN MARIAN | EVONIK DEGUSSA GMBH |
| EP3500559 | HETEROCYCLIC LIPOXON ANALOGS AND USES THEROF | GUIRY PATRICK | UNIV DUBLIN |
| EP3500573 | GABA(A) RECEPTOR MODULATORS AND METHODS TO CONTROL AIRWAY HYPERRESPONSIVENESS AND INFLAMMATION IN ASTHMA | ARNOLD ALEXANDER E | UWM RES FOUNDATION INC |
| EP3500574 | SECO-CYCLOPROPAPYRROLOINDOLE COMPOUNDS, ANTIBODY-DRUG CONJUGATES THEREOF, AND METHODS OF MAKING AND USE | YANG FUKANG | SQUIBB BRISTOL MYERS CO |
| EP3500859 | MARKER FOR NEURAL STEM CELLS | LUNDGREN ÅKERLUND EVY | XINTELA AB |
| EP3501482 | TWO-PACKAGE DENTAL ADHESIVE COMPOSITION | KISHI HIROTO | TOKUYAMA DENTAL CORP |
| EP3501484 | COMPOSITION FOR TRANSDERMAL DELIVERY, COMPRISING NANOEMULSION AND MODIFIED LAYERED DOUBLE HYDROXIDE | LEE JONG HYEON | H&A PHARMACHEM CO LTD |
| EP3501486 | COMPOSITION, PROCESS, AND DEVICE FOR TEMPORARY COLORING OF KERATIN FIBERS | PFOHMANN STEFANIE | KAO CORP |
| EP3501488 | AQUEOUS SILICONE POLYMER COMPOSITIONS | HUGGINS JOHN | MOMENTIVE PERFORMANCE MAT GMBH |
| EP3501544 | LIGAND CAPABLE OF MULTIVALENTLY BINDING TO GLUTAMINE TRANSPORTER, AND COMPOSITION COMPRISING SAME | NISHIYAMA NOBUHIRO | TOKYO INST TECH |
| EP3501549 | TREATMENT OF AMD USING AAV SFLT-1 | CONSTABLE IAN J | AVALANCHE AUSTRALIA PTY LTD |
| EP3502122 | MALIGNANT TUMOR TARGET PEPTIDE | FUKUDA MICHIKO | AIST |
| EP3502123 | ENZYMES AND METHODS FOR CLEAVING N-GLYCANS FROM GLYCOPROTEINS | GARRIDO DANIEL | UNIV CALIFORNIA |
| EP3502129 | A CONJUGATE COMPRISING OXYNTOMODULIN AND AN IMMUNOGLOBULIN FRAGMENT, AND USE THEREOF | JUNG SUNG YOUB | HANMI SCIENCE CO LTD |
| EP3502142 | BISPECIFIC ANTIBODY AND ANTIBODY CONJUGATE FOR TUMOUR THERAPY AND USE THEREOF | YU HAOYANG | BENHEALTH BIOPHARMACEUTIC SHENZHEN CO LTD |
| EP3502240 | TARGETING BCL11A DISTAL REGULATORY ELEMENTS FOR FETAL HEMOGLOBIN REINDUCTION | ORKIN STUART H | CHILDRENS MEDICAL CT CORP |
| EP3503745 | DIETARY MACRO/MICRONUTRITIONAL SUPPLEMENT FOR PATIENTS UNDERGOING KIDNEY DIALYSIS | DABDOUB ATIF | DABDOUB ATIF |
| EP3503855 | WOUND DRESSING WITH ANALGESIC BORDER ADHESIVE | LOCKE CHRISTOPHER BRIAN | KCI LICENSING INC |
| EP3503868 | ANTIPERSPIRANT OR DEODORANT COMPOSITION | STRUILLOU ARNAUD | FIRMENICH & CIE |
| EP3503871 | HAIR FOLLICLE STEM CELL ACTIVATION AND HAIR GROWTH | LOWRY WILLIAM | UNIV CALIFORNIA |
| EP3503884 | METHOD FOR TREATING PRURITUS AND/OR ITCH | LAUDON MOSHE | NEURIM PHARMA 1991 |
| EP3503895 | ANTIVIRAL PRODRUGS OF TENOFOVIR | DA COSTA DANIEL | MERCK SHARP & DOHME |
| EP3504194 | N-(PYRIDIN-2-YL)PYRIDINE-SULFONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE | PHILLIPS DEAN PAUL | NOVARTIS AG |
| EP3504197 | NEW TRIFLUOROMETHYLPROPANAMIDE DERIVATIVES AS HTRA1 INHIBITORS | HORNSPERGER BENOIT | HOFFMANN LA ROCHE |
| EP3504205 | HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC CONDITIONS AND DISORDERS | CHAO JIANHUA | ARDELYX INC |
| EP3504210 | 7-SUBSTITUTED SULFONIMIDOYLPURINONE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION | GAO LU | HOFFMANN LA ROCHE |
| EP3504212 | SUBSTITUTED PYRROLIZINE COMPOUNDS AND USES THEREOF | DU JINFA | GILEAD SCIENCES INC |
| EP3504218 | COMPOSITION COMPRISING SILICON AND METHOD FOR PREPARING SAME | CROIZET-BERGER KARINE | SILINNOV SCRL |
| EP3504229 | REGULATION OF GENE EXPRESSION USING ENGINEERED NUCLEASES | MILLER JEFFREY C | SANGAMO THERAPEUTICS INC |
| EP3504316 | METHODS FOR TREATING AN IMMUNE DISORDER-RELATED DISEASE BY REDUCING AUTOREACTIVITY IN A T CELL COMPARTMENT | ZHAO YONG | UNIV HACKENSACK MEDICAL CENTER |
| EP3504327 | ENGINEERED TARGET SPECIFIC NUCLEASES | MILLER JEFFREY C | SANGAMO THERAPEUTICS INC |
| EP3505150 | HAIR TREATMENT METHOD AND HAIR TREATMENT TOOL | IIKUBO RINA | KAO CORP |
| EP3505153 | A PHARMACEUTICAL COMPOSITION COMPRISING ACETYLCYSTEINE WHICH IS FREE OF METHYL PARABEN VE PROPYL PARABEN | SARIKAYA ALI OSMAN | ABDI IBRAHIM ILAC SANAYI VE TICARET A S |
| EP3505157 | DRY POWDER KETAMINE COMPOSITION FOR PULMONARY ADMINISTRATION IN TREATMENT-RESISTANT DEPRESSION | WIECZOREK MACIEJ | CELON PHARMA SA |
| EP3505161 | SUBLINGUAL PHARMACEUTICAL COMPOSITION OF EDARAVONE AND (+)-2-BORNEOL | WANG YIJUN | YANTAI YENEPHARMA CO LTD |
| EP3505169 | MEDICAMENT COMPRISING PILOCARPINE AND THYMOXAMINE | SHARMA ANANT | PRESBYOPIA TREAT LIMITED |
| EP3505170 | AZOLE COMPOUND OPHTHALMIC PREPARATION | ZHENG QINYUAN | BIOTOOL LLC |
| EP3505175 | GLUCOSYL STEVIA COMPOSITION | MARKOSYAN AVETIK | PURECIRCLE USA INC |
| EP3505181 | PREPARATION OF ENZYME REPLACEMENT THERAPY FOR MUCOPOLYSACCHARIDOSIS IIID | DICKSON PATRICIA | LOS ANGELES BIOMEDICAL RES INST HARBOR UCLA MEDICAL CT |
| EP3505195 | REGENERATIVE MEDICAL MATERIAL, PREPARATION METHOD THEREFOR, AND USE THEREOF | HU FANG | HU FANG |
| EP3505515 | CRYSTALS OF CYCLIC AMINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF | TAKAHASHI HIROZUMI | TORAY INDUSTRIES |
| EP3505516 | CRYSTAL OF SALT OF QUINAZOLINE DERIVATIVE | TANG SONG | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD |
| EP3505540 | SUGAMMADEX SODIUM REFINING METHOD | WANG BINGYONG | WANG BINGYONG |
| EP3506873 | PERSONAL CARE GEL AND METHOD | SYED FARRAH | COLGATE PALMOLIVE CO |
| EP3506876 | COMPOSITION FOR NAIL FUNGUS | LICHT FLEMMING | UNIGROUP APS |
| EP3506884 | DRUG DELIVERY COMPOSITIONS AND USES THEREOF | GOLDBERG MICHAEL SOLOMON | DANA FARBER CANCER INST INC |
| EP3506899 | COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF LYMPHATIC SYSTEM DISORDERS | HAKONARSON HAKON | CHILDRENS HOSPITAL PHILADELPHIA |
| EP3506901 | USE OF TRYPTOPHAN METABOLITES FOR TREATING MUSCLE ATROPHY | RAYNAL SOPHIE N | METABRAIN RES |
| EP3506916 | GOLD OPTIMIZED CAR T-CELLS | WANG BENJAMIN | CHIMERA BIOENGINEERING INC |
| EP3506983 | SUBSTITUTED UREAS AND METHODS OF MAKING AND USING SAME | TOUNGE BRETT A | MEBIAS DISCOVERY LLC |
| EP3507276 | TOLL LIKE RECEPTOR MODULATOR COMPOUNDS | CHIN GREGORY | GILEAD SCIENCES INC |
| EP3507278 | SUBSTITUTED TRICYCLIC HETEROCYCLIC COMPOUNDS | MARCOUX DAVID | SQUIBB BRISTOL MYERS CO |
| EP3507291 | FUSED BICYCLIC SGC STIMULATORS | RENNIE GLEN ROBERT | CYCLERION THERAPEUTICS INC |
| EP3508191 | GEL-LIKE COMPOSITION, AND EXTERNAL-USE AGENT FOR SKIN AND COSMETIC MATERIAL IN WHICH SAID GEL-LIKE COMPOSITION IS USED | TSUJI TADAO | KANEKA CORP |
| EP3508192 | INTRAORAL DENTAL PLAQUE DISPERSANT | UCHINO YOSUKE | KAO CORP |
| EP3508194 | AQUEOUS GELLING AGENT COMPOSITION AND COSMETIC PREPARATION USING SAME | SAKAMOTO TAKAO | ADEKA CORP |
| EP3508196 | ARIPIPRAZOLE PRODRUG COMPOSITIONS | CRESSWELL PHILIP | ALKERMES PHARMA IRELAND LTD |
| EP3508207 | CELL PREPARATION AND METHOD FOR PRODUCING CELL PREPARATION | SHIMOHATA TAKAYOSHI | UNIV NIIGATA |
| EP3508270 | NANOCAPSULE COMPOSITIONS FOR THE CONTROLLED RELEASED OF AGENTS OF THERAPEUTIC INTEREST | VALLET REGí MARIA | FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIV 12 DE OCTUBRE |
| EP3508477 | C5AR ANTAGONISTS | FAN PINGCHEN | CHEMOCENTRYX INC |
| EP3508483 | DIHYDROPYRIMIDINE COMPOUND AND PREPARATION METHOD AND USE THEREOF | SONG SHUAI | SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD |
| EP3508484 | HETEROCYCLIC AMIDES AS KINASE INHIBITORS | BANDYOPADHYAY DEEPAK | GLAXOSMITHKLINE IP DEV LTD |
| EP3508487 | PYRAZOLO[1,5-a]PYRIMIDINE COMPOUND | CLARK RICHARD | EISAI R&D MAN CO LTD |
| EP3508495 | IL-21 (HETERODIMERIC FC-FUSED IL-21) FUSED TO IMMUNOGLOBULIN HEAVY CHAIN CONSTANT REGION HETERODIMER (HETERODIMERIC FC), AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | LEE KYUNG-MI | UNIV KOREA RES & BUS FOUND |
| EP3508568 | LEUCONOSTOC HOLZAPFELII STRAIN HAVING HAIR LOSS PREVENTION, HAIR GROWTH PROMOTION OR SEXUAL FUNCTION IMPROVEMENT EFFECTS, AND COMPOSITION COMPRISING SAME | YUM KYU JIN | COENBIO CO LTD |
| EP3508579 | PRODUCTION OF RECOMBINANT VACCINE IN E. COLI BY ENZYMATIC CONJUGATION | WACKER MICHAEL | GLAXOSMITHKLINE BIOLOGICALS SA |
| EP3508582 | METHODS FOR GENETIC CONTROL OF INSECT INFESTATIONS IN PLANTS AND COMPOSITIONS THEREOF | BAUM JAMES A | MONSANTO TECHNOLOGY LLC |
| EP3509541 | LENTICULES FOR INTRASTROMAL CORNEAL IMPLANTATION | KLOPOTEK PETER J | GEBAUER KLOPOTEK PATENT VERWALTUNGS UG HAFTUNGSBESCHRAENKT |
| EP3509561 | PERFUME COMPOSITIONS | STURGIS DAVID ARTHUR | PROCTER & GAMBLE |
| EP3509562 | AEROSOL COMPOSITIONS | STURGIS DAVID ARTHUR | PROCTER & GAMBLE |
| EP3509567 | MEDICAL DEVICE FOR THE TREATMENT OF HPV CUTANEOUS INFECTIONS | POLI ELENA | POLI MD S R L |
| EP3509583 | ESTROGEN RECEPTOR LIGANDS, COMPOSITIONS AND METHODS RELATED THERETO | JUNG MICHAEL E | UNIV CALIFORNIA |
| EP3509589 | NOVEL USES | SNYDER GRETCHEN | INTRA CELLULAR THERAPIES INC |
| EP3509591 | NOVEL JAK1 SELECTIVE INHIBITORS AND USES THEREOF | LIANG CONGXIN | TLL PHARMACEUTICAL LLC |
| EP3509618 | SELF-ASSEMBLING PEPTIDE POLYMER | ULIJN REIN V | UNIV CITY NEW YORK RES FOUND |
| EP3509626 | FIBRONECTIN OR ILK INHIBITORS FOR USE IN THE TREATMENT OF LEUKEMIA | KRAUSE DANIELA | CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG SPEYER HAUS |
| EP3509705 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | STURGIS DAVID ARTHUR | PROCTER & GAMBLE |
| EP3509706 | METHOD FOR INCREASING LIPOLYSIS USING A COMPOSITION COMPRISING BIOACTIVE NELUMBO NUCIFERA (LOTUS) EXTRACT | CUCUMEL KARINE | ISP INVESTMENTS LLC |
| EP3510024 | PYRIDYL SUBSTITUTED INDOLE COMPOUNDS | DYCKMAN ALARIC J | SQUIBB BRISTOL MYERS CO |
| EP3510033 | COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF ENDOSOMAL TOLL-LIKE RECEPTORS | ALPER PHILLIP | NOVARTIS AG |
| EP3510036 | IMIDAZOQUINOLINE DERIVATIVES AND THEIR USE IN THERAPY | BAZIN-LEE HELENE G | GLAXOSMITHKLINE BIOLOGICALS SA |
| EP3510044 | AMYLIN ANALOGUES | MATHIESEN JESPER MOSOLFF | ZEALAND PHARMA AS |
| EP3510045 | MONOCLONAL ANTIBODIES AGAINST HEMAGGLUTININ OF H5-SEROTYPE INFLUENZA VIRUSES AND THEIR USES, HYBRIDOMAS PRODUCING SAID ANTIBODIES, COMPOSITIONS AND DIAGNOSTIC KITS | SACZYNSKA VIOLETTA | INST BIOTECHNOLOGII I ANTYBIOTYKOW |
| EP3510084 | METHOD FOR PRODUCING A CROSS-LINKED MOULDED BODY FROM UHMWPE | MULLIEZ MARIE ANNE | AESCULAP AG |
| EP3510182 | PRODUCT CONTAINER WITH ELECTROCHEMISTRY DEVICE | JOHANSSON PATRIK | COLGATE PALMOLIVE CO |
| EP3510860 | REDUCING THE REPRODUCTIVE CAPACITY OF MAMMALS | MAYER LORRETTA P | SENESTECH INC |
| EP3510988 | DELIVERY DEVICE FOR ORAL INTAKE OF AN AGENT | TSABARI MOSHE | INTEC PHARMA LTD |
| EP3510990 | ORAL COMPOSITION | TAKAHASHI YUKO | KAO CORP |
| EP3510992 | SKIN WHITENING COMPOSITION CONTAINING MANNOSYLERYTHRITOL LIPID | YOO JAE WON | AMOREPACIFIC CORP |
| EP3511001 | PIRFENIDONE-CONTAINING TABLET AND CAPSULE FORMULATION | GUJJAR CHAITANYA YOGANANDA | TIEFENBACHER ALFRED E GMBH & CO KG |
| EP3511003 | CYCLIC AMINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF | MORITA YASUHIRO | TORAY INDUSTRIES |
| EP3511006 | COMPOSITION FOR PREVENTING, IMPROVING OR TREATING HAIR LOSS COMPRISING DEOXYCHOLIC ACID AS ACTIVE INGREDIENT | GWON HYEON CHEOL | SAMSUNG LIFE PUBLIC WELFARE FOUNDATION |
| EP3511018 | STABLE FORMULATIONS OF IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS AND USES THEREOF | MEYVIS YVES | ABLYNX NV |
| EP3511020 | MANUFACTURE OF SURFACTANT-CONTAINING COMPOSITIONS | KRAUS GOTTFRIED | NOVARTIS AG |
| EP3511327 | TYROSINE KINASE INHIBITOR AND APPLICATION THEREOF | SUN FANG | SHANGHAI XIANGJIN BIOTECHNOLOGY CO LTD |
| EP3511328 | MONOBACTAM ORGANIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS | AULAKH VIRENDER SINGH | NOVARTIS AG |
| EP3511333 | CRYSTAL FORM AND SALT FORM OF 7H-PYRROLO[2,3-D]PYRIMIDINE COMPOUND AND PREPARATION METHOD THEREFOR | MAO WEIWEI | WUXI FORTUNE PHARMACEUTICAL CO LTD |
| EP3511420 | METHODS AND COMPOSITIONS FOR INHIBITING VIRAL ENTRY INTO CELLS | HOLMES MICHAEL C | SANGAMO THERAPEUTICS INC |
| EP3512524 | METHOD AND COMPOSITIONS FOR TREATING VIRAL INFECTION | NEWMAN ROBERT A | PHOENIX BIOTECHNOLOGY INC |
| EP3512556 | COMBINED TREATMENT WITH A TLR7 AGONIST AND AN HBV CAPSID ASSEMBLY INHIBITOR | DAI LUE | HOFFMANN LA ROCHE |
| EP3512562 | ANTINEOPLASTIC FUSION PROTEIN | PAWLAK SEBASTIAN DOMINIK | ADAMED PHARMA S A |
| EP3512626 | FORMALDEHYDE-FREE ACTIVE SUBSTANCE CAPSULES | ROST BENJAMIN | SYMRISE AG |
| EP3512832 | TETRAHYDROISOQUINOLINE KAPPA OPIOID ANTAGONISTS | CARROLL FRANK IVY | RES TRIANGLE INST |
| EP3512835 | A PROCESS FOR PURIFICATION OF CARFILZOMIB INTERMEDIATE | CABRI WALTER | FRESENIUS KABI ONCOLOGY LTD |
| EP3512849 | 7-SUBSTITUTED 1-ARYL-NAPHTHYRIDINE-3-CARBOXYLIC ACID AMIDES AND USE THEREOF | TELLER HENRIK | BAYER AG |
| EP3512856 | NOVEL CYTOTOXIC AGENTS AND CONJUGATES THEREOF | JAIN NARESHKUMAR | POLYTHERICS LTD |
| EP3512857 | SPIRO BICYCLIC INHIBITORS OF MENIN-MLL INTERACTION | ANGIBAUD PATRICK RENé | JANSSEN PHARMACEUTICA NV |
| EP3512861 | CYCLIC DINUCLEOTIDES AS STING (STIMULATOR OF INTERFERON GENES) AGONISTS | YOSHIKAWA MASATO | TAKEDA PHARMACEUTICALS CO |
| EP3512864 | AMIDE DERIVATIVES OF SQUALAMINE FOR THE TREATMENT OF INFECTIONS | BRUNEL JEAN-MICHEL | VIRBAC |
| EP3512865 | ESTERS OF 3-POLYAMINE DERIVATIVES OF BILE ACIDS FOR THE TREATMENT OF INFECTIONS | BRUNEL JEAN-MICHEL | VIRBAC |
| EP3512876 | FACTOR VIIA GLYCOFORMS | FELDMAN RICHARD IRA | BAYER HEALTHCARE LLC |
| EP3512882 | ANTI-C-MET ANTIBODIES AND ANTIBODY DRUG CONJUGATES THEREOF FOR EFFICIENT TUMOR INHIBITION | DOERNER ACHIM | MERCK PATENT GMBH |
| EP3513190 | ARTIFICIAL CELLS | CASTELL OLIVER | UNIV COLLEGE CARDIFF CONSULTANTS LTD |
| EP3513791 | DRUG, METHOD, USE AND COMPOUND FOR PREVENTING OR TREATING MLL-RELATED LEUKEMIA | IWAMURA HIROYUKI | FUJIFILM CORP |
| EP3513793 | HETEROCYCLYLAMINES AS PI3K INHIBITORS | LI YUN-LONG | INCYTE HOLDINGS CORP |
| EP3513803 | HEMOSTATIC COMPOSITIONS | GAGNIEU CHRISTIAN | BIOMUP |
| EP3514153 | PYRIMIDINE COMPOUND AND PHARMACEUTICAL USE THEREOF | HAM YOUNG JIN | HANMI PHARM IND CO LTD |
| EP3514160 | NAHLSGEN OPTICAL RESOLUTION METHOD | WATANABE BUNTA | UNIV KYOTO |
| EP3514173 | DKK-1 ANTIBODIES | CHEDID MARCIO | LILLY CO ELI |
| EP3514176 | ANTIBODY SPECIFICALLY BINDING TO IL-17A AND FUNCTIONAL FRAGMENT THEREOF | SONG NANMENG | BEIJING HANMI PHARMACEUTICAL CO LTD |
| EP3514238 | PROTEOGLYCAN DEGRADING MUTANTS FOR TREATMENT OF CNS | GRUSKIN ELLIOTT A | ACORDA THERAPEUTICS INC |
| EP3515397 | STABLE FOAM COMPOSITIONS AND METHODS OF USING THE SAME TO PROVIDE ENHANCED SENSORY AND VISUAL BENEFITS TO SKIN | CHAKRAVARTY SUDEEP | PROCTER & GAMBLE |
| EP3515399 | COSMETIC OR PHARMACEUTICAL COMPOSITION FOR SKIN TAUGHTENING, SKIN FIXATION AND WRINKLE REDUCTION | BUSCH KLAUS-UWE | MAYSER PHARMA AG |
| EP3515400 | COMPOSITIONS COMPRISING SPECIFIC SURFACTANTS AND HIGH LEVELS OF GLYCERIN | YANG LIN | UNILEVER PLC |
| EP3515403 | USE OF AN AMPHOLYTE COPOLYMER AS COLLOIDAL STABILIZER IN A PROCESS OF ENCAPSULATING FRAGRANCE | BLONDEL FRéDéRIC | SPCM SA |
| EP3515415 | NANOPARTICULATE PRODRUGS | FATTAL ELIAS | CENTRE NAT RECH SCIENT |
| EP3515418 | USE OF C-MET INHIBITORS TO TREAT CANCERS HARBOURING MET MUTATIONS | FRIGAULT MELANIE MAE | ASTRAZENECA AB |
| EP3515425 | PHARMACEUTICAL COMPOSITION | CORR STUART | MEXICHEM FLUOR SA DE CV |
| EP3515429 | COMPOSITIONS AND USES THEREOF FOR TREATING INFLAMMATORY DISEASES AND PROBIOTIC COMPOSITIONS | BRADLEY BENJAMIN | CHAIN BIOTECHNOLOGY LTD |
| EP3515432 | PHARMACEUTICAL COMPOSITION | CORR STUART | MEXICHEM FLUOR SA DE CV |
| EP3515439 | PHARMACEUTICAL COMPOSITION | CORR STUART | MEXICHEM FLUOR SA DE CV |
| EP3515441 | PHARMACEUTICAL COMPOSITION | CORR STUART | MEXICHEM FLUOR SA DE CV |
| EP3515455 | COMPOUNDS FOR TREATMENT OF LIPOPROTEIN METABOLISM DISORDERS | GUSTAFSEN CAMILLA | UNIV AARHUS |
| EP3515458 | THIOSULFATE FOR TREATING HEPATIC ISCHEMIA/REPERFUSION INJURY | SETTMACHER UTZ | UNIV JENA |
| EP3515469 | TREATMENT OF AGE-RELATED MACULAR DEGENERATION | CAMPBELL MATTHEW | THE PROVOST FELLOWS FOUND SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIV T |
| EP3515498 | INHIBITORS OF GPR132 FOR USE IN PREVENTING AND/OR TREATING CHEMOTHERAPY-INDUCED NEUROPATHIC PAIN | SCHIFFMANN SUSANNE | FRAUNHOFER GES FORSCHUNG |
| EP3515563 | DETERGENT PRODUCT FOR COSMETIC USE | RODOLFI ALBERTO | COPMA S C A R L |
| EP3515887 | TRPV4 ANTAGONISTS | BRNARDIC EDWARD J | GLAXOSMITHKLINE IP NO 2 LTD |
| EP3515888 | TRPV4 ANTAGONISTS | BRNARDIC EDWARD J | GLAXOSMITHKLINE IP NO 2 LTD |
| EP3515894 | INDAZOLE COMPOUNDS FOR USE IN TENDON AND/OR LIGAMENT INJURIES | BURSULAYA BADRY | NOVARTIS AG |
| EP3515895 | COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION AND/OR FIBROSIS | DUGGAN KAREN ANNETTE | VECTUS BIOSYSTEMS LTD |
| EP3515897 | PIPERAZINE CARBAMATES AND METHODS OF MAKING AND USING SAME | GRICE CHERYL A | ABIDE THERAPEUTICS INC |
| EP3515920 | NEW ANTIMICROBIAL COMPOUNDS, THEIR USE FOR THE TREATMENT OF MAMMALIAN INFECTIONS AND A NEW METABOLIC MECHANISM | KLOSS FLORIAN | LEIBNIZ INST FUER NATURSTOFF FORSCHUNG UND INFEKTIONSBIOLOGIE E V HANS KNOELL INST HKI |
| EP3515924 | CRYSTALLINE FORMS | LEUENBERGER DANIEL | IDORSIA PHARMACEUTICALS LTD |
| EP3515929 | HEPATITIS B THERAPEUTIC VACCINES | WU CHIA-MAO | THEVAX GENETICS VACCINE CO LTD |
| EP3516052 | RECOMBINANT DGKK GENE FOR FRAGILE X SYNDROME GENE THERAPY | MOINE HERVé | UNIV STRASBOURG |
| EP3516060 | ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF EYE DISEASE | VAN DIEPEN HESTER CATHARINA | PROQR THERAPEUTICS II BV |
| EP3516665 | SHIELDING ASSEMBLY FOR A RADIOISOTOPE DELIVERY SYSTEM HAVING MULTIPLE RADIATION DETECTORS | SCHIMMOELLER ANDREW | BRACCO DIAGNOSTICS INC |
| EP3517105 | TRANSDERMAL ADHESIVE COMPOSITIONS, DEVICES, AND METHODS | DIZIO JAMES P | 3M INNOVATIVE PROPERTIES CO |
| EP3517112 | HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME | DUFFEY MATTHEW | MILLENNIUM PHARM INC |
| EP3517119 | COMPOSITION COMPRISING NEW LACTOBACILLUS SALIVARIUS STRAIN AND METHOD FOR THE PREVENTION AND TREATMENT OF OTITIS AND UPPER RESPIRATORY INFECTIONS | JIMéNEZ QUINTANA ESTHER ANTONIA | PROBISEARCH S L U |
| EP3517175 | COMPOSITION FOR IMPROVING EYE HEALTH COMPRISING TETRASELMIS | PAN CHEOL-HO | KOREA INST SCI & TECH |
| EP3517528 | ACID ADDITION SALT OF BENZIMIDAZOLE DERIVATIVE | KIM EUN SUN | CJ HEALTHCARE CORP |
| EP3517532 | METHODS OF PRODUCING ANAMORELIN HYDROCHLORIDE HAVING CONTROLLED CHLORIDE CONTENT | KUWABE SHIN-ITSU | HELSINN HEALTHCARE SA |
| EP3517536 | AMINOTRIAZINE DERIVATIVES USEFUL AS TANK-BINDING KINASE INHIBITOR COMPOUNDS | DU ZHIMIN | GILEAD SCIENCES INC |
| EP3517599 | COMPOSITION FOR IMPROVING SKIN CONDITION INCLUDING FERMENTED PEARL PRODUCT | BAEK EUN JONG | SEMPIO FOODS CO |
| EP3518867 | ORAL CARE COMPOSITION | DELFANTI CRISTINA | UNILEVER PLC A COMPANY REGISTERED IN ENGLAND AND WALES UNDER COMPANY NO 41424 OF |
| EP3518868 | ORAL CARE COMPOSITION | JOINER ANDREW | UNILEVER PLC NO 41424 |
| EP3518882 | ORAL CARE COMPOSITIONS AND DISPENSING SYSTEM THEREFOR | PIERCE ROBERT | COLGATE PALMOLIVE CO |
| EP3518905 | PHARMACEUTICAL COMPOSITIONS OF 5-HT6 ANTAGONIST | NIROGI RAMAKRISHNA | SUVEN LIFE SCIENCES LTD |
| EP3518911 | METHODS FOR TREATING OVARIAN CANCER | HATTERSLEY GARY | RADIUS HEALTH INC |
| EP3518916 | COMPOSITION COMPRISING AT LEAST ONE WATER-SOLUBLE PHARMACEUTICALLY ACCEPTABLE SALT OF ELAFIBRANOR HAVING IMPROVED INTESTINAL ABSORPTION | LARUELLE CLAUDE | NASHPHARM |
| EP3518921 | COMPOSITIONS COMPRISING A CANNABINOID RECEPTOR BINDING LIGAND | GüNTHER BERNHARD | NOVALIQ GMBH |
| EP3518962 | METHODS FOR REDUCING LIVER FIBROSIS AND TREATING LYSOSOMAL ACID LIPASE DEFICIENCY IN PATIENTS BASED ON ISHAK FIBROSIS STAGE | QUINN ANTHONY | ALEXION PHARMA INC |
| EP3518984 | NANOCLUSTER CAPPED MESOPOROUS NANOPARTICLES, METHODS OF MAKING AND USE | ALSAIARI SHAHAD | UNIV KING ABDULLAH SCI & TECH |
| EP3518986 | BIODEGRADABLE, SECOND-HARMONIC-GENERATING NANOPROBE FOR BIOMEDICAL IMAGING APPLICATIONS | PANTAZIS PERIKLIS | ETH ZUERICH |
| EP3519051 | TREATMENT CANCERS USING COMBINATION COMPRISING PARP INHIBITORS | WANG LAI | BEIGENE LTD |
| EP3519387 | TETRAHYDROPYRIDINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS | CHOI SUN-HO | DONG A ST CO LTD |
| EP3519397 | CYANO-SUBTITUTED HETEROCYCLES WITH ACTIVITY AS INHIBITORS OF USP30 | STOCKLEY MARTIN LEE | MISSION THERAPEUTICS LTD |
| EP3519398 | PYRIDINE COMPOUND | INAGAKI HIROAKI | DAIICHI SANKYO CO LTD |
| EP3519401 | MODULATOR OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS, METHODS OF TREATMENT, AND PROCESS FOR MAKING THE MODULATOR | ALCACIO TIMOTHY | VERTEX PHARMA |
| EP3519403 | COMPOUNDS AND THEIR USE AS PDE4 ACTIVATORS | ADAM JULIA MARY | MIRONID LTD |
| EP3519407 | DIMETHYLAMINOETHANOL SALT OF A GLP-1 RECEPTOR MODULATOR | VIDAL EPHRAIM | CELGENE INT II SARL |
| EP3519412 | CYANOPYRROLIDINE DERIVATIVES WITH ACTIVITY AS INHIBITORS OF USP30 | STOCKLEY MARTIN LEE | MISSION THERAPEUTICS LTD |
| EP3519416 | CHROMANE, ISOCHROMANE AND DIHYDROISOBENZOFURAN DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE | SEBHAT IYASSU K | MERCK SHARP & DOHME |
| EP3519418 | BRIDGED PIPERIDINE DERIVATIVES | BARTELS BJOERN | HOFFMANN LA ROCHE |
| EP3519423 | ENDOSOMOLYTIC AGENTS FOR GENE THERAPY | BAKER TERENCE SEWARD | UCB BIOPHARMA SPRL |
| EP3519429 | BACTERIAL INHIBITORS | XIE HUA | MEHARRY MEDICAL COLLEGE |
| EP3519437 | BISPECIFIC ANTIBODIES AGAINST CD3 | KLEIN CHRISTIAN | HOFFMANN LA ROCHE |
| EP3519578 | COMPOSITIONS FOR TRANSFECTING RESISTANT CELL TYPES | THOMAS ANITHA | PREC NANOSYSTEMS INC |
| EP3520769 | HAIR COLORING COMPOSITIONS AND METHODS THEREOF | SCHROTT ADAM | KAO USA INC |
| EP3520779 | DPI FORMULATION CONTAINING SULFOALKYL ETHER CYCLODEXTRIN | PIPKIN JAMES D | CYDEX PHARMACEUTICALS INC |
| EP3520805 | COMPOSITIONS FOR TREATING MYELOFIBROSIS | SEEHRA JASBIR | ACCELERON PHARMA INC |
| EP3520808 | COMPOSITIONS FOR TREATING CELIAC SPRUE DISEASE | SIEGEL JUSTIN BLOOMFIELD | UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION |
| EP3520815 | ANTIBODIES TO TGFBETA | LEDBETTER STEVEN R | GENZYME CORP |
| EP3520823 | GENE THERAPY FOR NEUROMETABOLIC DISORDERS | PASSINI MARCO A | GENZYME CORP |
| EP3521276 | CRYSTAL FORM AND SALT FORM OF AND PREPARATION METHOD FOR TYROSINE KINASE INHIBITOR | LONG CHAOFENG | GUANGDONG RAYNOVENT BIOTECH CO LTD |
| EP3521281 | 1-[(PYRIDIN-3-YL-SULFONYL)-1H-PYRROL-3-YL]METHANAMINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | GENG ZHONGYI | JIANGSU JIBEIER PHARMACEUTICAL CO LTD |
| EP3521282 | QUINAZOLINE DERIVATIVES USED TO TREAT HIV | JANSA PETR | GILEAD SCIENCES INC |
| EP3521288 | HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS AS INHIBITORS OF BTK ACTIVITY | CRAWFORD JAMES JOHN | HOFFMANN LA ROCHE |
| EP3521295 | APPLICATION OF METAL COMPLEXES IN ANTI-TUMOR AND ANTI-BACTERIAL THERAPY | GUTSCHE CLAUDIA SIMONE | BIOLITEC UNTERNEHMENSBETEILIGUNGS II AG |
| EP3521297 | MODIFIED FLUORINATED NUCLEOSIDE ANALOGUES | CLARK JEREMY | GILEAD PHARMASSET LLC |
| EP3521312 | A COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMENT OF PERIPHERAL T CELL LYMPHOMA | BONNAFOUS CéCILE | INNATE PHARMA SA |
| EP3522817 | APPLICATION DEVICE WITH REDOX INITIATOR SYSTEM, METHOD OF PRODUCTION AND USE THEREOF | THALACKER CHRISTOPH | 3M INNOVATIVE PROPERTIES CO |
| EP3522852 | SHADE-COORDINATED, VENEERING PORCELAIN SYSTEM FOR DENTAL PROSTHESES | BANASIAK SLAWOMIR | DENTSPLY SIRONA INC |
| EP3522855 | PROCESS FOR MANUFACTURE OF NON-AQUEOUS ORAL CARE COMPOSITIONS | FORREST RICHARD AARON | UNILEVER PLC |
| EP3522858 | PERSONAL CARE COMPOSITIONS SUBSTANTIALLY FREE OF SULFATED SURFACTANTS AND CONTAINING A GEL NETWORK | HUTTON HOWARD DAVID III | PROCTER & GAMBLE |
| EP3522862 | HAIR COSMETIC COMPOSITIONS CONTAINING THIOL-BASED COMPOUNDS AND METHODS FOR CLEANSING AND TREATING HAIR | GREGOLIN MARINA TAVARES | OREAL |
| EP3522871 | LYOPHILIZATION METHODS THAT PROVIDE STABLY DEHYDRATED PROTOZOANS FOR USE AS POTENT LIVE VACCINES | DAOUSSI RIM | ZOETIS SERVICES LLC |
| EP3522872 | AMLODIPINE FORMULATIONS | BRAUER SCOTT | SILVERGATE PHARMACEUTICALS INC |
| EP3522876 | METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA) | GARCIA-GARCIA JOSE CARLOS | PROCTER & GAMBLE |
| EP3522878 | METHODS FOR INHIBITING CONVERSION OF CHOLINE TO TRIMETHYLAMINE (TMA) | GARCIA-GARCIA JOSE CARLOS | PROCTER & GAMBLE |
| EP3522903 | NUTRITIONAL SUPPLEMENTS AFFECTING CARDIOVASCULAR EFFICIENCY | LI YANMEI | BEIJING GINGKO GROUP BIOLOGICAL TECH CO LTD |
| EP3522904 | LIQUID COMPOSITION FOR USE IN THE TREATMENT OF GASTROESOPHAGEAL REFLUX | BIFFI ANDREA | SOFAR SWISS SA |
| EP3522911 | COMPOSITIONS COMPRISING RELAXIN AND METHODS OF USE THEREOF | NAZARIAN ARA | BETH ISRAEL DEACONESS MEDICAL CT INC |
| EP3522919 | VACCINE | GERARD CATHERINE MARIE GHISLAINE | GLAXOSMITHKLINE BIOLOGICALS SA |
| EP3522928 | TRANSLOCATION OF SYNTHETIC POLYMERS BY LIPID MEMBRANES | FLEURY JEAN BAPTIST | FORSCHUNGSZENTRUM JUELICH GMBH |
| EP3522933 | METHODS FOR PREPARING ANTIBODY DRUG CONJUGATES | PILLOW THOMAS | HOFFMANN LA ROCHE |
| EP3522985 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF KIDNEY CANCER | SIEGFRIED GéRALDINE | INST NAT SANTE RECH MED |
| EP3522993 | MONOSUBSTITUTED UREA DERIVATIVES AS A SELF-TANNING SUBSTANCE | OSTHOFF JULIAN | MERCK PATENT GMBH |
| EP3523277 | SUBSTITUTED PYRROLIDINES AS CFTR MODULATORS | ALTENBACH ROBERT J | ABBVIE SARL |
| EP3523283 | CRYSTALLINE AND SALT FORMS OF PPAR AGONIST COMPOUNDS | LAGU BHARAT | MITOBRIDGE INC |
| EP3523287 | BENZO[b]THIOPHENE COMPOUNDS AS STING AGONISTS | ALTMAN MICHAEL D | MERCK SHARP & DOHME |
| EP3523291 | CYANO-SUBSTITUTED HETEROCYCLES WITH ACTIVITY AS INHIBITORS OF USP30 | STOCKLEY MARTIN LEE | MISSION THERAPEUTICS LTD |
| EP3523292 | HETEROARYL COMPOUNDS AND THEIR USE AS MER INHIBITORS | KIM HADONG | DONG A SOCIO HOLDINGS CO LTD |
| EP3523293 | SUBSTITUTED PYRROLIDINES AND THEIR USE IN THE TREATMENT OF CYSTIC FIIBROSIS | ALTENBACH ROBERT J | ABBVIE SARL |
| EP3523295 | DEUTERATED N-(5-(2,3-DIHYDROBENZO[B][1,4]DIOXINE-6-CARBOXAMIDO)-2-FLUOROPHENYL)-2-((4-ETHYLPIPERAZIN-1 -YL)METHYL)QUINOLINE-6-CARBOXAMIDE | JONES KEITH | CANCER RESEARCH TECH LTD |
| EP3523297 | NOVEL FURAZAN-3-CARBOXYLIC ACID DERIVATIVES AND USE THEREOF IN TREATMENT OF CANCER | RADEMANN JÖRG | UNIV BERLIN FREIE |
| EP3523304 | BICYCLIC HETEROARYL DERIVATIVES | BARTELS BJOERN | HOFFMANN LA ROCHE |
| EP3523305 | IMIDAZOPYRIDAZINE COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES | SPERGEL STEVEN H | SQUIBB BRISTOL MYERS CO |
| EP3523316 | MELANOCORTIN-1-RECEPTOR AGONISTS | HEIDL MARC | DSM IP ASSETS BV |
| EP3523320 | PEPTIDES FOR BINDING EPIDERMAL GROWTH FACTOR | DAI MINGHUA | 3M INNOVATIVE PROPERTIES CO |
| EP3523332 | ANTI-HUMAN 4-1 BB ANTIBODIES AND USE THEREOF | KWON BYOUNG S | EUTILEX CO LTD |
| EP3523811 | PRODUCTION OF RE-188/186 PARTICLES | NIKULA TUOMO | ONCOBETA INT GMBH |
| EP3524230 | PHARMACEUTICAL FORMULATIONS COMPRISING CCR3 ANTAGONISTS | FETSCHER ALFRED | ALKAHEST INC |
| EP3524249 | QUANTIFYING MGMT PROTEIN FOR OPTIMAL CANCER THERAPY OF GLIOBLASTOMA | HEMBROUGH TODD | NANTOMICS LLC |
| EP3524259 | METHODS, ARTICLES AND KITS FOR ALLERGIC DESENSITIZATION VIA THE ORAL MUCOSA | FRANCOIS CEDRIC | ALLOVATE LLC |
| EP3524270 | TREATING ATROPHIC AGE RELATED MACULAR DEGENERATION | ROBINSON MICHAEL R | ALLERGAN INC |
| EP3524276 | BIOCOMPATIBLE MAGNETIC MATERIALS | HSIEH WEN-YUAN | MEGAPRO BIOMEDICAL CO LTD |
| EP3524600 | PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF NOVEL SUBSTITUTED 6,7-DIHYDRO-5H-BENZO[7]ANNULENE COMPOUNDS | BOUABOULA MONSIF | SANOFI SA |
| EP3524601 | N-{3-[3-CYCLOPROPYL-5-(2-FLUORO-4-IODOPHENYLAMINO)-6,8-DIMETHYL-2,4,7-TRIOXO-3,4,6,7-TETRAHYDRO-2H-PYRIDO[4,3-D]PYRIMIDIN-1-YL]-PHENYL}-CYCLOPROPANECARBOXAMIDE DIMETHYL SULPHOXIDE SOLVATE AS AN MEK1/2 INHIBITOR | REPIK ALEXEY EVGENIEVICH | R PHARM JOINT STOCK COMPANY R PHARM JSC |
| EP3524679 | MICRO-RNA MIR-19 AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT OF MEDICAL CONDITIONS IN WHICH LOW ADRENALINE OR NORADRENALINE LEVEL IS THERAPEUTICALLY BENEFICIAL | CHEN ALON | YEDA RES & DEV |
| EP3524685 | INTERLEUKIN -13 BINDING PROTEINS | WU CHENGBIN | ABBVIE BAHAMAS LTD |
| EP3525762 | PHARMACEUTICAL COMPOSITION COMPRISING PRASUGREL BESYLATE | KARAVAS EVANGELOS | PHARMATHEN SA |
| EP3525768 | CONTAINER AND CLOSURE ASSEMBLY WITH PREDETERMINED HUMIDITY AND RELATED METHOD | BIESECKER LONGACRE LISSA | DRUG PLASTICS & GLASS COMPANY INC |
| EP3525769 | ORODISPERSIBLE TABLET CONTAINING BURLULIPASE AND PHARMACEUTICAL COMPOSITION PRODUCED THEREFROM | FUHRHERR RICHARD | NORDMARK ARZNEIMITTEL GMBH & CO KG |
| EP3525774 | LASOFOXIFENE TREATMENT OF ER+ BREAST CANCER | ANDREANO KAITLYN | UNIV DUKE |
| EP3525780 | METHODS OF TREATMENT OF INFLAMMATION RELATED CONDITIONS USING PLURIPOTENT ANTI-INFLAMMATORY AND METABOLIC MODULATORS | BATTHYáNY CARLOS | INST PASTEUR DE MONTEVIDEO |
| EP3525781 | COMPOSITION COMPRISING EPA AND DHA FOR AN ENHANCED EFFICACY OF ANTICANCER AGENTS | WESTPHAL MARTIN | FRESENIUS KABI DEUTSCHLAND GMBH |
| EP3525802 | CANCER STEM CELL EXOSOMES | NIAZI KAYVAN | VBC HOLDINGS LLC |
| EP3525807 | INHIBITOR OF RNA POLYMERASE II | SVANBORG CATHARINA | LINNANE PHARMA AB |
| EP3525830 | PYRROLOBENZODIAZEPINE CONJUGATES | HOWARD PHILIP WILSON | MEDIMMUNE LTD |
| EP3525834 | COACERVATE HYALURONAN HYDROGELS FOR DERMAL FILLER APPLICATIONS | LIU FUTIAN | ALLERGAN INC |
| EP3526207 | HETEROCYCLIC COMPOUNDS HAVING ACTIVITY AS MODULATORS OF MUSCARINIC M1 AND/OR M4 RECEPTORS IN THE TREATMENT OF CNS DISEASES AND PAINS. | BROWN GILES ALBERT | HEPTARES THERAPEUTICS LTD |
| EP3526212 | SUBSTITUTED 6-(1H-PYRAZOL-1-YL)PYRIMIDIN-4-AMINE DERIVATIVES AND USES THEREOF | GIESE ANJA | BAYER AG |
| EP3526218 | HETEROCYCLIC SULFONES AS ROR GAMMA MODULATORS | LIU QINGJIE | SQUIBB BRISTOL MYERS CO |
| EP3526219 | BICYCLIC PYRIDONE LACTAMS AND METHODS OF USE THEREOF | PATEL SNAHEL | HOFFMANN LA ROCHE |
| EP3526223 | METHOD FOR ISOLATION AND PURIFICATION OF NALTREXONE | KAVALA MIROSLAV | SANECA PHARMACEUTICALS A S |
| EP3526239 | HIF 1-ALPHA ANTISENSE OLIGONUCLEOTIDES | CHUNG SHIN | OLIPASS CORP |
| EP3527192 | AMINO ACID DERIVATIVES AND THEIR USES | GAMBOGI ROBERT J | JOHNSON & JOHNSON CONSUMER INC |
| EP3527195 | PHARMACEUTICAL PREPARATION CONTAINING POLYETHYLENE GYLCOL LOXENATIDE AND PREPARATION METHOD THEREOF | DONG LI | JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD |
| EP3527201 | LIPID NANOPARTICLE FILM MATERIAL COMPOSITION | CHENG GUANG | NANJING LUYE PHARMACEUTICAL CO LTD |
| EP3527210 | COMPOSITION, APPLICATION THEREOF AND TREATMENT METHOD | GE CHUANSHENG | KANGPU BIOPHARMACEUTICALS LTD |
| EP3527213 | TREATMENT OF CANCER USING A SMAD3 INHIBITOR | LAN HUI YAO | UNIV HONG KONG CHINESE |
| EP3527215 | AGENT FOR PROMOTING EXPRESSION OF N-ACETYLGALACTOSAMINYLTRANSFERASE CONTAINING EXTRACT FROM INFLAMED TISSUES INOCULATED WITH VACCINIA VIRUS | SAKAI DAISUKE | TOKAI UNIV EDUCATIONAL SYSTEM |
| EP3527222 | THERAPEUTIC COMPOSITIONS AND METHODS FOR ANTIBODY AND FC-CONTAINING TARGETING MOLECULE-BASED TARGETED DELIVERY OF BIOACTIVE MOLECULES BY BACTERIAL MINICELLS | GIACALONE MATTHEW | VAXIION THERAPEUTICS LLC |
| EP3527563 | DNA-PK INHIBITORS | MAXWELL JOHN PATRICK | VERTEX PHARMA |
| EP3527569 | DIHYDROPYRROLOPYRIDINE INHIBITORS OF ROR-GAMMA FOR USE IN TREATING DRYE EYE | CLAREMON DAVID A | VITAE PHARMACEUTICALS LLC |
| EP3527572 | PYRAZOLOPYRIMIDINE COMPOUND AS PI3K INHIBITOR AND USE THEREOF | YE BAOHUAN | SHENZHEN BO LI JIAN MEDICINE CO LTD |
| EP3527592 | (METH)ACRYLIC SILICONE GRAFT COPOLYMER AND A METHOD FOR PREPARING THE SAME | HATA RYUNOSUKE | SHINETSU CHEMICAL CO |
| EP3528777 | SKIN CLEANSING COMPOSITIONS AND METHODS | SMITH III EDWARD DEWEY | PROCTER & GAMBLE |
| EP3528788 | LIPID FORMULATIONS OF CARMUSTINE | GONDALIYA DEEPAK PRAGJIBHAI | EMCURE PHARMACEUTICALS LTD |
| EP3528808 | METHODS OF USING INDAZOLE-3-CARBOXAMIDES AND THEIR USE AS WNT/B-CATENIN SIGNALING PATHWAY INHIBITORS | DESHMUKH VISHAL | SAMUMED LLC |
| EP3528811 | METHODS OF TREATING DEPRESSION | SRINIVASAN SUNDAR | RUNDLE RES LLC |
| EP3528818 | PHARMACEUTICAL COMPOSITIONS | HULL WADE | HULL WADE |
| EP3528825 | METHODS AND COMPOSITIONS FOR CHANGING THE COMPOSITION OF THE SKIN MICROBIOME USING COMPLEX MIXTURES OF BACTERIAL STRAINS | PÄTZOLD BERNHARD | S BIOMEDIC NV |
| EP3528835 | ANTIVIRAL COMPOSITIONS FOR THE TREATMENT OF INFECTIONS LINKED TO CORONAVIRUSES | ROSA-CALATRAVA MANUEL | UNIV CLAUDE BERNARD LYON |
| EP3528902 | RINGING GEL COMPOSITION | TCHAKALOVA VERA | FIRMENICH & CIE |
| EP3529247 | HETEROCYCLIC FXR MODULATORS | XU XIAODONG | HEPAGENE THERAPEUTICS INC |
| EP3529361 | SECRETABLE VARIANT IMMUNOMODULATORY PROTEINS AND ENGINEERED CELL THERAPY | SWANSON RYAN | ALPINE IMMUNE SCIENCES INC |
| EP3530257 | SELF-ADHESIVE DENTAL COMPOSITE RESIN | ISHIHARA SHUMEI | KURARAY NORITAKE DENTAL INC |
| EP3530258 | MULTI-PACK TYPE DENTAL CEMENT | KAWANA MARIKO | KURARAY NORITAKE DENTAL INC |
| EP3530267 | COMPOSITION FOR ALLEVIATING, PREVENTING OR TREATING FEMALE MENOPAUSAL SYMPTOMS, CONTAINING, AS ACTIVE INGREDIENT, PINITOL, D-CHIRO-INOSITOL OR ANALOG COMPOUNDS THEREOF | MYEONG HYEON-KOON | DY NATURAL CO LTD |
| EP3530268 | THERAPEUTIC TREATMENT | SEARS DOUGLAS | SEARS DOUGLAS |
| EP3530279 | PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING FEMALE SEXUAL DYSFUNCTIONS | MYASOEDOV NIKOLAI FEDOROVICH | COMPANY LTD IVIX |
| EP3530663 | PROCESS FOR PREPARING GEM-DIFLUORINATED C-GLYCOSIDE COMPOUNDS | SLILATY STEVE N | ADVANOMICS CORP |
| EP3530667 | PEPTIDE HAVING ANTI-OBESITY AND ANTI-DIABETES EFFICACY AND USE THEREOF | CHUNG YONG JI | CAREGEN CO LTD |
| EP3532005 | PHARMACEUTICAL PACKS COMPRISING HOLOGRAPHIC LIDDING MATERIAL, AND METHOD OF MAKING THE SAME | DEVENS CLAUDE SCOTT | HOLOGRAPHYX INC |
| EP3532008 | TREATMENT OF GYNOID LIPODYSTROPHY | ABTS HARRY FRANK | MERZ PHARMA GMBH & CO KGAA |
| EP3532010 | DELAYED RELEASE DELIVERY SYSTEMS AND METHODS | LEE WILSON A (DR ) | ELC MAN LLC |
| EP3532014 | MULTI-PHASE ORAL COMPOSITION | RAJAIAH JAYANTH | PROCTER & GAMBLE |
| EP3532015 | PRODUCT COMPOSITION COMPRISING A DISCRETE PARTICLE AND AN AQUEOUS BASE COMPOSITION | YOKOGI JUNICHI | PROCTER & GAMBLE |
| EP3532023 | COMPOSITIONS CONTAINING PHENOLIC COMPOUNDS HAVING SYNERGISTIC ANTIOXIDANT BENEFITS | PAN ZHI | OREAL |
| EP3532024 | COSMETIC USE AND METHOD FOR IMPROVING PHYSIOLOGICAL FUNCTIONS OF THE SKIN BY INCREASING THE EXPRESSION OF UBIAD1 | CUCUMEL KARINE | ISP INVESTMENTS LLC |
| EP3532025 | PERSONAL CARE COMPOSITIONS COMPRISING SURFACE-MODIFIED PARTICLES AND NON-VOLATILE FUNCTIONALISED SILICONE | JONES CHRISTOPHER CLARKSON | UNILEVER NV |
| EP3532029 | LIQUID PHARMACEUTICAL COMPOSITION | JEZEK JAN | FRESENIUS KABI DEUTSCHLAND GMBH |
| EP3532036 | PROCESS FOR ISOLATING AND LYOPHILIZING EXTRACELLULAR VESICLES | PERTEGHELLA SARA | PHARMAEXCEED S R L |
| EP3532076 | NOVEL IMMUNOTHERAPEUTIC TREATMENTS FOR TUMOURS | GJERTSEN BJØRN TORE | BERGEN TEKNOLOGIOVERFOERING AS |
| EP3532098 | COMBINATION OF ANTI CD19 ANTIBODY WITH A BCL-2 INHIBITOR AND USES THEREOF | ENDELL JAN | MORPHOSYS AG |
| EP3532101 | USE OF ANTIBODIES TO TIMP-2 FOR THE IMPROVEMENT OF RENAL FUNCTION | MCPHERSON PAUL | ASTUTE MEDICAL INC |
| EP3532111 | BONE BIOACTIVE COMPOSITION AND USES THEREOF | AL ATARI ABOUASI MAHER | BIOINTELLIGENCE SYSTEMS S L |
| EP3532165 | USE OF CATIONIC POLYMER HAVING QUATERNARY AMMONIUM GROUPS FOR THE PROTECTION OF HAIR AGAINST UV DAMAGE | MENDROK-EDINGER CHRISTINE | DSM IP ASSETS BV |
| EP3532170 | AEROSOL SPRAY CONTAINING VIABLE BACTERIAL SPECIES | HENKENS TIM | YUN NV |
| EP3532458 | BENZYLAMINOPYRIDYLCYCLOPROPANECARBOXYLIC ACIDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | ECKHARDT MATTHIAS | BOEHRINGER INGELHEIM INT |
| EP3532462 | ACYL SULFONAMIDE NAV1.7 INHIBITORS | WU YONG-JIN | SQUIBB BRISTOL MYERS CO |
| EP3532478 | CRYSTALLINE FORMS OF DARUNAVIR FREE BASE, HYDRATE, SOLVATES AND SALTS | LAI CHIAJEN | GILEAD SCIENCES INC |
| EP3532486 | ANTIBODY-COUPLED CYCLIC PEPTIDE TYROSINE TYROSINE COMPOUNDS AS MODULATORS OF NEUROPEPTIDE Y RECEPTORS | MACIELAG MARK | JANSSEN PHARMACEUTICA NV |
| EP3532490 | ADAPTER CHIMERIC ANTIGEN RECEPTOR EXPRESSING CELLS FOR TARGETING OF MULTIPLE ANTIGENS | KAISER ANDREW | MILTENYI BIOTEC GMBH |
| EP3532499 | ANTI-IL-33 ANTIBODIES AND USES THEREOF | BENSCHOP ROBERT JAN | LILLY CO ELI |
| EP3532593 | DELAYED RELEASE DELIVERY SYSTEMS AND METHODS | LEE WILSON A (DR ) | ELC MAN LLC |
| EP3532594 | DELAYED RELEASE DELIVERY SYSTEMS AND METHODS | LEE WILSON A (DR ) | ELC MAN LLC |
| EP3532609 | CANCER-KILLING CELLS | BLYTH ALEX | LIFT BIOSCIENCES LTD |
| EP3532642 | DIGITAL ANALYSIS OF BLOOD SAMPLES TO DETERMINE EFFICACY OF CANCER THERAPIES FOR SPECIFIC CANCERS | HABER DANIEL | MASSACHUSETTS GEN HOSPITAL |
| EP3533346 | REFINED CHLOROGENIC ACID-CONTAINING COMPOSITION | HOTTA YUSUKE | KAO CORP |
| EP3533438 | GELATINOUS COMPOSITION | TSUJI TADAO | KANEKA CORP |
| EP3533440 | OIL-IN-WATER TYPE DERMATOLOGICAL COMPOSITION FOR EXTERNAL USE | YABUSAKI YUSUKE | SHISEIDO CO LTD |
| EP3533457 | ANTI-INFLAMMATORY PHARMACEUTICAL PRODUCTS | CONSALVO ANGELO P | RESOTHER PHARMA APS |
| EP3533792 | CRYSTALLINE FORMS OF AN ANDROGEN RECEPTOR MODULATOR | DILHAS ANNA | ARAGON PHARMACEUTICALS INC |
| EP3533796 | AMINO PYRAZOLOPYRIMIDINE COMPOUND USED AS NEUROTROPHIC FACTOR TYROSINE KINASE RECEPTOR INHIBITOR | ZHU LI | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD |
| EP3533803 | AMYLOID-BETA BINDING ANTIBODIES | BARGHORN STEFAN | ABBVIE INC |
| EP3534868 | COSMETIC PAD AND METHOD FOR PRODUCING A COSMETIC PAD | KAI-WING MAN | KAI WING MAN |
| EP3534871 | ALUMINUM-FREE ANTIPERSPIRANT/DEODORANT COMPOSITIONS | HILLIARD JR PETER R | COLGATE PALMOLIVE CO |
| EP3534874 | COSMETIC METHOD | NEGOSANTI FRANCESCA | CENTRO DERMATOLOGICO S R L |
| EP3534885 | FARNESYLTRANSFERASE INHIBITORS FOR USE IN METHODS OF TREATING CANCER | GUALBERTO ANTONIO | KURA ONCOLOGY INC |
| EP3535238 | AMINOOXYLIPIDS FOR THE CONSTRUCTION OF SELF-ASSEMBLING LIPOSOMAL SYSTEMS ENABLING THEIR SUBSEQUENT MODIFICATION BY BIOLOGICALLY FUNCTIONAL MOLECULES | LEDVINA MIROSLAV | VS CHEMICKO TECHNOLOGICKA V PRAZE |
| EP3535243 | TRICYCLIC HETEROCYCLIC DERIVATIVES AND USES THEREOF | MARSHALL ANDREW JAMES | AUCKLAND UNISERVICES LTD |
| EP3535258 | SUBSTITUTED BICYCLE HETEROCYCLIC DERIVATIVES USEFUL AS ROMK CHANNEL INHIBITORS | GUNAGA PRASHANTHA | SQUIBB BRISTOL MYERS CO |
| EP3535266 | BICYCLIC HETEROARYL DERIVATIVES | BARTELS BJOERN | HOFFMANN LA ROCHE |
| EP3535284 | DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS | SCHLOM JEFFREY | US HEALTH |
| EP3535298 | ANTIBODIES TO PD-1 AND USES THEREOF | MABRY GEORGE ROBERT III | JOUNCE THERAPEUTICS INC |
| EP3536302 | CURABLE COMPOSITION | AKIZUMI HIRONOBU | TOKUYAMA DENTAL CORP |
| EP3536307 | DERMAL FILLER COMPOSITIONS INCLUDING ANTIOXIDANTS | LIU FUTIAN | ALLERGAN INC |
| EP3536310 | SYRINGE | BRYANT ANDREW | NOVARTIS AG |
| EP3536311 | STORAGE STABLE COMPOSITION COMPRISING RIFAXIMIN ALPHA | SCHWARZ FRANZ XAVER | SANDOZ AG |
| EP3536315 | INHIBITOR OF ATP-DEPENDENT REVERSE TRANSPORTERS OF CELLS AND METHOD FOR PRODUCING SAME | SHTYRLIN YURJ GRIGOR'EVICH | AKTSIONERNOE OBSHCHESTVO TATKHIMFARMPREPARATY |
| EP3536324 | 4-OXO-3,4-DIHYDRO-1,2,3-BENZOTRIAZINES AS MODULATORS OF GPR139 | HITCHCOCK STEPHAN | TAKEDA PHARMACEUTICALS CO |
| EP3536328 | FOOD OR BEVERAGE PRODUCT, OR PROBIOTIC COMPOSITION, COMPRISING LACTOBACILLUS JOHNSONII 456 | YAMAMOTO MITSUKO L | UNIV CALIFORNIA |
| EP3536334 | CANCER STEM CELL TARGETED CANCER VACCINES | CIRRITO THOMAS P | STEMLINE THERAPEUTICS INC |
| EP3536339 | METHODS FOR IMPROVING ASTHMA SYMPTOMS USING BENRALIZUMAB | WARD CHRISTINE | ASTRAZENECA AB |
| EP3536380 | RAPID-ACTING INSULIN COMPOSITIONS | CHRISTE MICHAEL EDWARD | LILLY CO ELI |
| EP3536686 | METHOD FOR PRODUCING A RADIOPHARMACEUTICAL COMPOSITION | KIRIU MASATO | NIHON MEDIPHYSICS CO LTD |
| EP3536687 | SMALL MOLECULE MYRISTATE INHIBITORS OF BCR-ABL AND METHODS OF USE | GRAY NATHANAEL S | DANA FARBER CANCER INST INC |
| EP3536692 | PYRAZOLOPYRIMIDINYL INHIBITORS OF UBIQUITIN-ACTIVATING ENZYME | AFROZE ROUSHAN | MILLENNIUM PHARM INC |
| EP3536698 | LANOSTEROL PRODRUG COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF | LIU YIZHI | ZHONGSHAN OPHTHALMIC CT SUN YAT SEN UNIV |
| EP3536701 | NOVEL PEPTIDE AND COSMETIC COMPOSITION FOR INHIBITING SKIN AGING OR SKIN WRINKLE FORMATION, CONTAINING SAME | CHUNG JI-HYUNG | COLLEGE OF MEDICINE POCHON CHA UNIV INDUSTRY ACADEMIC COOPERATION FOUNDATION |
| EP3536703 | CONSENSUS PROSTATE ANTIGENS, NUCLEIC ACID MOLECULES ENCODING THE SAME AND USES THEREOF | WEINER DAVID B | UNIV PENNSYLVANIA |
| EP3536704 | GENE THERAPY FOR RENAL FAILURE | FISHER LAURENT BERNARD | BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC |
| EP3536790 | VECTOR FOR EXPRESSING HUMAN EPIDERMAL GROWTH FACTOR OR SKIN-PERMEABLE HUMAN EPIDERMAL GROWTH FACTOR, AND MICROALGAE TRANSFORMED WITH VECTOR | PAN CHEOL-HO | KOREA INST SCI & TECH |
| EP3536802 | EFFECTIVENESS DETERMINATION MARKER IN DISEASE TREATMENT BY PD-1 SIGNAL INHIBITOR | HONJO TASUKU | UNIV KYOTO |
| EP3538054 | ALUMINUM-FREE ANTIPERSPIRANT/DEODORANT COMPOSITIONS | HILLIARD JR PETER R | COLGATE PALMOLIVE CO |
| EP3538056 | ORAL CARE COMPOSITIONS | REGE AARTI | COLGATE PALMOLIVE CO |
| EP3538059 | ALUMINUM-FREE ANTIPERSPIRANT/DEODORANT COMPOSITIONS | HILLIARD JR PETER R | COLGATE PALMOLIVE CO |
| EP3538066 | HYALURONIC ACID DERMAL FILLERS CROSSLINKED WITH CITRIC ACID, METHOD FOR MAKING SAME AND USES THEREOF | MONDON KARIN | ANTEIS SA |
| EP3538118 | SAPROPHYTIC LIVE BACTERIA FOR USE IN TREATMENT OF HIDRADENITIS SUPPURATIVA | RING HANS CHRISTIAN | SJÆLLANDS UNIV |
| EP3538133 | TRUNCATED VON WILLEBRAND FACTOR POLYPEPTIDES FOR TREATING HEMOPHILIA | SCHULTE STEFAN | CSL BEHRING LENGNAU AG |
| EP3538134 | TRUNCATED VON WILLEBRAND FACTOR POLYPEPTIDES FOR EXTRAVASCULAR ADMINISTRATION IN THE TREATMENT OR PROPHYLAXIS OF A BLOOD COAGULATION DISORDER | PESTEL SABINE | CSL BEHRING LENGNAU AG |
| EP3538258 | COLLOIDAL SUSPENSION OF FUNCTIONALISED NANOPARTICLES OF A FLUORIDE OF AN ALKALINE-EARTH ELEMENT | FAURE ANNE-CHARLOTTE FRANÇOISE | MATHYM |
| EP3538512 | NEW ANTHELMINTIC QUINOLINE-3-CARBOXAMIDE DERIVATIVES | HüBSCH WALTER | BAYER ANIMAL HEALTH GMBH |
| EP3538516 | PHENOXYTRIAZOLES | BARTELS BJOERN | HOFFMANN LA ROCHE |
| EP3538519 | INDAZOLE DERIVATIVES AS ALPHA V INTEGRIN ANTAGONISTS | YE XIANG-YANG | SQUIBB BRISTOL MYERS CO |
| EP3538523 | PYRIMIDINONE DERIVATIVES AS CDC7 INHIBITORS | CARSWELL EMMA L | CANCER RESEARCH TECH LTD |
| EP3538527 | AZOLE AMIDES AND AMINES AS ALPHA V INTEGRIN INHIBITORS | DEVASTHALE PRATIK | SQUIBB BRISTOL MYERS CO |
| EP3538542 | CYCLIC PEPTIDES MULTIMERS TARGETING ALPHA 4BETA 7 INTEGRIN | MORSHED MONZUR M | ENCYCLE THERAPEUTICS INC |
| EP3538547 | IL2 AND TNF MUTANT IMMUNOCONJUGATES | NERI DARIO | PHILOGEN SPA |
| EP3538652 | A HIGHLY STABLE, PROTEASE-RESISTANT E. COLI ASPARAGINASE | MAGGI MARISTELLA | UNIV DEGLI STUDI DI PAVIA |
| EP3539543 | PYRIDYL HYDRAZONES FOR THE TREATMENT OF TUBERCULOSIS AND RELATED DISEASES | ALMEIDA FERREIRA ANA LúCIA | TECNIMEDE SOCIEDADE TECNICO MEDICINAL S |
| EP3539545 | CRYSTALLINE FORM OF GNRH RECEPTOR ANTAGONIST AND PREPARATION METHOD THEREFOR | ZHANG QUANLIANG | JIANGSU HENGRUI MEDICINE CO |
| EP3539551 | METHOD OF TREATING MELANOCORTIN-4 RECEPTOR-ASSOCIATED DISORDERS IN HETEROZYGOUS CARRIERS | TARTAGLIA LOUIS A | RHYTHM PHARMACEUTICALS INC |
| EP3539553 | ACTIVATION AND EXPANSION OF NKG2C+ NK CELLS | ROMAGNANI CHIARA | DEUTSCHES RHEUMA FORSCHUNGSZENTRUM BERLIN |
| EP3539618 | A COSMETIC PRODUCT AND A METHOD OF PRODUCING SAID COSMETIC PRODUCT | MOROSINI AMBRA | CHROMAVIS SPA |
| EP3539961 | POLYCYCLIC AMIDE DERIVATIVES AS CDK9 INHIBITORS | PIKE KURT GORDON | ASTRAZENECA AB |
| EP3539964 | BASE ACETAMIDE GLYCERIN ETHER MOLECULE, CHEMICAL SYNTHESIS METHOD THEREFOR, AND APPLICATIONS THEREOF IN FIELD OF GENE THERAPY | YANG ZHENJUN | UNIV BEIJING |
| EP3539990 | HER3 INHIBITION IN LOW-GRADE SEROUS CANCERS | LIVINGSTONE DAVID | DANA FARBER CANCER INST INC |
| EP3541346 | ORAL CARE COMPOSITIONS | REGE AARTI | COLGATE PALMOLIVE CO |
| EP3541352 | ORAL CARE COMPOSITIONS AND METHODS OF USE | REGE AARTI | COLGATE PALMOLIVE CO |
| EP3541354 | ORAL CARE COMPOSITIONS AND METHODS FOR WHITENING TEETH | YUAN SHAOTANG | COLGATE PALMOLIVE CO |
| EP3541357 | ORAL DELIVERY VEHICLE | WITTORFF HELLE | FERTIN PHARMA AS |
| EP3541359 | TABLET COMPRISING SEPARATE BINDER AND ERYTHRITOL | WITTORFF HELLE | FERTIN PHARMA AS |
| EP3541363 | METHOD, FACILITY AND TANK FOR THE MANUFACTURE OF A LIQUID ACID CONCENTRATE USED FOR HEMODIALYSIS MACHINES | EYRARD THIERRY | FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH |
| EP3541380 | METHODS FOR TREATING MULTIPLE OSTEOCHONDROMA (MO) | LEMIRE ISABELLE | CLEMENTIA PHARMACEUTICALS INC |
| EP3541383 | COMBINATION THERAPY FOR CANCER WITH EXON 14 SKIPPING MUTATION(S) OR EXON 14 SKIPPING PHENOTYPE | YAN SAU-CHI BETTY | LILLY CO ELI |
| EP3541387 | DOSE AND REGIMEN FOR HDM2-P53 INTERACTION INHIBITORS | FERRETTI STEPHANE | NOVARTIS AG |
| EP3541478 | COSMETIC, NUTRACEUTICAL OR PHARMACEUTICAL - PREFERABLY DERMATOLOGICAL - USE OF AN EXTRACT OF LEAVES FROM THE LANSIUM DOMESTICUM PLANT FOR REDUCING THE PIGMENTATION OF THE SKIN AND/OR SKIN APPENDAGES | DEGRAVE VéRONIQUE | BASF BEAUTY CARE SOLUTIONS FRANCE SAS |
| EP3541794 | 4-((6-(2-(2,4-DUFLUOROPHENYL)-1,1-DIFLUORO-2-HYDROXY-3-(5-MERCAPTO-1H-1,2,4-TRIAZOL-1-YL)PROPYL)PYRIDIN-3-YL)OXY)BENZONITRILE AND PROCESSES OF PREPARATION | GRAY KAITLYN | DOW AGROSCIENCES LLC |
| EP3541814 | 2-SUBSTITUTED AMINO-NAPHTH[1,2-D]IMIDAZOL-5-ONE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF CROSS REFERENCE TO RELATED APPLICATIONS | KITANO HIROYUKI | BIOELECTRON TECH CORP |
| EP3542779 | DENTAL COMPOSITION | MAIER MAXIMILIAN | DENTSPLY DETREY GMBH |
| EP3542804 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING BRAIN CANCER INCLUDING CRYSTAL POLYMORPH OF TETRAARSENIC HEXOXIDE, AND METHOD FOR PREPARING SAME | BAE ILL JU | CHEMAS CO LTD |
| EP3542811 | BLACK RICE SPROUTING LIQUID HAVING ANTI-INFLAMMATORY EFFECT AND MANUFACTURING METHOD THEREOF | KIM SUNG HYUN | WELLBEINGGO CO LTD |
| EP3542812 | GLYCOPEPTIDE COMPOSITIONS | JASPRICA IVONA | XELLIA PHARMACEUTICALS APS |
| EP3542819 | NOVEL VACCINE COMPOSITIONS COMPRISING IMMUNOSTIMULATORY OLIGONUCLEOTIDES | DOMINOWSKI PAUL JOSEPH | ZOETIS SERVICES LLC |
| EP3542851 | IMPLANTABLE DEVICES FOR DELIVERY OF BIOACTIVE AGENTS | OLLERENSHAW JEREMY | SORRENTO THERAPEUTICS INC |
| EP3542863 | HAIR OIL AND ITS USE | MIFTARI FILIZ | MIFTARI FILIZ |
| EP3543238 | NUCLEOSIDE DERIVATIVE HAVING PHYSICAL ACTIVITIES INCLUDING ANTI-VIRAL ACTIVITY | MITSUYA HIROAKI | NAT CENTER FOR GLOBAL HEALTH AND MEDICINE |
| EP3543252 | METHOD FOR INCREASING THE SECRETION LEVELS OF INTERLEUKIN 2 AND PROTEINS DERIVED FROM IT | ROJAS DORANTES GERTRUDIS | CT INMUNOLOGIA MOLECULAR |
| EP3544576 | DYE COMPOSITION COMPRISING 12-HYDROXYSTEARIC ACID, AN ORGANIC AMINE AND A DYE | FAMEAU ANNE-LAURE | OREAL |
| EP3544594 | MESOPOROUS SILICA MATERIALS FOR THE CONTROLLED RELEASE OF ACTIVE SUBSTANCES AND THEIR APPLICATIONS | BERNARDOS BAU ANDREA | UNIV VALENCIA POLITECNICA |
| EP3544598 | CANNABINOIDS FOR PROPHYLACTIC TREATMENT OF INVOLUNTARY WEIGHT LOSS | KOHL AGNES | AOP ORPHAN PHARMACEUTICALS AG |
| EP3544613 | GSK-3 INHIBITORS | HARTZ RICHARD A | SQUIBB BRISTOL MYERS CO |
| EP3544619 | NEURAL TISSUE UNIT AND USE OF SUCH A UNIT FOR IMPLANTATION IN THE NERVOUS SYSTEM OF A MAMMAL | FEYEUX MAXIME | UNIV BORDEAUX |
| EP3544630 | NUTRITIONAL COMPOSITION WITH RESISTANT STARCH USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES | PAZIENZA VALERIO | FOND DI RELIGIONE E DI CULTO CASA SOLLIEVO DELLA SOFFERENZA OPERA DI SAN PIO DA PIETRELCINA |
| EP3544634 | MET ANTIBODY DRUG CONJUGATES | FENG YIQING | LILLY CO ELI |
| EP3544636 | PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES | VAN BERKEL PATRICIUS HENDRIKUS CORNELIS | ADC THERAPEUTICS SA |
| EP3544687 | COMPOSITION FOR KERATIN FIBERS | HOSHINO AKITO | OREAL |
| EP3544951 | SUBSTITUTED HEXARIC ACID DERIVATIVES AND USES THEREOF | WARNAULT PIERRE | PLANT ADVANCED TECH PAT |
| EP3544958 | INDANYLAMINOPYRIDYLCYCLOPROPANECARBOXYLIC ACIDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | ECKHARDT MATTHIAS | BOEHRINGER INGELHEIM INT |
| EP3544961 | POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 | SPEARING PAUL K | UNIV VANDERBILT |
| EP3544970 | INHIBITORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES AND USES THEREOF | GRAY NATHANAEL S | DANA FARBER CANCER INST INC |
| EP3544976 | N-[5-(AMINOSULFONYL)-4-METHYL-1,3-THIAZOL-2-YL]-N-METHYL-2-[4-(2-PYRIDINYL)-PHENYL]-ACETAMIDE FREE BASE HEMIHYDRATE, METHODS OF MANUFACTURE AND USES THEREOF | BACHHAV YOGESHWAR | AICURIS ANTI INFECTIVE CURES GMBH |
| EP3544977 | A MALEATE SALT OF THE FREE BASE OF N-[5-(AMINOSULFONYL)-4-METHYL-1,3-THIAZOL-2-YL]-N-METHYL-2-[4-(2-PYRIDINYL)-PHENYL]-ACETAMIDE, PHARMACEUTICAL FORMULATIONS, METHODS OF MANUFACTURE AND USES THEREOF FOR THE TREATMENT OF HERPES VIRUSES | BACHHAV YOGESHWAR | AICURIS ANTI INFECTIVE CURES GMBH |
| EP3544979 | OXADIAZOLONES AS TRANSIENT RECEPTOR POTENTIAL CHANNEL INHIBITORS | BEAUMIER FRANCIS | HOFFMANN LA ROCHE |
| EP3544980 | GSK-3 INHIBITORS | HARTZ RICHARD A | SQUIBB BRISTOL MYERS CO |
| EP3544981 | BENZODIAZOLIUM COMPOUNDS AS ENAC INHIBITORS | MCCARTHY CLIVE | ENTERPRISE THERAPEUTICS LTD |
| EP3545094 | APTAMERS FOR USE IN INHIBITION AND/OR SUPPRESSION OF TLR9 ACTIVATION | HABERLAND ANNEKATHRIN | BERLIN CURES GMBH |
| EP3545941 | METHOD FOR PRODUCING COATING FILM FOR COSMETIC PREPARATION | UCHIYAMA MASAYUKI | KAO CORP |
| EP3545948 | USE OF GOLD CLUSTER OR GOLD CLUSTER-CONTAINING SUBSTANCE IN PREPARATION OF DRUG FOR PREVENTING AND/OR TREATING GLAUCOMA | SUN TAOLEI | SHENZHEN PROFOUND VIEW PHARMA TECH CO LTD |
| EP3545965 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS | WEINSCHENK TONI | IMMATICS BIOTECHNOLOGIES GMBH |
| EP3545978 | TRIAZINE BASED RADIOPHARMACEUTICALS AND RADIOIMAGING AGENTS | BABICH JOHN W | MOLECULAR INSIGHT PHARM INC |
| EP3546457 | PYRAZOLO-HETEROARYL DERIVATIVE, PREPARATION METHOD AND MEDICAL USE THEREOF | ZHANG GUOBAO | JIANGSU HENGRUI MEDICINE CO |
| EP3546458 | PYRIDO[3, 4-D]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | MIZUNO TSUYOSHI | TEIJIN PHARMA LTD |
| EP3546461 | 7-BENZYL-4-(2-METHYLBENZYL)-2,4,6,7,8,9-HEXAHYDROIMIDAZO[1,2-A]PYRIDO[3,4-E]PYRIMIDIN-5(1H)-ONE, SALTS THEREOF AND METHODS OF USING THE SAME IN COMBINATION THERAPY | STOGNIEW MARTIN | ONCOCEUTICS INC |
| EP3546472 | METHOD FOR PURIFYING P1,P4-DI(URIDINE 5'-)TETRAPHOSPHATE | OHBA YUSUKE | YAMASA CORP |
| EP3546569 | THERAPEUTICS USING ADIPOSE CELLS AND CELL SECRETIONS | VESEY GRAHAM | CELL IDEAS PTY LTD |
| EP3547851 | L. SALIVARIUS SGL03:PROBIOTIC ACTIVITIES AND PRODUCTION OF ANTIMICROBIAL PROTEINS | MARINI UMBERTO | SINTAL DIETETICS S R L |
| EP3547996 | COSMETIC COMPOSITION FOR ENHANCING PROPERTIES OF PRE-COLORED KERATIN FIBERS | LIPINSKI NORMEN | KAO GERMANY GMBH |
| EP3548000 | ATROPINE PHARMACEUTICAL COMPOSITIONS | PURI NAVNEET | NEVAKAR INC |
| EP3548017 | COMPOSITION COMPRISING GLUTATHION TIOESTER AND SECOIRIDOIDS OF THE PLANT OLEA EUROPEA FOR TREATING HAIR LOSS | LIGURI GIANFRANCO | SOLOSALE S R L |
| EP3548026 | 5-[[4-[2-[5-(1-HYDROXYETHYL)PYRIDIN-2-YL]ETHOXY]PHENYL]METHYL]-1,3-THIAZOLIDINE- 2,4-DIONE FOR TREATING NONALCOHOLIC FATTY LIVER DISEASE | PIZCUETA LALANZA MARIA PILAR | MINORYX THERAPEUTICS S L |
| EP3548052 | USE OF A BACTERIAL COMPOSITION FOR TREATING FOOT INFECTIONS OF UNGULATES | LAYUS MICHEL | NOLIVADE |
| EP3548059 | COMBINATIONS OF LYSOBACTIN AND AMINOGLYCOSIDES AGAINST DISEASES CAUSED BY GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA IN NON-HUMAN ANIMALS | SCHIFFER GUIDO | BAYER ANIMAL HEALTH GMBH |
| EP3548081 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROME | REILLY MARY | OPSONA THERAPEUTICS LTD |
| EP3548091 | PREPARATION OF SOLID CYCLODEXTRIN COMPLEXES FOR OPHTHALMIC ACTIVE PHARMACEUTICAL INGREDIENT DELIVERY | LOFTSSON THORSTEINN | OCULIS SA |
| EP3548125 | INHALER WITH SWIRL END PLUG | GRANT CHRISTOPHER JOHN | PHILIP MORRIS PRODUCTS SA |
| EP3548126 | INHALER WITH SIZED CAVITY | ZUBER GERARD | PHILIP MORRIS PRODUCTS SA |
| EP3548135 | CORE-SHELL MICRONEEDLE DEVICES AND USES THEREOF | GU ZHEN | UNIV NORTH CAROLINA STATE |
| EP3548145 | REFLECTIVE SKIN-SPREAD COMPOSITION | KULBIS JOHN F | ROAD WISE LLC |
| EP3548475 | SULFONAMIDE ANALOGUES OF GALIELLALACTONE | JOHANSSON MARTIN | GLACTONE PHARMA DEV AB |
| EP3548478 | PYRIMIDINE COMPOUNDS CONTAINING ACIDIC GROUPS | WU TOM YAO-HSIANG | APROS THERAPEUTICS INC |
| EP3548495 | PYRAZOLOPYRIMIDINE DERIVATIVES AS CAM KINASE INHIBITORS | ELZEIN ELFATIH | GILEAD SCIENCES INC |
| EP3548508 | NEW COMPOUNDS AS PEPTIDIC TRIGONAL GLP1/GLUCAGON/GIP RECEPTOR AGONISTS | BOSSART MARTIN | SANOFI SA |
| EP3548544 | AQUEOUS DISPERSION OF POLYALKENE SUPRAMOLECULAR POLYMER AND ITS USE IN COSMETICS | PECCHIA OLIVIER | OREAL |
| EP3548613 | BACTERIAL GLUTAMINYL CYCLASES AND INHIBITORS THEREOF FOR USE IN THE TREATMENT OF PERIODONTITIS | BUCHHOLZ MIRKO | FRAUNHOFER GES FORSCHUNG |
| EP3549573 | METHOD FOR AFFECTING HAPTIK PERCEPTION | GARCIA DEVIN | JOHNSON & JOHNSON CONSUMER INC |
| EP3549591 | ADIPOSE-DERIVED MESENCHYMAL STEM CELLS FOR STOMATITIS TREATMENT | ARZI BOAZ | UNIV CALIFORNIA |
| EP3549601 | NON-LIPIDATED VARIANTS OF NEISSERIA MENINGITIDIS ORF2086 ANTIGENS | ANDERSON ANNALIESA SYBIL | WYETH LLC |
| EP3549611 | SWITCH COSTIMULATORY RECEPTORS | JUNE CARL H | UNIV PENNSYLVANIA |
| EP3549758 | MULTILAYER NANOFIBER SHEET AND ADHESION METHOD FOR SAME | AMARI NAOMI | KAO CORP |
| EP3549928 | METHODS OF SUSTAINING DIETARY KETOSIS AND ITS EFFECTS ON MUSCLE FATIGUE | D'AGOSTINO DOMINIC PAUL | UNIV SOUTH FLORIDA |
| EP3549936 | 1,2,4-OXADIAZOLE BENZOIC ACID COMPOUND AND ITS USE FOR NONSENSE SUPPRESSION AND THE TREATMENT OF DISEASE | KARP GARY MITCHELL | PTC THERAPEUTICS INC |
| EP3550306 | ANTI-CANCER AGENT SENSITIVITY-DETERMINING MARKER | TANIGAWARA YUSUKE | UNIV KEIO |
| EP3551163 | USE OF BIO-BASED POLYMER IN A COSMETIC, DERMATOLOGICAL OR PHARMACEUTICAL COMPOSITION | FISCHER DIRK | CLARIANT INT LTD |
| EP3551164 | ORAL MEDICAMENT COMPRISING AN OSMOTIC LAXATIVE INCORPORATED INTO A MATRIX BASED ON PLANT FATS | SALSARULO GéRARD | SALSARULO PHARMA |
| EP3551180 | TREATMENT FOR PRIMARY BILIARY CHOLANGITIS | JAIN MUKUL | CADILA HEALTHCARE LTD |
| EP3551187 | NINTEDANIB FOR USE IN METHODS FOR THE TREATMENT OF INTERSTITIAL LUNG DISEASES BY COADMINISTRATION WITH OLODATEROL | WOLLIN STEFAN | BOEHRINGER INGELHEIM INT |
| EP3551196 | PROBIOTIC IMMUNOMODULATORY COMPOSITIONS | SINKKONEN AKI | UNIV HELSINKI |
| EP3551208 | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF ALOPECIA COMPRISING EREMOCHLOA OPHIUROIDES EXTRACT OR FRACTIONS THEREOF AS AN ACTIVE INGREDIENT | CHUNG BYUNG YEOUP | KOREA ATOMIC ENERGY RES |
| EP3551209 | INSULIN-FC FUSIONS AND METHODS OF USE | LANCASTER THOMAS M | AKSTON BIOSCIENCES CORP |
| EP3551211 | LEBECETIN, A C-TYPE LECTIN, AS NEOVASCULARIZATION INHIBITOR | GUILLONNEAU XAVIER | UNIV SORBONNE |
| EP3551221 | NOVEL T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME | ALTEN LEONIE | IMMATICS BIOTECHNOLOGIES GMBH |
| EP3551610 | BICYCLO[1.1.1]PENTANE INHIBITORS OF DUAL LEUCINE ZIPPER (DLK) KINASE FOR THE TREATMENT OF DISEASE | SOTH MICHAEL J | UNIV TEXAS |
| EP3551614 | DIMERIC CONTRAST AGENTS | BOI VALERIA | BRACCO IMAGING SPA |
| EP3551617 | COMPOSITIONS AND METHODS RELATED TO PYRIDINOYLPIPERIDINE 5-HT1F AGONISTS | ALLIERI BRIGIDA | COLUCID PHARMACEUTICALS INC |
| EP3551624 | A SUBSTITUTED BENZIMIDAZOLE DERIVATIVE AS A MODULATOR OF TNF ACTIVITY | HEER JAG PAUL | UCB BIOPHARMA SPRL |
| EP3551633 | SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | LIANG XIFU | LEO PHARMA AS |
| EP3551634 | SUBSTITUTED PYRAZOLOAZEPIN-8-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | LIANG XIFU | LEO PHARMA AS |
| EP3551652 | GLP-1/GLP-2 DUAL AGONISTS | DUE LARSEN BJARNE | ZEALAND PHARMA AS |
| EP3551664 | ANTIBODIES AND POLYPEPTIDES DIRECTED AGAINST CD127 | POIRIER NICOLAS | OSE IMMUNOTHERAPEUTICS |
| EP3552600 | COMPOSITION CONTAINING DENDROBIUM CANDIDUM EXTRACT AND PREPARATION METHOD AND USE THEREOF | ZHANG XUE | SHANGHAI TRADITIONAL CHINESE MEDICINE CO LTD |
| EP3552616 | HYDROLYSATE OF WATER EXTRACT OF SYZYGIUM SAMARANGENSE, AND PREPARATION PROCESS AND USE THEREOF | CHIANG CHUN-HUI | |
| EP3552617 | DRUG RESISTANT IMMUNOTHERAPY FOR TREATMENT OF A CANCER | SPENCER H TRENT | UNIV EMORY |
| EP3552695 | DISPERSION OF DROPS FROM A FIRST PHASE DISPERSED IN A SECOND PHASE SUBSTANTIALLY NON-MISCIBLE WITH THE FIRST PHASE | GOUTAYER MATHIEU | CAPSUM |
| EP3553056 | (HETERO)ARYLAMIDE COMPOUND FOR INHIBITING PROTEIN KINASE ACTIVITY | WANG YIHAN | SHENZHEN TARGETRX INC |
| EP3553059 | HYDROBROMATE OF BENZODIAZEPINE DERIVATIVE, PREPARATION METHOD AND USE THEREOF | HUANG HAOXI | CHENGDU BRILLIANT PHARMACEUTICAL CO LTD |
| EP3553169 | NORMALIZATION OF CULTURE OF CORNEAL ENDOTHELIAL CELLS | KINOSHITA SHIGERU | KYOTO PREFECTURAL PUBLIC UNIV CORP |
| EP3554461 | COSMETIC COMPOSITION COMPRISING SOLID FATTY SUBSTANCES AND A GELLING POLYMER | GUIRAMAND CAROLE | OREAL |
| EP3554501 | DEXMEDETOMIDINE OR MEDETOMIDINE FOR USE IN TREATING SEPARATION ANXIETY IN DOGS | KORPIVAARA MIRA | ORION CORP |
| EP3554506 | BYCYCLIC HETEROARYL DERIVATIVES AS CFTR POTENTIATORS | STROHBACH JOSEPH WALTER | CYSTIC FIBROSIS FOUND THERAPEUTICS INC |
| EP3554524 | COMPOSITION FOR USE IN TREATING DYSPHORIA, DEPRESSION AND/OR MOOD SWINGS RELATING TO PREMENSTRUAL SYNDROME (PMS) | MORRA SOSSIO | SERELYS PHARMA S A M |
| EP3554533 | POLYPEPTIDES FOR MANAGING VIRAL INFECTIONS | GEORGE SANIL | UNIV EMORY |
| EP3554534 | INSULIN CONTAINING PHARMACEUTICAL COMPOSITIONS | NORRMAN MATHIAS | NOVO NORDISK AS |
| EP3554619 | FLUID DELIVERY APPARATUS AND METHOD OF ASSEMBLY | ROSS RUSSELL F | SORRENTO THERAPEUTICS INC |
| EP3555000 | STANNOUS COMPATIBLE SILICA | GALLIS KARL W | EVONIK DEGUSSA GMBH |
| EP3555065 | COMPOUNDS AS MODULATORS OF ROR GAMMA | HUGHES ROBERT OWEN | BOEHRINGER INGELHEIM INT |
| EP3555086 | 1,4-THIAZINE DIOXIDE AND 1,2,4-THIADIAZINE DIOXIDE DERIVATIVES AS BETA-SECRETASE INHIBITORS AND METHODS OF USE | ALLEN JENNIFER R | AMGEN INC |
| EP3555088 | BISARYL AMIDES AS NRF2 REGULATORS | CALLAHAN JAMES FRANCIS | GLAXOSMITHKLINE IP DEV LTD |
| EP3555103 | AZEPANE INHIBITORS OF MENIN-MLL INTERACTION | ANGIBAUD PATRICK RENé | JANSSEN PHARMACEUTICA NV |
| EP3555104 | NRF2 COMPOUNDS | BROOKS CARL A | GLAXOSMITHKLINE IP DEV LTD |
| EP3555110 | DENTAL COMPOSITION | FIK CHRISTOPH P | DENTSPLY DETREY GMBH |
| EP3555121 | NOVEL ENDOLYSIN | MENDES DE OLIVEIRA HUGO ALEXANDRE | UNIV DO MINHO |
| EP3555139 | IMMUNE CELLS EXPRESSING AN ANTIGEN BINDING RECEPTOR AND A CHIMERIC COSTIMULATORY RECEPTOR | LOCK DOMINIK | MILTENYI BIOTEC GMBH |
| EP3556214 | METHODS FOR THE PREVENTION OF INFECTIONS OF EPITHELIAL CELLS IN AN ANIMAL | VULDERS CARLY | INTRACARE B V |
| EP3556226 | COMPLEX SYNBIOTIC FOR ESTABLISHING HEALTHY INTESTINAL FLORA | RAAB ANDREAS | RAAB VITALFOOD GMBH |
| EP3556345 | ORALLY DISINTEGRATED TABLET COMPRISING CARBAMATE COMPOUND | BAEK MYOUNG KI | SK BIOPHARMACEUTICALS CO LTD |
| EP3556346 | ESTERS FOR TREATMENT OF OCULAR INFLAMMATORY CONDITIONS | GALLOIS-BERNOS ANNABELLE | JOHNSON & JOHNSON VISION CARE |
| EP3556347 | PHARMACEUTICAL COMPOSITION | CORR STUART | MEXICHEM FLUOR SA DE CV |
| EP3556348 | PHARMACEUTICAL COMPOSITION | CORR STUART | MEXICHEM FLUOR SA DE CV |
| EP3556349 | PARENTERAL LIQUID PREPARATION COMPRISING CARBAMATE COMPOUND | BAEK MYOUNG KI | SK BIOPHARMACEUTICALS CO LTD |
| EP3556355 | PARTICLES CONTAINING AMORPHOUS EMPAGLIFLOZIN, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATION | KOVALCIK PAVEL | ZENTIVA KS |
| EP3556356 | DIKETOPIPERAZINE MICROPARTICLES WITH DEFINED ISOMER CONTENT | SOMERVILLE KARLA | MANNKIND CORP |
| EP3556368 | ONYCHOMYCOSIS THERAPEUTIC AGENT | MIZUTANI MASAYA | KANEKA CORP |
| EP3556369 | OLAPARIB ORAL SUSTAINED AND CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION AND USES THEREOF | GAN YONG | SHANGHAI INST MATERIA MEDICA CAS |
| EP3556377 | ANTIVIRAL IMMUNOTROPIC AGENT FOR THE TREATMENT OF ACUTE RESPIRATORY VIRAL INFECTIONS | CHERTORIZHSKY EVGENY ALEXANDROVICH | PVP LABS PTE LTD |
| EP3556755 | SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES | PARUCH KAMIL | UNIV MASARYKOVA |
| EP3556761 | PYRROLO-AROMATIC HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF | YIN HUIJUN | THE NATIONAL INSTITUTES OF PHARMACEUTICAL RES |
| EP3556775 | ANTI-LAG-3 ANTIBODIES TO TREAT HEMATOLOGICAL MALIGNANCIES | GUTIERREZ ANDRES A | SQUIBB BRISTOL MYERS CO |
| EP3556857 | CDC45L PEPTIDES AND VACCINES INCLUDING THE SAME | NISHIMURA YASUHARU | ONCOTHERAPY SCIENCE INC |
| EP3557254 | PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF | STEYAERT JAN | VIB VZW |
| EP3557255 | PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF | STEYAERT JAN | VIB VZW |
| EP3558213 | LILY OF THE VALLEY ODORANT | CHAPUIS CHRISTIAN | FIRMENICH & CIE |
| EP3558220 | OXIDIZING COMPOSITION FOR TREATING KERATIN FIBRES, COMPRISING A SCLEROGLUCAN GUM AND A PHOSPHORUS-BASED SEQUESTRANT | SIMONET FRéDéRIC | OREAL |
| EP3558227 | SILICONE-IN-WATER COSMETIC | KIKUCHI MASAHIRO | LVMH RECH |
| EP3558229 | HAIR COMPOSITION COMPRISING A GUANIDINE SALT, AN ALKANOLAMINE, AMMONIUM HYDROXIDE AND A POLYOL | BODELIN SOPHIE | OREAL |
| EP3558230 | SOLID COSMETIC COMPOSITION COMPRISING A SILICONE POLYAMIDE, A SILICONE RESIN AND A DISPERSED AQUEOUS PHASE | MANET SYLVIE | OREAL |
| EP3558235 | USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION | EUDELINE -LY ANNABELLE | OREAL |
| EP3558241 | HAIR COMPOSITION COMPRISING A GUANIDINE SALT, AN ALKANOLAMINE AND AMMONIUM HYDROXIDE AND CATIONIC AND/OR AMPHOTERIC POLYMERS | MEGUENI AMINE | OREAL |
| EP3558246 | PERSONAL CARE COMPOSITIONS WITH GLUTATHIONE PRECURSOR COMPRISING 4-SUBSTITUTED RESORCINOLS AND AMINO ACIDS | GUELAKIS MARIAN PEREIRA | UNILEVER PLC |
| EP3558249 | COSMETIC COMPOSITION COMPRISING ASCORBYL PHOSPHATE, NIACINAMIDE, AND ALLANTOIN | MESAROS SZILVIA | DSM IP ASSETS BV |
| EP3558254 | PROCESS FOR DYEING KERATIN FIBRES USING AT LEAST ONE PARTICULAR 2- OR 4-AZOPYRIDINIUM DYE AND AT LEAST ONE FLUORESCENT DYE | BLAISE CHRISTIAN | OREAL |
| EP3558255 | TOPICAL SKIN LIGHTENING ADDITIVE AND COMPOSITION WITH AMINO ACIDS AND NICOTINAMIDE COMPOUNDS | DAMODARAN ANITA | UNILEVER PLC |
| EP3558278 | LIQUID CANNABINOID COMPOSITION | SCHOU SØREN CHRISTIAN | MEDCAN PHARMA AS |
| EP3558300 | SOLID PHARMACEUTICAL FORMULATIONS OF ASIMADOLINE | SHIGETA KOSUKE | TIOGA PHARMACEUTICALS INC |
| EP3558306 | 6,5-FUSED HETEROARYL PIPERIDINE ETHER ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR | GAO XIAOLEI | MERCK SHARP & DOHME |
| EP3558313 | SUBSTANCES FOR TREATMENT OF FATTY LIVER-RELATED CONDITIONS | MARDINOGLU ADIL | SCANDIBIO THERAPEUTICS AB |
| EP3558322 | ANTIVIRAL BENZYL-AMINE PHOSPHODIAMIDE COMPOUNDS | DE LERA RUIZ MANUEL | MERCK SHARP & DOHME |
| EP3558338 | ARTHROFACTIN FOR THE TREATMENT OF ACNE | TOURNIER-COUTURIER LUCIE | OREAL |
| EP3558376 | A THERAPEUTIC COMBINATION COMPRISING A PULMONARY SURFACTANT AND A STEROID FOR THE TREATMENT OF EVOLVING BPD | FABBRI LAURA | CHIESI FARM SPA |
| EP3558381 | LIQUID HUMAN FIBRINOGEN COMPOSITION | DEBRAIZE CLéMENCE | LAB FRANCAIS DU FRACTIONNEMENT |
| EP3558385 | MEDICAL PREPARATION WITH A CARRIER BASED ON WATER INSOLUBLE HYALURONAN CONJUGATED TO AMINO ACIDS OR PEPTIDES, METHOD OF PREPARATION AND USE THEREOF | KAREL SERGEJ | CONTIPRO AS |
| EP3558387 | SPECIFIC ANTIBODY DRUG CONJUGATES (ADCS) HAVING KSP INHIBITORS | LERCHEN HANS-GEORG | BAYER PHARMA AG |
| EP3558396 | DIFFERENTIAL DIAGNOSIS OF PARKINSON'S DISEASE | JONES PAUL ALEXANDER | GE HEALTHCARE LTD |
| EP3558462 | PROCESS FOR DYEING AND RELAXING CURLS OF KERATIN FIBRES, USING REDUCING AGENTS AND HAIR DYES, AND ASSOCIATED KIT | BURCKBUCHLER VIRGINIE | OREAL |
| EP3558463 | PROCESS FOR TREATING KERATIN FIBRES WITH A PHOTOCROSSLINKABLE POLYVINYL ALCOHOL | JEGOU GWENAËLLE | OREAL |
| EP3558468 | COSMETIC COMPOSITION COMPRISING ROYAL JELLY OF THE OUESSANT BLACK BEE | KURFURST ROBIN | LVMH RECH |
| EP3558920 | IMPROVED SYNTHESIS OF LYSINE ACETYLSALICYLATE 路 GLYCINE PARTICLES | NOCKER KARLHEINZ | VENTALEON GMBH |
| EP3558951 | METHOD FOR THE MANUFACTURING OF DELMOPINOL | DE FAVERI CARLA | LUNDBECK PHARMACEUTICALS ITALY S P A |
| EP3558955 | BENZISOTHIAZOLE, ISOTHIAZOLO[3,4-B]PYRIDINE, QUINAZOLINE, PHTHALAZINE, PYRIDO[2,3-D]PYRIDAZINE AND PYRIDO[2,3-D]PYRIMIDINE DERIVATIVES AS KRAS G12C INHIBITORS FOR TREATING LUNG, PANCREATIC OR COLORECTAL CANCER | LANMAN BRIAN ALAN | AMGEN INC |
| EP3558968 | IMIDAZOPYRAZINE INHIBITORS OF BRUTON'S TYROSINE KINASE | PODOLL TERRY | ACERTA PHARMA BV |
| EP3558970 | COMPOUNDS USEFUL AS IMMUNOMODULATORS | YEUNG KAP-SUN | SQUIBB BRISTOL MYERS CO |
| EP3558973 | PYRIDINE DERIVATIVES AS IMMUNOMODULATORS | WU LIANGXING | INCYTE CORP |
| EP3558979 | NOVEL BENZYLAMINO SUBSTITUTED QUINAZOLINES AND DERIVATIVES AS SOS1 INHIBITORS | GMACHL MICHAEL | BOEHRINGER INGELHEIM INT |
| EP3558980 | COMPOUNDS FOR USE IN THE TREATMENT OF KINETOPLASTID INFECTION | BIANCOFIORE ILARIA | C N C C S S C A R L COLLEZIONE NAZ DEI COMPOSTI CHIMICI E CENTRO SCREENING |
| EP3558981 | PYRAN DERVATIVES AS CYP11A1 (CYTOCHROME P450 MONOOXYGENASE 11A1) INHIBITORS | DIN BELLE DAVID | ORION CORP |
| EP3558988 | PYRAZOLO[3,4-B]PYRIDINES AND IMIDAZO[1,5-B]PYRIDAZINES AS PDE1 INHIBITORS | KEHLER JAN | H LUNDBECK AS |
| EP3558989 | TRIAZOLO[1,5-A]PYRIDINE DERIVATIVES AS IMMUNOMODULATORS | WU LIANGXING | INCYTE CORP |
| EP3558997 | AMINO-TRIAZOLOPYRIDINE COMPOUNDS AND THEIR USE IN TREATING CANCER | FINLAY MAURICE RAYMOND VERSCHOYLE | ASTRAZENECA AB |
| EP3559009 | COMPOSITIONS AND METHODS FOR INHIBITING ARGINASE ACTIVITY | SJOGREN ERIC B | CALITHERA BIOSCIENCES INC |
| EP3559023 | A MULTI-EPITOPE DNA VACCINE FOR HEARTWATER | PRETORIUS ALRI | AGRICULTURAL RESEARCH COUNCIL |
| EP3560482 | NOVEL PREPARATION CONTAINING BENZIMIDAZOLE DERIVATIVE | LIM HYUNGSUK | CJ HEALTHCARE CORP |
| EP3560493 | OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS | HUNT HAZEL | CORCEPT THERAPEUTICS INC |
| EP3560495 | MICRONEEDLE DEVICE | HORI RYOTA | HISAMITSU PHARMACEUTICAL CO |
| EP3560500 | PROGESTERONE FORMULATIONS | CACACE JANICE LOUISE | THERAPEUTICSMD INC |
| EP3560503 | RNA INTERFERENCE IN DERMAL AND FIBROTIC INDICATIONS | KHVOROVA ANASTASIA | PHIO PHARM CORP |
| EP3560505 | NOVEL THERAPEUTIC AGENT FOR PRIONOID DISEASES | KANEDA YASUFUMI | UNIV OSAKA |
| EP3560507 | TRADITIONAL CHINESE MEDICINE COMBINATION FOR REGULATING IMMUNE FUNCTION AND PREPARATION METHOD THEREFOR | ZHONG HONGGUANG | JIANGZHONG PHARMACEUTICAL CO LTD |
| EP3560923 | ANTI PARASITIC DIHYDROAZOLE COMPOUNDS AND COMPOSITIONS COMPRISING SAME | LE HIR DE FALLOIS LOIC PATRICK | BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC |
| EP3560924 | IMIDAZOLONYL QUINOLINES AND THEIR USE AS ATM KINASE INHIBITORS | FUCHSS THOMAS | MERCK PATENT GMBH |
| EP3560925 | NOVEL COMPOUND AND PHARMACEUTICALLY-ACCEPTABLE SALT THEREOF | TAMURA KEIJI | MEIJI SEIKA PHARMA CO LTD |
| EP3560928 | FUSED IMIDAZOLE COMPOUND HAVING INDOLEAMINE 2,3-DIOXYGENASE INHIBITORY ACTIVITY | YU JINDI | SHENZHEN CHIPSCREEN BIOSCIENCES CO LTD |
| EP3560929 | CRYSTALLINE 6,7-UNSATURATED-7-CARBAMOYL MORPHINANE DERIVATIVE, AND METHOD FOR PRODUCING SAME | TAMURA YOSHINORI | SHIONOGI & CO |
| EP3560941 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND DIAGNOSTIC COMPOUND INCLUDING THE ORGANOMETALLIC COMPOUND | KWAK YOONHYUN | SAMSUNG ELECTRONICS CO LTD |
| EP3562451 | ADHESIVE PATCH CONTAINING AN IMPROVED RELEASE LINER SYSTEM | RAMJIT RAVI | EUROMED INC |
| EP3562465 | NOVEL ANTIOXIDANTS FOR COSMETICS AND PHARMACEUTICAL COMPOSITIONS CONTAINING GLYCEROL ALKYL ETHERS | ENGEL TIM | SACHEM INC |
| EP3562466 | NATURAL-BASED AND PEROXIDE-FREE DENTAL WHITENING GEL | BOCHENEK STEPHANE | BOCHENEK STEPHANE |
| EP3562471 | SKIN AND HAND CLEANSING COMPOSITIONS COMPRISING SCRUBBING MATERIALS | KAMPS NICOLE | DEB IP LTD |
| EP3562472 | USE OF COCONUT WATER AS EXTRACTION SOLVENT | MAKERRI CAROLINE | BASF BEAUTY CARE SOLUTIONS FRANCE SAS |
| EP3562481 | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF ANEMIA | VENN-WATSON STEPHANIE KAY | US NAVY |
| EP3562484 | ORGANIC COMPOUNDS | LI PENG | INTRA CELLULAR THERAPIES INC |
| EP3562554 | COSMETIC PRODUCT IN THE FORM OF A FOAM AND MAKE-UP METHOD | NOE BRIGITTE | LVMH RECH |
| EP3562809 | PYRAZOLOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF | ROMERO F ANTHONY | HOFFMANN LA ROCHE |
| EP3562816 | NRF2 ACTIVATOR | LUCAS BRIAN STUART | BIOGEN MA INC |
| EP3562822 | POLY-ADP RIBOSE POLYMERASE (PARP) INHIBITORS | TAKAHASHI TAISUKE | MITOBRIDGE INC |
| EP3562946 | ONCOLYTIC VIRUSES AND THERAPEUTIC MOLECULES | ERBS PHILIPPE | TRANSGENE SA |
| EP3563111 | GREEN PRIMARY EXPLOSIVE | OZALP YAMAN SENIZ | ATILIM UNIV |
| EP3563837 | BACTERIOPHAGE THERAPY | DANGLAS PASCAL | FERRING BV |
| EP3563840 | PATCH | TANAKA RYO | HISAMITSU PHARMACEUTICAL CO |
| EP3563851 | ANTITUMOR AGENT AND BROMODOMAIN INHIBITOR | MAKITA KEIKO | FUJIFILM CORP |
| EP3563859 | CARDIOSPHERE-DERIVED EXOSOMES FOR TISSUE REGENERATION | MARBáN EDUARDO | CEDARS SINAI MEDICAL CENTER |
| EP3563862 | METHODS FOR THE PREVENTION AND TREATMENT OF BURN INJURIES AND SECONDARY COMPLICATIONS | TOMPKINS RONALD | THE GENERAL HOSPITAL CORP D/B/A MASSACHUSETTS GENERAL HOSPITAL |
| EP3563873 | APPLICATION OF COMBINATION OF POLYETHYLENE GLYCOL AND LOCAL ANESTHETIC IN NON-NARCOTIC ANALGESIA | FENG ZEWANG | JENKEM TECH CO LTD TIANJIN |
| EP3563935 | METHOD FOR MANUFACTURING COATING FILM | AMARI NAOMI | KAO CORP |
| EP3564216 | PYRIMIDINE DERIVATIVE | TAKEDA YASUYUKI | DAIICHI SANKYO CO LTD |
| EP3564217 | P2X4 RECEPTOR ANTAGONIST | SAKUMA SHOGO | NIPPON CHEMIPHAR CO |
| EP3564224 | CRYSTALLINE FORM OF VORTIOXETINE HYDROBROMIDE AS ANTIDEPRESSANT DRUG | GIAFFREDA STEFANO LUCA | DIPHARMA FRANCIS SRL |
| EP3564234 | NMDA ANTAGONIST PRODRUGS | NORDVALL GUNNAR | ASTRAZENECA AB |
| EP3564246 | A GOLD(III) COMPLEX, A CONJUGATE OF THE GOLD(III) COMPLEX, A PHARMACEUTICAL COMPOSITION COMPRISING THE GOLD(III) COMPLEX AND USES AND A PROCESS FOR PREPARING THE GOLD(III) COMPLEX | SOTO GONZáLEZ SARA MARíA | UNIV ALMERIA |
| EP3564264 | VACCINE COMPOSITION COMPRISING A MUTATION OF HUMAN INTERLEUKIN-15 | RODRIGUEZ ALVAREZ YUNIER | CT INGENIERIA GENETICA BIOTECNOLOGIA |
| EP3565523 | METHOD FOR COLORING OR BLEACHING HAIR FIBERS | EVERAERT EMMANUEL PAUL JOS MARIE | HERCULES LLC |
| EP3565525 | ORAL DOSAGE FORM FOR ENHANCED SOLUBILIZATION OF A POORLY SOLUBLE ACTIVE AGENT AND METHOD OF PREPARATION | ROSSEL BART | OYSTERSHELL NV |
| EP3565581 | COMPOSITION COMPRISING ALKALINE PHOSPHATASE FOR USE IN THE TREATMENT OF ARTHRITIDES | BRANDS RUDI | AMRIF B V |
| EP3565602 | NOVEL PROCESS FOR PREPARING WATER SOLUBLE FORSKOLIN | KUBIN ANDREAS | SCIPHARM S A R L |
| EP3565639 | HAIR GROWTH AGENT | FERK FRANZ | FERK FRANZ |
| EP3565641 | BARRIER PATCH WITH SOLUBLE FILM AND METHODS OF IMPROVING SKIN APPEARANCE | BOSWELL EMILY CHARLOTTE | PROCTER & GAMBLE |
| EP3565828 | A SIRP1 ALPHA-41BBL FUSION PROTEIN AND METHODS OF USE THEREOF | SHANI NOAM | KAHR MEDICAL LTD |
| EP3566689 | DENTAL ADHESIVE COMPOSITION INCLUDING CHAIN TRANSFER AGENT | MIYATA SHUNSUKE | SHOFU INC |
| EP3566693 | EYE DEVICE | RAKIC JEAN-MARIE | EYED PHARMA |
| EP3566703 | PHARMACEUTICAL COMPOSITIONS COMPRISING (3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL)METHANOL | GIL DANIEL W | ALLERGAN INC |
| EP3566706 | THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE | AGRESTA SAMUEL V | AGIOS PHARMACEUTICALS INC |
| EP3566712 | COMPOSITION FOR CONTROLLED OVARIAN STIMULATION | ARCE JOAN-CARLES | FERRING BV |
| EP3566713 | INJECTABLE BIOMATERIALS | WEISS ANTHONY STEVEN | ALLERGAN PHARMACEUTICALS INT LTD |
| EP3566727 | FUNCTIONALIZED TISSUE MATRICES | OWENS RICK | LIFECELL CORP |
| EP3567042 | CDK INHIBITORS | TAVARES FRANCIS X | G1 THERAPEUTICS INC |
| EP3567114 | PROCESS FOR THE SYNTHESIS OF SILVER NANOPARTICLES USING PROBIOTIC STRAINS GROWN IN ALGAE, TERNARY MIXTURE THUS OBTAINED AND USES THEREOF | LETER BEATRICE | OCEAN FARMA S R L |
| EP3568123 | INTRODUCTION OF ACTIVE SUBSTANCES THAT ARE HARDLY WATER-SOLUBLE OR WATER-INSOLUBLE INTO A HYDROPHILIC THREE-DIMENSIONAL NETWORK MADE OF CELLULOSE USING LIPID-BASED NANOPARTICLES/VESICLES | FISCHER DAGMAR | BLUME GABRIELE |
| EP3568135 | BICYCLIC INHIBITORS OF HISTONE DEACETYLASE | FULLER NATHAN OLIVER | RODIN THERAPEUTICS INC |
| EP3568146 | VEGETABLE EXTRACT TO PREVENT AND TREAT HAIR LOSS | GIULIANI GIAMMARIA | GIULIANI SPA |
| EP3569069 | PRODUCT COMPRISING A MASTIC EXTRACT | LUTZ PATRICK JAY | LINCOLN MFG INC |
| EP3569220 | SURFACTANT COMPOSITION MADE OF ESTERS OF ISOSORBIDE- AND 1.3-PROPANEDIOL-OLIGOMERS | RODIER JEAN-DAVID | GATTEFOSSE SAS |
| EP3569237 | SODIUM NITRITE-CONTAINING PHARMACEUTICAL COMPOSITIONS | SHERMAN CRAIG | HOPE MEDICAL ENTPR INC D B A HOPE PHARMACEUTICALS |
| EP3569252 | ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS | GELLER BRUCE L | UNIV OREGON STATE |
| EP3569616 | MONOCLONAL ANTIBODY RESISTING AGAINST PD-1 AND APPLICATIONS THEREOF | ZHANG FAMING | TAIZHOU HANZHONG BIOPHARMACEUTICS INC |
| EP3569619 | CD123 SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR CANCER IMMUNOTHERAPY | GALETTO ROMAN | CELLECTIS |
| EP3569711 | LIGAND-MODIFIED DOUBLE-STRANDED NUCLEIC ACIDS | BROWN BOB DALE | DICERNA PHARMACEUTICALS INC |
| EP3570819 | MEDICAL TREATMENT COMPRISING ENTERAL ADMINISTRATION OF EDARAVONE | MOOLENAAR SYTSKE HYKE | TREEWAY TW001 B V |
| EP3570821 | METHOD FOR FABRICATION OF A TWO-LAYERED PRODUCT BASED ON ELECTROSPUN FIBRES | HANSEN JENS | AFYX THERAPEUTICS AS |
| EP3570822 | METHOD FOR PREPARING ELECTROSPUN FIBERS WITH A HIGH CONTENT OF A BIOADHESIVE SUBSTANCE | HANSEN JENS | AFYX THERAPEUTICS AS |
| EP3570830 | PSILOCYBIN AND/OR PSILOCIN IN COMBINATION WITH CANNABINOIDS AND/OR TERPENES | KüÇüKSEN MURAT | PROCARE BEHEER B V |
| EP3570834 | BICYCLIC INHIBITORS OF HISTONE DEACETYLASE | FULLER NATHAN OLIVER | RODIN THERAPEUTICS INC |
| EP3570845 | SIZING COMPOSITION FOR MINERAL WOOL BASED ON A HYDROGENATED SUGAR AND INSULATING PRODUCTS OBTAINED | SALOMON PIERRE | SAINT GOBAIN ISOVER |
| EP3570858 | PROBIOTICS FOR AGGREGATION WITH DISEASE-ASSOCIATED SPECIES IN THE ORAL CAVITY | GÖTZ MARCUS RUDOLF | SYMRISE AG |
| EP3570860 | EXTRACT FROM POLYPORE FUNGUS, COMPOSITION COMPRISING THIS EXTRACT AND USE THEREOF | CAR HALINA | UNIV MEDYCZNY W BIALYMSTOKU |
| EP3570882 | NOVEL STABLE FORMULATION FOR FXIA ANTIBODIES | OLBRICH CARSTEN | BAYER PHARMA AG |
| EP3571193 | POTASSIUM CHANNEL MODULATORS | AMRUTKAR DIPAK VASANTRAO | CADENT THERAPEUTICS INC |
| EP3571202 | HETEROCYCLIC SPIRO COMPOUNDS AS MAGL INHIBITORS | BRODNEY MICHAEL AARON | PFIZER |
| EP3571208 | IMMUNOPROTEASOME INHIBITORS | LOU YAN | PRINCIPIA BIOPHARMA INC |
| EP3572050 | EXCREMENT TREATMENT AGENT FOR USE IN COLOSTOMIES | ADACHI KANICHI | EXCELSIOR INC |
| EP3572074 | STABILIZED FORMULATIONS OF MOLINDONE | CHANG RONG-KUN | SUPERNUS PHARMACEUTICALS INC |
| EP3572079 | ETAMSYLATE FOR TREATMENT OF HERPES VIRUS INFECTIONS | CUEVAS SáNCHEZ PEDRO | DOBECURE S L |
| EP3572081 | ANTIVIRAL DRUG FOR SEVERE FEVER WITH THROMBOCYTOPENIA SYNDROME | BABA MASANORI | UNIV KAGOSHIMA |
| EP3572086 | CRYSTALLINE POLYMORPHIC FORMS OF MONOSODIUM N-[8-(2-HYDROXYBENZOYL)AMINO]CAPRYLATE | LEVCHIK HALINA | EMISPHERE TECH INC |
| EP3572401 | ASK1 INHIBITOR AND PREPARATION METHOD AND USE THEREOF | WU CHENGDE | FUJIAN COSUNTER PHARMACEUTICAL CO LTD |
| EP3572413 | 1,2-DIHYDRO-3H-PYRAZOLO[3,4-D]PYRIMIDIN-3-ONE DERIVATIVE AS WEE1 INHIBITOR | QIAN WENYUAN | SHIJIAZHUANG SAGACITY NEW DRUG DEV CO LTD |
| EP3572421 | PEPTIDE, COMPLEX OF PEPTIDE AND SIRNA AND USE THEREOF | CHEN PU | POSITEC POWER TOOLS SUZHOU CO LTD |
| EP3572443 | COPOLYMER CONTAINING CYCLIC NITROXIDE RADICAL AND TRIALKOXYSILYL IN SIDE CHAIN, AND USE THEREOF | NAGASAKI YUKIO | UNIV TSUKUBA |
| EP3572515 | GLYCOPROTEIN HORMONE LONG-ACTING SUPERAGONISTS | SZKUDLINSKI MARIUSZ | TROPHOGEN INC |
| EP3573621 | GLYCOPEPTIDE DERIVATIVES FOR USE IN THE TREATMENT AND/OR PREVENTION AND/OR ATTENUATION OF FIBROSIS DISEASES | DELIENCOURT-GODEFROY GéRALDINE | TFCHEM |
| EP3573630 | PREVENTION AND TREATMENT OF BONE AND CARTILAGE DAMAGE OR DISEASE | LUNDGREN ÅKERLUND EVY | XINTELA AB |
| EP3573635 | METHOD FOR THE TREATMENT OF THROMBOEMBOLISM | ALLEN LYNN | EKOS CORP |
| EP3573656 | CORE/SHELL STRUCTURE PLATFORM FOR IMMUNOTHERAPY | SHEN HAIFA | METHODIST HOSPITAL |
| EP3573663 | A composition comprising at least one GNRH antagonist | LARSEN FINN | ANTEV LTD |
| EP3573667 | PHAGE CONJUGATES AND USES THEREOF | DE BERARDINIS PIERGIUSEPPE | CONSIGLIO NAZIONALE RICERCHE |
| EP3573717 | CYCLIC DINUCLEOTIDES AS STING AGONISTS | EMANUEL STUART | JANSSEN BIOTECH INC |
| EP3573719 | ACTIVE AGENT-CONTAINING ARTICLES THAT EXHIBIT CONSUMER ACCEPTABLE ARTICLE IN-USE PROPERTIES | PRATT MICHAEL SEAN | PROCTER & GAMBLE |
| EP3573721 | ACTIVE AGENT-CONTAINING ARTICLES THAT EXHIBIT CONSUMER ACCEPTABLE ARTICLE IN-USE PROPERTIES | DENOME FRANK WILLIAM | PROCTER & GAMBLE |
| EP3573778 | NANOMATERIAL AND METHOD OF PRODUCTION OF A NANOMATERIAL FOR MEDICAL APPLICATIONS, SUCH AS MRI OR SERS | SPADAVECCHIA JOLANDA | UNIV PARIS NORD |
| EP3573952 | BENZYLAMINOPYRIDYLCYCLOPROPANECARBOXYLIC ACIDS, PHARMACEUTICALCOMPOSITIONS AND USES THEREOF | ECKHARDT MATTHIAS | BOEHRINGER INGELHEIM INT |
| EP3573959 | BENZYLAMINOPYRAZINYLCYCLOPROPANECARBOXYLIC ACIDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | ECKHARDT MATTHIAS | BOEHRINGER INGELHEIM INT |
| EP3573963 | NRF2 ACTIVATOR | CAPACCI ANDREW GEORGE | BIOGEN MA INC |
| EP3573965 | INDANYLAMINOPYRAZINYLCYCLOPROPANECARBOXYLIC ACIDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | ECKHARDT MATTHIAS | BOEHRINGER INGELHEIM INT |
| EP3573982 | BIS-HETEROARYL DERIVATIVES AS MODULATORS OF PROTEIN AGGREGATION | HALL ADRIAN | UCB BIOPHARMA SPRL |
| EP3573983 | N-[4-FLUORO-5-[[(2S,4S)-2-METHYL-4-[(5-METHYL-1,2,4-OXADIAZOL-3-YL)METHOXY]-1-PIPERIDYL]METHYL]THIAZOL-2-YL]ACETAMIDE AS OGA INHIBITOR | DREYFUS NICOLAS JACQUES FRANCOIS | LILLY CO ELI |
| EP3573987 | TYROSINE AMIDE DERIVATIVES AS RHO- KINASE INHIBITORS | ACCETTA ALESSANDRO | CHIESI FARM SPA |
| EP3574891 | OILY COMPOSITION, METHOD FOR PRODUCING SAME, OIL-BASED BASE AGENT AND EXTERNAL PREPARATION FOR SKIN | OMORI MINORU | YOKOZEKI OIL & FAT IND CO LTD |
| EP3574900 | NEW APPLICATIONS OF RIFAMYCIN-NITROIMIDAZOLE COUPLING MOLECULES | MA ZHENKUN | TENNOR THERAPEUTICS SUZHOU LTD |
| EP3574912 | COMPOSITION FOR TREATING DIABETIC DISEASE | LEE SAM-GOO | LEE SAM GOO |
| EP3574914 | CORTICOSTEROID COMPOSITIONS | LICALSI CYNTHIA | MERITAGE PHARMA INC |
| EP3574922 | MODIFIED OR POLYMER-CONJUGATED FUMAGILLOL METAP2 INHIBITORS FOR USE IN IMPROVING OR RESTORING INSULIN SENSITIVITY | PETERSEN JOHN S | SYNDEVRX INC |
| EP3574924 | PATIENT SELECTION METHOD FOR INFLAMMATION | LOW PHILIP S | PURDUE RESEARCH FOUNDATION |
| EP3574950 | TRANSDERMAL DELIVERY OF HIGH VISCOSITY BIOACTIVE AGENTS | ROSS RUSSELL F | SORRENTO THERAPEUTICS INC |
| EP3575284 | PHENYLDIFLUOROMETHYL-SUBSTITUTED PROLINEAMIDE COMPOUND | NAKAJIMA YUTAKA | ASTELLAS PHARMA INC |
| EP3575288 | QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS | JOHNSON JAMES A | SQUIBB BRISTOL MYERS CO |
| EP3575293 | ETHANE-SULFONATE SALT OF QUINOLINE DERIVATIVE | NEKADO TAKAHIRO | ONO PHARMACEUTICAL CO |
| EP3576717 | NANOPARTICLE-BASED LIVER-TARGETING THERAPY | COULTER TOM | MIDATECH LTD |
| EP3576718 | A LOZENGE | THYRESSON KRISTINA | JOHNSON & JOHNSON CONSUMER INC |
| EP3576719 | ABUSE DETERRENT FORMULATIONS OF AMPHETAMINE | BAKER DAVID | VALLON PHARMACEUTICALS INC |
| EP3576757 | METHOD OF PREDICTING RESPONSE TO IMMUNOTHERAPY | BORDEAUX JENNIFER | NOVARTIS AG |
| EP3576772 | COMPOSITIONS AND METHODS FOR IMPROVING SEXUAL FUNCTION | AVERBACK PAUL | NYMOX CORP |
| EP3576778 | FUNCTIONAL SCREENING OF ANTIGENIC POLYPEPTIDES-USE FOR THE IDENTIFICATION OF ANTIGENS ELICITING A PROTECTIVE IMMUNE RESPONSE AND FOR THE SELECTION OF ANTIGENS WITH OPTIMAL PROTECTIVE ACTIVITY | AMINO ROGERIO | PASTEUR INSTITUT |
| EP3576795 | ORAL THYROID THERAPEUTIC AGENT | BECKER ACHIM | BERLIN CHEMIE AG |
| EP3577108 | N1 -(4-(5-(CYCLOPROPYLMETHYL)-1 -METHYL-1 H-PYRAZOL-4-YL)PYRIDIN-2-YL)CYCLOHEXANE-1,4-DIAMINE DERIVATIVES AND RELATED COMPOUNDS AS CK1 AND/OR IRAKI INHIBITORS FOR TREATING CANCER | LI DANSU | YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD |
| EP3577110 | ATAZANAVIR (ATV) ANALOGUES FOR TREATING HIV INFECTIONS | BACON ELIZABETH M | GILEAD SCIENCES INC |
| EP3577217 | RETARGETING OF VIRUSES OR VLPs | GRUBER JENS | DEUTSCHES PRIMATENZENTRUM GMBH DPZ LEIBNIZ INST FUER PRIMATENFORSCHUNG |
| EP3577521 | STRUCTURED COMPOSITE OF MATRIX MATERIAL AND NANOPARTICLES | HASSELMANN SEBASTIAN | FRAUNHOFER GES FORSCHUNG |
| EP3578160 | COMPOSITION OF GEL/GEL TYPE BASED ON HYDROPHOBIC COATED PIGMENTS AND A GLYCOL COMPOUND | VALVERDE ELODIE | OREAL |
| EP3578172 | SOLID SOLUTION COMPOSITIONS AND USE IN CHRONIC INFLAMMATION | BANNISTER ROBIN MARK | INFIRST HEALTHCARE LTD |
| EP3578183 | RNA INTERFERENCE IN OCULAR INDICATIONS | LIBERTINE LYN | PHIO PHARM CORP |
| EP3578192 | POLYPEPTIDE SPERM STABILISER FOR SEMEN USED IN ARTIFICIAL INSEMINATION | ROMERO MEJíA FERNANDO GONZALO | UNIV LA FRONTERA |
| EP3578558 | HIGHLY EFFECTIVE PHOTOPROTECTIVE AGENTS | BERTE' FERRUCCIO | 3V SIGMA SPA |
| EP3578560 | QUINAZOLINE COMPOUND | KURAMOTO KAZUYUKI | ASTELLAS PHARMA INC |
| EP3578562 | L-VALINATE AMIDE BENZOXABOROLE DERIVATIVES FOR THE TREATMENT OF PARASITIC DISEASES | AKAMA TSUTOMU | ANACOR PHARMACEUTICALS INC |
| EP3578563 | GUANINE ANALOGS AS TELOMERASE SUBSTRATES AND TELOMERE LENGTH AFFECTORS | GRYAZNOV SERGEI M | GERON CORP |
| EP3578587 | NOVEL COMPOUND HEXADECAPHLORETHOL ISOLATED FROM ISHIGE OKAMURAE AND USE THEREOF | JEON YOU-JIN | JEJU NATIONAL UNIV INDUSTRY ACADEMIC COOPERATION FOUNDATION |
| EP3578656 | COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE PCSK9 GENE | TAN PAMELA | ALNYLAM PHARMACEUTICALS INC |
| EP3579811 | COSMETIC SUNSCREEN STICK | TOSHIHIKO SHIMODA | BEIERSDORF AG |
| EP3579818 | A HAIR CONDITIONING COMPOSITION | CAO QUNHUA | UNILEVER NV |
| EP3579820 | LIQUID COMPOSITION CONTAINING PRADOFLOXACIN | HEEP IRIS | BAYER ANIMAL HEALTH GMBH |
| EP3579823 | GASTROINTESTINAL RELEASE CAPSULE FOR USE IN A METHOD FOR DESENSITISING AND/OR INDUCING TOLERANCE IN A PATIENT WITH A PEANUT ALLERGY | FAUQUERT JEAN-LUC | CENTRE HOSPITALIER ET UNIV DE CLERMONT FERRAND |
| EP3579836 | METHODS FOR AUTISM SPECTRUM DISORDER PHARMACOTHERAPY | VAUGHAN BRENT | PERFECT DAYLIGHT LTD |
| EP3579849 | GENE THERAPY | BIGGER BRIAN | UNIV MANCHESTER |
| EP3579865 | THERAPEUTIC COMPOSITIONS | FROSTEGÅRD JOHAN | ANNEXIN PHARMACEUTICALS AB |
| EP3579874 | 1-(4-AMINO-5-BROMO-6-(1 H-PYRAZOL-1-YL)PYRIMIDIN-2-YL)-1 H-PYRAZOL-4-OL AND USE THEREOF IN THE TREATMENT OF CANCER | BILIC SANELA | NOVARTIS AG |
| EP3579883 | PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES | VAN BERKEL PATRICIUS HENDRIKUS CORNELIS | ADC THERAPEUTICS SA |
| EP3579913 | IMPLANTABLE ELECTRODE WITH DEXAMETHASONE COATING | TRITTHART THOMAS | MED EL ELEKTROMEDIZINISCHE GERAETE GMBH |
| EP3579927 | A POLYMER | HOESSEL PETER | BASF SE |
| EP3579928 | FUNCTIONALIZED CALCIUM CARBONATE FOR SUN PROTECTION BOOSTING | BUDDE TANJA | OMYA INT AG |
| EP3580208 | NOVEL HETEROCYCLIC COMPOUND, ITS PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | LEE BONG-YONG | DAE WOONG PHARMA |
| EP3580220 | AMINOTRIAZOLOPYRIDINES AS KINASE INHIBITORS | GUO JUNQING | SQUIBB BRISTOL MYERS CO |
| EP3580222 | INDANYLAMINOAZADIHYDROBENZOFURANYLACETIC ACIDS, PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DIABETES | ECKHARDT MATTHIAS | BOEHRINGER INGELHEIM INT |
| EP3580277 | OIL-IN-WATER MICROEMULSIONS AND THE PREPARATION THEREOF | LIANG XINYU | WACKER CHEMIE AG |
| EP3580549 | A COMPANION DIAGNOSTIC METHOD FOR USE IN THE TREATMENT OF CYSTIC FIBROSIS WITH ALGINATE OLIGOMERS | LEWIS PAUL | ALGIPHARMA AS |
| EP3581180 | ANTIMICROBIAL COMPOSITIONS WITH EFFERVESCENT AGENTS | LI DANPING | MELINTA SUBSIDIARY CORP |
| EP3581182 | COMBINATION TREATING PROSTATE CANCER, PHARMACEUTICAL COMPOSITION AND TREATMENT METHOD | GE CHUANSHENG | KANGPU BIOPHARMACEUTICALS LTD |
| EP3581184 | APILIMOD FOR USE IN THE TREATMENT OF RENAL CANCER | BEEHARRY NEIL | AI THERAPEUTICS INC |
| EP3581190 | ENGINEERED NATURAL KILLER CELLS AND USES THEREOF | O'DWYER MICHAEL EAMON PETER | ONK THERAPEUTICS LTD |
| EP3581654 | METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GLYCOLATE OXIDASE (HAO1) BY DOUBLE-STRANDED RNA | BROWN BOB D | DICERNA PHARMACEUTICALS INC |
| EP3581656 | 5' TRIPHOSPHATE OLIGONUCLEOTIDE WITH BLUNT END AND USES THEREOF | HARTMANN GUNTHER | UNIV BONN RHEINISCHE FRIEDRICH WILHELMS |
| EP3582745 | USE OF A PARTICULATE MINERAL TO REDUCE POLLUTION | PAGIS LAURE | IMERTECH SAS |
| EP3582747 | A PERSONAL CARE COMPOSITION | EVANS RICHARD LIVESEY | UNILEVER NV |
| EP3582764 | TREATMENT OF ALCOHOL USE DISORDER | SÖDERPALM BO | SOEDERPALM BO |
| EP3582765 | MIDODRINE HYDROCHLORIDE ORAL SOLUTION AND USES THEREOF | NANDI INDRANIL | VERTICE PHARMA LLC |
| EP3582767 | PHARMACEUTICAL ACTIVE INGREDIENT AND USE THEREOF, IN PARTICULAR FOR THE PREVENTION AND TREATMENT OF METABOLIC DISORDERS IN HUMANS AND ANIMALS | PELTIER SéBASTIEN | VALBIOTIS |
| EP3582780 | AMINO PYRIMIDINE COMPOUNDS USEFUL AS SSAO INHIBITORS | FAN MENGYANG | LILLY CO ELI |
| EP3582796 | COMPOSITION FOR COUGH | MERCATI VALENTINO | ABOCA SPA SOCIETA AGRICOLA |
| EP3582853 | CYCLIC DI-NUCLEOTIDES COMPOUNDS FOR THE TREATMENT OF CANCER | KIM DAE-SHIK | EISAI R&D MAN CO LTD |
| EP3582857 | PACKAGED PERSONAL CLEANSING PRODUCT | SMYTH KELSEY MARIE | PROCTER & GAMBLE |
| EP3583083 | ZIRCONIA ARTICLE WITH HIGH ALUMINA CONTENT, PROCESS OF PRODUCTION AND USE THEREOF | THEELKE BJÖRN | 3M INNOVATIVE PROPERTIES CO |
| EP3583934 | BIOCIDAL AGENT | AFONINA IRINA VASIL'EVNA | VERTA RES PRODUCTION COMPANY LTD |
| EP3585364 | PARTICLE-DROP STRUCTURES AND METHODS FOR MAKING AND USING THE SAME | DI CARLO DINO | THE REGENTS OF UNIV OF CALIFORNIA |
| EP3585365 | COMBINATION OF ATR KINASE INHIBITORS WITH PARP INHIBITORS | WENGNER ANTJE MARGRET | BAYER PHARMA AG |
| EP3585382 | USE OF 3-[5-AMINO-4-(3-CYANOBENZOYL)-PYRAZOL-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMIDE IN THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | MACKINNON ALASTAIR | MEREO BIOPHARMA 1 LTD |
| EP3585383 | USE OF 3-[5-AMINO-4-(3-CYANOBENZOYL)-PYRAZOL-1-YL]-N-CYCLOPROPYL-4-METHYLBENZAMIDE IN THE PREVENTION OR REDUCTION OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | PARKIN JACQUELINE | MEREO BIOPHARMA 1 LTD |
| EP3585438 | CHEMILUMINESCENT ANDROSTENEDIONE CONJUGATES | ZHENG YI FENG | SIEMENS HEALTHCARE DIAGNOSTICS INC |
| EP3585440 | NICOTINE-CONTAINING TRANSPARENT TRANSDERMAL THERAPEUTIC SYSTEM | HILLE THOMAS | LTS LOHMANN THERAPIE SYSTEME AG |
| EP3585776 | 5-(PYRIMIDIN-4-YL)-2-(PYRROLIDIN-1-YL)NICOTINONITRILE COMPOUNDS AS IKKE, TBK1 AND/OR SIK2 KINASES INHIBITORS | NEWTON GARY KARL | DOMAINEX LTD |
| EP3585793 | NOVEL IMMUNE STIMULATING MACROLIDE | WINQVIST OLA | IMMUNE SYSTEM REGULATION HOLDING AB |
| EP3585795 | NOVEL IMMUNE STIMULATING MACROLIDES | WINQVIST OLA | IMMUNE SYSTEM REGULATION HOLDING AB |
| EP3585796 | NOVEL IMMUNE STIMULATING MACROLIDES | WINQVIST OLA | IMMUNE SYSTEM REGULATION HOLDING AB |
| EP3586821 | STEM CELL STIMULATING COMPOSITIONS AND METHODS | TUROVETS NIKOLAY | MEDICELL TECH LLC |
| EP3586826 | COMPOSITIONS AND METHODS FOR STABILIZING PROTEIN-CONTAINING FORMULATIONS | ESUE OSIGWE | HOFFMANN LA ROCHE |
| EP3586832 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CONSTIPATION | BAASCH BASTIAN | SYNFORMULAS GMBH |
| EP3586833 | TRANSDERMAL PATCH BASE AND TRANSDERMAL PATCH USING SAME | TSURUSHIMA KEIICHIRO | HISAMITSU PHARMACEUTICAL CO |
| EP3586838 | AMIDE DERIVATIVE | SONEDA TSUYOSHI | DAIICHI SANKYO CO LTD |
| EP3586840 | NOVEL THERAPY | SVANBORG CATHARINA | LINNANE PHARMA AB |
| EP3586848 | PHARMACEUTICAL COMPOSITION COMPRISING COMPOUND CAPABLE OF PENETRATING BLOOD-BRAIN BARRIER AS EFFECTIVE INGREDIENT FOR PREVENTING OR TREATING BRAIN CANCER | CHOI HWAN GEUN | DAEGU GYEONGBUK MEDICAL INNOVATION FOUND |
| EP3586852 | MODIFIED CELL EXPANSION AND USES THEREOF | XIAO LEI | INNOVATIVE CELLULAR THERAPEUTICS INC |
| EP3586862 | METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH | WILSON D TRAVIS | STEALTH PEPTIDES INT INC |
| EP3586925 | ZINC PHOSPHATE COMPLEX | NAWROCKI SHIRI | COLGATE PALMOLIVE CO |
| EP3586926 | COMPOSITIONS AND METHODS FOR TREATING SKIN CONDITIONS USING LIGHT AND GLUCOSAMINE HYDROCHLORIDE | CHEN MICHELLE | JOHNSON & JOHNSON CONSUMER INC |
| EP3587349 | BARIUM SULFATE SPHERICAL COMPOSITE POWDER AND METHOD FOR PRODUCING SAME | KAMADA SATOSHI | SAKAI CHEMICAL INDUSTRY CO |
| EP3587392 | NANOSTRUCTURED FORMULATIONS FOR THE DELIVERY OF SILIBININ AND OTHER ACTIVE INGREDIENTS FOR TREATING OCULAR DISEASES | BLANCO ANNA RITA | DISTRETTO TECNOLOGICO SICILIA MICRO E NANO SISTEMI S C A R L |
| EP3587406 | 2-HYDROXY-1-{4-[(4-PHENYLPHENYL)CARBONYL]PIPERAZIN-1-YL}ETHAN-1-ONE DERIVATIVES AND RELATED COMPOUNDS AS FATTY ACID SYNTHASE (FASN) INHIBITORS FOR THE TREATMENT OF CANCER | BAIR KENNETH W | FORMA THERAPEUTICS INC |
| EP3587411 | PIPERIDINE OR THIOMORPHOLINE LINKED IMIDAZOLE AND TRIAZOLE DERIVATIVES AND USES THEREOF FOR IMPROVING THE PHARMACOKINETICS OF A DRUG | COBURN CRAIG A | MERCK SHARP & DOHME |
| EP3587418 | INHIBITORS OF CREB BINDING PROTEIN (CBP) | SCHILLER SHAWN E R | FORMA THERAPEUTICS INC |
| EP3587420 | TRI-CYCLE COMPOUND AND APPLICATIONS THEREOF | HE HAIYING | FUJIAN COSUNTER PHARMACEUTICAL CO LTD |
| EP3587562 | METHODS MODULATING IMMUNOREGULATORY EFFECT OF STEM CELLS | SHI YUFANG | UNIV RUTGERS |
| EP3587579 | METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF BETA-CATENIN BY DOUBLE-STRANDED RNA | BROWN BOB DALE | DICERNA PHARMACEUTICALS INC |
| EP3589269 | INTRANASAL ADMINISTRATION OF PHYSIOLOGICALLY ACTIVE SUBSTANCES | PELLIKAAN HUBERT CLEMENS | DUTCH RENEWABLE ENERGY B V |
| EP3589270 | TRANSMUCOSAL DELIVERY SYSTEM FOR IDEBENONE | LINN MICHAEL | LTS LOHMANN THERAPIE SYSTEME AG |
| EP3589274 | COMPOSITIONS COMPRISING PGI2-RECEPTOR AGONISTS AND PROCESSES FOR THE PREPARATION THEREOF | SHAO ZEZHI JESSE | ARENA PHARM INC |
| EP3589331 | PER-ORAL NEGATIVE CONTRAST AGENT FOR ABDOMINAL CT | CASAL-DUJAT LUCIA | LUMENT AB |
| EP3589374 | CHLORHEXIDINE-BASED MOUTHWASH PREVENTING TEETH-STAINING | BARATTO GIOVANNI | UNIFARCO S P A |
| EP3589615 | PYRIDYL DERIVATIVES AS BROMODOMAIN INHIBITORS | ATKINSON STEPHEN JOHN | GLAXOSMITHKLINE IP NO 2 LTD |
| EP3589625 | ISOQUINOLIN AND NAPHTHYDRIN COMPOUNDS | LEI HUI | LILLY CO ELI |
| EP3589630 | CYCLIC SULFAMIDE COMPOUNDS AND METHODS OF USING SAME | TURNER WILLIAM W JR | ASSEMBLY BIOSCIENCES INC |
| EP3589631 | IMIDAZO[4,5-c]RING COMPOUNDS CONTAINING GUANIDINE SUBSTITUTED BENZAMIDE GROUPS | MERRILL BRYON A | 3M INNOVATIVE PROPERTIES CO |
| EP3589637 | COMPOUNDS USEFUL FOR INHIBITING ROR-GAMMA-T | LUGAR CHARLES WILLIS III | LILLY CO ELI |
| EP3589638 | COMPOUNDS USEFUL FOR INHIBITING ROR-GAMMA-T | CLARKE CHRISTIAN ALEXANDER | LILLY CO ELI |
| EP3589784 | USE OF A VISCOSE FIBER | BACHMANN ALEXANDER | KELHEIM FIBRES GMBH |
| EP3590517 | HETEROARYL-KETONE FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS | HUNT HAZEL | CORCEPT THERAPEUTICS INC |
| EP3590520 | COMPOSITIONS FOR PROVIDING HEMATOPOIETIC FUNCTION WITHOUT HLA MATCHING | BERNSTEIN IRWIN D | HUTCHINSON FRED CANCER RES |
| EP3590523 | GROWTH PROMOTING PEPTIDES AND USES THEREOF | KHALDI NORA | NURITAS LTD |
| EP3590530 | ANTIGEN-SPECIFIC T CELL RECEPTORS AND T CELL EPITOPES | SAHIN UGUR | BIONTECH CELL & GENE THERAPIES GMBH |
| EP3590541 | DRUG-CONJUGATES, CONJUGATION METHODS, AND USES THEREOF | MIAO ZHENWEI | CONCORTIS BIOSYSTEMS CORP |
| EP3590924 | NOVEL ISOINDOLINE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | LEE WEN-CHERNG | KANGPU BIOPHARMACEUTICALS LTD |
| EP3590928 | PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS | MC GOWAN DAVID CRAIG | JANSSEN SCIENCES IRELAND UNLIMITED CO |
| EP3590929 | SPIRO COMPOUND AND USE THEREOF | ZHANG PENG | MEDSHINE DISCOVERY INC |
| EP3590933 | PYRAZOLE AMINOPYRIMIDINE DERIVATIVES AS LRRK2 MODULATORS | BAKER-GLENN CHARLES | GENENTECH INC |
| EP3590934 | PYRAZOLYL QUINOXALINE KINASE INHIBITORS | SAXTY GORDON | ASTEX THERAPEUTICS LTD |
| EP3590936 | METHOD FOR PRODUCING HETEROCYCLIC COMPOUND | KANEMATSU MAKOTO | TAKEDA PHARMACEUTICALS CO |
| EP3590940 | HEXAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AND RELATED COMPOUNDS AS AUTOTAXIN (ATX) INHIBITORS AND AS INHIBITORS OF THE LYSOPHOSPHATIDIC ACID (LPA) PRODUCTION FOR TREATING E.G. RENAL DISEASES | HERT JéRÔME | HOFFMANN LA ROCHE |
| EP3590942 | HEPATITIS B VIRUS SURFACE ANTIGEN INHIBITOR | SUN FEI | FUJIAN COSUNTER PHARMACEUTICAL CO LTD |
| EP3590962 | SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST INTRACELLULAR ANTIGENS | SINGH SUNANDA | SINGH BIOTECHNOLOGY LLC |
| EP3592327 | LIPID MIXTURE OF OCTYLDODECANOL AND HYDROGENATED RAPESEED OIL | ZEWUHN MERLE | BEIERSDORF AG |
| EP3592341 | TOPICAL COMPOSITIONS CONTAINING SYNTHETIC ESTERS OF SINAPINIC ACID AND METHODS FOR TREATING KERATIN SURFACES | PERNODET NADINE | ELC MAN LLC |
| EP3592391 | PHARMACEUTICAL COMPOSITION COMPRISING SELEXIPAG | HELLERBRAND KLAUS | ACTELION PHARMACEUTICALS LTD |
| EP3592393 | RELEASABLE CONJUGATES | KWIATKOWSKI MAREK | QUIAPEG PHARMACEUTICALS AB |
| EP3592432 | GARDENIA EXTRACT FOR KERATIN FIBRE DYEING | FIORINI CHRISTEL | FABRE PIERRE DERMO COSMETIQUE |
| EP3592433 | USE OF AGAVE EXTRACTS FOR PROTECTING CAPILLARY FIBRE | TUFEU SYLVIE | LABORATOIRES DE BIOLOGIE VEGETALE YVES ROCHER |
| EP3592730 | PRODRUGS OF SULFASALAZINE, PHARMACEUTICAL COMPOSITIONS THEREOF AND THEIR USE IN THE TREATMENT OF AUTOIMMUNE DISEASE | MASCHA MENSONIDES-HARSEMA MARGUéRITE | TRULY TRANSLATIONAL SWEDEN AB |
| EP3592733 | 2- OR 3-IMIDAZOLINES AS CARBAPENEMASES INHIBITORS | CARIOU KEVIN | CENTRE NAT RECH SCIENT |
| EP3592734 | AMINE SALT OF (1R,3S)-3-(5-CYANO-4-PHENYL-1,3-THIAZOL-2-YLCARBAMOYL)CYCLOPENTANE CARBOXYLIC ACID | CASTRO PALOMINO LARIA JULIO | PALOBIOFARMA SL |
| EP3592742 | JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE | FATHEREE PAUL R | THERAVANCE BIOPHARMA R&D IP LLC |
| EP3592745 | PYRIMIDOPYRIMIDINONES USEFUL AS WEE-1 KINASE INHIBITORS | HEWITT PETER | ALMAC DISCOVERY LTD |
| EP3592756 | LINCOSAMIDE DERIVATIVES, PREPARATION AND USE THEREOF AS ANTIMICROBIAL AGENT | JANATA JIRI | MIKROBIOLOGICKY USTAV AV CR V V I |
| EP3592869 | SPECIFIC BACTERIA FOR USE AS A DRUG, IN PARTICULAR TO COMBAT OVERWEIGHT, OBESITY, CARDIOMETABOLIC DISEASES AND INFLAMMATORY BOWEL DISEASES | VINCENT CLAUDE | INTERNATIONAL NUTRITION RES COMPANY S A R L |
| EP3593787 | COMPOSITION | CASUGBO CHRISTIA | UNILEVER PLC |
| EP3593793 | ONE-POT FORMULATION OF BIOPOLYMER PARTICLES | BÄUMLER PD DR HANS | WANITCARE GMBH |
| EP3593799 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING PRURITUS, CONTAINING PYRAZOLE DERIVATIVE AS ACTIVE INGREDIENT, AND SCREENING METHOD FOR DETECTING SAME | OH UHTAEK | SEOUL NAT UNIV R&DB FOUNDATION |
| EP3593810 | METHODS OF MEASURING POTENTIAL FOR THERAPEUTIC POTENCY AND DEFINING DOSAGES FOR AUTOLOGOUS CELL THERAPIES | WONG PO FOO CHERYL | BIOCARDIA INC |
| EP3594202 | SUBSTITUTED PYRROLIDINE COMPOUND AND USE THEREOF | MIKAMI SATOSHI | TAKEDA PHARMACEUTICALS CO |
| EP3594221 | GPR84 RECEPTOR ANTAGONIST AND USE THEREOF | NAN FAJUN | SHANGHAI INST MATERIA MEDICA CAS |
| EP3594223 | TREATMENT OF BIOFILMS | STENSEN WENCHE | AMICOAT AS |
| EP3594238 | ANTIBODY COMPOSITIONS FOR TUMOR TREATMENT | DAVIS SAMUEL | REGENERON PHARMA |
| EP3594248 | HYDROXYPROPYL METHYL CELLULOSE HARD CAPSULES AND PROCESS OF MANUFACTURE | CADE DOMINIQUE NICOLAS | CAPSUGEL BELGIUM NV |
| EP3594348 | C/EBP ALPHA SHORT ACTIVATING RNA COMPOSITIONS AND METHODS OF USE | SAERTROM PAL | MINA THERAPEUTICS LTD |
| EP3595614 | MONOCHROMATIC DENTAL SHAPED ARTICLE AND BLANK FOR MAKING DENTAL RESTORATIONS | HAGENBUCH KONRAD | IVOCLAR VIVADENT AG |
| EP3595617 | NAIL VARNISH COMPOSITIONS | MARTINEZ FRANCISCO | FIABILA SAS |
| EP3595625 | CONCENTRATE COMPRISING AT LEAST ONE MANNOSYLERYTHRITOL LIPID AND AT LEAST ONE POLYGLYCEROL AND FATTY ACID ESTER | PEETERS HILDE | OLEON N V |
| EP3595626 | ORAL CARE COMPOSITIONS | JOINER ANDREW | UNILEVER PLC |
| EP3595627 | COMBINATION OF AQUEOUS EXTRACTS OF WATERCRESS AND NASTURTIUM AND ATP FOR USE IN THE TREATMENT OF ALOPECIA | DAUNES-MARION SYLVIE | FABRE PIERRE DERMO COSMETIQUE |
| EP3595628 | COMPOSITIONS FOR RETARDING THE DECOMPOSITION OF MELATONIN IN SOLUTION | UTTENTHAL LARS OTTO | REPOCEUTICALS APS |
| EP3595632 | COMPOSITION FOR USE IN THE TREATMENT OF ENDOMETRIOSIS AND SYMPTOMS ASSOCIATED WITH ENDOMETRIOSIS | SIGNORILE PIETRO GIULIO | SISTEMI SALUTE S R L |
| EP3595637 | COMBINATION OF ACTIVE INGREDIENTS, COMPOSITIONS COMPRISING IT AND THEIR USE IN THE TREATMENT OF SARCOPENIA | PIZZONI ANGELO | APHARM SRL |
| EP3595650 | COMPOSITION FOR USE IN THE REDUCTION OF HAIR GROWTH | DI MAIO UMBERTO | NEILOS S R L |
| EP3595668 | BENZAZEPINE COMPOUNDS, CONJUGATES, AND USES THEREOF | COBURN CRAIG ALAN | SILVERBACK THERAPEUTICS INC |
| EP3595693 | CANNABINOID FORMULATIONS AND DOSAGE | COHEN SHMUEL | IZUN PHARMACEUTICALS CORP |
| EP3595780 | POLYMER MEMBRANE AND METHODS OF MANUFACTURING THEREOF | MONTEUX CéCILE | CENTRE NAT RECH SCIENT |
| EP3596054 | 5-CARBOXAMIDE-2-THIOBARBITURIC ACIDS AND USE THEREOF AS MEDICAMENTS | DE VIVO MARCO | FONDAZIONE ST ITALIANO TECNOLOGIA |
| EP3596079 | PHARMACOLOGICALLY ACTIVE ARYL-SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES | BORZA ISTVáN | RICHTER GEDEON NYRT |
| EP3596080 | PHARMACOLOGICALLY ACTIVE ALICYCLIC-SUBSTITUTED PYRAZOLO[1,5-a | BORZA ISTVáN | RICHTER GEDEON NYRT |
| EP3596113 | ANTIGEN RECEPTORS AND USES THEREOF | VOSS RALF HOLGER | BIONTECH CELL&GENE THERAPIES GMBH |
| EP3596196 | FILTER APPARATUS | SARKANEN JERTTA-RIINA | EVERFILL OY |
| EP3597180 | DEBRANCHING ENZYME MODIFIED STARCH, THE PREPARING METHOD AND USE THEREOF IN HARD CAPSULE PRODUCTION | CHANG RUEI-JAN | |
| EP3597186 | MYC G-QUADRUPLEX STABILIZING SMALL MOLECULES AND THEIR USE | SCHNEEKLOTH JOHN JR | US HEALTH |
| EP3597210 | USE OF AMINO ACID SEQUENCES FROM MYCOBACTERIUM TUBERCULOSIS OR CORRESPONDING NUCLEIC ACIDS THEREOF FOR DIAGNOSIS AND PREVENTION OF TUBERCULAR INFECTION, DIAGNOSTIC KIT AND VACCINE THEREFROM | AMICOSANTE MASSIMO | CELLESTIS LTD |
| EP3597644 | AMINE CATIONIC LIPIDS AND USES THEREOF | BROWN BOB DALE | DICERNA PHARMACEUTICALS INC |
| EP3597649 | SUBSTITUTED [1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL COMPOUNDS AS PDE2 INHIBITORS | BREITENBUCHER JAMES | DART NEUROSCIENCE CAYMAN LTD |
| EP3598868 | NEW POLYIMINO KETOALDEHYDES | HULAJ BESIM | NOVUM SPERO LTD |
| EP3599237 | PHARMACEUTICAL COMPOSITION OF THE GLUCOSYLCERAMIDE SYNTHASE INHIBITOR ELIGLUSTAT FOR THE TREATMENT GAUCHER'S DISEASE COMPRISING ADJUSTING THE INDIVIDUAL THERAPEUTICAL DOSE TO THE P450 METABOLISM OF THE PATIENT | LIU HANLAN | GENZYME CORP |
| EP3600248 | INJECTABLE AND BIODEGRADABLE POLYMER FORMULATIONS FOR CONTROLLED RELEASE OF BIOLIGIC AGENTS | BEGOVAC PAUL C | GORE & ASS |
| EP3600252 | COMPARTMENTALISED GEL MATRIX AND METHOD OF PRODUCTION | BAYLEY JOHN HAGAN PRYCE | UNIV OXFORD INNOVATION LTD |
| EP3600255 | STABLE HOT-MELT EXTRUDATE CONTAINING VALSARTAN AND SACUBITRIL | RALLABANDI BALA RAMESHA CHARY | TIEFENBACHER ALFRED E GMBH & CO KG |
| EP3600278 | STATIN FOR PREVENTION/REDUCTION OF ISCHEMIA-RELATED DAMAGE | BADIMON MAESTRO LINA | FUNDACIO INST DE RECERCA DE LHOSPITAL DE LA SANTA CREU I SANT PAU |
| EP3600307 | COMPOSITIONS FOR USE IN METHODS OF INHIBITING PROTEIN KINASES | CUNY GREGORY | UNIV HOUSTON SYSTEM |
| EP3600342 | METHOD FOR DESIGNING RIG-I LIGANDS | FELD MICHA | RIGONTEC GMBH |
| EP3600433 | AN AGENT THAT INCREASES THE EXPRESSION OF THE BCL2-ASSOCIATED AGONIST OF CELL DEATH FOR THE TREATMENT OF CANCER | DALGLEISH ANGUS | LDN PHARMA LTD |
| EP3600486 | CARBOHYDRATE COMPOSITION FOR DIALYSIS | GRENTZMANN GUIDO | OPTERION HEALTH AG |
| EP3600557 | PHARMACEUTICAL COMPOSITION COMPRISING GLUTATIONE DISULFIDE AND GLUTATHIONE DISULFIDE S-OXIDE | BALAZOVSKIJ MARK BORISOVICH | OBSCHESTVO S OGRANICHENNOY OTVETSTVENNOSTJU IVA FARM |
| EP3600559 | COSMETIC ARTICLE PROVIDED WITH A MESH | VILLECROZE HéLèNE | CHANEL PARFUMS BEAUTE |
| EP3600560 | ANTIMICROBIAL PERSONAL CLEANSING COMPOSITIONS | TURNER GRAHAM ANDREW | UNILEVER PLC |
| EP3600564 | SUNSCREEN CONTAINING POLYGLYCERYL-10 STEARATE AND CITRONELLOL | SPROCK SARAH | BEIERSDORF AG |
| EP3600565 | SUNSCREEN CONTAINING POLYGLYCERYL-10 STEARATE AND LINALOOL | SPROCK SARAH | BEIERSDORF AG |
| EP3601225 | SUBSTITUTED INDOLINE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS | BARDIOT DOROTHéE ALICE MARIE-EVE | JANSSEN PHARMACEUTICALS INC |
| EP3601240 | PROCESS FOR MAKING ARYLOMYIN RING ANALOGS | PETRONIJEVIC FILIP | HOFFMANN LA ROCHE |
| EP3601252 | TETRAHYDRATE OF H3 LIGAND, ITS PROCESS OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | CAPET MARC | BIOPROJET SOC CIV |
| EP3601253 | NOVEL PTEFB INHIBITING MACROCYCLIC COMPOUNDS | LüCKING ULRICH | BAYER AG |
| EP3601266 | SUBSTITUTED INDOLINE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS | KESTELEYN BART RUDOLF ROMANIE | JANSSEN PHARMACEUTICALS INC |
| EP3601268 | PROCESS FOR THE PREPARATION OF 6-(CYCLOPROPANEAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE | CHEN KE | SQUIBB BRISTOL MYERS CO |
| EP3601273 | 4-PIPERIDIN-N-(PYRIMIDIN-4-YL)CHROMAN-7-SULFONAMIDE DERIVATIVES AS SODIUM CHANNEL INHIBITORS | SUTHERLIN DANIEL | GENENTECH INC |
| EP3601281 | CRYSTALLINE FORMS OF 4-(1-(1,1-DI(PYRIDIN-2-YL)ETHYL)-6-(3,5-DIMETHYLISOXAZOL-4-YL)-1H- PYRROLO[3,2-B]PYRIDIN-3-YL)BENZOIC ACID THAT INHIBITS BROMODOMAIN | LIN JACK | PLEXXIKON INC |
| EP3601282 | NOVEL PYRIDO[2,3-B]INDOLE COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION | DEY FABIAN | HOFFMANN LA ROCHE |
| EP3601283 | FUSED IMIDAZO-PIPERIDINE JAK INHIBITOR COMPOUND | FATHEREE PAUL R | THERAVANCE BIOPHARMA R&D IP LLC |
| EP3601287 | 2,6-DISUBSTITUTED-9-CYCLOPENTYL-9H-PURINES, USE THEREOF AS MEDICAMENTS, AND PHARMACEUTICAL COMPOSITIONS | GUCKY TOMAS | UNIV PALACKEHO |
| EP3601288 | ISOMERICALLY PURE 18F-LABELLED TETRAHYDROFOLATES | MOSER RUDOLF | MERCK PATENT GMBH |
| EP3601290 | 11,13-MODIFIED SAXITOXINS FOR THE TREATMENT OF PAIN | MULCAHY JOHN | SITEONE THERAPEUTICS INC |
| EP3601313 | MODIFIED CYCLIC DINUCLEOTIDE COMPOUNDS | OOST THORSTEN | BOEHRINGER INGELHEIM INT |
| EP3601347 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING PROSTATE CANCER USING PROGASTRIN BINDING MOLECULE | PRIEUR ALEXANDRE | PROGASTRINE ET CANCERS S A R L |
| EP3601352 | TYPE 1 INTERFERON RECEPTOR ANTAGONISTS FOR USE IN METHODS OF TREATING TUBERCULOSIS AND OTHER INFECTIOUS DISEASES | WABL MATTHIAS | AUSTRIANNI GMBH |
| EP3603370 | MOVING ROBOT, METHOD FOR CONTROLLING MOVING ROBOT, AND MOVING ROBOT SYSTEM | KO KYOUNGSUK | LG ELECTRONICS INC |
| EP3603419 | MIXTURES OF BRANCHED CHAIN KETO ACIDS (BCKA) AND METHOD FOR THE PRODUCTION OF SUCH MIXTURES | JARECKI CHRISTINE | EVONIK OPERATIONS GMBH |
| EP3603633 | MEDICAL USE OF ARTEMISININ DERIVATIVE FOR TREATING INFLAMMATORY BOWEL DISEASE | ZUO JIANPING | SHANGHAI INST MATERIA MEDICA CAS |
| EP3603643 | TABLETED MEDICINAL COMPOSITION COMPRISING NALFURAFINE | MINAKAMI SATOSHI | TORAY INDUSTRIES |
| EP3603651 | SCREENING METHODS FOR TARGETS FOR CANCER THERAPY | LIN STEVEN HSESHENG | STCUBE & CO INC |
| EP3604294 | COMPOUNDS AND COMPOSITIONS FOR MODULATING EGFR MUTANT KINASE ACTIVITIES | SUH BYUNG-CHUL | YUHAN CORP |
| EP3604301 | 4-PYRIDONE COMPOUND OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION AND FORMULATION INCLUDING SAME | OOKUBO MEGUMI | FUJIFILM CORP |
| EP3604339 | THERAPEUTIC ANTIBODIES AGAINST ROR-1 PROTEIN AND METHODS FOR USE OF SAME | KIPPS THOMAS J | UNIV CALIFORNIA |
| EP3604342 | FUSION PROTEIN, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN PREPARING OPHTHALMIC DISEASE TREATMENT, ANTI-INFLAMMATION AND ANTI-TUMOR MEDICAMENT | XU HANMEI | JIANGSU RONGTAI BIOTECH CO LTD |
| EP3604343 | FUSION PROTEIN, PREPARATION METHOD THEREFOR AND USE THEREOF | XU HANMEI | JIANGSU RONGTAI BIOTECH CO LTD |
| EP3604384 | HYDROPHILIC POLYMER DERIVATIVE HAVING SELF-IMMOLATIVE ACETAL LINKER AND COMPOSITE USING SAME | TSUBUSAKI TAKUMA | NOF CORP |
| EP3604388 | METHOD FOR PREPARING Y-BRANCHED HYDROPHILIC POLYMER CARBOXYLIC ACID DERIVATIVE | CHEN XIAOMENG | JENKEM TECH CO LTD BEIJING |
| EP3604500 | MODIFIED T LYMPHOCYTES HAVING IMPROVED SPECIFICITY | LIANG BITAO | CELGENE CORP |
| EP3604537 | DOUBLE-STRANDED RIBONUCLEIC ACID WITH INCREASED EFFECTIVENESS IN AN ORGANISM | WOPPMANN CLAUDIA | ALNYLAM EUROPE AG |
| EP3605104 | METHODS PREDICITNG RISK OF AN ADVERSE CLINICAL OUTCOME | SNIDER JAMES V | CRITICAL CARE DIAGNOSTICS INC |
| EP3606494 | POWDER FOR CLEANING AN INTERNAL BODY PART AND/OR AN IMPLANT, METHOD FOR PRODUCING SAID TYPE OF POWDER AND SUITABLE USES | DONNET MARCEL | FERTON HOLDING SA |
| EP3606497 | HAIR DYEING PROCESS USING A PIGMENT, A MALEIC ANHYDRIDE ACRYLIC POLYMER AND AN AMINE COMPOUND | CHODOROWSKI-KIMMES SANDRINE | OREAL |
| EP3606502 | HAIR DYEING PROCESS COMPRISING A PIGMENT AND AN AQUEOUS DISPERSION OF SUPRAMOLECULAR POLYMER | CHODOROWSKI-KIMMES SANDRINE | OREAL |
| EP3606505 | COMPOSITION FOR NASAL APPLICATION | UNKAUF MARKUS | MARIA CLEMENTINE MARTIN KLOSTERFRAU VERTRIEBSGES MBH |
| EP3606515 | STAT3 INHIBITOR FORMULATION | SHOEMAKER ROBERT H | US HEALTH |
| EP3606524 | DEUTERATED (S)-2-(4-(PIPERIDIN-3-YL)PHENYL)-2H-INDAZOLE-7-CARBOXAMIDE | LI GEORGE Y | COMBIPHOS CATALYSTS INC |
| EP3606534 | PHOSPHOLIPID DERIVATIVES AND THEIR USE AS MEDICAMENTS | DVORAK MICHAL | USTAV MOLEKULARNI GENETIKY AKADEMIE VED CR V V I |
| EP3606546 | GENETIC CONSTRUCT FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISORDER OR STROKE | WIDDOWSON PETER | QUETHERA LTD |
| EP3606558 | NOVEL COMPOUNDS AND THERAPEUTIC USES THEREOF | GLOSSOP MELANIE | CENTAURI THERAPEUTICS LTD |
| EP3606923 | (+)-ALPHA DIHYDROTETRABENAZINE SUCCINATE SALT | DUFFIELD ANDREW JOHN | ADEPTIO PHARMACEUTICALS LTD |
| EP3606926 | HETEROAROMATIC COMPOUNDS USEFUL IN THERAPY | WESTMAN JACOB | CUROVIR AB |
| EP3607933 | BODY COSMETIC | KIMURA SHOHEI | KAO CORP |
| EP3608308 | LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS | BARYZA JEREMY LEE | NOVARTIS AG |
| EP3608315 | PYRROLE COMPOUNDS AS INHIBITORS OF ERK PROTEIN KINASES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS | MARTINEZ-BOTELLA GABRIEL | VERTEX PHARMA |
| EP3608323 | PYRAN FUSED RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | XU WEIPING | BEIJING TIENYI LUFU PHARMATECH CO LTD |
| EP3609464 | XANTHOHUMOL-BASED COMPOSITIONS | REMON JEAN PAUL | REMON JEAN PAUL |
| EP3609469 | COSMETIC PREPARATION CONTAINING WHITE TRUFFLE EXTRACT AND COSMETIC METHOD THEREOF | COQUET CORINNE | ISP INVESTMENTS LLC |
| EP3609486 | METHOD FOR THE TREATMENT OF HEART DISEASE IN MAMMALS | AYME-DIETRICH ESTELLE | CEVA SANTE ANIMALE |
| EP3609513 | YEAST AND BACTERIAL PROBIOTICS COMBINATIONS AND METHODS OF USE TO IMPROVE SWINE PRODUCTION | DAVIS MARI ELLEN | CHURCH & DWIGHT CO INC |
| EP3609514 | CONSORTIA OF LIVING BACTERIA USEFUL FOR TREATMENT OF MICROBIOME DYSBIOSIS | LACROIX CHRISTOPHE | ETH ZUERICH |
| EP3609517 | EXTRACTS OF CYNARA CARDUNCULUS AND CITRUS AURANTIUM BERGAMIA, COMBINATIONS THEREOF, AND FORMULATIONS CONTAINING THEM | BOMBARDELLI EZIO | HERBAL E ANTIOXIDANT DERIVATIVES S R L ED IN FORM ABBREVIATA H&AD S R L |
| EP3609529 | RNA FOR TREATMENT OF AUTOIMMUNE DISEASES | SAHIN UGUR | BIONTECH RNA PHARMACEUTICALS GMBH |
| EP3609612 | COATED POWDERS HAVING HIGH PHOTOSTABILITY | SARKAS HARRY W | NANOPHASE TECH CORPORATION |
| EP3610856 | LIQUID FORMULATION OF PROTEIN CONJUGATE COMPRISING THE OXYNTOMODULIN AND AN IMMUNOGLOBULIN FRAGMENT | KIM HYUN UK | HANMI PHARM IND CO LTD |
| EP3610884 | PEPTIDE CONTAINING CONJUGATES FOR DUAL MOLECULAR DELIVERY OF OLIGONUCLEOTIDES | COLLETTI STEVEN L | MERCK SHARP & DOHME |
| EP3610905 | EXTENDED RELEASE OF NEUREGULIN FOR TREATING HEART FAILURE | ZHOU MINGDONG | ZENSUN SHANGHAI SCIENCE & TECH CO LTD |
| EP3610924 | ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) AND USES THEREOF | WANG CHANGYU | SQUIBB BRISTOL MYERS CO |
| EP3611169 | NEW GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING | BERGER MARKUS | BAYER PHARMA AG |
| EP3611180 | HYBRID IMMUNOGLOBULIN CONTAINING NON-PEPTIDYL LINKAGE | CAPON DANIEL J | CAPON DANIEL J |
| EP3611270 | KITS FOR IN VITRO ANTIGEN PRESENTATION, ASSESSING VACCINE EFFICACY, AND ASSESSING IMMUNOTOXICITY OF BIOLOGICS AND DRUGS | DAFTARIAN PIROUZ MOHAMMAD | UNIV MIAMI |
| EP3612153 | AN ANTIMICROBIAL COMPOSITION | CHU CHUNG-CHING | UNILEVER NV |
| EP3612237 | GENE THERAPY | KAJASTE-RUDNITSKI ANNA CHRISTINA | OSPEDALE SAN RAFFAELE SRL |
| EP3612520 | AN ISOXAZOLE DERIVATIVES AS NUCLEAR RECEPTOR AGONISTS AND USED THEREOF | KANG JAE-HOON | IL DONG PHARMA |
| EP3612523 | HETEROARYLCARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS | FRATTINI SARA | BOEHRINGER INGELHEIM INT |
| EP3612525 | PD-1/PD-L1 INHIBITORS | AKTOUDIANAKIS EVANGELOS | GILEAD SCIENCES INC |
| EP3612536 | OXEPINOPYRAZOLE DERIVATIVES AS INHIBITORS OF PI3-KINASE ACTIVITY | BAXTER ANDREW | GLAXOSMITHKLINE IP DEV LTD |
| EP3612538 | QUINONE-METHIDE PRECURSORS WITH BODIPY CHROMOPHORE, METHOD OF PREPARATION, BIOLOGICAL ACTIVITY AND APPLICATION IN FLUORESCENT LABELLING | BASARIC NIKOLA | RUDJER BOSKOVIC INST |
| EP3613408 | OIL-IN-WATER EMULSION COMPOSITION GEL | IMAIZUMI YUKI | FUJIFILM CORP |
| EP3613416 | APPLICATIONS OF SPERMINE AND ITS DERIVATIVE IN PREPARATION OF ANTITUMOR DRUG | ZHU WEI | GENEHEAL BIOTECHNOLOGY CO LTD |
| EP3613436 | ORAL SUSPENSION OF TEMOZOLOMIDE | ANNEREAU MAXIME | ORPHELIA PHARMA |
| EP3613439 | CHIMERIC ANTIGEN RECEPTOR AND METHODS OF USE THEREOF | WU CHIA-YUNG | UNIV CALIFORNIA |
| EP3613447 | HUMAN PANCREAS SCAFFOLDS | MAZZA GIUSEPPE | UCL BUSINESS PLC |
| EP3613737 | NOVEL INHIBITOR OF CYCLIN-DEPENDENT KINASE CDK9 | ZHOU GANG | GENFLEET THERAPEUTICS SHANGHAI INC |
| EP3613745 | SOLID FORMS AND FORMULATIONS OF (S)-4-(8-AMINO-3-(1-(BUT-2-YNOYL)PYRROLIDIN-2-YL)IMIDAZO[1,5-A]PYRAZIN-1-YL)-N-(PYRIDIN-2-YL)BENZAMIDE | BLATTER FRITZ | ACERTA PHARMA BV |
| EP3613752 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND | LEE SUNYOUNG | SAMSUNG ELECTRONICS CO LTD |
| EP3613758 | PEPTIDE HAVING ANTI-DIABETIC AND ANTI-OBESITY EFFECTS, AND USE THEREOF | CHUNG YONG JI | CAREGEN CO LTD |
| EP3613759 | PEPTIDE HAVING ANTI-DIABETIC AND ANTI-OBESITY EFFECTS, AND USE THEREOF | CHUNG YONG JI | CAREGEN CO LTD |
| EP3613760 | PEPTIDE HAVING ANTI-DIABETIC AND ANTI-OBESITY EFFECTS, AND USE THEREOF | CHUNG YONG JI | CAREGEN CO LTD |
| EP3613792 | MULTI-ARM TARGETED ANTI-CANCER CONJUGATE | YUAN JIANDONG | BRIGHT GENE BIO MEDICAL TECH CO LTD |
| EP3614992 | ANTIDANDRUFF HAIR CARE COMPOSITION COMPRISING PYRITHIONE | CHEN GUOQIANG | UNILEVER NV |
| EP3614993 | ORAL CARE COMPOSITION BASED ON ZINC OXIDE AND CALCIUM DIHYDROGEN PHOSPHATE | LI XIAOKE | UNILEVER NV |
| EP3614994 | ORAL CARE COMPOSITION | LI XIAOKE | UNILEVER NV |
| EP3615014 | TOPICAL PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST AMITRIPTYLINE, FOR THE TREATMENT OF PERIPHERAL NEUROPATHIC PAIN | GRéCO CéLINE | ALGOTHERAPEUTIX |
| EP3615026 | A PARP INHIBITOR IN COMBINATION WITH A GLUCOCORTICOID AND/OR ASCORBIC ACID AND/OR A PROTEIN GROWTH FACTOR FOR THE TREATMENT OF IMPAIRED WOUND HEALING | WOLFF-WINISKI BARBARA | AKRIBES BIOMEDICAL GMBH |
| EP3615027 | METHODS OF USE FOR TRISUBSTITUTED BENZOTRIAZOLE DERIVATIVES AS DIHYDROOROTATE OXYGENASE INHIBITORS | NELLORE KAVITHA | AURIGENE DISCOVERY TECH LTD |
| EP3615034 | RUCAPARIB, TALAZOPARIB, VELIPARIB, OLAPARIB AND AZD 2461 FOR TREATING IMPAIRED SKIN WOUND HEALING | WOLFF-WINISKI BARBARA | AKRIBES BIOMEDICAL GMBH |
| EP3615035 | USE OF 20-HYDROXYECDYSONE AND THE DERIVATIVES THEREOF IN THE TREATMENT OF MYOPATHIES | DILDA PIERRE | BIOPHYTIS |
| EP3615037 | TRIAZOLE BISPHOSPHONATE GERANYLGERANYL DIPHOSPHATE SYNTHASE INHIBITORS | HOLSTEIN SARAH | UNIV NEBRASKA |
| EP3615038 | NUTRACEUTICAL AND/OR PHARMACEUTICAL COMPOSITION FOR STIMULATING THE PRODUCTION OF BETA-DEFENSINS-2 | SAGUET THIBAUT | USINES CHIMIQUES DIVRY LA BATAILLE |
| EP3615089 | METHOD OF SYNTHESIZING 18F RADIOLABELED BIOMOLECULAR AGENTS | PAGEL MARK D | UNIV ARIZONA |
| EP3615522 | C5-ANILINOQUINAZOLINE COMPOUNDS AND THEIR USE IN TREATING CANCER | GRECU TUDOR | ASTRAZENECA AB |
| EP3615526 | PHENOXYQUINAZOLINE COMPOUNDS AND THEIR USE IN TREATING CANCER | GRECU TUDOR | ASTRAZENECA AB |
| EP3615533 | FUSED INDAZOLE PYRIDONE COMPOUNDS AS ANTIVIRALS | FU JIPING | NOVARTIS AG |
| EP3615534 | FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | BROOKINGS DANIEL CHRISTOPHER | UCB BIOPHARMA SRL |
| EP3615545 | PYRROLOPYRIMIDINE DERIVATIVES USEFUL AS INHIBITORS OF INFLUENZA VIRUS REPLICATION | JACOBSON IRINA C | COCRYSTAL PHARMA INC |
| EP3615943 | KIT FOR THE ASSESSMENT OF ENDOMETRIAL RECEPTIVITY | SCAMBIA GIOVANNI | MOLIPHARMA S R L |
| EP3616680 | COMPOUND CONTAINING BASIC DYE AND AMINO ACID, HAIR DYING DYE, AND HAIR DYING COMPOSITION | NAITO KEIGO | HODOGAYA CHEMICAL CO LTD |
| EP3616686 | SUBLINGUAL FORMULATION OF RILUZOLE | CORIC VLADIMIR | BIOHAVEN PHARM HOLDING CO LTD |
| EP3616698 | ADHESIVE PATCH | KOMINAMI KAZUYA | HISAMITSU PHARMACEUTICAL CO |
| EP3616699 | ADHESIVE PATCH | SHIMA TAKITO | HISAMITSU PHARMACEUTICAL CO |
| EP3616706 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS | WEINSCHENK TONI | IMMATICS BIOTECHNOLOGIES GMBH |
| EP3616720 | PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT | YOSHIDA TETSUYA | SHIONOGI & CO |
| EP3616727 | INSULIN ANALOG CONJUGATES AND USE THEREOF | HWANG SANG YOUN | HANMI PHARM IND CO LTD |
| EP3617205 | BICYCLIC HETEROCYCLES AS FGFR INHIBITORS | LU LIANG | INCYTE CORP |
| EP3617218 | DIHYDROARTEMISININ-STEROID CONJUGATE AND PREPARATION METHOD AND USE THEREOF | ZHANG JINGHUA | YUNBAIYAO ZHENGWU SCIENCE AND TECH SHANGHAI CO LTD |
| EP3617277 | LUSTROUS PIGMENT HAVING ELECTROMAGNETIC WAVE-TRANSMITTING CHARACTERISTICS, COMPOSITION CONTAINING THIS PIGMENT, AND COATED BODY | NAKAMURA KOICHIRO | NIPPON SHEET GLASS CO LTD |
| EP3618845 | PEPTIDES FOR TREATMENT OF DIABETES | ALENFALL JAN | FOLLICUM AB |
| EP3618847 | GAP JUNCTION INTERCELLULAR COMMUNICATION MODULATORS AND THEIR USE FOR THE TREATMENT OF DIABETIC EYE DISEASE | LARSEN BJARNE DUE | ZEALAND PHARMA AS |
| EP3618932 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION, AND USES THEREOF IN THE COSMETIC FIELD AND IN THE ADJUVANT TREATMENT OF DERMATOLOGICAL PATHOLOGIES | TERNO MASSIMO TARCISIO | ST GANASSINI S P A DI RICERCHE BIOCHIMICHE |
| EP3619202 | TRISUBSTITUTED PYRIMIDINE COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CANCER, RETINAL DISORDERS, AND CARDIOMYOPATHIES | DE VIVO MARCO | FONDAZIONE ST ITALIANO TECNOLOGIA |
| EP3619212 | 2-(HET)ARYL-SUBSTITUTED CONDENSED BICYCLIC HETEROCYCLIC DERIVATIVES AS PEST CONTROL AGENTS | MOSRIN MARC | BAYER AG |
| EP3619314 | SELF-INACTIVATING VIRAL VECTOR | TRIPODI MARCO | RES & INNOVATION UK |
| EP3620155 | BROMOCRIPTINE FORMULATIONS | CINOTTA ANTHONY | VEROSCIENCE LLC |
| EP3620166 | COMPOSITION FOR ANTI-OBESITY COMPRISING THE PULVERIZED MATERIAL OF ODONTELLA AURITA AS AN ACTIVE INGREDIENT | PAN CHEOL-HO | KOREA INST SCI & TECH |
| EP3620167 | TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING DISEASES CAUSED BY HUMAN PAPILLOMAVIRUS, PREPARATION METHOD THEREFOR AND USE THEREOF | DU ZHUANSHE | BEIJING PATBORN BIOTECHNOLOGY DEV CO LTD |
| EP3620176 | A PROCESS FOR PREPARING A DRY POWDER FORMULATION COMPRISING AN ANTICHOLINERGIC, A CORTICOSTEROID AND A BETA-ADRENERGIC | CAFIERO CLAUDIO | CHIESI FARM SPA |
| EP3620212 | FERMENTED VIOLET EXTRACT, METHOD FOR OBTAINING SUCH AN EXTRACT AND USE IN COSMETICS | ROLLAN SERGE | LE JARDIN DELEN ATELIER DE CREATION |
| EP3620213 | RETINOL OIL COMPOSITION | PARSA RAMINE | JOHNSON & JOHNSON CONSUMER INC |
| EP3620447 | IONIZABLE CATIONIC LIPIDS | DEROSA FRANK | TRANSLATE BIO MA INC |
| EP3620454 | CARBOXYLIC ACID DERIVATIVE AS AT2R RECEPTOR ANTAGONIST | ZHANG YANG | SHANDONG DANHONG PHARMACEUTICAL CO LTD |
| EP3620456 | COMPOUND WITH KINASE INHIBITORY ACTIVITY AND PREPARATION METHOD AND USE THEREOF | ZHANG FUYAO | SELECTION BIOSCIENCE LLC |
| EP3621089 | PARTICLE WITH IMPROVED COLOUR SHIELDING | RIST KAI | IVOCLAR VIVADENT AG |
| EP3621576 | PHOTOSTABLE COMPOSITION MADE FROM PERLITE/TITANIUM/SILICA COMPOSITE PARTICLES | CANDAU DIDIER | OREAL |
| EP3621577 | NOVEL FRAGRANCE COMPOSITIONS AND PRODUCTS WITH MOOD ENHANCING EFFECTS | PRIGGE KATHARINE A | SYMRISE AG |
| EP3621579 | PERFUMING COMPOSITION | BEAUSSOUBRE PASCAL | FIRMENICH & CIE |
| EP3621580 | PROCESS FOR PREPARING A PERFUMING COMPOSITION | BEAUSSOUBRE PASCAL | FIRMENICH & CIE |
| EP3621581 | PVD-ALUMINUM PIGMENT DISPERSION AND COSMETIC FORMULATIONS | SCHILLING CHRISTINE | ECKART GMBH |
| EP3621582 | LIQUID PERSONAL CLEANSING COMPOSITION | KRANZMANN ALYSSA NICOLE | UNILEVER PLC |
| EP3621585 | ORAL CARE COMPOSITIONS | BARFOOT RICHARD JONATHAN | UNILEVER PLC |
| EP3621587 | HAIR STYLING COMPRISING POLYQUATERNIUM-4,POLYQUATERNIUM-37 AND C12-15 ALKYL BENZOATE | CAO MI | BEIERSDORF AG |
| EP3621589 | A PROCESS FOR PREPARING A DRY POWDER FORMULATION COMPRISING AN ANTICHOLINERGIC, A CORTICOSTEROID AND A BETA-ADRENERGIC | CAVECCHI ALESSANDRO | CHIESI FARM SPA |
| EP3621590 | A PROCESS FOR PREPARING A DRY POWDER FORMULATION COMPRISING AN ANTICHOLINERGIC, A CORTICOSTEROID AND A BETA-ADRENERGIC | CAVECCHI ALESSANDRO | CHIESI FARM SPA |
| EP3621605 | BETAINE FOR THE PREVENTION OF OBESITY | LERíN MARTíNEZ CARLOS | SANT JOAN DE DEU HOSPITAL |
| EP3621636 | PREVENTION AND/OR TREATMENT OF INFLAMMATORY SKIN DISEASE | PARDO CORTES LUBA MILENA | UNILEVER PLC |
| EP3621698 | DYE COMPOSITION BASED ON COPOLYMERS DERIVED FROM THE POLYMERIZATION OF AT LEAST ONE CROTONIC ACID MONOMER OR CROTONIC ACID DERIVATIVE AND OF AT LEAST ONE THICKENING POLYMER BEARING (METH)ACRYLIC ACID UNIT(S), AND PROCESS FOR DYEING KERATIN FIBERS USING SAME | SENECA DAVID | OREAL |
| EP3621699 | ORAL CARE COMPOSITIONS | JOINER ANDREW | UNILEVER PLC |
| EP3621949 | PROCESS FOR THE SYNTHESIS OF N-ACYL AMINO ACIDS WITHOUT THE USE OF SOLVENTS OR ACID CHLORIDE | DACOSTA GEORGES | SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC |
| EP3621950 | TRPV1 MODULATOR COMPOUNDS | DEVESA GINER ISABEL | ANTALGENICS S L |
| EP3621959 | METHOD FOR THE SYNTHESIS OF AN N-ACYL COMPOUND WITHOUT THE USE OF ORGANIC SOLVENT OR ACID CHLORIDE | DACOSTA GEORGES | SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC |
| EP3621960 | THIENOPYRIDINES AND BENZOTHIOPHENES USEFUL AS IRAK4 INHIBITORS | AHMAD SALEEM | SQUIBB BRISTOL MYERS CO |
| EP3622000 | A POLYESTER | SCHICK MICHAEL BERNHARD | BASF SE |
| EP3622946 | COSMETIC HAIR COMPOSITION MADE OF ALOE VERA AND COCONUT OIL AND METHOD FOR PREPARING SAME | BOVAËRE SARAH | LABORATOIRES LEA |
| EP3622953 | COMBINATION TREATMENT OF CANCER | BRüNNER NILS AAGE | SCANDION ONCOLOGY AS |
| EP3623361 | LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS | BRITO LUIS | NOVARTIS AG |
| EP3623792 | METHODS FOR ISOLATING MICROVESICLES AND EXTRACTING NUCLEIC ACIDS FROM BIOLOGICAL SAMPLES | SKOG JOHAN KARL OLOV | EXOSOME DIAGNOSTICS INC |
| EP3624755 | NAIL VARNISH COMPOSITION CONTAINING EMBOSSED EFFECT PIGMENTS AND SURFACE-MODIFIED EMBOSSED EFFECT PIGMENTS | SCHILLING CHRISTINE | ECKART GMBH |
| EP3624772 | COMPOSITION FOR THE TREATMENT OF FORMS OF SKIN INFLAMMATION | MUSCAS GIANCARLO | MUSCAS GIANCARLO |
| EP3624807 | USE OF OLIGOSACCHARIDE COMPOUNDS FOR TREATING WOUNDS OF ARTERIOPATHIC DIABETIC PATIENTS | BOHBOT SERGE | URGO RECH INNOVATION ET DEVELOPPEMENT |
| EP3625220 | CGRP RECEPTOR ANTAGONISTS | COATES DAVID ANDREW | LILLY CO ELI |
| EP3625221 | 3-METHYL-PYRROLIDINE-2,5-DIONE DERIVATIVES USEFUL AS CGRP RECEPTOR ANTAGONISTS | MCMAHON JENNIFER ANNE | LILLY CO ELI |
| EP3625222 | PHENYL DERIVATIVES AS PGE2 RECEPTOR MODULATORS | BOSS CHRISTOPH | IDORSIA PHARMACEUTICALS LTD |
| EP3625223 | PYRIMIDINE DERIVATIVES | BOSS CHRISTOPH | IDORSIA PHARMACEUTICALS LTD |
| EP3625224 | N-SUBSTITUTED INDOLE DERIVATIVES | FRETZ HEINZ | IDORSIA PHARMACEUTICALS LTD |
| EP3625228 | PYRIMIDINE DERIVATIVES AS PGE2 RECEPTOR MODULATORS | BOSS CHRISTOPH | IDORSIA PHARMACEUTICALS LTD |
| EP3625232 | SUBSTITUTED METHANOPYRIDO [2, 1-A]ISOINDOLONESAS MACHR MODULATORS FOR TREATING VARIOUS ASSOCIATED PATHOPHYSIOLOGICAL CONDITIONS AND PROCESS FOR PREPARATION THEREOF | PANDEY GANESH | COUNCIL SCIENT IND RES |
| EP3626245 | THERAPEUTIC AGENT FOR EYEGROUND DISEASE | ISHIBASHI TATSURO | UNIV KYUSHU NAT UNIV CORP |
| EP3626257 | METHODS AND COMPOSITIONS FOR CNS DELIVERY OF ARYLSULFATASE A | SALAMAT-MILLER NAZILA | SHIRE HUMAN GENETIC THERAPIES |
| EP3626258 | METHODS AND COMPOSITIONS FOR CNS DELIVERY OF IDURONATE-2-SULFATASE | ZHU GAOZHONG | SHIRE HUMAN GENETIC THERAPIES |
| EP3626713 | CYCLOPROPYLAMINES AS LSD1 INHIBITORS | WU LIANGXING | INCYTE CORP |
| EP3626729 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS | WEINSCHENK TONI | IMMATICS BIOTECHNOLOGIES GMBH |
| EP3626731 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS | WEINSCHENK TONI | IMMATICS BIOTECHNOLOGIES GMBH |
| EP3628004 | SELF-REGULATING OSMOTIC GASTRORETENTIVE DRUG DELIVERY SYSTEMS | #VALUE! | KASHIV BIOSCIENCES LLC |
| EP3628304 | COSMETIC GEL COMPRISING A TRIGLYCERIDE OIL | DAHMS GERD | CLARIANT INT LTD |
| EP3628331 | A PROCESS FOR PREPARING A DRY POWDER FORMULATION COMPRISING AN ANTICHOLINERGIC, A CORTICOSTEROID AND A BETA-ADRENERGIC | CAFIERO CLAUDIO | CHIESI FARM SPA |
| EP3628677 | METHOD FOR PREPARING A CYCLOPEPTIDE | CHEN CHIEN-TIEN | |
| EP3628680 | MODULATION OF COMPLEMENT ACTIVITY | HOARTY MICHELLE DENISE | RA PHARMACEUTICALS INC |
| EP3628686 | HUMANIZATION OF RABBIT ANTIBODIES USING A UNIVERSAL ANTIBODY FRAMEWORK | BORRAS LEONARDO | ESBATECH ALCON BIOMED RES UNIT |
| EP3628687 | BCMA CHIMERIC ANTIGEN RECEPTORS | MORGAN RICHARD | BLUEBIRD BIO INC |
| EP3628741 | MALIGNANT GLIOMA CAR-T THERAPEUTIC VECTOR BASED ON OCTS TECHNOLOGY, AND CONSTRUCTION METHOD AND APPLICATION THEREOF | QI WEI | SHANGHAI UNICAR THERAPY BIO MEDICINE TECH CO LTD |
| EP3630050 | BICARBONATE-BASED AQUEOUS COSMETIC COMPOSITION | MILLET MAGALI | LABORATOIRES M & L |
| EP3630051 | COMPOSITION FOR SCAR REMODELING | BIDAN CATHERINE | FABRE PIERRE DERMO COSMETIQUE |
| EP3630052 | LIQUID CLEANSING COMPOSITION | YOKUBINAS LEONORA | UNILEVER PLC |
| EP3630057 | PERFUMES IN THE FORM OF AQUEOUS MICROEMULSIONS | BOUCENNA VERDIER ORIANA | CHANEL PARFUMS BEAUTE |
| EP3630068 | A METHOD FOR PREPARING A FUNCTIONAL SYNTHETIC CELL IN FORM OF A GIANT UNILAMELLAR VESICLE | SPATZ JOACHIM P | MAX PLANCK GESELLSCHAFT |
| EP3630098 | COMBINATION OF A 5-HT6 RECEPTOR ANTAGONIST AND AN ACETYLCHOLINESTERASE INHIBITOR FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE IN A PATIENT SUBPOPULATION CARRYING APOE4 ALLELES | WINDFELD KRISTIAN | H LUNDBECK AS |
| EP3630111 | COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS | COMITA-PREVOIR JANELLE | ENTASIS THERAPEUTICS INC |
| EP3630134 | FORMATION OF STABLE CARTILAGE | ROBEY PAMELA GEHRON | US HEALTH |
| EP3630136 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | SAVIGNAC HELENE | 4D PHARMA RES LTD |
| EP3630188 | A PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF METHOTREXATE AND NOVOBIOCIN, AND THE USE OF SAID COMPOSITION IN THERAPY | MASCHA MENSONIDES-HARSEMA MARGUéRITE | TRULY TRANSLATIONAL SWEDEN AB |
| EP3630202 | STAINING COMPOSITION WITH IMPROVED STAINING INTENSITY | MELLES GERRIT REINOLD JACOB | D O R C DUTCH OPHTHALMIC RES CENTER INTERNATIONAL B V |
| EP3630242 | INHALER ARTICLE WITH OCCLUDED AIRFLOW ELEMENT | BUEHLER FREDERIC ULYSSE | PHILIP MORRIS PRODUCTS SA |
| EP3630724 | SUBSTITUTED INDOLINE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS | BONFANTI JEAN-FRANÇOIS | JANSSEN PHARMACEUTICALS INC |
| EP3630726 | CRYSTALLINE SOLID FORMS OF SALTS OF N-{4-[(6,7-DIMETHOXYQUINOLIN-4-YL) OXY]PHENYL}-N'-(4-FLUORPHENYL) CYCLOPROPANE-1,1-DICARBOXAMIDE, PROCESSES FOR MAKING, AND METHODS OF USE | SHAH KHALID | EXELIXIS INC |
| EP3630729 | PYRIMIDINE COMPOUND | SHINOHARA TOMOICHI | OTSUKA PHARMA CO LTD |
| EP3630730 | POLYSUBSTITUTED PYRIMIDINES INHIBITING THE FORMATION OF PROSTAGLANDIN E2, A METHOD OF PRODUCTION THEREOF AND USE THEREOF | KOLMAN VIKTOR | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I |
| EP3630752 | SUBSTITUTED NITROGEN CONTAINING COMPOUNDS | YADAV NAVNATH DNYANOBA | SQUIBB BRISTOL MYERS CO |
| EP3630761 | KRAS G12C INHIBITORS AND METHODS OF USING THE SAME | LANMAN BRIAN ALAN | AMGEN INC |
| EP3630780 | 1,3-DIAZO-4-OXA-[3.3.1]-BICYCLIC DERIVATIVES, PROCESS FOR THEIR MANUFACTURE AND THEIR USE AS A MEDICAMENT, IN PARTICULAR FOR TREATING DIABETES | BERTI FRANCESCO | UNIV PISA |
| EP3632411 | IMPROVED KIT FOR PREPARING INJECTABLE CARMUSTINE SOLUTIONS | GONDALIYA DEEPAK PRAGJIBHAI | EMCURE PHARMACEUTICALS LTD |
| EP3632446 | IMMUNOABLATIVE THERAPIES | DEISHER THERESA | AVM BIOTECHNOLOGY LLC |
| EP3632454 | COMPOSITION CONTAINING PORIA COCOS BARK EXTRACT FOR PREVENTING, IMPROVING OR TREATING NEURODEGENERATIVE DISORDERS | CHOI SANG ZIN | NEUROBO PHARMACEUTICALS INC |
| EP3632469 | CYP2J2 ANTAGONISTS IN THE TREATMENT OF PAIN | SISIGNANO MARCO | FRAUNHOFER GES FORSCHUNG |
| EP3632902 | 1,2,4-OXADIAZOLE BENZOIC ACID COMPOUND AND ITS USE FOR NONSENSE SUPPRESSION AND THE TREATMENT OF DISEASE | KARP GARY MITCHELL | PTC THERAPEUTICS INC |
| EP3632912 | PYRIDOQUINAZOLINE DERIVATIVES USEFUL AS PROTEIN KINASE INHIBITORS | KURZ GUIDO | ONCOSTELLAE S L |
| EP3632917 | METHOD FOR PREPARING HETEROCYCLIC DERIVATIVE COMPOUND, COMPOSITION CONTAINING SAME COMPOUND, AND HYDRATE OF SAME COMPOUND | PYUN DO KYU | JW PHARMACEUTICAL CORP |
| EP3634368 | POWDER CONTAINING CRYSTALS COMPRISING INGREDIENTS ENCLOSED THEREIN | BEHRENS KOLJA | SYMRISE AG |
| EP3634374 | HAIR TREATMENT COMPRISING POLYORGANOSILOXANES WITH POLYHYDROXYAROMATIC MOIETIES | DUSSAUD ANNE | MOMENTIVE PERFORMANCE MAT INC |
| EP3634377 | PHARMACEUTICAL FORMULATION | BOYER SCOTT | KLARIA PHARMA HOLDING AB |
| EP3634383 | SUCROSE ACETATE ISOBUTYRATE-BASED COMPOSITIONS, METHODS AND USES THEREOF | DA MOTA MARTINS GON ALVES CRISTIANA | ASSOCIATION FOR THE ADVANCEMENT OF TISSUE ENGINEERING CELL BASED TECH & THERAPIES A4TEC ASSOCIACAO |
| EP3634384 | LEVODOPA INFUSION SOLUTION | ERIKSSON ELIAS | DIZLIN PHARMACEUTICALS AB |
| EP3634409 | OREXIN RECEPTOR ANTAGONISTS | SHEPPARD DAVID | BENEVOLENTAI BIO LTD |
| EP3634955 | PIPERIDINONE FORMYL PEPTIDE 2 RECEPTOR AGONISTS | SHIRUDE PRAVIN SUDHAKAR | SQUIBB BRISTOL MYERS CO |
| EP3634956 | ARYL HETEROCYCLIC PIPERIDINONE FORMYL PEPTIDE 2 RECEPTOR AND FORMYL PEPTIDE 1 RECEPTOR AGONISTS | SHIRUDE PRAVIN SUDHAKAR | SQUIBB BRISTOL MYERS CO |
| EP3634957 | NMDA RECEPTOR MODULATORS, COMPOSITIONS COMPRISING SAME AND USE OF THESE COMPOUNDS IN THE TREATMENT OF DISEASES INVOLVING THE CENTRAL NERVOUS SYSTEM | ALAMI MOUÂD | ADPUERIVITAM |
| EP3634958 | CYCLOPROPYL UREA FORMYL PEPTIDE 2 RECEPTOR AND FORMYL PEPTIDE 1 RECEPTOR AGONISTS | SMALLHEER JOANNE M | SQUIBB BRISTOL MYERS CO |
| EP3634961 | (4-(([1,2,4]TRIAZOLO[4,3-A]PYRIDINE-6-YL)OXY)-1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL) UREIDO DERIVATIVES AS ANTI-INFLAMMATORY P38 MAPK INHIBITORS FOR TREATING DISEASES OF THE RESPIRATORY TRACT | CAPALDI CARMELIDA | CHIESI FARM SPA |
| EP3634974 | TUNICAMYCIN ANALOGUES | DAVIS BENJAMIN GUY | UNIV OXFORD INNOVATION LTD |
| EP3635096 | METHOD FOR THE ISOLATION OF SUBPOPULATIONS OF CARDIAC PROGENITOR CELLS AND RELATED USES IN THE MEDICAL FIELD | POMPILIO GIULIO | CENTRO CARDIOLOGICO MONZINO SPA |
| EP3635098 | T-CELLS MODIFIED TO OVEREXPRESS PHF19 | JI YUN | US HEALTH |
| EP3636252 | EYE DROP FOR TREATING EYE DRYNESS | LIU ZUGUO | UNIV XIAMEN |
| EP3636254 | ANTIOXIDANT COMPOSITIONS | FRATI LUIGI | FRATI LUIGI |
| EP3636263 | ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL | CHOW KEN | ALLERGAN INC |
| EP3636270 | TRACE ELEMENTS | SMITH WILLIAM ALFRED | WARBURTON TECHNOLOGY LTD |
| EP3636273 | NOVEL FORMULATIONS AND USES FOR CURCUMA EXTRACTS | PATHER INDIRAN | CALIFORNIA NORTHSTATE COLLEGE OF PHARMACY LLC |
| EP3636297 | MATERIAL FOR REMOVING ACTIVATED LEUKOCYTE-ACTIVATED PLATELET COMPLEX | TOMITA NAOTOSHI | TORAY INDUSTRIES |
| EP3636322 | STABILIZED HYDROGEN PEROXIDE COMPOSITION | SPAID MATTHEW | CAVEX HOLLAND BV |
| EP3638189 | CURABLE COMPOSITION FOR PRODUCING A DENTAL COMPOSITE CROWN AND PROCESS OF PRODUCTION | HERRMANN ANDREAS | 3M INNOVATIVE PROPERTIES CO |
| EP3638198 | COMPOSITION FOR PREVENTING HAIR LOSS AND PROMOTING HAIR GROWTH | ÖGER VURAL | CAPILLI MED GMBH |
| EP3638202 | OIL CLEANSER COMPOSITION | BAI LU | DOW GLOBAL TECHNOLOGIES LLC |
| EP3638221 | COMPOSITIONS AND METHODS FOR TREATMENT OF A FIBROTIC DISEASE | JOHNASEN BERIT | AVEXXIN AS |
| EP3638233 | TINOSTAMUSTINE FOR USE IN TREATING OVARIAN CANCER | MEHRLING THOMAS JORG | EURO CELTIQUE SA |
| EP3638281 | MEDICAL PREPARATION FOR ENHANCING TISSUE OXYGENATION IN CASE OF DIABETIC FOOT AND USE OF IT | TROFIMOV ALEKSANDR VLADISLAVOVICH | OMNIPEP ESTAB |
| EP3638291 | DOSAGE REGIMES FOR THE ADMINISTRATION OF GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES | SONNE KIM | ZEALAND PHARMA AS |
| EP3638376 | RINSE-OFF CONDITIONER COMPOSITIONS COMPRISING MICROCAPSULES | VERHOVNIK GLENN | FIRMENICH & CIE |
| EP3638670 | SUBSTITUTED PYRROLOPYRIDINE-DERIVATIVES AS MAP4K1 MODULATORS FOR THE TREATMENT OF CANCER DISEASES | SCHMEES NORBERT | BAYER PHARMA AG |
| EP3638676 | SUBSTITUTED BRIDGED DIAZEPANE DERIVATIVES AND USE THEREOF AS TASK-1 AND TASK-3 INHIBITORS | DELBECK MARTINA | BAYER PHARMA AG |
| EP3638686 | PEPTIDYL KETOAMIDES AS INHIBITORS OF ROHOMBOID PROTEASES | STRISOVSKY KVIDO | USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CESKE REPUBLIKY V V I |
| EP3638698 | ANTI-TMPRSS2 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS | PURCELL LISA | REGENERON PHARMA |
| EP3638796 | EXPRESSION VECTORS COMPRISING ENGINEERED GENES | SCHORGE STEPHANIE | UCL BUSINESS LTD |
| EP3639818 | GLUCOSE CONSUMPTION PROMOTER AND GLYCOLYSIS PROMOTER | SORIMACHI KENJI | SHINKO SANGYO CO LTD |
| EP3639819 | ANTI-INFLAMMATORY AND ANALGESIC DRUG FOR EXTERNAL USE | ISHIBASHI MASAKI | MEDRX CO LTD |
| EP3639828 | USE OF OXYGENATED CHOLESTEROL SULFATES (OCS) FOR TREATING ACUTE LIVER FAILURE | REN SHUNLIN | UNIV VIRGINIA COMMONWEALTH |
| EP3639835 | USE OFCIMICIFUGAE FOETIDAE | ZENG HUI | BEIJING DITAN HOSPITAL CAPITAL MEDICAL UNIV |
| EP3639836 | USE OF ISOFERULIC ACID, ISOFERULIC ACID-CONTAINING TRADITIONAL CHINESE MEDICINE EXTRACT AND CIMICIFUGAE FOETIDAE | ZENG HUI | BEIJING DITAN HOSPITAL CAPITAL MEDICAL UNIV |
| EP3640243 | PIPERAZINE DERIVATIVES FOR THE TREATMENT OF HYPERTENSION AND/OR FIBROSIS | DUGGAN KAREN ANNETTE | VECTUS BIOSYSTEMS LTD |
| EP3640245 | POLY(ADP-RIBOSE) POLYMERASE INHIBITOR, PREPARATION METHOD AND USE | ZHANG FUYAO | SELECTION BIOSCIENCE LLC |
| EP3640250 | COMPOUND AS GLS1 INHIBITOR | LIAO YONGGANG | MEDSHINE DISCOVERY INC |
| EP3640251 | 6,7,8,9-TETRAHYDRO-3H-PYRAZOLO[4,3-F]ISOQUINOLINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER | SCOTT JAMES STEWART | ASTRAZENECA AB |
| EP3641719 | DENTAL ADHESIVE | MAURAT VINCENT | PRODUITS DENTAIRES PIERRE ROLLAND |
| EP3641728 | AN OIL-IN-WATER NANOEMULSION COMPOSITION OF CLOBETASOL | SANAGUSTIN AQUILUE JAVIER | SALVAT LAB SA |
| EP3641730 | PARTICLE AND PHARMACEUTICAL COMPOSITION COMPRISING AN INSOLUBLE CAMPTOTHECIN COMPOUND WITH DOUBLE CORE-SHELL STRUCTURE AND METHOD FOR MANUFACTURING THE SAME | PARK YOUNG HWAN | SNBIOSCIENCE INC |
| EP3641735 | PHARMACEUTICAL TABLET COMPOSITION COMPRISING BILASTINE FORM 3 AND A WATER-SOLUBLE FILLER | GUJJAR CHAITANYA YOGANANDA | TIEFENBACHER ALFRED E GMBH & CO KG |
| EP3641765 | USE OF CICLOPIROX AS A MODULATOR OF THE HEME GROUP BIOSYNTHESIS AND IN THE TREATMENT OF PORPHYRIAS AND OTHER DISEASES | MILLET AGUILAR-GALINDO OSCAR | ASOCIACION CENTRO DE INVESTIG COOPERATIVA EN BIOCIENCIAS CIC BIOGUNE |
| EP3642181 | METHOD FOR PREPARING INTERMEDIATE OF 4-METHOXYPYRROLE DERIVATIVE | SHIN JEONG-TAEK | DAE WOONG PHARMA |
| EP3643308 | COUMARIN-LIKE CYCLIC COMPOUND AS MEK INHIBITOR AND USE THEREOF | MAO QINGHUA | CSTONE PHARMACEUTICALS |
| EP3643310 | COMPOSITION FOR REVERSE CONTROL OF CELLULAR SENESCENCE COMPRISING PDK1 INHIBITOR | CHO KWANG HYUN | KOREA ADVANCED INST SCI & TECH |
| EP3643709 | ISOINDOLINE DERIVATIVE, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF | GE CHUANSHENG | KANGPU BIOPHARMACEUTICALS LTD |
| EP3643717 | 7-SITE SUBSTITUTED PYRROLE TRIAZINE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, AND PREPARATION METHOD THEREFOR AND USES THEREOF | YANG CHUNHAO | SHANGHAI INST MATERIA MEDICA CAS |
| EP3643777 | NOVEL MUSCULOSKELETAL STEM CELL AND MEDIUM FOR INDUCING DIFFERENTIATION OF MUSCULOSKELETAL STEM CELL | HAN MYUNG-KWAN | CELLATOZ THERAPEUTICS INC |
| EP3644943 | COMPOSITION COMPRISING AN ANTISEPTIC, A VOLATILE SULFUR COMPOUND NEUTRALIZER, AND AN ANTICARIOGENIC AGENT | MATA MOLINER MONTSERRAT | LACER SA |
| EP3644949 | SOLID CLEANING COSMETIC COMPOSITION | LAVABLE NADINE | OREAL |
| EP3644958 | INTRAVAGINALLY APPLICABLE DEVICES COMPRISING ANTIVIRAL COMPOUNDS | BACHHAV YOGESHWAR | AICURIS ANTI INFECTIVE CURES GMBH |
| EP3644961 | ISOTRETINOIN ORAL-MUCOSAL FORMULATIONS AND METHODS FOR USING SAME | TAN HOCK S | SKYLINE BIOSCIENCES LLC |
| EP3644973 | TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ASENAPINE AND SILICONE ACRYLIC HYBRID POLYMER | MOHR PATRICK | LTS LOHMANN THERAPIE SYSTEME AG |
| EP3645046 | AMINOGLYCOSIDE DERIVATIVES AND NANO-ASSEMBLIES THEREOF, INCLUDING THOSE WITH QUORUM SENSING INHIBITORY FUNCTION | HO DUY-KHIET | HELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH |
| EP3645116 | CAVITATION-ENHANCED TARGETED DRUG DELIVERY AND DOSING | LEVY YOAV | INSIGHTEC LTD |
| EP3645117 | ULTRASOUND FREQUENCY AND MICROBUBBLE SIZE OPTIMIZATION IN MICROBUBBLE-ENHANCED ULTRASOUND TREATMENT | DE PICCIOTTO RAFI | INSIGHTEC LTD |
| EP3645123 | DYE COMPOSITION BASED ON COPOLYMERS DERIVED FROM THE POLYMERIZATION OF AT LEAST ONE CROTONIC ACID MONOMER OR CROTONIC ACID DERIVATIVE AND ON SILICONE | SENECA DAVID | OREAL |
| EP3645535 | NEW SALT OF N-(2,6-DIETHYLPHENYL)-8-({4-[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]-2-METHOXYPHENYL}AM INO)-1-METHYL-4,5-DIHYDRO-1H-PYRAZOLO[4,3-H]QUINAZOLINE-3-CARBOXAMIDE, ITS PREPARATION AND FORMULATIONS CONTAINING IT | ZAMPIERI MASSIMO | SERVIER LAB |
| EP3645539 | PYRIDO-IMIDAZO RIFAMYCIN DERIVATIVES AS ANTIBACTERIAL AGENT | MARCHI EGIDIO | BIOFER SPA |
| EP3645550 | COMPSTATIN ANALOGS WITH INCREASED SOLUBILITY AND IMPROVED PHARMACOKINETIC PROPERTIES | LAMBRIS JOHN D | UNIV PENNSYLVANIA |
| EP3645565 | BISPECIFIC ANTIBODIES TO ROR1 AND CD3 | NATHWANI AMIT | UCL BUSINESS LTD |
| EP3645570 | VISTA ANTIGEN-BINDING MOLECULES | BOYD-KIRKUP JEROME DOUGLAS | HUMMINGBIRD BIOSCIENCE HOLDINGS PTE LTD |
| EP3645571 | HER3 ANTIGEN-BINDING MOLECULES | BOYD-KIRKUP JEROME DOUGLAS | HUMMINGBIRD BIOSCIENCE HOLDINGS PTE LTD |
| EP3646881 | COMPOSITION FOR CONTROLLED OVARIAN STIMULATION | ARCE JOAN-CARLES | FERRING BV |
| EP3648731 | ORAL CARE COMPOSITION | GREEN ALISON KATHARINE | UNILEVER NV |
| EP3648784 | COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES | DELGADO GONZALEZ RAQUEL | LUBRIZOL ADVANCED MAT INC |
| EP3648794 | USE OF MACROAZAPYRIDINOPHANES METAL COMPLEXES IN THE TREATMENT OF DISEASES | MULLOR SANJOSé JOSé LUIS | BIONOS BIOTECH S L |
| EP3648842 | DISPOSABLE UNIT DOSE FOR THE TREATMENT OF PERIODONTOSIS | DUHAMEL FRANÇOIS | 3DOM SAS |
| EP3649109 | ETHYNYL COMPOUNDS, THEIR PREPARATION AND THEIR THERAPEUTIC USE FOR THE TREATMENT OF MALARIA | PASCAL CéCILE | SANOFI SA |
| EP3649110 | MYOBACTERIUM TUBERCULOSIS-THIOREDOXIN REDUCTASE INHIBITOR AS AN ANTITUBERCULAR AGENT | KOCH OLIVER | UNIV DORTMUND TECH |
| EP3649119 | NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS | MAMMOLITI OSCAR | GALAPAGOS NV |
| EP3649124 | FLUOROPIPERIDINE COMPOUNDS AS PURE 5-HT6 RECEPTOR ANTAGONISTS | NIROGI RAMAKRISHNA | SUVEN LIFE SCIENCES LTD |
| EP3649127 | NEW SUBSTITUTED AZAINDOLINE DERIVATIVES AS NIK INHIBITORS | HYND GEORGE | JANSSEN PHARMACEUTICA NV |
| EP3649980 | BONDABLE DENTAL ASSEMBLIES INCLUDING A COMPRESSIBLE MATERIAL | CINADER DAVID K | 3M INNOVATIVE PROPERTIES CO |
| EP3650007 | UNIT FOR THE MICRONIZATION AND DOSAGE OF SOLID ACTIVE AGENTS | KóKAI TAMáS | KOKAI TAMAS |
| EP3650010 | IMPROVED TABLETING PROCESS | RÖHRICH TILLMANN | SIEGFRIED AG |
| EP3650014 | COMBINATION FORMULATION OF TWO ANTIVIRAL COMPOUNDS | GORMAN ERIC | GILEAD PHARMASSET LLC |
| EP3650016 | STABILIZED MODIFIED RELEASE VITAMIN D FORMULATION AND METHOD OF ADMINISTERING SAME | WHITE JAY A | OPKO IRELAND GLOBAL HOLDINGS LTD |
| EP3650035 | RED ALGAE EXTRACT FOR USE IN THE PREVENTION OR TREATMENT OF AN INTESTINAL DISORDER | AUBERT PHILIPPE | AMADEITE |
| EP3650439 | SALTS OR CO-CRYSTALS OF 3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)-PHENOL | GRUSS MICHAEL | GRUENENTHAL GMBH |
| EP3650450 | CRYSTAL FORM II OF THIENOPYRIDINE DERIVATIVE BISULFATE AND PREPARATION METHOD THEREFOR AND USE THEREOF | GU JINGKAI | ZHONGRONG KAITE BEIJING BIOTECHNOLOGY CO LTD |
| EP3650457 | METHOD FOR PRODUCING A RECOMBINANT PEPTIDE AND RESULTANT PEPTIDE | MYASOEDOV NIKOLAY FEDOROVICH | IVIX COMPANY LTD |
| EP3650852 | BLOOD BASED BIOMARKERS FOR DIAGNOSING ATHEROSCLEROTIC CORONARY ARTERY DISEASE | VOROS SZILARD | GLOBAL GENOMICS GROUP LLC |
| EP3651727 | SKIN COMPOSITION BOOSTER OIL | BUCHALOVA MARIA | UNILEVER PLC |
| EP3651736 | LONG-ACTING FORMULATIONS | ANDRIES KOENRAAD JOZEF LODEWIJK MARCEL | JANSSEN PHARMACEUTICA NV |
| EP3651862 | HIGH GLYCEROL COMPOSITION COMPRISING BLENDS OF ALKYL ISETHIONATE AND ALKYL TAURATE | CARNALI JOSEPH ORESTE | UNILEVER PLC |
| EP3652148 | AMORPHOUS FORM OF VILANTEROL TRIFENATATE AND PROCESSES FOR THE PREPARATION THEREOF | LOURENÇO NUNO TORRES | HOVIONE SCIENTIA LTD |
| EP3652165 | FIVE MEMBERED-AMINOHETEROCYCLIC AND 5,6-OR 6,6-MEMBERED BICYCLIC AMINOHETEROCYCLIC INHIBITORS OF ROCK FOR THE TREATMENT OF HEART FAILURE | PINTO DONALD J P | SQUIBB BRISTOL MYERS CO |
| EP3652167 | SPIROHEPTANYL HYDANTOINS AS ROCK INHIBITORS | VOKITS BENJAMIN P | SQUIBB BRISTOL MYERS CO |
| EP3652171 | COOLING COMPOSITION | HUBOUX ALEXANDRE | FIRMENICH & CIE |
| EP3652172 | SALT OF SUBSTITUTED UREA DERIVATIVE AND USE THEREOF IN MEDICINE | CHEN LIANG | NORTH & SOUTH BROTHER PHARMACY INVESTMENT CO LTD |
| EP3652176 | NOVEL SUBSTITUTED XANTHINE DERIVATIVES | GERLACH KAI | BOEHRINGER INGELHEIM INT |
| EP3652182 | 2-OXO-1-IMIDAZOLIDINYL IMIDAZOTHIADIAZOLE DERIVATIVES | PROVINS LAURENT | UCB BIOPHARMA SRL |
| EP3652183 | 2-OXO-1,3-OXAZOLIDINYL IMIDAZOTHIADIAZOLE DERIVATIVES | PROVINS LAURENT | UCB BIOPHARMA SRL |
| EP3652234 | POLY(GLYCEROL SEBACATE)-INTERLEUKIN INHIBITOR COPOLYMERS AND METHODS OF MAKING AND USE | GABRIELE PETER D | SECANT GROUP LLC |
| EP3653195 | DENTAL CEMENT KIT | HARA DAISUKE | SHOFU INC |
| EP3653217 | MESENCHYMAL STEM CELLS FOR USE IN IMPROVING PULMONARY FUNCTION | AGGARWAL SUDEEPTA | MESOBLAST INT SARL |
| EP3653223 | DEVICE FOR THE ORAL DELIVERY OF THERAPEUTIC COMPOUNDS | IMRAN MIR | RANI THERAPEUTICS LLC |
| EP3653227 | NOVEL POLYMERIC HGH PRODRUGS | KURPIERS THOMAS | ASCENDIS PHARMA ENDOCRINOLOGY DIV A/S |
| EP3653721 | METHOD AND COMPOSITION FOR HYDROLYZING EGGSHELL MEMBRANE | LA NUEZ GARCíA MANUEL A | EGGNOVO S L |
| EP3654932 | TYROTHRICIN FOR USE IN THE TREATMENT OR PROPHYLAXIS OF BODY ODOUR AND PREPARATIONS THEREFOR | LEIBBRAND THOMAS | LEIBBRAND THOMAS |
| EP3654973 | COMPOSITIONS AGAINST CANDIDA INFECTIONS | CAMMUE BRUNO | UNIV LEUVEN KATH |
| EP3654984 | TOPICAL TREATMENT FOR PREVENTING AND MITIGATING SKIN CYTOTOXICITY DUE TO THERAPY WITH TYROSINE KINASE INHIBITORS | ROMANO MARIA CONCETTA | EUCARE S R L |
| EP3655006 | ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE | LANCASTER THOMAS M | AKSTON BIOSCIENCES CORP |
| EP3655014 | CLUSTERIN FOR USE IN THE TREATMENT OF THROMBOTIC MICROANGIOPATHIES | AUGUSTO JEAN-FRANÇOIS | UNIV BORDEAUX |
| EP3655109 | COSMETIC OR PHARMACEUTICAL COMPOSITION FOR PROMOTING HAIR GROWTH, COMPRISING A LYOPHILISATE OF DEDIFFERENTIATED SEA FENNEL CELLS | CATTUZZATO LAETITIA | BIOTECHMARINE |
| EP3655138 | PROCESS FOR THE PURIFICATION OF HYALURONIC ACID | CORSA VINCENZA | FIDIA FARM SPA |
| EP3655397 | LIPOPHILIC MACROCYCLIC LIGANDS, COMPLEXES THEREOF, AND USES OF SAME | ROUSSEAUX OLIVIER | GUERBET SA |
| EP3655407 | PYROPHEOPHORBIDE CONJUGATE AND USE THEREOF IN THE TREATMENT OF CANCER AND AS A FLUORESCENT MARKER | AZAIS HENRI | INST NAT SANTE RECH MED |
| EP3655414 | DEFEROXAMINE DERIVATIVES AS MEDICAMENTS | TRUKSA JAROSLAV | BIOTECHNOLOGICKY USTAV AV CR V V I |
| EP3655424 | PEPTIDES MODULATING SPERM MOTILITY BY MODULATING THE PHOSPHOPROTEIN PHOSPHATASE 1 COMPLEX. | FARDILHA MARGARIDA SÂNCIO DA CRUZ | UNIV OF WOLVERHAMPTON |
| EP3655425 | PEPTIDES WITH ANTIBIOTIC POTENTIAL AGAINST MYCOBACTERIUM TUBERCULOSIS | GODALY GABRIELA ZUZANA VICTORIA | ADENIUM BIOTECH APS |
| EP3656215 | STABILIZATION OF THROMBOCYTES AT AMBIENT TEMPERATURES | MULLER ROLF | BIOMATRICA INC |
| EP3656443 | USE OF TRL AGONIST AND ANTI-CD47 AGENT TO ENHANCE PHAGOCYTOSIS OF CANCER CELLS | WEISSMAN IRVING L | UNIV LELAND STANFORD JUNIOR |
| EP3656765 | SALTS OR CO-CRYSTALS OF 3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)-PHENOL | GRUSS MICHAEL | GRUENENTHAL GMBH |
| EP3656782 | PEPTIDE AMIDE COMPOUND AND PREPARATION METHOD AND MEDICAL USE THEREOF | ZHANG CHEN | SICHUAN HAISCO PHARMACEUTICAL CO LTD |
| EP3656856 | LIVE, ATTENUATED CORONAVIRUS COMPRISING A VARIANT REPLICASE GENE ENCODING POLYPROTEINS COMPRISING A MUTATION IN NSP-10. | BICKERTON ERICA | THE PIRBRIGHT INST |
| EP3658111 | ACTIVE SUBSTANCE COMBINATIONS OF N-(4-AMINO-2-METHYLQUINOLINE-6-YL)-2-((4-ETHYLPHENOXY)METHYL)BENZAMIDE AND ONE OR MORE COSMETICALLY OR DERMATOLOGICALLY ACCEPTABLE AROMATIC SUBSTANCES | SIEFKEN WILFRIED | BEIERSDORF AG |
| EP3658112 | ACTIVE SUBSTANCE COMBINATIONS OF N-(4-AMINO-2-METHYLQUINOLINE-6-YL)-2-((4-ETHYLPHENOXY)METHYL) AND ONE OR MORE COSMETICALLY OR DERMATOLOGICALLY ACCEPTABLE PRESERVATIVES AND/OR PRESERVATIVE AUXILIARIES | SIEFKEN WILFRIED | BEIERSDORF AG |
| EP3658122 | PHARMACEUTICAL COMPOSITION COMPRISING SACUBITRIL AND VALSARTAN | DYMACEK BOHUMIL | SYNTHON BV |
| EP3658126 | BIODEGRADABLE MULTILAYER NANOCAPSULES FOR THE DELIVERY OF BIOLOGICALLY ACTIVE AGENTS IN TARGET CELLS | SUKHORUKOV GLEB | UNIV FREIBURG ALBERT LUDWIGS |
| EP3658131 | COMPOSITION FOR THE TREATMENT OF BACTERIAL VAGINOSIS | RUSSO VINCENZO | FARMA DERMA S R L |
| EP3658147 | COMBINATION COMPRISING PALBOCICLIB AND 6-(2,4-DICHLOROPHENYL)-5-[4-[(3S)-1-(3-FLUOROPROPYL)PYRROLIDIN-3-YL]OXYPHENYL]-8,9-DIHYDRO-7H-BENZO[7]ANNULENE-2-CARBOXYLIC ACID AND ITS USE FOR THE TREATMENT OF CANCER | BOUABOULA MONSIF | SANOFI SA |
| EP3658149 | SOLID COMPLEX COMPRISING (Z)-7-((1R,2R,3R,5S)-2-((S,E)-5-(2,5-DICHLOROTHIOPHEN-3-YL)-3-HYDROXYPENT-1-EN-1-YL)-3,5-DIHYDROXYCYCLOPENTYL)HEPT-5-ENAMIDE, PREPARATION AND USES THEREOF | WU KE | ALLERGAN INC |
| EP3658160 | USE OF RHAMNOSE AND DERIVATIVES THEREOF AS ANTIFUNGAL AGENTS | GRANGER CORINNE JEANNE ROSE | ISDIN SA |
| EP3658174 | LACTOFERRICIN AND LACTOFERRAMPIN FOR TREATING INFECTIONS | RAPACIOLI SILVIA | BICT SRL |
| EP3658192 | GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF | HOBSON ADRIAN D | ABBVIE INC |
| EP3658237 | CROSS POLYMERS COMPOSED OF POLYSACCHARIDES AND POLYAMINO ACIDS, AND USES THEREOF | DOCóN MARíA JESúS VICENT | POLYPEPTIDE THERAPEUTIC SOLUTIONS S L |
| EP3658522 | IMMUNOMODULATOR COMPOUNDS | LANGE CHRISTOPHER | CHEMOCENTRYX INC |
| EP3659590 | COMPOSITION, PARTICULATE MATERIALS AND METHODS FOR MAKING PARTICULATE MATERIALS | YU CHENGZHANG | UNIV QUEENSLAND |
| EP3659620 | CANCER IMMUNOTHERAPY BY DELIVERING CLASS II MHC ANTIGENS USING A VLP-REPLICON | CHATTERJEE DEB K | THE US SECRETARY DEPT OF HEALTH & HUMAN SERVICES OFFICE OF TECHNOLOGY TRANSFER |
| EP3660033 | LONG-ACTING COMPSTATIN ANALOGS AND RELATED COMPOSITIONS AND METHODS | FRANCOIS CEDRIC | APELLIS PHARMACEUTICALS INC |
| EP3660047 | HUMAN ANTIBODIES TO FEL D1 AND METHODS OF USE THEREOF | ORENGO JAMIE | REGENERON PHARMA |
| EP3661478 | NOVEL SURFACTANT COMPOSITION, PRODUCTION METHOD THEREOF, AND USE OF SAME AS AN EMULSIFIER FOR THE PRODUCTION OF TOPICAL OIL-IN-WATER EMULSIONS | CLEMENCEAU FLORENCE | SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC |
| EP3661482 | COMPOSITION COMPRISING A MYRTLE EXTRACT AND A FLUORINE SALT FOR ORAL APPLICATION | FIORINI CHRISTEL | PF MEDICAMENT |
| EP3661490 | COMPOSITION FOR USE IN THE PREVENTION AND/OR TREATMENT OF ONCOLOGIC TREATMENT INDUCED OROGASTROINTESTINAL MUCOSITIS | RODRIGUEZ VILABOA DEBORAH | MUCOSA INNOVATIONS S L |
| EP3661520 | ADJUVANT THERAPY FOR USE IN PROSTATE CANCER TREATMENT | DEBRUYNE F M J | FUND SA |
| EP3661534 | A SYNERGISTIC COMPOSITION AS A PROMOTER OF AUTOPHAGY | GIULIANI GIAMMARIA | GIULIANI SPA |
| EP3661602 | PHOSPHOLIPID ANALOGUES | BIRUKOV KONSTANTIN | KARL FRANZENS UNIV GRAZ |
| EP3661925 | NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS | COOPER MATTHEW | INFLAZOME LTD |
| EP3661928 | NOVEL N-[(PYRIMIDINYLAMINO)PROPANYL]-, N-[(PYRIDYLAMINO)PROPANYL]- AND N-[(PYRAZINYLAMINO)PROPANYL]ARYLCARBOXAMIDES | RIETHER DORIS | BOEHRINGER INGELHEIM INT |
| EP3661929 | ISOCHROMAN COMPOUNDS AND USES THEREOF | BOWEN CARRIE A | SUNOVION PHARMACEUTICALS INC |
| EP3661936 | [1,2,4]TRIAZOLO[4,3-A]PYRAZIN-6(5H)-ONE DERIVATIVES | GENIN MICHAEL JAMES | LILLY CO ELI |
| EP3661937 | CRYSTALLINE FORMS OF ETHYL ((S)-((((2R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-4-FLUORO-2,5-DIHYDROFURAN-2-YL)OXY)METHYL)(PHENOXY)PHOSPHORYL)-L-ALANINATE (GS-9131) FOR TREATING VIRAL INFECTIONS | LAPINA OLGA VIKTOROVNA | GILEAD SCIENCES INC |
| EP3662049 | ENCAPSULATION METHOD | CHEN XUE | DOW GLOBAL TECHNOLOGIES LLC |
| EP3662751 | PYRAZOLO[4,3-C]QUINOLINE DERIVATIVES FOR INHIBITION OF B-GLUCURONIDASE | CHEN YEH-LONG | |
| EP3662894 | NANOPARTICLES COMPRISING TACROLIMUS | BEIER WOLFGANG | LEON NANODRUGS GMBH |
| EP3662925 | COMPOSITION COMPRISING FSH FOR TREATMENT OF INFERTILITY | ARCE SAEZ JOAN CARLOS | FERRING BV |
| EP3662932 | ANTI-CGRP COMPOSITIONS AND USE THEREOF | KOVACEVICH BRIAN ROBERT | ALDERBIO HOLDINGS LLC |
| EP3663399 | MODIFIED FACTOR IX POLYPEPTIDES AND USES THEREOF | MADISON EDWIN L | CATALYST BIOSCIENCES INC |
| EP3664774 | HAIR COSMETIC | TETSU MAKIO | KAO CORP |
| EP3664775 | A PERSONAL CARE COMPOSITION | DUTTA MAITREYEE | UNILEVER NV |
| EP3664779 | MICRO-NEEDLE ARRAY COMPRISING A COLOR CHANGE INDICATOR | HENNING ANDREAS | LTS LOHMANN THERAPIE SYSTEME AG |
| EP3664872 | POLYMERIC COMPOSITIONS, DELIVERY DEVICES, AND METHODS | BARRY JOHN | BAXTER INT |
| EP3664894 | SACCHAROMYCES BOULARDII FOR THE TREATMENT OF MOOD DISORDERS | SIMON O'BRIEN EMMANUELLE | BIOCODEX |
| EP3665174 | [1,2,4]TRIAZOLO DERIVATIVES AS PDE1 INHIBITORS FOR THE TREATMENT OF DIABETES | GENIN MICHAEL JAMES | LILLY CO ELI |
| EP3665179 | SELECTIVE INHIBITORS OF PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) | LUENGO JUAN | PRELUDE THERAPEUTICS INC |
| EP3666249 | COMPLEXES OF ORGANIC SILICON COMPOUNDS WITH BORON CITRATE AND DIMETHYLETHANOLAMINE | SZCZEPANIAK STANISLAW | JEDNOSTKA INNOWACYJNO WDROZENIOWA INWEX SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA |
| EP3666262 | PHARMACEUTICAL ORAL DOSAGE FORMS FOR TREATMENT OF METABOLIC DISORDERS AND RELATED DISEASES THROUGH ORCHESTRATED RELEASE OF ENTEROKINES | DEUSCH KAI | APHAIA PHARMA AG |
| EP3666767 | PYRIDAZINONE COMPOUND, METHOD FOR PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF | HU YOUHONG | SHANGHAI INST MATERIA MEDICA CAS |
| EP3666771 | LPA ANTAGONISTS | CHENG PETER TAI WAH | SQUIBB BRISTOL MYERS CO |
| EP3666778 | A CRYSTALLINE CYCLIC BORONIC ACID ESTER DERIVATIVE, METHOD FOR THE PREPARATION AND THERAPEUTIC USES THEREOF | HIRST GAVIN | REMPEX PHARMACEUTICALS INC |
| EP3668489 | WATER-MISCIBLE PREPARATION OF A LIPOPHILIC COMPOUND | BINDRICH UTE | DEUTSCHES INST FUER LEBENSMITTELTECHNIK E V |
| EP3668510 | FORMULATIONS CONTAINING DEUTERATED DOMPERIDONE | PATEL PIYUSH | CINDOME PHARMA INC |
| EP3668513 | PYRUVATE KINASE ACTIVATORS FOR USE IN TREATING BLOOD DISORDERS | CIANCHETTA GIOVANNI | AGIOS PHARMACEUTICALS INC |
| EP3668516 | STABLE LYOPHILISATES COMPRISING 5,10-METHYLENE-(6R)-TETRAHYDROFOLIC ACID AND A DICARBOXYLIC ACID | MOSER RUDOLF | MERCK PATENT GMBH |
| EP3668519 | USE OF GINSENOSIDE M1 FOR MANUFACTURING MEDICAMENT FOR TREATING ORAL CANCER | HUA KUO-FENG | |
| EP3668604 | ORAL CARE COMPOSITION | LI XIAOKE | UNILEVER NV |
| EP3668607 | METHOD FOR PRODUCING ZINC OXIDE PLATELETS WITH CONTROLLED SIZE AND MORPHOLOGY | SUVACI ENDER | ENTEKNO ENDUESTRIYEL TEKNOLOJIK VE NANO MALZEMELER SANAYI VE TICARET ANONIM SIRKETI |
| EP3668850 | AMBER ODORANT | LEM GEORGE | FIRMENICH & CIE |
| EP3668853 | NOVEL COMPOUNDS | PORRAS DE FRANCISCO ESTHER | GLAXOSMITHKLINE IP DEV LTD |
| EP3668856 | NOVEL TETRAZOLE COMPOUNDS AND THEIR USE IN THE TREATMENT OF TUBERCULOSIS | ALEMPARTE-GALLARDO CARLOS | GLAXOSMITHKLINE IP DEV LTD |
| EP3668864 | NOVEL N-(2,2-DIFLUOROETHYL)-N-[(PYRIMIDINYLAMINO)PROPANYL]ARYLCARBOXAMIDES | RIETHER DORIS | BOEHRINGER INGELHEIM INT |
| EP3668868 | TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS HAVING A TRICYCLIC MOIETY, CONJUGATES THEREOF, AND METHODS AND USES THEREFOR | YOUNG IAN S | SQUIBB BRISTOL MYERS CO |
| EP3668870 | 6-AMINO-7,9-DIHYDRO-8H-PURIN-8-ONE DERIVATIVES AS IMMUNOSTIMULANT TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS | HE LIQI | SQUIBB BRISTOL MYERS CO |
| EP3668871 | 6-AMINO-7,9-DIHYDRO-8H-PURIN-8-ONE DERIVATIVES AS IMMUNOSTIMULANT TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS | HE LIQI | SQUIBB BRISTOL MYERS CO |
| EP3668873 | IMIDAZO[1,2-A]IMIDAZOL-2-ONE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS PARKINSON'S DISEASE | JAESCHKE GEORG | HOFFMANN LA ROCHE |
| EP3668874 | PYRROLOBENZODIAZEPINE CONJUGATES | DIMASI NAZZARENO | MEDIMMUNE LTD |
| EP3668879 | NOVEL COMPOUNDS | PORRAS DE FRANCISCO ESTHER | GLAXOSMITHKLINE IP DEV LTD |
| EP3668880 | INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN 2,3-DIOXYGENASE | BOSS CHRISTOPH | IDORSIA PHARMACEUTICALS LTD |
| EP3669859 | AQUEOUS PERFUMES | ROMAINE CAROLYN | CHANEL INC |
| EP3669871 | APPLICATION OF AMD3100 IN PREPARATION OF DRUG FOR TREATMENT AND/OR PREVENTION OF DYSCRASIA, AND PHARMACEUTICAL COMPOSITION THEREOF | XIANG PENG | UNIV SUN YAT SEN |
| EP3669886 | BONE MORPHOGENETIC PROTEINS | MORRELL NICHOLAS W | CAMBRIDGE ENTPR LTD |
| EP3670499 | PYRAZOLE DERIVATIVES USEFUL AS 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP) INHIBITORS | BRODDEFALK JOHAN OLOF | ASTRAZENECA AB |
| EP3672568 | PERSONAL CARE COMPOSITION | WU QIANG | COLGATE PALMOLIVE CO |
| EP3672571 | PHARMACEUTICAL AQUEOUS FORMULATION COMPRISING 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-DIMORPHOLIN-4-YL-1,3,5-TRIAZIN-2-YL)PHENYL]UREA | HUSSEY JAMES JOSEPH | PFIZER |
| EP3672580 | COMPOSITION COMPRISING A XANTOPHYLL AND AN OMEGA- 3 FATTY ACID AND METHOD OF USE THEREOF | JOHNSON ELIZABETH JUDITH | NEWTRICIOUS BV |
| EP3672594 | COMBINATION PRODUCT OF BCL-2 INHIBITOR AND MDM2 INHIBITOR AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF DISEASES | YANG DAJUN | ASCENTAGE PHARMA SUZHOU CO LTD |
| EP3672595 | COMBINATION PRODUCT OF BCL-2 INHIBITOR AND CHEMOTHERAPEUTIC AGENT AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF DISEASES | YANG DAJUN | ASCENTAGE PHARMA SUZHOU CO LTD |
| EP3672614 | ENGINEERED EXTRACELLULAR VESICLES AND USES THEREOF | DOOLEY KEVIN P | CODIAK BIOSCIENCES INC |
| EP3672641 | COMPOSITION COMPRISING VEGF ANTAGONISTS AND A CATIONIC PEPTIDE AND USES THEREOF | CORDEIRO FRANCESCA | UCL BUSINESS LTD |
| EP3672953 | BENZIMIDAZOLE DERIVATIVES USEFUL AS POTASSIUM CHANNEL INHIBITORS | SØRENSEN ULRIK | ACESION PHARMA APS |
| EP3672967 | AZAINDOLYLPYRIDONE AND DIAZAINDOLYLPYRIDONE COMPOUNDS | LINDSTRÖM JOHAN | SPRINT BIOSCIENCE AB |
| EP3672971 | TRIAZOLO PYRIDINES AS MODULATORS OF GAMMA-SECRETASE | HEINE NIKLAS | BOEHRINGER INGELHEIM INT |
| EP3673914 | SOLID COMPOSITIONS COMPRISING RECOMBINANT CLOSTRIDIUM BOTULINUM NEUROTOXINS | COSSINS AIMEE | IPSEN BIOINNOVATION LTD |
| EP3673928 | THROMBORESISTANT/BACTERICIDAL S-NITROSO-N-ACETYLPENICILLAMINE (SNAP)-DOPED NITRIC OXIDE RELEASE POLYMERS WITH ENHANCED STABILITY | BRISBOIS ELIZABETH J | UNIV MICHIGAN REGENTS |
| EP3675800 | PHOTOINITIATOR MODIFIED POLYACIDIC POLYMER | MAIER MAXIMILIAN | DENTSPLY DETREY GMBH |
| EP3675879 | USE OF CEREBROLYSIN | WINTER STEFAN | EVER NEURO PHARMA GMBH |
| EP3675894 | COMPOSITION FOR CONTROLLED OVARIAN STIMULATION | ARCE SAEZ JOAN-CARLES | FERRING BV |
| EP3676263 | 3-HYDROXY-IMIDAZOLIDIN-4-ONE COMPOUNDS AS INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE | DE MAN ADRIANUS PETRUS ANTONIUS | NETHERLANDS TRANSLATIONAL RES CENTER B V |
| EP3676276 | SPIROTHIETANE NUCLEOSIDES | TAHRI ABDELLAH | JANSSEN PHARMACEUTICA NV |
| EP3676279 | CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS | DODD DHARMPAL S | SQUIBB BRISTOL MYERS CO |
| EP3677278 | ISOFORM SELECTIVE TGFBETA1 INHIBITORS AND USE THEREOF | DATTA ABHISHEK | SCHOLAR ROCK INC |
| EP3678498 | COMPOSITION FOR CALCIUM SUPPLEMENTATION | DINI LAURA | ABIOGEN PHARMA SPA |
| EP3678587 | SCAFFOLDS, SYSTEMS, METHODS, AND COMPUTER PROGRAM PRODUCTS FOR REGENERATING A PULP | LEVIN MARTIN DAVID | LEVIN MARTIN DAVID |
| EP3678638 | IN VITRO INTESTINAL DRUG DISPOSITION DEVICE | BERGSTRÖM CHRISTEL | BERGSTROEM CHRISTEL |
| EP3678642 | SYSTEM FOR DELIVERY OF MEDICAL COMPONENTS TO THE LUNGS | MØRCH YRR | SINTEF TTO AS |
| EP3678646 | TRANSDERMAL DELIVERY SYSTEM INCLUDING AN EMULSIFIER | WAUER GABRIEL | LTS LOHMANN THERAPIE SYSTEME AG |
| EP3678692 | GENOTYPE STRATIFICATION IN DIABETES TREATMENT AND PREVENTION | ESSEN-MÖLLER ANDERS | DIAMYD MEDICAL AB |
| EP3679010 | CARBONIC ACID ADDUCTS | ENGERT BEATRICE | JENCLUSTER GMBH |
| EP3679017 | CO-CRYSTAL OF AN ORALLY AVAILABLE HIF PROLYL HYDROXYLASE INHIBITOR | LENGAUER HANNES | SANDOZ AG |
| EP3679039 | TYROSINE ANALOGUES DERIVATIVES AS RHO- KINASE INHIBITORS | ACCETTA ALESSANDRO | CHIESI FARM SPA |
| EP3679051 | PREPARATION AND USE OF REACTIVE OXYGEN SPECIES SCAVENGER | XIANG JIA-NING | XW LAB INC |
| EP3679798 | METHODS AND MATERIALS FOR ASSESSING AND TREATING ARTHRITIS | TANEJA VEENA | MAYO FOUND MEDICAL EDUCATION & RES |
| EP3679922 | SYRINGE | BRYANT ANDREW | NOVARTIS AG |
| EP3679923 | CERAMIDE LEVELS IN THE TREATMENT AND PREVENTION OF INFECTIONS | SCHUCHMAN EDWARD | ICAHN SCHOOL MED MOUNT SINAI |
| EP3680243 | PENTACYCLIC COMPOUND | OHASHI YOSHIAKI | EISAI R&D MAN CO LTD |
| EP3680329 | ENGINEERED MEGANUCLEASES WITH RECOGNITION SEQUENCES FOUND IN THE HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE | NICHOLSON MICHAEL G | PREC BIOSCIENCES INC |
| EP3681316 | DEVICES AND METHODS FOR THE PREPARATION OF A NUTRITIONAL FORMULA | FIRST ERIC | ALCRESTA THERAPEUTICS INC |
| EP3681461 | AN ANTIMICROBIAL COMPOSITION | DAS SOMNATH | UNILEVER NV |
| EP3681463 | SYNTHESIS AND USE OF 2-ETHYL-5,5-DIMETHYL-CYCLOHEXANOL AS FRAGRANCE AND FLAVOR MATERIAL | CHANDRASEKARAN VIJAYANAND | SYMRISE AG |
| EP3681502 | FORMULATIONS CONTAINING DOMPERIDONE | PATEL PIYUSH | CINDOME PHARMA INC |
| EP3681512 | ABX196 FOR USE IN THE TREATMENT OF BLADDER CANCER | CRABE SANDRINE | ABIVAX |
| EP3681527 | USE OF SCLERITINE AS AGENT FOR PROTECTING CELLS AGAINST TOXIC AGENTS | BENCHAOUIR RACHID | CENTRE SCIENT DE MONACO |
| EP3681856 | COMPOUNDS HAVING PRESERVATIVE, ANTIMICROBIAL AND ANTISEPTIC ACTIVITY | FUMAGALLI LAURA | UNIV DEGLI STUDI MILANO |
| EP3681872 | HETEROARYL SUBSTITUTED BETA-HYDROXYETHYLAMINES FOR USE IN TREATING HYPERGLYCAEMIA | PELCMAN BENJAMIN | ATROGI AB |
| EP3682894 | CELL AUTOPHAGY INHIBITOR AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | TAN NINGHUA | UNIV CHINA PHARMA |
| EP3682905 | MODIFIED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACIDS, AND USES THEREOF | DE FOUGEROLLES ANTONIN | MODERNATX INC |
| EP3682944 | TREATING CANCER USING ELECTROMAGNETIC FIELDS IN COMBINATION WITH OTHER TREATMENT REGIMENS | PALTI YORAM | NOVOCURE LTD |
| EP3683207 | N-ALKYLARYL-5-OXYARYL-OCTAHYDRO-CYCLOPENTA[C]PYRROLE NEGATIVE ALLOSTERIC MODULATORS OF NR2B | ANDERSON DAVID R | CADENT THERAPEUTICS INC |
| EP3683209 | PROCESS FOR PREPARING [(5-(3-CHLOROPHENYL)-3-HYDROXYPYRIDINE-2-CARBONYL)-AMINO]ACETIC ACID FROM 5-((3-CHLOROPHENYL)-3-CHLORO-PYRIDIN-2-YL)-NITRILE, AND PROCESS FOR PREPARING 5-((HALOPHENYL)-3-HALO-PYRIDIN-2-YL)-NITRILE DERIVATIVES | LANTHIER CHRISTOPHER M | AKEBIA THERAPEUTICS INC |
| EP3683222 | NOVEL BICYCLIC OR TRICYCLIC HETEROCYCLIC COMPOUND | OKUYAMA MASAHIRO | MITSUBISHI TANABE PHARMA CORP |
| EP3684327 | NOVEL COMPOSITION | HIPPALGOANKAR KANCHAN | GLAXOSMITHKLINE CONSUMER HEALTHCARE UK IP LTD |
| EP3684329 | POWDER COMPOSITION COMPRISING HAIR DIRECT DYES | GASSELIN CELINE | KAO CORP |
| EP3684355 | OVOTIOLS FOR THE TREATMENT OF CHRONIC LOW GRADE SYSTEMIC INFLAMMATION (CLGSI) AND RELATED DISEASES | PALUMBO ANNA | UNIV DEGLI STUDI G DANNUNZIO CHIETI PESCARA |
| EP3684362 | NICOTINE FORMULATION | NOLAN CHRISTOPHER | YATZZ LTD |
| EP3684380 | AQUEOUS FORMULATION FOR THE TOPICAL TREATMENT OF SKIN CONDITIONS | ROZITTA KAIJSER-GRIGORIANTS | ROSADERMA B V |
| EP3685826 | SYRINGE | SIGG JUERGEN | NOVARTIS AG |
| EP3685848 | COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION | YU PAUL | BRIGHAM & WOMENS HOSPITAL INC |
| EP3686189 | PRODUCTION METHOD FOR 5-HYDROXY-1H-IMIDAZOLE-4-CARBOXAMIDE路3/4HYDRATE | HASHIMOTO TOMOHIRO | FUJIFILM CORP |
| EP3686194 | 2-(2,4,5-SUBSTITUTED-ANILINO)PYRIMIDINE COMPOUNDS | BUTTERWORTH SAM | ASTRAZENECA AB |
| EP3686271 | METHOD FOR PREPARING TISSUE, PARTICULARLY ADIPOSE TISSUE, FOR TRANSPLANTATION FROM LOBULAR FAT EXTRACTED BY LIPOSUCTION | TREMOLADA CARLO | LIPOGEMS INT S P A |
| EP3687313 | COMPOSITION FOR THE TREATMENT OF CONSTIPATION | DI MAIO UMBERTO | NEILOS S R L |
| EP3687314 | COMPOSITION FOR THE TREATMENT OF CONSTIPATION | DI MAIO UMBERTO | NEILOS S R L |
| EP3687493 | COMPOSITION SUITABLE FOR FORMING A GEL GASTRIC RAFT | GARDIER SYLVIE | LABORATOIRES ARKOPHARMA |
| EP3687506 | SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS | KOTIAN PRAVIN L | BIOCRYST PHARM INC |
| EP3687513 | TREATMENT OF FRAGILE X SYNDROME WITH CANNABIDIOL | BONN-MILLER MARCEL | ZYNERBA PHARMACEUTICALS INC |
| EP3687523 | TREATMENT OF CHOLESTATIC PRURITUS | BOUDES POL | CYMABAY THERAPEUTICS INC |
| EP3687630 | COSMETIC PREPARATION CONTAINING CETYL-DIGLYCERYL TRIS(TRIMETHYLSILOXY)SILYLETHYL DIMETHICONE | BLUCK MANUELA | BEIERSDORF AG |
| EP3687631 | HAIR STYLING COMPOSITION CONTAINING VINYL CAPROLACTAM/VP/DIMETHYLAMINOETHYL METHACRYLATE COPOLYMER | WU SHUIPING | BEIERSDORF AG |
| EP3687979 | RESORCINOL DERIVATIVES FOR THEIR COSMETIC USE | MARAT XAVIER | OREAL |
| EP3687996 | SALTS OF PYRROLOTRIAZINE DERIVATIVES USEFUL AS TAM INHIBITORS | JIA ZHONGJIANG | INCYTE CORP |
| EP3689379 | A PROCESS FOR PREPARING A DRY POWDER FORMULATION COMPRISING AN ANTICHOLINERGIC, A CORTICOSTEROID AND A BETA-ADRENERGIC | CAFIERO CLAUDIO | CHIESI FARM SPA |
| EP3689853 | METHOD OF SYNTHESIZING THYROID HORMONE ANALOGS AND POLYMORPHS THEREOF | HESTER D KEITH | MADRIGAL PHARMACEUTICALS INC |
| EP3689871 | 4,6,7-TRISUBSTITUTED 1,2-DIHYDROPYRROL[3,4-C]PYRIDIN/PYRIMIDIN-3-ONE DERIVATIVE AND USE | GUO SHUCHUN | SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD |
| EP3689875 | USE OF TRIAZOLOPYRIMIDINE, TRIAZOLOPYRIDINE COMPOUNDS AND COMPOSITION THEREOF FOR TREATING PRC2-MEDIATED DISEASES | ZHOU BING | SHANGHAI INST MATERIA MEDICA CAS |
| EP3689878 | 4-IMIDAZOPYRIDAZIN-1-YL-BENZAMIDES AND 4-IMIDAZOTRIAZIN-1-YL-BENZAMIDES AS BTK-INHIBITORS | BARF TJEERD A | MERCK SHARP & DOHME |
| EP3689899 | MND PROMOTER CHIMERIC ANTIGEN RECEPTORS | MORGAN RICHARD | BLUEBIRD BIO INC |
| EP3691655 | A NUCLEIC ACID MOLECULE WITH ANTI-INFLAMMATORY AND ANTI-COAGULANT AND ORGAN-PROTECTIVE PROPERTIES | JEDLINA LUIZA ANNA | APTAHEM AB |
| EP3691688 | HYDROGEL COMPOSITIONS FOR THE TREATMENT OF MOLLUSCUM CONTAGIOSUM | GONZáLEZ PLáGARO JORDI | LABORATORIO REIG JOFRE S A |
| EP3691750 | HAIRSTYLING COMPOSITION | RAJAMANOHARAN DAYANI | UNILEVER PLC |
| EP3692096 | INVERSE EMULSION THICKENERS | CAMILLERI LEE | SCOTT BADER CO |
| EP3692130 | COMPOSITION COMPRISING PRECURSOR FOR VOLATILES | HÄTZELT ANDRé | HENKEL AG & CO KGAA |
| EP3692131 | COMPOSITION COMPRISING PRECURSORS FOR VOLATILES | HÄTZELT ANDRé | HENKEL AG & CO KGAA |
| EP3692974 | DENTAL MATERIALS WITH IMPROVED MECHANICAL CHARACTERISTICS | MOSZNER NORBERT | IVOCLAR VIVADENT AG |
| EP3692976 | DENTAL MATERIALS BASED ON REDOX SYSTEMS WITH LOW ODOR CUMOLHYDE-HYDROPEROXIDE DERIVATIVES | MOSZNER NORBERT | IVOCLAR VIVADENT AG |
| EP3692979 | DAHLIA PINNATA COMPOSITION, DAHLIA PINNATA COMPOSITION POWDER, COSMETIC COMPOSITION, AND PRODUCING METHOD THEREFOR | PARK RAE HYUN | BARAM INT CO LTD |
| EP3692983 | ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF | ETTER JEFFREY B | CELGENE CORP |
| EP3693025 | ADENO-ASSOCIATED VIRUS VIRIONS WITH VARIANT CAPSID AND METHODS OF USE THEREOF | SCHAFFER DAVID V | UNIV CALIFORNIA |
| EP3693400 | CHEMICAL POLYMERIZATION INITIATOR, ADHESIVE COMPOSITION, ADHESIVE COMPOSITION KIT, DENTAL MATERIAL, DENTAL MATERIAL KIT, AND METHOD FOR STORING ADHESIVE COMPOSITION | FUKUDOME KEISHI | TOKUYAMA DENTAL CORP |
| EP3694470 | COMPOSITIONS WITH INCREASED COLOR SHADE STABILITY | HUTSON ASHLEY L | AVON PROD INC |
| EP3694477 | TOPICAL PRODUCTS WITH A BIPHASIC SYSTEM | BOTTAI ELENA | CMED AESTHETICS S R L |
| EP3694840 | PIPERAZINE DERIVATIVES AS MAGL INHIBITORS | BENZ JOERG | HOFFMANN LA ROCHE |
| EP3695745 | COSMETIC SHEET AND MANUFACTURING METHOD THEREOF, IMAGE PROCESSING DEVICE, AND IMAGE PROCESSING METHOD | ONODERA MARI | PANASONIC IP MAN CO LTD |
| EP3695803 | KIT AND METHOD FOR IMPROVED BONE REGENERATION | SOLAKOGLU ÖNDER | SOLAKOGLU OENDER |
| EP3697375 | AEROSOL FOAM SKIN CLEANSER | WEI KARL SHIQING | PROCTER & GAMBLE |
| EP3697383 | COMPOSITION FOR TREATING CONSTIPATION | DI MAIO UMBERTO | NEILOS S R L |
| EP3697385 | LIPOSOME DRUG FORM WITH LIGHT-CONVERTING NANOPARTICLES, A METHOD OF ITS PREPARATION AND USE | ENGSTOVá HANA | INST OF PHYSIOLOGY CAS |
| EP3697405 | NOVEL MEK-INHIBITOR FOR THE TREATMENT OF VIRAL AND BACTERIAL INFECTIONS | LUDWIG STEPHAN | ATRIVA THERAPEUTICS GMBH |
| EP3697788 | BIS(PENTAHYDROXYHEXYL)AMINO SUBSTITUTED 2-{[(3-AMINO-PYRAZIN-2-YL)FORMAMIDO]METHYL}-1H-1,3-BENZODIAZOL-3-IUM DERIVATIVES AS ENAC INHIBITORS FOR TREATING RESPIRATORY DISEASES | HAY DUNCAN ALEXANDER | ENTERPRISE THERAPEUTICS LTD |
| EP3697789 | CONDENSED IMIDAZOLE DERIVATIVES SUBSTITUTED BY TERTIARY HYDROXY GROUPS AS PI3K-GAMMA INHIBITORS | DOUTY BRENT | INCYTE CORP |
| EP3697890 | ADIPOSE TISSUE SPLITTING KIT | TIRYAKI KEMAL TUNC | TIRYAKI KEMAL TUNC |
| EP3698768 | HEALING COMPOSITION | VILLAIN EMELINE | LES LABORATOIRES BROTHIER |
| EP3698778 | STABILIZED TOPICAL FORMULATIONS CONTAINING CORE-SHELL MICROCAPSULES | TOLEDANO OFER | SOL GEL TECH LTD |
| EP3698796 | PHARMACEUTICAL COMBINATION OF A TRICYCLIC BETA-LACTAMASE INHIBITOR WITH SPECIFIC BETA-LACTAM ANTIBIOTICS | CASAREZ ANTHONY | NOVARTIS AG |
| EP3700500 | NON-SOAP LIQUID CLEANSER COMPOSITION COMPRISING CAPRYLIC ACID | AGARKHED AJIT MANOHAR | UNILEVER PLC |
| EP3700502 | COMPOSITION COMPRISING A STRUCTURES AQUEOUS PHASE AND SERICIN | PATIL NIVEDITA JAGDISH | UNILEVER NV |
| EP3700506 | TOPICAL FORMULATIONS FOR TREATING DERMATOLOGICAL DISORDERS INCLUDING MALE PATTERN BALDNESS | HASSON VICTOR | TOPIRX THERAPEUTICS INC |
| EP3700507 | STABLE AQUEOUS SOLUTIONS COMPRISING PUFAS | ALEO DANILO | FOR HEALTH PHARMA S R L |
| EP3700510 | LIQUID FILLED FORMULATIONS OF PDE5 INHIBITORS | SCAMMELLS PETER JOHN | M W ENCAP LTD |
| EP3700890 | NEW ALCOXYAMINO DERIVATIVES FOR TREATING PAIN AND PAIN RELATED CONDITIONS | ALMANSA-ROSALES CARMEN | ESTEVE PHARMACEUTICALS SA |
| EP3700895 | POLYCYCLIC AMIDES AS MUSCARINIC M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS | NIROGI RAMAKRISHNA | SUVEN LIFE SCIENCES LTD |
| EP3700913 | PRODRUGS OF SUBSTITUTED TRIAZOLE DERIVATIVES AND USES THEREOF | COLLIN-KROEPELIN MARIE-PIERRE | BAYER AG |
| EP3700925 | NOVEL T-CELL RECEPTOR | SEWELL ANDREW | UNIV COLLEGE CARDIFF CONSULTANTS LTD |
| EP3701795 | MICROCAPSULE AND METHOD FOR PRODUCING THE SAME | SAITO HIROAKI | SHINETSU CHEMICAL CO |
| EP3701944 | ORODISPERSIBLE DOSAGE UNIT CONTAINING AN ESTETROL COMPONENT | JASPART SéVERINE FRANCINE ISABELLE | ESTETRA SPRL |
| EP3701959 | RNA REPLICON FOR VERSATILE AND EFFICIENT GENE EXPRESSION | BEISSERT TIM | BIONTECH RNA PHARMACEUTICALS GMBH |
| EP3703657 | SUCKABLE AND/OR MELT-IN-MOUTH TABLET BASED ON HYALURONIC ACID AND CHONDROITIN SULPHATE AND SALTS THEREOF FOR USE IN THE TREATMENT OF A SUBPOPULATION OF GERD PATIENTS | BIFFI ANDREA | SOFAR SWISS SA |
| EP3704082 | MULTINUCLEAR COMPLEXES AND THEIR PREPARATION | ROODT ANDREAS | UNIV FREE STATE |
| EP3704122 | FUSED TRIAZOLE AGONISTS OF THE APJ RECEPTOR | DRANSFIELD PAUL JOHN | AMGEN INC |
| EP3704134 | ANTIMICROBIAL TETRAPEPTIDES | HEIDL MARC | DSM IP ASSETS BV |
| EP3704146 | TRIFAB-CONTORSBODY | BRINKMANN ULRICH | HOFFMANN LA ROCHE |
| EP3705115 | COMPOSITION CONTAINING SELEXIPAG | GUJJAR CHAITANYA YOGANANDA | ALFRED E TIEFENBACHER (GMBH & CO KG) |
| EP3706796 | EXOSOMES COMPRISING RNA THERAPEUTICS | ERRICHELLI LORENZO | EVOX THERAPEUTICS LTD |
| EP3706871 | A HAIR CARE COMPOSITION COMPRISING SILK FIBROIN | CAO HAN | UNILEVER NV |
| EP3707133 | BTK INHIBITOR COMPOUNDS | HENRY KENNETH JAMES JR | LILLY CO ELI |
| EP3707140 | PURINE BASED COMPOUNDS AS TOLL-LIKE RECEPTOR 9 ANTAGONIST | TALUKDAR ARINDAM | COUNCIL SCIENT IND RES |
| EP3707141 | SUBSTITUTED 2,4-DIHYDRO-3H-1,2,4-TRIAZOL-3-ONES AND USE OF SAME | BIBER NICOLE | BAYER AG |
| EP3707142 | PYRROLOPYRAZINE DERIVATIVES AS ALPHA V INTEGRIN INHIBITORS | ZHAO GUOHUA | BRISTOL MYERS SQUIBB CO |
| EP3707229 | CYCLOHEXENE PROPANAL DERIVATIVES AS PERFUMING INGREDIENTS | QUINTAINE JULIE | FIRMENICH & CIE |
| EP3709957 | W/O EMULSION FOR IMPREGNATING NONWOVEN FABRIC | BALLEZ MIKE | DR SCHUMACHER GMBH |
| EP3709960 | HAIR CARE COMPOSITION | LIU JINGJING | UNILEVER NV |
| EP3710118 | EMULSION COMPRISING AN ANIONIC ACRYLIC COPOLYMER AND A LIPOPHILIC POLYMER | FAGEON LAURE | OREAL |
| EP3710438 | TRIAZOLE N-LINKED CARBAMOYL CYCLOHEXYL ACIDS AS LPA ANTAGONISTS | SHI YAN | BRISTOL MYERS SQUIBB CO |
| EP3710485 | ANTI-SEZ6 ANTIBODY DRUG CONJUGATES AND METHODS OF USE | LIU DAVID | ABBVIE STEMCENTRX LLC |
| EP3710513 | METHOD FOR MANUFACTURING A HYPERBRANCHED POLYESTER POLYOL DERIVATIVE | HAAG RAINER | FREIE UNIVERSITÄT BERLIN |
| EP3712148 | CRYSTAL FORM OF URAT1 INHIBITOR, AND PREPARATION METHOD THEREFOR | WANG JIANFEI | MEDSHINE DISCOVERY INC |
| EP3712152 | 4,5,6,7-TETRAHYDRO-1H-IMIDAZO[4,5-C]PYRIDINE AND 1,4,5,6,7,8-HEXAHYDROIMIDAZO[4,5-D]AZEPINE DERIVATIVES AS JANUS KINASE INHIBITORS | FYFE MATTHEW COLIN THOR | TOPIVERT PHARMA LTD |
| EP3712153 | PYRAZOLO[1,5-A]PYRAZIN-4-YL DERIVATIVES AS JAK-INHIBITORS | BROWN MATTHEW FRANK | PFIZER |
| EP3713546 | LIQUID FORMULATION COMPRISING PAEONOL AND APOCYNIN | LARKINS NICHOLAS JOHN | AKL RESEARCH&DEVELOPMENT LTD |
| EP3713923 | 2-PHENYLPYRIMIDINE-4-CARBOXAMIDES AS AHR INHIBITORS | LEFRANC JULIEN | BAYER AG |
| EP3713927 | PYRIDINONE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS | ARISTA LUCA | NOVARTIS AG |
| EP3713936 | SUBSTITUTED TRIFLUOROMETHYLOXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI | WIEBE CHRISTINE | BASF SE |
| EP3713939 | IMPROVED PROCESS FOR THE SYNTHESIS OF LINKER-DRUG VC-SECO | JANOUSEK VLADIMíR | BYONDIS BV |
| EP3714060 | PROCESS FOR THE PURIFICATION OF A SIALIC ACID FROM A FERMENTATION BROTH | JENNEWEIN STEFAN | JENNEWEIN BIOTECHNOLOGIE GMBH |
| EP3714897 | ARTIFICIAL SPUTUM, METHOD OF PRODUCING AN ARTIFICIAL SPUTUM | BEUTLER MARKUS | IMLRED GMBH |
| EP3715347 | PIPERIDIN-4-YL AZETIDINE DERIVATIVES AS JAK1 INHIBITORS | HUANG TAISHENG | INCYTE HOLDINGS CORP |
| EP3716935 | COSMETIC COMPOSITION FOR BLURRING SURFACE IMPERFECTIONS OF SKIN | HU QINGHONG | UNILEVER NV |
| EP3716970 | CORROLES FOR TREATING HUMAN CYTOMEGALOVIRUS INFECTIONS | GROS CLAUDE | UNIV BOURGOGNE |
| EP3716971 | CORROLES FOR TREATING POXVIRUS INFECTION | GROS CLAUDE | UNIV BOURGOGNE |
| EP3717025 | IMAGING AGENTS | MERCIER JOËL | UCB BIOPHARMA SRL |
| EP3717488 | SUBSTITUTED FURANOPYRIMIDINE COMPOUNDS AS PDE1 INHIBITORS | BOOKSER BRETT | DART NEUROSCIENCE LLC |
| EP3720412 | HAIR CARE COMPOSITION | FEI CONGWEI | UNILEVER NV |
| EP3720418 | NICOTINE TABLET | NIELSEN BRUNO PROVSTGAARD | FERTIN PHARMA AS |
| EP3720854 | SOLID PHASE SYNTHESIS OF NIR FLUORESCENT PROBE | CAMPANELLA RAPHAEL | BRACCO IMAGING SPA |
| EP3720855 | IMIDAZOPYRIDINE DERIVATIVES AND THE USE THEREOF AS MEDICAMENT | GIOVANNINI RICCARDO | BOEHRINGER INGELHEIM INT |
| EP3720857 | 2-OXO-5H-CHROMENO[4,3-B]PYRIDINES FOR USE IN THE TREATMENT OF HEPATITIS B | MAMMOLITI OSCAR | GALAPAGOS NV |
| EP3720862 | SYNTHESIS OF NOROXYMORPHONE | BOUDIER ANDREAS | SIEGFRIED AG |
| EP3721898 | SYNTHETIC PEPTIDES, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND USES THEREOF IN TREATING THROMBOEMBOLISM-RELATED DISEASES | WU HAN-CHUNG | |
| EP3721904 | FORMULATIONS OF T1H ANTIBODY | RAMANI KARTHIK | BIOCON LTD |
| EP3723709 | PERFUME MIXTURES CONTAINING 8,8-DIMETHYL-6,10-DIOXASPIRO[4,5]DECANE | HÖLSCHER BERND | SYMRISE AG |
| EP3723714 | PROPANEDIOL MONOACETATE MONONITRATE | MENDROK-EDINGER CHRISTINE | DSM IP ASSETS BV |
| EP3723718 | COSMETIC COMPOSITIONS COMPRISING SILICONE ELASTOMER AND EMOLLIENT | DOBKOWSKI BRIAN JOHN | UNILEVER NV |
| EP3723719 | NEW GLYCERYL POLYRHAMNOSIDES, PROCESS FOR THE PREPARATION THEREOF, AND COSMETIC AND/OR PHARMACEUTICAL COMPOSITION COMPRISING SAME | CATTUZZATO LAETITIA | SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC |
| EP3723721 | COMPLEX OF LACTOFERRIN AND SILICA, PROCESS FOR PREPARING AND COMPOSITIONS FOR ORAL HYGIENE | CISTERNAS CISTERNAS JASNA ISABEL | L I CO RICE S R L |
| EP3723777 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | YUILLE SAMANTHA | 4D PHARMA RES LTD |
| EP3723807 | COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES | KEHLER JAN | H LUNDBECK AS |
| EP3723808 | COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES | KEHLER JAN | H LUNDBECK AS |
| EP3723858 | FIXAXFX BISPECIFIC ANTIBODY WITH COMMON LIGHT CHAIN | WANG WEI | KYMAB LTD |
| EP3724173 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | J S KNUTSEN LARS | NMD PHARMA AS |
| EP3724203 | PREPARATION OF METAL-PYRIDINE DERIVATIVE COMPLEXES FOR USE IN MEDICAL IMAGING | KOZHEVNIKOV VALERY | UNIV OF NORTHUMBRIA AT NEWCASTLE |
| EP3725778 | FORMULATIONS OF ENZALUTAMIDE | LORENZ DOUGLAS ALAN | MEDIVATION PROSTATE THERAPEUTICS LLC |
| EP3725803 | BINDING MOLECULES THAT BIND HUMAN COMPLEMENT FACTOR C2B AND USES THEREOF | HACK CORNELIS ERIK | BROTEIO PHARMA B V |
| EP3727314 | DEODORANT COMPOSITIONS | COX DIANA SHEILA | UNILEVER PLC |
| EP3727315 | A TOPICAL COMPOSITION | AGARWAL KHUSHBU | UNILEVER NV |
| EP3727316 | A TOPICAL COMPOSITION BASED ON NIACINAMIDE DERIVATIVE | AGARWAL KHUSHBU | UNILEVER NV |
| EP3727448 | METHOD FOR MANUFACTURING MESOPOROUS SILICA NANOPARTICLES WITH ENCAPSULATED SUPERPARAMAGNETIC CLUSTERS | CORNE GAËLLE | LUXEMBOURG INST SCIENCE & TECH LIST |
| EP3727471 | A BODY FLUID LEAKAGE DETECTION AQUEOUS COMPOSITION | JOHANSSON HENRIK | MAGLE CHEMOSWED HOLDING AB |
| EP3727579 | HEATABLE IMPLANT DEVICE FOR TUMOR TREATMENT | DE CLERCK LUC | MEDICAL DEVELOPMENT TECH S A |
| EP3727602 | OIL-IN-WATER EMULSIFIED COSMETIC | KITAMURA MIYAKO | LVMH RECH |
| EP3728215 | PREPARATION OF RACEMIC NICOTINE BY REACTION OF ETHYL NICOTINATE WITH N-VINYLPYRROLIDONE IN THE PRESENCE OF AN ALCOHOLATE BASE AND SUBSEQUENT PROCESS STEPS | WEBER BEAT | SIEGFRIED AG |
| EP3728218 | AMINO INDOLE COMPOUNDS USEFUL AS TLR INHIBITORS | DYCKMAN ALARIC J | SQUIBB BRISTOL MYERS CO |
| EP3728246 | META TYROSINE DERIVATIVES AS RHO-KINASE INHIBITORS | ACCETTA ALESSANDRO | CHIESI FARM SPA |
| EP3728247 | OXADIAZOLE DERIVATIVES AS RHO-KINASE INHIBITORS | ACCETTA ALESSANDRO | CHIESI FARM SPA |
| EP3728261 | CO-CRYSTAL OF AN ORALLY AVAILABLE JANUS KINASE INHIBITOR | ENKELMANN DENNIS DIMO | SANDOZ AG |
| EP3728264 | DIAZAINDOLE COMPOUNDS | DYCKMAN ALARIC J | SQUIBB BRISTOL MYERS CO |
| EP3730154 | SMALL MOLECULE DRUG CONJUGATES | KRALL NIKOLAUS | EIDGENOESSICHE TECHNISCHE HOCHSCHULE ZUERICH |
| EP3730944 | CARDIAC TROPONIN I DETECTION DURING PREGNANCY FOR CARDIOVASCULAR DISEASE IDENTIFICATION AND RISK ASSESSMENT | BESHIRI AGIM | ABBOTT LAB |
| EP3731799 | NON-SPHERICAL MICROCAPSULE | JIN HUAJIN | UNILEVER NV |
| EP3731802 | NON-SPHERICAL MICROCAPSULE | JIN HUAJIN | UNILEVER NV |
| EP3731807 | METHOD TO PREPARE A FILLER WITH A HYALURONIC ACID BASE COMPRISING A NEUTRALIZATION STEP | ZERBINATI NICOLA | MATEX LAB S P A |
| EP3731815 | DRY POWDER KETAMINE COMPOSITION FOR USE IN THE TREATMENT OF DEPRESSION BY PULMONARY ADMINISTRATION | WIECZOREK MACIEJ | CELON PHARMA SA |
| EP3731872 | PROCESS FOR PROVIDING PEGYLATED PROTEIN COMPOSITION | KOEHNLEIN WOLFGANG | HOFFMANN LA ROCHE |
| EP3732177 | DIHYDROPYRIMIDINYLTHIAZOLE FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | HAN XINGCHUN | HOFFMANN LA ROCHE |
| EP3732277 | NON-SPHERICAL MICROCAPSULE | JIN HUAJIN | UNILEVER NV |
| EP3735178 | ULTRASOUND TRANSDUCER ACOUSTIC COUPLING | DEVADASAN DHILAN SKUKUNAN | KONINKLIJKE PHILIPS NV |
| EP3735985 | A NOVEL ORTHOBUNYAVIRUS IN HUMAN ENCEPHALITIS AND ITS DIAGNOSTIC AND THERAPEUTIC APPLICATIONS | ELOIT MARC | PASTEUR INSTITUT |
| EP3736267 | MODULATORS OF THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR PROTEIN AND METHODS OF USE | ALTENBACH ROBERT J | ABBVIE OVERSEAS SARL |
| EP3736270 | MODULATORS OF THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR PROTEIN AND METHODS OF USE | ALTENBACH ROBERT J | ABBVIE OVERSEAS SARL |
| EP3736296 | METHOD OF CROSSLINKING GLYCOSAMINOGLYCANS | AUZELY-VELTY RACHEL | GALDERMA RES & DEV |
| EP3737677 | TETRAHYDROISOQUINOLINE COMPOUNDS | VEGA GARCíA MIGUEL | ALLINKY BIOPHARMA |
| EP3737756 | METHODS AND SYSTEMS FOR SUPERCOILING DNA | KING GRAEME ALAN | STICHTING VU |
| EP3737765 | ENHANCED IMMUNE CELLS USING DUAL SHRNA AND COMPOSITION INCLUDING THE SAME | KIM CHAN HYUK | CUROCELL INC |
| EP3738993 | SLOW RELEASE OF INSECT REPELLENT COMPOUND | SCHAEFER SASCHA | HENKEL AG & CO KGAA |
| EP3740191 | OPHTHALMIC COMPOSITIONS COMPRISING BILASTINE, A BETA-CYCLODEXTRIN AND AT LEAST ONE GELLING AGENT | HERNáNDEZ HERRERO GONZALO | FAES FARMA SA |
| EP3740493 | INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN 2,3-DIOXYGENASE | BOSS CHRISTOPH | IDORSIA PHARMACEUTICALS LTD |
| EP3743037 | TRANSPARENT NANOEMULSIONS COMPRISING LAURIC OIL | QUAN CONGLING | UNILEVER PLC |
| EP3743038 | PROCESS FOR MAKING TRANSPARENT NANOEMULSIONS COMPRISING LAURIC OIL | QUAN CONGLING | UNILEVER PLC |
| EP3743064 | TREATMENT OF PROTEINURIA | JONASSEN THOMAS ENGELBRECHT NORDKILD | SYNACT PHARMA APS |
| EP3743420 | HETEROCYCLYLAMINO-SUBSTITUTED TRIAZOLES AS MODULATORS OF RHO-ASSOCIATED PROTEIN KINASE | JONES CLIFFORD D | REDX PHARMA PLC |
| EP3743508 | DEVICE FOR PRODUCING GLOBULES OF ADIPOSE TISSUE | MARTINELLI PAOLO ANTONIO | BH SWISS SA |
| EP3743721 | USE OF MINAPRINE TO REDUCE TUMOR GROWTH | PERFETTINI JEAN LUC | ROUSSY INST GUSTAVE |
| EP3744213 | COSMETIC | YAMANAKA REIKO | TAIKI CORP LTD |
| EP3744339 | FERMENTED EXTRACT OF AERIAL PARTS OF NEROLI | LEGANGNEUX DAVID | CHANEL PARFUMS BEAUTE |
| EP3745872 | A COMBINATION PRODUCT FOR PROPHYLAXIS AND TREATMENT OF IRRITABLE BOWEL SYNDROME | KIELY BARRY | PREC GROUP LIMITED |
| EP3746047 | INJECTABLE COMPOSITION | FRANCO RODRíGUEZ GUILLERMO | FARM ROVI LAB SA |
| EP3747508 | DNA ALKYLATING AGENTS FOR USE IN THE TREATMENT OF CANCER | DUAN JIAN-XIN | ASCENTA PHARMACEUTICALS LTD |
| EP3747999 | DNA MODIFYING FUSION PROTEINS AND METHODS OF USE THEREOF | JOUNG KEITH J | MASSACHUSETTS GEN HOSPITAL |
| EP3749278 | ORAL CARE COMPOSITION | DONG WENYAN | UNILEVER NV |
| EP3749296 | ESTERS OF HYDROXY-BENZOIC ACIDS FOR USE IN THE TREATMENT OF RHINOVIRUS | LINDBERG FREDRIK | ENZYMATICA AB |
| EP3749336 | WOUND TREATMENT GEL OBTAINABLE BY COMBINING PLATELET RICH PLASMA WITH AUTOLOGOUSLY DERIVED THROMBIN | HADFIELD JANET | BIOTHERAPY SERVICES LTD |
| EP3749670 | 5-ALKYLTHIO-7-[(4-ARYLBENZYL)AMINO]-1(2)H-PYRAZOLO[4,3-D]PYRIMIDINES FOR TREATMENT OF LYMPHOMA | HAVLICEK LIBOR | UNIV PALACKEHO |
| EP3752124 | FUEL INCLUDING POLY-OXYGENATED METAL HYDROXIDE | WOODMANSEE JOHN W JR | HEMOTEK LLC |
| EP3752129 | MULTI-USE TORASEMIDE COMPOSITION | MOREAU MARINETTE | VETOQUINOL SA |
| EP3752131 | CONTINUOUS PROCESS FOR COATING LIPOSOMIAL VECTORS WITH POLYMER | BARBA ANNA ANGELA | ENG4LIFE S R L |
| EP3752132 | PHARMACEUTICAL COMPOSITION OF BRIGATINIB | MARTIN NOLWENN | SANDOZ AG |
| EP3752513 | BINUCLEAR PALLADACYCLES AND THEIR USE IN THE TREATMENT OF CANCER | BLANCKENBERG ANGELIQUE | UNIV STELLENBOSCH |
| EP3755373 | ORAL SOLUTIONS COMPRISING TRAMADOL | PANAGIOTOPOULOS TSAMPIKOS DIMITRIOS | LABOSERVE PHARMACEUTICAL COMPANY S A |
| EP3755383 | TRICARBONYL COMPLEXES OF TRANSITION METALS WITH BENZO-HETEROCYCLIC DERIVATIVES OF THE CYCLOPENTADIENYL ANION | MAVROIDI BARBARA | NATIONAL CENTER FOR SCIENT RESEARCH DEMOKRITOS |
| EP3758685 | CAPSULES WITH OPACIFIER | PALANGETIC LJILJANA | CAPSUGEL BELGIUM NV |
| EP3760633 | OXAZINO-QUINAZOLINE AND OXAZINO-QUINAZOLINE TYPE COMPOUND, PREPARATION METHOD THEREFOR, AND USES THEREOF | ZHANG QIANG | BEIJING SCITECH MQ PHARMACEUTICALS LTD |
| EP3762380 | PHENYLPYRROLIDINONE FORMYL PEPTIDE 2 RECEPTOR AGONISTS | SHIRUDE PRAVIN SUDHAKAR | SQUIBB BRISTOL MYERS CO |
| EP3763712 | INDOLIZINE COMPOUNDS, PREPARATION METHOD AND USE THEREOF | CHEN XUXING | SHANGHAI HAIHE PHARMACEUTICAL CO LTD |
| EP3763820 | RETROVIRAL TRANSDUCTION USING POLOXAMERS | ANASTASOV NATASA | HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM GESUNDHEIT & UMWELT GMBH |
| EP3764975 | A SANITIZER COMPOSITION | BAPAT MOHINI ANAND | UNILEVER NV |
| EP3764983 | A SUSTAINED RELEASE FORMULATION COMPRISING ACEMETACIN WITH BIMODAL IN VITRO RELEASE | YILDIRIM ERSIN | SANTA FARMA ILAC SANAYI A S |
| EP3764984 | HIGHLY STABLE FORMULATIONS OF THYROID HORMONE IN SOFT CAPSULES | CARUCCI SIMONE | ALTERGON SA |
| EP3765084 | PREPARATION BASED ON INTERPENETRATING POLYMER NETWORKS FOR WOUND HEALING | POLAKOVA LENKA | USTAV MAKROMOLEKULARNI CHEMIE AV CR V V I |
| EP3765475 | SUBSTITUTED PYRIDOPYRROLOPYRIMIDINE RIBONUCLEOSIDES FOR THERAPEUTIC USES | VESELOVSKA LUCIA | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I |
| EP3766484 | SOLID PHARMACEUTICAL DOSAGE FORM COMPRISING VALSARTAN AND SACUBITRIL | SEDMAK GREGOR | ZENTIVA KS |
| EP3768241 | TOPICAL COMPOSITION | CRUTCHLEY NIGEL | MC2 THERAPEUTICS LTD |
| EP3768246 | SAPOSIN C PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING CANCER | MONSON ELLEN K | BEXION PHARMACEUTICALS INC |
| EP3769753 | PROCESS FOR THE PREPARATION OF STERILE OPHTHALMIC AQUEOUS FLUTICASONE PROPIONATE FORM A NANOCRYSTALS SUSPENSIONS | BUKOWSKI JEAN-MICHEL | NICOX OPHTHALMICS INC |
| EP3773012 | COMPOSITION FOR USE IN PREVENTION OR REDUCTION OF OXIDATIVE STRESS AND NEURODEGENERATIVE DISEASES | RASI SIMO | RASI SIMO |
| EP3773422 | NANOEMULSIONS AND A METHOD FOR MAKING THE SAME | LOU ANJING | UNILEVER PLC |
| EP3773428 | ANTIPERSPIRANT PRODUCTS | ASKEM HARRIET JADE | UNILEVER PLC |
| EP3773429 | MICROCAPSULES FOR USE IN COSMETIC COMPOSITIONS | JIN HUAJIN | UNILEVER NV |
| EP3773433 | NON-ALUMINIUM ANTIPERSPIRANT COMPOSITIONS | ZDRAVKOVA ANELIYA NIKOLOVA | UNILEVER PLC |
| EP3773457 | PERSONAL CLEANSING COMPOSITION | COOK JOANNE LOUISE | UNILEVER PLC |
| EP3773463 | SKIN CARE KIT | LIU JIANFEI | UNILEVER NV |
| EP3773496 | ORAL POUCHED PRODUCT | STAHL MY LY LAO | NCP NEXTGEN AS |
| EP3773737 | SAPONIN CONJUGATED TO EPITOPE-BINDING PROTEINS | POSTEL RUBEN | SAPREME TECH BV |
| EP3773925 | ORAL CARE COMPOSITION BASED ON CALCIUM PHOSPHATE POLYIONIC CLUSTERS | LI XIAOKE | UNILEVER NV |
| EP3773926 | ORAL CARE COMPOSITION | ANACHKOV SVETOSLAV EMILOV | UNILEVER NV |
| EP3774823 | POLYMORPH OF SODIUM NERIDRONATE AND PREPARATION PROCESS THEREOF | DINI LAURA | ABIOGEN PHARMA SPA |
| EP3777841 | LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE AND SOLID PREPARATION | OGURO TSUBASA | SHINETSU CHEMICAL CO |
| EP3778595 | PANCREATITIS TREATMENT | VELICELEBI GONUL | CALCIMEDICA INC |
| EP3781601 | CROSS-LINKED STARCH-BASED POLYMERS FOR DRUG-DELIVERY | TROTTA FRANCESCO | ROQUETTE FRERES |
| EP3800251 | PEPTIDE HAVING ACCUMULATION SPECIFIC TO PANCREATIC CANCER, AND USE OF SAID PEPTIDE | KONDO EISAKU | UNIV NIIGATA |
| EP3800252 | PEPTIDE HAVING ACCUMULATION SPECIFIC TO PANCREATIC CANCER, AND USE OF SAID PEPTIDE | KONDO EISAKU | UNIV NIIGATA |
| EP3800270 | NOVEL BIOMARKER FOR PREDICTING SENSITIVITY TO MET INHIBITOR, AND USE THEREOF | JIN DONG HOON | WELLMARKER BIO CO LTD |
| EP3801774 | ENHANCED STABILITY OF ZINC PYRITHIONE IN OXIDATIVE ENVIRONMENTS, SUCH AS SCALP SEBACEOUS FLUID | BREYFOGLE LAURIE ELLEN | PROCTER & GAMBLE |
| EP3806818 | HYDROPHILIC CYCLODEXTRIN-CONTAINING SILICONE GELS | BURKE SARAH | WACKER CHEMIE AG |
| EP3811927 | A STABLE PARENTERAL DOSAGE FORM OF CETRORELIX ACETATE | JOSHI JAYDIP | SUN PHARMACEUTICAL IND LTD |
| EP3813762 | STABILIZED AMORPHOUS CALCIUM PHOSPHATE DOPED WITH FLUORIDE IONS AND A PROCESS FOR PRODUCING THE SAME | IAFISCO MICHELE | CURASEPT A D S S R L |
| EP3818086 | TREATMENT AND PREVENTION OF CANCER USING HER3 ANTIGEN-BINDING MOLECULES | BOYD-KIRKUP JEROME DOUGLAS | HUMMINGBIRD BIOSCIENCE HOLDINGS PTE LTD |
| EP3820439 | MUCOADHESIVE DISPERSION NANOPARTICLE SYSTEM AND METHOD FOR PRODUCTION THE SAME | TZACHEV CHRISTO TZACHEV | LEAD BIOTHERAPEUTICS LTD |
| EP3820446 | PHARMACEUTICAL COMPOSITIONS COMPRISING RPL554 IN HFA-134A FOR ADMINISTRATION BY INHALATION | SPARGO PETER LIONEL | VERONA PHARMA PLC |
| EP3833434 | COMPOUNDS USEFUL IN MODULATING THE FARNESOID X RECEPTOR AND METHODS OF MAKING AND USING THE SAME | SHARMA RAJIV | INORBIT THERAPEUTICS AB |
| EP3880654 | 2-FORMYL-3-HYDROXYPHENYLOXYMETHYL COMPOUNDS CAPABLE OF MODULATING HEMOGLOBIN | LI ZHE | GLOBAL BLOOD THERAPEUTICS INC |
https://blog.sciencenet.cn/blog-681765-1359826.html
上一篇：2021年生活和运动用品领域在欧专利的布局与竞争——耐克创新公司、菲利蒲莫里斯公司、博西家用电器有限公司领先
下一篇：2021年医学诊断与外科领域在欧专利的布局与竞争——皇家飞利浦、柯惠、爱惜康公司领先，国内上海联影医疗科技有限公司领先
扫一扫，分享此博文
全部作者的精选博文
全部作者的其他最新博文
- • 2023年细分技术领域下中国局专利的发展竞争态势——广东、北京、江苏领先
- • 2023年半导体器件（H01L）类的中国局专利的发展态势及竞争——我国半导体技术研发有待加强
- • 2023年数字信息传输（H04L）类的中国局专利的发展态势及竞争——通信技术研发逐渐放缓
- • 2023年数据处理（G06F）类的中国局专利的发展竞争态势——增长54%、我国信息化技术水平较高，创新能力较强
- • 2023年韩国在华专利的技术领域状况——半导体、光学、电池、显示技术较强，计算机软件、人工智能、电子商务技术较弱
- • 2023年德国在华专利的技术领域状况——机械、汽车、电气等传统技术方面有优势，计算机等新兴技术方面处于劣势